Citrus Sinensis ID: 024809
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 262 | 2.2.26 [Sep-21-2011] | |||||||
| A2YNT8 | 339 | Serine/threonine-protein | N/A | no | 0.992 | 0.766 | 0.781 | 1e-117 | |
| Q0D4J7 | 339 | Serine/threonine-protein | yes | no | 0.992 | 0.766 | 0.777 | 1e-116 | |
| Q75LR7 | 342 | Serine/threonine-protein | no | no | 0.992 | 0.760 | 0.768 | 1e-116 | |
| Q02066 | 332 | Abscisic acid-inducible p | N/A | no | 0.996 | 0.786 | 0.767 | 1e-113 | |
| Q940H6 | 362 | Serine/threonine-protein | yes | no | 0.923 | 0.668 | 0.741 | 1e-107 | |
| Q9M9E9 | 343 | Serine/threonine-protein | no | no | 0.839 | 0.641 | 0.808 | 1e-105 | |
| Q75H77 | 362 | Serine/threonine-protein | no | no | 0.851 | 0.616 | 0.786 | 1e-105 | |
| Q75V57 | 361 | Serine/threonine-protein | no | no | 0.851 | 0.617 | 0.777 | 1e-104 | |
| P0C5D6 | 334 | Serine/threonine-protein | no | no | 0.961 | 0.754 | 0.699 | 1e-103 | |
| A2ZAB5 | 334 | Serine/threonine-protein | N/A | no | 0.961 | 0.754 | 0.699 | 1e-103 |
| >sp|A2YNT8|SAPK2_ORYSI Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. indica GN=SAPK2 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 421 bits (1082), Expect = e-117, Method: Compositional matrix adjust.
Identities = 207/265 (78%), Positives = 229/265 (86%), Gaps = 5/265 (1%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEYAAGGELFERIC+AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS A
Sbjct: 77 MEYAAGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSIA 136
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
PR+KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL +KEYDGK+ADVWSCGVTLYVMLVG
Sbjct: 137 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLARKEYDGKVADVWSCGVTLYVMLVG 196
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
AYPFEDP++P+NFRKTI RILSV Y PDYVRVS+EC+HLLSRIFVAN E+RITIPEIKN
Sbjct: 197 AYPFEDPDEPRNFRKTITRILSVQYMVPDYVRVSMECRHLLSRIFVANPEQRITIPEIKN 256
Query: 181 HPWFLRNLPIELTE--GGSWQSHDVNNPSQSLEEVLSLIHEATKPLEAPRVGGHLLG-SS 237
HPWFL+NLPIE+T+ S Q +D+N PSQ LEE++++I EA KP + + G + G S
Sbjct: 257 HPWFLKNLPIEMTDEYQMSVQMNDINTPSQGLEEIMAIIQEARKPGDGSKFSGQIPGLGS 316
Query: 238 MELDDLDADADLEDTETSGDFVCPL 262
MEL D D D D E SGDFVC L
Sbjct: 317 MEL--DDIDTDDIDVEDSGDFVCAL 339
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. indica (taxid: 39946) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q0D4J7|SAPK2_ORYSJ Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. japonica GN=SAPK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 418 bits (1074), Expect = e-116, Method: Compositional matrix adjust.
Identities = 206/265 (77%), Positives = 229/265 (86%), Gaps = 5/265 (1%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEYAAGGELFERIC+AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS A
Sbjct: 77 MEYAAGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSIA 136
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
PR+KICDFGYSKSS+LHSQPKSTVGTPAYIAPEVL +KEYDGK+ADVWSCGVTLYVMLVG
Sbjct: 137 PRLKICDFGYSKSSLLHSQPKSTVGTPAYIAPEVLARKEYDGKVADVWSCGVTLYVMLVG 196
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
AYPFEDP++P+NFRKTI RILSV Y PDYVRVS+EC+HLLSRIFVAN E+RITIPEIKN
Sbjct: 197 AYPFEDPDEPRNFRKTITRILSVQYMVPDYVRVSMECRHLLSRIFVANPEQRITIPEIKN 256
Query: 181 HPWFLRNLPIELTE--GGSWQSHDVNNPSQSLEEVLSLIHEATKPLEAPRVGGHLLG-SS 237
HPWFL+NLPIE+T+ S Q +D+N PSQ LEE++++I EA KP + + G + G S
Sbjct: 257 HPWFLKNLPIEMTDEYQMSVQMNDINTPSQGLEEIMAIIQEARKPGDGSKFSGQIPGLGS 316
Query: 238 MELDDLDADADLEDTETSGDFVCPL 262
MEL D D D D E SGDFVC L
Sbjct: 317 MEL--DDVDTDDIDVEDSGDFVCAL 339
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q75LR7|SAPK1_ORYSJ Serine/threonine-protein kinase SAPK1 OS=Oryza sativa subsp. japonica GN=SAPK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 416 bits (1070), Expect = e-116, Method: Compositional matrix adjust.
Identities = 206/268 (76%), Positives = 226/268 (84%), Gaps = 8/268 (2%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ+CHRDLKLENTLLDGS
Sbjct: 77 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSVT 136
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
PR+KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL++KEYDGK+ADVWSCGVTLYVMLVG
Sbjct: 137 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLSRKEYDGKVADVWSCGVTLYVMLVG 196
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
AYPFEDP+DP+NFRKTI RILSV YS PDYVRVS +C+HLLSRIFV N E+RITIPEIKN
Sbjct: 197 AYPFEDPDDPRNFRKTITRILSVQYSIPDYVRVSADCRHLLSRIFVGNPEQRITIPEIKN 256
Query: 181 HPWFLRNLPIELTE--GGSWQSHDVNNPSQSLEEVLSLIHEATKPLEAPRVGG----HLL 234
HPWFL+NLPIE+T+ S Q D+N PSQSLEEV+++I EA KP +A ++ G L
Sbjct: 257 HPWFLKNLPIEMTDEYQRSMQLADMNTPSQSLEEVMAIIQEARKPGDAMKLAGAGQVACL 316
Query: 235 GSSMELDDLDADADLEDTETSGDFVCPL 262
GS D D D E SGDFVC L
Sbjct: 317 GSMDLD--DIDDIDDIDIENSGDFVCAL 342
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q02066|AAIP_WHEAT Abscisic acid-inducible protein kinase (Fragment) OS=Triticum aestivum PE=2 SV=1 | Back alignment and function description |
|---|
Score = 408 bits (1049), Expect = e-113, Method: Compositional matrix adjust.
Identities = 205/267 (76%), Positives = 233/267 (87%), Gaps = 6/267 (2%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEYA+GGELF+RICNAGRFSEDE RFFFQQLISGVSYCHSMQ+CHRDLKLENTLLDGS A
Sbjct: 67 MEYASGGELFQRICNAGRFSEDEGRFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSVA 126
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
PR+KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL+++EYDGK+ADVWSCGVTLYVMLVG
Sbjct: 127 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLSRREYDGKVADVWSCGVTLYVMLVG 186
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
AYPFEDP++P+NFRKTI RILSV YS PDYVRVS++C HLLSRIFV N ++RITIPEIKN
Sbjct: 187 AYPFEDPDEPRNFRKTITRILSVQYSVPDYVRVSMDCIHLLSRIFVGNPQQRITIPEIKN 246
Query: 181 HPWFLRNLPIELTE--GGSWQSHDVNNPSQSLEEVLSLIHEATKPLE-APRVGGHL--LG 235
HPWFL+ LP+E+T+ S Q D+N PSQSLEE +++I EA KP + A V G + LG
Sbjct: 247 HPWFLKRLPVEMTDEYQRSMQLADMNTPSQSLEEAMAIIQEAQKPGDNALGVAGQVACLG 306
Query: 236 SSMELDDLDADADLEDTETSGDFVCPL 262
SM+LDD+D D D D E+SGDFVCPL
Sbjct: 307 -SMDLDDIDFDIDDIDVESSGDFVCPL 332
|
Involved in water-stress responses. Triticum aestivum (taxid: 4565) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q940H6|SRK2E_ARATH Serine/threonine-protein kinase SRK2E OS=Arabidopsis thaliana GN=SRK2E PE=1 SV=1 | Back alignment and function description |
|---|
Score = 387 bits (994), Expect = e-107, Method: Compositional matrix adjust.
Identities = 181/244 (74%), Positives = 208/244 (85%), Gaps = 2/244 (0%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEYA+GGELFERICNAGRFSEDEARFFFQQLISGVSYCH+MQ+CHRDLKLENTLLDGS A
Sbjct: 94 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 153
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
PR+KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL KKEYDGK+ADVWSCGVTLYVMLVG
Sbjct: 154 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
AYPFEDPE+PKNFRKTI RIL+V Y+ PDYV +S EC+HL+SRIFVA+ KRI+IPEI+N
Sbjct: 214 AYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 273
Query: 181 HPWFLRNLPIELTEGGSW--QSHDVNNPSQSLEEVLSLIHEATKPLEAPRVGGHLLGSSM 238
H WFL+NLP +L + Q + + P QS+EE++ +I EAT P + H L S+
Sbjct: 274 HEWFLKNLPADLMNDNTMTTQFDESDQPGQSIEEIMQIIAEATVPPAGTQNLNHYLTGSL 333
Query: 239 ELDD 242
++DD
Sbjct: 334 DIDD 337
|
Activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as stomata closure in response to drought, plant pathogens, or decreases in atmospheric relative humidity (RH). Involved in the resistance to drought by avoiding water loss. Required for the stomata closure mediated by pathogen-associated molecular pattern (PAMPs) (e.g. flg22 and LPS) of pathogenic bacteria such as P.syringae pv. tomato (Pst) and E.coli O157:H7. As a plant defense process, stomata are closed transiently in order to limit invaders, but actively reopened by bacteria after a few hours; virulent strains (e.g. Pst DC3000) are more efficient than avirulent strains (e.g. Pst DC3000 AvrRpt2) in reopening stomata. Mediates the phosphorylation and activation of the S-type anion efflux channel SLAC1, and thus promotes stomata closure. Essential for stomatal closure in response to reactive oxygen species (ROS). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M9E9|SRK2C_ARATH Serine/threonine-protein kinase SRK2C OS=Arabidopsis thaliana GN=SRK2C PE=1 SV=1 | Back alignment and function description |
|---|
Score = 381 bits (978), Expect = e-105, Method: Compositional matrix adjust.
Identities = 182/225 (80%), Positives = 200/225 (88%), Gaps = 5/225 (2%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEYAAGGELF RIC+AGRFSEDEARFFFQQLISGV+YCHS+QICHRDLKLENTLLDGS A
Sbjct: 77 MEYAAGGELFGRICSAGRFSEDEARFFFQQLISGVNYCHSLQICHRDLKLENTLLDGSEA 136
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
PRVKICDFGYSKS VLHSQPK+TVGTPAYIAPEVL+ KEYDGKIADVWSCGVTLYVMLVG
Sbjct: 137 PRVKICDFGYSKSGVLHSQPKTTVGTPAYIAPEVLSTKEYDGKIADVWSCGVTLYVMLVG 196
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
AYPFEDP DPK+FRKTIGRIL Y+ PDYVRVS EC+HLLSRIFVAN EKRITI EIKN
Sbjct: 197 AYPFEDPSDPKDFRKTIGRILKAQYAIPDYVRVSDECRHLLSRIFVANPEKRITIEEIKN 256
Query: 181 HPWFLRNLPIELTEGGSWQSHDVNNPS-QSLEEVLSLIHEATKPL 224
H WFL+NLP+E+ EG S +N PS Q++EE++ +I EA KP+
Sbjct: 257 HSWFLKNLPVEMYEG----SLMMNGPSTQTVEEIVWIIEEARKPI 297
|
Involved in gene regulation and confers tolerance to drought and osmotic stress. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q75H77|SAPKA_ORYSJ Serine/threonine-protein kinase SAPK10 OS=Oryza sativa subsp. japonica GN=SAPK10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 380 bits (975), Expect = e-105, Method: Compositional matrix adjust.
Identities = 177/225 (78%), Positives = 198/225 (88%), Gaps = 2/225 (0%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEYA+GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ+CHRDLKLENTLLDGSTA
Sbjct: 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSTA 155
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
PR+KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL KKEYDGKIADVWSCGVTLYVMLVG
Sbjct: 156 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
AYPFEDP++PKNFRKTI RIL V YS PDYV +S EC+ L++RIFVAN RI+IPEI+N
Sbjct: 216 AYPFEDPDEPKNFRKTIQRILGVQYSIPDYVHISPECRDLIARIFVANPATRISIPEIRN 275
Query: 181 HPWFLRNLPIELTEGG--SWQSHDVNNPSQSLEEVLSLIHEATKP 223
HPWFL+NLP +L + S Q + P QS++E++ ++ EAT P
Sbjct: 276 HPWFLKNLPADLMDDSKMSSQYEEPEQPMQSMDEIMQILAEATIP 320
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q75V57|SAPK9_ORYSJ Serine/threonine-protein kinase SAPK9 OS=Oryza sativa subsp. japonica GN=SAPK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 379 bits (972), Expect = e-104, Method: Compositional matrix adjust.
Identities = 175/225 (77%), Positives = 198/225 (88%), Gaps = 2/225 (0%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEYA+GGELFERIC+AGRFSEDEARFFFQQLISGVSYCHSMQ+CHRDLKLENTLLDGSTA
Sbjct: 95 MEYASGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSTA 154
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
PR+KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL KKEYDGKIADVWSCGVTLYVMLVG
Sbjct: 155 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 214
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
AYPFEDPEDPKNFRKTI +IL V YS PDYV +S EC+ L++RIFV N RIT+PEIKN
Sbjct: 215 AYPFEDPEDPKNFRKTIQKILGVQYSIPDYVHISPECRDLITRIFVGNPASRITMPEIKN 274
Query: 181 HPWFLRNLPIELTEGG--SWQSHDVNNPSQSLEEVLSLIHEATKP 223
HPWF++N+P +L + G S Q + + P Q++ E++ ++ EAT P
Sbjct: 275 HPWFMKNIPADLMDDGMVSNQYEEPDQPMQNMNEIMQILAEATIP 319
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P0C5D6|SAPK3_ORYSJ Serine/threonine-protein kinase SAPK3 OS=Oryza sativa subsp. japonica GN=SAPK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 373 bits (958), Expect = e-103, Method: Compositional matrix adjust.
Identities = 179/256 (69%), Positives = 208/256 (81%), Gaps = 4/256 (1%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEYAAGGELFE+IC AGRFSEDEAR+FFQQLISGVSYCHS++ICHRDLKLENTLLDGS
Sbjct: 78 MEYAAGGELFEQICTAGRFSEDEARYFFQQLISGVSYCHSLEICHRDLKLENTLLDGSPT 137
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
PRVKICDFGYSKS++LHS+PKSTVGTPAYIAPEVL++KEYDGK+ADVWSCGVTLYVMLVG
Sbjct: 138 PRVKICDFGYSKSALLHSKPKSTVGTPAYIAPEVLSRKEYDGKVADVWSCGVTLYVMLVG 197
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
+YPFEDP DP+NFRKTI RIL V YS PDYVRVS +C+ LLS+IFVA+ KRITIPEIK
Sbjct: 198 SYPFEDPGDPRNFRKTISRILGVQYSIPDYVRVSSDCRRLLSQIFVADPSKRITIPEIKK 257
Query: 181 HPWFLRNLPIELT--EGGSWQSHDVNNPSQSLEEVLSLIHEATKPLEAPRVGGHLLGSSM 238
H WFL+NLP E++ E ++ D P+Q++EE++ +I EA P + LL
Sbjct: 258 HTWFLKNLPKEISEREKADYKDTDAAPPTQAVEEIMRIIQEAKVPGDMAAADPALLAELA 317
Query: 239 EL--DDLDADADLEDT 252
EL DD + AD DT
Sbjct: 318 ELKSDDEEEAADEYDT 333
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2ZAB5|SAPK3_ORYSI Serine/threonine-protein kinase SAPK3 OS=Oryza sativa subsp. indica GN=SAPK3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 373 bits (958), Expect = e-103, Method: Compositional matrix adjust.
Identities = 179/256 (69%), Positives = 208/256 (81%), Gaps = 4/256 (1%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEYAAGGELFE+IC AGRFSEDEAR+FFQQLISGVSYCHS++ICHRDLKLENTLLDGS
Sbjct: 78 MEYAAGGELFEQICTAGRFSEDEARYFFQQLISGVSYCHSLEICHRDLKLENTLLDGSPT 137
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
PRVKICDFGYSKS++LHS+PKSTVGTPAYIAPEVL++KEYDGK+ADVWSCGVTLYVMLVG
Sbjct: 138 PRVKICDFGYSKSALLHSKPKSTVGTPAYIAPEVLSRKEYDGKVADVWSCGVTLYVMLVG 197
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
+YPFEDP DP+NFRKTI RIL V YS PDYVRVS +C+ LLS+IFVA+ KRITIPEIK
Sbjct: 198 SYPFEDPGDPRNFRKTISRILGVQYSIPDYVRVSSDCRRLLSQIFVADPSKRITIPEIKK 257
Query: 181 HPWFLRNLPIELT--EGGSWQSHDVNNPSQSLEEVLSLIHEATKPLEAPRVGGHLLGSSM 238
H WFL+NLP E++ E ++ D P+Q++EE++ +I EA P + LL
Sbjct: 258 HTWFLKNLPKEISEREKADYKDTDAAPPTQAVEEIMRIIQEAKVPGDMAAADPALLAELA 317
Query: 239 EL--DDLDADADLEDT 252
EL DD + AD DT
Sbjct: 318 ELKSDDEEEAADEYDT 333
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 262 | ||||||
| 357489739 | 339 | Serine-threonine protein kinase [Medicag | 0.996 | 0.769 | 0.846 | 1e-130 | |
| 356500711 | 338 | PREDICTED: serine/threonine-protein kina | 1.0 | 0.775 | 0.870 | 1e-128 | |
| 255545790 | 338 | Serine/threonine-protein kinase SAPK1, p | 1.0 | 0.775 | 0.870 | 1e-128 | |
| 356552912 | 338 | PREDICTED: serine/threonine-protein kina | 1.0 | 0.775 | 0.862 | 1e-127 | |
| 224066977 | 337 | predicted protein [Populus trichocarpa] | 0.996 | 0.774 | 0.885 | 1e-127 | |
| 356500713 | 346 | PREDICTED: serine/threonine-protein kina | 1.0 | 0.757 | 0.844 | 1e-126 | |
| 224082109 | 343 | predicted protein [Populus trichocarpa] | 1.0 | 0.763 | 0.865 | 1e-125 | |
| 359492886 | 335 | PREDICTED: serine/threonine-protein kina | 0.988 | 0.773 | 0.816 | 1e-122 | |
| 11138330 | 325 | putative serine/threonine kinase GDBrPK | 0.988 | 0.796 | 0.816 | 1e-122 | |
| 359480471 | 338 | PREDICTED: serine/threonine-protein kina | 0.992 | 0.769 | 0.825 | 1e-120 |
| >gi|357489739|ref|XP_003615157.1| Serine-threonine protein kinase [Medicago truncatula] gi|355516492|gb|AES98115.1| Serine-threonine protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 469 bits (1207), Expect = e-130, Method: Compositional matrix adjust.
Identities = 221/261 (84%), Positives = 239/261 (91%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEYAAGGELFERIC+AGRFSEDEARFFFQQLISGVSYCHSM ICHRDLKLENTLLDGSTA
Sbjct: 77 MEYAAGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMLICHRDLKLENTLLDGSTA 136
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG
Sbjct: 137 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 196
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
AYPFEDP DPK+F+KTI +ILSV Y PD+VRVS EC +LLS+IFVAN EKRITIPEIKN
Sbjct: 197 AYPFEDPADPKDFKKTISKILSVQYKVPDFVRVSPECINLLSQIFVANPEKRITIPEIKN 256
Query: 181 HPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHEATKPLEAPRVGGHLLGSSMEL 240
HPWFLRNLP+EL EGGSWQS+DVNNPSQS++EVLS++ EA KPL P++GG L SM+L
Sbjct: 257 HPWFLRNLPVELMEGGSWQSNDVNNPSQSVDEVLSILQEARKPLNNPKIGGLLSVGSMDL 316
Query: 241 DDLDADADLEDTETSGDFVCP 261
D+ D DADLED ET GDF+CP
Sbjct: 317 DEFDLDADLEDIETFGDFMCP 337
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356500711|ref|XP_003519175.1| PREDICTED: serine/threonine-protein kinase SAPK2-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 464 bits (1193), Expect = e-128, Method: Compositional matrix adjust.
Identities = 228/262 (87%), Positives = 246/262 (93%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEYA+GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA
Sbjct: 77 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 136
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT+KEYDGKIADVWSCGVTLYVMLVG
Sbjct: 137 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTRKEYDGKIADVWSCGVTLYVMLVG 196
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
AYPFEDP DP+NF+KTIG+ILSV YS PDYVRVS+EC+HLLS+IFVA+ EKRITIPEIKN
Sbjct: 197 AYPFEDPADPRNFKKTIGKILSVQYSVPDYVRVSMECRHLLSQIFVASPEKRITIPEIKN 256
Query: 181 HPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHEATKPLEAPRVGGHLLGSSMEL 240
HPWFLRNLP+ELTEGGSWQ +DVNNPSQ++EEVLS+I EA K L P+VGG L G SM+L
Sbjct: 257 HPWFLRNLPMELTEGGSWQMNDVNNPSQNVEEVLSIIQEARKSLNVPKVGGLLTGGSMDL 316
Query: 241 DDLDADADLEDTETSGDFVCPL 262
DD DAD DLED ETSG+FVCP+
Sbjct: 317 DDFDADEDLEDLETSGEFVCPI 338
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255545790|ref|XP_002513955.1| Serine/threonine-protein kinase SAPK1, putative [Ricinus communis] gi|223547041|gb|EEF48538.1| Serine/threonine-protein kinase SAPK1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 462 bits (1189), Expect = e-128, Method: Compositional matrix adjust.
Identities = 228/262 (87%), Positives = 244/262 (93%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEYAAGGELFERI NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA
Sbjct: 77 MEYAAGGELFERISNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 136
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
PRVKICDFGYSKS+VLHSQPKSTVGTPAYIAPEVL+KKEYDGKIADVWSCGVTLYVML+G
Sbjct: 137 PRVKICDFGYSKSTVLHSQPKSTVGTPAYIAPEVLSKKEYDGKIADVWSCGVTLYVMLIG 196
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
AYPFEDP+DPKNFRKTIGRILSVHYS PDYVRVS+ECKHLLSRIFV N EKRI+IPEIK+
Sbjct: 197 AYPFEDPDDPKNFRKTIGRILSVHYSIPDYVRVSIECKHLLSRIFVVNPEKRISIPEIKD 256
Query: 181 HPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHEATKPLEAPRVGGHLLGSSMEL 240
HPWFL+NLPIEL EGGS QSHDVNNPSQ++EEV+S+I EA K + P+ G +LL SM+L
Sbjct: 257 HPWFLKNLPIELMEGGSCQSHDVNNPSQNIEEVVSIIQEARKAVVLPKSGNNLLEGSMDL 316
Query: 241 DDLDADADLEDTETSGDFVCPL 262
DD DADAD ED ETSGDFVCPL
Sbjct: 317 DDADADADCEDIETSGDFVCPL 338
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356552912|ref|XP_003544806.1| PREDICTED: serine/threonine-protein kinase SAPK2-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 461 bits (1186), Expect = e-127, Method: Compositional matrix adjust.
Identities = 226/262 (86%), Positives = 246/262 (93%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEYA+GGELFERICNAGRFSEDEARFFFQQL+SGVSYCHSMQICHRDLKLENTLLDGSTA
Sbjct: 77 MEYASGGELFERICNAGRFSEDEARFFFQQLVSGVSYCHSMQICHRDLKLENTLLDGSTA 136
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT+KEYDGK+ADVWSCGVTLYVMLVG
Sbjct: 137 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTRKEYDGKVADVWSCGVTLYVMLVG 196
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
AYPFEDPEDP+NF+KTIG+ILSV YS PDYVRVS+EC+HLLS+IFVA+ EKRI IPEIKN
Sbjct: 197 AYPFEDPEDPRNFKKTIGKILSVQYSVPDYVRVSMECRHLLSQIFVASPEKRIKIPEIKN 256
Query: 181 HPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHEATKPLEAPRVGGHLLGSSMEL 240
HPWFLRNLPIE EGGSWQ +DVNNPSQS+EEVLS+I EA K L P+VGG L+G SM+L
Sbjct: 257 HPWFLRNLPIEQMEGGSWQMNDVNNPSQSVEEVLSIIQEARKSLNVPKVGGLLIGGSMDL 316
Query: 241 DDLDADADLEDTETSGDFVCPL 262
DDLDAD DLED +TSG+FVCP+
Sbjct: 317 DDLDADEDLEDLQTSGEFVCPI 338
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224066977|ref|XP_002302308.1| predicted protein [Populus trichocarpa] gi|222844034|gb|EEE81581.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 460 bits (1184), Expect = e-127, Method: Compositional matrix adjust.
Identities = 231/261 (88%), Positives = 244/261 (93%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEYAAGGELFERICNAGRFSEDEAR FFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA
Sbjct: 77 MEYAAGGELFERICNAGRFSEDEARIFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 136
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
PRVKICDFGYSKS+VLHSQPKSTVGTPAYIAPEVL KKEYDGKI+DVWSCGVTLYVMLVG
Sbjct: 137 PRVKICDFGYSKSAVLHSQPKSTVGTPAYIAPEVLLKKEYDGKISDVWSCGVTLYVMLVG 196
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
AYPFEDP+DPKNFRKTIGRILSV+YS PDY+RVS+EC HLLSRIFVAN EKRITIPEIKN
Sbjct: 197 AYPFEDPDDPKNFRKTIGRILSVNYSIPDYIRVSVECNHLLSRIFVANPEKRITIPEIKN 256
Query: 181 HPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHEATKPLEAPRVGGHLLGSSMEL 240
HPWFL+NLPIEL EG SWQS DVNN SQS+EEVLS+I EA+KP+ + GHLLG SM+L
Sbjct: 257 HPWFLKNLPIELMEGQSWQSIDVNNLSQSIEEVLSIIQEASKPVSLSKAVGHLLGGSMDL 316
Query: 241 DDLDADADLEDTETSGDFVCP 261
DDLDADADLED ETSGDFVCP
Sbjct: 317 DDLDADADLEDIETSGDFVCP 337
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356500713|ref|XP_003519176.1| PREDICTED: serine/threonine-protein kinase SAPK2-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 457 bits (1177), Expect = e-126, Method: Compositional matrix adjust.
Identities = 228/270 (84%), Positives = 246/270 (91%), Gaps = 8/270 (2%)
Query: 1 MEYAAGGELFERICNAGRFSEDE--------ARFFFQQLISGVSYCHSMQICHRDLKLEN 52
MEYA+GGELFERICNAGRFSEDE ARFFFQQLISGVSYCHSMQICHRDLKLEN
Sbjct: 77 MEYASGGELFERICNAGRFSEDEVILVTFHQARFFFQQLISGVSYCHSMQICHRDLKLEN 136
Query: 53 TLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGV 112
TLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT+KEYDGKIADVWSCGV
Sbjct: 137 TLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTRKEYDGKIADVWSCGV 196
Query: 113 TLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKR 172
TLYVMLVGAYPFEDP DP+NF+KTIG+ILSV YS PDYVRVS+EC+HLLS+IFVA+ EKR
Sbjct: 197 TLYVMLVGAYPFEDPADPRNFKKTIGKILSVQYSVPDYVRVSMECRHLLSQIFVASPEKR 256
Query: 173 ITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHEATKPLEAPRVGGH 232
ITIPEIKNHPWFLRNLP+ELTEGGSWQ +DVNNPSQ++EEVLS+I EA K L P+VGG
Sbjct: 257 ITIPEIKNHPWFLRNLPMELTEGGSWQMNDVNNPSQNVEEVLSIIQEARKSLNVPKVGGL 316
Query: 233 LLGSSMELDDLDADADLEDTETSGDFVCPL 262
L G SM+LDD DAD DLED ETSG+FVCP+
Sbjct: 317 LTGGSMDLDDFDADEDLEDLETSGEFVCPI 346
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224082109|ref|XP_002306567.1| predicted protein [Populus trichocarpa] gi|222856016|gb|EEE93563.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 454 bits (1169), Expect = e-125, Method: Compositional matrix adjust.
Identities = 231/267 (86%), Positives = 248/267 (92%), Gaps = 5/267 (1%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-----QICHRDLKLENTLL 55
MEYAAGGELFERIC+AG+FSEDEARFFFQQLISGVSYCHSM QICHRDLKLENTLL
Sbjct: 77 MEYAAGGELFERICSAGKFSEDEARFFFQQLISGVSYCHSMIFMLQQICHRDLKLENTLL 136
Query: 56 DGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY 115
DG+T PRVKICDFGYSKS+VLHSQPKS VGTPAYIAPEVL+KKEYDGKIADVWSCGVTLY
Sbjct: 137 DGNTVPRVKICDFGYSKSAVLHSQPKSAVGTPAYIAPEVLSKKEYDGKIADVWSCGVTLY 196
Query: 116 VMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITI 175
VMLVGAYPFEDP+ PKNFRKTIGRILSVHYS PDYVRVS+ECKHLL+RIFVA+ EKRITI
Sbjct: 197 VMLVGAYPFEDPDGPKNFRKTIGRILSVHYSIPDYVRVSIECKHLLTRIFVADPEKRITI 256
Query: 176 PEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHEATKPLEAPRVGGHLLG 235
PEIKNHPWFL+NLPIEL EGGSWQS+DVNNPSQS+EEVLS+I EA+KP+ + HLLG
Sbjct: 257 PEIKNHPWFLKNLPIELMEGGSWQSNDVNNPSQSVEEVLSIIQEASKPVFLSKGEEHLLG 316
Query: 236 SSMELDDLDADADLEDTETSGDFVCPL 262
SSM+LDDLDADADLED ETSGDFVCPL
Sbjct: 317 SSMDLDDLDADADLEDIETSGDFVCPL 343
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359492886|ref|XP_003634478.1| PREDICTED: serine/threonine-protein kinase SAPK2 [Vitis vinifera] gi|302141990|emb|CBI19193.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 444 bits (1142), Expect = e-122, Method: Compositional matrix adjust.
Identities = 214/262 (81%), Positives = 235/262 (89%), Gaps = 3/262 (1%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEYAAGGELF RICNAGRFSEDEARFFFQQLISGVSYCHSM+ICHRDLKLENTLLDGSTA
Sbjct: 77 MEYAAGGELFGRICNAGRFSEDEARFFFQQLISGVSYCHSMRICHRDLKLENTLLDGSTA 136
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL++KEYDGK++DVWSCGVTLYVMLVG
Sbjct: 137 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLSRKEYDGKLSDVWSCGVTLYVMLVG 196
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
AYPFEDP+DP+NFRKTIGRILSVHYS PDYVRVS+EC+HLLSR+FVAN +KRITIPEIK
Sbjct: 197 AYPFEDPDDPRNFRKTIGRILSVHYSIPDYVRVSIECRHLLSRVFVANPDKRITIPEIKT 256
Query: 181 HPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHEATKPLEAPRVGGHLLGSSMEL 240
HPWFL+NLPIE+ +GGSWQ +DVNNPSQS+EE+LS+I EA K + GG + SM+
Sbjct: 257 HPWFLKNLPIEMMDGGSWQKNDVNNPSQSVEEILSIIQEARKTTGVRKAGGPFMEGSMD- 315
Query: 241 DDLDADADLEDTETSGDFVCPL 262
LD ED ETSGDFVCPL
Sbjct: 316 --LDDIDADEDIETSGDFVCPL 335
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|11138330|gb|AAG31326.1| putative serine/threonine kinase GDBrPK [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 444 bits (1141), Expect = e-122, Method: Compositional matrix adjust.
Identities = 214/262 (81%), Positives = 235/262 (89%), Gaps = 3/262 (1%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEYAAGGELF RICNAGRFSEDEARFFFQQLISGVSYCHSM+ICHRDLKLENTLLDGSTA
Sbjct: 67 MEYAAGGELFGRICNAGRFSEDEARFFFQQLISGVSYCHSMRICHRDLKLENTLLDGSTA 126
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL++KEYDGK++DVWSCGVTLYVMLVG
Sbjct: 127 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLSRKEYDGKLSDVWSCGVTLYVMLVG 186
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
AYPFEDP+DP+NFRKTIGRILSVHYS PDYVRVS+EC+HLLSR+FVAN +KRITIPEIK
Sbjct: 187 AYPFEDPDDPRNFRKTIGRILSVHYSIPDYVRVSIECRHLLSRVFVANPDKRITIPEIKT 246
Query: 181 HPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHEATKPLEAPRVGGHLLGSSMEL 240
HPWFL+NLPIE+ +GGSWQ +DVNNPSQS+EE+LS+I EA K + GG + SM+
Sbjct: 247 HPWFLKNLPIEMMDGGSWQKNDVNNPSQSVEEILSIIQEARKTTGVRKAGGPFMEGSMD- 305
Query: 241 DDLDADADLEDTETSGDFVCPL 262
LD ED ETSGDFVCPL
Sbjct: 306 --LDDIDADEDIETSGDFVCPL 325
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359480471|ref|XP_003632469.1| PREDICTED: serine/threonine-protein kinase SAPK2-like [Vitis vinifera] gi|297741826|emb|CBI33139.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 438 bits (1126), Expect = e-120, Method: Compositional matrix adjust.
Identities = 218/264 (82%), Positives = 241/264 (91%), Gaps = 4/264 (1%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEYAAGGELFERICNAGRFSEDEAR+FFQQLISGVSYCHSMQICHRDLKLENTLLDGS A
Sbjct: 77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPA 136
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
PR+KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL++KEYDGKIADVWSCGVTLYVMLVG
Sbjct: 137 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLSRKEYDGKIADVWSCGVTLYVMLVG 196
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
AYPFEDP+DP+NFRKTI RILSVHYS PDYVRVS+ECKHLLSRIFVAN EKRITIPEI+N
Sbjct: 197 AYPFEDPDDPRNFRKTIARILSVHYSIPDYVRVSMECKHLLSRIFVANPEKRITIPEIQN 256
Query: 181 HPWFLRNLPIELTEGG--SWQSHDVNNPSQSLEEVLSLIHEATKPLEAPRVGGHLLGSSM 238
HPWF+RNLPIE +GG S Q+ VN+PSQS+++++ +I EA +E P+VGGH G+SM
Sbjct: 257 HPWFIRNLPIEFMQGGEASAQTDYVNDPSQSIDDIVKIIQEAR--IEGPKVGGHFFGASM 314
Query: 239 ELDDLDADADLEDTETSGDFVCPL 262
+LDDLD DADL+D E SGDFVC L
Sbjct: 315 DLDDLDEDADLDDIEASGDFVCAL 338
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 262 | ||||||
| TAIR|locus:2118929 | 362 | OST1 "OPEN STOMATA 1" [Arabido | 0.908 | 0.657 | 0.745 | 2.9e-96 | |
| TAIR|locus:2032075 | 343 | SNRK2-8 "SNF1-RELATED PROTEIN | 0.839 | 0.641 | 0.808 | 4.7e-96 | |
| TAIR|locus:2206046 | 361 | SNRK2.10 "SNF1-related protein | 0.870 | 0.631 | 0.753 | 7e-93 | |
| TAIR|locus:2174999 | 361 | SNRK2.3 "sucrose nonfermenting | 0.847 | 0.614 | 0.765 | 1.7e-91 | |
| TAIR|locus:2159597 | 353 | SNRK2.1 "SNF1-related protein | 0.851 | 0.631 | 0.737 | 1.2e-90 | |
| TAIR|locus:2160559 | 360 | SNRK2.5 "SNF1-related protein | 0.851 | 0.619 | 0.734 | 4e-90 | |
| TAIR|locus:2140104 | 350 | SNRK2.7 "SNF1-related protein | 1.0 | 0.748 | 0.649 | 6.5e-90 | |
| TAIR|locus:2045319 | 339 | SNRK2.9 "SNF1-related protein | 0.866 | 0.669 | 0.679 | 2.2e-80 | |
| TAIR|locus:2094672 | 512 | KIN11 "SNF1 kinase homolog 11" | 0.832 | 0.425 | 0.428 | 1.6e-40 | |
| TAIR|locus:2102132 | 535 | KIN10 "AT3G01090" [Arabidopsis | 0.690 | 0.338 | 0.486 | 2e-40 |
| TAIR|locus:2118929 OST1 "OPEN STOMATA 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 957 (341.9 bits), Expect = 2.9e-96, P = 2.9e-96
Identities = 179/240 (74%), Positives = 204/240 (85%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEYA+GGELFERICNAGRFSEDEARFFFQQLISGVSYCH+MQ+CHRDLKLENTLLDGS A
Sbjct: 94 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 153
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
PR+KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL KKEYDGK+ADVWSCGVTLYVMLVG
Sbjct: 154 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
AYPFEDPE+PKNFRKTI RIL+V Y+ PDYV +S EC+HL+SRIFVA+ KRI+IPEI+N
Sbjct: 214 AYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 273
Query: 181 HPWFLRNLPIELTEGGSW--QSHDVNNPSQSLEEVLSLIHEATKPLEAPRVGGHLLGSSM 238
H WFL+NLP +L + Q + + P QS+EE++ +I EAT P + H L S+
Sbjct: 274 HEWFLKNLPADLMNDNTMTTQFDESDQPGQSIEEIMQIIAEATVPPAGTQNLNHYLTGSL 333
|
|
| TAIR|locus:2032075 SNRK2-8 "SNF1-RELATED PROTEIN KINASE 2-8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 955 (341.2 bits), Expect = 4.7e-96, P = 4.7e-96
Identities = 182/225 (80%), Positives = 200/225 (88%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEYAAGGELF RIC+AGRFSEDEARFFFQQLISGV+YCHS+QICHRDLKLENTLLDGS A
Sbjct: 77 MEYAAGGELFGRICSAGRFSEDEARFFFQQLISGVNYCHSLQICHRDLKLENTLLDGSEA 136
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
PRVKICDFGYSKS VLHSQPK+TVGTPAYIAPEVL+ KEYDGKIADVWSCGVTLYVMLVG
Sbjct: 137 PRVKICDFGYSKSGVLHSQPKTTVGTPAYIAPEVLSTKEYDGKIADVWSCGVTLYVMLVG 196
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
AYPFEDP DPK+FRKTIGRIL Y+ PDYVRVS EC+HLLSRIFVAN EKRITI EIKN
Sbjct: 197 AYPFEDPSDPKDFRKTIGRILKAQYAIPDYVRVSDECRHLLSRIFVANPEKRITIEEIKN 256
Query: 181 HPWFLRNLPIELTEGGSWQSHDVNNPS-QSLEEVLSLIHEATKPL 224
H WFL+NLP+E+ EG S +N PS Q++EE++ +I EA KP+
Sbjct: 257 HSWFLKNLPVEMYEG----SLMMNGPSTQTVEEIVWIIEEARKPI 297
|
|
| TAIR|locus:2206046 SNRK2.10 "SNF1-related protein kinase 2.10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 925 (330.7 bits), Expect = 7.0e-93, P = 7.0e-93
Identities = 174/231 (75%), Positives = 195/231 (84%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEYAAGGELFERIC+AGRFSEDEAR+FFQQLISGVSYCH+MQICHRDLKLENTLLDGS A
Sbjct: 77 MEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQICHRDLKLENTLLDGSPA 136
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
PR+KICDFGYSKSS+LHS PKSTVGTPAYIAPEVL++ EYDGK+ADVWSCGVTLYVMLVG
Sbjct: 137 PRLKICDFGYSKSSLLHSMPKSTVGTPAYIAPEVLSRGEYDGKMADVWSCGVTLYVMLVG 196
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
AYPFED EDPKNF+KTI RI++V Y PDYV +S +CKHLLSRIFV NS KRITI +IK
Sbjct: 197 AYPFEDQEDPKNFKKTIQRIMAVKYKIPDYVHISQDCKHLLSRIFVTNSNKRITIGDIKK 256
Query: 181 HPWFLRNLPIELTEGGSWQSHDVNNPS---QSLEEVLSLIHEATKPLEAPR 228
HPWFL+NLP ELTE NP+ QS+EE++ ++ EA P R
Sbjct: 257 HPWFLKNLPRELTEIAQAAYFRKENPTFSLQSVEEIMKIVEEAKTPARVSR 307
|
|
| TAIR|locus:2174999 SNRK2.3 "sucrose nonfermenting 1(SNF1)-related protein kinase 2.3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 912 (326.1 bits), Expect = 1.7e-91, P = 1.7e-91
Identities = 173/226 (76%), Positives = 196/226 (86%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEYA+GGEL+ERICNAGRFSEDEARFFFQQL+SGVSYCHSMQICHRDLKLENTLLDGS A
Sbjct: 95 MEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPA 154
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
PR+KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL ++EYDGKIADVWSCGVTLYVMLVG
Sbjct: 155 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
AYPFEDPE+P+++RKTI RILSV YS PD +R+S EC HL+SRIFVA+ RI+IPEIK
Sbjct: 215 AYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274
Query: 181 HPWFLRNLPIEL---TEGGSWQSHDVNNPSQSLEEVLSLIHEATKP 223
H WFL+NLP +L + GS Q + P QSL+ ++ +I EAT P
Sbjct: 275 HSWFLKNLPADLMNESNTGS-QFQEPEQPMQSLDTIMQIISEATIP 319
|
|
| TAIR|locus:2159597 SNRK2.1 "SNF1-related protein kinase 2.1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 904 (323.3 bits), Expect = 1.2e-90, P = 1.2e-90
Identities = 166/225 (73%), Positives = 191/225 (84%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEYA+GGELF+RIC AGRFSE EAR+FFQQLI GV YCHS+QICHRDLKLENTLLDGS A
Sbjct: 77 MEYASGGELFDRICTAGRFSEAEARYFFQQLICGVDYCHSLQICHRDLKLENTLLDGSPA 136
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
P +KICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL+++EYDGK ADVWSCGVTLYVMLVG
Sbjct: 137 PLLKICDFGYSKSSILHSRPKSTVGTPAYIAPEVLSRREYDGKHADVWSCGVTLYVMLVG 196
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
AYPFEDP DPKNFRKTI RI++V Y PDYV +S ECKHLLSRIFV NS KRIT+ EIKN
Sbjct: 197 AYPFEDPNDPKNFRKTIQRIMAVQYKIPDYVHISQECKHLLSRIFVTNSAKRITLKEIKN 256
Query: 181 HPWFLRNLPIELTEGG--SWQSHDVNNPSQSLEEVLSLIHEATKP 223
HPW+L+NLP EL E ++ D + QS+E+++ ++ EA P
Sbjct: 257 HPWYLKNLPKELLESAQAAYYKRDTSFSLQSVEDIMKIVGEARNP 301
|
|
| TAIR|locus:2160559 SNRK2.5 "SNF1-related protein kinase 2.5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 899 (321.5 bits), Expect = 4.0e-90, P = 4.0e-90
Identities = 166/226 (73%), Positives = 191/226 (84%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEYA+GGELFERICNAGRFSE EAR+FFQQLI GV YCHS+QICHRDLKLENTLLDGS A
Sbjct: 77 MEYASGGELFERICNAGRFSEAEARYFFQQLICGVDYCHSLQICHRDLKLENTLLDGSPA 136
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
P +KICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL+++EYDGK ADVWSCGVTLYVMLVG
Sbjct: 137 PLLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKHADVWSCGVTLYVMLVG 196
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
YPFEDP+DP+NFRKTI RI++V Y PDYV +S EC+HLLSRIFV NS KRIT+ EIK
Sbjct: 197 GYPFEDPDDPRNFRKTIQRIMAVQYKIPDYVHISQECRHLLSRIFVTNSAKRITLKEIKK 256
Query: 181 HPWFLRNLPIELTEGGSWQSHDVNNPS---QSLEEVLSLIHEATKP 223
HPW+L+NLP ELTE + PS QS+E+++ ++ EA P
Sbjct: 257 HPWYLKNLPKELTEPAQAAYYKRETPSFSLQSVEDIMKIVGEARNP 302
|
|
| TAIR|locus:2140104 SNRK2.7 "SNF1-related protein kinase 2.7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 897 (320.8 bits), Expect = 6.5e-90, P = 6.5e-90
Identities = 178/274 (64%), Positives = 207/274 (75%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEYAAGGELFERICNAGRFSEDE R++F+QLISGVSYCH+MQICHRDLKLENTLLDGS +
Sbjct: 77 MEYAAGGELFERICNAGRFSEDEGRYYFKQLISGVSYCHAMQICHRDLKLENTLLDGSPS 136
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
+KICDFGYSKSSVLHSQPKSTVGTPAY+APEVL++KEY+GKIADVWSCGVTLYVMLVG
Sbjct: 137 SHLKICDFGYSKSSVLHSQPKSTVGTPAYVAPEVLSRKEYNGKIADVWSCGVTLYVMLVG 196
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
AYPFEDPEDP+N R TI RILSVHY+ PDYVR+S ECKHLLSRIFVA+ +KRIT+PEI+
Sbjct: 197 AYPFEDPEDPRNIRNTIQRILSVHYTIPDYVRISSECKHLLSRIFVADPDKRITVPEIEK 256
Query: 181 HPWFLRN---LPIE---LTEGGSWQSHDVNNPSQSLEEVLSLIHEATKPLEAP-RVGG-H 232
HPWFL+ +P E G + + QS+EE++ +I EA K + GG
Sbjct: 257 HPWFLKGPLVVPPEEEKCDNGVEEEEEEEEKCRQSVEEIVKIIEEARKGVNGTDNNGGLG 316
Query: 233 LLGSSMXXXXXXXXXXXXXXXX----SGDFVCPL 262
L+ S+ +GDFVC L
Sbjct: 317 LIDGSIDLDDIDDADIYDDVDDDEERNGDFVCAL 350
|
|
| TAIR|locus:2045319 SNRK2.9 "SNF1-related protein kinase 2.9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 807 (289.1 bits), Expect = 2.2e-80, P = 2.2e-80
Identities = 159/234 (67%), Positives = 185/234 (79%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEYAAGGELFERI + GRFSE EAR+FFQQLI GV Y H++QICHRDLKLENTLLDGS A
Sbjct: 77 MEYAAGGELFERISSVGRFSEAEARYFFQQLICGVHYLHALQICHRDLKLENTLLDGSPA 136
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
PR+KICDFGYSKSSVLHS PKSTVGTPAYIAPEV + EYDGK DVWSCGV LYVMLVG
Sbjct: 137 PRLKICDFGYSKSSVLHSNPKSTVGTPAYIAPEVFCRSEYDGKSVDVWSCGVALYVMLVG 196
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
AYPFEDP+DP+NFRKT+ +I++V+Y P YV +S +C+ LLSRIFVAN R T+ EIK+
Sbjct: 197 AYPFEDPKDPRNFRKTVQKIMAVNYKIPGYVHISEDCRKLLSRIFVANPLHRSTLKEIKS 256
Query: 181 HPWFLRNLPIELTEGGS--WQSHDVN--NPS-QSLEEVLSLIHEA-TKP-LEAP 227
H WFL+NLP EL E + +VN N S Q +EE++ ++ EA T P L P
Sbjct: 257 HAWFLKNLPRELKEPAQAIYYQRNVNLINFSPQRVEEIMKIVGEARTIPNLSRP 310
|
|
| TAIR|locus:2094672 KIN11 "SNF1 kinase homolog 11" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 431 (156.8 bits), Expect = 1.6e-40, P = 1.6e-40
Identities = 99/231 (42%), Positives = 132/231 (57%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY GELF+ I GR EDEAR FFQQ+ISGV YCH + HRDLK EN LLD
Sbjct: 97 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSRC- 155
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
+KI DFG S K++ G+P Y APEV++ K Y G DVWSCGV LY +L G
Sbjct: 156 -NIKIADFGLSNVMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG 214
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
PF+D P F+K G I Y+ P ++ S E + L+ R+ + + KRITIPEI+
Sbjct: 215 TLPFDDENIPNLFKKIKGGI----YTLPSHL--SSEARDLIPRMLIVDPVKRITIPEIRQ 268
Query: 181 HPWFLRNLPIELTEGGS---WQSHDVNNPSQSLEEVLSLIHEATKPLEAPR 228
H WF +LP L Q+ +N + ++EV+++ + + LE+ R
Sbjct: 269 HRWFQTHLPRYLAVSPPDTVEQAKKINE--EIVQEVVNMGFDRNQVLESLR 317
|
|
| TAIR|locus:2102132 KIN10 "AT3G01090" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 430 (156.4 bits), Expect = 2.0e-40, P = 2.0e-40
Identities = 92/189 (48%), Positives = 113/189 (59%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY GELF+ I GR EDEAR FFQQ+ISGV YCH + HRDLK EN LLD
Sbjct: 119 MEYVNSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKC- 177
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
VKI DFG S K++ G+P Y APEV++ K Y G DVWSCGV LY +L G
Sbjct: 178 -NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG 236
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
PF+D P F+K G I Y+ P ++ S + L+ R+ V + KR+TIPEI+
Sbjct: 237 TLPFDDENIPNLFKKIKGGI----YTLPSHL--SPGARDLIPRMLVVDPMKRVTIPEIRQ 290
Query: 181 HPWFLRNLP 189
HPWF +LP
Sbjct: 291 HPWFQAHLP 299
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q0D4J7 | SAPK2_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.7773 | 0.9923 | 0.7669 | yes | no |
| Q02066 | AAIP_WHEAT | 2, ., 7, ., 1, 1, ., 1 | 0.7677 | 0.9961 | 0.7861 | N/A | no |
| Q940H6 | SRK2E_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7418 | 0.9236 | 0.6685 | yes | no |
| A2YNT8 | SAPK2_ORYSI | 2, ., 7, ., 1, 1, ., 1 | 0.7811 | 0.9923 | 0.7669 | N/A | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 262 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-72 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-62 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-53 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-46 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-45 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-44 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-43 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-42 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-38 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-38 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-37 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-37 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-36 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-34 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-34 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-34 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-34 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-34 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-34 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-33 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-32 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-32 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-32 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-32 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-32 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-32 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-31 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-30 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-30 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-30 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-29 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-29 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-29 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-29 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-29 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-29 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-28 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-28 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-28 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-27 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-27 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-27 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-27 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-27 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-27 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-26 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-26 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-26 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-26 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-26 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-25 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-25 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-25 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-24 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-24 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-24 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-24 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-24 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-24 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-24 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-24 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-24 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-23 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-23 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-23 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-22 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-22 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-22 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-22 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-21 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-21 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-21 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-20 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-20 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-20 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-20 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-20 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-20 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-20 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-20 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-19 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-19 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-19 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-19 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-19 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-19 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-18 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-18 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-18 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-17 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-17 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-17 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-17 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-17 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-17 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-17 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-16 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-16 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-16 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-16 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-16 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-16 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-14 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-14 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-14 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-13 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-13 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-13 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-13 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-12 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-12 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-12 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-11 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 9e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-09 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-09 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-09 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-08 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-08 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-08 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-08 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-08 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-07 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-07 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-07 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-07 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-07 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-07 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-06 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-06 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-06 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-05 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-05 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-05 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-05 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-05 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-05 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-05 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-05 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-05 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-05 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-05 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-05 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-05 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 8e-05 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-05 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-04 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-04 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-04 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-04 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-04 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-04 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-04 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-04 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-04 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-04 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-04 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-04 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-04 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-04 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.001 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 0.001 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.002 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 0.002 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.002 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 220 bits (563), Expect = 6e-72
Identities = 76/185 (41%), Positives = 103/185 (55%), Gaps = 7/185 (3%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY GG+LF+ + GR SEDEARF+ +Q++S + Y HS I HRDLK EN LLD
Sbjct: 76 MEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDG- 134
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
VK+ DFG ++ + + VGTP Y+APEVL K Y + D+WS GV LY +L G
Sbjct: 135 -HVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAV-DIWSLGVILYELLTG 192
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFP-DYVRVSLECKHLLSRIFVANSEKRITIPEIK 179
PF + + +I FP +S E K L+ ++ V + EKR+T E
Sbjct: 193 KPPFPGDDQLL---ELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEAL 249
Query: 180 NHPWF 184
HP+F
Sbjct: 250 QHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 195 bits (497), Expect = 6e-62
Identities = 80/187 (42%), Positives = 102/187 (54%), Gaps = 6/187 (3%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY GG+LF+ + G SEDEA+ Q++ G+ Y HS I HRDLK EN LLD +
Sbjct: 77 MEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDEN-- 134
Query: 61 PRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
VKI DFG +K + S +T VGTP Y+APEVL G DVWS GV LY +L
Sbjct: 135 GVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLT 194
Query: 120 GAYPFEDPEDPKNFRKTIGRILS--VHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPE 177
G PF E+ + + I RIL + + P + S E K L+ + + KR T E
Sbjct: 195 GKPPFSG-ENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEE 253
Query: 178 IKNHPWF 184
I HPWF
Sbjct: 254 ILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 171 bits (437), Expect = 6e-53
Identities = 77/188 (40%), Positives = 105/188 (55%), Gaps = 13/188 (6%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+EYA GGELF + GRFSE+ ARF+ +++ + Y HS+ I +RDLK EN LLD
Sbjct: 72 LEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADG- 130
Query: 61 PRVKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+K+ DFG +K S+ + GTP Y+APEVL K Y GK D WS GV LY ML
Sbjct: 131 -HIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVDWWSLGVLLYEMLT 188
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRIT---IP 176
G PF + + + K IL FP++ +S E + L+S + + KR+
Sbjct: 189 GKPPFYAEDRKEIYEK----ILKDPLRFPEF--LSPEARDLISGLLQKDPTKRLGSGGAE 242
Query: 177 EIKNHPWF 184
EIK HP+F
Sbjct: 243 EIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 156 bits (398), Expect = 1e-46
Identities = 74/191 (38%), Positives = 104/191 (54%), Gaps = 20/191 (10%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD--GS 58
MEY GGELF + +GRF E ARF+ Q++ + Y HS+ I +RDLK EN LLD G
Sbjct: 80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGY 139
Query: 59 TAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 118
+KI DFG++K + + + GTP Y+APE++ K Y GK D W+ G+ +Y ML
Sbjct: 140 ----IKITDFGFAK--RVKGRTYTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEML 192
Query: 119 VGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI----- 173
G PF D + + K IL FP + S + K L+ + + KR+
Sbjct: 193 AGYPPFFDDNPIQIYEK----ILEGKVRFPSF--FSPDAKDLIRNLLQVDLTKRLGNLKN 246
Query: 174 TIPEIKNHPWF 184
+ +IKNHPWF
Sbjct: 247 GVNDIKNHPWF 257
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 2e-45
Identities = 66/184 (35%), Positives = 86/184 (46%), Gaps = 40/184 (21%)
Query: 1 MEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
MEY GG L + + N G+ SEDE Q++ G+ Y HS I HRDLK EN LLD
Sbjct: 70 MEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDN 129
Query: 60 APRVKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 118
+VK+ DFG SK + S K+ VGTPAY+APEVL K Y + +D+WS GV LY +
Sbjct: 130 -GKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL- 187
Query: 119 VGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEI 178
E K L+ ++ + EKR + EI
Sbjct: 188 ------------------------------------PELKDLIRKMLQKDPEKRPSAKEI 211
Query: 179 KNHP 182
H
Sbjct: 212 LEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 4e-44
Identities = 60/187 (32%), Positives = 91/187 (48%), Gaps = 9/187 (4%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+EY +GG L + G+ E R + +Q++ G++Y HS I HRD+K N L+D
Sbjct: 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDG- 138
Query: 61 PRVKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVM 117
VK+ DFG +K S GTP ++APEV+ +EY AD+WS G T+ M
Sbjct: 139 -VVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRA-ADIWSLGCTVIEM 196
Query: 118 LVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPE 177
G P+ + +P IG P++ +S E K L + + +KR T E
Sbjct: 197 ATGKPPWSELGNPMAALYKIGSSGEPPE-IPEH--LSEEAKDFLRKCLRRDPKKRPTADE 253
Query: 178 IKNHPWF 184
+ HP+
Sbjct: 254 LLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 1e-43
Identities = 74/196 (37%), Positives = 103/196 (52%), Gaps = 19/196 (9%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY GG+L + N G ED AR + +++ + Y HS I HRDLK +N L+D +
Sbjct: 72 MEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNG- 130
Query: 61 PRVKICDFGYSK---------SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCG 111
+K+ DFG SK + + K VGTP YIAPEV+ + + K D WS G
Sbjct: 131 -HLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-SKTVDWWSLG 188
Query: 112 VTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEK 171
LY LVG PF + + IL+ +P+ V VS E L+S++ V + EK
Sbjct: 189 CILYEFLVGIPPFHG----ETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEK 244
Query: 172 RI---TIPEIKNHPWF 184
R+ +I EIKNHP+F
Sbjct: 245 RLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 2e-42
Identities = 68/209 (32%), Positives = 99/209 (47%), Gaps = 34/209 (16%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+EYA GEL + I G E RF+ +++ + Y HS I HRDLK EN LLD
Sbjct: 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDM- 139
Query: 61 PRVKICDFGYSK---------------------SSVLHSQPKSTVGTPAYIAPEVLTKKE 99
+KI DFG +K + S VGT Y++PE+L +K
Sbjct: 140 -HIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP 198
Query: 100 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159
GK +D+W+ G +Y ML G PF + F+K IL + YSFP + K
Sbjct: 199 A-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK----ILKLEYSFPP--NFPPDAKD 251
Query: 160 LLSRIFVANSEKRITI----PEIKNHPWF 184
L+ ++ V + + R+ + E+K HP+F
Sbjct: 252 LIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 134 bits (341), Expect = 2e-38
Identities = 65/185 (35%), Positives = 101/185 (54%), Gaps = 17/185 (9%)
Query: 1 MEYAAGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD 56
MEYA GG+L ++I + F E++ +F QL + Y HS +I HRD+K +N L
Sbjct: 78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT 137
Query: 57 GSTAPRVKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVT 113
+ VK+ DFG SK S+V + K+ VGTP Y++PE+ K Y+ K +D+WS G
Sbjct: 138 --SNGLVKLGDFGISKVLSSTVDLA--KTVVGTPYYLSPELCQNKPYNYK-SDIWSLGCV 192
Query: 114 LYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI 173
LY + +PFE +N + +IL Y P + S E ++L+S + + E+R
Sbjct: 193 LYELCTLKHPFEG----ENLLELALKILKGQYP-PIPSQYSSELRNLVSSLLQKDPEERP 247
Query: 174 TIPEI 178
+I +I
Sbjct: 248 SIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 6e-38
Identities = 72/192 (37%), Positives = 100/192 (52%), Gaps = 16/192 (8%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY GGEL+ + + G F E ARF+ ++ Y H+ I +RDLK EN LLD +
Sbjct: 72 MEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLD--SN 129
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
VK+ DFG++K + + GTP Y+APE++ K YD D WS G+ LY +L G
Sbjct: 130 GYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYD-FSVDYWSLGILLYELLTG 188
Query: 121 AYPF-EDPEDPKNFRKTIGRILSV--HYSFPDYVRVSLECKHLLSRIFVANSEKRI---- 173
PF ED EDP + IL FP+Y + K L+ ++ N E+R+
Sbjct: 189 RPPFGEDDEDP---MEIYNDILKGNGKLEFPNY--IDKAAKDLIKQLLRRNPEERLGNLK 243
Query: 174 -TIPEIKNHPWF 184
I +IK H WF
Sbjct: 244 GGIKDIKKHKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 2e-37
Identities = 60/187 (32%), Positives = 93/187 (49%), Gaps = 13/187 (6%)
Query: 1 MEYAAGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL--DG 57
ME+ +GG L + + + + +E + + ++L+ G+ Y HS I HRD+K N LL DG
Sbjct: 76 MEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDG 135
Query: 58 STAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVM 117
VK+ DFG S + VGTP ++APEV+ K YD K AD+WS G+T +
Sbjct: 136 E----VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYK-ADIWSLGITAIEL 190
Query: 118 LVGAYPFEDPEDPKNFRKTIGRIL-SVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIP 176
G P+ + K + +I + + + S E K L + N EKR T
Sbjct: 191 AEGKPPYSEL----PPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAE 246
Query: 177 EIKNHPW 183
++ HP+
Sbjct: 247 QLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 7e-37
Identities = 70/217 (32%), Positives = 96/217 (44%), Gaps = 41/217 (18%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY GG+L + F E+ ARF+ +L+ + H + HRD+K +N L+D
Sbjct: 80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADG- 138
Query: 61 PRVKICDFGYSK--------------------------SSVLHSQPK----STVGTPAYI 90
+K+ DFG K H Q + STVGTP YI
Sbjct: 139 -HIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYI 197
Query: 91 APEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS--VHYSFP 148
APEVL Y + D WS GV LY ML G PF ++T +I++ FP
Sbjct: 198 APEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSD----TLQETYNKIINWKESLRFP 252
Query: 149 DYVRVSLECKHLLSRIFVANSEKRIT-IPEIKNHPWF 184
VS E L+ R + + E R+ EIK+HP+F
Sbjct: 253 PDPPVSPEAIDLICR-LLCDPEDRLGSFEEIKSHPFF 288
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 6e-36
Identities = 75/190 (39%), Positives = 102/190 (53%), Gaps = 15/190 (7%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY GG+L I +GRF E ARF+ +++ G+ + H I +RDLKL+N LLD
Sbjct: 75 MEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEG- 133
Query: 61 PRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+KI DFG K +L ST GTP YIAPE+L+ + Y G D W+ GV LY ML
Sbjct: 134 -HIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPY-GPAVDWWALGVLLYEMLA 191
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIP--- 176
G PFE ++ + F+ IL +P + +S E K +L N EKR+
Sbjct: 192 GQSPFEGDDEDELFQS----ILEDEVRYPRW--LSKEAKSILKSFLTKNPEKRLGCLPTG 245
Query: 177 --EIKNHPWF 184
+IK HP+F
Sbjct: 246 EQDIKGHPFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-34
Identities = 74/186 (39%), Positives = 107/186 (57%), Gaps = 11/186 (5%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY GG+L I ++GRF E ARF+ ++I G+ + H I +RDLKL+N LLD
Sbjct: 75 MEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG- 133
Query: 61 PRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+KI DFG K ++ ST GTP YIAPE+L ++Y+ + D WS GV LY ML+
Sbjct: 134 -HIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESV-DWWSFGVLLYEMLI 191
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIP-EI 178
G PF ++ + F IL+ FP + +S E K LS++F + KR+ + +I
Sbjct: 192 GQSPFHGEDEDELFDS----ILNDRPHFPRW--ISKEAKDCLSKLFERDPTKRLGVDGDI 245
Query: 179 KNHPWF 184
+ HP+F
Sbjct: 246 RQHPFF 251
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 2e-34
Identities = 64/191 (33%), Positives = 97/191 (50%), Gaps = 12/191 (6%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
++Y GGELF + F+E E R + +++ + + H + I +RD+KLEN LLD
Sbjct: 84 LDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEG- 142
Query: 61 PRVKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVLTKKEYD-GKIADVWSCGVTLYVM 117
V + DFG SK + + + S GT Y+APEV+ K D WS GV + +
Sbjct: 143 -HVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFEL 201
Query: 118 LVGAYPFEDPEDPKNFRKTIG-RILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI--- 173
L GA PF + +N + I RIL FP +S E + + ++ + +KR+
Sbjct: 202 LTGASPFT-VDGEQNSQSEISRRILKSKPPFPK--TMSAEARDFIQKLLEKDPKKRLGAN 258
Query: 174 TIPEIKNHPWF 184
EIKNHP+F
Sbjct: 259 GADEIKNHPFF 269
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 3e-34
Identities = 69/189 (36%), Positives = 102/189 (53%), Gaps = 16/189 (8%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY GGELF + N+GRFS F+ +++ + Y HS +I +RDLK EN LLD
Sbjct: 80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG- 138
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
+K+ DFG++K L + + GTP Y+APEV+ K + K D W+ G+ +Y MLVG
Sbjct: 139 -HIKLTDFGFAKK--LRDRTWTLCGTPEYLAPEVIQSKGH-NKAVDWWALGILIYEMLVG 194
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI-----TI 175
PF D N +IL+ FP + + L K L+ ++ V + +R+
Sbjct: 195 YPPFFD----DNPFGIYEKILAGKLEFPRH--LDLYAKDLIKKLLVVDRTRRLGNMKNGA 248
Query: 176 PEIKNHPWF 184
++KNH WF
Sbjct: 249 DDVKNHRWF 257
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 5e-34
Identities = 72/191 (37%), Positives = 98/191 (51%), Gaps = 15/191 (7%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEYA GGELF + FSED ARF+ +++S + Y HS + +RDLKLEN +LD
Sbjct: 74 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG- 132
Query: 61 PRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+KI DFG K + T GTP Y+APEVL +Y G+ D W GV +Y M+
Sbjct: 133 -HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMC 190
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI-----T 174
G PF + + K F IL FP +S E K LL+ + + ++R+
Sbjct: 191 GRLPFYNQDHEKLFE----LILMEEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPED 244
Query: 175 IPEIKNHPWFL 185
EI H +F
Sbjct: 245 AKEIMEHRFFA 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 6e-34
Identities = 68/218 (31%), Positives = 95/218 (43%), Gaps = 39/218 (17%)
Query: 1 MEYAAGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
M+Y GGELF + SE+ ARF+ +++ + Y H + I +RDLK EN LL S
Sbjct: 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHES 139
Query: 59 -----------------TAPRVKICDFGYSKSSVLHSQP-----------KSTVGTPAYI 90
P K G +SSV S VGT YI
Sbjct: 140 GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYI 199
Query: 91 APEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDY 150
APEV++ + + D W+ G+ LY ML G PF+ N +T IL +FP
Sbjct: 200 APEVISGDGHGSAV-DWWTLGILLYEMLYGTTPFKG----SNRDETFSNILKKEVTFPGS 254
Query: 151 VRVSLECKHLLSRIFVANSEKRI----TIPEIKNHPWF 184
VS + L+ ++ V + KR+ EIK HP+F
Sbjct: 255 PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 9e-34
Identities = 72/190 (37%), Positives = 101/190 (53%), Gaps = 15/190 (7%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY GG+ + N G SED ARF+ ++ V H + HRDLK EN L+D S
Sbjct: 80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASG- 138
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
+K+ DFG SK V + S VG+P Y+APEVL K YD + D WS G LY L G
Sbjct: 139 -HIKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRGKGYDFTV-DYWSLGCMLYEFLCG 194
Query: 121 AYPF------EDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRIT 174
PF E E+ K +++T+ R Y P + +S E L++++ S + +
Sbjct: 195 FPPFSGSTPNETWENLKYWKETLQR---PVYDDPRF-NLSDEAWDLITKLINDPSRRFGS 250
Query: 175 IPEIKNHPWF 184
+ +IKNHP+F
Sbjct: 251 LEDIKNHPFF 260
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 2e-33
Identities = 65/193 (33%), Positives = 102/193 (52%), Gaps = 17/193 (8%)
Query: 1 MEYAAGGELFERICNAGRFSEDEA--RFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
MEY +GG L E + GR DE R + QL+ G++Y HS I HRD+K N LD +
Sbjct: 78 MEYCSGGTL-EELLEHGRI-LDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHN 135
Query: 59 TAPRVKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI--ADVWSCG 111
+K+ DFG + ++ + + +S GTPAY+APEV+T + G AD+WS G
Sbjct: 136 GV--IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLG 193
Query: 112 VTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY-SFPDYVRVSLECKHLLSRIFVANSE 170
+ M G P+ + ++ F + + + + H PD +++S E K L R ++ +
Sbjct: 194 CVVLEMATGKRPWSELDN--EF-QIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPK 250
Query: 171 KRITIPEIKNHPW 183
KR T E+ HP+
Sbjct: 251 KRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 123 bits (308), Expect = 7e-33
Identities = 66/203 (32%), Positives = 97/203 (47%), Gaps = 20/203 (9%)
Query: 1 MEYAAGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG 57
MEY GG L + + G SE EA F Q++S + Y HS I HRD+K EN LLD
Sbjct: 77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDR 136
Query: 58 STAPRVKICDFGYSK-------SSVLHSQPKSTVGTPAYIAPEVL--TKKEYDGKIADVW 108
VK+ DFG +K +S + + P ++VGTP Y+APEVL Y +D+W
Sbjct: 137 DG-RVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIW 195
Query: 109 SCGVTLYVMLVGAYPFEDPEDP-------KNFRKTIGRILSVHYSFPDYVRVSLECKHLL 161
S G+TLY +L G PFE ++ K + L+ S + +S LL
Sbjct: 196 SLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLL 255
Query: 162 SRIFVANSEKRITIPEIKNHPWF 184
++ + + R++ +H
Sbjct: 256 KKLLAKDPKNRLSSSSDLSHDLL 278
|
Length = 384 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 1e-32
Identities = 72/232 (31%), Positives = 103/232 (44%), Gaps = 60/232 (25%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY GG++ + F+E+E RF+ + I + H + HRD+K +N LLD
Sbjct: 80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKG- 138
Query: 61 PRVKICDFGYSK---------------------SSVLHSQPK------------------ 81
+K+ DFG S+P
Sbjct: 139 -HIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAY 197
Query: 82 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPF--EDPEDP----KNFRK 135
STVGTP YIAPEV + Y K D WS GV +Y MLVG PF ++P++ N+++
Sbjct: 198 STVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKE 256
Query: 136 TIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIP---EIKNHPWF 184
T+ FPD V +S E K L+ R +E+R+ EIK+HP+F
Sbjct: 257 TL--------QFPDEVPLSPEAKDLIKR-LCCEAERRLGNNGVNEIKSHPFF 299
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-32
Identities = 68/188 (36%), Positives = 93/188 (49%), Gaps = 13/188 (6%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+ + GGELF + GRF ARF+ +L+ + H + +RDLK EN LLD
Sbjct: 72 LAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLD--YQ 129
Query: 61 PRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+ +CDFG K ++ +T GTP Y+APE+L Y K D W+ GV LY ML
Sbjct: 130 GHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYT-KAVDWWTLGVLLYEMLT 188
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITI---P 176
G PF D + +RK IL FPD + K LL + + +R+
Sbjct: 189 GLPPFYDENVNEMYRK----ILQEPLRFPDGFDR--DAKDLLIGLLSRDPTRRLGYNGAQ 242
Query: 177 EIKNHPWF 184
EIKNHP+F
Sbjct: 243 EIKNHPFF 250
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-32
Identities = 70/189 (37%), Positives = 103/189 (54%), Gaps = 16/189 (8%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+E+ GGELF + AGRF D A+F+ +L+ Y HS I +RDLK EN LLD
Sbjct: 97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKG- 155
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
VK+ DFG++K + + + GTP Y+APEV+ K + GK D W+ GV LY + G
Sbjct: 156 -HVKVTDFGFAKK--VPDRTFTLCGTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAG 211
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI-TIP--- 176
PF D + P FR +IL+ FP++ + L+ + + KR+ T+
Sbjct: 212 YPPFFD-DTP--FR-IYEKILAGRLKFPNW--FDGRARDLVKGLLQTDHTKRLGTLKGGV 265
Query: 177 -EIKNHPWF 184
++KNHP+F
Sbjct: 266 ADVKNHPYF 274
|
Length = 329 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 6e-32
Identities = 68/187 (36%), Positives = 101/187 (54%), Gaps = 13/187 (6%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
ME+ GG+L I + GRF A F+ +++ G+ + HS I +RDLKL+N +LD
Sbjct: 75 MEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG- 133
Query: 61 PRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+KI DFG K +V ST GTP YIAPE+L +Y + D WS GV LY ML+
Sbjct: 134 -HIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSV-DWWSFGVLLYEMLI 191
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR-VSLECKHLLSRIFVANSEKRITIP-E 177
G PF ++ + F S+ P Y R ++ E K +L ++F + +R+ +
Sbjct: 192 GQSPFHGDDEDELFE-------SIRVDTPHYPRWITKESKDILEKLFERDPTRRLGVVGN 244
Query: 178 IKNHPWF 184
I+ HP+F
Sbjct: 245 IRGHPFF 251
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 7e-32
Identities = 71/187 (37%), Positives = 106/187 (56%), Gaps = 13/187 (6%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY GG+L I + +F A F+ ++I G+ + HS I +RDLKL+N LLD T
Sbjct: 75 MEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLD--TD 132
Query: 61 PRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+KI DFG K ++L T GTP YIAPE+L ++Y+ + D WS GV LY ML+
Sbjct: 133 GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSV-DWWSFGVLLYEMLI 191
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR-VSLECKHLLSRIFVANSEKRITIP-E 177
G PF ++ + F+ S+ P Y R ++ E K +L ++FV E+R+ + +
Sbjct: 192 GQSPFHGHDEEELFQ-------SIRMDNPCYPRWLTREAKDILVKLFVREPERRLGVKGD 244
Query: 178 IKNHPWF 184
I+ HP+F
Sbjct: 245 IRQHPFF 251
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 9e-32
Identities = 69/190 (36%), Positives = 99/190 (52%), Gaps = 14/190 (7%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
++Y GGELF + F E ARF+ ++ S + Y HS+ I +RDLK EN LLD +
Sbjct: 75 LDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLD--SQ 132
Query: 61 PRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
V + DFG K + HS+ ST GTP Y+APEVL K+ YD + D W G LY ML
Sbjct: 133 GHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD-RTVDWWCLGAVLYEMLY 191
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI----TI 175
G PF + + + + + L + + +S+ +HLL + + KR+
Sbjct: 192 GLPPFYSRDTAEMYDNILNKPLRLKPN------ISVSARHLLEGLLQKDRTKRLGAKDDF 245
Query: 176 PEIKNHPWFL 185
EIKNH +F
Sbjct: 246 LEIKNHVFFS 255
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-31
Identities = 58/192 (30%), Positives = 92/192 (47%), Gaps = 20/192 (10%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
++ GG+L + +FSE++ +F+ +++ + Y HS I HRD+K +N LLD
Sbjct: 79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQG- 137
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
V I DF + + ST GTP Y+APEVL ++ Y D WS GVT Y L G
Sbjct: 138 -HVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRG 195
Query: 121 AYPFEDPEDPKNFRKTIGRIL------SVHYSFPDYVRVSLECKHLLSRIFVANSEKRI- 173
P+ + R +I V Y S E ++++ + +KR+
Sbjct: 196 KRPYR-----GHSRTIRDQIRAKQETADVLYPATW----STEAIDAINKLLERDPQKRLG 246
Query: 174 -TIPEIKNHPWF 184
+ ++KNHP+F
Sbjct: 247 DNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 1e-30
Identities = 67/192 (34%), Positives = 103/192 (53%), Gaps = 13/192 (6%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
++Y +GGE+F + FSEDE RF+ ++I + + H + I +RD+KLEN LLD +
Sbjct: 84 LDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLD--SE 141
Query: 61 PRVKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 118
V + DFG SK + + + S GT Y+APE++ K GK D WS G+ ++ +L
Sbjct: 142 GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELL 201
Query: 119 VGAYPFEDPEDPKNFRKTIG-RILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI---- 173
GA PF E +N + + RIL FP + E + LL ++ + +KR+
Sbjct: 202 TGASPFT-LEGERNTQSEVSRRILKCDPPFPS--FIGPEAQDLLHKLLRKDPKKRLGAGP 258
Query: 174 -TIPEIKNHPWF 184
EIK HP+F
Sbjct: 259 QGASEIKEHPFF 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-30
Identities = 66/190 (34%), Positives = 106/190 (55%), Gaps = 15/190 (7%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+++ GG+LF R+ F+E++ +F+ +L + + HS+ I +RDLK EN LLD
Sbjct: 77 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG- 135
Query: 61 PRVKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+K+ DFG SK S+ H + S GT Y+APEV+ ++ + + AD WS GV ++ ML
Sbjct: 136 -HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLT 193
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI-----T 174
G+ PF+ K+ ++T+ IL P + +S E + LL +F N R+
Sbjct: 194 GSLPFQG----KDRKETMTMILKAKLGMPQF--LSPEAQSLLRALFKRNPANRLGAGPDG 247
Query: 175 IPEIKNHPWF 184
+ EIK HP+F
Sbjct: 248 VEEIKRHPFF 257
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-30
Identities = 65/194 (33%), Positives = 95/194 (48%), Gaps = 17/194 (8%)
Query: 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
MEY GG+L + +F ED A+F+ +L+ + H M HRD+K EN L+D +
Sbjct: 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTG 139
Query: 60 APRVKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIA-----DVWSCGV 112
+K+ DFG + ++ K VGTP YIAPEVLT DGK D WS GV
Sbjct: 140 --HIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGV 197
Query: 113 TLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH--YSFPDYVRVSLECKHLLSRIFVANSE 170
Y M+ G PF E KT I++ FP+ +VS + L+ + + +
Sbjct: 198 IAYEMIYGRSPFH--EG--TSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSL-LCGQK 252
Query: 171 KRITIPEIKNHPWF 184
+R+ + HP+F
Sbjct: 253 ERLGYEGLCCHPFF 266
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 1e-29
Identities = 72/190 (37%), Positives = 99/190 (52%), Gaps = 15/190 (7%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY GGELF + FSED RF+ +++S + Y HS +I +RDLKLEN +LD
Sbjct: 74 MEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDG- 132
Query: 61 PRVKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+KI DFG K + + K+ GTP Y+APEVL +Y G+ D W GV +Y M+
Sbjct: 133 -HIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMC 190
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI-----T 174
G PF + + K F IL FP +S + K LLS + + + KR+
Sbjct: 191 GRLPFYNQDHEKLFE----LILMEDIKFPR--TLSADAKSLLSGLLIKDPNKRLGGGPDD 244
Query: 175 IPEIKNHPWF 184
EI H +F
Sbjct: 245 AKEIMRHSFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-29
Identities = 64/189 (33%), Positives = 94/189 (49%), Gaps = 15/189 (7%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY GG+ I G ED A+ + +++ GV H I HRD+K EN L+D
Sbjct: 76 MEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID--QT 133
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
+K+ DFG S++ + K VGTP Y+APE + D K++D WS G ++ L G
Sbjct: 134 GHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFG 189
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL--ECKHLLSRIFVANSEKRI---TI 175
PF E P ILS ++P+ V+ E L++R+ + KR+
Sbjct: 190 YPPFH-AETPD---AVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGY 245
Query: 176 PEIKNHPWF 184
EIK+HP+F
Sbjct: 246 QEIKSHPFF 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-29
Identities = 69/190 (36%), Positives = 99/190 (52%), Gaps = 15/190 (7%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+EY +GGELF + G F ED A F+ ++ + + H I +RDLK EN LLD
Sbjct: 79 LEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG- 137
Query: 61 PRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
VK+ DFG K S+ T GT Y+APE+L + + GK D WS G +Y ML
Sbjct: 138 -HVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLT 195
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI-----T 174
GA PF +N +KTI +IL + P Y ++ E + LL ++ N R+
Sbjct: 196 GAPPFT----AENRKKTIDKILKGKLNLPPY--LTPEARDLLKKLLKRNPSSRLGAGPGD 249
Query: 175 IPEIKNHPWF 184
E+++HP+F
Sbjct: 250 AAEVQSHPFF 259
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-29
Identities = 71/192 (36%), Positives = 101/192 (52%), Gaps = 20/192 (10%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEYAAGG+L I + FSE A F+ ++ G+ Y H +I +RDLKL+N LLD T
Sbjct: 81 MEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD--TE 137
Query: 61 PRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
VKI DFG K + ST GTP ++APEVLT+ Y + D W GV +Y MLV
Sbjct: 138 GFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIYEMLV 196
Query: 120 GAYPF--EDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI---- 173
G PF +D E+ I++ +P + +S E ++ R+ N E+R+
Sbjct: 197 GESPFPGDDEEE------VFDSIVNDEVRYPRF--LSREAISIMRRLLRRNPERRLGSGE 248
Query: 174 -TIPEIKNHPWF 184
++K P+F
Sbjct: 249 KDAEDVKKQPFF 260
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-29
Identities = 68/191 (35%), Positives = 101/191 (52%), Gaps = 15/191 (7%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEYA GGELF + F+E+ ARF+ +++S + Y HS + +RD+KLEN +LD
Sbjct: 74 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG- 132
Query: 61 PRVKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+KI DFG K + + K+ GTP Y+APEVL +Y G+ D W GV +Y M+
Sbjct: 133 -HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMC 190
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI-----T 174
G PF + + + F IL FP +S E K LL+ + + ++R+
Sbjct: 191 GRLPFYNQDHERLFEL----ILMEEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSD 244
Query: 175 IPEIKNHPWFL 185
E+ H +FL
Sbjct: 245 AKEVMEHRFFL 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 8e-29
Identities = 65/189 (34%), Positives = 102/189 (53%), Gaps = 14/189 (7%)
Query: 2 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAP 61
+Y +GGELF + GRFSED A+F+ +L+ + + H I +RDLK EN LLD +
Sbjct: 76 DYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATG-- 133
Query: 62 RVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
+ +CDFG SK+++ ++ +T GT Y+APEVL ++ K D WS GV ++ M G
Sbjct: 134 HIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
Query: 121 AYPFEDPEDPKNFRK-TIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI----TI 175
PF + + +R G++ FP V +S E + + + N + R+
Sbjct: 194 WSPFYAEDTQQMYRNIAFGKV-----RFPKNV-LSDEGRQFVKGLLNRNPQHRLGAHRDA 247
Query: 176 PEIKNHPWF 184
E+K HP+F
Sbjct: 248 VELKEHPFF 256
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-28
Identities = 71/231 (30%), Positives = 98/231 (42%), Gaps = 53/231 (22%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
M+Y GG++ + G F ED ARF+ +L + H M HRD+K +N L+D
Sbjct: 80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG- 138
Query: 61 PRVKICDFG-------------YSK---------------SSVLHSQPK----------- 81
+K+ DFG Y K S + + K
Sbjct: 139 -HIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQ 197
Query: 82 -----STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKT 136
S VGTP YIAPEVL + Y ++ D WS GV LY MLVG PF + K
Sbjct: 198 RCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQPPFLADTPAETQLKV 256
Query: 137 IGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI---TIPEIKNHPWF 184
I ++H P ++S E L+ R+ +E R+ EIK HP+F
Sbjct: 257 INWETTLH--IPSQAKLSREASDLILRL-CCGAEDRLGKNGADEIKAHPFF 304
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-28
Identities = 69/195 (35%), Positives = 104/195 (53%), Gaps = 21/195 (10%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY GG+L I G+F E A F+ ++ G+ + HS I +RDLKL+N +LD
Sbjct: 80 MEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEG- 138
Query: 61 PRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+KI DFG K ++ + T GTP YIAPE++ + Y GK D W+ GV LY ML
Sbjct: 139 -HIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLA 196
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR---VSLECKHLLSRIFVANSEKRITI- 175
G PF+ ++ + F+ I+ + S+P + VS+ CK LL++ + KR+
Sbjct: 197 GQPPFDGEDEDELFQS----IMEHNVSYPKSLSKEAVSI-CKGLLTK----HPAKRLGCG 247
Query: 176 ----PEIKNHPWFLR 186
+I+ H +F R
Sbjct: 248 PTGERDIREHAFFRR 262
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 9e-28
Identities = 65/191 (34%), Positives = 92/191 (48%), Gaps = 12/191 (6%)
Query: 1 MEYAAGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
M GG+L I N G F E A F+ Q+I G+ + H +I +RDLK EN LLD
Sbjct: 72 MTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDH 131
Query: 59 TAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 118
V+I D G + + K GTP Y+APEVL + YD D ++ G TLY M+
Sbjct: 132 G--NVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS-VDWFALGCTLYEMI 188
Query: 119 VGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI----- 173
G PF ++ + R L + +PD + S E K L + + EKR+
Sbjct: 189 AGRSPFRQRKEKVEKEELKRRTLEMAVEYPD--KFSPEAKDLCEALLQKDPEKRLGCRGG 246
Query: 174 TIPEIKNHPWF 184
+ E++ HP F
Sbjct: 247 SADEVREHPLF 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-27
Identities = 64/191 (33%), Positives = 98/191 (51%), Gaps = 17/191 (8%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY GG + +++ G +E R + +Q++ GV Y HS I HRD+K N L D +A
Sbjct: 83 MEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRD--SA 140
Query: 61 PRVKICDFGYSKS-SVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYV 116
VK+ DFG SK + S KS GTP +++PEV++ + Y G+ ADVWS G T+
Sbjct: 141 GNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVE 199
Query: 117 MLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV---RVSLECKHLLSRIFVANSEKRI 173
ML P+ + E + I + + VS + ++ L R FV N++KR
Sbjct: 200 MLTEKPPWAEFE-------AMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRP 252
Query: 174 TIPEIKNHPWF 184
+ E+ H +
Sbjct: 253 SAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 1e-27
Identities = 73/191 (38%), Positives = 100/191 (52%), Gaps = 16/191 (8%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGST 59
MEYA GGELF + FSED ARF+ +++S + Y HS + +RDLKLEN +LD
Sbjct: 74 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG 133
Query: 60 APRVKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 118
+KI DFG K + + K+ GTP Y+APEVL +Y G+ D W GV +Y M+
Sbjct: 134 --HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMM 190
Query: 119 VGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI----- 173
G PF + + K F IL FP +S E K LLS + + ++R+
Sbjct: 191 CGRLPFYNQDHEKLFE----LILMEEIRFPR--TLSPEAKSLLSGLLKKDPKQRLGGGPD 244
Query: 174 TIPEIKNHPWF 184
EI H +F
Sbjct: 245 DAKEIMQHKFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 1e-27
Identities = 65/190 (34%), Positives = 100/190 (52%), Gaps = 15/190 (7%)
Query: 1 MEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL--DG 57
MEY GG L + I N R +E + + ++++ G+ Y HS + HRD+K +N LL DG
Sbjct: 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDG 153
Query: 58 STAPRVKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYV 116
S VK+ DFG++ + + S+ S VGTP ++APEV+ +K+Y K+ D+WS G+
Sbjct: 154 S----VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKV-DIWSLGIMCIE 208
Query: 117 MLVGAYP-FEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITI 175
M G P +P P I + + + S E K L++ V + EKR +
Sbjct: 209 MAEGEPPYLREP--PLRALFLI-TTKGIP-PLKNPEKWSPEFKDFLNKCLVKDPEKRPSA 264
Query: 176 PEIKNHPWFL 185
E+ HP FL
Sbjct: 265 EELLQHP-FL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-27
Identities = 67/193 (34%), Positives = 95/193 (49%), Gaps = 19/193 (9%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY GG+L +I + +F E +RF+ ++ + + H + +RDLKL+N LLD
Sbjct: 75 MEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG- 133
Query: 61 PRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
K+ DFG K +L+ +T GTP YIAPE+L + EY + D W+ GV +Y M+
Sbjct: 134 -HCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSV-DWWALGVLMYEMMA 191
Query: 120 GAYPFE-DPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI----- 173
G PFE D ED IL +P V +S E +L N KR+
Sbjct: 192 GQPPFEADNED-----DLFESILHDDVLYP--VWLSKEAVSILKAFMTKNPNKRLGCVAS 244
Query: 174 --TIPEIKNHPWF 184
IK HP+F
Sbjct: 245 QGGEDAIKQHPFF 257
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-27
Identities = 70/199 (35%), Positives = 102/199 (51%), Gaps = 22/199 (11%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY GG+L + N E ARF+ +++ + HSM HRD+K +N LLD S
Sbjct: 122 MEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG- 179
Query: 61 PRVKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYD---GKIADVWSCGVT 113
+K+ DFG + ++ + VGTP YI+PEVL + D G+ D WS GV
Sbjct: 180 -HLKLADFGTCMKMDANGMVRCD--TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 236
Query: 114 LYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYS--FPDYVRVSLECKHLLSRIFVANSEK 171
LY MLVG PF + T +I+ S FPD + +S + K L+ F+ + E
Sbjct: 237 LYEMLVGDTPFYA----DSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLI-CAFLTDREV 291
Query: 172 RI---TIPEIKNHPWFLRN 187
R+ + EIK+HP+F +
Sbjct: 292 RLGRNGVDEIKSHPFFKND 310
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-27
Identities = 60/188 (31%), Positives = 90/188 (47%), Gaps = 15/188 (7%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL--DGS 58
+EYA G L + I G F E + Q++ G++Y H + HRD+K N L DG
Sbjct: 78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGV 137
Query: 59 TAPRVKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVM 117
VK+ DFG + K + + S VGTP ++APEV+ +D+WS G T+ +
Sbjct: 138 ----VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTA-SDIWSLGCTVIEL 192
Query: 118 LVGAYPFEDPEDPKNFRKTIGRILSV-HYSFPDYVRVSLECKHLLSRIFVANSEKRITIP 176
L G P+ D +P + RI+ H P+ +S E K L + F + R T
Sbjct: 193 LTGNPPYYD-LNPMA---ALFRIVQDDHPPLPE--GISPELKDFLMQCFQKDPNLRPTAK 246
Query: 177 EIKNHPWF 184
++ HPW
Sbjct: 247 QLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-27
Identities = 63/184 (34%), Positives = 90/184 (48%), Gaps = 9/184 (4%)
Query: 1 MEYAAGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
MEYA GG L E I ED FF Q++ + + H+ I HRDLK +N LLD
Sbjct: 78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKH 137
Query: 59 TAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 118
VKI DFG SK S+ + VGTP YI+PE+ K Y+ K +D+W+ G LY +
Sbjct: 138 KMV-VKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQK-SDIWALGCVLYELA 195
Query: 119 VGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEI 178
FE N + +I+S ++ P R S + + L+ + + KR + +I
Sbjct: 196 SLKRAFE----AANLPALVLKIMSGTFA-PISDRYSPDLRQLILSMLNLDPSKRPQLSQI 250
Query: 179 KNHP 182
P
Sbjct: 251 MAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-26
Identities = 65/189 (34%), Positives = 99/189 (52%), Gaps = 16/189 (8%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+E+ GGE F + RF D F+ Q++ Y S+ I +RDLK EN LLD
Sbjct: 110 LEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGF 169
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
+K+ DFG++K V+ ++ + GTP YIAPE+L + GK AD W+ G+ +Y +LVG
Sbjct: 170 --IKMTDFGFAK--VVDTRTYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVG 224
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI-----TI 175
PF E ++K + I+ FP ++ + CKHL+ ++ + KR
Sbjct: 225 CPPFYANEPLLIYQKILEGII----YFPKFLDNN--CKHLMKKLLSHDLTKRYGNLKKGA 278
Query: 176 PEIKNHPWF 184
+K HPWF
Sbjct: 279 QNVKEHPWF 287
|
Length = 340 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-26
Identities = 68/190 (35%), Positives = 100/190 (52%), Gaps = 15/190 (7%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY GG+L +I GRF E A F+ ++ G+ + HS I +RDLKL+N +LD
Sbjct: 80 MEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG- 138
Query: 61 PRVKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+KI DFG K ++ K+ GTP YIAPE++ + Y GK D W+ GV LY ML
Sbjct: 139 -HIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLA 196
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITI-PE- 177
G PFE ++ + F+ I+ + ++P +S E + + + KR+ PE
Sbjct: 197 GQAPFEGEDEDELFQS----IMEHNVAYPK--SMSKEAVAICKGLMTKHPGKRLGCGPEG 250
Query: 178 ---IKNHPWF 184
IK H +F
Sbjct: 251 ERDIKEHAFF 260
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 5e-26
Identities = 65/207 (31%), Positives = 101/207 (48%), Gaps = 31/207 (14%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY GG+ + N G D AR +F + + + Y H+ I HRDLK +N L+ ++
Sbjct: 80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI--TSM 137
Query: 61 PRVKICDFGYSKSSVLHS----------------QPKSTVGTPAYIAPEVLTKKEYDGKI 104
+K+ DFG SK ++ K GTP YIAPEV+ ++ Y GK
Sbjct: 138 GHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKP 196
Query: 105 ADVWSCGVTLYVMLVGAYPF--EDPEDPKNFRKTIGRILSVHYSFPDYVR-VSLECKHLL 161
D W+ G+ LY LVG PF + PE+ G+++S +P+ + + + L+
Sbjct: 197 VDWWAMGIILYEFLVGCVPFFGDTPEE------LFGQVISDDIEWPEGDEALPADAQDLI 250
Query: 162 SRIFVANSEKRITIP---EIKNHPWFL 185
SR+ N +R+ E+K H +FL
Sbjct: 251 SRLLRQNPLERLGTGGAFEVKQHRFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 6e-26
Identities = 67/189 (35%), Positives = 96/189 (50%), Gaps = 14/189 (7%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
++Y GGELF + F E ARF+ ++ S + Y HS+ I +RDLK EN LLD +
Sbjct: 75 LDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD--SQ 132
Query: 61 PRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+ + DFG K ++ H+ ST GTP Y+APEVL K+ YD + D W G LY ML
Sbjct: 133 GHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLY 191
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI----TI 175
G PF + + + + L + + + R HLL + + KR+
Sbjct: 192 GLPPFYSRNTAEMYDNILNKPLQLKPNITNSAR------HLLEGLLQKDRTKRLGAKDDF 245
Query: 176 PEIKNHPWF 184
EIKNH +F
Sbjct: 246 MEIKNHIFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 8e-26
Identities = 69/195 (35%), Positives = 105/195 (53%), Gaps = 21/195 (10%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY GG+L I G+F E +A F+ ++ G+ + H I +RDLKL+N +LD +
Sbjct: 80 MEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLD--SE 137
Query: 61 PRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+KI DFG K ++ T GTP YIAPE++ + Y GK D W+ GV LY ML
Sbjct: 138 GHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVDWWAYGVLLYEMLA 196
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR---VSLECKHLLSRIFVANSEKRITI- 175
G PF+ ++ + F+ I+ + S+P + VS+ CK L+++ + KR+
Sbjct: 197 GQPPFDGEDEDELFQS----IMEHNVSYPKSLSKEAVSI-CKGLMTK----HPSKRLGCG 247
Query: 176 PE----IKNHPWFLR 186
PE I+ H +F R
Sbjct: 248 PEGERDIREHAFFRR 262
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-25
Identities = 60/182 (32%), Positives = 88/182 (48%), Gaps = 6/182 (3%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+E GG L + + G F E R + +Q++ G+ Y H HRD+K N L+D +
Sbjct: 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGV 140
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
VK+ DFG +K V S KS G+P ++APEV+ ++ G AD+WS G T+ M G
Sbjct: 141 --VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATG 198
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
P+ E K IGR PD+ +S E K + + + R T E+
Sbjct: 199 KPPWSQLEGVAAVFK-IGRS-KELPPIPDH--LSDEAKDFILKCLQRDPSLRPTAAELLE 254
Query: 181 HP 182
HP
Sbjct: 255 HP 256
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-25
Identities = 56/192 (29%), Positives = 83/192 (43%), Gaps = 18/192 (9%)
Query: 1 MEYAAGGELFERICNA----GRFSEDEARFFFQQLISGVSYCH-----SMQICHRDLKLE 51
MEY GG+L + I E+ QL+ + CH + HRDLK
Sbjct: 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPA 139
Query: 52 NTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSC 110
N LD + VK+ DFG +K S T VGTP Y++PE L YD K +D+WS
Sbjct: 140 NIFLDAN--NNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEK-SDIWSL 196
Query: 111 GVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSE 170
G +Y + + PF +N + +I + Y R S E ++ + + +
Sbjct: 197 GCLIYELCALSPPFT----ARNQLQLASKIKEGKFRRIPY-RYSSELNEVIKSMLNVDPD 251
Query: 171 KRITIPEIKNHP 182
KR + E+ P
Sbjct: 252 KRPSTEELLQLP 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-25
Identities = 65/189 (34%), Positives = 90/189 (47%), Gaps = 10/189 (5%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+EY GG + + GRF E RFF +Q++ G++Y HS I HRDLK +N L+D
Sbjct: 87 LEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGI 146
Query: 61 PRVKICDFGYSKSS---VLHSQPKSTVGTPAYIAPEV--LTKKEYDGKIADVWSCGVTLY 115
KI DFG SK S + Q S G+ ++APEV + Y K+ D+WS G +
Sbjct: 147 --CKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKV-DIWSLGCVVL 203
Query: 116 VMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV-RVSLECKHLLSRIFVANSEKRIT 174
M G P+ D E K +G S PD +S L+ F N + R T
Sbjct: 204 EMFAGRRPWSDEEAIAAMFK-LGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPT 262
Query: 175 IPEIKNHPW 183
E+ HP+
Sbjct: 263 ARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-25
Identities = 54/126 (42%), Positives = 71/126 (56%), Gaps = 4/126 (3%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
ME+ GG+L I + RF E ARF+ ++ S + + H I +RDLKL+N LLD
Sbjct: 75 MEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEG- 133
Query: 61 PRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
K+ DFG K + + + ST GTP YIAPE+L + Y G D W+ GV LY ML
Sbjct: 134 -HCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPSVDWWAMGVLLYEMLC 191
Query: 120 GAYPFE 125
G PFE
Sbjct: 192 GHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (248), Expect = 1e-24
Identities = 57/204 (27%), Positives = 80/204 (39%), Gaps = 46/204 (22%)
Query: 15 NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSS 74
G S + + QL+ G++YCHS +I HRDLK +N L++ +K+ DFG +++
Sbjct: 91 RPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRD--GVLKLADFGLARA- 147
Query: 75 VLHSQPKST----VGTPAYIAPEVLTK-KEYDGKIADVWSCGVTLYVMLVGAYPFE---- 125
P T V T Y APE+L K Y + D+WS G M+ G F
Sbjct: 148 --FGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAV-DIWSVGCIFAEMITGKPLFPGDSE 204
Query: 126 --------------DPEDPKNFRKTIGRILSVHYS--FPDYVRVSL---------ECKHL 160
E K Y FP + L E L
Sbjct: 205 IDQLFKIFQILGTPTEESWPGVTK------LPDYKPTFPKFPPKDLEKVLPRLDPEGIDL 258
Query: 161 LSRIFVANSEKRITIPEIKNHPWF 184
LS++ N KRI+ E HP+F
Sbjct: 259 LSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 2e-24
Identities = 55/125 (44%), Positives = 70/125 (56%), Gaps = 4/125 (3%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
++Y GGELF + F E ARF+ ++ S + Y HS+ I +RDLK EN LLD +
Sbjct: 75 LDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLD--SQ 132
Query: 61 PRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
V + DFG K V + ST GTP Y+APEVL K+ YD + D W G LY ML
Sbjct: 133 GHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYD-RTVDWWCLGAVLYEMLY 191
Query: 120 GAYPF 124
G PF
Sbjct: 192 GLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 2e-24
Identities = 62/189 (32%), Positives = 94/189 (49%), Gaps = 14/189 (7%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+++ GGELF + F E ARF+ ++ S + Y HS+ I +RDLK EN LLD +
Sbjct: 75 LDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLD--SQ 132
Query: 61 PRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
V + DFG K + S +T GTP Y+APEV+ K+ YD + D W G LY ML
Sbjct: 133 GHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTV-DWWCLGAVLYEMLY 191
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI----TI 175
G PF + + + + + L + SL +L + + ++R+
Sbjct: 192 GLPPFYCRDVAEMYDNILHKPLVLRPG------ASLTAWSILEELLEKDRQRRLGAKEDF 245
Query: 176 PEIKNHPWF 184
EI+ HP+F
Sbjct: 246 LEIQEHPFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 3e-24
Identities = 61/187 (32%), Positives = 95/187 (50%), Gaps = 15/187 (8%)
Query: 1 MEYAAGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
MEYA GG L+++I F E+ ++ Q++S VSY H I HRD+K N L +
Sbjct: 78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL--T 135
Query: 59 TAPRVKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY 115
A +K+ DFG SK S ++ + VGTP Y++PE+ +Y+ K +D+W+ G LY
Sbjct: 136 KAGLIKLGDFGISKILGSEYSMAE--TVVGTPYYMSPELCQGVKYNFK-SDIWALGCVLY 192
Query: 116 VMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITI 175
+L F D N + +I+ +Y+ P S E L+ + + EKR T
Sbjct: 193 ELLTLKRTF----DATNPLNLVVKIVQGNYT-PVVSVYSSELISLVHSLLQQDPEKRPTA 247
Query: 176 PEIKNHP 182
E+ + P
Sbjct: 248 DEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 3e-24
Identities = 50/130 (38%), Positives = 76/130 (58%), Gaps = 6/130 (4%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEYA GG + + AG +E ++++ + Y H + + HRD+K N L+ +
Sbjct: 81 MEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV--TNT 137
Query: 61 PRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTK-KEYDGKIADVWSCGVTLYVML 118
VK+CDFG + +S +ST VGTP ++APEV+T+ K YD K AD+WS G+T+Y M
Sbjct: 138 GNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTK-ADIWSLGITIYEMA 196
Query: 119 VGAYPFEDPE 128
G P+ D +
Sbjct: 197 TGNPPYSDVD 206
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 4e-24
Identities = 62/190 (32%), Positives = 99/190 (52%), Gaps = 13/190 (6%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL--DGS 58
ME+ GG L + I R +E++ ++ +S+ H+ + HRD+K ++ LL DG
Sbjct: 95 MEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDG- 152
Query: 59 TAPRVKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVM 117
RVK+ DFG+ ++ S + KS VGTP ++APEV+++ Y G D+WS G+ + M
Sbjct: 153 ---RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEM 208
Query: 118 LVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPE 177
+ G P+ + E P K I L + +VS + L R+ V + +R T E
Sbjct: 209 VDGEPPYFN-EPPLQAMKRIRDNLPPK--LKNLHKVSPRLRSFLDRMLVRDPAQRATAAE 265
Query: 178 IKNHPWFLRN 187
+ NHP FL
Sbjct: 266 LLNHP-FLAK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 4e-24
Identities = 56/188 (29%), Positives = 98/188 (52%), Gaps = 17/188 (9%)
Query: 1 MEYAAGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG 57
M+Y GG+L+++I NA R F ED+ +F Q+ + + H +I HRD+K +N L
Sbjct: 78 MDYCEGGDLYKKI-NAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTK 136
Query: 58 STAPRVKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTL 114
+K+ DFG ++ VL+S ++ +GTP Y++PE+ + Y+ K +D+W+ G L
Sbjct: 137 DGT--IKLGDFGIAR--VLNSTVELARTCIGTPYYLSPEICENRPYNNK-SDIWALGCVL 191
Query: 115 YVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRIT 174
Y M + FE N + + +I+ Y P S + ++L+S++F N R +
Sbjct: 192 YEMCTLKHAFE----AGNMKNLVLKIIRGSYP-PVSSHYSYDLRNLVSQLFKRNPRDRPS 246
Query: 175 IPEIKNHP 182
+ I
Sbjct: 247 VNSILEKN 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 5e-24
Identities = 61/196 (31%), Positives = 90/196 (45%), Gaps = 23/196 (11%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY GG + + G+ E F ++++ G+ Y H HRD+K N LL S
Sbjct: 78 MEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL--SEE 134
Query: 61 PRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
VK+ DFG S + S+ + VGTP ++APEV+ + YD K AD+WS G+T +
Sbjct: 135 GDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEK-ADIWSLGITAIELAK 193
Query: 120 GAYPFED--P-----EDPKNFRKTI-GRILSVHYSFPDYVRVSLE--------CKHLLSR 163
G P D P PKN ++ G S F D+V + L K LL
Sbjct: 194 GEPPLSDLHPMRVLFLIPKNNPPSLEGNKFS--KPFKDFVSLCLNKDPKERPSAKELLKH 251
Query: 164 IFVANSEKRITIPEIK 179
F+ ++K + +
Sbjct: 252 KFIKKAKKTSYLTLLI 267
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 9e-24
Identities = 61/189 (32%), Positives = 84/189 (44%), Gaps = 19/189 (10%)
Query: 1 MEYAAGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD 56
MEYA G+L + I + E E F QL+ G+ H +I HRDLK N LL
Sbjct: 78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILL- 136
Query: 57 GSTAPRVKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY 115
VKI D G SK VL K+ +GTP Y+APEV + Y K +D+WS G LY
Sbjct: 137 -VANDLVKIGDLGISK--VLKKNMAKTQIGTPHYMAPEVWKGRPYSYK-SDIWSLGCLLY 192
Query: 116 VMLVGAYPFE--DPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI 173
M A PFE +D + ++ Y P S + ++ + + + R
Sbjct: 193 EMATFAPPFEARSMQDLRY------KVQRGKYP-PIPPIYSQDLQNFIRSMLQVKPKLRP 245
Query: 174 TIPEIKNHP 182
+I P
Sbjct: 246 NCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 1e-23
Identities = 68/223 (30%), Positives = 102/223 (45%), Gaps = 45/223 (20%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
ME+ GG++ + SE+ +F+ + + + H + HRD+K +N LLD
Sbjct: 80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKG- 138
Query: 61 PRVKICDFGYSKS-----------SVLHSQPK-------------------------STV 84
VK+ DFG ++ H+ P STV
Sbjct: 139 -HVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTV 197
Query: 85 GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH 144
GTP YIAPEV + Y+ K+ D WS GV +Y ML+G PF + +RK + ++
Sbjct: 198 GTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETL- 255
Query: 145 YSFPDYVRVSLECKHLLSRIFVANSEKRI---TIPEIKNHPWF 184
FP V +S + K L+ R F +SE RI + EIK+HP+F
Sbjct: 256 -VFPPEVPISEKAKDLILR-FCTDSENRIGSNGVEEIKSHPFF 296
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 1e-23
Identities = 61/190 (32%), Positives = 89/190 (46%), Gaps = 15/190 (7%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+EY GG + + N G F E R F +Q++ G++Y H+ I HRD+K N L+D
Sbjct: 85 LEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG 144
Query: 61 PRVKICDFGYSK-------SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVT 113
+KI DFG SK S+ + S G+ ++APEV+ + Y K AD+WS G
Sbjct: 145 --IKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRK-ADIWSLGCL 201
Query: 114 LYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI 173
+ ML G +PF D + K P +S E L + F + KR
Sbjct: 202 VVEMLTGKHPFPDCTQLQAIFKIGENASP---EIPS--NISSEAIDFLEKTFEIDHNKRP 256
Query: 174 TIPEIKNHPW 183
T E+ HP+
Sbjct: 257 TAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 1e-23
Identities = 61/193 (31%), Positives = 98/193 (50%), Gaps = 14/193 (7%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
++Y GGELF + RF E E + + +++ + + H + I +RD+KLEN LLD +
Sbjct: 84 LDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG- 142
Query: 61 PRVKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVLTKKE--YDGKIADVWSCGVTLYV 116
V + DFG SK + S GT Y+AP+++ + +D K D WS GV +Y
Sbjct: 143 -HVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHD-KAVDWWSMGVLMYE 200
Query: 117 MLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI--- 173
+L GA PF + + + RIL +P +S K ++ R+ + + +KR+
Sbjct: 201 LLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EMSALAKDIIQRLLMKDPKKRLGCG 258
Query: 174 --TIPEIKNHPWF 184
EIK HP+F
Sbjct: 259 PSDADEIKKHPFF 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 3e-23
Identities = 56/185 (30%), Positives = 89/185 (48%), Gaps = 6/185 (3%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QICHRDLKLENTLLDGST 59
+EY GG L + + G+ E + +Q++ G+ Y H+ I HRD+K N L+ ++
Sbjct: 78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI--NS 135
Query: 60 APRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 118
VKI DFG SK +T VGT Y++PE + + E AD+WS G+TL
Sbjct: 136 KGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERI-QGESYSYAADIWSLGLTLLECA 194
Query: 119 VGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEI 178
+G +PF P P +F + + I S E + +S + +KR + E+
Sbjct: 195 LGKFPFLPPGQP-SFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAEL 253
Query: 179 KNHPW 183
HP+
Sbjct: 254 LQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 6e-23
Identities = 51/130 (39%), Positives = 73/130 (56%), Gaps = 10/130 (7%)
Query: 1 MEYAAGGELFERI-CNAGR-FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
MEYA G+L + + GR ED+ FF Q++ G+++ HS +I HRD+K N LD
Sbjct: 78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAY 137
Query: 59 TAPRVKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY 115
VKI D G +K +L + VGTP Y++PE+ K Y+ K +DVW+ GV LY
Sbjct: 138 D--NVKIGDLGVAK--LLSDNTNFANTIVGTPYYLSPELCEDKPYNEK-SDVWALGVVLY 192
Query: 116 VMLVGAYPFE 125
G +PF+
Sbjct: 193 ECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 1e-22
Identities = 63/194 (32%), Positives = 94/194 (48%), Gaps = 15/194 (7%)
Query: 1 MEYAAGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD 56
M GG+L I N F E A F+ Q+ISG+ + H +I +RDLK EN LLD
Sbjct: 72 MTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLD 131
Query: 57 GSTAPRVKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY 115
V+I D G + + S+ K GTP ++APE+L +EYD + D ++ GVTLY
Sbjct: 132 --NDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSV-DYFALGVTLY 188
Query: 116 VMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI-- 173
M+ PF + ++ RIL+ ++PD + S K + + EKR+
Sbjct: 189 EMIAARGPFRARGEKVENKELKQRILNDSVTYPD--KFSPASKSFCEALLAKDPEKRLGF 246
Query: 174 ---TIPEIKNHPWF 184
++ HP F
Sbjct: 247 RDGNCDGLRTHPLF 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-22
Identities = 70/194 (36%), Positives = 100/194 (51%), Gaps = 18/194 (9%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY GG+L + N E ARF+ +++ + HSM HRD+K +N LLD S
Sbjct: 122 MEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG- 179
Query: 61 PRVKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLTKK---EYDGKIADVWSCGVT 113
+K+ DFG +K ++ + VGTP YI+PEVL + Y G+ D WS GV
Sbjct: 180 -HLKLADFGTCMKMNKEGMVRCD--TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 236
Query: 114 LYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI 173
LY MLVG PF + K + S+ +FPD +S E K+L+ F+ + E R+
Sbjct: 237 LYEMLVGDTPFYADSLVGTYSKIMNHKNSL--TFPDDNDISKEAKNLIC-AFLTDREVRL 293
Query: 174 ---TIPEIKNHPWF 184
+ EIK H +F
Sbjct: 294 GRNGVEEIKRHLFF 307
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 5e-22
Identities = 60/218 (27%), Positives = 92/218 (42%), Gaps = 44/218 (20%)
Query: 1 MEYAAGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL--DG 57
MEY L E + + R E + + + + L+ GV+Y H+ I HRDLK N L+ DG
Sbjct: 78 MEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADG 136
Query: 58 STAPRVKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVL-TKKEYDGKIADVWSCGVTL 114
+KI DFG ++ S V T Y APE+L ++YD + D+W+ G
Sbjct: 137 V----LKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGV-DLWAVGCIF 191
Query: 115 YVMLVGAYPFEDPEDPKNFRKTIGRILSV-----------HYSFPDYVRVSL-ECK---- 158
+L G+ P E N + + + S PDY +++ E K
Sbjct: 192 AELLNGS-PLFPGE---NDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPL 247
Query: 159 ------------HLLSRIFVANSEKRITIPEIKNHPWF 184
LL + V + KR++ E HP+F
Sbjct: 248 EEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 6e-22
Identities = 69/202 (34%), Positives = 102/202 (50%), Gaps = 30/202 (14%)
Query: 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
M+Y GG+L + R ED ARF+ +++ + H + HRD+K +N LLD
Sbjct: 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD--K 137
Query: 60 APRVKICDFGYSKSSVLHSQPKST------VGTPAYIAPEVLTKKEYDGK-----IADVW 108
+++ DFG S L T VGTP YI+PE+L E DGK D W
Sbjct: 138 NGHIRLADFG----SCLRLLADGTVQSNVAVGTPDYISPEILQAME-DGKGRYGPECDWW 192
Query: 109 SCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV--HYSFPDYVR-VSLECKHLLSRIF 165
S GV +Y ML G PF ++ +T G+I++ H+ FP V VS E K L+ R+
Sbjct: 193 SLGVCMYEMLYGETPFY----AESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRL- 247
Query: 166 VANSEKRI---TIPEIKNHPWF 184
+ + E R+ + + K+HP+F
Sbjct: 248 ICSPETRLGRNGLQDFKDHPFF 269
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 6e-22
Identities = 66/194 (34%), Positives = 101/194 (52%), Gaps = 18/194 (9%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY GG+L + N E A+F+ +++ + HSM + HRD+K +N LLD
Sbjct: 122 MEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG- 179
Query: 61 PRVKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLTKK---EYDGKIADVWSCGVT 113
+K+ DFG ++ ++ + VGTP YI+PEVL + Y G+ D WS GV
Sbjct: 180 -HLKLADFGTCMKMDETGMVRCD--TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 236
Query: 114 LYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI 173
L+ MLVG PF + K + S+ +FP+ V +S K+L+ F+ + E R+
Sbjct: 237 LFEMLVGDTPFYADSLVGTYSKIMDHKNSL--NFPEDVEISKHAKNLIC-AFLTDREVRL 293
Query: 174 ---TIPEIKNHPWF 184
+ EIK HP+F
Sbjct: 294 GRNGVEEIKQHPFF 307
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 2e-21
Identities = 67/241 (27%), Positives = 107/241 (44%), Gaps = 69/241 (28%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
ME+ GG+L + FSED RF+ + + + H + HRD+K +N L+D
Sbjct: 80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGG- 138
Query: 61 PRVKICDFG-------------YSK----------------------SSVLHSQPK---- 81
+K+ DFG Y K + + S+ +
Sbjct: 139 -HIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATW 197
Query: 82 ---------STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPF--EDPEDP 130
STVGTP YIAPE+ ++ Y G+ D WS G ++ L+G PF E+ +
Sbjct: 198 KKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFECLIGWPPFCSENSHET 256
Query: 131 K----NFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI---TIPEIKNHPW 183
N+R+T+ FPD + +S+E + L+ R+ + N+E R+ EIK+HP+
Sbjct: 257 YRKIINWRETL--------YFPDDIHLSVEAEDLIRRL-ITNAENRLGRGGAHEIKSHPF 307
Query: 184 F 184
F
Sbjct: 308 F 308
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 3e-21
Identities = 54/193 (27%), Positives = 95/193 (49%), Gaps = 15/193 (7%)
Query: 1 MEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDG 57
MEY GG L + GR E ++ G++Y H +I HRD+K N L++
Sbjct: 78 MEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN- 135
Query: 58 STAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVM 117
+ ++K+CDFG S V +S K+ VGT +Y+APE + +Y K +D+WS G++L +
Sbjct: 136 -SRGQIKLCDFGVSGQLV-NSLAKTFVGTSSYMAPERIQGNDYSVK-SDIWSLGLSLIEL 192
Query: 118 LVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV----RVSLECKHLLSRIFVANSEKRI 173
G +P+ DP + I +L + P + S + + ++ + + +R
Sbjct: 193 ATGRFPYPPENDPPD---GIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERP 249
Query: 174 TIPEIKNHPWFLR 186
+ E+ HP+ +
Sbjct: 250 SYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 5e-21
Identities = 44/129 (34%), Positives = 70/129 (54%), Gaps = 7/129 (5%)
Query: 1 MEYAAGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
MEY G + + +I N +E+E Q + G+ Y HS + HRD+K N LL+
Sbjct: 77 MEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLN-- 133
Query: 59 TAPRVKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVM 117
+ K+ DFG S + + ++ + +GTP ++APEV+ + Y+ K AD+WS G+T M
Sbjct: 134 EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNK-ADIWSLGITAIEM 192
Query: 118 LVGAYPFED 126
G P+ D
Sbjct: 193 AEGKPPYSD 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 5e-21
Identities = 59/190 (31%), Positives = 96/190 (50%), Gaps = 16/190 (8%)
Query: 1 MEYAAGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG 57
MEY GG+L +RI N R FSED+ +F Q+ G+ + H +I HRD+K +N L
Sbjct: 78 MEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLS- 135
Query: 58 STAPRVKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTL 114
K+ DFG ++ L+ + VGTP Y++PE+ + Y+ K D+WS G L
Sbjct: 136 KNGMVAKLGDFGIAR--QLNDSMELAYTCVGTPYYLSPEICQNRPYNNK-TDIWSLGCVL 192
Query: 115 YVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRIT 174
Y + +PFE N + + +I +++ P S + + L+S++F + R +
Sbjct: 193 YELCTLKHPFEG----NNLHQLVLKICQGYFA-PISPNFSRDLRSLISQLFKVSPRDRPS 247
Query: 175 IPEIKNHPWF 184
I I P+
Sbjct: 248 ITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 6e-21
Identities = 70/231 (30%), Positives = 112/231 (48%), Gaps = 38/231 (16%)
Query: 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
M+Y GG+L + R ED ARF+ +++ + H + HRD+K +N LLD +
Sbjct: 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNG 139
Query: 60 APRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLTKKEYD----GKIADVWSCGVT 113
+++ DFG +S+ VGTP YI+PE+L E G D WS GV
Sbjct: 140 --HIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVC 197
Query: 114 LYVMLVGAYPFEDPEDPKNFRKTIGRILS--VHYSFPDYVR-VSLECKHLLSRIFVANSE 170
+Y ML G PF ++ +T G+I++ + FP ++ VS E K L+ R+ + + E
Sbjct: 198 MYEMLYGETPFY----AESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRL-ICSRE 252
Query: 171 KRI---TIPEIKNHPWFLRNLPIELTEGGSWQS---------HDVNNPSQS 209
+R+ I + K H +F EG W++ DV++PS +
Sbjct: 253 RRLGQNGIEDFKKHAFF---------EGIDWENIRNLEAPYIPDVSSPSDT 294
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 1e-20
Identities = 62/187 (33%), Positives = 97/187 (51%), Gaps = 12/187 (6%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY GG + +++ G +E R + +Q++ G+SY HS I HRD+K N L D +A
Sbjct: 85 MEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRD--SA 142
Query: 61 PRVKICDFGYSK--SSVLHSQP--KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYV 116
VK+ DFG SK ++ S +S GTP +++PEV++ + Y G+ ADVWS G T+
Sbjct: 143 GNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY-GRKADVWSLGCTVVE 201
Query: 117 MLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIP 176
ML P+ + E I +I + + +S + L IFV + R +
Sbjct: 202 MLTEKPPWAEYEA----MAAIFKIATQPTNPQLPSHISEHARDFLGCIFV-EARHRPSAE 256
Query: 177 EIKNHPW 183
E+ HP+
Sbjct: 257 ELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 1e-20
Identities = 62/195 (31%), Positives = 87/195 (44%), Gaps = 16/195 (8%)
Query: 1 MEYAAGGELFE---RICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL-- 55
M Y +GG L + G E ++++ G+ Y HS HRD+K N LL
Sbjct: 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGE 137
Query: 56 DGSTAPRVKICDFGYSKS-----SVLHSQPKSTVGTPAYIAPEVLT-KKEYDGKIADVWS 109
DGS VKI DFG S S K+ VGTP ++APEV+ YD K AD+WS
Sbjct: 138 DGS----VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFK-ADIWS 192
Query: 110 CGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANS 169
G+T + GA P+ K T+ + DY + S + ++S +
Sbjct: 193 FGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDP 252
Query: 170 EKRITIPEIKNHPWF 184
KR T E+ H +F
Sbjct: 253 SKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-20
Identities = 43/126 (34%), Positives = 71/126 (56%), Gaps = 4/126 (3%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+E+ +GG+L + + E+ ARF+ ++ +++ H I +RDLKL+N LLD
Sbjct: 75 IEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEG- 133
Query: 61 PRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+K+ D+G K + ST GTP YIAPE+L ++Y + D W+ GV ++ M+
Sbjct: 134 -HIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV-DWWALGVLMFEMMA 191
Query: 120 GAYPFE 125
G PF+
Sbjct: 192 GRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 2e-20
Identities = 63/190 (33%), Positives = 91/190 (47%), Gaps = 23/190 (12%)
Query: 6 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVK- 64
GG+L + G FSE E RF+ ++I G+ + H+ + +RDLK N LLD R+
Sbjct: 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISD 140
Query: 65 ---ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK-EYDGKIADVWSCGVTLYVMLVG 120
CDF K P ++VGT Y+APEVL K YD AD +S G L+ +L G
Sbjct: 141 LGLACDFSKKK-------PHASVGTHGYMAPEVLQKGVAYDSS-ADWFSLGCMLFKLLRG 192
Query: 121 AYPFEDPEDPKNFRKTIGR-ILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITI---- 175
PF + + I R L++ PD S E + LL + + +R+
Sbjct: 193 HSPFRQHKTKD--KHEIDRMTLTMAVELPD--SFSPELRSLLEGLLQRDVNRRLGCLGRG 248
Query: 176 -PEIKNHPWF 184
E+K HP+F
Sbjct: 249 AQEVKEHPFF 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-20
Identities = 65/209 (31%), Positives = 96/209 (45%), Gaps = 31/209 (14%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+E+ GG L +F D AR Q++SG++Y H I HRD+K N L++ +A
Sbjct: 151 LEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHRRHIVHRDIKPSNLLIN--SA 204
Query: 61 PRVKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEV----LTKKEYDGKIADVWSCGVTLY 115
VKI DFG S+ P S+VGT AY++PE L YDG D+WS GV++
Sbjct: 205 KNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSIL 264
Query: 116 VMLVGAYPFEDPEDPKNFRKTIGR-------ILSVHYSFPDY--VRVSLECKHLLSRIFV 166
+G +PF +GR + ++ S P S E +H +S
Sbjct: 265 EFYLGRFPF-----------GVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQ 313
Query: 167 ANSEKRITIPEIKNHPWFLRNLPIELTEG 195
KR + ++ HP+ LR P + G
Sbjct: 314 REPAKRWSAMQLLQHPFILRAQPGQGQGG 342
|
Length = 353 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 2e-20
Identities = 45/199 (22%), Positives = 78/199 (39%), Gaps = 39/199 (19%)
Query: 18 RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH 77
+F+E + + + +QL+ G+ Y HS I HRD+K N L++ +K+ DFG ++
Sbjct: 96 KFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDG--VLKLADFGLARPYTKR 153
Query: 78 SQPKST--VGTPAYIAPEVLT-KKEYDGKIADVWSCGVTLYVMLVGAYPF---------- 124
+ T V T Y PE+L Y ++ D+WS G L + +G F
Sbjct: 154 NSADYTNRVITLWYRPPELLLGATRYGPEV-DMWSVGCILAELFLGKPIFQGSTELEQLE 212
Query: 125 -----------------EDPEDPKNFR--KTIGRILSVHYSFPDYVRVSLECKHLLSRIF 165
+N + K R L + + LL ++
Sbjct: 213 KIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKH----LIDPSALDLLDKLL 268
Query: 166 VANSEKRITIPEIKNHPWF 184
+ +KRI+ + H +F
Sbjct: 269 TLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-20
Identities = 62/193 (32%), Positives = 94/193 (48%), Gaps = 16/193 (8%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+E+ AGG + + G F E + +QL+ G+SY H QI HRD+K N L+D ST
Sbjct: 82 VEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLID-STG 140
Query: 61 PRVKICDFGYSKSSVLHSQPKST-------VGTPAYIAPEVLTKKEYDGKIADVWSCGVT 113
R++I DFG ++ L ++ +GT A++APEVL ++Y G+ DVWS G
Sbjct: 141 QRLRIADFG--AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQY-GRSCDVWSVGCV 197
Query: 114 LYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY--SFPDYVRVSLECKHLLSRIFVANSEK 171
+ M P+ + E N I +I S S P+++ L + + R E
Sbjct: 198 IIEMATAKPPW-NAEKHSNHLALIFKIASATTAPSIPEHLSPGL--RDVTLRCLELQPED 254
Query: 172 RITIPEIKNHPWF 184
R E+ HP F
Sbjct: 255 RPPSRELLKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-20
Identities = 65/186 (34%), Positives = 97/186 (52%), Gaps = 12/186 (6%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+EY GG + +++ G +E+ R + +Q++ GVSY HS I HRD+K N L D +A
Sbjct: 85 VEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRD--SA 142
Query: 61 PRVKICDFGYSK--SSVLHSQP--KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYV 116
VK+ DFG SK ++ S KS GTP +++PEV++ + Y G+ ADVWS T+
Sbjct: 143 GNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGY-GRKADVWSVACTVVE 201
Query: 117 MLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIP 176
ML P+ + E K + PD VS C+ L +IFV ++R T
Sbjct: 202 MLTEKPPWAEYEAMAAIFKIATQ--PTKPMLPD--GVSDACRDFLKQIFV-EEKRRPTAE 256
Query: 177 EIKNHP 182
+ HP
Sbjct: 257 FLLRHP 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 3e-20
Identities = 45/129 (34%), Positives = 67/129 (51%), Gaps = 5/129 (3%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
M+Y G+LF+ + G+ SE E + +QL+ ++ H I H D+KLEN L D +
Sbjct: 88 MDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAK- 146
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
R+ +CD+G K P GT Y +PE + YD D W+ GV Y +L G
Sbjct: 147 DRIYLCDYGLCKII---GTPSCYDGTLDYFSPEKIKGHNYDVSF-DWWAVGVLTYELLTG 202
Query: 121 AYPFEDPED 129
+PF++ ED
Sbjct: 203 KHPFKEDED 211
|
Length = 267 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-20
Identities = 70/229 (30%), Positives = 104/229 (45%), Gaps = 57/229 (24%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
ME+ GG++ + +E+E +F+ + + + H + HRD+K +N LLD +
Sbjct: 80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLD--SK 137
Query: 61 PRVKICDFGYSKS-----------SVLHSQPK-------------------------STV 84
VK+ DFG ++ HS P STV
Sbjct: 138 GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTV 197
Query: 85 GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPF--EDPEDP----KNFRKTIG 138
GTP YIAPEV + Y+ K+ D WS GV +Y ML+G PF E P++ N+++T+
Sbjct: 198 GTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETL- 255
Query: 139 RILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIP---EIKNHPWF 184
FP V +S + K L+ R F E RI P EIK +P+F
Sbjct: 256 -------IFPPEVPISEKAKDLILR-FCCEWEHRIGAPGVEEIKTNPFF 296
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-20
Identities = 65/198 (32%), Positives = 102/198 (51%), Gaps = 22/198 (11%)
Query: 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
M+Y GG+L + R ED ARF+ +++ + H + HRD+K +N L+D +
Sbjct: 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG 139
Query: 60 APRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLTKKEYDGK-----IADVWSCGV 112
+++ DFG + +S+ VGTP YI+PE+L E DGK D WS GV
Sbjct: 140 --HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME-DGKGKYGPECDWWSLGV 196
Query: 113 TLYVMLVGAYPFEDPEDPKNFRKTIGRILS--VHYSFPDYVR-VSLECKHLLSRIFVANS 169
+Y ML G PF ++ +T G+I++ + FP V VS + K L+ R+ + +
Sbjct: 197 CMYEMLYGETPFY----AESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRL-ICSR 251
Query: 170 EKRI---TIPEIKNHPWF 184
E R+ I + K HP+F
Sbjct: 252 EHRLGQNGIEDFKQHPFF 269
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 5e-20
Identities = 62/185 (33%), Positives = 98/185 (52%), Gaps = 12/185 (6%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
ME+ GG + +++ + G +E+ R + +Q++ GVSY HS I HRD+K N L D +
Sbjct: 85 MEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRD--SV 142
Query: 61 PRVKICDFGYSKS----SVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYV 116
VK+ DFG SK + + KS GTP +++PEV++ + Y G+ AD+WS G T+
Sbjct: 143 GNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVE 201
Query: 117 MLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIP 176
ML P+ + E K + + P + VS C+ L RIFV ++ R +
Sbjct: 202 MLTEKPPWAEFEAMAAIFKIATQ--PTNPVLPPH--VSDHCRDFLKRIFV-EAKLRPSAD 256
Query: 177 EIKNH 181
E+ H
Sbjct: 257 ELLRH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 7e-20
Identities = 62/201 (30%), Positives = 89/201 (44%), Gaps = 26/201 (12%)
Query: 1 MEYAAGGELFERI-----CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL 55
MEY GG L + I GR E + ++ G+SY HS +I HRD+K N LL
Sbjct: 80 MEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL 138
Query: 56 DGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY 115
+VK+CDFG S V S + GT Y+APE + K Y +DVWS G+TL
Sbjct: 139 T--RKGQVKLCDFGVSGELVN-SLAGTFTGTSFYMAPERIQGKPYSIT-SDVWSLGLTLL 194
Query: 116 VMLVGAYPFEDPEDPKNFRKTIGRILSVHY---SFP--------DYVRVSLECKHLLSRI 164
+ +PF PE +G I + Y + ++ S E K + +
Sbjct: 195 EVAQNRFPFP-PEGEPP----LGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQC 249
Query: 165 FVANSEKRITIPEIKNHPWFL 185
+ +R T ++ HPW
Sbjct: 250 LEKDPTRRPTPWDMLEHPWIK 270
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 2e-19
Identities = 54/194 (27%), Positives = 83/194 (42%), Gaps = 33/194 (17%)
Query: 19 FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78
E + + QL+ G+++CHS I HRDLK EN L++ +K+ DFG ++S S
Sbjct: 95 LPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGV--LKLADFGLARS--FGS 150
Query: 79 QPK---STVGTPAYIAPEVL-TKKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPED--- 129
+ V T Y APE+L K Y + D+WS G +L +P + D
Sbjct: 151 PVRPYTHYVVTRWYRAPELLLGDKGYSTPV-DIWSVGCIFAELLSRRPLFPGKSEIDQLF 209
Query: 130 ----------PKNFRKTIGRILSVHYSFPDYVRVSLE---------CKHLLSRIFVANSE 170
P+ + K + +SFP + L LLS++ +
Sbjct: 210 KIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPH 269
Query: 171 KRITIPEIKNHPWF 184
KRIT + HP+F
Sbjct: 270 KRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-19
Identities = 69/234 (29%), Positives = 100/234 (42%), Gaps = 55/234 (23%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
M+Y GG++ + F E ARF+ +L + H M HRD+K +N L+D
Sbjct: 80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILID--LD 137
Query: 61 PRVKICDFG-------------YSKSSVLHS---QPK----------------------- 81
+K+ DFG Y K S + +P
Sbjct: 138 GHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRAT 197
Query: 82 ---------STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKN 132
S VGTP YIAPEVL +K Y ++ D WS GV L+ MLVG PF P +
Sbjct: 198 KQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQPPFLAPTPTET 256
Query: 133 FRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEK--RITIPEIKNHPWF 184
K I ++H P V++S E L++++ + E+ R +IK HP+F
Sbjct: 257 QLKVINWENTLH--IPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFF 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-19
Identities = 62/189 (32%), Positives = 97/189 (51%), Gaps = 13/189 (6%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL--DGS 58
MEY AGG L + + E + ++ + + + HS Q+ HRD+K +N LL DGS
Sbjct: 95 MEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS 153
Query: 59 TAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVM 117
VK+ DFG+ +ST VGTP ++APEV+T+K Y K+ D+WS G+ M
Sbjct: 154 ----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV-DIWSLGIMAIEM 208
Query: 118 LVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPE 177
+ G P+ + E+P I + P+ ++S + L+R + EKR + E
Sbjct: 209 VEGEPPYLN-ENPLRALYLIATNGTPELQNPE--KLSAIFRDFLNRCLEMDVEKRGSAKE 265
Query: 178 IKNHPWFLR 186
+ HP FL+
Sbjct: 266 LLQHP-FLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 2e-19
Identities = 55/195 (28%), Positives = 83/195 (42%), Gaps = 33/195 (16%)
Query: 20 SEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79
++D ++F Q++ G+ Y HS + HRDLK N L++ + +KICDFG ++
Sbjct: 101 TDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDED 158
Query: 80 PKST----VGTPAYIAPEV-LTKKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPED--- 129
K V T Y APE+ L+ Y I D+WS G +L +P D D
Sbjct: 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAI-DIWSVGCIFAELLTRKPLFPGRDYIDQLN 217
Query: 130 ---------PKNFRKTIGRILSVHY--SFPDYVRVSL---------ECKHLLSRIFVANS 169
+ K I + +Y S P + L E LL ++ V +
Sbjct: 218 LIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDP 277
Query: 170 EKRITIPEIKNHPWF 184
+KRIT E HP+
Sbjct: 278 KKRITADEALAHPYL 292
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-19
Identities = 59/194 (30%), Positives = 95/194 (48%), Gaps = 15/194 (7%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+EY GG+L + + E+ ARF+ ++ +++ H I +RDLKL+N LLD
Sbjct: 75 IEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADG- 133
Query: 61 PRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+K+ D+G K + ST GTP YIAPE+L +EY G D W+ GV ++ M+
Sbjct: 134 -HIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMA 191
Query: 120 GAYPFE---DPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI--- 173
G PF+ D D IL P + +S++ H+L + ++R+
Sbjct: 192 GRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRF--LSVKASHVLKGFLNKDPKERLGCQ 249
Query: 174 ---TIPEIKNHPWF 184
+IK+H +F
Sbjct: 250 PQTGFSDIKSHTFF 263
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 6e-19
Identities = 64/185 (34%), Positives = 91/185 (49%), Gaps = 15/185 (8%)
Query: 1 MEYAAGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD 56
MEY +GG+L ++I + F E E F Q++ + HS ++ HRDLK N L
Sbjct: 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLM 203
Query: 57 GSTAPRVKICDFGYSKS---SVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVT 113
+ +K+ DFG+SK SV S GTP Y+APE+ +K Y K AD+WS GV
Sbjct: 204 PTGI--IKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKK-ADMWSLGVI 260
Query: 114 LYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI 173
LY +L PF+ P R+ + ++L Y P VS K LL + N R
Sbjct: 261 LYELLTLHRPFKGPSQ----REIMQQVLYGKYD-PFPCPVSSGMKALLDPLLSKNPALRP 315
Query: 174 TIPEI 178
T ++
Sbjct: 316 TTQQL 320
|
Length = 478 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 8e-19
Identities = 63/206 (30%), Positives = 101/206 (49%), Gaps = 18/206 (8%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+EY GG+L + + E+ ARF+ ++ ++Y H I +RDLKL+N LLD +
Sbjct: 75 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD--SE 132
Query: 61 PRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+K+ D+G K + ST GTP YIAPE+L ++Y G D W+ GV ++ M+
Sbjct: 133 GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMA 191
Query: 120 GAYPFE-----DPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI- 173
G PF+ D D IL P +S++ +L + ++R+
Sbjct: 192 GRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKAASVLKSFLNKDPKERLG 249
Query: 174 TIPE-----IKNHPWFLRNLPIELTE 194
P+ I+ HP+F RN+ +L E
Sbjct: 250 CHPQTGFADIQGHPFF-RNVDWDLME 274
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-18
Identities = 60/193 (31%), Positives = 97/193 (50%), Gaps = 12/193 (6%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL--DGS 58
MEY AGG L + + E + ++ + + + HS Q+ HRD+K +N LL DGS
Sbjct: 95 MEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS 153
Query: 59 TAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVM 117
VK+ DFG+ +ST VGTP ++APEV+T+K Y K+ D+WS G+ M
Sbjct: 154 ----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV-DIWSLGIMAIEM 208
Query: 118 LVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPE 177
+ G P+ + E+P I + P+ R+S + L+R + ++R + E
Sbjct: 209 VEGEPPYLN-ENPLRALYLIATNGTPELQNPE--RLSAVFRDFLNRCLEMDVDRRGSAKE 265
Query: 178 IKNHPWFLRNLPI 190
+ HP+ P+
Sbjct: 266 LLQHPFLKLAKPL 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-18
Identities = 59/189 (31%), Positives = 98/189 (51%), Gaps = 11/189 (5%)
Query: 1 MEYAAGGEL---FERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG 57
ME GG L + +E F+ +Q++ G+ Y H QI HRD+K +N L++
Sbjct: 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVN- 142
Query: 58 STAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTK--KEYDGKIADVWSCGVTL 114
+ + VKI DFG SK + ++ ++ GT Y+APEV+ K + Y G AD+WS G T+
Sbjct: 143 TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGY-GAPADIWSLGCTI 201
Query: 115 YVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRIT 174
M G PF + +P+ +G + +H P+ +S E K+ + R F + +KR +
Sbjct: 202 VEMATGKPPFIELGEPQAAMFKVG-MFKIHPEIPE--SLSAEAKNFILRCFEPDPDKRAS 258
Query: 175 IPEIKNHPW 183
++ P+
Sbjct: 259 AHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 1e-18
Identities = 60/190 (31%), Positives = 101/190 (53%), Gaps = 17/190 (8%)
Query: 1 MEYAAGGELFERICN---AGR-FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD 56
++YA G+L + I + R F E EA F Q++ V + HS + HRD+K N LL
Sbjct: 118 LDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILL- 176
Query: 57 GSTAPRVKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVT 113
+ VK+ DFG+SK ++V ++ GTP Y+APE+ +K Y K AD++S GV
Sbjct: 177 -CSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK-ADMFSLGVL 234
Query: 114 LYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYS-FPDYVRVSLECKHLLSRIFVANSEKR 172
LY +L PF D +N + + + L+ Y P +S E + +++ + ++ ++R
Sbjct: 235 LYELLTLKRPF----DGENMEEVMHKTLAGRYDPLPP--SISPEMQEIVTALLSSDPKRR 288
Query: 173 ITIPEIKNHP 182
+ ++ N P
Sbjct: 289 PSSSKLLNMP 298
|
Length = 496 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-18
Identities = 63/189 (33%), Positives = 90/189 (47%), Gaps = 21/189 (11%)
Query: 6 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVK- 64
GG+L + G FSE E RF+ ++I G+ + H+ + +RDLK N LLD R+
Sbjct: 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISD 140
Query: 65 ---ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGA 121
CDF K P ++VGT Y+APEVL K AD +S G L+ +L G
Sbjct: 141 LGLACDFSKKK-------PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGH 193
Query: 122 YPFEDPEDPKNFRKTIGRI-LSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITI----- 175
PF + + I R+ L+V+ PD S E K LL + + KR+
Sbjct: 194 SPFRQHKTKD--KHEIDRMTLTVNVELPD--SFSPELKSLLEGLLQRDVSKRLGCLGRGA 249
Query: 176 PEIKNHPWF 184
E+K H +F
Sbjct: 250 QEVKEHVFF 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 3e-18
Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 25/201 (12%)
Query: 1 MEYAAGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL--DG 57
+E+ GG L + R +E + R+ +Q++ +++ HS ++ HRDLK N LL DG
Sbjct: 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDG 140
Query: 58 STAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL---TKKE--YDGKIADVWSCG 111
VK+ DFG S + Q + T +GTP ++APEV+ T K+ YD K AD+WS G
Sbjct: 141 D----VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYK-ADIWSLG 195
Query: 112 VTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV----RVSLECKHLLSRIFVA 167
+TL + E P N + + +IL S P + + S L V
Sbjct: 196 ITLIELAQM----EPPHHELNPMRVLLKILK---SEPPTLDQPSKWSSSFNDFLKSCLVK 248
Query: 168 NSEKRITIPEIKNHPWFLRNL 188
+ + R T E+ HP+
Sbjct: 249 DPDDRPTAAELLKHPFVSDQS 269
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 7e-18
Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 36/207 (17%)
Query: 8 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICD 67
EL E + G D R + QL+ ++YCHS I HRD+K EN L+ S +K+CD
Sbjct: 88 ELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGV--LKLCD 143
Query: 68 FGYSKSSVLHSQPKST----VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYP 123
FG++++ L ++P S V T Y APE+L GK DVW+ G + +L G
Sbjct: 144 FGFARA--LRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPL 201
Query: 124 FEDPEDPKNF---RKTIGRILSVHYS------------FPD-YVRVSLECKH--LLSRI- 164
F D +K +G + H FP+ SLE ++ +S
Sbjct: 202 FPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPA 261
Query: 165 --FVANS-----EKRITIPEIKNHPWF 184
F+ ++R+T E+ HP+F
Sbjct: 262 LDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 7e-18
Identities = 62/195 (31%), Positives = 99/195 (50%), Gaps = 16/195 (8%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSMQICHRDLKLENTLL--D 56
MEY AGG L + + DEA+ ++ + + + H+ Q+ HRD+K +N LL D
Sbjct: 95 MEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMD 151
Query: 57 GSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY 115
GS VK+ DFG+ +ST VGTP ++APEV+T+K Y K+ D+WS G+
Sbjct: 152 GS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV-DIWSLGIMAI 206
Query: 116 VMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITI 175
M+ G P+ + E+P I + P+ ++S + L+R + EKR +
Sbjct: 207 EMVEGEPPYLN-ENPLRALYLIATNGTPELQNPE--KLSPIFRDFLNRCLEMDVEKRGSA 263
Query: 176 PEIKNHPWFLRNLPI 190
E+ HP+ P+
Sbjct: 264 KELLQHPFLKLAKPL 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-17
Identities = 56/189 (29%), Positives = 100/189 (52%), Gaps = 12/189 (6%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTL--LDGS 58
ME+ GG L + I + R +E++ + ++ + Y HS + HRD+K ++ L LDG
Sbjct: 97 MEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDG- 154
Query: 59 TAPRVKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVM 117
RVK+ DFG+ ++ S + KS VGTP ++APEV+++ Y ++ D+WS G+ + M
Sbjct: 155 ---RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV-DIWSLGIMVIEM 210
Query: 118 LVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPE 177
+ G P+ + P K + S + ++S + L R+ ++R T E
Sbjct: 211 VDGEPPYFS-DSPVQAMKRLRD--SPPPKLKNAHKISPVLRDFLERMLTREPQERATAQE 267
Query: 178 IKNHPWFLR 186
+ +HP+ L+
Sbjct: 268 LLDHPFLLQ 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 80.2 bits (197), Expect = 1e-17
Identities = 67/225 (29%), Positives = 110/225 (48%), Gaps = 29/225 (12%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL--DGS 58
MEY AGG L + + E + ++ + + + HS Q+ HRD+K +N LL DGS
Sbjct: 96 MEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS 154
Query: 59 TAPRVKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVM 117
VK+ DFG+ ++ + S+ + VGTP ++APEV+T+K Y K+ D+WS G+ M
Sbjct: 155 ----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV-DIWSLGIMAIEM 209
Query: 118 LVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPE 177
+ G P+ + E+P I + P+ ++S + L+R + EKR + E
Sbjct: 210 IEGEPPYLN-ENPLRALYLIATNGTPELQNPE--KLSAIFRDFLNRCLDMDVEKRGSAKE 266
Query: 178 IKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHEATK 222
+ H FL+ + P SL +++ EATK
Sbjct: 267 LLQHQ-FLK----------------IAKPLSSLTPLIAAAKEATK 294
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 1e-17
Identities = 59/188 (31%), Positives = 91/188 (48%), Gaps = 16/188 (8%)
Query: 2 EYAAGGELFERI----CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG 57
EY G +L ++ SE++ +F QL+ GV Y H +I HRDLK +N L
Sbjct: 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN 141
Query: 58 STAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYV 116
+ +KI DFG S+ + +T GTP Y++PE L + YD K +D+WS G LY
Sbjct: 142 NL---LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSK-SDIWSLGCILYE 197
Query: 117 MLVGAYPFEDPEDPKNFRKTIGRILSVHY-SFPDYVRVSLECKHLLSRIFVANSEKRITI 175
M A+ FE +NF + RI+ S P+ S + ++ + + R +
Sbjct: 198 MCCLAHAFEG----QNFLSVVLRIVEGPTPSLPE--TYSRQLNSIMQSMLNKDPSLRPSA 251
Query: 176 PEIKNHPW 183
EI +P+
Sbjct: 252 AEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 1e-17
Identities = 61/203 (30%), Positives = 85/203 (41%), Gaps = 47/203 (23%)
Query: 18 RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH 77
S D ++F Q++ G+ Y HS + HRDLK N LL+ T +KICDFG ++ +
Sbjct: 102 HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN--TNCDLKICDFGLARIADPE 159
Query: 78 SQPKST----VGTPAYIAPEV-LTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP-K 131
V T Y APE+ L K Y I D+WS G L ML F P K
Sbjct: 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAI-DIWSVGCILAEMLSNRPLF-----PGK 213
Query: 132 NFRKTIGRILSVHYSFP--------------DYVRVSLECK-----------------HL 160
++ + IL V + P +Y++ SL K L
Sbjct: 214 DYLHQLNLILGVLGT-PSQEDLNCIISLRARNYIK-SLPFKPKVPWNKLFPNADPKALDL 271
Query: 161 LSRIFVANSEKRITIPEIKNHPW 183
L ++ N KRIT+ E HP+
Sbjct: 272 LDKMLTFNPHKRITVEEALAHPY 294
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 1e-17
Identities = 56/178 (31%), Positives = 90/178 (50%), Gaps = 17/178 (9%)
Query: 1 MEYAAGGELFERI-CNAGR-FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
MEY GG+L ++I G+ F ED +F Q+ GV + H ++ HRD+K +N L +
Sbjct: 77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL--T 134
Query: 59 TAPRVKICDFGYSKSSVLHSQPKS----TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTL 114
+VK+ DFG S+ L + P + VGTP Y+ PE+ Y+ K +D+WS G L
Sbjct: 135 QNGKVKLGDFG---SARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNK-SDIWSLGCIL 190
Query: 115 YVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKR 172
Y + +PF+ +++ I ++ Y P S E + L+ ++F N R
Sbjct: 191 YELCTLKHPFQ----ANSWKNLILKVCQGSYK-PLPSHYSYELRSLIKQMFKRNPRSR 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 1e-17
Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 42/206 (20%)
Query: 1 MEYAAGG---ELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD 56
ME GG +L + + G R E+ + ++ + G++Y H ++ HRD+K +N LL
Sbjct: 88 MELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILL- 146
Query: 57 GSTAPRVKICDFGYSKSSVLHSQPKST-------VGTPAYIAPEVLTKKE-----YDGKI 104
+ VK+ DFG S +Q ST +GTP ++APEV+ E YD +
Sbjct: 147 -TKNAEVKLVDFGVS------AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDAR- 198
Query: 105 ADVWSCGVTLYVMLVGAYPFED--PED-----PKNFRKTIGRILSVHYSFPDYVRVSLEC 157
+DVWS G+T + G P D P P+N T+ + F D++ L
Sbjct: 199 SDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLI- 257
Query: 158 KHLLSRIFVANSEKRITIPEIKNHPW 183
N E+R + E+ HP+
Sbjct: 258 ---------KNYEQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-17
Identities = 66/232 (28%), Positives = 93/232 (40%), Gaps = 51/232 (21%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD---- 56
M+Y GG++ + G F ED ARF+ +L V H M HRD+K +N L+D
Sbjct: 80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH 139
Query: 57 ----------------------GSTAPRVKICDFGYS------------------KSSVL 76
R DF +++
Sbjct: 140 IKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQ 199
Query: 77 HSQ--PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFR 134
H + S VGTP YIAPEVL + Y ++ D WS GV LY MLVG PF +
Sbjct: 200 HQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQPPFLAQTPLETQM 258
Query: 135 KTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEK--RITIPEIKNHPWF 184
K I S+H P ++S E L+ ++ ++ + EIK HP+F
Sbjct: 259 KVINWQTSLH--IPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFF 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-17
Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 13/208 (6%)
Query: 6 GGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRV 63
GG+L I N G F E+ A F+ +++ G+ H +RDLK EN LLD +
Sbjct: 84 GGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG--HI 141
Query: 64 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYP 123
+I D G + + VGT Y+APEVL + Y D W G +Y M+ G P
Sbjct: 142 RISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRY-TLSPDYWGLGCLIYEMIEGQSP 200
Query: 124 FEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIP-----EI 178
F ++ + R+L + + S E K + + + ++R+ E+
Sbjct: 201 FRGRKEKVKREEVDRRVLETEEVYS--AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEV 258
Query: 179 KNHPWFLRNLPIELTEGGSWQSHDVNNP 206
K HP F RN+ + E G V +P
Sbjct: 259 KRHP-FFRNMNFKRLEAGMLDPPFVPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 4e-17
Identities = 61/200 (30%), Positives = 82/200 (41%), Gaps = 39/200 (19%)
Query: 17 GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK--SS 74
F + E + QL+SGV++ H I HRDLK N LL + +KICDFG ++ S
Sbjct: 101 QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL--NNRGILKICDFGLAREYGS 158
Query: 75 VLHSQPKSTVGTPAYIAPEVLT-KKEYDGKIADVWSCG------VTLYVMLVGA------ 121
L + V T Y APE+L KEY I D+WS G +T + G
Sbjct: 159 PLKPYTQLVV-TLWYRAPELLLGAKEYSTAI-DMWSVGCIFAELLTKKPLFPGKSEIDQL 216
Query: 122 --------YPFED--PE-------DPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 164
P E P K F K L FP +S LL+R+
Sbjct: 217 NKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKK--FPAL-SLSDNGFDLLNRL 273
Query: 165 FVANSEKRITIPEIKNHPWF 184
+ KRI+ + HP+F
Sbjct: 274 LTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 7e-17
Identities = 55/188 (29%), Positives = 80/188 (42%), Gaps = 26/188 (13%)
Query: 19 FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78
+ + +QL+ GV + HS +I HRDLK +N L+ ++ +VKI DFG ++
Sbjct: 104 LPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILV--TSDGQVKIADFGLARIYSFEM 161
Query: 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVM--LVGAYPFEDPEDP--KNFR 134
S V T Y APEVL + Y + D+WS G + + D K F
Sbjct: 162 ALTSVVVTLWYRAPEVLLQSSYATPV-DMWSVGCIFAELFRRRPLFRGTSEADQLDKIFD 220
Query: 135 KTIGR---------ILSVHYSFPDYVRVSLE------CK---HLLSRIFVANSEKRITIP 176
IG + SFP Y S + C+ LL ++ N KRI+
Sbjct: 221 V-IGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAF 279
Query: 177 EIKNHPWF 184
E HP+F
Sbjct: 280 EALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 7e-17
Identities = 42/116 (36%), Positives = 63/116 (54%), Gaps = 8/116 (6%)
Query: 15 NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSS 74
+ D+A +Q++ G+ Y H+ +I HRD+K EN ++ +V I D G ++
Sbjct: 150 RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN--DVDQVCIGDLGAAQFP 207
Query: 75 VLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYP---FEDP 127
V+ GT APEVL + +Y+ K AD+WS G+ L+ ML AYP FEDP
Sbjct: 208 VVAPAFLGLAGTVETNAPEVLARDKYNSK-ADIWSAGIVLFEML--AYPSTIFEDP 260
|
Length = 357 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 8e-17
Identities = 41/102 (40%), Positives = 67/102 (65%), Gaps = 6/102 (5%)
Query: 31 LISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI 90
++ G++Y S++I HRD+K N L++ T +VK+CDFG S V +S K+ VGT AY+
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVN--TRGQVKLCDFGVSTQLV-NSIAKTYVGTNAYM 160
Query: 91 APEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKN 132
APE ++ ++Y G +DVWS G++ + +G +P+ P+ KN
Sbjct: 161 APERISGEQY-GIHSDVWSLGISFMELALGRFPY--PQIQKN 199
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 1e-16
Identities = 57/197 (28%), Positives = 84/197 (42%), Gaps = 40/197 (20%)
Query: 19 FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78
FSE R Q++ G+++ H HRDLK EN L+ G VKI DFG ++ + S
Sbjct: 96 FSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPE--VVKIADFGLARE--IRS 151
Query: 79 QPKST--VGTPAYIAPEVLTK-KEYDGKIADVWSCG---VTLYVM--------------- 117
+P T V T Y APE+L + Y + D+W+ G LY +
Sbjct: 152 RPPYTDYVSTRWYRAPEILLRSTSYSSPV-DIWALGCIMAELYTLRPLFPGSSEIDQLYK 210
Query: 118 ---LVGAYPFED--PEDPK-----NFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVA 167
++G P + PE K FR S+H P+ S E L+ +
Sbjct: 211 ICSVLGT-PTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPN---ASPEAIDLIKDMLRW 266
Query: 168 NSEKRITIPEIKNHPWF 184
+ +KR T + HP+F
Sbjct: 267 DPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-16
Identities = 60/192 (31%), Positives = 98/192 (51%), Gaps = 12/192 (6%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL--DGS 58
ME+ GG L + I R +E++ ++ +S H+ + HRD+K ++ LL DG
Sbjct: 96 MEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDG- 153
Query: 59 TAPRVKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVM 117
RVK+ DFG+ ++ S + KS VGTP ++APE++++ Y G D+WS G+ + M
Sbjct: 154 ---RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEM 209
Query: 118 LVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPE 177
+ G P+ + E P K I L + +VS K L R+ V + +R T E
Sbjct: 210 VDGEPPYFN-EPPLKAMKMIRDNLPP--KLKNLHKVSPSLKGFLDRLLVRDPAQRATAAE 266
Query: 178 IKNHPWFLRNLP 189
+ HP+ + P
Sbjct: 267 LLKHPFLAKAGP 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-16
Identities = 48/128 (37%), Positives = 70/128 (54%), Gaps = 7/128 (5%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY GG + + AG F E + ++++ G+ Y HS + HRD+K N LL S
Sbjct: 81 MEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL--SEQ 137
Query: 61 PRVKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 118
VK+ DFG + + +Q K + VGTP ++APEV+ + YD K AD+WS G+T +
Sbjct: 138 GDVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK-ADIWSLGITAIELA 195
Query: 119 VGAYPFED 126
G P D
Sbjct: 196 KGEPPNSD 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-16
Identities = 50/187 (26%), Positives = 84/187 (44%), Gaps = 14/187 (7%)
Query: 6 GGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRV 63
GG+L I N G F E+ A F+ ++ G+ H +I +RDLK EN LLD +
Sbjct: 84 GGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG--HI 141
Query: 64 KICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAY 122
+I D G + + + + VGT Y+APEV+ + Y D W G +Y M+ G
Sbjct: 142 RISDLGLA-VEIPEGETIRGRVGTVGYMAPEVVKNERY-TFSPDWWGLGCLIYEMIEGKS 199
Query: 123 PFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI-----TIPE 177
PF ++ + R+ + + + S + + ++ + R+ E
Sbjct: 200 PFRQRKEKVKREEVERRVKEDQEEYSE--KFSEAARSICRQLLTKDPGFRLGCRGEGAEE 257
Query: 178 IKNHPWF 184
+K HP+F
Sbjct: 258 VKAHPFF 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-16
Identities = 45/123 (36%), Positives = 66/123 (53%), Gaps = 16/123 (13%)
Query: 1 MEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL--DG 57
MEY GG L + G SE + + ++ + G++Y H HRD+K N LL DG
Sbjct: 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDG 138
Query: 58 STAPRVKICDFGYS---KSSVLHSQPKSTVGTPAYIAPEVL---TKKEYDGKIADVWSCG 111
VK+ DFG S +++ ++ KS +GTP ++APEV K YDGK D+W+ G
Sbjct: 139 D----VKLADFGVSAQLTATI--AKRKSFIGTPYWMAPEVAAVERKGGYDGK-CDIWALG 191
Query: 112 VTL 114
+T
Sbjct: 192 ITA 194
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 3e-16
Identities = 51/159 (32%), Positives = 73/159 (45%), Gaps = 14/159 (8%)
Query: 27 FFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGY-----SKSSVLHSQPK 81
+F QL S + + HS +I HRD+K N + + VK+ D G SK++ HS
Sbjct: 111 YFVQLCSALEHMHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSL-- 166
Query: 82 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIL 141
VGTP Y++PE + + Y+ K +D+WS G LY M PF D N +I
Sbjct: 167 --VGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFY--GDKMNLYSLCKKIE 221
Query: 142 SVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
Y S E + L+SR + EKR I +
Sbjct: 222 KCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-16
Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 1 MEYAAGG---ELFERICNAGRFSEDEARFFFQQLISGVSYC-HSMQICHRDLKLENTLLD 56
MEY G +L+ ED R ++ G+ + I HRD+K N L++
Sbjct: 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN 137
Query: 57 GSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI-----ADVWSCG 111
G+ +VK+CDFG S +++ S K+ +G +Y+APE + + +DVWS G
Sbjct: 138 GNG--QVKLCDFGVS-GNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLG 194
Query: 112 VTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP----DYVRVSLECKHLLSRIFVA 167
+++ M +G YP+ PE N + I V P Y S + + +++
Sbjct: 195 LSILEMALGRYPYP-PETYANIFAQLSAI--VDGDPPTLPSGY---SDDAQDFVAKCLNK 248
Query: 168 NSEKRITIPEIKNHPWFL--RNLPIELTE 194
+R T ++ HPW + +N +++ E
Sbjct: 249 IPNRRPTYAQLLEHPWLVKYKNADVDMAE 277
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 3e-16
Identities = 50/188 (26%), Positives = 76/188 (40%), Gaps = 23/188 (12%)
Query: 1 MEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
MEY GG+L + R S + F Q+ G+ Y S HRDL N L+ +
Sbjct: 80 MEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGEN 139
Query: 59 TAPRVKICDFG-----YSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVT 113
VKI DFG Y K + ++APE L + ++ K +DVWS GV
Sbjct: 140 L--VVKISDFGLSRDLYDDDYYKVKGGKLPI---RWMAPESLKEGKFTSK-SDVWSFGVL 193
Query: 114 LYVMLVGA---YPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSE 170
L+ + YP + + K R+ P+ ++ L+C + + E
Sbjct: 194 LWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELYKLMLQC-------WAEDPE 246
Query: 171 KRITIPEI 178
R T E+
Sbjct: 247 DRPTFSEL 254
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 4e-16
Identities = 42/131 (32%), Positives = 68/131 (51%), Gaps = 10/131 (7%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
ME+ GG + + G E + +Q++ GV+Y H+ + HRD+K N +L +
Sbjct: 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGI 140
Query: 61 PRVKICDFGYSKS------SVLHSQP-KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVT 113
+K+ DFG ++ HS KS GTP ++APEV+ + Y G+ +D+WS G T
Sbjct: 141 --IKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGY-GRKSDIWSIGCT 197
Query: 114 LYVMLVGAYPF 124
++ M G P
Sbjct: 198 VFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 4e-16
Identities = 42/139 (30%), Positives = 61/139 (43%), Gaps = 16/139 (11%)
Query: 1 MEYAAGGEL--FERICNAGRFSEDEARFFFQQLIS-------GVSYCHSMQICHRDLKLE 51
+EY GG+L + R S +++ + L+S G+ Y S + HRDL
Sbjct: 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAAR 134
Query: 52 NTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLTKKEYDGKIADVW 108
N L+ VKI DFG S+ + G I APE L + K +DVW
Sbjct: 135 NCLVG--EDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSK-SDVW 191
Query: 109 SCGVTLY-VMLVGAYPFED 126
S GV L+ + +GA P+
Sbjct: 192 SFGVLLWEIFTLGATPYPG 210
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 5e-16
Identities = 54/197 (27%), Positives = 79/197 (40%), Gaps = 34/197 (17%)
Query: 19 FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFG----YSKSS 74
+E+ R+F QL+ G+ Y HS + HRDLK N L++ ++I DFG S S
Sbjct: 104 LTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDC--ELRIGDFGMARGLSSSP 161
Query: 75 VLHSQ-PKSTVGTPAYIAPEVL-TKKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPED- 129
H V T Y APE+L + EY I D+WS G ML +P ++
Sbjct: 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAI-DMWSVGCIFAEMLGRRQLFPGKNYVHQ 220
Query: 130 -----------PKNFRKTIGRILSVHY--SFPDYVRVSLE----CKH-----LLSRIFVA 167
+ IG Y + P V LLS++
Sbjct: 221 LKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQF 280
Query: 168 NSEKRITIPEIKNHPWF 184
+ E+RIT+ + HP+
Sbjct: 281 DPEERITVEQALQHPFL 297
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 6e-16
Identities = 51/188 (27%), Positives = 77/188 (40%), Gaps = 22/188 (11%)
Query: 1 MEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
MEY GG+L + N + S + F Q+ G+ Y S HRDL N L+ +
Sbjct: 80 MEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGEN- 138
Query: 60 APRVKICDFG-----YSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTL 114
VKI DFG Y K + ++APE L + ++ K +DVWS GV L
Sbjct: 139 -LVVKISDFGLSRDLYDDDYYRKRGGKLPI---RWMAPESLKEGKFTSK-SDVWSFGVLL 193
Query: 115 YVMLVGA---YPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEK 171
+ + YP E+ + K R+ P+ + L+C + + E
Sbjct: 194 WEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYDLMLQC-------WAEDPED 246
Query: 172 RITIPEIK 179
R T E+
Sbjct: 247 RPTFSELV 254
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-16
Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 31/198 (15%)
Query: 12 RICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYS 71
R+ + + ++F Q++ G+ Y HS + HRDLK N L++ + +KICDFG +
Sbjct: 98 RLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENC--DLKICDFGLA 155
Query: 72 KSSVLHSQPKSTVGTPAYIAPEV-LTKKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPE 128
+ + Q V T Y APE+ LT ++YD ++ D+WS G ML G +P +D
Sbjct: 156 R--IQDPQMTGYVSTRYYRAPEIMLTWQKYDVEV-DIWSAGCIFAEMLEGKPLFPGKDHV 212
Query: 129 D------------PKNFRKTIGRILSVHY--SFPDYVRVSLECK---------HLLSRIF 165
+ P + TI ++ + S P V K LL ++
Sbjct: 213 NQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKML 272
Query: 166 VANSEKRITIPEIKNHPW 183
V + +KRI+ E HP+
Sbjct: 273 VFDPQKRISAAEALAHPY 290
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 7e-16
Identities = 50/187 (26%), Positives = 79/187 (42%), Gaps = 30/187 (16%)
Query: 24 ARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKS 82
+ F QL+ G+++CH ++ HRDLK +N L++ +K+ DFG +++ + + +
Sbjct: 102 VKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRG--ELKLADFGLARAFGIPVNTFSN 159
Query: 83 TVGTPAYIAPEVLT-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIL 141
V T Y AP+VL + Y I D+WS G + M+ G F + K I RI+
Sbjct: 160 EVVTLWYRAPDVLLGSRTYSTSI-DIWSVGCIMAEMITGRPLFPGTNNEDQLLK-IFRIM 217
Query: 142 SVH--------YSFPDYVRVSLECKH----------------LLSRIFVANSEKRITIPE 177
P+Y LL R+ N E RI+ +
Sbjct: 218 GTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHD 277
Query: 178 IKNHPWF 184
HPWF
Sbjct: 278 ALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-15
Identities = 60/199 (30%), Positives = 83/199 (41%), Gaps = 44/199 (22%)
Query: 20 SEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK-SSVLHS 78
S+D ++F QL+ G+ Y HS + HRDLK N LL+ + +KICDFG ++ +S
Sbjct: 106 SDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC--DLKICDFGLARTTSEKGD 163
Query: 79 QPKSTVGTPAYIAPEV-LTKKEYDGKIADVWSCG---------------------VTLYV 116
V T Y APE+ L EY I DVWS G + L
Sbjct: 164 FMTEYVVTRWYRAPELLLNCSEYTTAI-DVWSVGCIFAELLGRKPLFPGKDYVHQLKLIT 222
Query: 117 MLVGAYPFEDPE--DPKNFRKTIGRILSVHYSFPDYVRVSLECKH---------LLSRIF 165
L+G+ ED + R+ I S P R S LL ++
Sbjct: 223 ELLGSPSEEDLGFIRNEKARRYI-------RSLPYTPRQSFARLFPHANPLAIDLLEKML 275
Query: 166 VANSEKRITIPEIKNHPWF 184
V + KRIT+ E HP+
Sbjct: 276 VFDPSKRITVEEALAHPYL 294
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-15
Identities = 54/189 (28%), Positives = 96/189 (50%), Gaps = 16/189 (8%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
ME+ GG L + I R +E++ ++ +SY H+ + HRD+K ++ LL ++
Sbjct: 98 MEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL--TSD 154
Query: 61 PRVKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
R+K+ DFG+ ++ S + KS VGTP ++APEV+++ Y G D+WS G+ + M+
Sbjct: 155 GRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMID 213
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFP----DYVRVSLECKHLLSRIFVANSEKRITI 175
G P+ + + R+ + + P D +VS + L + V +R T
Sbjct: 214 GEPPYFNEPPLQAMRR-------IRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATA 266
Query: 176 PEIKNHPWF 184
E+ HP+
Sbjct: 267 QELLQHPFL 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-15
Identities = 63/220 (28%), Positives = 96/220 (43%), Gaps = 39/220 (17%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGST 59
ME+ GG L + + AGR E+ ++ G++Y +I HRD+K N L+ ++
Sbjct: 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILV--NS 135
Query: 60 APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+K+CDFG S ++ S S VGT +Y++PE L Y + +D+WS G++L M +
Sbjct: 136 RGEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHYTVQ-SDIWSLGLSLVEMAI 193
Query: 120 GAYPFEDPEDPKNFRKTIGRILS----------VHYSFPDYVR-----------VSLECK 158
G YP P D K GR +S V PD R V+
Sbjct: 194 GRYPIP-PPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPP 252
Query: 159 HLLSRIF------------VANSEKRITIPEIKNHPWFLR 186
L S F N ++R + E+ HP+ R
Sbjct: 253 KLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 2e-15
Identities = 56/190 (29%), Positives = 74/190 (38%), Gaps = 38/190 (20%)
Query: 29 QQLISGVSYCHSMQICHRDLKLENTLL--DGSTAPRVKICDFGYSKSSVLHSQPK----S 82
+ G+ Y HS I HRDLK N L+ DG +K+ DFG ++S P
Sbjct: 109 LMTLRGLEYLHSNWILHRDLKPNNLLIASDG----VLKLADFGLARS---FGSPNRKMTH 161
Query: 83 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS 142
V T Y APE+L + G D+WS G +L+ PF + + I L
Sbjct: 162 QVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV-PFLPGDSDIDQLGKIFEALG 220
Query: 143 --------VHYSFPDYVRV---------------SLECKHLLSRIFVANSEKRITIPEIK 179
S PDYV S + LL R+ N KRIT +
Sbjct: 221 TPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQAL 280
Query: 180 NHPWFLRNLP 189
HP+F N P
Sbjct: 281 EHPYF-SNDP 289
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 4e-15
Identities = 59/196 (30%), Positives = 86/196 (43%), Gaps = 26/196 (13%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY GG + + G E + ++++ G+ Y HS + HRD+K N LL S
Sbjct: 81 MEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL--SEH 137
Query: 61 PRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 118
VK+ DFG + + +Q K VGTP ++APEV+ + YD K AD+WS G+T +
Sbjct: 138 GEVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELA 195
Query: 119 VGAYPFEDPED-------PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEK 171
G P + PKN T L +YS P K +
Sbjct: 196 KGEPPHSELHPMKVLFLIPKNNPPT----LEGNYSKP--------LKEFVEACLNKEPSF 243
Query: 172 RITIPEIKNHPWFLRN 187
R T E+ H + +R
Sbjct: 244 RPTAKELLKHKFIVRF 259
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 8e-15
Identities = 61/196 (31%), Positives = 97/196 (49%), Gaps = 25/196 (12%)
Query: 1 MEYAAGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL--DG 57
+E+ GG + + R +E + + +Q++ + Y HSM+I HRDLK N LL DG
Sbjct: 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG 147
Query: 58 STAPRVKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVL---TKKE--YDGKIADVWSCG 111
+K+ DFG S +V Q + S +GTP ++APEV+ T K+ YD K AD+WS G
Sbjct: 148 D----IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYK-ADIWSLG 202
Query: 112 VTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV----RVSLECKHLLSRIFVA 167
+TL M E P + + +L + S P + + S+E + L
Sbjct: 203 ITLIEM-------AQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDK 255
Query: 168 NSEKRITIPEIKNHPW 183
+ E R + ++ HP+
Sbjct: 256 HPETRPSAAQLLEHPF 271
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-14
Identities = 45/127 (35%), Positives = 65/127 (51%), Gaps = 5/127 (3%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY GG + + G E ++++ G+ Y HS + HRD+K N LL S
Sbjct: 81 MEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLL--SEQ 137
Query: 61 PRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
VK+ DFG + ++T VGTP ++APEV+ + YD K AD+WS G+T +
Sbjct: 138 GDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK-ADIWSLGITAIELAK 196
Query: 120 GAYPFED 126
G P D
Sbjct: 197 GEPPNSD 203
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-14
Identities = 47/140 (33%), Positives = 73/140 (52%), Gaps = 6/140 (4%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QICHRDLKLENTLLDGST 59
ME+ GG L + + A R E+ ++ G++Y QI HRD+K N L++ +
Sbjct: 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVN--S 139
Query: 60 APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+K+CDFG S ++ S S VGT +Y++PE L Y + +D+WS G++L + +
Sbjct: 140 RGEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVELAI 197
Query: 120 GAYPFEDPEDPKNFRKTIGR 139
G YP P D K GR
Sbjct: 198 GRYPIP-PPDAKELEAIFGR 216
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-14
Identities = 45/126 (35%), Positives = 62/126 (49%), Gaps = 5/126 (3%)
Query: 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCH-SMQICHRDLKLENTLLDGS 58
+E A GE F + RF+E+ F Q++ + Y H +I HRDL N +L
Sbjct: 91 IEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML--G 148
Query: 59 TAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 118
+V I DFG +K S+ S VGT Y PE++ + Y G+ ADVW+ G LY M
Sbjct: 149 EDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMC 207
Query: 119 VGAYPF 124
PF
Sbjct: 208 TLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-14
Identities = 50/184 (27%), Positives = 80/184 (43%), Gaps = 6/184 (3%)
Query: 1 MEYAAGGELFERICNAGRFSEDEAR--FFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
M GG+L I N G + R + Q+ G+ + HSM I +RD+K EN LLD
Sbjct: 72 MSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQ 131
Query: 59 TAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 118
R + D G + GT Y+APE+L ++ Y + D ++ G ++Y M+
Sbjct: 132 GNCR--LSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPV-DWFAMGCSIYEMV 188
Query: 119 VGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEI 178
G PF+D ++ + R L F ++ + E K + E R+ E
Sbjct: 189 AGRTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFTEESKDICRLFLAKKPEDRLGSREK 247
Query: 179 KNHP 182
+ P
Sbjct: 248 NDDP 251
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-14
Identities = 36/89 (40%), Positives = 52/89 (58%), Gaps = 9/89 (10%)
Query: 42 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLT---- 96
+ HRD+K N LLD S VK+CDFG S V S+ K+ + G AY+APE +
Sbjct: 135 GVIHRDVKPSNILLDASG--NVKLCDFGISGRLV-DSKAKTRSAGCAAYMAPERIDPPDP 191
Query: 97 KKEYDGKIADVWSCGVTLYVMLVGAYPFE 125
+YD + ADVWS G++L + G +P++
Sbjct: 192 NPKYDIR-ADVWSLGISLVELATGQFPYK 219
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-14
Identities = 64/196 (32%), Positives = 95/196 (48%), Gaps = 25/196 (12%)
Query: 1 MEYAAGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTL--LDG 57
+E+ AGG + + R +E + R +Q + ++Y H +I HRDLK N L LDG
Sbjct: 81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG 140
Query: 58 STAPRVKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVL---TKKE--YDGKIADVWSCG 111
+K+ DFG S + Q + S +GTP ++APEV+ T K+ YD K ADVWS G
Sbjct: 141 D----IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYK-ADVWSLG 195
Query: 112 VTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV----RVSLECKHLLSRIFVA 167
+TL M E P + + +L + S P + R S E K L +
Sbjct: 196 ITLIEM-------AQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEK 248
Query: 168 NSEKRITIPEIKNHPW 183
N + R T ++ HP+
Sbjct: 249 NVDARWTTTQLLQHPF 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 3e-14
Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 17/162 (10%)
Query: 31 LISGVSYCHS-MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPA 88
++ + Y HS + + HRD+K N L++ +VK+CDFG S V S K+ G
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLIN--RNGQVKLCDFGISGYLV-DSVAKTIDAGCKP 168
Query: 89 YIAPE----VLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH 144
Y+APE L +K YD K +DVWS G+T+ + G +P++ + P K + V
Sbjct: 169 YMAPERINPELNQKGYDVK-SDVWSLGITMIELATGRFPYDSWKTPFQQLKQV-----VE 222
Query: 145 YSFPDYV--RVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184
P + S E + +++ N ++R PE+ HP+F
Sbjct: 223 EPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFF 264
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-14
Identities = 48/139 (34%), Positives = 72/139 (51%), Gaps = 6/139 (4%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QICHRDLKLENTLLDGST 59
ME+ GG L + + AGR E +I G++Y +I HRD+K N L++ +
Sbjct: 82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN--S 139
Query: 60 APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+K+CDFG S ++ S S VGT +Y++PE L Y + +D+WS G++L M +
Sbjct: 140 RGEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAI 197
Query: 120 GAYPFEDPEDPKNFRKTIG 138
G YP P D K G
Sbjct: 198 GRYPIP-PPDAKELELMFG 215
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-14
Identities = 54/196 (27%), Positives = 77/196 (39%), Gaps = 38/196 (19%)
Query: 19 FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78
FSED + F +QL+ G++YCH HRD+K N LL+ ++K+ DFG ++
Sbjct: 113 FSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG--QIKLADFGLARLYNSEE 170
Query: 79 QPKST--VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE-------- 128
T V T Y PE+L +E G DVWSCG L + F+ +
Sbjct: 171 SRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI 230
Query: 129 -------DPKNF--------------RKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVA 167
P + +K R L +SF + LL +
Sbjct: 231 SRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSF-----IPTPALDLLDHMLTL 285
Query: 168 NSEKRITIPEIKNHPW 183
+ KR T E N PW
Sbjct: 286 DPSKRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-14
Identities = 55/202 (27%), Positives = 88/202 (43%), Gaps = 32/202 (15%)
Query: 10 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFG 69
F + + QL+ G+++CHS ++ HRDLK +N L++ A +K+ DFG
Sbjct: 88 FMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFG 145
Query: 70 YSKSSVLHSQPKST----VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFE 125
+++ + P T V T Y APE+L +Y D+WS G M+ F
Sbjct: 146 LARAFGV---PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP 202
Query: 126 -DPEDPKNFR--KTIGRILSVHY-----------SFPDYVRVSL---------ECKHLLS 162
D E + FR +T+G V + SFP + R + + LLS
Sbjct: 203 GDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLS 262
Query: 163 RIFVANSEKRITIPEIKNHPWF 184
++ + KRI+ HP+F
Sbjct: 263 QMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 6e-14
Identities = 37/130 (28%), Positives = 68/130 (52%), Gaps = 5/130 (3%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QICHRDLKLENTLLDGST 59
ME+ G L G + ++ G++Y +++ +I HRD+K N L++
Sbjct: 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNS-- 139
Query: 60 APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
++K+CDFG S +++S + VGT Y++PE + +Y K +DVWS G+++ + +
Sbjct: 140 RGQIKLCDFGVS-GELINSIADTFVGTSTYMSPERIQGGKYTVK-SDVWSLGISIIELAL 197
Query: 120 GAYPFEDPED 129
G +PF
Sbjct: 198 GKFPFAFSNI 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 6e-14
Identities = 56/212 (26%), Positives = 85/212 (40%), Gaps = 54/212 (25%)
Query: 19 FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78
FSE + + QL+ G+ Y H I HRDLK+ N LL +KI DFG +++ L +
Sbjct: 105 FSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLPA 162
Query: 79 QPKS-TVGTPAYIAPEVLT-KKEYDGKIADVWSCG---------------------VTLY 115
+P + V T Y APE+L Y I D+W+ G + L
Sbjct: 163 KPMTPKVVTLWYRAPELLLGCTTYTTAI-DMWAVGCILAELLAHKPLLPGKSEIEQLDLI 221
Query: 116 VMLVGA-----YP----------FEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 160
+ L+G +P F P+ P N L + + +S L
Sbjct: 222 IQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNN-------LKHKFPW-----LSEAGLRL 269
Query: 161 LSRIFVANSEKRITIPEIKNHPWFLRN-LPIE 191
L+ + + + +KR T E +F LP E
Sbjct: 270 LNFLLMYDPKKRATAEEALESSYFKEKPLPCE 301
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 7e-14
Identities = 40/96 (41%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 21 EDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80
E E + G++Y HS + HRD+K N LL + VK+ DFG S+ L S
Sbjct: 114 EVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL--TEPGTVKLADFG---SASLVSPA 168
Query: 81 KSTVGTPAYIAPEV---LTKKEYDGKIADVWSCGVT 113
S VGTP ++APEV + + +YDGK DVWS G+T
Sbjct: 169 NSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGIT 203
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 8e-14
Identities = 55/187 (29%), Positives = 80/187 (42%), Gaps = 36/187 (19%)
Query: 27 FFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--- 83
+ QL+ G++YCHS ++ HRDLK +N L+D +K+ DFG +++ P T
Sbjct: 104 YLYQLLQGIAYCHSHRVLHRDLKPQNLLID--REGALKLADFGLARA---FGVPVRTYTH 158
Query: 84 -VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFRKTIGRIL 141
V T Y APE+L D+WS G M+ F D E + FR I R L
Sbjct: 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR--IFRTL 216
Query: 142 SV---------------HYSFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPE 177
+FP + R L + LLS++ V + KRI+
Sbjct: 217 GTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKA 276
Query: 178 IKNHPWF 184
HP+F
Sbjct: 277 ALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (169), Expect = 9e-14
Identities = 38/134 (28%), Positives = 58/134 (43%), Gaps = 14/134 (10%)
Query: 1 MEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
EY GG+L F R + + + + Q+ G+ Y S HRDL N L+ +
Sbjct: 80 TEYMPGGDLLDFLRK-HGEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTEN 138
Query: 59 TAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLTKKEYDGKIADVWSCGVT 113
VKI DFG S+ ++ + APE L ++ K +DVWS GV
Sbjct: 139 --LVVKISDFGLSR--DIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSK-SDVWSFGVL 193
Query: 114 LY-VMLVGAYPFED 126
L+ + +G P+
Sbjct: 194 LWEIFTLGEQPYPG 207
|
Length = 258 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 9e-14
Identities = 60/229 (26%), Positives = 91/229 (39%), Gaps = 33/229 (14%)
Query: 18 RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH 77
+ SED +F Q++ G+ Y H+ I HRDLK N ++ +KI DFG ++ +
Sbjct: 114 KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC--ELKILDFGLARQT--D 169
Query: 78 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFE------------ 125
S+ V T Y APEV+ + + D+WS G + ML G F+
Sbjct: 170 SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIM 229
Query: 126 --------------DPEDPKNFRKTIGRILSVHYSFPDYVR-VSLECKHLLSRIFVANSE 170
ED KN+ K + R F + + ++L ++ V ++E
Sbjct: 230 KVTGTPSKEFVQKLQSEDAKNYVKKLPRFRK--KDFRSLLPNANPLAVNVLEKMLVLDAE 287
Query: 171 KRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHE 219
RIT E HP+F E + QSLEE L
Sbjct: 288 SRITAAEALAHPYFEEFHDPEDETEAPPYDDSFDEVDQSLEEWKRLTFT 336
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-13
Identities = 52/189 (27%), Positives = 92/189 (48%), Gaps = 17/189 (8%)
Query: 1 MEYAAGGELFERIC-NAGRF-SEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
M + GG+L+ ++ G+ E++ +F Q+ + Y H I HRDLK +N L +
Sbjct: 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRT 138
Query: 59 TAPRVKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY 115
+K+ D G ++ VL +Q + +GTP Y++PE+ + K Y+ K +DVW+ G +Y
Sbjct: 139 NI--IKVGDLGIAR--VLENQCDMASTLIGTPYYMSPELFSNKPYNYK-SDVWALGCCVY 193
Query: 116 VMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR-VSLECKHLLSRIFVANSEKRIT 174
M + F + K+ + RI + P + S E L++ + EKR +
Sbjct: 194 EMATLKHAF----NAKDMNSLVYRI--IEGKLPPMPKDYSPELGELIATMLSKRPEKRPS 247
Query: 175 IPEIKNHPW 183
+ I P+
Sbjct: 248 VKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-13
Identities = 55/187 (29%), Positives = 87/187 (46%), Gaps = 14/187 (7%)
Query: 6 GGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRV 63
GG+L I + G F E A F+ ++ G+ H +I +RDLK EN LLD +
Sbjct: 84 GGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHG--HI 141
Query: 64 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYP 123
+I D G + K VGT Y+APEV+ + Y D W+ G LY M+ G P
Sbjct: 142 RISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSP 200
Query: 124 FEDPEDPKNFRKTIGRIL-SVHYSFPDYVRVSLECKHLLSRIFVANSEKRI-----TIPE 177
F+ K R+ + R++ V + + + S + + L + + ++R+ E
Sbjct: 201 FQQ-RKKKIKREEVERLVKEVQEEYSE--KFSPDARSLCKMLLCKDPKERLGCQGGGARE 257
Query: 178 IKNHPWF 184
+K HP F
Sbjct: 258 VKEHPLF 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-13
Identities = 42/134 (31%), Positives = 71/134 (52%), Gaps = 11/134 (8%)
Query: 1 MEYAAGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
ME+ G + + + N ED + ++++ G+++ H+ ++ HRD+K +N LL +
Sbjct: 98 MEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL--T 155
Query: 59 TAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKE-----YDGKIADVWSCGV 112
VK+ DFG S ++T +GTP ++APEV+ E YD + +D+WS G+
Sbjct: 156 ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYR-SDIWSLGI 214
Query: 113 TLYVMLVGAYPFED 126
T M GA P D
Sbjct: 215 TAIEMAEGAPPLCD 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-13
Identities = 52/192 (27%), Positives = 86/192 (44%), Gaps = 18/192 (9%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
ME+ GG L + G SE + + ++ + G+ Y HS HRD+K N LL +
Sbjct: 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNG- 143
Query: 61 PRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTKKEYDG--KIADVWSCGVTLYVM 117
VK+ DFG S + ++ KS +GTP ++APEV + G ++ D+W+ G+T
Sbjct: 144 -HVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGIT---- 198
Query: 118 LVGAYPFEDPEDPK-NFRKTIGRILSVHYSF-----PDYVRVSLECKHLLSRIFVANSEK 171
A + + P + L +F D ++ S H + N +K
Sbjct: 199 ---AIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKK 255
Query: 172 RITIPEIKNHPW 183
R T ++ HP+
Sbjct: 256 RPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-13
Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 7/112 (6%)
Query: 11 ERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGY 70
E+ N E R + Q++ G+ +CHS I HRD+K EN L+ S + VK+CDFG+
Sbjct: 91 EKYPNG--LDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV--SQSGVVKLCDFGF 146
Query: 71 SKSSVLHSQPKST--VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
++ ++ T V T Y APE+L G+ D+W+ G + ML G
Sbjct: 147 AR-TLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-13
Identities = 60/235 (25%), Positives = 103/235 (43%), Gaps = 41/235 (17%)
Query: 19 FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78
SED+ ++ Q++ G+ Y HS I HRDLK N ++ +KI DFG ++ + +
Sbjct: 114 LSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC--ELKILDFGLARHA--DA 169
Query: 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFE------------- 125
+ V T Y APEV+ + + D+WS G + ML G F+
Sbjct: 170 EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 229
Query: 126 -------------DPEDPKNFRKTIGRILSVHYS--FPDYVRVSLECKHLLSRIFVANSE 170
+ + K++ K++ + +S FP + S + LL ++ + +
Sbjct: 230 VTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFP---KASPQAVDLLEKMLELDVD 286
Query: 171 KRITIPEIKNHPWF--LRNLPIELTEGGSW-QSHDVNNPSQSLEEVLSLIHEATK 222
KR+T E HP+F R+ E TE + S + N S++E I++ K
Sbjct: 287 KRLTATEALEHPYFDSFRD-ADEETEQQPYDDSLE--NEKLSVDEWKKHIYKEVK 338
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-13
Identities = 51/186 (27%), Positives = 81/186 (43%), Gaps = 12/186 (6%)
Query: 6 GGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRV 63
GG+L I N G F E A F+ +L G+ +I +RDLK EN LLD +
Sbjct: 84 GGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRG--HI 141
Query: 64 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYP 123
+I D G + + VGT Y+APEV+ ++Y D W G +Y M+ G P
Sbjct: 142 RISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFS-PDWWGLGCLIYEMIQGQSP 200
Query: 124 FEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITI-----PEI 178
F ++ + R+ + + + S + K + + N ++R+ +
Sbjct: 201 FRKRKERVKREEVDRRVKEDQEEYSE--KFSEDAKSICRMLLTKNPKERLGCRGNGAAGV 258
Query: 179 KNHPWF 184
K HP F
Sbjct: 259 KQHPIF 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 3e-13
Identities = 53/168 (31%), Positives = 76/168 (45%), Gaps = 32/168 (19%)
Query: 1 MEYAAGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQ-------ICHRDLK 49
ME+ G+L I G+ E +QL+ ++YCH+++ + HRDLK
Sbjct: 93 MEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLK 152
Query: 50 LENTLLDGS-------TA--------PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 94
+N L TA P KI DFG SK+ + S S VGTP Y +PE+
Sbjct: 153 PQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPEL 212
Query: 95 L--TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRI 140
L K YD K +D+W+ G +Y + G PF NF + I +
Sbjct: 213 LLHETKSYDDK-SDMWALGCIIYELCSGKTPF---HKANNFSQLISEL 256
|
Length = 1021 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 4e-13
Identities = 51/204 (25%), Positives = 84/204 (41%), Gaps = 35/204 (17%)
Query: 9 LFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICD 67
L+E I R E + + QL+ + + H I HRD+K EN L+ +K+ D
Sbjct: 86 LYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDDI---LKLAD 142
Query: 68 FGYSKSSVLHSQPKST--VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVM--LVGAYP 123
FG + ++S+P T + T Y APE L Y G D+W+ G + + L +P
Sbjct: 143 FGSCRG--IYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFP 200
Query: 124 FED--------------PEDPKNFRKTIGRILSVHYSFPD---------YVRVSLECKHL 160
+ P+ + R ++ Y+FP S E L
Sbjct: 201 GTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN--YNFPSKKGTGLRKLLPNASAEGLDL 258
Query: 161 LSRIFVANSEKRITIPEIKNHPWF 184
L ++ + ++RIT + HP+F
Sbjct: 259 LKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 5e-13
Identities = 56/191 (29%), Positives = 75/191 (39%), Gaps = 33/191 (17%)
Query: 25 RFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST- 83
R+ QL+ + Y HS + HRDLK N LL+ RVK+ DFG ++S +
Sbjct: 110 RYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDC--RVKLADFGLARSLSELEENPENP 167
Query: 84 -----VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRK--- 135
V T Y APE+L K D+WS G L ML+G F K
Sbjct: 168 VLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIE 227
Query: 136 TIGR-----ILSVHYSFPDYVRVSLECKH-----------------LLSRIFVANSEKRI 173
IG I S+ F + SL + LL ++ V N KR+
Sbjct: 228 VIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRL 287
Query: 174 TIPEIKNHPWF 184
T E HP+
Sbjct: 288 TAEEALEHPYV 298
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 7e-13
Identities = 52/195 (26%), Positives = 80/195 (41%), Gaps = 32/195 (16%)
Query: 18 RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH 77
S D + F Q++ G+ Y HS I HRD+K N L++ + +KICDFG ++
Sbjct: 99 PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNC--VLKICDFGLARVEEPD 156
Query: 78 SQPKST--VGTPAYIAPEVLT-KKEYDGKIADVWSCGVTLYVMLVGAYPFE--------- 125
T V T Y APE+L + Y + D+WS G +L F+
Sbjct: 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAV-DIWSVGCIFAELLGRRILFQAQSPIQQLD 215
Query: 126 -------DP--EDPKNFRK-TIGRILSVHYSFPDYVRVSL-------ECKHLLSRIFVAN 168
P E ++ + IL + P + E HLL R+ V +
Sbjct: 216 LITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFD 275
Query: 169 SEKRITIPEIKNHPW 183
+KRI+ + HP+
Sbjct: 276 PDKRISAADALAHPY 290
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 8e-13
Identities = 55/190 (28%), Positives = 80/190 (42%), Gaps = 32/190 (16%)
Query: 24 ARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST 83
R F QL+ G++YCH ++ HRDLK +N L+ S +K+ DFG +++ + S+ S
Sbjct: 105 VRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI--SERGELKLADFGLARAKSVPSKTYSN 162
Query: 84 -VGTPAYIAPEVLT-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIL 141
V T Y P+VL EY + D+W G Y M G F D ++ I R+L
Sbjct: 163 EVVTLWYRPPDVLLGSTEYSTSL-DMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVL 221
Query: 142 S----------------VHYSFPDYVRVSL-----------ECKHLLSRIFVANSEKRIT 174
YSFP Y L + L + +KRI+
Sbjct: 222 GTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRIS 281
Query: 175 IPEIKNHPWF 184
E HP+F
Sbjct: 282 AAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-13
Identities = 40/116 (34%), Positives = 65/116 (56%), Gaps = 5/116 (4%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY GG L + G SE + + ++ + G++Y HS HRD+K N LL +
Sbjct: 85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL--TDN 142
Query: 61 PRVKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDG--KIADVWSCGVT 113
VK+ DFG +K + ++ KS +GTP ++APEV ++ G ++ D+W+ G+T
Sbjct: 143 GDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGIT 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-12
Identities = 53/204 (25%), Positives = 74/204 (36%), Gaps = 35/204 (17%)
Query: 12 RICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYS 71
+ G SE+ AR F QL+ G+ Y HS + HRDLK N ++ +KI DFG +
Sbjct: 104 NVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL-VLKIGDFGLA 162
Query: 72 KSSVLHSQPKS----TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG------- 120
+ H K + T Y +P +L K D+W+ G ML G
Sbjct: 163 RIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA 222
Query: 121 -----------AYPFEDPED--------PKNFRKTIGRILSVHYSFPDYV-RVSLECKHL 160
+ P ED P R G D + V+ E
Sbjct: 223 HELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEP---RRPLRDLLPGVNPEALDF 279
Query: 161 LSRIFVANSEKRITIPEIKNHPWF 184
L +I N R+T E HP+
Sbjct: 280 LEQILTFNPMDRLTAEEALMHPYM 303
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-12
Identities = 53/187 (28%), Positives = 87/187 (46%), Gaps = 29/187 (15%)
Query: 25 RFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST- 83
+ F QL+ G++YCH ++ HRDLK +N L++ +K+ DFG +++ + ++ S
Sbjct: 107 KLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERG--ELKLADFGLARAKSIPTKTYSNE 164
Query: 84 VGTPAYIAPEVLT-KKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPEDPKNF------- 133
V T Y P++L +Y +I D+W G Y M G +P E+ +F
Sbjct: 165 VVTLWYRPPDILLGSTDYSTQI-DMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGT 223
Query: 134 --RKTIGRILS----VHYSFPDY---------VRVSLECKHLLSRIFVANSEKRITIPEI 178
+T ILS Y++P Y R+ + LLS++ KRI+ E
Sbjct: 224 PTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEA 283
Query: 179 KNHPWFL 185
HP+F
Sbjct: 284 MKHPYFH 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 52/200 (26%), Positives = 85/200 (42%), Gaps = 45/200 (22%)
Query: 18 RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH 77
+ S+D +F Q++ G+ Y HS I HRDLK N ++ +KI DFG ++ H
Sbjct: 114 KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC--ELKILDFGLAR----H 167
Query: 78 SQPKST--VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPEDPKNF 133
+ + T V T Y APE++ + + D+WS G + +L G +P D D
Sbjct: 168 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID---- 223
Query: 134 RKTIGRILSV------------------HY--SFPDYVR---------VSLECKHLLSRI 164
+ RI+++ +Y S P + + LL ++
Sbjct: 224 --QLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKM 281
Query: 165 FVANSEKRITIPEIKNHPWF 184
V + +KRIT E HP+
Sbjct: 282 LVLDPDKRITAAEALAHPYL 301
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-12
Identities = 39/86 (45%), Positives = 54/86 (62%), Gaps = 11/86 (12%)
Query: 32 ISGVSYCHSMQICHRDLKLENTLLDGSTAP-RVKICDFGYSKSSVLHSQPKSTVGTPAYI 90
+ G++Y HS + HRD+K N LL T P +VK+ DFG S+ S S VGTP ++
Sbjct: 131 LQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFG---SASKSSPANSFVGTPYWM 184
Query: 91 APEV---LTKKEYDGKIADVWSCGVT 113
APEV + + +YDGK+ DVWS G+T
Sbjct: 185 APEVILAMDEGQYDGKV-DVWSLGIT 209
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-12
Identities = 44/134 (32%), Positives = 70/134 (52%), Gaps = 11/134 (8%)
Query: 1 MEYAAGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
ME+ G + + I N E+ + ++++ G+S+ H ++ HRD+K +N LL +
Sbjct: 88 MEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL--T 145
Query: 59 TAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKE-----YDGKIADVWSCGV 112
VK+ DFG S ++T +GTP ++APEV+ E YD K +D+WS G+
Sbjct: 146 ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFK-SDLWSLGI 204
Query: 113 TLYVMLVGAYPFED 126
T M GA P D
Sbjct: 205 TAIEMAEGAPPLCD 218
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-12
Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 26/200 (13%)
Query: 5 AGGELFE--RICNAGRFSE------------DEA--RFFFQQLISGVSYCHSMQICHRDL 48
GG+L+ +CN G +E DEA + + G+ + H+ +I HRD+
Sbjct: 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDV 154
Query: 49 KLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLT-KKEYDGKI-- 104
K N LL +T VK+ DFG S + + ++VGTP ++APEV+ +++YD
Sbjct: 155 KGNNILL--TTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDA 212
Query: 105 -ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSR 163
DVWS G+T + G P D K K I R P+ + H +S+
Sbjct: 213 RCDVWSLGITAIELGDGDPPLFDMHPVKTLFK-IPRNPPPTLLHPE--KWCRSFNHFISQ 269
Query: 164 IFVANSEKRITIPEIKNHPW 183
+ + E R ++ + HP+
Sbjct: 270 CLIKDFEARPSVTHLLEHPF 289
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-12
Identities = 39/86 (45%), Positives = 55/86 (63%), Gaps = 11/86 (12%)
Query: 32 ISGVSYCHSMQICHRDLKLENTLLDGSTAP-RVKICDFGYSKSSVLHSQPKSTVGTPAYI 90
+ G++Y HS + HRD+K N LL T P +VK+ DFG S+ + S S VGTP ++
Sbjct: 135 LQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFG---SASIASPANSFVGTPYWM 188
Query: 91 APEV---LTKKEYDGKIADVWSCGVT 113
APEV + + +YDGK+ DVWS G+T
Sbjct: 189 APEVILAMDEGQYDGKV-DVWSLGIT 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 4e-12
Identities = 51/197 (25%), Positives = 80/197 (40%), Gaps = 34/197 (17%)
Query: 18 RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVL 76
++ + F Q++ G+ Y HS + HRDLK N L++ +KICDFG ++ S
Sbjct: 101 PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADC--ELKICDFGLARGFSEN 158
Query: 77 H--SQPKST--VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPED--- 129
+ T V T Y APE++ + K DVWS G L L+G P +D
Sbjct: 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCIL-AELLGRKPVFKGKDYVD 217
Query: 130 ------------PKNFRKTIGRILSVHY--SFPDYVRVSL---------ECKHLLSRIFV 166
+ IG + +Y S P+ + LL ++
Sbjct: 218 QLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLA 277
Query: 167 ANSEKRITIPEIKNHPW 183
+ KRI++ E HP+
Sbjct: 278 FDPTKRISVEEALEHPY 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-12
Identities = 54/187 (28%), Positives = 80/187 (42%), Gaps = 31/187 (16%)
Query: 25 RFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST- 83
+ F QL+ G+SYCH +I HRDLK +N L++ +K+ DFG +++ + ++ S
Sbjct: 106 KIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKG--ELKLADFGLARAKSVPTKTYSNE 163
Query: 84 VGTPAYIAPEVLT-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS 142
V T Y P+VL EY I D+W G LY M G P K I R+L
Sbjct: 164 VVTLWYRPPDVLLGSTEYSTPI-DMWGVGCILYEMATGR-PMFPGSTVKEELHLIFRLLG 221
Query: 143 V----------------HYSFPDYV---------RVSLECKHLLSRIFVANSEKRITIPE 177
Y FP Y R+ + LLS + + ++ RI+
Sbjct: 222 TPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEA 281
Query: 178 IKNHPWF 184
H +F
Sbjct: 282 ALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 5e-12
Identities = 57/188 (30%), Positives = 85/188 (45%), Gaps = 37/188 (19%)
Query: 27 FFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--- 83
+ Q++ G++YCHS ++ HRDLK +N L+D T +K+ DFG +++ + P T
Sbjct: 107 YLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN-ALKLADFGLARAFGI---PVRTFTH 162
Query: 84 -VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPF--EDPEDPKNFRKTIGRI 140
V T Y APE+L + D+WS G ++ +V P D E + F+ I RI
Sbjct: 163 EVVTLWYRAPEILLGSRHYSTPVDIWSVGC-IFAEMVNQKPLFPGDSEIDELFK--IFRI 219
Query: 141 LSVHY--------SFPDY--------------VRVSLECK--HLLSRIFVANSEKRITIP 176
L S PDY V +LE LLS++ + KRIT
Sbjct: 220 LGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITAR 279
Query: 177 EIKNHPWF 184
H +F
Sbjct: 280 AALEHEYF 287
|
Length = 294 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 5e-12
Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 41/209 (19%)
Query: 13 ICNAGRFSEDEAR--FFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGY 70
+C D R + Q++ G+ + HS I HRDLK N ++ +KI DFG
Sbjct: 112 LCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGL 169
Query: 71 SKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP 130
++++ + V T Y APEV+ Y + D+WS G + ++ G+ F+ +
Sbjct: 170 ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENV-DIWSVGCIMGELVKGSVIFQGTDHI 228
Query: 131 KNFRKTIGRI---------------------------LSVHYSFPDYVRVS--------- 154
+ K I ++ +S FPD++ S
Sbjct: 229 DQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKT 288
Query: 155 LECKHLLSRIFVANSEKRITIPEIKNHPW 183
+ + LLS++ V + +KRI++ E HP+
Sbjct: 289 SQARDLLSKMLVIDPDKRISVDEALRHPY 317
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-12
Identities = 38/103 (36%), Positives = 55/103 (53%), Gaps = 12/103 (11%)
Query: 27 FFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGY-----SKSSVLHSQPK 81
+F QL S V + HS ++ HRD+K N + + VK+ D G SK++ H
Sbjct: 111 YFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH---- 164
Query: 82 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPF 124
S VGTP Y++PE + + Y+ K +D+WS G LY M PF
Sbjct: 165 SLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-12
Identities = 40/109 (36%), Positives = 57/109 (52%), Gaps = 7/109 (6%)
Query: 8 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICD 67
EL E + N ++ R + QLI + +CH I HRD+K EN L+ S +K+CD
Sbjct: 88 ELLEEMPNGV--PPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI--SHNDVLKLCD 143
Query: 68 FGYSKSSVLHSQPKST--VGTPAYIAPEVLTKKEYDGKIADVWSCGVTL 114
FG++++ S T V T Y +PE+L Y GK D+WS G L
Sbjct: 144 FGFARNLSEGSNANYTEYVATRWYRSPELLLGAPY-GKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 7e-12
Identities = 49/184 (26%), Positives = 73/184 (39%), Gaps = 30/184 (16%)
Query: 27 FFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVG 85
F QL+ GV++CH + HRDLK +N L+D +KI D G ++ S+ +
Sbjct: 115 FMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKG-LLKIADLGLGRAFSIPVKSYTHEIV 173
Query: 86 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFR--KTIG---- 138
T Y APEVL + D+WS G M F D E + K +G
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE 233
Query: 139 ------------------RILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
+ + + PD +S E LL ++ + KRI+
Sbjct: 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPD---LSPEGLDLLQKMLRYDPAKRISAKAALT 290
Query: 181 HPWF 184
HP+F
Sbjct: 291 HPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 8e-12
Identities = 39/116 (33%), Positives = 53/116 (45%), Gaps = 9/116 (7%)
Query: 27 FFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ---PKST 83
F Q+ G+ Y S + HRDL N L++ VKI DFG +K K
Sbjct: 114 FSSQICKGMDYLGSQRYIHRDLAARNILVESED--LVKISDFGLAKVLPEDKDYYYVKEP 171
Query: 84 VGTPA-YIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG 138
+P + APE L ++ +DVWS GVTLY + P + P P F + IG
Sbjct: 172 GESPIFWYAPECLRTSKFSSA-SDVWSFGVTLYELFTYGDPSQSP--PAEFLRMIG 224
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-12
Identities = 57/247 (23%), Positives = 109/247 (44%), Gaps = 43/247 (17%)
Query: 7 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKIC 66
G I + ++D +F Q++ G+ Y HS I HRDLK N ++ +KI
Sbjct: 105 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC--ELKIL 162
Query: 67 DFGYSKSSVLHSQPKST--VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGA--Y 122
DFG ++ H+ + T V T Y APE++ + + D+WS G + +L G +
Sbjct: 163 DFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 218
Query: 123 PFED------------------------PEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 158
P D E +N+ +++ ++ ++++ ++ +
Sbjct: 219 PGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAV 277
Query: 159 HLLSRIFVANSEKRITIPEIKNHPWFLR-----NLPIELTEGGSWQSHDVNN---PSQSL 210
LL ++ V +S+KRIT + H +F + + P+ S++S D+ S +
Sbjct: 278 DLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTY 337
Query: 211 EEVLSLI 217
+EV+S +
Sbjct: 338 DEVISFV 344
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 8e-12
Identities = 45/117 (38%), Positives = 58/117 (49%), Gaps = 11/117 (9%)
Query: 27 FFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS---SVLHSQPKST 83
F QQ+ G++Y HS HRDL N LLD VKI DFG +K+ + + +
Sbjct: 112 FAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVRED 169
Query: 84 VGTPAY-IAPEVLTKKEYDGKIA-DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG 138
+P + A E L KE A DVWS GVTLY +L + P PK F + IG
Sbjct: 170 GDSPVFWYAVECL--KENKFSYASDVWSFGVTLYELLTHCDSKQSP--PKKFEEMIG 222
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 9e-12
Identities = 54/198 (27%), Positives = 85/198 (42%), Gaps = 32/198 (16%)
Query: 14 CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS 73
CN G + + F QL+ G+++CHS + HRDLK +N L++ + +K+ DFG +++
Sbjct: 92 CN-GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNG--ELKLADFGLARA 148
Query: 74 -SVLHSQPKSTVGTPAYIAPEVLT-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPK 131
+ + V T Y P+VL K Y I D+WS G + P D
Sbjct: 149 FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI-DMWSAGCIFAELANAGRPLFPGNDVD 207
Query: 132 NFRKTIGRIL---------SVHYSFPDYV----------------RVSLECKHLLSRIFV 166
+ K I R+L V PDY +++ + LL + V
Sbjct: 208 DQLKRIFRLLGTPTEESWPGVS-KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLV 266
Query: 167 ANSEKRITIPEIKNHPWF 184
N +RI+ E HP+F
Sbjct: 267 CNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-11
Identities = 36/86 (41%), Positives = 53/86 (61%), Gaps = 11/86 (12%)
Query: 32 ISGVSYCHSMQICHRDLKLENTLLDGSTAP-RVKICDFGYSKSSVLHSQPKSTVGTPAYI 90
+ G++Y HS + HRD+K N LL + P VK+ DFG S+ + + VGTP ++
Sbjct: 125 LQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFG---SASIMAPANXFVGTPYWM 178
Query: 91 APEV---LTKKEYDGKIADVWSCGVT 113
APEV + + +YDGK+ DVWS G+T
Sbjct: 179 APEVILAMDEGQYDGKV-DVWSLGIT 203
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 1e-11
Identities = 43/132 (32%), Positives = 62/132 (46%), Gaps = 8/132 (6%)
Query: 23 EARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS 82
+ R +QL+ V Y H ++ HRD+KLEN L+ ++ + DFG + +
Sbjct: 268 QTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG--KIVLGDFGTAMPFEKEREAFD 325
Query: 83 T--VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAY-PFED-PEDP-KNFRKTI 137
VGT A +PE+L Y +I D+WSCG+ L ML + P D P K K I
Sbjct: 326 YGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII 384
Query: 138 GRILSVHYSFPD 149
+ FPD
Sbjct: 385 DSLSVCDEEFPD 396
|
Length = 501 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 1e-11
Identities = 52/204 (25%), Positives = 78/204 (38%), Gaps = 52/204 (25%)
Query: 30 QLISGVSYCHSMQICHRDLKLENTLL--DGSTAPRVKICDFGYSKSSVLHSQPKS----- 82
Q+++GV Y HS + HRDLK N L+ +G VKI D G ++ + ++ K
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR--LFNAPLKPLADLD 173
Query: 83 -TVGTPAYIAPEVLT-KKEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKN---FRKT 136
V T Y APE+L + Y I D+W+ G +L F+ K F++
Sbjct: 174 PVVVTIWYRAPELLLGARHYTKAI-DIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRD 232
Query: 137 -IGRILSV-----------------------HYSFPDYVRVSL------------ECKHL 160
+ RI V + Y SL + L
Sbjct: 233 QLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDL 292
Query: 161 LSRIFVANSEKRITIPEIKNHPWF 184
L ++ + KRIT E HP+F
Sbjct: 293 LRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 29/238 (12%)
Query: 7 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKIC 66
G I + S++ +F QL+ G+ Y HS I HRDLK N ++ ++I
Sbjct: 103 GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC--ELRIL 160
Query: 67 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGA--YPF 124
DFG ++ + + V T Y APE++ + + D+WS G + +L G +P
Sbjct: 161 DFGLARQA--DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218
Query: 125 EDPEDP-KNFRKTIG--------RILSVH-----YSFPDYVRVSLE---------CKHLL 161
D D K + +G +I S H S P + L+ LL
Sbjct: 219 NDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLL 278
Query: 162 SRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHE 219
++ V +S+KRI+ E HP+F + E N +++EE L +E
Sbjct: 279 EKMLVLDSDKRISASEALAHPYFSQYHDPEDEPEAEPYDESPENKERTIEEWKELTYE 336
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-11
Identities = 53/189 (28%), Positives = 86/189 (45%), Gaps = 35/189 (18%)
Query: 25 RFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST- 83
+ F Q++ G++YCH ++ HRDLK +N L++ +K+ DFG +++ + ++ S
Sbjct: 107 KIFLYQILRGLAYCHRRKVLHRDLKPQNLLIN--ERGELKLADFGLARAKSVPTKTYSNE 164
Query: 84 VGTPAYIAPEVLT-KKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPEDPKNFRKTIGRI 140
V T Y P+VL EY +I D+W G + M G +P ED + I R+
Sbjct: 165 VVTLWYRPPDVLLGSSEYSTQI-DMWGVGCIFFEMASGRPLFPGSTVEDELHL---IFRL 220
Query: 141 LSV----------------HYSFPDYV---------RVSLECKHLLSRIFVANSEKRITI 175
L +Y+FP Y R+ E LL++ S+KRI+
Sbjct: 221 LGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISA 280
Query: 176 PEIKNHPWF 184
E H +F
Sbjct: 281 EEAMKHAYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 3e-11
Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 12/90 (13%)
Query: 41 MQICHRDLKLENTLLDGSTAPRVKICDFGYS---KSSVLHSQPKSTVGTPAYIAPEVL-- 95
++I HRD+K N LLD + +K+CDFG S S+ ++ G Y+APE +
Sbjct: 127 LKIIHRDVKPSNILLDRNGN--IKLCDFGISGQLVDSIAKTR---DAGCRPYMAPERIDP 181
Query: 96 -TKKEYDGKIADVWSCGVTLYVMLVGAYPF 124
+ YD + +DVWS G+TLY + G +P+
Sbjct: 182 SARDGYDVR-SDVWSLGITLYEVATGKFPY 210
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-11
Identities = 47/151 (31%), Positives = 70/151 (46%), Gaps = 14/151 (9%)
Query: 27 FFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGY-----SKSSVLHSQPK 81
+F QL S + + HS ++ HRD+K N + + VK+ D G SK++ H
Sbjct: 111 YFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH---- 164
Query: 82 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIL 141
S VGTP Y++PE + + Y+ K +D+WS G LY M PF D N +I
Sbjct: 165 SLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIE 221
Query: 142 SVHYSFPDYVRVSLECKHLLSRIFVANSEKR 172
Y S E + L++ + EKR
Sbjct: 222 QCDYPPLPSDHYSEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 4e-11
Identities = 38/100 (38%), Positives = 58/100 (58%), Gaps = 4/100 (4%)
Query: 25 RFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTV 84
+ + QL ++Y HS ICHRDLK +N L+D +T +K+CDFG +K+ + + S +
Sbjct: 173 KLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHT-LKLCDFGSAKNLLAGQRSVSYI 231
Query: 85 GTPAYIAPEV-LTKKEYDGKIADVWSCGVTLYVMLVGAYP 123
+ Y APE+ L Y I D+WS G + M++G YP
Sbjct: 232 CSRFYRAPELMLGATNYTTHI-DLWSLGCIIAEMILG-YP 269
|
Length = 440 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 45/158 (28%), Positives = 66/158 (41%), Gaps = 33/158 (20%)
Query: 28 FQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFG----------------YS 71
F ++ + + Y HS + HRDLK +N LL V I D+G
Sbjct: 119 FHKICATIEYVHSKGVLHRDLKPDNILL--GLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176
Query: 72 KSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 128
+ ++ +S P VGTP Y+APE L D+++ GV LY ML ++P
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES-TDIYALGVILYQMLTLSFP----- 230
Query: 129 DPKNFRKTIGRILSV--HYSFPDYVRVSLECKHLLSRI 164
+R+ GR +S P V E LS+I
Sbjct: 231 ----YRRKKGRKISYRDVILSPIEVAPYREIPPFLSQI 264
|
Length = 932 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 50/208 (24%), Positives = 80/208 (38%), Gaps = 48/208 (23%)
Query: 18 RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH 77
+ +E + + + QL+ G++Y H I HRD+K N L+D +KI DFG ++
Sbjct: 111 KLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIADFGLAR--PYD 166
Query: 78 SQPK--------------STVGTPAYIAPE-VLTKKEYDGKIADVWSCGVTLYVM----- 117
P + V T Y PE +L ++ Y + D+W G M
Sbjct: 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAV-DIWGIGCVFAEMFTRRP 225
Query: 118 -LVGAYPFE------------DPEDPKNFRKTIGRILSVHYSFPDYVR--------VSLE 156
L G + E +R G +SF +Y R + E
Sbjct: 226 ILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPG--CEGVHSFTNYPRTLEERFGKLGPE 283
Query: 157 CKHLLSRIFVANSEKRITIPEIKNHPWF 184
LLS++ + KR+T + HP+F
Sbjct: 284 GLDLLSKLLSLDPYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 3e-10
Identities = 52/208 (25%), Positives = 82/208 (39%), Gaps = 53/208 (25%)
Query: 18 RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL--DGSTAPRVKICDFGYSKSSV 75
+F+ E + + L++G+ Y H +I HRD+K N L+ DG +K+ DFG +++
Sbjct: 115 KFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI----LKLADFGLARAFS 170
Query: 76 LHSQPKST-----VGTPAYIAPEVLTKKEYDGKIADVWSCG------------------- 111
L K V T Y PE+L + G D+W G
Sbjct: 171 LSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ 230
Query: 112 --VTLYVMLVGA-----YP-------FEDPEDPKN-FRKTIGRILSVHYSFPDYVRVSLE 156
+TL L G+ +P F+ E P+ RK R+ YV+
Sbjct: 231 HQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKP-------YVK-DPH 282
Query: 157 CKHLLSRIFVANSEKRITIPEIKNHPWF 184
L+ ++ V + KRI NH +F
Sbjct: 283 ALDLIDKLLVLDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-10
Identities = 53/187 (28%), Positives = 81/187 (43%), Gaps = 42/187 (22%)
Query: 30 QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS------SVLHSQPKST 83
Q++ G+ +CHS ++ HRDLK +N L+D +K+ DFG +++ H
Sbjct: 109 QILQGILFCHSRRVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRVYTHE----- 161
Query: 84 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPF--EDPEDPKNFRKTIGRIL 141
V T Y APEVL D+WS G T++ + P D E + FR I RIL
Sbjct: 162 VVTLWYRAPEVLLGSPRYSTPVDIWSIG-TIFAEMATKKPLFHGDSEIDQLFR--IFRIL 218
Query: 142 SV---------------HYSFPDYVRVSLECK---------HLLSRIFVANSEKRITIPE 177
+FP + + SL LL ++ + + KRI+ +
Sbjct: 219 GTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKK 278
Query: 178 IKNHPWF 184
NHP+F
Sbjct: 279 ALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-10
Identities = 55/209 (26%), Positives = 88/209 (42%), Gaps = 41/209 (19%)
Query: 13 ICNAGRFSEDEAR--FFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGY 70
+C + D R + Q++ G+ + HS I HRDLK N ++ +KI DFG
Sbjct: 115 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGL 172
Query: 71 SKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGA--YPFED-- 126
++++ V T Y APEV+ Y + D+WS G + M+ G +P D
Sbjct: 173 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHI 231
Query: 127 --------------PEDPKNFRKTI-----GRILSVHYS----FPDYV---------RVS 154
PE K + T+ R YS FPD + +
Sbjct: 232 DQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKA 291
Query: 155 LECKHLLSRIFVANSEKRITIPEIKNHPW 183
+ + LLS++ V ++ KRI++ E HP+
Sbjct: 292 SQARDLLSKMLVIDASKRISVDEALQHPY 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-10
Identities = 37/102 (36%), Positives = 53/102 (51%), Gaps = 5/102 (4%)
Query: 25 RFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST- 83
R F QL+ G++Y H I HRDLK +N L+ S +K+ DFG +++ + SQ S+
Sbjct: 106 RLFMFQLLRGLAYIHGQHILHRDLKPQNLLI--SYLGELKLADFGLARAKSIPSQTYSSE 163
Query: 84 VGTPAYIAPEVLT-KKEYDGKIADVWSCGVTLYVMLVGAYPF 124
V T Y P+VL +Y + D+W G ML G F
Sbjct: 164 VVTLWYRPPDVLLGATDYSSAL-DIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-09
Identities = 31/94 (32%), Positives = 47/94 (50%), Gaps = 7/94 (7%)
Query: 30 QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS---TVGT 86
Q + V++CH HRD+K EN L+ + ++K+CDFG+++ +L V T
Sbjct: 108 QTLQAVNFCHKHNCIHRDVKPENILI--TKQGQIKLCDFGFAR--ILTGPGDDYTDYVAT 163
Query: 87 PAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
Y APE+L G DVW+ G +L G
Sbjct: 164 RWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 31/97 (31%), Positives = 48/97 (49%), Gaps = 3/97 (3%)
Query: 22 DEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK 81
+ + +Q + G+ + H+ I HRDLK EN L+ ++ +VK+ DFG ++
Sbjct: 108 ETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV--TSGGQVKLADFGLARIYSCQMALT 165
Query: 82 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 118
V T Y APEVL + Y + D+WS G M
Sbjct: 166 PVVVTLWYRAPEVLLQSTYATPV-DMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-09
Identities = 40/124 (32%), Positives = 60/124 (48%), Gaps = 13/124 (10%)
Query: 2 EYAAGGELFERI-CNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
E A G L +R+ +A G F + Q+ +G+ Y S + HRDL N LL ++
Sbjct: 75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILL--AS 132
Query: 60 APRVKICDFGYSKSSVLH-----SQPKSTVGTP-AYIAPEVLTKKEYDGKIADVWSCGVT 113
+VKI DFG ++ + + V P A+ APE L + + +DVW GVT
Sbjct: 133 DDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLRTRTFS-HASDVWMFGVT 189
Query: 114 LYVM 117
L+ M
Sbjct: 190 LWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-09
Identities = 49/178 (27%), Positives = 80/178 (44%), Gaps = 28/178 (15%)
Query: 18 RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK--SSV 75
R E + + + G+ + H + HRD+K N LL +T VK+ DFG S +S
Sbjct: 120 RMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILL--TTEGGVKLVDFGVSAQLTST 177
Query: 76 LHSQPKSTVGTPAYIAPEVLTKKE-----YDGKIADVWSCGVTLYVMLVGAYPFEDPED- 129
+ ++VGTP ++APEV+ ++ YD + DVWS G+T + G P D
Sbjct: 178 RLRR-NTSVGTPFWMAPEVIACEQQLDSTYDAR-CDVWSLGITAIELGDGDPPLADLHPM 235
Query: 130 ------PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181
P+N T+ + F D++R + + EKR T+ ++ H
Sbjct: 236 RALFKIPRNPPPTLHQPELWSNEFNDFIR----------KCLTKDYEKRPTVSDLLQH 283
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-09
Identities = 36/114 (31%), Positives = 52/114 (45%), Gaps = 3/114 (2%)
Query: 17 GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL 76
G + + F QL+ G+SY H I HRDLK +N L+ S +K+ DFG +++ +
Sbjct: 98 GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI--SDTGELKLADFGLARAKSV 155
Query: 77 HSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPED 129
S S V T Y P+VL D+W G M+ G F +D
Sbjct: 156 PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD 209
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-09
Identities = 45/135 (33%), Positives = 64/135 (47%), Gaps = 21/135 (15%)
Query: 2 EYAAGGELFERICNAGRFSEDEARFFFQQLIS-------GVSYCHSMQICHRDLKLENTL 54
EY + G C E RF QL+ G++Y S Q HRDL N L
Sbjct: 79 EYMSNG------CLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCL 132
Query: 55 LDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLTKKEYDGKIADVWSCG 111
+D VK+ DFG S+ VL + S+VG+ + PEVL ++ K +DVW+ G
Sbjct: 133 VDDQGC--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSK-SDVWAFG 188
Query: 112 VTLY-VMLVGAYPFE 125
V ++ V +G P+E
Sbjct: 189 VLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 4e-09
Identities = 34/112 (30%), Positives = 53/112 (47%), Gaps = 9/112 (8%)
Query: 30 QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS---SVLHSQPKSTVGT 86
Q+ G+SY H + H+D+ N ++D +VKI D S+ H +
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEEL--QVKITDNALSRDLFPMDYHCLGDNENRP 182
Query: 87 PAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE--DPEDPKNFRK 135
++A E L KEY +DVWS GV L+ +M +G P+ DP + + K
Sbjct: 183 VKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK 233
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 5e-09
Identities = 38/136 (27%), Positives = 64/136 (47%), Gaps = 14/136 (10%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
M Y + +L + G E F + +++ + Y HS HR +K + LL G
Sbjct: 81 MAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDG- 138
Query: 61 PRVKICDFGYS--------KSSVLHSQPKSTVGTPAYIAPEVLTK--KEYDGKIADVWSC 110
+V + YS + V+H PKS+V +++PEVL + + Y+ K D++S
Sbjct: 139 -KVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKS-DIYSV 196
Query: 111 GVTLYVMLVGAYPFED 126
G+T + G PF+D
Sbjct: 197 GITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-09
Identities = 53/191 (27%), Positives = 80/191 (41%), Gaps = 22/191 (11%)
Query: 1 MEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
ME+ G L E + N + + + + Q+ G+ Y S Q HRDL N L++
Sbjct: 87 MEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH 146
Query: 60 APRVKICDFGYSKSSVLHSQP---KSTVGTPAY-IAPEVLTKKEYDGKIADVWSCGVTLY 115
+VKI DFG +K+ + K + +P + APE L + ++ +DVWS GVTLY
Sbjct: 147 --QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKF-YIASDVWSFGVTLY 203
Query: 116 VMLVGAYPFEDPEDPKNFRKTIG------------RILSVHYSFPDYVRVSLECKHLLSR 163
+L Y + F K IG R+L P E L+ +
Sbjct: 204 ELL--TYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRK 261
Query: 164 IFVANSEKRIT 174
+ KR T
Sbjct: 262 CWEFQPSKRTT 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-09
Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 3/89 (3%)
Query: 30 QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAY 89
QL+ G+ + HS ++ HRDLK +N L+ +++ ++K+ DFG ++ S V T Y
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILV--TSSGQIKLADFGLARIYSFQMALTSVVVTLWY 175
Query: 90 IAPEVLTKKEYDGKIADVWSCGVTLYVML 118
APEVL + Y + D+WS G M
Sbjct: 176 RAPEVLLQSSYATPV-DLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 9e-09
Identities = 41/139 (29%), Positives = 69/139 (49%), Gaps = 14/139 (10%)
Query: 30 QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP----KSTVG 85
Q+ G+ + S + HRDL N LL + VKICDFG ++ ++ P K +
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARD--IYKDPDYVRKGSAR 237
Query: 86 TP-AYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEDPKNFRKTI---GRI 140
P ++APE + K Y + +DVWS GV L+ + +GA P+ + + F + + R+
Sbjct: 238 LPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM 296
Query: 141 LSVHYSFPDYVRVSLECKH 159
+ + P+ R+ L C
Sbjct: 297 RAPENATPEIYRIMLACWQ 315
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-08
Identities = 37/101 (36%), Positives = 54/101 (53%), Gaps = 7/101 (6%)
Query: 30 QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVG-TP 87
Q+ G+SY ++ HRDL N L+ T VKI DFG +K V + + G P
Sbjct: 117 QIAKGMSYLEEKRLVHRDLAARNVLV--KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVP 174
Query: 88 -AYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 126
++A E + + Y K +DVWS GVT++ +M GA P+E
Sbjct: 175 IKWMALESILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-08
Identities = 53/209 (25%), Positives = 84/209 (40%), Gaps = 41/209 (19%)
Query: 13 ICNAGRFSEDEAR--FFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGY 70
+C + D R + Q++ G+ + HS I HRDLK N ++ +KI DFG
Sbjct: 108 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGL 165
Query: 71 SKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGA--YPFED-- 126
++++ V T Y APEV+ Y + D+WS G + M+ +P D
Sbjct: 166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYI 224
Query: 127 --------------PEDPKNFRKTI-----GRILSVHYSFPDYVRVSL------------ 155
PE K + T+ R +FP SL
Sbjct: 225 DQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKA 284
Query: 156 -ECKHLLSRIFVANSEKRITIPEIKNHPW 183
+ + LLS++ V + KRI++ E HP+
Sbjct: 285 SQARDLLSKMLVIDPAKRISVDEALQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 33/102 (32%), Positives = 50/102 (49%), Gaps = 9/102 (8%)
Query: 25 RFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK--- 81
+FF QL+ + Y H+ + HRDLK +N L + ++KICDFG ++ + +
Sbjct: 106 QFFLYQLLRALKYIHTANVFHRDLKPKNILANADC--KLKICDFGLARVAFNDTPTAIFW 163
Query: 82 -STVGTPAYIAPEVLTK--KEYDGKIADVWSCGVTLYVMLVG 120
V T Y APE+ +Y I D+WS G +L G
Sbjct: 164 TDYVATRWYRAPELCGSFFSKYTPAI-DIWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 49/200 (24%), Positives = 79/200 (39%), Gaps = 44/200 (22%)
Query: 26 FFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVG 85
+ Q++ G+ + HS I HRDLK N ++ +KI DFG ++++ V
Sbjct: 122 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVV 179
Query: 86 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPED------------PK 131
T Y APEV+ Y + D+WS G + M+ G +P D D
Sbjct: 180 TRYYRAPEVILGMGYKENV-DIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSD 238
Query: 132 NFRKTIG-------------RILSVHYSFPDYV----------RVSLECKHLLSRIFVAN 168
F + S FPD + + + + LLS++ V +
Sbjct: 239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVID 298
Query: 169 SEKRITIPEIKNHP----WF 184
EKRI++ + HP W+
Sbjct: 299 PEKRISVDDALQHPYINVWY 318
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-08
Identities = 41/129 (31%), Positives = 57/129 (44%), Gaps = 15/129 (11%)
Query: 8 ELFERIC-------NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
E E C G+ S+D Q + G+ Y HRDL N L+ S+
Sbjct: 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV--SST 136
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLTKKEYDGKIADVWSCGVTLY-V 116
VK+ DFG ++ VL + S+ G + PEV +Y K +DVWS GV ++ V
Sbjct: 137 GVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK-SDVWSFGVLMWEV 194
Query: 117 MLVGAYPFE 125
G PFE
Sbjct: 195 FTEGKMPFE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-08
Identities = 26/72 (36%), Positives = 38/72 (52%), Gaps = 2/72 (2%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY GG++ + G F E+ A + ++ + Y H I HRDLK +N L+ S
Sbjct: 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI--SNE 140
Query: 61 PRVKICDFGYSK 72
+K+ DFG SK
Sbjct: 141 GHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-08
Identities = 46/161 (28%), Positives = 75/161 (46%), Gaps = 21/161 (13%)
Query: 30 QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP----KSTVG 85
Q+ G+ + S + HRDL N LL + VKICDFG ++ ++ P K
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARD--IYKDPDYVRKGDAR 242
Query: 86 TP-AYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEDPKNF---RKTIGRI 140
P ++APE + + Y + +DVWS GV L+ + +GA P+ + + F K R+
Sbjct: 243 LPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 301
Query: 141 LSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181
+ Y+ P+ + L+C H +R T E+ H
Sbjct: 302 RAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 5e-08
Identities = 34/101 (33%), Positives = 47/101 (46%), Gaps = 8/101 (7%)
Query: 29 QQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA 88
+ + Y S HRDL N L+ G VK+ DFG ++ VL Q S+ GT
Sbjct: 107 SDVCEAMEYLESNGFIHRDLAARNCLV-GEDNV-VKVSDFGLAR-YVLDDQYTSSQGTKF 163
Query: 89 YI---APEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 125
+ PEV + K +DVWS GV ++ V G P+E
Sbjct: 164 PVKWAPPEVFDYSRFSSK-SDVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 6e-08
Identities = 38/112 (33%), Positives = 51/112 (45%), Gaps = 17/112 (15%)
Query: 29 QQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKIC--DFGY------SKSSVLHSQP 80
+QL+S + Y H I HRD+K EN L++G IC DFG S S+ H
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPE----DICLGDFGAACFARGSWSTPFHYGI 322
Query: 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPK 131
TV T APEVL Y + D+WS G+ ++ V A F +
Sbjct: 323 AGTVDTN---APEVLAGDPYTPSV-DIWSAGLVIFEAAVHTASLFSASRGDE 370
|
Length = 461 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 6e-08
Identities = 50/227 (22%), Positives = 84/227 (37%), Gaps = 52/227 (22%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
M+ A +L + + R +E + + Q+++G++ H HRDL N ++ +
Sbjct: 99 MDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFIN--SK 155
Query: 61 PRVKICDFGYSKSSVL-----------HSQPK----STVGTPAYIAPEVLTKKEYDGKIA 105
KI DFG ++ Q + S V T Y APE+L E
Sbjct: 156 GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAV 215
Query: 106 DVWSCGVTLYVMLVGA--YPFEDPEDPKNFRKTIGRILSV-----HYSFPDYVRVSLECK 158
D+WS G +L G +P E+ D +GRI + ++P ++ L +
Sbjct: 216 DMWSVGCIFAELLTGKPLFPGENEID------QLGRIFELLGTPNEDNWPQAKKLPLYTE 269
Query: 159 H---------------------LLSRIFVANSEKRITIPEIKNHPWF 184
LL + N +RI+ E H +F
Sbjct: 270 FTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF 316
|
Length = 335 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 7e-08
Identities = 39/131 (29%), Positives = 59/131 (45%), Gaps = 8/131 (6%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
ME A G L + + + + Q+ G++Y S HRDL N LL
Sbjct: 74 MELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL--VNR 131
Query: 61 PRVKICDFGYSKS-SVLHSQPKSTVGT--P-AYIAPEVLTKKEYDGKIADVWSCGVTLYV 116
+ KI DFG S++ ++T P + APE + ++ K +DVWS GVTL+
Sbjct: 132 HQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSK-SDVWSYGVTLWE 190
Query: 117 ML-VGAYPFED 126
GA P+ +
Sbjct: 191 AFSYGAKPYGE 201
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 8e-08
Identities = 44/140 (31%), Positives = 70/140 (50%), Gaps = 16/140 (11%)
Query: 30 QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP----KSTVG 85
Q+ G+ + S + HRDL N LL S VKICDFG ++ ++ P K
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGDAR 236
Query: 86 TP-AYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE----DPEDPKNFRKTIGR 139
P ++APE + K Y + +DVWS GV L+ + +GA P+ D E + ++ R
Sbjct: 237 LPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT-R 294
Query: 140 ILSVHYSFPDYVRVSLECKH 159
+ + Y+ P+ + L+C H
Sbjct: 295 MRAPEYATPEIYSIMLDCWH 314
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 8e-08
Identities = 35/119 (29%), Positives = 57/119 (47%), Gaps = 12/119 (10%)
Query: 15 NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSS 74
+ G FS + + + +G+ Y M HRDL N L++ + K+ DFG S+
Sbjct: 100 HDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLE--CKVSDFGLSR-- 155
Query: 75 VLHSQPKSTVGTPA------YIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 126
VL P+ T T + APE + +++ +DVWS G+ ++ VM G P+ D
Sbjct: 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSFGERPYWD 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 8/97 (8%)
Query: 34 GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP---AYI 90
G++Y S + HRDL N L+ + VK+ DFG ++ VL Q S+ GT +
Sbjct: 112 GMAYLESSNVIHRDLAARNCLVGENQV--VKVSDFGMTR-FVLDDQYTSSTGTKFPVKWS 168
Query: 91 APEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 126
+PEV + +Y K +DVWS GV ++ V G P+E+
Sbjct: 169 SPEVFSFSKYSSK-SDVWSFGVLMWEVFSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 40/119 (33%), Positives = 59/119 (49%), Gaps = 15/119 (12%)
Query: 27 FFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK------SSVLHSQP 80
F Q+ G+ Y M++ HRDL N L+ + ++KI DFG S+ S V S+
Sbjct: 132 FAWQISRGMQYLAEMKLVHRDLAARNVLV--AEGRKMKISDFGLSRDVYEEDSYVKRSKG 189
Query: 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEDPKNFRKT 136
+ V ++A E L Y + +DVWS GV L+ ++ +G YP PE N KT
Sbjct: 190 RIPV---KWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKT 244
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-07
Identities = 41/123 (33%), Positives = 57/123 (46%), Gaps = 14/123 (11%)
Query: 1 MEYAAGGELFER-ICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
MEY G L + + R + + Q+ G+ Y S + HRDL N L++
Sbjct: 86 MEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESEN 145
Query: 60 APRVKICDFGYSKSSVLHSQPKS--TVGTPA-----YIAPEVLTKKEYDGKIADVWSCGV 112
RVKI DFG +K + Q K V P + APE LT+ ++ +DVWS GV
Sbjct: 146 --RVKIGDFGLTK---VLPQDKEYYKVREPGESPIFWYAPESLTESKFS-VASDVWSFGV 199
Query: 113 TLY 115
LY
Sbjct: 200 VLY 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-07
Identities = 49/178 (27%), Positives = 74/178 (41%), Gaps = 14/178 (7%)
Query: 8 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICD 67
+LF + +G ++A ++L+ ++Y H I HRD+K EN LD + D
Sbjct: 171 DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPE--NAVLGD 228
Query: 68 FGYSKSSVLHS-QPKST--VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPF 124
FG + H P+ GT +PE+L Y K D+WS G+ L+ M V
Sbjct: 229 FGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKNVTL 287
Query: 125 ---EDPEDPKNFRKTIGRILSVH-YSFPDYVRVSLECKHLLSRIFVANSEKRITIPEI 178
+ R I R + VH FP +L CKH + + TIP +
Sbjct: 288 FGKQVKSSSSQLRSII-RCMQVHPLEFPQNGSTNL-CKHF--KQYAIVLRPPYTIPPV 341
|
Length = 392 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-07
Identities = 36/118 (30%), Positives = 56/118 (47%), Gaps = 9/118 (7%)
Query: 1 MEYAAGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
EY A G L + + + GR + + F + G+ Y HRDL N L+
Sbjct: 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSED 138
Query: 59 TAPRVKICDFGYSKSSVLHSQPKSTVGTPA-YIAPEVLTKKEYDGKIADVWSCGVTLY 115
K+ DFG +K + SQ + + P + APE L +K++ K +DVWS G+ L+
Sbjct: 139 LV--AKVSDFGLAKEA---SQGQDSGKLPVKWTAPEALREKKFSTK-SDVWSFGILLW 190
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 4e-07
Identities = 33/102 (32%), Positives = 54/102 (52%), Gaps = 6/102 (5%)
Query: 84 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV 143
+GTP Y+APE+L K + G D W+ GV L+ L G PF D E P+ + IL+
Sbjct: 541 LGTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFND-ETPQ---QVFQNILNR 595
Query: 144 HYSFPD-YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184
+P+ ++S+ ++ + + + KR + E+K HP F
Sbjct: 596 DIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLF 637
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 4e-07
Identities = 37/141 (26%), Positives = 58/141 (41%), Gaps = 23/141 (16%)
Query: 1 MEYAAGGEL--FERICNAGRFSEDEARF--------FFQ---QLISGVSYCHSMQICHRD 47
ME A G+L + R R + F Q ++ G++Y + + HRD
Sbjct: 88 MELMAKGDLKSYLRSR---RPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRD 144
Query: 48 LKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGT--PA-YIAPEVLTKKEYDGKI 104
L N ++ VKI DFG ++ + P ++APE L + K
Sbjct: 145 LAARNCMVAEDLT--VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTK- 201
Query: 105 ADVWSCGVTLYVML-VGAYPF 124
+DVWS GV L+ M + P+
Sbjct: 202 SDVWSFGVVLWEMATLAEQPY 222
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 8e-07
Identities = 42/133 (31%), Positives = 60/133 (45%), Gaps = 18/133 (13%)
Query: 30 QLISGVSYCHSMQICHRDLKLENTLL--DGSTAPRVKICDFGYSKSSVLHSQP------- 80
Q++ G+ Y H+ + HRDLK N L+ +G RVKI D G+++ L + P
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR---LFNSPLKPLADL 172
Query: 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPF----EDPEDPKNF-RK 135
V T Y APE+L + K D+W+ G +L F ED + F
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHD 232
Query: 136 TIGRILSVHYSFP 148
+ RI SV FP
Sbjct: 233 QLDRIFSV-MGFP 244
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 9e-07
Identities = 42/142 (29%), Positives = 64/142 (45%), Gaps = 30/142 (21%)
Query: 1 MEYAAGGEL--FERICNAGRFSEDEARFFFQQLI-------SGVSYCHSMQICHRDLKLE 51
EY G L F R E++ +F QL+ SG+ Y M HRDL
Sbjct: 84 TEYMENGSLDKFLR--------ENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAAR 135
Query: 52 NTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGT-----PA-YIAPEVLTKKEYDGKIA 105
N L++ + K+ DFG S+ L ++T T P + APE + +++ +
Sbjct: 136 NILVNSNL--VCKVSDFGLSR--RLED-SEATYTTKGGKIPIRWTAPEAIAYRKFTSA-S 189
Query: 106 DVWSCGVTLY-VMLVGAYPFED 126
DVWS G+ ++ VM G P+ D
Sbjct: 190 DVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 9e-07
Identities = 31/101 (30%), Positives = 44/101 (43%), Gaps = 11/101 (10%)
Query: 30 QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYS---KSSV-LHSQPKSTVG 85
Q+ G++Y HRDL N L+ K+ DFG + K V L S K
Sbjct: 112 QVAEGMAYLEEQNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSSDKKIPY- 168
Query: 86 TPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 125
+ APE + + K +DVWS G+ LY + G P+
Sbjct: 169 --KWTAPEAASHGTFSTK-SDVWSFGILLYEMFTYGQVPYP 206
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 30/103 (29%), Positives = 43/103 (41%), Gaps = 9/103 (8%)
Query: 2 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS-TA 60
EY G L E + G E Q++ ++ H+ I HRDLK +N ++ +
Sbjct: 59 EYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVR 118
Query: 61 PRVKICDFGYSK-----SSVLHSQPKST---VGTPAYIAPEVL 95
P K+ DFG + T +GTP Y APE L
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL 161
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-06
Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 15/134 (11%)
Query: 2 EYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
EY G L F R + G+F+ + + + SG+ Y M HRDL N L++ +
Sbjct: 85 EYMENGSLDAFLRK-HDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL 143
Query: 60 APRVKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVLTKKEYDGKIADVWSCGVT 113
K+ DFG S+ VL P++ T + APE + +++ +DVWS G+
Sbjct: 144 V--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIV 198
Query: 114 LY-VMLVGAYPFED 126
++ VM G P+ +
Sbjct: 199 MWEVMSYGERPYWE 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 53/205 (25%), Positives = 81/205 (39%), Gaps = 53/205 (25%)
Query: 30 QLISGVSYCHSMQICHRDLKLENTLL--DGSTAPRVKICDFGYSKSSVLHSQP------- 80
Q++ G+ Y H+ + HRDLK N L+ +G RVKI D G+++ L + P
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR---LFNSPLKPLADL 172
Query: 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML---------------------- 118
V T Y APE+L + K D+W+ G +L
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 232
Query: 119 -------VGAYP----FED----PEDP---KNFRK-TIGRILSVHYSFPDYVRVSLECKH 159
V +P +ED PE K+FR+ T + Y V+ + H
Sbjct: 233 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFH 292
Query: 160 LLSRIFVANSEKRITIPEIKNHPWF 184
LL ++ + KRIT + P+F
Sbjct: 293 LLQKLLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-06
Identities = 37/117 (31%), Positives = 55/117 (47%), Gaps = 9/117 (7%)
Query: 2 EYAAGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
EY A G L + + + GR D F + + Y + HRDL N L+ S
Sbjct: 80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV--SE 137
Query: 60 APRVKICDFGYSKSSVLHSQPKSTVGTPA-YIAPEVLTKKEYDGKIADVWSCGVTLY 115
K+ DFG +K + S + T P + APE L +K++ K +DVWS G+ L+
Sbjct: 138 DNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLW 190
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-06
Identities = 36/110 (32%), Positives = 54/110 (49%), Gaps = 9/110 (8%)
Query: 27 FFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ---PKST 83
F Q+ +G+ + S HRDL N L+ VKICDFG ++ + S ST
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLI--CEGKLVKICDFGLARDIMRDSNYISKGST 301
Query: 84 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEDPKN 132
++APE + Y ++DVWS G+ L+ + +G P+ PE P N
Sbjct: 302 FLPLKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPY--PELPMN 348
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-06
Identities = 39/128 (30%), Positives = 57/128 (44%), Gaps = 10/128 (7%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
ME + G L + GR + F + G+ Y S ++ HRDL N L+ S
Sbjct: 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV--S 134
Query: 59 TAPRVKICDFGYSKSSVLHSQPKSTVGTPA-YIAPEVLTKKEYDGKIADVWSCGVTLY-V 116
K+ DFG ++ + S P + APE L K++ K +DVWS GV L+ V
Sbjct: 135 EDGVAKVSDFGLAR---VGSMGVDNSKLPVKWTAPEALKHKKFSSK-SDVWSYGVLLWEV 190
Query: 117 MLVGAYPF 124
G P+
Sbjct: 191 FSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-06
Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 9/103 (8%)
Query: 27 FFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGT 86
F Q+ G+ + S HRDL N LL + VKICDFG ++ ++H + G+
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLL--AQGKIVKICDFGLAR-DIMHDSNYVSKGS 298
Query: 87 P----AYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 124
++APE + Y ++DVWS G+ L+ + +G P+
Sbjct: 299 TFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPY 340
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 4e-06
Identities = 49/144 (34%), Positives = 65/144 (45%), Gaps = 17/144 (11%)
Query: 27 FFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFG-----YSK---SSVLHS 78
F Q+ G+ Y S + HRDL N +LD S VK+ DFG Y K S H+
Sbjct: 103 FGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHNHT 160
Query: 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEDPKNFRK 135
K V ++A E L +++ K +DVWS GV L+ +M GA YP D D +
Sbjct: 161 GAKLPV---KWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL 216
Query: 136 TIGRILSVHYSFPDYVRVSLECKH 159
R+L Y V L C H
Sbjct: 217 QGRRLLQPEYCPDPLYEVMLSCWH 240
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 5e-06
Identities = 32/115 (27%), Positives = 55/115 (47%), Gaps = 7/115 (6%)
Query: 15 NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSS 74
N R + + Q+ G+SY +++ HRDL N L+ VKI DFG ++
Sbjct: 102 NKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPN--HVKITDFGLARLL 159
Query: 75 VLHSQPKSTVGTPA---YIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 125
+ G ++A E + + + + +DVWS GVT++ +M GA P++
Sbjct: 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQ-SDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 5e-06
Identities = 30/94 (31%), Positives = 46/94 (48%), Gaps = 5/94 (5%)
Query: 29 QQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK--STVGT 86
+ ++ + Y H +I HRD+K EN ++ V + DFG + V + K GT
Sbjct: 189 RSVLRAIQYLHENRIIHRDIKAENIFINHPG--DVCLGDFGAACFPVDINANKYYGWAGT 246
Query: 87 PAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
A APE+L + Y G D+WS G+ L+ M
Sbjct: 247 IATNAPELLARDPY-GPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 8e-06
Identities = 35/117 (29%), Positives = 62/117 (52%), Gaps = 10/117 (8%)
Query: 27 FFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGT 86
+ QL + ++Y S + HRD+ N L+ S+ VK+ DFG S+ S K++ G
Sbjct: 112 YSYQLSTALAYLESKRFVHRDIAARNVLV--SSPDCVKLGDFGLSRYLEDESYYKASKGK 169
Query: 87 -P-AYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEDPKNFRKTIGRI 140
P ++APE + + + +DVW GV ++ ++++G PF+ ++ IGRI
Sbjct: 170 LPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMLGVKPFQGVKN----NDVIGRI 221
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-05
Identities = 34/107 (31%), Positives = 51/107 (47%), Gaps = 7/107 (6%)
Query: 27 FFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK---SSVLHSQPKST 83
F + SG+ Y S HRDL N +L+ + V + DFG SK + + Q +
Sbjct: 117 FMTDIASGMEYLSSKSFIHRDLAARNCMLNENMN--VCVADFGLSKKIYNGDYYRQGRIA 174
Query: 84 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPED 129
+IA E L + Y K +DVWS GVT++ + G P+ E+
Sbjct: 175 KMPVKWIAIESLADRVYTTK-SDVWSFGVTMWEIATRGQTPYPGVEN 220
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 2e-05
Identities = 35/110 (31%), Positives = 51/110 (46%), Gaps = 16/110 (14%)
Query: 18 RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH 77
F+ D A G+ Y Q HRDL N L+ + KI DFG S+ ++
Sbjct: 116 HFAADVA--------RGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVY 165
Query: 78 SQPKSTVGT-PA-YIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 124
K T+G P ++A E L Y +DVWS GV L+ ++ +G P+
Sbjct: 166 V--KKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 212
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-05
Identities = 37/136 (27%), Positives = 61/136 (44%), Gaps = 17/136 (12%)
Query: 2 EYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
E+ G L F R N G+F+ + + + +G+ Y M HRDL N L++ +
Sbjct: 85 EFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL 143
Query: 60 APRVKICDFGYSKSSVLHSQPKSTVGTPA--------YIAPEVLTKKEYDGKIADVWSCG 111
K+ DFG S+ L T + + APE + +++ +DVWS G
Sbjct: 144 V--CKVSDFGLSR--FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYG 198
Query: 112 VTLY-VMLVGAYPFED 126
+ ++ VM G P+ D
Sbjct: 199 IVMWEVMSYGERPYWD 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 43/145 (29%), Positives = 72/145 (49%), Gaps = 25/145 (17%)
Query: 1 MEYAAGGELFERICNAGR-----FSEDEAR-----FFFQQLIS-------GVSYCHSMQI 43
+EYA+ G L E + A R +S D AR F+ L+S G+ Y S +
Sbjct: 100 VEYASKGNLREYL-RARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKC 158
Query: 44 CHRDLKLENTLLDGSTAPRVKICDFGYSK--SSVLHSQPKSTVGTPA-YIAPEVLTKKEY 100
HRDL N L+ + +KI DFG ++ +++ + + + P ++APE L + Y
Sbjct: 159 IHRDLAARNVLVTENNV--MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVY 216
Query: 101 DGKIADVWSCGVTLY-VMLVGAYPF 124
+ +DVWS GV ++ + +G P+
Sbjct: 217 THQ-SDVWSFGVLMWEIFTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-05
Identities = 36/119 (30%), Positives = 52/119 (43%), Gaps = 7/119 (5%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
ME A G L + + +E Q+ G+ Y HRDL N LL T
Sbjct: 74 MELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL--VTQ 131
Query: 61 PRVKICDFGYSK---SSVLHSQPKSTVGTPA-YIAPEVLTKKEYDGKIADVWSCGVTLY 115
KI DFG SK + + + K+ P + APE + ++ K +DVWS GV ++
Sbjct: 132 HYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSK-SDVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 32/102 (31%), Positives = 53/102 (51%), Gaps = 11/102 (10%)
Query: 30 QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA- 88
Q+ G++Y ++ HRDL N L+ T VKI DFG +K +L + K
Sbjct: 117 QIAKGMNYLEERRLVHRDLAARNVLV--KTPQHVKITDFGLAK--LLGADEKEYHAEGGK 172
Query: 89 ----YIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 125
++A E + + Y + +DVWS GVT++ +M G+ P++
Sbjct: 173 VPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 28/101 (27%), Positives = 45/101 (44%), Gaps = 10/101 (9%)
Query: 30 QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ---PKSTVGT 86
Q+ G++Y S HRDL N L+ + KI DFG ++ ++ +
Sbjct: 111 QIAEGMAYLESRNYIHRDLAARNILVGENLV--CKIADFGLAR--LIEDDEYTAREGAKF 166
Query: 87 P-AYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 125
P + APE + K +DVWS G+ L ++ G P+
Sbjct: 167 PIKWTAPEAANYGRFTIK-SDVWSFGILLTEIVTYGRVPYP 206
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 36/108 (33%), Positives = 53/108 (49%), Gaps = 12/108 (11%)
Query: 30 QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVG--TP 87
Q+ SG+ Y S+ HRDL N L+ + +KI DFG S++ L+S V P
Sbjct: 138 QIASGMRYLESLNFVHRDLATRNCLVGKNY--TIKIADFGMSRN--LYSSDYYRVQGRAP 193
Query: 88 AYI---APEVLTKKEYDGKIADVWSCGVTLY--VMLVGAYPFEDPEDP 130
I A E + ++ K +DVW+ GVTL+ + L P+E D
Sbjct: 194 LPIRWMAWESVLLGKFTTK-SDVWAFGVTLWEILTLCREQPYEHLTDQ 240
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-05
Identities = 37/129 (28%), Positives = 55/129 (42%), Gaps = 8/129 (6%)
Query: 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
ME GG+ + G R E + +G+ Y S HRDL N L+
Sbjct: 72 MELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKN 131
Query: 60 APRVKICDFGYSKSSV--LHSQPKSTVGTPA-YIAPEVLTKKEYDGKIADVWSCGVTLY- 115
+KI DFG S+ +++ P + APE L Y + +DVWS G+ L+
Sbjct: 132 V--LKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE-SDVWSFGILLWE 188
Query: 116 VMLVGAYPF 124
+GA P+
Sbjct: 189 AFSLGAVPY 197
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-05
Identities = 34/116 (29%), Positives = 54/116 (46%), Gaps = 7/116 (6%)
Query: 27 FFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK---SSVLHSQPKST 83
F + SG+ Y S HRDL N +L+ + V + DFG SK S + Q ++
Sbjct: 118 FMIDIASGMEYLSSKNFIHRDLAARNCMLNENMT--VCVADFGLSKKIYSGDYYRQGCAS 175
Query: 84 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEDPKNFRKTIG 138
++A E L Y +DVW+ GVT++ +M G P+ E+ + + I
Sbjct: 176 KLPVKWLALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK 230
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 5e-05
Identities = 44/159 (27%), Positives = 68/159 (42%), Gaps = 23/159 (14%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLIS-------GVSYCHSMQICHRDLKLENT 53
ME GG+L + +A ++L+ G Y M HRDL N
Sbjct: 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNC 137
Query: 54 LLD--GSTAPR-VKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI--- 104
L+ G A R VKI DFG ++ S + + + ++APE L DGK
Sbjct: 138 LVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLL----DGKFTTQ 193
Query: 105 ADVWSCGVTLY-VMLVG--AYPFEDPEDPKNFRKTIGRI 140
+DVWS GV ++ ++ +G YP + ++ GR+
Sbjct: 194 SDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRL 232
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 5e-05
Identities = 37/110 (33%), Positives = 55/110 (50%), Gaps = 16/110 (14%)
Query: 18 RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH 77
+F+ D A +G+ Y Q HRDL N L+ + A KI DFG S+ ++
Sbjct: 123 QFASDVA--------TGMQYLSEKQFIHRDLAARNVLVGENLAS--KIADFGLSRGEEVY 172
Query: 78 SQPKSTVGT-PA-YIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 124
K T+G P ++A E L Y K +DVWS GV L+ ++ +G P+
Sbjct: 173 V--KKTMGRLPVRWMAIESLNYSVYTTK-SDVWSFGVLLWEIVSLGGTPY 219
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 6e-05
Identities = 45/140 (32%), Positives = 66/140 (47%), Gaps = 14/140 (10%)
Query: 27 FFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRV-KICDFGYSKSSVLHSQ--PKST 83
F Q+ G+S+ S HRDL N LL T R+ KICDFG ++ S K
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIRNDSNYVVKGN 275
Query: 84 VGTPA-YIAPEVLTKKEYDGKIADVWSCGVTLYVML-VGAYPFED-PEDPKNFRKTIG-- 138
P ++APE + Y + +DVWS G+ L+ + +G+ P+ P D K F K I
Sbjct: 276 ARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSSPYPGMPVDSK-FYKMIKEG 333
Query: 139 -RILSVHYSFPDYVRVSLEC 157
R+LS + + + C
Sbjct: 334 YRMLSPECAPSEMYDIMKSC 353
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 6e-05
Identities = 30/100 (30%), Positives = 51/100 (51%), Gaps = 9/100 (9%)
Query: 30 QLISGVSYCHSMQICHRDLKLENTLL-DGSTAPRVKICDFGYSK---SSVLHSQPKSTVG 85
Q+ +G+ Y S HRDL N L+ +G T VKI DFG S+ S+ + ++
Sbjct: 132 QIAAGMEYLSSHHFVHRDLAARNCLVGEGLT---VKISDFGLSRDIYSADYYRVQSKSLL 188
Query: 86 TPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 124
++ PE + ++ + +D+WS GV L+ + G P+
Sbjct: 189 PVRWMPPEAILYGKFTTE-SDIWSFGVVLWEIFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 7e-05
Identities = 40/142 (28%), Positives = 58/142 (40%), Gaps = 34/142 (23%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHSMQICHRDLKLENT 53
ME GG L + + + R ++L+ +G+ Y S HRDL N
Sbjct: 71 MELVPGGSLLTFL------RKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNC 124
Query: 54 LLDGSTAPRVKICDFG---------YSKSSVLHSQP-KSTVGTPAYIAPEVLTKKEYDGK 103
L+ + +KI DFG Y+ S L P K T APE L Y +
Sbjct: 125 LVGENNV--LKISDFGMSREEEGGIYTVSDGLKQIPIKWT-------APEALNYGRYTSE 175
Query: 104 IADVWSCGVTLY-VMLVGAYPF 124
+DVWS G+ L+ +G P+
Sbjct: 176 -SDVWSYGILLWETFSLGDTPY 196
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 7e-05
Identities = 43/156 (27%), Positives = 67/156 (42%), Gaps = 11/156 (7%)
Query: 27 FFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ--PKSTV 84
F Q+ G+++ S HRDL N LL + VKICDFG ++ + S K
Sbjct: 146 FSYQVAKGMAFLASKNCIHRDLAARNVLL--THGKIVKICDFGLARDIMNDSNYVVKGNA 203
Query: 85 GTPA-YIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEDPKNFRKTIGRILS 142
P ++APE + Y + +DVWS G+ L+ + +G+ P+ F K I
Sbjct: 204 RLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE--- 259
Query: 143 VHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEI 178
Y E ++ + A+ KR T +I
Sbjct: 260 -GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 7e-05
Identities = 32/121 (26%), Positives = 51/121 (42%), Gaps = 13/121 (10%)
Query: 2 EYAAGGELFERICNAGRFSEDEARFFFQ--QLISGVSYCHSMQICHRDLKLENTLLDGST 59
E+ G L + + R + + Q+ S + Y HRDL N L+
Sbjct: 82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV--GE 139
Query: 60 APRVKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTL 114
VK+ DFG S+ + H+ K + + APE L ++ K +DVW+ GV L
Sbjct: 140 NHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SDVWAFGVLL 195
Query: 115 Y 115
+
Sbjct: 196 W 196
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 8e-05
Identities = 39/142 (27%), Positives = 63/142 (44%), Gaps = 26/142 (18%)
Query: 1 MEYAAGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTL--LD 56
M Y + +L IC SE + Q ++ + Y H M HR +K + L +D
Sbjct: 81 MAYGSAKDL---ICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD 137
Query: 57 GSTAPRVKICDFGY----------SKSSVLHSQPKSTVGTPAYIAPEVLTK--KEYDGKI 104
G K+ G + V+H PK +V +++PEVL + + YD K
Sbjct: 138 G------KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK- 190
Query: 105 ADVWSCGVTLYVMLVGAYPFED 126
+D++S G+T + G PF+D
Sbjct: 191 SDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 9e-05
Identities = 29/93 (31%), Positives = 44/93 (47%), Gaps = 6/93 (6%)
Query: 30 QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK---SSVLHSQPKSTVGT 86
Q+ SG+ Y S+ HRDL N L+ +KI DFG S+ S + V
Sbjct: 137 QIASGMKYLASLNFVHRDLATRNCLVGNHYT--IKIADFGMSRNLYSGDYYRIQGRAVLP 194
Query: 87 PAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
++A E + ++ +DVW+ GVTL+ M
Sbjct: 195 IRWMAWESILLGKFT-TASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 33/102 (32%), Positives = 53/102 (51%), Gaps = 13/102 (12%)
Query: 30 QLISGVSYCHSMQICHRDLKLENTLL-DGSTAPRVKICDFGYSKSSVLHSQP---KSTVG 85
Q+ G+ + S + HRDL N L+ + +KI DFG ++ +H K+T G
Sbjct: 140 QVARGMEFLASKKCIHRDLAARNVLVTEDHV---MKIADFGLARD--IHHIDYYRKTTNG 194
Query: 86 -TPA-YIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 124
P ++APE L + Y + +DVWS GV L+ + +G P+
Sbjct: 195 RLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPY 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 1e-04
Identities = 49/189 (25%), Positives = 81/189 (42%), Gaps = 20/189 (10%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+++A GG+L+ I E+ + + +++ + H I RDL N LLD
Sbjct: 64 LQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD--DR 121
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
+++ F S V S V Y APEV E + + D WS G L+ +L G
Sbjct: 122 GHIQLTYFS-RWSEVEDSCDGEAVEN-MYCAPEVGGISE-ETEACDWWSLGAILFELLTG 178
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI-----TI 175
E N T+ + P++ VS E + LL ++ N +R+ +
Sbjct: 179 KTLVECHPSGINTHTTL--------NIPEW--VSEEARSLLQQLLQFNPTERLGAGVAGV 228
Query: 176 PEIKNHPWF 184
+IK+HP+F
Sbjct: 229 EDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 1e-04
Identities = 39/130 (30%), Positives = 57/130 (43%), Gaps = 30/130 (23%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHSMQICHRDLKLENT 53
ME GG+ + R +DE + +QL+ +G++Y S HRDL N
Sbjct: 71 MELVPGGDFLSFL----RKKKDELKT--KQLVKFALDAAAGMAYLESKNCIHRDLAARNC 124
Query: 54 LLDGSTAPRVKICDFGYSK--------SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIA 105
L+ + +KI DFG S+ SS L P + APE L Y + +
Sbjct: 125 LVGENNV--LKISDFGMSRQEDDGIYSSSGLKQIPIK------WTAPEALNYGRYSSE-S 175
Query: 106 DVWSCGVTLY 115
DVWS G+ L+
Sbjct: 176 DVWSYGILLW 185
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 1e-04
Identities = 31/102 (30%), Positives = 46/102 (45%), Gaps = 7/102 (6%)
Query: 27 FFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK---SSVLHSQPKST 83
F + G+ Y + HRDL N +L V + DFG SK S + Q +
Sbjct: 118 FMVDIALGMEYLSNRNFIHRDLAARNCMLREDM--TVCVADFGLSKKIYSGDYYRQGRIA 175
Query: 84 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 124
+IA E L + Y K +DVW+ GVT++ + G P+
Sbjct: 176 KMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 1e-04
Identities = 31/100 (31%), Positives = 51/100 (51%), Gaps = 7/100 (7%)
Query: 29 QQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK---SSVLHSQPKSTVG 85
QQ+ +G+ Y S HRDL N L+ + VKI DFG S+ S+ + T+
Sbjct: 127 QQIAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIGDFGMSRDVYSTDYYRVGGHTML 184
Query: 86 TPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 124
++ PE + +++ + +DVWS GV L+ + G P+
Sbjct: 185 PIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPW 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 1e-04
Identities = 31/99 (31%), Positives = 50/99 (50%), Gaps = 7/99 (7%)
Query: 30 QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK---SSVLHSQPKSTVGT 86
Q+ SG+ Y S HRDL N L+ + VKI DFG S+ S+ + T+
Sbjct: 131 QIASGMVYLASQHFVHRDLATRNCLVGANLL--VKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 87 PAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 124
++ PE + +++ + +DVWS GV L+ + G P+
Sbjct: 189 IRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPW 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 28/100 (28%), Positives = 47/100 (47%), Gaps = 10/100 (10%)
Query: 30 QLISGVSYCHSMQICHRDLKLENTLL-DGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA 88
Q+ SG++Y + HRDL N L+ + + K+ DFG ++ + ++ G
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLVGENNI---CKVADFGLAR-VIKEDIYEAREGAKF 166
Query: 89 YI---APEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 124
I APE + K +DVWS G+ L ++ G P+
Sbjct: 167 PIKWTAPEAALYNRFSIK-SDVWSFGILLTEIVTYGRMPY 205
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 1e-04
Identities = 35/112 (31%), Positives = 52/112 (46%), Gaps = 8/112 (7%)
Query: 16 AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV 75
A S + F + G+ Y Q HRDL N L+ + KI DFG S+
Sbjct: 118 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLSRGQE 175
Query: 76 LHSQPKSTVGT-PA-YIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 124
++ K T+G P ++A E L Y +DVWS GV L+ ++ +G P+
Sbjct: 176 VYV--KKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 224
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 1e-04
Identities = 45/145 (31%), Positives = 69/145 (47%), Gaps = 25/145 (17%)
Query: 1 MEYAAGGELFERICNAGR-----FSED-----EARFFFQQLIS-------GVSYCHSMQI 43
+EYA+ G L E + A R +S D E + F+ L+S G+ Y S +
Sbjct: 97 VEYASKGNLREYL-RARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKC 155
Query: 44 CHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVG--TPAYIAPEVLTKKEY 100
HRDL N L+ +KI DFG ++ + K+T G ++APE L + Y
Sbjct: 156 IHRDLAARNVLVTEDNV--MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVY 213
Query: 101 DGKIADVWSCGVTLY-VMLVGAYPF 124
+ +DVWS GV L+ + +G P+
Sbjct: 214 THQ-SDVWSFGVLLWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 37/129 (28%), Positives = 60/129 (46%), Gaps = 10/129 (7%)
Query: 2 EYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
EY A G L F + G+ + F Q+ G++Y HRDL+ N L+ S
Sbjct: 81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV--SE 138
Query: 60 APRVKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLTKKEYDGKIADVWSCGVTLY- 115
+ KI DFG ++ + ++ + G + APE + + K +DVWS G+ LY
Sbjct: 139 SLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLYE 196
Query: 116 VMLVGAYPF 124
++ G P+
Sbjct: 197 IVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 30 QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGT-P 87
Q+ G+ Y S + HRDL N L+ +KI DFG ++ + K+T G P
Sbjct: 148 QVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDYYKKTTNGRLP 205
Query: 88 A-YIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 124
++APE L + Y + +DVWS GV L+ + +G P+
Sbjct: 206 VKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 4e-04
Identities = 35/152 (23%), Positives = 62/152 (40%), Gaps = 17/152 (11%)
Query: 1 MEYAAGGEL-----FERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL 55
+E+ G+L R A +D + ++ SG+ + H H DL L N L
Sbjct: 74 LEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL 133
Query: 56 DGSTAPRVKICDFG--YSKSSVLHSQPKSTVGTP-AYIAPEVLTKKEYDGKIAD------ 106
+ VKI D+G + + K P ++APE++ + D D
Sbjct: 134 TADLS--VKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSN 191
Query: 107 VWSCGVTLYVML-VGAYPFEDPEDPKNFRKTI 137
+WS GVT++ + P+ D D + ++ +
Sbjct: 192 IWSLGVTMWELFTAADQPYPDLSDEQVLKQVV 223
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 4e-04
Identities = 29/91 (31%), Positives = 46/91 (50%), Gaps = 10/91 (10%)
Query: 30 QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA- 88
Q+ SG+ Y S+ HRDL N L+ VKI DFG S+ ++S VG
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRD--IYSTDYYRVGGRTM 185
Query: 89 ----YIAPEVLTKKEYDGKIADVWSCGVTLY 115
++ PE + +++ + +D+WS GV L+
Sbjct: 186 LPIRWMPPESILYRKFTTE-SDIWSFGVVLW 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 4e-04
Identities = 23/93 (24%), Positives = 41/93 (44%), Gaps = 9/93 (9%)
Query: 29 QQLISGVSYCHSMQICHRDLKLENTLL-----DGSTAPRVKICDFGYSKSSVLHSQPKST 83
+QL S + Y ++ H ++ +N L+ + P +K+ D G + + +
Sbjct: 108 KQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVER 167
Query: 84 VGTPAYIAPEVLTKKEYDGKIA-DVWSCGVTLY 115
+ +IAPE + + IA D WS G TL
Sbjct: 168 I---PWIAPECIRNGQASLTIAADKWSFGTTLL 197
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 4e-04
Identities = 32/107 (29%), Positives = 54/107 (50%), Gaps = 12/107 (11%)
Query: 30 QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA- 88
Q+ SG+ Y S+ HRDL N L+ + +KI DFG S++ L++ + A
Sbjct: 146 QIASGMKYLSSLNFVHRDLATRNCLVGENLT--IKIADFGMSRN--LYAGDYYRIQGRAV 201
Query: 89 ----YIAPEVLTKKEYDGKIADVWSCGVTLY--VMLVGAYPFEDPED 129
++A E + ++ +DVW+ GVTL+ +ML P+ + D
Sbjct: 202 LPIRWMAWECILMGKFT-TASDVWAFGVTLWEILMLCKEQPYGELTD 247
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 5e-04
Identities = 37/137 (27%), Positives = 61/137 (44%), Gaps = 9/137 (6%)
Query: 1 MEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
ME A+GG L + + + Q+ G+ Y HRDL N LL
Sbjct: 73 MEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL--VN 130
Query: 60 APRVKICDFGYSKSSVL---HSQPKSTVGTP-AYIAPEVLTKKEYDGKIADVWSCGVTLY 115
KI DFG SK+ + + +S P + APE + +++ + +DVWS G+T++
Sbjct: 131 QHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGITMW 189
Query: 116 VML-VGAYPFEDPEDPK 131
G P++ + P+
Sbjct: 190 EAFSYGQKPYKKMKGPE 206
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 5e-04
Identities = 33/101 (32%), Positives = 52/101 (51%), Gaps = 11/101 (10%)
Query: 30 QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK----STVG 85
Q+ G+ Y ++ HR+L N LL + V+I DFG + +L+ K S
Sbjct: 117 QIAKGMYYLEEHRMVHRNLAARNILLKSDS--IVQIADFGVA--DLLYPDDKKYFYSEHK 172
Query: 86 TP-AYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPF 124
TP ++A E + Y + +DVWS GVT++ M+ GA P+
Sbjct: 173 TPIKWMALESILFGRYTHQ-SDVWSYGVTVWEMMSYGAEPY 212
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 7e-04
Identities = 44/170 (25%), Positives = 73/170 (42%), Gaps = 20/170 (11%)
Query: 17 GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL 76
G + + Q+ SG+ Y S HRDL N L+ VKI DFG S+ +
Sbjct: 117 GELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV--GYDLVVKIGDFGMSRD--V 172
Query: 77 HSQPKSTVGTPA-----YIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYP-FEDPED 129
++ VG ++ PE + +++ + +DVWS GV L+ + G P + +
Sbjct: 173 YTTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSNE 231
Query: 130 PKNFRKTIGRILSVHYSFPDYV-RVSLECKHLLSRIFVANSEKRITIPEI 178
T GR+L + P V + L C + + ++RI I +I
Sbjct: 232 EVIECITQGRLLQRPRTCPSEVYDIMLGC-------WKRDPQQRINIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 8e-04
Identities = 29/99 (29%), Positives = 50/99 (50%), Gaps = 7/99 (7%)
Query: 30 QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS--SVLHSQPKSTVGTP 87
Q+ G+ Y S + HRDL N L+ +KI DFG ++ + + + S P
Sbjct: 142 QVARGMEYLESRRCIHRDLAARNVLVTEDNV--MKIADFGLARGVHDIDYYKKTSNGRLP 199
Query: 88 A-YIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 124
++APE L + Y + +DVWS G+ ++ + +G P+
Sbjct: 200 VKWMAPEALFDRVYTHQ-SDVWSFGILMWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.001
Identities = 36/109 (33%), Positives = 54/109 (49%), Gaps = 10/109 (9%)
Query: 21 EDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL-DGSTAPRVKICDFGYSKSSVLHSQ 79
+D RF Q + G+ + S HRD+ N LL DG A KICDFG ++ + S
Sbjct: 212 DDLLRFSSQ-VAQGMDFLASKNCIHRDVAARNVLLTDGRVA---KICDFGLARDIMNDSN 267
Query: 80 --PKSTVGTPA-YIAPEVLTKKEYDGKIADVWSCGVTLYVML-VGAYPF 124
K P ++APE + Y + +DVWS G+ L+ + +G P+
Sbjct: 268 YVVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPY 315
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.001
Identities = 20/68 (29%), Positives = 32/68 (47%), Gaps = 3/68 (4%)
Query: 28 FQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS--SVLHSQPKSTVG 85
+Q++ + HS I HRD+K +N + + KI D G + ++ PK +
Sbjct: 261 MRQILFALDGLHSTGIVHRDVKPQNIIFSEGSG-SFKIIDLGAAADLRVGINYIPKEFLL 319
Query: 86 TPAYIAPE 93
P Y APE
Sbjct: 320 DPRYAAPE 327
|
Length = 566 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.001
Identities = 29/102 (28%), Positives = 51/102 (50%), Gaps = 11/102 (10%)
Query: 30 QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA- 88
Q+ G+ Y ++ HRDL N L+ + VKI DFG ++ +L K
Sbjct: 117 QIAKGMMYLEERRLVHRDLAARNVLV--KSPNHVKITDFGLAR--LLEGDEKEYNADGGK 172
Query: 89 ----YIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 125
++A E + +++ + +DVWS GVT++ +M G P++
Sbjct: 173 MPIKWMALECIHYRKFTHQ-SDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 46/155 (29%), Positives = 72/155 (46%), Gaps = 27/155 (17%)
Query: 9 LFERICNAGRFSEDE-ARFFFQQLISGVS--YCHS-MQICHRDLKLENTLLDGS------ 58
L + I G FS A+ FQ +GV+ Y H+ + + H DLK EN L++ S
Sbjct: 218 LLDWIMKHGPFSHRHLAQIIFQ---TGVALDYFHTELHLMHTDLKPENILMETSDTVVDP 274
Query: 59 -----TAP---RVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSC 110
P RV+ICD G HS+ + V T Y +PEV+ + D+WS
Sbjct: 275 VTNRALPPDPCRVRICDLG-GCCDERHSR-TAIVSTRHYRSPEVVLGLGWMYS-TDMWSM 331
Query: 111 GVTLYVMLVGAYPFEDPEDPKNF---RKTIGRILS 142
G +Y + G ++ ++ ++ KT+GR+ S
Sbjct: 332 GCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPS 366
|
Length = 467 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.002
Identities = 27/106 (25%), Positives = 46/106 (43%), Gaps = 12/106 (11%)
Query: 30 QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKI-----CDFGYSKSSVLHSQPKSTV 84
Q+ G+ + + + HRDL N L+ S+ VK+ Y+ +
Sbjct: 125 QIALGMDHLSNARFVHRDLAARNCLV--SSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182
Query: 85 GTPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPED 129
++APE + + ++ K +DVWS GV ++ V G PF D
Sbjct: 183 ---RWLAPEAVQEDDFSTK-SDVWSFGVLMWEVFTQGELPFYGLSD 224
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 37.8 bits (88), Expect = 0.002
Identities = 27/83 (32%), Positives = 39/83 (46%), Gaps = 13/83 (15%)
Query: 38 CHSMQICHRDLKLENTLL--DGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 95
+++ HR K N LL DG G SV P+ + P ++APEV+
Sbjct: 27 LGALRELHRQAKSGNILLTWDGLLKL------DG----SVAFKTPEQSRPDPYFMAPEVI 76
Query: 96 TKKEYDGKIADVWSCGVTLYVML 118
+ Y K AD++S G+TLY L
Sbjct: 77 QGQSYTEK-ADIYSLGITLYEAL 98
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 37.5 bits (87), Expect = 0.004
Identities = 26/90 (28%), Positives = 46/90 (51%), Gaps = 6/90 (6%)
Query: 29 QQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK---SSVLHSQPKSTVG 85
+Q+ +G++Y + HRDL N L+ + VKI DFG S+ S+ + ++
Sbjct: 137 KQVAAGMAYLSERKFVHRDLATRNCLVGENM--VVKIADFGLSRNIYSADYYKASENDAI 194
Query: 86 TPAYIAPEVLTKKEYDGKIADVWSCGVTLY 115
++ PE + Y + +DVW+ GV L+
Sbjct: 195 PIRWMPPESIFYNRYTTE-SDVWAYGVVLW 223
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 262 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.98 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.98 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.98 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.98 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.98 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.98 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.98 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.98 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.98 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.98 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.98 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.95 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.94 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.94 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.93 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.93 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.92 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.91 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.91 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.9 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.9 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.89 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.86 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.82 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.8 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.78 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.78 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.75 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.66 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.66 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.64 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.63 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.63 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.61 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.59 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.58 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.55 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.53 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.47 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.42 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.39 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.32 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.3 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.3 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.29 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.28 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.24 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.22 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.18 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.16 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.05 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.93 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 98.89 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.83 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.81 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.81 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.74 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.69 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.65 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.59 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.54 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.52 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.43 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.28 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.07 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.06 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 98.04 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.01 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.75 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.54 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.26 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.16 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.11 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 96.28 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 95.97 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 95.25 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.15 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 95.14 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.12 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 95.08 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 95.02 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 94.99 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 94.98 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 94.82 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 94.53 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 94.41 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 94.29 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 94.23 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 93.78 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 93.69 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 93.42 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 93.15 | |
| PLN02236 | 344 | choline kinase | 93.07 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 92.96 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 92.6 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 92.57 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 92.47 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 92.32 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 92.14 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 91.81 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 91.66 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 91.56 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 91.24 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 91.17 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 90.19 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 88.62 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 88.33 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 88.11 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 87.24 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 84.33 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 84.24 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 84.07 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-48 Score=327.36 Aligned_cols=183 Identities=30% Similarity=0.517 Sum_probs=160.0
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~-~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
||||+||||.++++..++++|..+..++.+|++||.|||. .+||||||||+|||++..+ .|||||||.++..... .
T Consensus 157 mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG--eVKicDFGVS~~lvnS-~ 233 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG--EVKICDFGVSGILVNS-I 233 (364)
T ss_pred hhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC--CEEeccccccHHhhhh-h
Confidence 8999999999999999999999999999999999999995 8999999999999998877 8999999999876554 6
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCC-CChhHHHHHhccccc-ccccCCCcccCCHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP-EDPKNFRKTIGRILS-VHYSFPDYVRVSLEC 157 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 157 (262)
.++++||..|||||.+.+..|..+ +||||||+.+.|+.+|++||... .........+..|.. .....|.. .+|+++
T Consensus 234 a~tfvGT~~YMsPERi~g~~Ys~~-sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~-~fS~ef 311 (364)
T KOG0581|consen 234 ANTFVGTSAYMSPERISGESYSVK-SDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG-EFSPEF 311 (364)
T ss_pred cccccccccccChhhhcCCcCCcc-cceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc-cCCHHH
Confidence 788999999999999999988777 89999999999999999999875 222333444444444 34445553 599999
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 024809 158 KHLLSRIFVANSEKRITIPEIKNHPWFLRNL 188 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 188 (262)
++||.+||++||.+|+|+.|+++|||+++..
T Consensus 312 ~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 312 RSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 9999999999999999999999999998654
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-49 Score=333.76 Aligned_cols=183 Identities=39% Similarity=0.669 Sum_probs=159.9
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-CCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS-TAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~-~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||++||+|++.+..++.+.|...+.+++||+.||.|||+.||+||||||+|||+..+ .+-.+||+|||+|+.......
T Consensus 255 lE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sf 334 (475)
T KOG0615|consen 255 LEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSF 334 (475)
T ss_pred EEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcccccee
Confidence 7999999999999999999999999999999999999999999999999999999766 223789999999998877777
Q ss_pred CCccccCCCCCCcccccCCc--CCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccC--CCcccCCH
Q 024809 80 PKSTVGTPAYIAPEVLTKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSL 155 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 155 (262)
.++.+|||.|.|||++.+.+ ++..++|+||+||+||-+++|.+||........+.+ ++.++.+.+ +.|..++.
T Consensus 335 m~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~e---QI~~G~y~f~p~~w~~Ise 411 (475)
T KOG0615|consen 335 MKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKE---QILKGRYAFGPLQWDRISE 411 (475)
T ss_pred hhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHH---HHhcCcccccChhhhhhhH
Confidence 88999999999999998755 344458999999999999999999987655443332 344455554 46778999
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
++++||.+||+.||++|||+.|+|+||||+.
T Consensus 412 ea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~ 442 (475)
T KOG0615|consen 412 EALDLINWMLVVDPENRPSADEALNHPWFKD 442 (475)
T ss_pred HHHHHHHHhhEeCcccCcCHHHHhcChhhhc
Confidence 9999999999999999999999999999974
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=330.00 Aligned_cols=180 Identities=50% Similarity=0.868 Sum_probs=163.8
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCC-CCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSS-VLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~-~~~~~ 79 (262)
||||.||+|+++|.+.++++|..++.+++|++.|++|||++||+||||||+|||++.+. +++||+|||++... .....
T Consensus 99 mEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~-~~~Kl~DFG~s~~~~~~~~~ 177 (370)
T KOG0583|consen 99 MEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNE-GNLKLSDFGLSAISPGEDGL 177 (370)
T ss_pred EEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCC-CCEEEeccccccccCCCCCc
Confidence 89999999999999999999999999999999999999999999999999999999882 38999999999877 45567
Q ss_pred CCccccCCCCCCcccccCCc-CCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 158 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (262)
..+.+||+.|+|||++.+.. |.++++||||+||+||.|++|+.||...+... +..++....+.+|.+.. |++++
T Consensus 178 l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~----l~~ki~~~~~~~p~~~~-S~~~~ 252 (370)
T KOG0583|consen 178 LKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN----LYRKIRKGEFKIPSYLL-SPEAR 252 (370)
T ss_pred ccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH----HHHHHhcCCccCCCCcC-CHHHH
Confidence 78899999999999999988 99999999999999999999999999854443 33446777888888655 99999
Q ss_pred HHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 159 HLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 159 ~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
+|+++||..||.+|+|+.+++.||||+.
T Consensus 253 ~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 253 SLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 9999999999999999999999999997
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=325.81 Aligned_cols=178 Identities=38% Similarity=0.673 Sum_probs=162.4
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-CC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (262)
+|+|+.|+|..+++.++.++|.+++++++||+.||.|||+++|+|||||..|+|++.+- +|||+|||+|...... +.
T Consensus 97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~--~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENM--NVKIGDFGLATQLEYDGER 174 (592)
T ss_pred EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcC--cEEecccceeeeecCcccc
Confidence 59999999999999999999999999999999999999999999999999999998887 8999999999877644 56
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
..+.+|||.|.|||++.+.++.-. +||||+||+||.||+|++||+.. .+..+..++....+.+|. .+|.++++
T Consensus 175 k~TlCGTPNYIAPEVl~k~gHsfE-vDiWSlGcvmYtLL~G~PPFetk----~vkety~~Ik~~~Y~~P~--~ls~~A~d 247 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSGHSFE-VDIWSLGCVMYTLLVGRPPFETK----TVKETYNKIKLNEYSMPS--HLSAEAKD 247 (592)
T ss_pred cceecCCCcccChhHhccCCCCCc-hhhhhhhhHHHhhhhCCCCcccc----hHHHHHHHHHhcCccccc--ccCHHHHH
Confidence 778999999999999998887655 89999999999999999999874 455666667778889998 89999999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
||.+||..||.+|||+.++|.|+||++.
T Consensus 248 LI~~lL~~~P~~Rpsl~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 248 LIRKLLRPNPSERPSLDEVLDHPFFKSG 275 (592)
T ss_pred HHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence 9999999999999999999999999554
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=327.66 Aligned_cols=181 Identities=41% Similarity=0.805 Sum_probs=170.0
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
+||++||.||+++..+|+|+|.+++++++||+.|+.|||..+|+||||||+|+|++... ++||+|||+|..-......
T Consensus 91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~--nIKIADFGMAsLe~~gklL 168 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKN--NIKIADFGMASLEVPGKLL 168 (786)
T ss_pred EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhccc--CEeeeccceeecccCCccc
Confidence 48999999999999999999999999999999999999999999999999999999877 7999999999876666777
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 160 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 160 (262)
.+.||+|.|.+||++.+..|++.++||||+|||||.||||+.||.+ ++++.++.+++.+.+.+|. .+++++++|
T Consensus 169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD----dNir~LLlKV~~G~f~MPs--~Is~eaQdL 242 (786)
T KOG0588|consen 169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD----DNIRVLLLKVQRGVFEMPS--NISSEAQDL 242 (786)
T ss_pred cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC----ccHHHHHHHHHcCcccCCC--cCCHHHHHH
Confidence 8899999999999999999999999999999999999999999985 5677888888999999996 799999999
Q ss_pred HHHhcccCCCCCCCHhHHhcCccccccCC
Q 024809 161 LSRIFVANSEKRITIPEIKNHPWFLRNLP 189 (262)
Q Consensus 161 i~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 189 (262)
|++||..||.+|+|.++|+.|||+.....
T Consensus 243 Lr~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 243 LRRMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred HHHHhccCccccccHHHHhhCchhhcCCC
Confidence 99999999999999999999999987543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=320.24 Aligned_cols=177 Identities=37% Similarity=0.670 Sum_probs=157.4
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC-
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ- 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~- 79 (262)
|||++||+|.++|++.+.|++..+++++.||+.||+|||++|||||||||+|||++.++ ++||+|||.|+.+.....
T Consensus 153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dm--hikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDG--HIKITDFGSAKILSPSQKS 230 (604)
T ss_pred EEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCC--cEEEeeccccccCChhhcc
Confidence 69999999999999999999999999999999999999999999999999999999888 999999999975432111
Q ss_pred -------------CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccccc
Q 024809 80 -------------PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYS 146 (262)
Q Consensus 80 -------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 146 (262)
..+++||-.|.+||++..... ++.+|+|+||||+|+|+.|++||.+.+....+ ++|+...+.
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~-~~~sDiWAlGCilyQmlaG~PPFra~NeyliF----qkI~~l~y~ 305 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA-GPSSDLWALGCILYQMLAGQPPFRAANEYLIF----QKIQALDYE 305 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcCCCC-CcccchHHHHHHHHHHhcCCCCCccccHHHHH----HHHHHhccc
Confidence 145789999999999987655 45589999999999999999999997765544 456677888
Q ss_pred CCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 147 FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 147 ~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
||. .+++.+++||+++|+.||.+|+|+++|.+||||..
T Consensus 306 fp~--~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 306 FPE--GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred CCC--CCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 888 78899999999999999999999999999999975
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=303.87 Aligned_cols=180 Identities=39% Similarity=0.671 Sum_probs=154.9
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC-CCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (262)
+||+.||+|+.+|.+.+.|+|..++.|+..|+.||.|||++|||||||||+|||++.++ +++|+|||+++.... ...
T Consensus 104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~G--Hi~LtDFgL~k~~~~~~~~ 181 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQG--HIKLTDFGLCKEDLKDGDA 181 (357)
T ss_pred EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCC--cEEEeccccchhcccCCCc
Confidence 58999999999999999999999999999999999999999999999999999998887 999999999984433 345
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
..+++||+.|||||++.+.+|+.. +|+||||+++|+|++|.+||.+.+......++ .......+. ..++.++++
T Consensus 182 t~tfcGT~eYmAPEil~~~gy~~~-vDWWsLGillYeML~G~pPF~~~~~~~~~~~I----~~~k~~~~p-~~ls~~ard 255 (357)
T KOG0598|consen 182 TRTFCGTPEYMAPEILLGKGYDKA-VDWWSLGILLYEMLTGKPPFYAEDVKKMYDKI----LKGKLPLPP-GYLSEEARD 255 (357)
T ss_pred cccccCCccccChHHHhcCCCCcc-cchHhHHHHHHHHhhCCCCCcCccHHHHHHHH----hcCcCCCCC-ccCCHHHHH
Confidence 567899999999999999988654 89999999999999999999987665544444 333322222 148999999
Q ss_pred HHHHhcccCCCCCC----CHhHHhcCccccccC
Q 024809 160 LLSRIFVANSEKRI----TIPEIKNHPWFLRNL 188 (262)
Q Consensus 160 li~~~L~~dp~~R~----s~~e~l~hp~~~~~~ 188 (262)
+++++|+++|.+|. .+.++.+||||..-.
T Consensus 256 ll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~in 288 (357)
T KOG0598|consen 256 LLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGIN 288 (357)
T ss_pred HHHHHhccCHHHhcCCCCChHHhhcCcccccCC
Confidence 99999999999995 789999999997643
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=296.04 Aligned_cols=175 Identities=42% Similarity=0.750 Sum_probs=158.1
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||++||.|++++++.++|+|..++.++.||+.||+|||+++|++|||||+|||++.++ .+||+|||+|+... ...
T Consensus 123 meyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G--~iKitDFGFAK~v~--~rT 198 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNG--HIKITDFGFAKRVS--GRT 198 (355)
T ss_pred EeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCC--cEEEEeccceEEec--CcE
Confidence 89999999999999999999999999999999999999999999999999999999888 99999999998543 346
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 160 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 160 (262)
.+.||||.|+|||++...+|. +++|.|||||++|||+.|.+||...+.. .+..+|....+.||. .+++++++|
T Consensus 199 ~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~~----~iY~KI~~~~v~fP~--~fs~~~kdL 271 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNPI----QIYEKILEGKVKFPS--YFSSDAKDL 271 (355)
T ss_pred EEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCChH----HHHHHHHhCcccCCc--ccCHHHHHH
Confidence 778999999999999998885 5589999999999999999999886654 445556777888888 689999999
Q ss_pred HHHhcccCCCCCC-----CHhHHhcCccccc
Q 024809 161 LSRIFVANSEKRI-----TIPEIKNHPWFLR 186 (262)
Q Consensus 161 i~~~L~~dp~~R~-----s~~e~l~hp~~~~ 186 (262)
|+++|+.|-.+|. ...+|..||||+.
T Consensus 272 l~~LL~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 272 LKKLLQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred HHHHHhhhhHhhhcCcCCCccccccCccccc
Confidence 9999999999994 5678999999973
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=294.22 Aligned_cols=180 Identities=36% Similarity=0.648 Sum_probs=160.0
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
+|.|+.|.|++++.+.-.+||+..+.||+|++.|+.|||.++||||||||+|||++++. ++||+|||+|.....+.+.
T Consensus 102 Fdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~--~i~isDFGFa~~l~~GekL 179 (411)
T KOG0599|consen 102 FDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNM--NIKISDFGFACQLEPGEKL 179 (411)
T ss_pred hhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeecccc--ceEEeccceeeccCCchhH
Confidence 57899999999999998999999999999999999999999999999999999999887 8999999999998888888
Q ss_pred CccccCCCCCCcccccCCcC-----CCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccccc--CCCcccC
Q 024809 81 KSTVGTPAYIAPEVLTKKEY-----DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYS--FPDYVRV 153 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 153 (262)
...+|||+|.|||.+....+ +++.+|+|++|||||.++.|.+||..... ..++..++.+++. .|+|.++
T Consensus 180 relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ----mlMLR~ImeGkyqF~speWadi 255 (411)
T KOG0599|consen 180 RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ----MLMLRMIMEGKYQFRSPEWADI 255 (411)
T ss_pred HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH----HHHHHHHHhcccccCCcchhhc
Confidence 88999999999999865332 34558999999999999999999987432 3344556655554 4789999
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 154 SLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 154 ~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
|.+.++||.+||+.||.+|+|++|+|.||||.+
T Consensus 256 s~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 256 SATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred cccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 999999999999999999999999999999954
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=301.07 Aligned_cols=221 Identities=26% Similarity=0.363 Sum_probs=173.0
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC---C
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL---H 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~---~ 77 (262)
+|+|+ -||.+.|+.++.|++..+..+++|+++||+|+|+.||+||||||.|+|++.+. .+||+|||+|+.... .
T Consensus 105 ~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c--~lKI~DFGLAR~~~~~~~~ 181 (359)
T KOG0660|consen 105 FELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADC--DLKICDFGLARYLDKFFED 181 (359)
T ss_pred hhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCC--CEEeccccceeeccccCcc
Confidence 47775 49999999988899999999999999999999999999999999999999888 789999999997643 3
Q ss_pred CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc--------------
Q 024809 78 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-------------- 143 (262)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------------- 143 (262)
...+.++.|.||+|||++.....+++++||||+||||.||++|++.|.+.+...++..++..+...
T Consensus 182 ~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar 261 (359)
T KOG0660|consen 182 GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKAR 261 (359)
T ss_pred cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHH
Confidence 344678899999999999877666777999999999999999999999887766655443322110
Q ss_pred ----------cccC-CCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCCccccCCCCccccCCCCCCCCHHH
Q 024809 144 ----------HYSF-PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEE 212 (262)
Q Consensus 144 ----------~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (262)
...| ..+++.++.+.+|+++||++||.+|+|++|+|+|||+.....++......-........ .+.++
T Consensus 262 ~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~~~~~~~~-~~~~~ 340 (359)
T KOG0660|consen 262 PYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPIFDSFEHE-LTEEE 340 (359)
T ss_pred HHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCCCCcccccc-ccHHH
Confidence 0010 01346889999999999999999999999999999999877654432111111112222 56788
Q ss_pred HHHHhHHhcCCCC
Q 024809 213 VLSLIHEATKPLE 225 (262)
Q Consensus 213 ~~~~~~~~~~~~~ 225 (262)
+.+++.++...+.
T Consensus 341 ~r~~i~~e~~~~~ 353 (359)
T KOG0660|consen 341 LRELIYKEILDFH 353 (359)
T ss_pred HHHHHHHHHHhhC
Confidence 8888887754443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=305.40 Aligned_cols=183 Identities=36% Similarity=0.538 Sum_probs=150.6
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-CCCCcEEEeccCCCcCCCC--
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG-STAPRVKICDFGYSKSSVL-- 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~-~~~~~~kl~Dfg~a~~~~~-- 76 (262)
|||++||+|.+++.+.+ +|+|..++.+.+|+++||.|||++|||||||||+|||++. ++ .+||+|||+++....
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~--~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNG--DVKLADFGLAKKLESKG 172 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCC--eEEeccCcccccccccc
Confidence 89999999999999887 7999999999999999999999999999999999999988 46 899999999986542
Q ss_pred --CCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCC-CChhHHHHHhcccccccccCCCcccC
Q 024809 77 --HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP-EDPKNFRKTIGRILSVHYSFPDYVRV 153 (262)
Q Consensus 77 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (262)
........||+.|||||++..+....+++|||||||++.||+||+.||... ........+.... ..+.+|. .+
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~--~~P~ip~--~l 248 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED--SLPEIPD--SL 248 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC--CCCCCCc--cc
Confidence 122345789999999999986444444689999999999999999999873 2222222222111 1224455 59
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCC
Q 024809 154 SLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLP 189 (262)
Q Consensus 154 ~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 189 (262)
|.++++||.+||+++|.+||||.++|+|||.....+
T Consensus 249 s~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 249 SDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 999999999999999999999999999999976543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=303.62 Aligned_cols=184 Identities=27% Similarity=0.441 Sum_probs=159.1
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
||||+- +|.++++.+. .|+|..++.||+||++||+|+|++|+.|||+||+|||+..+. .|||+|||+||.......
T Consensus 89 fE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~--~iKiaDFGLARev~SkpP 165 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGND--VIKIADFGLAREVRSKPP 165 (538)
T ss_pred HHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccc--eeEecccccccccccCCC
Confidence 799985 9999998665 599999999999999999999999999999999999998655 899999999997766556
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccc---------------cc
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS---------------VH 144 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------------~~ 144 (262)
-+.++.|+||+|||++.+..+++..+|||++|||++|+.+-++.|.|.++.+++.++-..+.. .+
T Consensus 166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mn 245 (538)
T KOG0661|consen 166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMN 245 (538)
T ss_pred cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhc
Confidence 677899999999999988887777799999999999999999999999888887766443322 23
Q ss_pred ccCCCc---------ccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 145 YSFPDY---------VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 145 ~~~~~~---------~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
+.+|.. +..++++.++|.+||.+||.+||||.|+|+||||+..
T Consensus 246 f~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 246 FRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred cCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 334432 2478899999999999999999999999999999753
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=283.31 Aligned_cols=182 Identities=38% Similarity=0.692 Sum_probs=156.2
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-APRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~-~~~~kl~Dfg~a~~~~~~~~ 79 (262)
+|+++||+|+.-|..+--++|..+..+++||+.||.|+|.+||||||+||+|+++.+.. ..-+||+|||+|........
T Consensus 89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~ 168 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEA 168 (355)
T ss_pred EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccc
Confidence 58999999998887776789999999999999999999999999999999999994322 22589999999987764445
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccccc--CCCcccCCHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYS--FPDYVRVSLEC 157 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 157 (262)
...++|||.|||||+++..+|..+ +|||+.|||||-++.|++||.+.+....+..+ ....+. .|.|..+++++
T Consensus 169 ~~G~~GtP~fmaPEvvrkdpy~kp-vDiW~cGViLfiLL~G~~PF~~~~~~rlye~I----~~g~yd~~~~~w~~is~~A 243 (355)
T KOG0033|consen 169 WHGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYEQI----KAGAYDYPSPEWDTVTPEA 243 (355)
T ss_pred cccccCCCcccCHHHhhcCCCCCc-chhhhhhHHHHHHHhCCCCCCCccHHHHHHHH----hccccCCCCcccCcCCHHH
Confidence 566899999999999998888644 89999999999999999999986665555554 334444 45688999999
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 158 KHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
++||++||..||.+|+|+.|+|+|||+.+.
T Consensus 244 k~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 244 KSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 999999999999999999999999999753
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=287.89 Aligned_cols=188 Identities=38% Similarity=0.628 Sum_probs=162.1
Q ss_pred CCCCCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCcEEEeccCCCcCCCCC
Q 024809 1 MEYAAGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-APRVKICDFGYSKSSVLH 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~--l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~-~~~~kl~Dfg~a~~~~~~ 77 (262)
||+++||+|+..|..++. |+|.++..|++||..|+.|||+.+|.||||||+|+|..... +..+||+|||+|+.....
T Consensus 138 mE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~ 217 (400)
T KOG0604|consen 138 MECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP 217 (400)
T ss_pred eecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCC
Confidence 899999999999998764 99999999999999999999999999999999999995433 337899999999977656
Q ss_pred CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCC--CcccCCH
Q 024809 78 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP--DYVRVSL 155 (262)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 155 (262)
....+.+-||.|.|||++....|+ +..|+||+||++|-|+||.+||-.......---+..+|....+.|| +|..+|.
T Consensus 218 ~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe 296 (400)
T KOG0604|consen 218 GDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSE 296 (400)
T ss_pred ccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHH
Confidence 667788999999999999888875 5589999999999999999999765543332334455666777775 6889999
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhcCccccccCC
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLP 189 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 189 (262)
+++++|+++|..+|.+|.|+.++++|||+.+...
T Consensus 297 ~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~ 330 (400)
T KOG0604|consen 297 AAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA 330 (400)
T ss_pred HHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence 9999999999999999999999999999987543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=301.73 Aligned_cols=182 Identities=37% Similarity=0.632 Sum_probs=158.4
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC----
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL---- 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~---- 76 (262)
|||++|||+..+|.+.+.|+|+.++.|+.+++.|++.||+.|+|||||||+|+||+..| ++||+|||++.....
T Consensus 220 MEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~G--HiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKG--HIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred EEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCC--CEeeccccccchhhhhhhh
Confidence 89999999999999999999999999999999999999999999999999999999888 999999999853210
Q ss_pred ------------------C--CC----C--------------------CccccCCCCCCcccccCCcCCCCchhHHHHHH
Q 024809 77 ------------------H--SQ----P--------------------KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGV 112 (262)
Q Consensus 77 ------------------~--~~----~--------------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ 112 (262)
. .. . ...+|||.|||||++.+.+|. ..+|+|||||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~-~~cDwWSLG~ 376 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG-KECDWWSLGC 376 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC-ccccHHHHHH
Confidence 0 00 0 124699999999999999975 5599999999
Q ss_pred HHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHHHHHhcccCCCCCC---CHhHHhcCccccccC
Q 024809 113 TLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI---TIPEIKNHPWFLRNL 188 (262)
Q Consensus 113 il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~---s~~e~l~hp~~~~~~ 188 (262)
|+||||.|.+||.+.+..+.+.+++.. ...+.+|....++++++|||.+||. ||.+|. +++||..||||+.-.
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~nw--r~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~ 452 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVNW--RETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVD 452 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHH--hhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCC
Confidence 999999999999998877777776544 3346778888899999999999999 999998 489999999998643
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=304.66 Aligned_cols=179 Identities=30% Similarity=0.537 Sum_probs=153.3
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-C
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-Q 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (262)
|||++||+|-+.+... .|+|.++..+++.+++||+|||.+||+|||||.+|||++.++ .+||+|||++..+.... .
T Consensus 349 MEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g--~vKltDFGFcaqi~~~~~K 425 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDG--SVKLTDFGFCAQISEEQSK 425 (550)
T ss_pred EeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCC--cEEEeeeeeeeccccccCc
Confidence 8999999999988776 599999999999999999999999999999999999998887 89999999998765543 6
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
..+.+|||.|||||++.+..|..+ +||||||+++.||+-|++||-.......+.. +..... ..+.....+|+.+++
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~K-VDIWSLGIMaIEMveGEPPYlnE~PlrAlyL-Ia~ng~--P~lk~~~klS~~~kd 501 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYL-IATNGT--PKLKNPEKLSPELKD 501 (550)
T ss_pred cccccCCCCccchhhhhhcccCcc-ccchhhhhHHHHHhcCCCCccCCChHHHHHH-HhhcCC--CCcCCccccCHHHHH
Confidence 678899999999999999888655 8999999999999999999987444333332 222223 333344489999999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
|+.+||+.|+.+|++|.|+|+||||+.
T Consensus 502 FL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 502 FLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred HHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 999999999999999999999999953
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=291.80 Aligned_cols=184 Identities=36% Similarity=0.610 Sum_probs=156.8
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-CC---CcEEEeccCCCcCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS-TA---PRVKICDFGYSKSSVL 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~-~~---~~~kl~Dfg~a~~~~~ 76 (262)
||||+||||.+||.+.++++|..++.++.||+.||++||+++||||||||.|||++.. .. ..+||+|||+|+....
T Consensus 88 MEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~ 167 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP 167 (429)
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence 8999999999999999999999999999999999999999999999999999999764 22 4789999999998877
Q ss_pred CCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHH
Q 024809 77 HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 156 (262)
Q Consensus 77 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (262)
.....+.+|+|.|||||++....|+.+ +|+||+|+|+|+|++|+.||...+..+-+. .+++-......++. .+++.
T Consensus 168 ~~~a~tlcGSplYMAPEV~~~~~YdAK-ADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~-~~~k~~~~~~~~~~--~~s~~ 243 (429)
T KOG0595|consen 168 GSMAETLCGSPLYMAPEVIMSQQYDAK-ADLWSIGTILYQCLTGKPPFDAETPKELLL-YIKKGNEIVPVLPA--ELSNP 243 (429)
T ss_pred hhHHHHhhCCccccCHHHHHhccccch-hhHHHHHHHHHHHHhCCCCccccCHHHHHH-HHhccccccCchhh--hccCc
Confidence 777778899999999999998899877 799999999999999999999866554443 22221111112222 46777
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKNHPWFLRNL 188 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 188 (262)
+.+++...|..+|..|.+..+-+.|+++....
T Consensus 244 ~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 244 LRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred hhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 88999999999999999999999999986544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=280.66 Aligned_cols=183 Identities=23% Similarity=0.444 Sum_probs=153.8
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCC-CCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV-LHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~-~~~ 78 (262)
+|||+. ++...+... .+++++.++.+++|++.|+.|+|++++|||||||+||||+.++ .+||||||+|+... ...
T Consensus 80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~g--vvKLCDFGFAR~L~~pgd 156 (396)
T KOG0593|consen 80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNG--VVKLCDFGFARTLSAPGD 156 (396)
T ss_pred eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCC--cEEeccchhhHhhcCCcc
Confidence 689987 666666544 4799999999999999999999999999999999999999888 89999999999776 344
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc---------------
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV--------------- 143 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------------- 143 (262)
.-+.++.|.||+|||++.+...+++.+||||+||++.||++|.+.|.+.++.+++..+...+...
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 45568999999999999997777888999999999999999999999999988876554332210
Q ss_pred cccCC----------CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 144 HYSFP----------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 144 ~~~~~----------~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
...+| .++.++.-+.+|+++||..||.+|++.+|+|.||||..
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 11111 23457788999999999999999999999999999954
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=284.48 Aligned_cols=179 Identities=34% Similarity=0.606 Sum_probs=155.8
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC--
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-- 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-- 76 (262)
||||+||+|+.+.+++ +.|+++.++.|+..|+.||+|||-.|||+|||||+||||..++ +|.|+||.++.....
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredG--HIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDG--HIMLSDFDLSLRCPVSP 233 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCC--cEEeeeccccccCCCCC
Confidence 8999999999999765 4699999999999999999999999999999999999998888 999999998642110
Q ss_pred -------------------------------C-C-----------------------CCCccccCCCCCCcccccCCcCC
Q 024809 77 -------------------------------H-S-----------------------QPKSTVGTPAYIAPEVLTKKEYD 101 (262)
Q Consensus 77 -------------------------------~-~-----------------------~~~~~~gt~~y~aPE~~~~~~~~ 101 (262)
. . ..+.++||-.|.|||++.+.+..
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 0 0 01235799999999999999886
Q ss_pred CCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHHHHHhcccCCCCCCC----HhH
Q 024809 102 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRIT----IPE 177 (262)
Q Consensus 102 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s----~~e 177 (262)
.. +|+|+||+++|||+.|..||.+.+..+.+.+++ .....||....++..++|||+++|++||++|.. |.|
T Consensus 314 sA-VDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv----~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~e 388 (459)
T KOG0610|consen 314 SA-VDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIV----GQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAE 388 (459)
T ss_pred ch-hhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHh----cCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHH
Confidence 44 899999999999999999999988877776654 445678888889999999999999999999998 999
Q ss_pred HhcCccccc
Q 024809 178 IKNHPWFLR 186 (262)
Q Consensus 178 ~l~hp~~~~ 186 (262)
|.+||||..
T Consensus 389 IK~HpFF~g 397 (459)
T KOG0610|consen 389 IKRHPFFEG 397 (459)
T ss_pred hhcCccccC
Confidence 999999975
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=266.19 Aligned_cols=185 Identities=28% Similarity=0.421 Sum_probs=157.2
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
+||++. ||...|+... .|+..+++.|+.++++||+|||++.|+||||||.|+||++++ .+||+|||+|+.+.....
T Consensus 80 fEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g--~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 80 FEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDG--QLKIADFGLARFFGSPNR 156 (318)
T ss_pred EEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCC--cEEeecccchhccCCCCc
Confidence 589986 9999998665 589999999999999999999999999999999999998888 899999999997754433
Q ss_pred -CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccccc-C------CC--
Q 024809 80 -PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYS-F------PD-- 149 (262)
Q Consensus 80 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~------~~-- 149 (262)
....+.|.||+|||++.+...++..+||||+|||+.||+-|.+.|.+.++.+++..++......... + |+
T Consensus 157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence 3334789999999999887777777999999999999999999999999999988887655432111 1 11
Q ss_pred -------------cccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 024809 150 -------------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL 188 (262)
Q Consensus 150 -------------~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 188 (262)
++..++++.+|+.+||.+||.+|+|+.|+|+|+||+...
T Consensus 237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P 288 (318)
T KOG0659|consen 237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP 288 (318)
T ss_pred HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence 123678899999999999999999999999999998643
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=287.35 Aligned_cols=183 Identities=35% Similarity=0.622 Sum_probs=159.4
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC--CcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA--PRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~--~~~kl~Dfg~a~~~~~~~ 78 (262)
||+|+||+|++.|.+. .++|..+..++.|++.|++|||+.||+||||||+|+|+..... +.+|++|||+|.......
T Consensus 115 mEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~ 193 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGE 193 (382)
T ss_pred EEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCc
Confidence 7999999999999887 4999999999999999999999999999999999999965532 479999999999776655
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 158 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (262)
.....+||+.|+|||++....|... +||||+||++|.|++|..||.+......+..+... ...+..+.|..++..++
T Consensus 194 ~~~~~~Gtp~y~APEvl~~~~y~~~-~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~--~~~f~~~~w~~is~~ak 270 (382)
T KOG0032|consen 194 RLHTIVGTPEYVAPEVLGGRPYGDE-VDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG--DFDFTSEPWDDISESAK 270 (382)
T ss_pred eEeeecCCccccCchhhcCCCCCcc-cchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC--CCCCCCCCccccCHHHH
Confidence 6677899999999999988787655 89999999999999999999998776665543332 12344566788999999
Q ss_pred HHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 159 HLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 159 ~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
+||++||..||.+|+|+.++|+|||+...
T Consensus 271 d~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 271 DFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 99999999999999999999999999764
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=286.41 Aligned_cols=178 Identities=40% Similarity=0.692 Sum_probs=150.3
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-CC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (262)
|||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..... ..
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~--~~kl~DfG~a~~~~~~~~~ 151 (323)
T cd05571 74 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG--HIKITDFGLCKEGISDGAT 151 (323)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC--CEEEeeCCCCcccccCCCc
Confidence 79999999999999888999999999999999999999999999999999999998776 8999999998753222 22
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
....+||+.|+|||++.+..+..+ +||||+||++|+|++|+.||...+....+.. +......+|. .+++++++
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~Pf~~~~~~~~~~~----~~~~~~~~p~--~~~~~~~~ 224 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL----ILMEEIRFPR--TLSPEAKS 224 (323)
T ss_pred ccceecCccccChhhhcCCCCCcc-ccCcccchhhhhhhcCCCCCCCCCHHHHHHH----HHcCCCCCCC--CCCHHHHH
Confidence 345679999999999987777544 8999999999999999999987554333322 2223334444 68999999
Q ss_pred HHHHhcccCCCCCC-----CHhHHhcCcccccc
Q 024809 160 LLSRIFVANSEKRI-----TIPEIKNHPWFLRN 187 (262)
Q Consensus 160 li~~~L~~dp~~R~-----s~~e~l~hp~~~~~ 187 (262)
||.+||+.||++|| ++.++++||||...
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 225 LLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred HHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 99999999999999 89999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=285.15 Aligned_cols=183 Identities=36% Similarity=0.618 Sum_probs=149.1
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 84 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~--~~kl~DfG~~~~~~~~~~~ 161 (332)
T cd05614 84 LDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEG--HVVLTDFGLSKEFLSEEKE 161 (332)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCC--CEEEeeCcCCccccccCCC
Confidence 79999999999999888899999999999999999999999999999999999998777 89999999997543222
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 158 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (262)
......||+.|+|||++.+....+.++|||||||++|+|++|+.||...............+......++. .+++.++
T Consensus 162 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 239 (332)
T cd05614 162 RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPS--FIGPEAQ 239 (332)
T ss_pred ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHH
Confidence 22345799999999999765544556899999999999999999997543322222222223333333333 5889999
Q ss_pred HHHHHhcccCCCCCC-----CHhHHhcCcccccc
Q 024809 159 HLLSRIFVANSEKRI-----TIPEIKNHPWFLRN 187 (262)
Q Consensus 159 ~li~~~L~~dp~~R~-----s~~e~l~hp~~~~~ 187 (262)
++|.+||+.||++|| +++++++||||...
T Consensus 240 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999999999999999 88899999999753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=283.58 Aligned_cols=183 Identities=26% Similarity=0.443 Sum_probs=157.4
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (262)
+|||+. ||..++...+ +|++.+++.+|+||+.||+|||++||+|||||.+||||+.++ .+||+|||+|+.+....
T Consensus 197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G--~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNG--VLKIADFGLARFYTPSGS 273 (560)
T ss_pred Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCC--CEEeccccceeeccCCCC
Confidence 699997 9999988754 799999999999999999999999999999999999999888 89999999999665443
Q ss_pred -CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccccc------CCC--
Q 024809 79 -QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYS------FPD-- 149 (262)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~------~~~-- 149 (262)
..+..+.|.||+|||++.+...++.++|+||+||||.||++|++.|.+.++.+++.+++......... +|.
T Consensus 274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~ 353 (560)
T KOG0600|consen 274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHAT 353 (560)
T ss_pred cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccc
Confidence 35667899999999999998877888999999999999999999999999988888877654332111 110
Q ss_pred ---------------cccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 150 ---------------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 150 ---------------~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
+..++..+.+|+..||..||.+|.||.++|+|+||..
T Consensus 354 ~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 354 IFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred ccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 1237788999999999999999999999999999943
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=270.32 Aligned_cols=184 Identities=26% Similarity=0.341 Sum_probs=156.5
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
||||+. ||.+++...+ +|++.+++.++.|+++||+|||.+.|+||||||+|+|++..+ .+||+|||+||.+.....
T Consensus 156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G--~lKiaDFGLAR~ygsp~k 232 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKG--ILKIADFGLAREYGSPLK 232 (419)
T ss_pred HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCC--cEEecccchhhhhcCCcc
Confidence 899997 9999998765 899999999999999999999999999999999999998777 899999999997765433
Q ss_pred -CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccc--------------
Q 024809 80 -PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH-------------- 144 (262)
Q Consensus 80 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-------------- 144 (262)
.+..+.|.||+|||++.+...++.++|+||+|||+.||+++++.|.+....+++.+++.......
T Consensus 233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k 312 (419)
T KOG0663|consen 233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVK 312 (419)
T ss_pred cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhh
Confidence 45568899999999999877666669999999999999999999999998888887765443211
Q ss_pred -ccCCCc-----------ccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 145 -YSFPDY-----------VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 145 -~~~~~~-----------~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
..++.. ..++....+|+..+|.+||.+|.||.++|+|.||...
T Consensus 313 ~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 313 KMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred ccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 111111 1156888999999999999999999999999999863
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=285.64 Aligned_cols=183 Identities=37% Similarity=0.624 Sum_probs=154.1
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
+|||..|.+...=.....+++.+++.|++.++.||+|||.+|||||||||+|+|++.++ +|||+|||.+.......
T Consensus 189 ley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g--~VKIsDFGVs~~~~~~~~~ 266 (576)
T KOG0585|consen 189 LEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG--TVKISDFGVSNEFPQGSDE 266 (576)
T ss_pred EEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC--cEEeeccceeeecccCCcc
Confidence 58999998754433332399999999999999999999999999999999999998877 99999999987543221
Q ss_pred ----CCCccccCCCCCCcccccC---CcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcc
Q 024809 79 ----QPKSTVGTPAYIAPEVLTK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV 151 (262)
Q Consensus 79 ----~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (262)
.....+|||.|+|||++.. ..+.+.+.||||+||+||.|+.|+.||-+.... .+..+|......||...
T Consensus 267 ~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~----~l~~KIvn~pL~fP~~p 342 (576)
T KOG0585|consen 267 GSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL----ELFDKIVNDPLEFPENP 342 (576)
T ss_pred ccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH----HHHHHHhcCcccCCCcc
Confidence 1223689999999999977 456788899999999999999999999875444 44445566677888888
Q ss_pred cCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCC
Q 024809 152 RVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLP 189 (262)
Q Consensus 152 ~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 189 (262)
.+..++++||.+||.+||.+|+++.++..|||..+...
T Consensus 343 e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~ 380 (576)
T KOG0585|consen 343 EINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD 380 (576)
T ss_pred cccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence 89999999999999999999999999999999987644
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=267.59 Aligned_cols=167 Identities=31% Similarity=0.481 Sum_probs=142.0
Q ss_pred CCCCCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHH--cC--CeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 1 MEYAAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHS--MQ--ICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 1 mE~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~aL~~LH~--~~--ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
||||.+|||.+.|+. ++.++|..+++++.|++.||.+||+ .+ |+||||||.||+++.++ .|||+|||+++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g--vvKLGDfGL~r 176 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG--VVKLGDFGLGR 176 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC--ceeeccchhHh
Confidence 899999999999963 3469999999999999999999999 55 99999999999999887 89999999999
Q ss_pred CCCCCC-CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccccc-CCCc
Q 024809 73 SSVLHS-QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYS-FPDY 150 (262)
Q Consensus 73 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~ 150 (262)
...... ...+.+|||.||+||.+...+|+.+ +||||+||++|||..-+.||.+. ++...-.+|....++ .|.
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~k-SDiWslGCllyEMcaL~~PF~g~----n~~~L~~KI~qgd~~~~p~- 250 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFK-SDIWSLGCLLYEMCALQSPFYGD----NLLSLCKKIEQGDYPPLPD- 250 (375)
T ss_pred HhcchhHHHHhhcCCCcccCHHHHhcCCCCcc-hhHHHHHHHHHHHHhcCCCcccc----cHHHHHHHHHcCCCCCCcH-
Confidence 765433 2356799999999999999999866 89999999999999999999985 344444445545544 332
Q ss_pred ccCCHHHHHHHHHhcccCCCCCCCH
Q 024809 151 VRVSLECKHLLSRIFVANSEKRITI 175 (262)
Q Consensus 151 ~~~~~~~~~li~~~L~~dp~~R~s~ 175 (262)
-..|.+++.+|..|+..||..||+.
T Consensus 251 ~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 251 EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHhhhHHHHHHHHHccCCcccCCCc
Confidence 2688999999999999999999985
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=281.33 Aligned_cols=178 Identities=30% Similarity=0.441 Sum_probs=152.6
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-C
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-Q 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (262)
||||.||++.+.++....++|..+.-++++++.||.|||+.+.+|||||+.|||+...+ .+||+|||++....... .
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g--~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESG--DVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccC--cEEEEecceeeeeechhhc
Confidence 89999999999999988789999999999999999999999999999999999998776 89999999998665443 3
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
..+++|||.|||||++....|+.+ +||||||++.+||.+|.+||...... +.+..|.+..++.- ...+|+.+++
T Consensus 168 r~tfvGTPfwMAPEVI~~~~Y~~K-ADIWSLGITaiEla~GePP~s~~hPm----rvlflIpk~~PP~L-~~~~S~~~kE 241 (467)
T KOG0201|consen 168 RKTFVGTPFWMAPEVIKQSGYDTK-ADIWSLGITAIELAKGEPPHSKLHPM----RVLFLIPKSAPPRL-DGDFSPPFKE 241 (467)
T ss_pred cccccccccccchhhhccccccch-hhhhhhhHHHHHHhcCCCCCcccCcc----eEEEeccCCCCCcc-ccccCHHHHH
Confidence 478999999999999998889877 79999999999999999999876552 22222222221111 1268899999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
||..||.+||+.||||.++|.|+|+++
T Consensus 242 FV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 242 FVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred HHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 999999999999999999999999975
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=276.31 Aligned_cols=186 Identities=30% Similarity=0.476 Sum_probs=159.6
Q ss_pred CCCCCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC
Q 024809 1 MEYAAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (262)
|||++. +|.++++. +++++.-.++-+++||++||.|||+.||+||||||.|+|++.+. +.+||||||.|+....
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~t-g~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDT-GVLKICDFGSAKVLVK 178 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCC-CeEEeccCCcceeecc
Confidence 799986 99999984 56899999999999999999999999999999999999998764 4899999999998887
Q ss_pred CCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc-------------
Q 024809 77 HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV------------- 143 (262)
Q Consensus 77 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------------- 143 (262)
++...++..|+.|+|||++.+...++.+.||||.||+++||+-|++.|.+.+..+++..+++.....
T Consensus 179 ~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~ 258 (364)
T KOG0658|consen 179 GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYT 258 (364)
T ss_pred CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccc
Confidence 7777889999999999999887666666999999999999999999999988888877765543211
Q ss_pred cccCCC----------cccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 024809 144 HYSFPD----------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL 188 (262)
Q Consensus 144 ~~~~~~----------~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 188 (262)
...+|. ....++++.+|+.++|+++|.+|.++.|++.||||..-.
T Consensus 259 ~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 259 EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR 313 (364)
T ss_pred cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence 111221 235789999999999999999999999999999997543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=285.24 Aligned_cols=178 Identities=31% Similarity=0.615 Sum_probs=156.1
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC-
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ- 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~- 79 (262)
.|||.| +|+.+|...+.++|+.++.+++|++.||.|||+++|+|||+||.|||+..++ ++|+||||+|+.+.....
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~--~~KlcdFg~Ar~m~~~t~v 156 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGG--TLKLCDFGLARAMSTNTSV 156 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCC--ceeechhhhhhhcccCcee
Confidence 489997 9999999999999999999999999999999999999999999999998877 999999999997765432
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....|||.|||||++.+..|+.. +|+||||||+|||++|++||-. ..+...++.|......+|. ..++.+++
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~-sDlWslGcilYE~~~G~PPF~a----~si~~Lv~~I~~d~v~~p~--~~S~~f~n 229 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHT-SDLWSLGCILYELYVGQPPFYA----RSITQLVKSILKDPVKPPS--TASSSFVN 229 (808)
T ss_pred eeeccCcccccCHHHHcCCCccch-hhHHHHHHHHHHHhcCCCCchH----HHHHHHHHHHhcCCCCCcc--cccHHHHH
Confidence 345679999999999998888766 8999999999999999999975 3344455555555556665 79999999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCccccccC
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWFLRNL 188 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 188 (262)
|++.+|.+||.+|+|..+++.|||++...
T Consensus 230 fl~gLL~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 230 FLQGLLIKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred HHHHHhhcChhhcccHHHHhcChHHhhhh
Confidence 99999999999999999999999997643
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=277.18 Aligned_cols=181 Identities=28% Similarity=0.473 Sum_probs=148.2
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
||||+||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .++|+|||++.......
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~--~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRG--HIRISDLGLAVQIPEGE 156 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC--CEEEeeCCCcEEcCCCC
Confidence 6899999999888643 3699999999999999999999999999999999999998776 89999999997654333
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 158 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (262)
......||+.|+|||++.+..++.+ +||||+||++|+|++|+.||...............+......++. .++.++.
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~ 233 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFS-PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSE--KFSEDAK 233 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcc-cCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCc--cCCHHHH
Confidence 3345679999999999988777655 899999999999999999998765433222222222222223333 5889999
Q ss_pred HHHHHhcccCCCCCCC-----HhHHhcCccccc
Q 024809 159 HLLSRIFVANSEKRIT-----IPEIKNHPWFLR 186 (262)
Q Consensus 159 ~li~~~L~~dp~~R~s-----~~e~l~hp~~~~ 186 (262)
+|+++||..||.+||+ ++++++||||..
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 234 SICRMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred HHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 9999999999999997 899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=283.75 Aligned_cols=180 Identities=34% Similarity=0.702 Sum_probs=163.1
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
+|+=+||+|++||.++ .+++|..+++|+.||+.|+.|||+..+|||||||+|+.+... .+-|||+|||++..+..+.+
T Consensus 96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEK-lGlVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEK-LGLVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeee-cCceEeeeccccccCCCcch
Confidence 3667899999999765 479999999999999999999999999999999999988543 34799999999998888888
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
..+.+|+..|.|||++.+..|+.+++||||||||||.|+||+.||+..++.+.+.. |+...|..|. .++.+|++
T Consensus 175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm----ImDCKYtvPs--hvS~eCrd 248 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM----IMDCKYTVPS--HVSKECRD 248 (864)
T ss_pred hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh----hhcccccCch--hhhHHHHH
Confidence 99999999999999999999999999999999999999999999999888766544 5566778887 79999999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
||..||+.||++|.|.++|..|+|++..
T Consensus 249 LI~sMLvRdPkkRAslEeI~s~~Wlq~~ 276 (864)
T KOG4717|consen 249 LIQSMLVRDPKKRASLEEIVSTSWLQAG 276 (864)
T ss_pred HHHHHHhcCchhhccHHHHhccccccCC
Confidence 9999999999999999999999999754
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=280.46 Aligned_cols=178 Identities=37% Similarity=0.673 Sum_probs=150.0
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-CC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (262)
||||+||+|.+++...+++++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..... ..
T Consensus 72 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~--~~kl~Dfg~~~~~~~~~~~ 149 (312)
T cd05585 72 LAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQG--HIALCDFGLCKLNMKDDDK 149 (312)
T ss_pred EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCC--cEEEEECcccccCccCCCc
Confidence 79999999999999888999999999999999999999999999999999999998777 8999999998753222 22
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....||+.|+|||++.+..++.+ +||||+||++|+|++|+.||........+.. +......+|. .+++++++
T Consensus 150 ~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslGvil~el~tg~~pf~~~~~~~~~~~----~~~~~~~~~~--~~~~~~~~ 222 (312)
T cd05585 150 TNTFCGTPEYLAPELLLGHGYTKA-VDWWTLGVLLYEMLTGLPPFYDENVNEMYRK----ILQEPLRFPD--GFDRDAKD 222 (312)
T ss_pred cccccCCcccCCHHHHcCCCCCCc-cceechhHHHHHHHhCCCCcCCCCHHHHHHH----HHcCCCCCCC--cCCHHHHH
Confidence 344679999999999988777554 8999999999999999999987554433333 2233344444 68899999
Q ss_pred HHHHhcccCCCCCC---CHhHHhcCcccccc
Q 024809 160 LLSRIFVANSEKRI---TIPEIKNHPWFLRN 187 (262)
Q Consensus 160 li~~~L~~dp~~R~---s~~e~l~hp~~~~~ 187 (262)
||.+||..||.+|| ++.+++.||||.+.
T Consensus 223 li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 223 LLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred HHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 99999999999997 57999999999753
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=275.62 Aligned_cols=175 Identities=38% Similarity=0.696 Sum_probs=148.9
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||++||+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.... ..
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~--~~kl~Dfg~~~~~~~--~~ 155 (291)
T cd05612 80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG--HIKLTDFGFAKKLRD--RT 155 (291)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC--CEEEEecCcchhccC--Cc
Confidence 79999999999999888999999999999999999999999999999999999998776 899999999875432 23
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 160 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 160 (262)
....||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+......+..+. .....+|. ..++.+++|
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~----~~~~~~~~--~~~~~~~~l 228 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHN-KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL----AGKLEFPR--HLDLYAKDL 228 (291)
T ss_pred ccccCChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----hCCcCCCc--cCCHHHHHH
Confidence 346799999999999877765 44899999999999999999998765544333332 22334444 468899999
Q ss_pred HHHhcccCCCCCCC-----HhHHhcCccccc
Q 024809 161 LSRIFVANSEKRIT-----IPEIKNHPWFLR 186 (262)
Q Consensus 161 i~~~L~~dp~~R~s-----~~e~l~hp~~~~ 186 (262)
|++||+.||.+|++ +.+++.||||..
T Consensus 229 i~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 229 IKKLLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred HHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence 99999999999995 999999999964
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=282.50 Aligned_cols=181 Identities=33% Similarity=0.572 Sum_probs=148.1
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
||||+||+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~--~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKG--HVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC--CEEEeeccCcccccccccc
Confidence 79999999999999888999999999999999999999999999999999999998776 89999999987432110
Q ss_pred ----------------------------------CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCC
Q 024809 79 ----------------------------------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPF 124 (262)
Q Consensus 79 ----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 124 (262)
.....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~-~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCc-hhhhhhHHHHHHHHhCCCCC
Confidence 0123579999999999988777654 89999999999999999999
Q ss_pred CCCCChhHHHHHhcccccccccCCCcccCCHHHHHHHHHhcccCCC---CCCCHhHHhcCcccccc
Q 024809 125 EDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSE---KRITIPEIKNHPWFLRN 187 (262)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~---~R~s~~e~l~hp~~~~~ 187 (262)
.+......+.++... .....+|....+++++++||.+|+. +|. .||+++++++||||...
T Consensus 237 ~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 237 CSETPQETYKKVMNW--KETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred CCCCHHHHHHHHHcC--cCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence 876655544443321 1233456556789999999999775 444 46899999999999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=279.64 Aligned_cols=178 Identities=35% Similarity=0.619 Sum_probs=150.0
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-CC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (262)
||||+||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++..... ..
T Consensus 75 ~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~--~~kL~DfG~~~~~~~~~~~ 152 (320)
T cd05590 75 MEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEG--HCKLADFGMCKEGIFNGKT 152 (320)
T ss_pred EcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC--cEEEeeCCCCeecCcCCCc
Confidence 79999999999999888999999999999999999999999999999999999998777 8999999998753222 22
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....||+.|+|||++.+..++.. +||||+||++|+|++|+.||...+....+..+ ......+|. .++.++++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i----~~~~~~~~~--~~~~~~~~ 225 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPS-VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI----LNDEVVYPT--WLSQDAVD 225 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCc-cchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH----hcCCCCCCC--CCCHHHHH
Confidence 344679999999999987776544 89999999999999999999876654433333 223333444 57899999
Q ss_pred HHHHhcccCCCCCCCH------hHHhcCcccccc
Q 024809 160 LLSRIFVANSEKRITI------PEIKNHPWFLRN 187 (262)
Q Consensus 160 li~~~L~~dp~~R~s~------~e~l~hp~~~~~ 187 (262)
||++||+.||.+|+++ ++++.||||...
T Consensus 226 li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 226 ILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred HHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence 9999999999999998 899999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=292.08 Aligned_cols=177 Identities=38% Similarity=0.678 Sum_probs=155.1
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCC-CCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV-LHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~-~~~~ 79 (262)
|||+.||| ..++...+.|++..++.|+..|+.||.|||++|||+||||.+|||++..| ++||+|||+++..- ....
T Consensus 448 mey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eG--h~kiADFGlcKe~m~~g~~ 524 (694)
T KOG0694|consen 448 MEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEG--HVKIADFGLCKEGMGQGDR 524 (694)
T ss_pred EEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccC--cEEecccccccccCCCCCc
Confidence 89999999 44555666899999999999999999999999999999999999998877 99999999998654 4455
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
..+++|||.|||||++.+..|+ .++|+|||||+||+||.|+.||.+.+..+.+.. |....+.+|. .+|.++.+
T Consensus 525 TsTfCGTpey~aPEil~e~~Yt-~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fds----I~~d~~~yP~--~ls~ea~~ 597 (694)
T KOG0694|consen 525 TSTFCGTPEFLAPEVLTEQSYT-RAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDS----IVNDEVRYPR--FLSKEAIA 597 (694)
T ss_pred cccccCChhhcChhhhccCccc-chhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HhcCCCCCCC--cccHHHHH
Confidence 6789999999999999998886 458999999999999999999999877666655 4455667777 58999999
Q ss_pred HHHHhcccCCCCCCC-----HhHHhcCcccccc
Q 024809 160 LLSRIFVANSEKRIT-----IPEIKNHPWFLRN 187 (262)
Q Consensus 160 li~~~L~~dp~~R~s-----~~e~l~hp~~~~~ 187 (262)
+++++|.++|++|.. +.+|..||||+.-
T Consensus 598 il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 598 IMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred HHHHHhccCcccccCCCCCCchhhhhCCccccC
Confidence 999999999999985 5789999999754
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=280.08 Aligned_cols=177 Identities=40% Similarity=0.704 Sum_probs=149.0
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC-CCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (262)
|||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.... ...
T Consensus 74 ~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~--~~kL~DfG~~~~~~~~~~~ 151 (328)
T cd05593 74 MEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDG--HIKITDFGLCKEGITDAAT 151 (328)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCC--cEEEecCcCCccCCCcccc
Confidence 79999999999998888899999999999999999999999999999999999998776 899999999875322 222
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....||+.|+|||++.+..+.. ++|||||||++|+|++|+.||...+....... +......+|. .+++++.+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslGvil~elltG~~Pf~~~~~~~~~~~----~~~~~~~~p~--~~~~~~~~ 224 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGR-AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL----ILMEDIKFPR--TLSADAKS 224 (328)
T ss_pred cccccCCcCccChhhhcCCCCCc-cCCccccchHHHHHhhCCCCCCCCCHHHHHHH----hccCCccCCC--CCCHHHHH
Confidence 33467999999999998777654 48999999999999999999987554333222 2223334444 68899999
Q ss_pred HHHHhcccCCCCCC-----CHhHHhcCccccc
Q 024809 160 LLSRIFVANSEKRI-----TIPEIKNHPWFLR 186 (262)
Q Consensus 160 li~~~L~~dp~~R~-----s~~e~l~hp~~~~ 186 (262)
||.+||+.||.+|+ ++.++++||||..
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 225 LLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred HHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 99999999999997 8999999999965
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=268.77 Aligned_cols=184 Identities=25% Similarity=0.383 Sum_probs=152.3
Q ss_pred CCCCCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC
Q 024809 1 MEYAAGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~----~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (262)
|||++- +|.+++.... .++...++.+++||+.||+|||++||+||||||.||||+.++ .+||+|||+|+....
T Consensus 96 fe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G--~lKlaDFGlAra~~i 172 (323)
T KOG0594|consen 96 FEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSG--VLKLADFGLARAFSI 172 (323)
T ss_pred EEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCC--cEeeeccchHHHhcC
Confidence 578875 9999997654 588899999999999999999999999999999999999876 899999999996653
Q ss_pred CC-CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc------------
Q 024809 77 HS-QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV------------ 143 (262)
Q Consensus 77 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------------ 143 (262)
.. .....++|.+|+|||++.+...+...+||||+|||++||++++..|.+..+.+++..++......
T Consensus 173 p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~ 252 (323)
T KOG0594|consen 173 PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLP 252 (323)
T ss_pred CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccc
Confidence 33 34567899999999999887555555899999999999999999999998888877776544321
Q ss_pred --cccCCCcc----------cCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 144 --HYSFPDYV----------RVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 144 --~~~~~~~~----------~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
...++.+. ..+++..+++.+||+++|.+|+|++.+|.||||...
T Consensus 253 ~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 253 DYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred cccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 11122221 233588999999999999999999999999999754
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=274.33 Aligned_cols=176 Identities=39% Similarity=0.738 Sum_probs=161.1
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||..||+|.+||..++.|+|.+++++++||+.|+.|||+++++|||||.+|||++.++ ++||+|||++..+......
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~--NiKIADFGLSNly~~~kfL 209 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNN--NIKIADFGLSNLYADKKFL 209 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCC--CeeeeccchhhhhccccHH
Confidence 89999999999999999999999999999999999999999999999999999999888 8999999999877666667
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 160 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 160 (262)
.+++|+|.|.+||++.+..|.++.+|.|||||+||.|+.|..||.+.+. ..++.+|..+.|..|. .++++.-|
T Consensus 210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh----k~lvrQIs~GaYrEP~---~PSdA~gL 282 (668)
T KOG0611|consen 210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH----KRLVRQISRGAYREPE---TPSDASGL 282 (668)
T ss_pred HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH----HHHHHHhhcccccCCC---CCchHHHH
Confidence 8899999999999999999999999999999999999999999998664 4445556666666665 56789999
Q ss_pred HHHhcccCCCCCCCHhHHhcCcccc
Q 024809 161 LSRIFVANSEKRITIPEIKNHPWFL 185 (262)
Q Consensus 161 i~~~L~~dp~~R~s~~e~l~hp~~~ 185 (262)
|+.||..||.+|.|+.++..|=|+.
T Consensus 283 IRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 283 IRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred HHHHHhcCcccchhHHHHhhhheee
Confidence 9999999999999999999998874
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=279.30 Aligned_cols=175 Identities=38% Similarity=0.689 Sum_probs=149.1
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++... ...
T Consensus 97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~--~~kl~Dfg~~~~~~--~~~ 172 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKG--HVKVTDFGFAKKVP--DRT 172 (329)
T ss_pred EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCC--CEEEeeccCceEcC--CCc
Confidence 79999999999999988999999999999999999999999999999999999998777 89999999997543 223
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 160 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 160 (262)
....||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+......+.. +......+|. .++..+++|
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~----i~~~~~~~p~--~~~~~~~~l 245 (329)
T PTZ00263 173 FTLCGTPEYLAPEVIQSKGHG-KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEK----ILAGRLKFPN--WFDGRARDL 245 (329)
T ss_pred ceecCChhhcCHHHHcCCCCC-CcceeechHHHHHHHHcCCCCCCCCCHHHHHHH----HhcCCcCCCC--CCCHHHHHH
Confidence 346799999999999887765 448999999999999999999987554333333 2233344454 478899999
Q ss_pred HHHhcccCCCCCCC-----HhHHhcCccccc
Q 024809 161 LSRIFVANSEKRIT-----IPEIKNHPWFLR 186 (262)
Q Consensus 161 i~~~L~~dp~~R~s-----~~e~l~hp~~~~ 186 (262)
|.+||+.||.+|++ +++++.||||..
T Consensus 246 i~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 246 VKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 99999999999997 799999999975
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=275.60 Aligned_cols=177 Identities=36% Similarity=0.656 Sum_probs=150.0
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-CC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (262)
|||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..... ..
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~--~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 80 MEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENMWDGVT 157 (323)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCC--cEEEccCCCceecCCCCCc
Confidence 79999999999999888899999999999999999999999999999999999998877 8999999998753322 22
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....||+.|+|||++.+..++.+ +||||+||++|+|++|+.||.+......+..+ ......+|. .++.++++
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i----~~~~~~~p~--~~s~~~~~ 230 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI----MEHNVAYPK--SMSKEAVA 230 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCc-cchhchhHHHHHHHhCCCCCCCCCHHHHHHHH----HhCCCCCCC--cCCHHHHH
Confidence 345679999999999988777644 89999999999999999999876554433332 233344454 68899999
Q ss_pred HHHHhcccCCCCCCCH-----hHHhcCccccc
Q 024809 160 LLSRIFVANSEKRITI-----PEIKNHPWFLR 186 (262)
Q Consensus 160 li~~~L~~dp~~R~s~-----~e~l~hp~~~~ 186 (262)
++.+||+.+|.+|+++ .++++||||+.
T Consensus 231 li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 231 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred HHHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 9999999999999984 89999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=275.43 Aligned_cols=178 Identities=37% Similarity=0.678 Sum_probs=149.6
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-CC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (262)
|||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..... ..
T Consensus 74 ~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~Dfg~~~~~~~~~~~ 151 (323)
T cd05595 74 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGAT 151 (323)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCC--CEEecccHHhccccCCCCc
Confidence 79999999999998888899999999999999999999999999999999999998776 8999999998753222 22
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....||+.|+|||++.+..++. ++|||||||++|+|++|+.||...+......... .....+|. .+++++++
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~----~~~~~~p~--~~~~~~~~ 224 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGR-AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL----MEEIRFPR--TLSPEAKS 224 (323)
T ss_pred cccccCCcCcCCcccccCCCCCc-hhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh----cCCCCCCC--CCCHHHHH
Confidence 33467999999999998777754 4899999999999999999998765443333322 22334444 68899999
Q ss_pred HHHHhcccCCCCCC-----CHhHHhcCcccccc
Q 024809 160 LLSRIFVANSEKRI-----TIPEIKNHPWFLRN 187 (262)
Q Consensus 160 li~~~L~~dp~~R~-----s~~e~l~hp~~~~~ 187 (262)
||.+||..||.+|+ ++.++++||||...
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 225 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred HHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 99999999999998 89999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=276.25 Aligned_cols=177 Identities=34% Similarity=0.670 Sum_probs=149.4
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC-CCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (262)
||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.... ...
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~--~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 80 MEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEG--HIKIADFGMCKENIFGGKT 157 (324)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCC--CEEEeecCcceecCCCCCc
Confidence 79999999999999888899999999999999999999999999999999999998776 899999999874322 222
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....||+.|+|||++.+..++.+ +||||+||++|+|++|+.||.+......+..+ ......+|. .++.++.+
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~pf~~~~~~~~~~~i----~~~~~~~~~--~~~~~~~~ 230 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI----MEHNVSYPK--SLSKEAVS 230 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH----HcCCCCCCC--CCCHHHHH
Confidence 334679999999999988776544 89999999999999999999876554443333 223334444 58899999
Q ss_pred HHHHhcccCCCCCCCH-----hHHhcCccccc
Q 024809 160 LLSRIFVANSEKRITI-----PEIKNHPWFLR 186 (262)
Q Consensus 160 li~~~L~~dp~~R~s~-----~e~l~hp~~~~ 186 (262)
++.+||..+|.+|+++ +++++||||..
T Consensus 231 li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 231 ICKGLLTKHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred HHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 9999999999999986 89999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=277.51 Aligned_cols=181 Identities=29% Similarity=0.564 Sum_probs=147.0
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC-CCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (262)
||||+||+|.+++...+++++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++.... ...
T Consensus 75 ~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~--~~kL~Dfg~~~~~~~~~~~ 152 (329)
T cd05588 75 IEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEG--HIKLTDYGMCKEGIRPGDT 152 (329)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC--CEEECcCccccccccCCCc
Confidence 79999999999998888999999999999999999999999999999999999998776 899999999874322 223
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChh-----HHHHHhcccccccccCCCcccCC
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPK-----NFRKTIGRILSVHYSFPDYVRVS 154 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 154 (262)
.....||+.|+|||++.+..++.+ +|+||+||++|+|++|+.||....... ........+.......|. .++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~~ 229 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR--SLS 229 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCc-cceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCC--CCC
Confidence 345679999999999988777644 899999999999999999996422111 011111222233334444 578
Q ss_pred HHHHHHHHHhcccCCCCCCC------HhHHhcCccccc
Q 024809 155 LECKHLLSRIFVANSEKRIT------IPEIKNHPWFLR 186 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s------~~e~l~hp~~~~ 186 (262)
.++.++|.+||+.||.+|+| ++++++||||..
T Consensus 230 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 230 VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 99999999999999999997 789999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=279.35 Aligned_cols=175 Identities=35% Similarity=0.628 Sum_probs=149.5
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++... ...
T Consensus 110 ~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~--~ikL~DFG~a~~~~--~~~ 185 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG--FIKMTDFGFAKVVD--TRT 185 (340)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC--CEEEecCCCCeecC--CCc
Confidence 79999999999999988999999999999999999999999999999999999998766 89999999997543 223
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 160 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 160 (262)
....||+.|+|||++.+..+. .++||||+||++|+|++|..||...+....+..+. .....+|. .++++++++
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~----~~~~~~p~--~~~~~~~~l 258 (340)
T PTZ00426 186 YTLCGTPEYIAPEILLNVGHG-KAADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL----EGIIYFPK--FLDNNCKHL 258 (340)
T ss_pred ceecCChhhcCHHHHhCCCCC-ccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHh----cCCCCCCC--CCCHHHHHH
Confidence 456799999999999877665 44899999999999999999998765544344333 22333444 578899999
Q ss_pred HHHhcccCCCCCC-----CHhHHhcCccccc
Q 024809 161 LSRIFVANSEKRI-----TIPEIKNHPWFLR 186 (262)
Q Consensus 161 i~~~L~~dp~~R~-----s~~e~l~hp~~~~ 186 (262)
|++||+.+|.+|+ |++++++||||..
T Consensus 259 i~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred HHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 9999999999995 8999999999975
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=275.53 Aligned_cols=178 Identities=36% Similarity=0.679 Sum_probs=148.3
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC-CCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (262)
||||.||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++ .++|+|||+++.... ...
T Consensus 75 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~ 152 (316)
T cd05620 75 MEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG--HIKIADFGMCKENVFGDNR 152 (316)
T ss_pred ECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC--CEEeCccCCCeecccCCCc
Confidence 79999999999999888899999999999999999999999999999999999998777 899999999874322 122
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....||+.|+|||++.+..++.+ +||||+||++|+|++|+.||...+....+.. +......+|. .++.++++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~el~~g~~Pf~~~~~~~~~~~----~~~~~~~~~~--~~~~~~~~ 225 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFS-VDWWSFGVLLYEMLIGQSPFHGDDEDELFES----IRVDTPHYPR--WITKESKD 225 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCCCCCC--CCCHHHHH
Confidence 345679999999999988777544 8999999999999999999987654333322 2222233444 47889999
Q ss_pred HHHHhcccCCCCCCCH-hHHhcCcccccc
Q 024809 160 LLSRIFVANSEKRITI-PEIKNHPWFLRN 187 (262)
Q Consensus 160 li~~~L~~dp~~R~s~-~e~l~hp~~~~~ 187 (262)
||.+||..||.+|+++ .++++||||...
T Consensus 226 li~~~l~~dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 226 ILEKLFERDPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred HHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence 9999999999999998 588999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=287.10 Aligned_cols=185 Identities=25% Similarity=0.386 Sum_probs=146.6
Q ss_pred CCCCCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC
Q 024809 1 MEYAAGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~----~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (262)
||||+| +|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ +.+||+|||+|+....
T Consensus 146 mE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~-~~vkL~DFGla~~~~~ 223 (440)
T PTZ00036 146 MEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNT-HTLKLCDFGSAKNLLA 223 (440)
T ss_pred EecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCC-CceeeeccccchhccC
Confidence 789986 7777664 345799999999999999999999999999999999999997543 2699999999986654
Q ss_pred CCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc-------------
Q 024809 77 HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV------------- 143 (262)
Q Consensus 77 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------------- 143 (262)
........||+.|+|||++.+....+.++||||+||++|+|++|..||.+....+.+.+++......
T Consensus 224 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~ 303 (440)
T PTZ00036 224 GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYA 303 (440)
T ss_pred CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhh
Confidence 4444567899999999998765444555899999999999999999999876665555443322110
Q ss_pred cccCCCc----------ccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 144 HYSFPDY----------VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 144 ~~~~~~~----------~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
...+|.. ...++++++||.+||+++|.+|||+.++|+||||...
T Consensus 304 ~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 304 DIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred cccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 0111110 1367899999999999999999999999999999753
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=279.82 Aligned_cols=180 Identities=35% Similarity=0.615 Sum_probs=148.9
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-CC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (262)
|||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||+++..... ..
T Consensus 75 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~--~~kl~Dfg~a~~~~~~~~~ 152 (330)
T cd05586 75 TDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATG--HIALCDFGLSKANLTDNKT 152 (330)
T ss_pred EcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC--CEEEecCCcCcCCCCCCCC
Confidence 79999999999999888999999999999999999999999999999999999998777 8999999998753222 23
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
....+||+.|+|||++.+....+.++||||+||++|+|++|+.||........+.. +......++. ..+++++++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~----i~~~~~~~~~-~~~~~~~~~ 227 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRN----IAFGKVRFPK-NVLSDEGRQ 227 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHH----HHcCCCCCCC-ccCCHHHHH
Confidence 34567999999999987654344558999999999999999999987554333322 2222333443 247899999
Q ss_pred HHHHhcccCCCCCC----CHhHHhcCcccccc
Q 024809 160 LLSRIFVANSEKRI----TIPEIKNHPWFLRN 187 (262)
Q Consensus 160 li~~~L~~dp~~R~----s~~e~l~hp~~~~~ 187 (262)
||++||..||.+|| ++.++++||||...
T Consensus 228 li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 228 FVKGLLNRNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred HHHHHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence 99999999999998 78999999999753
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=273.79 Aligned_cols=178 Identities=35% Similarity=0.604 Sum_probs=150.0
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-CC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (262)
|||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..... ..
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~ 156 (323)
T cd05584 79 LEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG--HVKLTDFGLCKESIHEGTV 156 (323)
T ss_pred EeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC--CEEEeeCcCCeecccCCCc
Confidence 79999999999999888899999999999999999999999999999999999998776 8999999998743222 22
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....||+.|+|||++.+..+. .++|||||||++|+|++|+.||...........+ ......+|. .+++++++
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~----~~~~~~~~~--~~~~~~~~ 229 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHG-KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI----LKGKLNLPP--YLTPEARD 229 (323)
T ss_pred ccccCCCccccChhhccCCCCC-CcceecccHHHHHHHhcCCCCCCCCCHHHHHHHH----HcCCCCCCC--CCCHHHHH
Confidence 3345799999999999877665 4489999999999999999999876554433333 223334443 57899999
Q ss_pred HHHHhcccCCCCCC-----CHhHHhcCcccccc
Q 024809 160 LLSRIFVANSEKRI-----TIPEIKNHPWFLRN 187 (262)
Q Consensus 160 li~~~L~~dp~~R~-----s~~e~l~hp~~~~~ 187 (262)
||.+||+.+|.+|| ++.++++||||...
T Consensus 230 li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 230 LLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred HHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 99999999999999 89999999999753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=279.91 Aligned_cols=181 Identities=38% Similarity=0.674 Sum_probs=149.4
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||+++......
T Consensus 80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKG--HIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC--CEEEeecccceeccccccc
Confidence 79999999999999888899999999999999999999999999999999999998777 89999999986432111
Q ss_pred -------------------------------------CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCC
Q 024809 79 -------------------------------------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGA 121 (262)
Q Consensus 79 -------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~ 121 (262)
.....+||+.|+|||++.+..++.+ +|||||||++|+|++|.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~~G~ 236 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE-CDWWSLGVIMYEMLVGY 236 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCe-eeeecchhHHHHhhcCC
Confidence 0112469999999999988777644 89999999999999999
Q ss_pred CCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHHHHHhcccCCCCCCC---HhHHhcCcccccc
Q 024809 122 YPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRIT---IPEIKNHPWFLRN 187 (262)
Q Consensus 122 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s---~~e~l~hp~~~~~ 187 (262)
.||...........+... .....+|....+++++++||.+||. +|.+|++ +.+++.||||+..
T Consensus 237 ~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 237 PPFCSDNPQETYRKIINW--KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCCCCHHHHHHHHHcC--CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 999876654443333221 1223445555689999999999996 9999998 9999999999753
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=275.47 Aligned_cols=177 Identities=35% Similarity=0.633 Sum_probs=149.9
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-CC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (262)
||||+||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..... ..
T Consensus 75 ~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~--~~kL~Dfg~~~~~~~~~~~ 152 (321)
T cd05591 75 MEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG--HCKLADFGMCKEGILNGVT 152 (321)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC--CEEEeecccceecccCCcc
Confidence 79999999999999888899999999999999999999999999999999999998777 8999999998753222 22
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....||+.|+|||++.+..++.+ +||||+||++|+|++|+.||........+..+ ......+|. .++.++.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i----~~~~~~~p~--~~~~~~~~ 225 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPS-VDWWALGVLMYEMMAGQPPFEADNEDDLFESI----LHDDVLYPV--WLSKEAVS 225 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCc-cceechhHHHHHHhcCCCCCCCCCHHHHHHHH----HcCCCCCCC--CCCHHHHH
Confidence 344679999999999987777554 89999999999999999999876654444333 223333444 47899999
Q ss_pred HHHHhcccCCCCCC-------CHhHHhcCccccc
Q 024809 160 LLSRIFVANSEKRI-------TIPEIKNHPWFLR 186 (262)
Q Consensus 160 li~~~L~~dp~~R~-------s~~e~l~hp~~~~ 186 (262)
+|.+||+.+|.+|+ ++.++++||||..
T Consensus 226 ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 226 ILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred HHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 99999999999999 8999999999965
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=276.15 Aligned_cols=181 Identities=29% Similarity=0.573 Sum_probs=147.1
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC-CCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (262)
||||+||+|..++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++.... ...
T Consensus 75 ~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~--~~kL~DfG~~~~~~~~~~~ 152 (329)
T cd05618 75 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG--HIKLTDYGMCKEGLRPGDT 152 (329)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC--CEEEeeCCccccccCCCCc
Confidence 79999999999998888899999999999999999999999999999999999998777 899999999875322 222
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCC-----hhHHHHHhcccccccccCCCcccCC
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPED-----PKNFRKTIGRILSVHYSFPDYVRVS 154 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (262)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||..... ..........+......+|. .++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~~ 229 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLS 229 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCc-cceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCC--CCC
Confidence 345679999999999988777544 8999999999999999999953211 11111112222333344554 678
Q ss_pred HHHHHHHHHhcccCCCCCCC------HhHHhcCccccc
Q 024809 155 LECKHLLSRIFVANSEKRIT------IPEIKNHPWFLR 186 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s------~~e~l~hp~~~~ 186 (262)
.+++++|.+||+.||.+|+| +.++++||||..
T Consensus 230 ~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 230 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred HHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 99999999999999999998 479999999965
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=276.11 Aligned_cols=179 Identities=37% Similarity=0.601 Sum_probs=149.6
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.... ..
T Consensus 80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kL~Dfg~a~~~~~--~~ 155 (333)
T cd05600 80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASG--HIKLTDFGLSKGIVT--YA 155 (333)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC--CEEEEeCcCCccccc--cc
Confidence 79999999999999888899999999999999999999999999999999999998776 899999999975432 34
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCc----ccCCHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDY----VRVSLE 156 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~ 156 (262)
....||+.|+|||++.+..++.+ +|||||||++|+|++|..||......+.+..+..... ....|.. ..++.+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~s~~ 232 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYDFT-VDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE--TLQRPVYDDPRFNLSDE 232 (333)
T ss_pred CCcccCccccChhHhcCCCCCCc-cceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc--cccCCCCCccccccCHH
Confidence 45679999999999988776544 8999999999999999999987655444333322111 1111211 257899
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
+.+||.+||..+|.+||++.+++.||||..
T Consensus 233 ~~~li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 233 AWDLITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred HHHHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=278.54 Aligned_cols=178 Identities=40% Similarity=0.679 Sum_probs=149.0
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC-CC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~-~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~ 78 (262)
|||++||+|..++...+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.... ..
T Consensus 74 ~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~--~~kL~Dfg~~~~~~~~~~ 151 (325)
T cd05594 74 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG--HIKITDFGLCKEGIKDGA 151 (325)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC--CEEEecCCCCeecCCCCc
Confidence 7999999999999888889999999999999999999997 7999999999999998777 899999999874322 22
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 158 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (262)
......||+.|+|||++.+..++. ++|||||||++|+|++|+.||.+.......... ......+|. .+++++.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i----~~~~~~~p~--~~~~~~~ 224 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGR-AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI----LMEEIRFPR--TLSPEAK 224 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCC-ccccccccceeeeeccCCCCCCCCCHHHHHHHH----hcCCCCCCC--CCCHHHH
Confidence 233467999999999998777654 489999999999999999999876543333322 222334444 5889999
Q ss_pred HHHHHhcccCCCCCC-----CHhHHhcCcccccc
Q 024809 159 HLLSRIFVANSEKRI-----TIPEIKNHPWFLRN 187 (262)
Q Consensus 159 ~li~~~L~~dp~~R~-----s~~e~l~hp~~~~~ 187 (262)
+||.+||+.||.+|+ ++.++++||||...
T Consensus 225 ~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 225 SLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred HHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 999999999999997 89999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=277.86 Aligned_cols=180 Identities=38% Similarity=0.642 Sum_probs=151.9
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
|||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~--~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADG--HIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC--CEEeecCCCCccCcccCcc
Confidence 79999999999999888899999999999999999999999999999999999998777 89999999987544322
Q ss_pred ----------------------------CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh
Q 024809 79 ----------------------------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP 130 (262)
Q Consensus 79 ----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 130 (262)
......||+.|+|||++.+..++.. +|||||||++|+|++|+.||......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCc-eeeEecchhhhhhccCCCCCCCCCHH
Confidence 2234579999999999988776544 89999999999999999999887654
Q ss_pred hHHHHHhcccccccccCCCcccCCHHHHHHHHHhcccCCCCCCC-HhHHhcCccccc
Q 024809 131 KNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRIT-IPEIKNHPWFLR 186 (262)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-~~e~l~hp~~~~ 186 (262)
....++.... ....+|....+++++++||.+||. +|.+|++ ++++++||||..
T Consensus 237 ~~~~~i~~~~--~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 237 ETYNKIINWK--ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred HHHHHHhccC--CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 4444433311 233455555689999999999997 9999999 999999999974
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=286.37 Aligned_cols=185 Identities=24% Similarity=0.382 Sum_probs=142.4
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCC--------------CcEEE
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSTA--------------PRVKI 65 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~-~~ivHrDlkp~Nili~~~~~--------------~~~kl 65 (262)
||++ ||+|.+++.+.+.+++..++.++.||+.||.|||+ .|||||||||+|||++.++. ..+||
T Consensus 211 ~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl 289 (467)
T PTZ00284 211 MPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRI 289 (467)
T ss_pred Eecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEE
Confidence 4566 77999999988889999999999999999999998 59999999999999976542 14899
Q ss_pred eccCCCcCCCCCCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccc-
Q 024809 66 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH- 144 (262)
Q Consensus 66 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~- 144 (262)
+|||.+.... ......+||+.|+|||++.+..+... +|||||||++|+|++|+.||.+....+.+..+........
T Consensus 290 ~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~ 366 (467)
T PTZ00284 290 CDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYS-TDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPS 366 (467)
T ss_pred CCCCccccCc--cccccccCCccccCcHHhhcCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH
Confidence 9999876322 23345689999999999988777654 8999999999999999999987665443322211110000
Q ss_pred ----------------------cc-CC------------CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCC
Q 024809 145 ----------------------YS-FP------------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLP 189 (262)
Q Consensus 145 ----------------------~~-~~------------~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 189 (262)
.. .+ .....++.+.+||.+||++||.+|||++|+|+||||.+..+
T Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~~ 446 (467)
T PTZ00284 367 EWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYP 446 (467)
T ss_pred HHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccccCC
Confidence 00 00 00012456789999999999999999999999999987544
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=268.79 Aligned_cols=181 Identities=28% Similarity=0.482 Sum_probs=143.3
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (262)
|||+.| +|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~--~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKG--ELKLADFGLARAKSVPTK 158 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC--CEEECcCcceeeccCCCc
Confidence 789985 9999987654 589999999999999999999999999999999999998776 89999999987543222
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc---------------
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV--------------- 143 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------------- 143 (262)
......|++.|+|||++.+....+.++||||+||++|+|++|+.||.+....+.+..+.......
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 22345789999999998764444555999999999999999999998766544443332211100
Q ss_pred cccCCC---------cccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 144 HYSFPD---------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 144 ~~~~~~---------~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
...+|. ...++.++++||++||++||.+|||++|+++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 001111 12467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=272.83 Aligned_cols=177 Identities=40% Similarity=0.735 Sum_probs=148.3
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-CC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (262)
|||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++..... ..
T Consensus 75 ~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~--~~kL~Dfg~a~~~~~~~~~ 152 (316)
T cd05592 75 MEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG--HIKIADFGMCKENMNGEGK 152 (316)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCC--CEEEccCcCCeECCCCCCc
Confidence 79999999999999888999999999999999999999999999999999999998776 8999999999754322 22
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....||+.|+|||++.+..++.+ +||||+||++|+|++|+.||.+.+....+..+ ......+|. .++.++.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i----~~~~~~~~~--~~~~~~~~ 225 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNES-VDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI----LNDRPHFPR--WISKEAKD 225 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCc-ccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH----HcCCCCCCC--CCCHHHHH
Confidence 344679999999999987776544 89999999999999999999876554433332 222233343 57889999
Q ss_pred HHHHhcccCCCCCCCHh-HHhcCccccc
Q 024809 160 LLSRIFVANSEKRITIP-EIKNHPWFLR 186 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~-e~l~hp~~~~ 186 (262)
||.+||..+|.+||++. +++.||||..
T Consensus 226 ll~~~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 226 CLSKLFERDPTKRLGVDGDIRQHPFFRG 253 (316)
T ss_pred HHHHHccCCHHHcCCChHHHHcCcccCC
Confidence 99999999999999875 8889999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=274.45 Aligned_cols=178 Identities=37% Similarity=0.637 Sum_probs=148.7
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-CC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (262)
|||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..... ..
T Consensus 75 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~--~~kl~Dfg~~~~~~~~~~~ 152 (323)
T cd05575 75 LDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQG--HVVLTDFGLCKEGIEHSKT 152 (323)
T ss_pred EcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC--cEEEeccCCCcccccCCCc
Confidence 79999999999999888899999999999999999999999999999999999998777 8999999998753222 22
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....||+.|+|||++.+..++. ++|||||||++|+|++|+.||...+..+.+..+.. .....+ ..++..+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~----~~~~~~--~~~~~~~~~ 225 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDR-TVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN----KPLRLK--PNISVSARH 225 (323)
T ss_pred cccccCChhhcChhhhcCCCCCc-cccccccchhhhhhhcCCCCCCCCCHHHHHHHHHc----CCCCCC--CCCCHHHHH
Confidence 33457999999999998777654 48999999999999999999987654443333322 222222 257899999
Q ss_pred HHHHhcccCCCCCCCH----hHHhcCcccccc
Q 024809 160 LLSRIFVANSEKRITI----PEIKNHPWFLRN 187 (262)
Q Consensus 160 li~~~L~~dp~~R~s~----~e~l~hp~~~~~ 187 (262)
+|.+||+.||.+||++ .++++||||...
T Consensus 226 li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 226 LLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred HHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence 9999999999999998 599999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=271.39 Aligned_cols=178 Identities=40% Similarity=0.714 Sum_probs=149.8
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-CC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (262)
|||++||+|..++.+.+++++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++..... ..
T Consensus 75 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~ 152 (318)
T cd05570 75 MEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEG--HIKIADFGMCKEGILGGVT 152 (318)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCC--cEEecccCCCeecCcCCCc
Confidence 79999999999999888899999999999999999999999999999999999998877 8999999998743222 22
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
....+||+.|+|||++.+..++.+ +||||+||++|+|++|+.||.+......+..+ ......+|. .++.++++
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i----~~~~~~~~~--~~~~~~~~ 225 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPA-VDWWALGVLLYEMLAGQSPFEGDDEDELFQSI----LEDEVRYPR--WLSKEAKS 225 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcc-hhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHH----HcCCCCCCC--cCCHHHHH
Confidence 334579999999999988777654 89999999999999999999876543333322 222333443 57899999
Q ss_pred HHHHhcccCCCCCCCH-----hHHhcCcccccc
Q 024809 160 LLSRIFVANSEKRITI-----PEIKNHPWFLRN 187 (262)
Q Consensus 160 li~~~L~~dp~~R~s~-----~e~l~hp~~~~~ 187 (262)
||++||..||.+|||+ .+++.||||...
T Consensus 226 li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 226 ILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred HHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 9999999999999999 999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=267.54 Aligned_cols=181 Identities=34% Similarity=0.540 Sum_probs=146.3
Q ss_pred CCCCCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC
Q 024809 1 MEYAAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (262)
|||++||+|..++.. +..+++..++.++.||+.||.|||++||+||||||+||+++.++ .++|+|||++.....
T Consensus 72 ~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~~l~dfg~~~~~~~ 149 (280)
T cd05608 72 MTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG--NVRISDLGLAVELKD 149 (280)
T ss_pred EeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEeeCccceecCC
Confidence 799999999988743 34699999999999999999999999999999999999998766 899999999875433
Q ss_pred CC-CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 77 HS-QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 77 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
.. ......||+.|+|||.+.+..++.+ +|+||+||++|+|++|+.||...............+......++. .++.
T Consensus 150 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 226 (280)
T cd05608 150 GQSKTKGYAGTPGFMAPELLQGEEYDFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPD--KFSP 226 (280)
T ss_pred CCccccccCCCcCccCHHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcc--cCCH
Confidence 22 2234579999999999988777644 899999999999999999998654332222222222222223333 5889
Q ss_pred HHHHHHHHhcccCCCCCC-----CHhHHhcCccccc
Q 024809 156 ECKHLLSRIFVANSEKRI-----TIPEIKNHPWFLR 186 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~-----s~~e~l~hp~~~~ 186 (262)
++++++.+||+.||.+|| +++++++||||+.
T Consensus 227 ~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 227 ASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred HHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence 999999999999999999 8899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=268.10 Aligned_cols=180 Identities=27% Similarity=0.394 Sum_probs=145.8
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||+. |+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 88 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~ 164 (290)
T cd07862 88 FEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADFGLARIYSFQM 164 (290)
T ss_pred EccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCC--CEEEccccceEeccCCc
Confidence 68997 5999998754 3589999999999999999999999999999999999998776 89999999997654443
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc-cccCC---------
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-HYSFP--------- 148 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~--------- 148 (262)
......||+.|+|||.+.+..++.+ +||||+||++|+|++|+.||.+....+.+..+....... ...++
T Consensus 165 ~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 243 (290)
T cd07862 165 ALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 243 (290)
T ss_pred ccccccccccccChHHHhCCCCCCc-cchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchh
Confidence 4445679999999999987776554 899999999999999999999877665555543321100 00000
Q ss_pred -----------CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 149 -----------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 149 -----------~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
....++..+++|+.+||+.||++|||+.++|+||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 244 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred ccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 012467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=266.25 Aligned_cols=181 Identities=26% Similarity=0.373 Sum_probs=142.4
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
|||++||.+..+......+++..++.++.|++.||.|||+.||+||||||+||+++.++ .+||+|||+++......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND--VLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC--cEEEeeccCcccccccccc
Confidence 79999987766655556799999999999999999999999999999999999998776 89999999997653222
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccc---------------c
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS---------------V 143 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------------~ 143 (262)
......||+.|+|||++.+..++. ++||||+||++|+|++|+.||.+....+....+...... .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~-~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGK-AVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred cccccccccccCCcHHHcCCCCCC-chhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 223457899999999998777654 489999999999999999999876544332222111000 0
Q ss_pred cccCCC-----------cccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 144 HYSFPD-----------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 144 ~~~~~~-----------~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
...++. ...++.++++||++||+.||.+|||++++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 001111 11367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=253.39 Aligned_cols=176 Identities=37% Similarity=0.680 Sum_probs=158.4
Q ss_pred CCCCCCCchHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~--~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
+||..+|+|+..+. ...+++|.....+++|++.||.|+|.++|+||||||+|+|++..+ .+|++|||.+.... ..
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~--~lkiAdfGwsV~~p-~~ 177 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAG--ELKIADFGWSVHAP-SN 177 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCC--CeeccCCCceeecC-CC
Confidence 69999999999999 667899999999999999999999999999999999999998777 89999999997654 56
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 158 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (262)
...+.+||..|.+||...+..++.. +|+|++|++.|+++.|..||......+ ..+++.+..+.+|. .++.+++
T Consensus 178 kR~tlcgt~dyl~pEmv~~~~hd~~-Vd~w~lgvl~yeflvg~ppFes~~~~e----tYkrI~k~~~~~p~--~is~~a~ 250 (281)
T KOG0580|consen 178 KRKTLCGTLDYLPPEMVEGRGHDKF-VDLWSLGVLCYEFLVGLPPFESQSHSE----TYKRIRKVDLKFPS--TISGGAA 250 (281)
T ss_pred CceeeecccccCCHhhcCCCCccch-hhHHHHHHHHHHHHhcCCchhhhhhHH----HHHHHHHccccCCc--ccChhHH
Confidence 6778999999999999999998866 899999999999999999999866444 44456666777785 7999999
Q ss_pred HHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 159 HLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 159 ~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
|+|.+||.++|.+|.+..|++.|||+..
T Consensus 251 dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 251 DLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHHHHHhccCccccccHHHHhhhHHHHh
Confidence 9999999999999999999999999864
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=274.26 Aligned_cols=181 Identities=30% Similarity=0.562 Sum_probs=146.8
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC-CCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (262)
||||+||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.... ...
T Consensus 75 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~--~~kl~Dfg~~~~~~~~~~~ 152 (327)
T cd05617 75 IEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADG--HIKLTDYGMCKEGLGPGDT 152 (327)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCC--CEEEeccccceeccCCCCc
Confidence 79999999999998888899999999999999999999999999999999999998777 899999999874322 223
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh---hHHHHHhcccccccccCCCcccCCHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP---KNFRKTIGRILSVHYSFPDYVRVSLE 156 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (262)
....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...... .........+......+|. .++..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~ 229 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFS-VDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR--FLSVK 229 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCch-heeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCC--CCCHH
Confidence 345679999999999987777544 89999999999999999999643211 1111112222222333444 57899
Q ss_pred HHHHHHHhcccCCCCCCCH------hHHhcCccccc
Q 024809 157 CKHLLSRIFVANSEKRITI------PEIKNHPWFLR 186 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~------~e~l~hp~~~~ 186 (262)
+.++|.+||+.||.+|+++ +++++||||..
T Consensus 230 ~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~ 265 (327)
T cd05617 230 ASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRS 265 (327)
T ss_pred HHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence 9999999999999999984 69999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=277.75 Aligned_cols=181 Identities=36% Similarity=0.617 Sum_probs=150.1
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
||||+||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 122 ~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~--~~kL~DfG~~~~~~~~~~~ 198 (370)
T cd05596 122 MEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMDANGMV 198 (370)
T ss_pred EcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCC--CEEEEeccceeeccCCCcc
Confidence 7999999999988764 699999999999999999999999999999999999998777 89999999987543222
Q ss_pred CCCccccCCCCCCcccccCCc---CCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
......||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||.+......+.++.... ....+|....++.
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~s~ 276 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHK--NSLTFPDDIEISK 276 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC--CcCCCCCcCCCCH
Confidence 223467999999999986532 23455899999999999999999998866554444443321 2344566667899
Q ss_pred HHHHHHHHhcccCCCC--CCCHhHHhcCccccc
Q 024809 156 ECKHLLSRIFVANSEK--RITIPEIKNHPWFLR 186 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~--R~s~~e~l~hp~~~~ 186 (262)
++++||.+||..+|.+ |+|+.++++||||+.
T Consensus 277 ~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 277 QAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred HHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 9999999999999998 999999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=276.22 Aligned_cols=181 Identities=34% Similarity=0.604 Sum_probs=149.3
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||++||+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++........
T Consensus 80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~--~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTG--HIKLADFGSAARLTANKM 157 (330)
T ss_pred ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCC--CEEeccCCCCeECCCCCc
Confidence 7999999999999876 6799999999999999999999999999999999999998776 899999999975433222
Q ss_pred --CCccccCCCCCCcccccC-----CcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCccc
Q 024809 80 --PKSTVGTPAYIAPEVLTK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR 152 (262)
Q Consensus 80 --~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (262)
.....||+.|+|||++.. ....+.++|||||||++|+|++|+.||........+..+.... ....+|....
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~ 235 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQ--RFLKFPEDPK 235 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCC--CccCCCCCCC
Confidence 223479999999999863 2223445899999999999999999998766655544443321 1234555567
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 153 VSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 153 ~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
+++++++||.+||. +|.+|||++++++||||..
T Consensus 236 ~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 236 VSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred CCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 89999999999998 9999999999999999975
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=277.99 Aligned_cols=181 Identities=35% Similarity=0.577 Sum_probs=146.7
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||+.||+||||||+|||++.++ ++||+|||+++......
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~--~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG--HIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCC--CEEEeeCcCCccccccccc
Confidence 79999999999999888899999999999999999999999999999999999998776 89999999975321000
Q ss_pred ----------------------------------------------CCCccccCCCCCCcccccCCcCCCCchhHHHHHH
Q 024809 79 ----------------------------------------------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGV 112 (262)
Q Consensus 79 ----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ 112 (262)
.....+||+.|+|||++.+..++.+ +|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlG~ 236 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL-CDWWSVGV 236 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCc-cceeehhh
Confidence 0123579999999999988777644 89999999
Q ss_pred HHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHHHHHhcc--cCCCCCCCHhHHhcCccccc
Q 024809 113 TLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFV--ANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 113 il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~--~dp~~R~s~~e~l~hp~~~~ 186 (262)
++|+|++|+.||...........+... .....+|....+++++++||.+|+. .+|..|+++.++++||||..
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQLKVINW--ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE 310 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHHHHHcc--ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence 999999999999876654443333221 1223455555789999999999654 45556999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=279.26 Aligned_cols=180 Identities=37% Similarity=0.620 Sum_probs=147.9
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC---
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH--- 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~--- 77 (262)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g--~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDG--HIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--CEEEeECCCCccccccccc
Confidence 79999999999998888899999999999999999999999999999999999998777 8999999997532100
Q ss_pred ---------------------------------------------CCCCccccCCCCCCcccccCCcCCCCchhHHHHHH
Q 024809 78 ---------------------------------------------SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGV 112 (262)
Q Consensus 78 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ 112 (262)
......+||+.|+|||++.+..++.. +|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlGv 236 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGV 236 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCe-eeEEechH
Confidence 00123469999999999988877654 89999999
Q ss_pred HHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHHHHHhcccCCCCCCC---HhHHhcCccccc
Q 024809 113 TLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRIT---IPEIKNHPWFLR 186 (262)
Q Consensus 113 il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s---~~e~l~hp~~~~ 186 (262)
++|+|++|+.||..........++... .....+|....+++++.++|.+|+ .+|.+|++ +.++++||||+.
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLETQMKVINW--QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcc--CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence 999999999999876654444333321 122344555678999999999986 59999997 999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=271.73 Aligned_cols=178 Identities=38% Similarity=0.702 Sum_probs=148.5
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-CC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (262)
|||++||+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++..... ..
T Consensus 75 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~ 152 (316)
T cd05619 75 MEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDG--HIKIADFGMCKENMLGDAK 152 (316)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC--CEEEccCCcceECCCCCCc
Confidence 79999999999999888899999999999999999999999999999999999998777 8999999998743222 22
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....||+.|+|||++.+..++.+ +||||+||++|+|++|+.||...+....+.. +......+|. .++.++++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~G~~pf~~~~~~~~~~~----i~~~~~~~~~--~~~~~~~~ 225 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTS-VDWWSFGVLLYEMLIGQSPFHGHDEEELFQS----IRMDNPCYPR--WLTREAKD 225 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCch-hhhhhHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCCCCCc--cCCHHHHH
Confidence 344679999999999987777554 8999999999999999999987654333322 2222233343 47889999
Q ss_pred HHHHhcccCCCCCCCHh-HHhcCcccccc
Q 024809 160 LLSRIFVANSEKRITIP-EIKNHPWFLRN 187 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~-e~l~hp~~~~~ 187 (262)
||.+||..+|.+||++. ++++||||...
T Consensus 226 li~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 226 ILVKLFVREPERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred HHHHHhccCHhhcCCChHHHHcCcccCCC
Confidence 99999999999999997 89999999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=279.02 Aligned_cols=180 Identities=35% Similarity=0.630 Sum_probs=147.1
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
||||+||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~--~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGG--HIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC--CEEEeeccccccccccccc
Confidence 79999999999999888899999999999999999999999999999999999998776 89999999986321100
Q ss_pred ----------------------------------------------CCCccccCCCCCCcccccCCcCCCCchhHHHHHH
Q 024809 79 ----------------------------------------------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGV 112 (262)
Q Consensus 79 ----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ 112 (262)
.....+||+.|+|||++.+..+.. ++||||+||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlGv 236 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ-ECDWWSLGA 236 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCC-ceeeEecch
Confidence 001246999999999998877754 489999999
Q ss_pred HHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHHHHHhcccCCCCC---CCHhHHhcCccccc
Q 024809 113 TLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKR---ITIPEIKNHPWFLR 186 (262)
Q Consensus 113 il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R---~s~~e~l~hp~~~~ 186 (262)
++|+|++|..||........+..+... .....+|....++.++++||.+||. +|.+| +|+.+++.||||..
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETYRKIINW--RETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHcc--CCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 999999999999876654444443321 1223455655789999999999998 77765 59999999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=270.01 Aligned_cols=178 Identities=34% Similarity=0.650 Sum_probs=149.2
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-C
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-Q 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (262)
|||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...... .
T Consensus 80 ~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~--~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 80 MEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEG--HIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC--CEEEeccccccccCCCCcc
Confidence 79999999999999888899999999999999999999999999999999999998776 89999999987533222 2
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....||+.|+|||++.+..++. ++||||+||++|+|++|+.||.+.........+ ......+|. .++.++++
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslGvil~elltG~~pf~~~~~~~~~~~i----~~~~~~~p~--~~~~~~~~ 230 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGK-SVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI----MEHNVSYPK--SLSKEAVS 230 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCC-ccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH----HhCCCCCCc--cCCHHHHH
Confidence 33457999999999998777654 489999999999999999999876544333332 223334444 57899999
Q ss_pred HHHHhcccCCCCCCC-----HhHHhcCcccccc
Q 024809 160 LLSRIFVANSEKRIT-----IPEIKNHPWFLRN 187 (262)
Q Consensus 160 li~~~L~~dp~~R~s-----~~e~l~hp~~~~~ 187 (262)
++.+||+.+|.+|++ .+++++||||...
T Consensus 231 li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 231 ICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred HHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 999999999999997 4789999999753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=277.91 Aligned_cols=181 Identities=35% Similarity=0.621 Sum_probs=148.9
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
||||+||+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.++ .++|+|||+++......
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~--~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKG--HVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC--CEEEeeccCCccccccccc
Confidence 79999999999999888899999999999999999999999999999999999998776 89999999986432110
Q ss_pred ----------------------------------CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCC
Q 024809 79 ----------------------------------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPF 124 (262)
Q Consensus 79 ----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 124 (262)
.....+||+.|+|||++.+..++.. +|||||||++|+|++|+.||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCc-ceeccccceeeecccCCCCC
Confidence 0123479999999999988777654 89999999999999999999
Q ss_pred CCCCChhHHHHHhcccccccccCCCcccCCHHHHHHHHHhcccCCCCCC---CHhHHhcCcccccc
Q 024809 125 EDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI---TIPEIKNHPWFLRN 187 (262)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~---s~~e~l~hp~~~~~ 187 (262)
........+.++... .....+|....++.++++||.+|+. +|.+|+ ++.++++||||...
T Consensus 237 ~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 237 CSETPQETYRKVMNW--KETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CCCCHHHHHHHHHcC--CCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence 876655444443321 1223455555689999999999875 999998 47999999999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=267.76 Aligned_cols=184 Identities=23% Similarity=0.410 Sum_probs=140.5
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-C
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-S 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~ 78 (262)
|||+. |+|.+++... +.+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++..... .
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~ 158 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTG--ELKLADFGLARAKSVPSH 158 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--CEEECCCCcceeccCCCc
Confidence 78996 5888887654 5699999999999999999999999999999999999998776 8999999998743222 2
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhH-HHHHhcccccc--------------
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKN-FRKTIGRILSV-------------- 143 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~-------------- 143 (262)
......||+.|+|||++.+......++||||+||++|+|++|..||.+..+... +..........
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 223467899999999987655445558999999999999999999987554322 21111110000
Q ss_pred ---ccc--CC-------CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 144 ---HYS--FP-------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 144 ---~~~--~~-------~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
.+. .+ .....++++++|+.+||+.||.+|||++++++||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 000 00 001245789999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=271.61 Aligned_cols=184 Identities=24% Similarity=0.400 Sum_probs=143.7
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC-
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ- 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~- 79 (262)
||||. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus 83 ~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~--~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 83 FELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADC--KLKICDFGLARVAFNDTPT 159 (338)
T ss_pred EecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC--cEEEccCccccccccccCc
Confidence 79995 69999999888899999999999999999999999999999999999998777 899999999975422211
Q ss_pred ---CCccccCCCCCCcccccC--CcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhc----------------
Q 024809 80 ---PKSTVGTPAYIAPEVLTK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG---------------- 138 (262)
Q Consensus 80 ---~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~---------------- 138 (262)
.....||+.|+|||++.+ ..+ +.++||||+||++|+|++|+.||.+......+..+..
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 238 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE 238 (338)
T ss_pred cccccCCCCCCCcCCHHHHhcccccc-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 134579999999999865 344 4458999999999999999999987554322211100
Q ss_pred -------cccccc-cc-CCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 024809 139 -------RILSVH-YS-FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL 188 (262)
Q Consensus 139 -------~~~~~~-~~-~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 188 (262)
.+.... .. .......++++.++|.+||..+|++|||++++++||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~ 297 (338)
T cd07859 239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA 297 (338)
T ss_pred hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence 000000 00 011235778899999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=275.80 Aligned_cols=180 Identities=32% Similarity=0.492 Sum_probs=157.2
Q ss_pred CCCCCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
||||+||+|.+.|...+ .|+|+.+..|+.|++.||.|||+++|+|||||+.|||++.++ .|+|+|||+|+......
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~--~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDK--KVKLGDFGLAKILNPED 160 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccC--ceeecchhhhhhcCCch
Confidence 79999999999997654 599999999999999999999999999999999999998877 78999999999877665
Q ss_pred -CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHH
Q 024809 79 -QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 157 (262)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (262)
...+.+||+.||.||++.+.+|..+ +|||||||++|||++-+.+|...+......++.... ..|-....+.++
T Consensus 161 ~~a~tvvGTp~YmcPEil~d~pYn~K-SDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-----~~Plp~~ys~el 234 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSDIPYNEK-SDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-----YSPLPSMYSSEL 234 (426)
T ss_pred hhhheecCCCcccCHHHhCCCCCCcc-CcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-----CCCCCccccHHH
Confidence 5667899999999999999998766 899999999999999999999876655555544333 123334789999
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 024809 158 KHLLSRIFVANSEKRITIPEIKNHPWFLRNL 188 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 188 (262)
+.+|+.||..+|..||++.++|.+|.++...
T Consensus 235 ~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~ 265 (426)
T KOG0589|consen 235 RSLVKSMLRKNPEHRPSALELLRRPHLLRYL 265 (426)
T ss_pred HHHHHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence 9999999999999999999999999887543
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=269.30 Aligned_cols=178 Identities=33% Similarity=0.600 Sum_probs=149.0
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC-CCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (262)
|||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.... ...
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~--~~kL~DfG~~~~~~~~~~~ 152 (325)
T cd05604 75 LDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQG--HVVLTDFGLCKEGIAQSDT 152 (325)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC--CEEEeecCCcccCCCCCCC
Confidence 79999999999999888999999999999999999999999999999999999998777 899999999874322 222
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+....+...... ....+ ...+..+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~----~~~~~--~~~~~~~~~ 225 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNT-VDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK----PLVLR--PGASLTAWS 225 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCc-CccccccceehhhhcCCCCCCCCCHHHHHHHHHcC----CccCC--CCCCHHHHH
Confidence 345679999999999988777654 89999999999999999999876554444433322 22222 257889999
Q ss_pred HHHHhcccCCCCCCCH----hHHhcCcccccc
Q 024809 160 LLSRIFVANSEKRITI----PEIKNHPWFLRN 187 (262)
Q Consensus 160 li~~~L~~dp~~R~s~----~e~l~hp~~~~~ 187 (262)
+|++||+.+|.+||++ .+++.||||...
T Consensus 226 ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 226 ILEELLEKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred HHHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 9999999999999987 589999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=273.37 Aligned_cols=181 Identities=35% Similarity=0.595 Sum_probs=148.0
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
||||+||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 122 ~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~--~~kL~DFG~a~~~~~~~~~ 198 (370)
T cd05621 122 MEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG--HLKLADFGTCMKMDETGMV 198 (370)
T ss_pred EcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC--CEEEEecccceecccCCce
Confidence 7999999999999765 699999999999999999999999999999999999998776 89999999997543222
Q ss_pred CCCccccCCCCCCcccccCCc---CCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
......||+.|+|||++.+.. +.+.++||||+||++|+|++|+.||........+.++.... ....+|....++.
T Consensus 199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~~~s~ 276 (370)
T cd05621 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK--NSLNFPEDVEISK 276 (370)
T ss_pred ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--cccCCCCcccCCH
Confidence 223567999999999987543 23455899999999999999999998766544444443221 2344566567899
Q ss_pred HHHHHHHHhcccCCCC--CCCHhHHhcCccccc
Q 024809 156 ECKHLLSRIFVANSEK--RITIPEIKNHPWFLR 186 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~--R~s~~e~l~hp~~~~ 186 (262)
.+++++.+||..++.+ |+|+.++++||||+.
T Consensus 277 ~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 277 HAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred HHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 9999999999866544 899999999999975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=277.87 Aligned_cols=180 Identities=37% Similarity=0.628 Sum_probs=147.3
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC---
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH--- 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~--- 77 (262)
||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~--~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG--HIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCC--CEEEEeCCCCccccccccc
Confidence 79999999999999888899999999999999999999999999999999999998776 8999999997422100
Q ss_pred -----------------------------------------CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHH
Q 024809 78 -----------------------------------------SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYV 116 (262)
Q Consensus 78 -----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ 116 (262)
......+||+.|+|||++.+..++.+ +|||||||++|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilye 236 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYE 236 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcc-eeeeeccceeee
Confidence 00113479999999999988777544 899999999999
Q ss_pred HHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHHHHHhcccCCCCCC---CHhHHhcCccccc
Q 024809 117 MLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI---TIPEIKNHPWFLR 186 (262)
Q Consensus 117 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~---s~~e~l~hp~~~~ 186 (262)
|++|+.||...........+... ......+....+++++.++|.+|+ .+|.+|+ |+.++++||||..
T Consensus 237 ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 237 MLVGQPPFLADTPAETQLKVINW--ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred hhhCCCCCCCCCHHHHHHHHhcc--CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 99999999876654433332221 122334455578999999999986 5999999 9999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=269.20 Aligned_cols=182 Identities=28% Similarity=0.492 Sum_probs=145.1
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~-~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||++||+|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++ .+||+|||+++.... ..
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~-~~ 158 (331)
T cd06649 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLID-SM 158 (331)
T ss_pred eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC--cEEEccCcccccccc-cc
Confidence 79999999999999888899999999999999999999986 699999999999998776 899999999875432 23
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcc--------------------
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGR-------------------- 139 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~-------------------- 139 (262)
.....||+.|+|||++.+..++. ++|||||||++|+|++|+.||......+ +...+..
T Consensus 159 ~~~~~g~~~y~aPE~~~~~~~~~-~~DiwslG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 159 ANSFVGTRSYMSPERLQGTHYSV-QSDIWSMGLSLVELAIGRYPIPPPDAKE-LEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred cccCCCCcCcCCHhHhcCCCCCc-hHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhcccccccccCCccccCcccccc
Confidence 34567999999999998777654 4899999999999999999997544321 1111110
Q ss_pred -----------------------cccccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 140 -----------------------ILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 140 -----------------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
+............+++++++||.+||++||++|||+.++++||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 000000000112467899999999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=271.18 Aligned_cols=177 Identities=35% Similarity=0.621 Sum_probs=148.2
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC-CCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (262)
|||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.... ...
T Consensus 75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~--~~kl~DfG~a~~~~~~~~~ 152 (325)
T cd05602 75 LDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG--HIVLTDFGLCKENIEHNGT 152 (325)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC--CEEEccCCCCcccccCCCC
Confidence 79999999999999888899999999999999999999999999999999999998776 899999999875322 222
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........+..+.. ....++ ..++..+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~----~~~~~~--~~~~~~~~~ 225 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN----KPLQLK--PNITNSARH 225 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCc-cccccccHHHHHHhcCCCCCCCCCHHHHHHHHHh----CCcCCC--CCCCHHHHH
Confidence 345679999999999988776544 8999999999999999999987655444333322 122222 368899999
Q ss_pred HHHHhcccCCCCCCCHh----HHhcCccccc
Q 024809 160 LLSRIFVANSEKRITIP----EIKNHPWFLR 186 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~----e~l~hp~~~~ 186 (262)
+|.+||+.+|.+|+++. ++++|+||..
T Consensus 226 li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 226 LLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred HHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence 99999999999999886 8999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=266.77 Aligned_cols=185 Identities=29% Similarity=0.440 Sum_probs=150.3
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|-||.+|+++++|+.. .+|+|..+..+++++++||.|||.+|.||||||+.||||+.+| .|||+|||.+..+...+
T Consensus 103 mpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG--~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDG--TVKLADFGVSASLFDSG 180 (516)
T ss_pred ehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCC--cEEEcCceeeeeecccC
Confidence 5689999999999854 3599999999999999999999999999999999999998888 99999999876544332
Q ss_pred C----C-CccccCCCCCCccccc--CCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc----cccC
Q 024809 79 Q----P-KSTVGTPAYIAPEVLT--KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV----HYSF 147 (262)
Q Consensus 79 ~----~-~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----~~~~ 147 (262)
. . ++++||++|||||++. ..+|+.+ +||||||++..||.+|..||......+.+...++.-.+. ....
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfK-aDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~ 259 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFK-ADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDK 259 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccch-hhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCCh
Confidence 1 1 4568999999999953 2567666 899999999999999999999876655554444332210 1122
Q ss_pred CCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 024809 148 PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL 188 (262)
Q Consensus 148 ~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 188 (262)
......+..++.+|..||++||.+||||+++|.|+||++..
T Consensus 260 d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 260 DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 23345778899999999999999999999999999998643
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=268.98 Aligned_cols=183 Identities=25% Similarity=0.425 Sum_probs=142.3
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
||++ |++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++... ...
T Consensus 99 ~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~--~~kl~Dfg~~~~~~--~~~ 172 (343)
T cd07878 99 TNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC--ELRILDFGLARQAD--DEM 172 (343)
T ss_pred eecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCC--CEEEcCCccceecC--CCc
Confidence 4565 7799877754 4699999999999999999999999999999999999998776 89999999997543 233
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc-----------------
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV----------------- 143 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----------------- 143 (262)
....||+.|+|||++.+....+.++|||||||++|+|++|+.||.+....+.+..........
T Consensus 173 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (343)
T cd07878 173 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYI 252 (343)
T ss_pred CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHh
Confidence 456799999999998775444556899999999999999999998765443333222111000
Q ss_pred --cccCC------CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCC
Q 024809 144 --HYSFP------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLP 189 (262)
Q Consensus 144 --~~~~~------~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 189 (262)
....+ .....++.+.+||.+||..||.+|||+.++++||||.....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~ 306 (343)
T cd07878 253 QSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD 306 (343)
T ss_pred hccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence 00000 01235677899999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=269.25 Aligned_cols=177 Identities=37% Similarity=0.651 Sum_probs=147.5
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-CC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (262)
||||+||+|..++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++..... ..
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~--~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEG--FVKIADFGLCKEGMGFGDR 157 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC--cEEeCcccCCccCCCCCCc
Confidence 799999999988865 4699999999999999999999999999999999999998877 8999999998753222 22
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....|++.|+|||.+.+..+..+ +|||||||++|+|++|+.||.+.+....+..+ ......+|. .++.++.+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~G~~pf~~~~~~~~~~~i----~~~~~~~p~--~~~~~~~~ 230 (324)
T cd05589 158 TSTFCGTPEFLAPEVLTETSYTRA-VDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI----VNDEVRYPR--FLSREAIS 230 (324)
T ss_pred ccccccCccccCHhHhcCCCCCcc-cchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH----HhCCCCCCC--CCCHHHHH
Confidence 345679999999999987776544 89999999999999999999876554443332 222333444 57899999
Q ss_pred HHHHhcccCCCCCC-----CHhHHhcCcccccc
Q 024809 160 LLSRIFVANSEKRI-----TIPEIKNHPWFLRN 187 (262)
Q Consensus 160 li~~~L~~dp~~R~-----s~~e~l~hp~~~~~ 187 (262)
+|.+||+.||.+|| ++.++++||||...
T Consensus 231 li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 231 IMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred HHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 99999999999999 79999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=272.02 Aligned_cols=181 Identities=35% Similarity=0.543 Sum_probs=160.0
Q ss_pred CCCCCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|..|+||||.-+|.+.+ .|+|+.++.|+.+|+.||++||..+||.|||||+|||+|+.+ +++|+|.|+|..+....
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~G--hvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHG--HVRISDLGLAVEIPEGK 341 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCC--CeEeeccceEEecCCCC
Confidence 45799999999998877 799999999999999999999999999999999999999888 99999999998777666
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 158 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (262)
.....+||.+|||||++.+..|+.. +|+|||||++|+|+.|+.||...........+-+++......+++ .+|++++
T Consensus 342 ~~~~rvGT~GYMAPEvl~ne~Y~~s-~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~--kFS~eak 418 (591)
T KOG0986|consen 342 PIRGRVGTVGYMAPEVLQNEVYDFS-PDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSD--KFSEEAK 418 (591)
T ss_pred ccccccCcccccCHHHHcCCcccCC-ccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhccc--ccCHHHH
Confidence 6667799999999999999887655 799999999999999999998877665555555556555666665 7999999
Q ss_pred HHHHHhcccCCCCCC-----CHhHHhcCccccc
Q 024809 159 HLLSRIFVANSEKRI-----TIPEIKNHPWFLR 186 (262)
Q Consensus 159 ~li~~~L~~dp~~R~-----s~~e~l~hp~~~~ 186 (262)
+|.+.+|++||.+|. ++.++.+||||+.
T Consensus 419 slc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 419 SLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD 451 (591)
T ss_pred HHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence 999999999999997 5679999999975
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=263.91 Aligned_cols=181 Identities=27% Similarity=0.478 Sum_probs=148.7
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||++||+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||+++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG--HIRISDLGLAVEIPEGE 156 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCC--CEEEeeCCCceecCCCC
Confidence 7999999999888654 3699999999999999999999999999999999999998776 89999999997654333
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 158 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (262)
......|++.|+|||++.+..++.. +||||+||++|+|++|+.||.+.............+......++. .++..+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 233 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNERYTFS-PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSE--KFSEAAR 233 (285)
T ss_pred ccccccCCCCccCcHHhcCCCCCcc-ccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCc--ccCHHHH
Confidence 3345679999999999987776544 899999999999999999998765433333332333322223333 5888999
Q ss_pred HHHHHhcccCCCCCC-----CHhHHhcCccccc
Q 024809 159 HLLSRIFVANSEKRI-----TIPEIKNHPWFLR 186 (262)
Q Consensus 159 ~li~~~L~~dp~~R~-----s~~e~l~hp~~~~ 186 (262)
+||.+||..||.+|| ++.++++||||..
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 234 SICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred HHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 999999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=268.58 Aligned_cols=177 Identities=36% Similarity=0.605 Sum_probs=147.3
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC-CCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (262)
||||+||+|...+...+.+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++.... ...
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~~~~~~~~~~~ 152 (321)
T cd05603 75 LDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQG--HVVLTDFGLCKEGVEPEET 152 (321)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC--CEEEccCCCCccCCCCCCc
Confidence 79999999999998888899999999999999999999999999999999999998777 899999999875322 222
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+....+..+. .....+|. ..+.++.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~----~~~~~~~~--~~~~~~~~ 225 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRT-VDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL----HKPLQLPG--GKTVAACD 225 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCc-CcccccchhhhhhhcCCCCCCCCCHHHHHHHHh----cCCCCCCC--CCCHHHHH
Confidence 344679999999999987777655 899999999999999999998765433333322 22233333 57889999
Q ss_pred HHHHhcccCCCCCCCH----hHHhcCccccc
Q 024809 160 LLSRIFVANSEKRITI----PEIKNHPWFLR 186 (262)
Q Consensus 160 li~~~L~~dp~~R~s~----~e~l~hp~~~~ 186 (262)
+|.+||+.+|.+|+++ .++++|+||..
T Consensus 226 li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 226 LLVGLLHKDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred HHHHHccCCHhhcCCCCCCHHHHhCCCCcCC
Confidence 9999999999999976 49999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=269.59 Aligned_cols=183 Identities=27% Similarity=0.431 Sum_probs=144.6
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||+.+ +|.+.+.. .+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++........
T Consensus 108 ~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~DfG~a~~~~~~~~~ 182 (364)
T cd07875 108 MELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAGTSFMM 182 (364)
T ss_pred EeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCC--cEEEEeCCCccccCCCCcc
Confidence 789975 78777754 489999999999999999999999999999999999998777 8999999999865443334
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc-----------------
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV----------------- 143 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----------------- 143 (262)
....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+.+++......
T Consensus 183 ~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (364)
T cd07875 183 TPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 261 (364)
T ss_pred cCCcccCCcCCHHHHhCCCCCch-hhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHh
Confidence 55689999999999988777654 899999999999999999998776554444433221100
Q ss_pred -cc--------------cCC----CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCC
Q 024809 144 -HY--------------SFP----DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLP 189 (262)
Q Consensus 144 -~~--------------~~~----~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 189 (262)
.. .++ .....+.++++||.+||+.||.+|||+.++|+||||.....
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 326 (364)
T cd07875 262 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 326 (364)
T ss_pred hCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccC
Confidence 00 000 00113567899999999999999999999999999975433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=288.60 Aligned_cols=180 Identities=39% Similarity=0.657 Sum_probs=155.7
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC-
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ- 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~- 79 (262)
|||++||||..++.+..++||+.+++|+..|+.||.-||+.|+|||||||+|||++..| ++||+|||.+-.+...+.
T Consensus 154 MdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~G--HikLADFGsClkm~~dG~V 231 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSG--HIKLADFGSCLKMDADGTV 231 (1317)
T ss_pred EecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccC--cEeeccchhHHhcCCCCcE
Confidence 89999999999999988999999999999999999999999999999999999999888 999999998866554332
Q ss_pred -CCccccCCCCCCcccccC----CcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc--cccCCCccc
Q 024809 80 -PKSTVGTPAYIAPEVLTK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV--HYSFPDYVR 152 (262)
Q Consensus 80 -~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 152 (262)
....+|||.|.+||++.. .+.+++.+|+||+||++|||++|..||.. +.+..+..+|+.. .+.||....
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa----dslveTY~KIm~hk~~l~FP~~~~ 307 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA----DSLVETYGKIMNHKESLSFPDETD 307 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH----HHHHHHHHHHhchhhhcCCCcccc
Confidence 356789999999999853 24567779999999999999999999986 4444555555543 677887778
Q ss_pred CCHHHHHHHHHhcccCCCCCCC---HhHHhcCcccccc
Q 024809 153 VSLECKHLLSRIFVANSEKRIT---IPEIKNHPWFLRN 187 (262)
Q Consensus 153 ~~~~~~~li~~~L~~dp~~R~s---~~e~l~hp~~~~~ 187 (262)
+|.++++||++++. +|..|.. ++++..||||...
T Consensus 308 VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~ 344 (1317)
T KOG0612|consen 308 VSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGI 344 (1317)
T ss_pred cCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCC
Confidence 99999999999976 7889988 9999999999754
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=262.15 Aligned_cols=180 Identities=26% Similarity=0.368 Sum_probs=144.4
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||+.+ +|.+++... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++ .+||+|||+++......
T Consensus 86 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~--~~kl~dfg~~~~~~~~~ 162 (288)
T cd07863 86 FEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG--QVKLADFGLARIYSCQM 162 (288)
T ss_pred Eccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--CEEECccCccccccCcc
Confidence 689985 899988764 3599999999999999999999999999999999999998777 89999999998654433
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccc-------cccc-----
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS-------VHYS----- 146 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-------~~~~----- 146 (262)
......||..|+|||++.+..++.+ +||||+||++|+|++|+.||.+......+.++...... ....
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd07863 163 ALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGA 241 (288)
T ss_pred cCCCccccccccCchHhhCCCCCCc-chhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccc
Confidence 3445678999999999987776544 89999999999999999999876655544443322110 0000
Q ss_pred CC---------CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 147 FP---------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 147 ~~---------~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
+. ....++..++++|.+||+.||.+|||+.+++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 242 FSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00 012467789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=272.01 Aligned_cols=183 Identities=27% Similarity=0.457 Sum_probs=143.5
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||++| +|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++........
T Consensus 105 ~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~--~~kl~Dfg~a~~~~~~~~~ 179 (359)
T cd07876 105 MELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTACTNFMM 179 (359)
T ss_pred EeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC--CEEEecCCCccccccCccC
Confidence 689976 67777643 489999999999999999999999999999999999998777 8999999999755433334
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccc------------------
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS------------------ 142 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~------------------ 142 (262)
....||+.|+|||++.+..+..+ +|||||||++|+|++|+.||.+.+....+.........
T Consensus 180 ~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (359)
T cd07876 180 TPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVE 258 (359)
T ss_pred CCCcccCCCCCchhccCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHh
Confidence 45688999999999988777655 89999999999999999999876654433322211100
Q ss_pred cccc---------CCC---------cccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCC
Q 024809 143 VHYS---------FPD---------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLP 189 (262)
Q Consensus 143 ~~~~---------~~~---------~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 189 (262)
.... ++. ....++++++||.+||..||++|||+.|+|+||||..+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 323 (359)
T cd07876 259 NRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD 323 (359)
T ss_pred hCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcC
Confidence 0000 011 1124678999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=261.31 Aligned_cols=178 Identities=42% Similarity=0.718 Sum_probs=157.7
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC-CCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (262)
|||++||.|+-++.+...|+|...+.+-..|+.||.|||+++||.||||.+|+|++.++ ++||+|||+++.... ...
T Consensus 247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDG--HIKitDFGLCKE~I~~g~t 324 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDG--HIKITDFGLCKEEIKYGDT 324 (516)
T ss_pred EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCC--ceEeeecccchhcccccce
Confidence 89999999999999998999999999999999999999999999999999999999888 999999999985433 445
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
..+++|||.|.|||++....| +.++|+|.+||++|+|+||+.||...+....+.. |......||. .++++++.
T Consensus 325 ~kTFCGTPEYLAPEVleDnDY-graVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeL----Il~ed~kFPr--~ls~eAkt 397 (516)
T KOG0690|consen 325 TKTFCGTPEYLAPEVLEDNDY-GRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFEL----ILMEDLKFPR--TLSPEAKT 397 (516)
T ss_pred eccccCChhhcCchhhccccc-cceeehhhhhHHHHHHHhccCcccccchhHHHHH----HHhhhccCCc--cCCHHHHH
Confidence 678999999999999988887 4558999999999999999999988766544433 4445667777 79999999
Q ss_pred HHHHhcccCCCCCC-----CHhHHhcCcccccc
Q 024809 160 LLSRIFVANSEKRI-----TIPEIKNHPWFLRN 187 (262)
Q Consensus 160 li~~~L~~dp~~R~-----s~~e~l~hp~~~~~ 187 (262)
|+..+|.+||.+|. .|.|+.+|+||..-
T Consensus 398 LLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 398 LLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASV 430 (516)
T ss_pred HHHHHhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence 99999999999997 57899999999753
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=271.61 Aligned_cols=178 Identities=35% Similarity=0.639 Sum_probs=149.6
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-CC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (262)
|||++||+|.+++.+...+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++..... ..
T Consensus 77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 77 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG--HIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCC--cEEEeeccCCcccCCCCCc
Confidence 79999999999998888899999999999999999999999999999999999998776 8999999998754333 22
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....||+.|+|||.+.+..+.. ++|||||||++|+|++|+.||...........+. .....+|. .+++++++
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~-~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~----~~~~~~p~--~~~~~~~~ 227 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQ-SADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL----KAKLGMPQ--FLSPEAQS 227 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCC-ccceeccceEeeeeccCCCCCCCCCHHHHHHHHH----cCCCCCCC--CCCHHHHH
Confidence 33467999999999998776654 4899999999999999999998765444333322 22333444 57899999
Q ss_pred HHHHhcccCCCCCCC-----HhHHhcCcccccc
Q 024809 160 LLSRIFVANSEKRIT-----IPEIKNHPWFLRN 187 (262)
Q Consensus 160 li~~~L~~dp~~R~s-----~~e~l~hp~~~~~ 187 (262)
||++||+.||.+||| +.+++.||||...
T Consensus 228 li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 228 LLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred HHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 999999999999999 6779999999753
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=267.29 Aligned_cols=174 Identities=30% Similarity=0.480 Sum_probs=145.0
Q ss_pred CCCCCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcC-CeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC
Q 024809 1 MEYAAGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQ-ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~aL~~LH~~~-ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~ 77 (262)
|||++||+|.+++.+ ...++...+..++.||++|++|||+++ ||||||||+|||++.+. .++||+|||+++.....
T Consensus 119 tEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~-~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 119 TEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG-KTLKIADFGLSREKVIS 197 (362)
T ss_pred EEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC-CEEEECCCccceeeccc
Confidence 799999999999987 568999999999999999999999999 99999999999998764 38999999999866543
Q ss_pred -CCCCccccCCCCCCccccc--CCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCC
Q 024809 78 -SQPKSTVGTPAYIAPEVLT--KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS 154 (262)
Q Consensus 78 -~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (262)
.......||+.|||||++. ...|+.+ +||||+|+++|||+||+.||.+............. .....+|. ..+
T Consensus 198 ~~~~~~~~GT~~wMAPEv~~~~~~~~~~K-~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~--~~Rp~~p~--~~~ 272 (362)
T KOG0192|consen 198 KTSMTSVAGTYRWMAPEVLRGEKSPYTEK-SDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVG--GLRPPIPK--ECP 272 (362)
T ss_pred cccccCCCCCccccChhhhcCCCCcCCcc-chhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc--CCCCCCCc--cCC
Confidence 3344478999999999999 4567655 89999999999999999999987763332222211 22233344 488
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 155 LECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
+.+..++.+||..||.+||+..+++.
T Consensus 273 ~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 273 PHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 99999999999999999999999876
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=260.59 Aligned_cols=182 Identities=26% Similarity=0.428 Sum_probs=145.3
Q ss_pred CCCCCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||++||+|.+++...+ .+++..+..++.|++.||.|||+.||+||||||+||+++.++ .++|+|||++.......
T Consensus 72 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~--~~~l~Dfg~~~~~~~~~ 149 (277)
T cd05607 72 MSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQG--NCRLSDLGLAVELKDGK 149 (277)
T ss_pred EecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCC--CEEEeeceeeeecCCCc
Confidence 79999999999886543 589999999999999999999999999999999999998776 89999999987654333
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 158 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (262)
......|++.|+|||++.+..++.+ +|+||+||++|+|++|+.||......................++ ...++.+++
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 227 (277)
T cd05607 150 TITQRAGTNGYMAPEILKEEPYSYP-VDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE-HQNFTEESK 227 (277)
T ss_pred eeeccCCCCCccCHHHHccCCCCCc-hhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc-cccCCHHHH
Confidence 3344578999999999987776544 89999999999999999999765432222222222222222222 135789999
Q ss_pred HHHHHhcccCCCCCCCH----hHHhcCccccc
Q 024809 159 HLLSRIFVANSEKRITI----PEIKNHPWFLR 186 (262)
Q Consensus 159 ~li~~~L~~dp~~R~s~----~e~l~hp~~~~ 186 (262)
+||.+||+.||.+||++ ++++.||||+.
T Consensus 228 ~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 228 DICRLFLAKKPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred HHHHHHhccCHhhCCCCccchhhhhcChhhcC
Confidence 99999999999999999 67889999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=256.02 Aligned_cols=220 Identities=25% Similarity=0.398 Sum_probs=168.1
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
||||.+ +|...+.. .++...++++++|++.|++|||+.||+||||||+||++..++ .+||.|||+|+.....-..
T Consensus 100 ~e~m~~-nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~--~lKi~dfg~ar~e~~~~~m 174 (369)
T KOG0665|consen 100 MELMDA-NLCQVILM--ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDC--TLKILDFGLARTEDTDFMM 174 (369)
T ss_pred HHhhhh-HHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchh--heeeccchhhcccCccccc
Confidence 688875 99888874 488999999999999999999999999999999999998877 8999999999876555456
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccc----------------
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH---------------- 144 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---------------- 144 (262)
+.++.|..|+|||++.+.+|... +||||+||++.+|++|...|.+.+..+++.++........
T Consensus 175 tpyVvtRyyrapevil~~~~ke~-vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~ 253 (369)
T KOG0665|consen 175 TPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVE 253 (369)
T ss_pred CchhheeeccCchheeccCCccc-chhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhh
Confidence 67889999999999999887655 8999999999999999999998777666665544332110
Q ss_pred -----------ccCCCc---------ccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCCccccCCCCcc-c-cC
Q 024809 145 -----------YSFPDY---------VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQ-S-HD 202 (262)
Q Consensus 145 -----------~~~~~~---------~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~-~-~~ 202 (262)
..+|+. ..-+..+++++.+||..+|++|.|+.++|+|||++-+......+.+.-+ . ..
T Consensus 254 ~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev~ap~pe~~d~~ 333 (369)
T KOG0665|consen 254 NRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEVEAPPPEIYDKQ 333 (369)
T ss_pred cChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccccccCCCCchhhhh
Confidence 011211 1133568999999999999999999999999999844332221111111 1 11
Q ss_pred CCCCCCCHHHHHHHhHHhcCCCCC
Q 024809 203 VNNPSQSLEEVLSLIHEATKPLEA 226 (262)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~ 226 (262)
..-..-+.++++..|.+.-+.+.+
T Consensus 334 ~d~~~~t~~e~ke~If~ev~~f~~ 357 (369)
T KOG0665|consen 334 LDEREHTIEEWKELIFKEVQRFEE 357 (369)
T ss_pred cccccCCHHHHHHHHHHHHHhhcc
Confidence 112223489999999988776654
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=268.00 Aligned_cols=182 Identities=26% Similarity=0.416 Sum_probs=143.1
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||+++ +|.+.+.. .+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++........
T Consensus 101 ~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~ 175 (355)
T cd07874 101 MELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAGTSFMM 175 (355)
T ss_pred hhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCC--CEEEeeCcccccCCCcccc
Confidence 789976 67777754 489999999999999999999999999999999999998777 8999999999865444344
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc-----------------
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV----------------- 143 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----------------- 143 (262)
....||+.|+|||++.+..+..+ +|||||||++|+|++|+.||.+......+...+......
T Consensus 176 ~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (355)
T cd07874 176 TPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254 (355)
T ss_pred CCccccCCccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHh
Confidence 55689999999999988777655 899999999999999999998765443333222111000
Q ss_pred ------ccc---------CC----CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 024809 144 ------HYS---------FP----DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL 188 (262)
Q Consensus 144 ------~~~---------~~----~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 188 (262)
... ++ .....+.++++||.+||..||.+|||+.|+|+||||....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~ 318 (355)
T cd07874 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY 318 (355)
T ss_pred cCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence 000 00 0112456789999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=261.50 Aligned_cols=181 Identities=29% Similarity=0.495 Sum_probs=145.2
Q ss_pred CCCCCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||++||+|.+++...+ .+++..+..++.|++.||.|||+.||+||||||+||+++.++ .++|+|||++.......
T Consensus 79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~--~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHG--HIRISDLGLAVHVPEGQ 156 (285)
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC--CEEEeeccceeecCCCc
Confidence 79999999999986543 599999999999999999999999999999999999998776 89999999987544333
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 158 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (262)
......|+..|+|||++.+..++.+ +|+||+||++|+|++|+.||......................++ ..++++++
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 233 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYS--EKFSPDAR 233 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcC--ccCCHHHH
Confidence 3344579999999999987776544 89999999999999999999875432211111111111111222 25788999
Q ss_pred HHHHHhcccCCCCCCC-----HhHHhcCccccc
Q 024809 159 HLLSRIFVANSEKRIT-----IPEIKNHPWFLR 186 (262)
Q Consensus 159 ~li~~~L~~dp~~R~s-----~~e~l~hp~~~~ 186 (262)
+|+.+||+.||.+||| ++++++||||.+
T Consensus 234 ~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 234 SLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 9999999999999999 899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=270.39 Aligned_cols=181 Identities=36% Similarity=0.589 Sum_probs=147.1
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
||||+||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 122 ~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~--~ikL~DfG~a~~~~~~~~~ 198 (371)
T cd05622 122 MEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMNKEGMV 198 (371)
T ss_pred EcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCC--CEEEEeCCceeEcCcCCcc
Confidence 7999999999998765 599999999999999999999999999999999999998776 89999999997543222
Q ss_pred CCCccccCCCCCCcccccCCc---CCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
......||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||...+....+.++.... ....+|....++.
T Consensus 199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~s~ 276 (371)
T cd05622 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK--NSLTFPDDNDISK 276 (371)
T ss_pred cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CcccCCCcCCCCH
Confidence 223567999999999987543 23455899999999999999999998766544444443322 2234566567999
Q ss_pred HHHHHHHHhcccCCCC--CCCHhHHhcCccccc
Q 024809 156 ECKHLLSRIFVANSEK--RITIPEIKNHPWFLR 186 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~--R~s~~e~l~hp~~~~ 186 (262)
.++++|.+||..++.+ |++++++++||||..
T Consensus 277 ~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 277 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred HHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence 9999999999844443 789999999999965
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=264.12 Aligned_cols=182 Identities=34% Similarity=0.640 Sum_probs=143.6
Q ss_pred CCCCCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||++||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++........
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNG--HIRLADFGSCLRLLADGT 157 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCC--CEEEEECCceeecCCCCC
Confidence 799999999999976 45799999999999999999999999999999999999998776 899999999865432222
Q ss_pred --CCccccCCCCCCcccccC----CcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCC-Cccc
Q 024809 80 --PKSTVGTPAYIAPEVLTK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP-DYVR 152 (262)
Q Consensus 80 --~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 152 (262)
.....||+.|+|||++.. ....+.++||||+||++|+|++|+.||......+.+..+..... ...++ ....
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~ 235 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE--HFQFPPDVTD 235 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCC--cccCCCccCC
Confidence 223569999999999863 22334558999999999999999999987655444444332211 12222 2235
Q ss_pred CCHHHHHHHHHhcccCCCC--CCCHhHHhcCccccc
Q 024809 153 VSLECKHLLSRIFVANSEK--RITIPEIKNHPWFLR 186 (262)
Q Consensus 153 ~~~~~~~li~~~L~~dp~~--R~s~~e~l~hp~~~~ 186 (262)
++.++++||++||..++++ |+++.++++||||..
T Consensus 236 ~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 236 VSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred CCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 7899999999999764444 789999999999965
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=258.49 Aligned_cols=180 Identities=33% Similarity=0.527 Sum_probs=144.7
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||++||+|.+++..++.+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++...... ..
T Consensus 76 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~--~~~l~dfg~~~~~~~~-~~ 152 (279)
T cd05633 76 LDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSKK-KP 152 (279)
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCC--CEEEccCCcceecccc-Cc
Confidence 79999999999999888899999999999999999999999999999999999998777 8999999998644322 22
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 160 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 160 (262)
....|++.|+|||.+......+.++|+||+||++|+|++|..||......... .............+. .++.+++++
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~--~~~~~~~~l 229 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTVNVELPD--SFSPELKSL 229 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhhcCCcCCcc--ccCHHHHHH
Confidence 34579999999999864333345589999999999999999999764432211 111111111222333 578999999
Q ss_pred HHHhcccCCCCCC-----CHhHHhcCccccc
Q 024809 161 LSRIFVANSEKRI-----TIPEIKNHPWFLR 186 (262)
Q Consensus 161 i~~~L~~dp~~R~-----s~~e~l~hp~~~~ 186 (262)
|.+||..||.+|+ |++++++||||+.
T Consensus 230 i~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 230 LEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred HHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence 9999999999999 6999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=268.88 Aligned_cols=183 Identities=26% Similarity=0.401 Sum_probs=145.5
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
|||+. ++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 83 ~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~--~~kL~Dfg~a~~~~~~~~~ 159 (372)
T cd07853 83 TELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNC--VLKICDFGLARVEEPDESK 159 (372)
T ss_pred eeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCC--CEEeccccceeecccCccc
Confidence 68887 58999998888899999999999999999999999999999999999998776 89999999997543221
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccc-----------------
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIL----------------- 141 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~----------------- 141 (262)
......+++.|+|||.+.+....+.++||||+||++|+|++|+.||.+......+..+.....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 239 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAH 239 (372)
T ss_pred cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHH
Confidence 223356899999999988755445568999999999999999999987665444333221110
Q ss_pred --cccccC-------CCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 142 --SVHYSF-------PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 142 --~~~~~~-------~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
...... ......++++.+||.+||+.||.+|||+.++++||||..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 293 (372)
T cd07853 240 ILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293 (372)
T ss_pred HHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence 000000 111246788999999999999999999999999999976
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=262.65 Aligned_cols=183 Identities=25% Similarity=0.375 Sum_probs=135.3
Q ss_pred CCCCCCCchHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC--CCCcEEEeccC
Q 024809 1 MEYAAGGELFERICNA---------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS--TAPRVKICDFG 69 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~---------~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~--~~~~~kl~Dfg 69 (262)
|||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+... ..+.+||+|||
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 79 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 588864 888887532 258999999999999999999999999999999999999432 23379999999
Q ss_pred CCcCCCCCC----CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh---------hHHHHH
Q 024809 70 YSKSSVLHS----QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP---------KNFRKT 136 (262)
Q Consensus 70 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------~~~~~~ 136 (262)
+++...... ......||+.|+|||++.+....+.++||||+||++|+|++|+.||...... ..+..+
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 237 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence 997543221 2234678999999999987554456689999999999999999999754321 111111
Q ss_pred hccccc------------------------cccc--------CCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 137 IGRILS------------------------VHYS--------FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 137 ~~~~~~------------------------~~~~--------~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
...... .... -......+.++.+||.+||+.||.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 110000 0000 00011235678999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=264.87 Aligned_cols=179 Identities=31% Similarity=0.491 Sum_probs=139.4
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-C
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-Q 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (262)
||||+||+|.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...... .
T Consensus 151 ~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~--~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 151 LEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAK--NVKIADFGVSRILAQTMDP 224 (353)
T ss_pred EecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC--CEEEcccccceeccccccc
Confidence 799999998643 3467889999999999999999999999999999999998776 89999999997553322 2
Q ss_pred CCccccCCCCCCcccccC----CcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccc-cccccCCCcccCC
Q 024809 80 PKSTVGTPAYIAPEVLTK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIL-SVHYSFPDYVRVS 154 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 154 (262)
.....||..|+|||.+.. ..+.+.++|||||||++|+|++|+.||....... +......+. ...... ...++
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~--~~~~~ 301 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD-WASLMCAICMSQPPEA--PATAS 301 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-HHHHHHHHhccCCCCC--CCccC
Confidence 345679999999998753 2344456899999999999999999997433221 111111111 111111 23678
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 024809 155 LECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL 188 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 188 (262)
.++++||.+||..||++|||+.|+++||||.+..
T Consensus 302 ~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 302 REFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 8999999999999999999999999999998653
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=269.31 Aligned_cols=183 Identities=20% Similarity=0.305 Sum_probs=140.2
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC--C
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH--S 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~--~ 78 (262)
|||+. |+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+..... .
T Consensus 162 ~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~--~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 162 LPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPG--DVCLGDFGAACFPVDINAN 238 (391)
T ss_pred EecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCC--CEEEEeCCccccccccccc
Confidence 57775 69999998888899999999999999999999999999999999999998776 8999999998643221 1
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCC-------hhHHHHHhcccccc--------
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPED-------PKNFRKTIGRILSV-------- 143 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~~~~~~~~~-------- 143 (262)
......||+.|+|||++.+..+. .++||||+||++|+|++|+.||-.... ...+..++......
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYG-PAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred ccccccCccCCCChhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 22345799999999999877765 458999999999999999987643221 11111111111000
Q ss_pred ------------------cccCC---CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 144 ------------------HYSFP---DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 144 ------------------~~~~~---~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
....+ ....++.++.+||.+||++||.+|||++|+|+||||+..
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 00001 111356789999999999999999999999999999753
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=277.15 Aligned_cols=179 Identities=31% Similarity=0.498 Sum_probs=147.3
Q ss_pred CCCCCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC
Q 024809 1 MEYAAGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~----~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (262)
|||++||+|.++|... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++ .+||+|||+++....
T Consensus 118 ~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~--~vkL~DFGls~~~~~ 195 (496)
T PTZ00283 118 LDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG--LVKLGDFGFSKMYAA 195 (496)
T ss_pred EeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCC--CEEEEecccCeeccc
Confidence 7999999999998653 3699999999999999999999999999999999999998776 899999999875432
Q ss_pred C---CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccC
Q 024809 77 H---SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRV 153 (262)
Q Consensus 77 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (262)
. .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+......+....... ...+| ..+
T Consensus 196 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k-~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~---~~~~~--~~~ 269 (496)
T PTZ00283 196 TVSDDVGRTFCGTPYYVAPEIWRRKPYSKK-ADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR---YDPLP--PSI 269 (496)
T ss_pred cccccccccccCCcceeCHHHhCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC---CCCCC--CCC
Confidence 2 12345679999999999988777644 899999999999999999998755433333322211 11122 368
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 154 SLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 154 ~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
++++.+++.+||..+|.+||++.++++|||++..
T Consensus 270 ~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 270 SPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 8999999999999999999999999999998653
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=264.65 Aligned_cols=182 Identities=31% Similarity=0.610 Sum_probs=145.1
Q ss_pred CCCCCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||++||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++........
T Consensus 80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~--~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG--HIRLADFGSCLKLMEDGT 157 (332)
T ss_pred EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC--CEEEeecchheecccCCc
Confidence 799999999999987 45799999999999999999999999999999999999998776 899999999865432221
Q ss_pred --CCccccCCCCCCcccccC----CcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCC-ccc
Q 024809 80 --PKSTVGTPAYIAPEVLTK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD-YVR 152 (262)
Q Consensus 80 --~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 152 (262)
.....||+.|+|||++.. ....+.++||||+||++|+|++|+.||...+..+.+.++..... ...+|. ...
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~~~p~~~~~ 235 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE--RFQFPAQVTD 235 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCc--cccCCCcccc
Confidence 223579999999999863 22234558999999999999999999987665555554433221 222333 235
Q ss_pred CCHHHHHHHHHhcccCCCC--CCCHhHHhcCccccc
Q 024809 153 VSLECKHLLSRIFVANSEK--RITIPEIKNHPWFLR 186 (262)
Q Consensus 153 ~~~~~~~li~~~L~~dp~~--R~s~~e~l~hp~~~~ 186 (262)
++.++++||++||..++.+ |+++.++++||||..
T Consensus 236 ~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 236 VSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred CCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 8999999999999765554 689999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=263.20 Aligned_cols=181 Identities=29% Similarity=0.516 Sum_probs=143.4
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~-~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||++||+|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++ .+||+|||++..... ..
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~--~~kL~Dfg~~~~~~~-~~ 158 (333)
T cd06650 82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLID-SM 158 (333)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC--CEEEeeCCcchhhhh-hc
Confidence 79999999999999888899999999999999999999985 799999999999998776 899999999875422 22
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcc--------------------
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGR-------------------- 139 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~-------------------- 139 (262)
.....|+..|+|||.+.+..++.+ +|+||+||++|+|++|+.||........ ...+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (333)
T cd06650 159 ANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAIGRYPIPPPDAKEL-ELMFGCPVEGDPAESETSPRPRPPGR 236 (333)
T ss_pred cccCCCCccccCHHHhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcchhHH-HHHhcCcccCCccccccCcccCCccc
Confidence 344579999999999987666544 8999999999999999999976443211 111100
Q ss_pred ---------------------cccc-cccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 140 ---------------------ILSV-HYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 140 ---------------------~~~~-~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
+... ....+ ....+.++++||.+||++||++|||+.+++.||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLP-SGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred hhhhhcccccccccHHHHHHHHhcCCCccCC-CCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 0000 00000 11356789999999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=270.66 Aligned_cols=172 Identities=37% Similarity=0.565 Sum_probs=145.5
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
||++.||.|.+.|.....+. ..+..|+.||+.|+.|||++|||||||||+|||+. +..++++|+|||.++..... .
T Consensus 395 ~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~-~~~g~lrltyFG~a~~~~~~--~ 470 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD-GSAGHLRLTYFGFWSELERS--C 470 (612)
T ss_pred ehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec-CCCCcEEEEEechhhhCchh--h
Confidence 79999999999998886666 88889999999999999999999999999999995 23348999999999854332 4
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 160 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 160 (262)
.+.+-|..|.|||++...+|+.. +||||||++||+|++|+.||.......++.. ++....++ ..+|.++++|
T Consensus 471 ~tp~~t~~y~APEvl~~~~yt~a-cD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~---~i~~~~~s----~~vS~~AKdL 542 (612)
T KOG0603|consen 471 DTPALTLQYVAPEVLAIQEYTEA-CDWWSLGVLLYEMLTGRTLFAAHPAGIEIHT---RIQMPKFS----ECVSDEAKDL 542 (612)
T ss_pred cccchhhcccChhhhccCCCCcc-hhhHHHHHHHHHHHhCCCccccCCchHHHHH---hhcCCccc----cccCHHHHHH
Confidence 45567889999999998888655 9999999999999999999998766533333 33333322 3799999999
Q ss_pred HHHhcccCCCCCCCHhHHhcCccc
Q 024809 161 LSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 161 i~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
|++||+.||.+|+++.+++.||||
T Consensus 543 l~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 543 LQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHhccCChhhCcChhhhccCcch
Confidence 999999999999999999999999
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=275.08 Aligned_cols=178 Identities=33% Similarity=0.503 Sum_probs=145.9
Q ss_pred CCCCCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC
Q 024809 1 MEYAAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (262)
||||+||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~--~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG--IIKLGDFGFSKQYSD 221 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCC--cEEEEeCcCceecCC
Confidence 799999999988753 34699999999999999999999999999999999999998776 899999999985432
Q ss_pred CC---CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccC
Q 024809 77 HS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRV 153 (262)
Q Consensus 77 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (262)
.. .....+||+.|+|||++.+..+.. ++|||||||++|+|++|+.||........+..... .... +....+
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~----~~~~-~~~~~~ 295 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKRYSK-KADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY----GKYD-PFPCPV 295 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCCCCc-HHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----CCCC-CCCccC
Confidence 21 133457999999999998777654 48999999999999999999987654433333222 1111 112357
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 154 SLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 154 ~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
+.+++++|.+||..+|++|||+.+++.|+|++.
T Consensus 296 s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 296 SSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 899999999999999999999999999999864
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=253.56 Aligned_cols=177 Identities=32% Similarity=0.564 Sum_probs=144.2
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||++||+|.+++..++.+++..++.++.|+++||.|||+.|++||||||+||+++.++. .++|+|||+++... ..
T Consensus 88 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~-~~~l~dfg~~~~~~---~~ 163 (267)
T PHA03390 88 MDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKD-RIYLCDYGLCKIIG---TP 163 (267)
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCC-eEEEecCccceecC---CC
Confidence 799999999999998888999999999999999999999999999999999999976542 69999999987543 22
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhH-HHHHhcccccccccCCCcccCCHHHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKN-FRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
....|+..|+|||++.+..++.+ +|+||+|+++|+|++|+.||........ ........ .... +.....++.+++
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~ 239 (267)
T PHA03390 164 SCYDGTLDYFSPEKIKGHNYDVS-FDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKL--PFIKNVSKNAND 239 (267)
T ss_pred ccCCCCCcccChhhhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccC--CcccccCHHHHH
Confidence 34568999999999987776544 8999999999999999999985443221 11111111 1111 222368999999
Q ss_pred HHHHhcccCCCCCCC-HhHHhcCcccc
Q 024809 160 LLSRIFVANSEKRIT-IPEIKNHPWFL 185 (262)
Q Consensus 160 li~~~L~~dp~~R~s-~~e~l~hp~~~ 185 (262)
||.+||+.+|.+|++ ++++|+||||.
T Consensus 240 li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 240 FVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HHHHHhccChhhCCchHHHHhcCCccc
Confidence 999999999999996 59999999996
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=272.87 Aligned_cols=182 Identities=27% Similarity=0.366 Sum_probs=147.9
Q ss_pred CCCCCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
+|.++- +|.++|+.++ +|+...++.++.||+.||.+||+.||||+||||+|||+.......|||+|||.|.... .
T Consensus 267 fELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~--q 343 (586)
T KOG0667|consen 267 FELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES--Q 343 (586)
T ss_pred ehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccC--C
Confidence 356654 9999999775 6999999999999999999999999999999999999987777789999999997543 2
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccc----------------
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS---------------- 142 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------------- 142 (262)
...+++-++.|+|||++.+..|+.. .||||||||++||++|.+.|.+.+..+++..++.....
T Consensus 344 ~vytYiQSRfYRAPEVILGlpY~~~-IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff 422 (586)
T KOG0667|consen 344 RVYTYIQSRFYRAPEVILGLPYDTA-IDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFF 422 (586)
T ss_pred cceeeeeccccccchhhccCCCCCc-cceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceeh
Confidence 3347888999999999999999877 89999999999999999999998877776655432210
Q ss_pred --------------------------------ccccCC-Ccc--------cCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 143 --------------------------------VHYSFP-DYV--------RVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 143 --------------------------------~~~~~~-~~~--------~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
.....| ... .-...+.+||++||++||.+|+|+.++|+|
T Consensus 423 ~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~H 502 (586)
T KOG0667|consen 423 TSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNH 502 (586)
T ss_pred hccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 000011 000 011357899999999999999999999999
Q ss_pred ccccc
Q 024809 182 PWFLR 186 (262)
Q Consensus 182 p~~~~ 186 (262)
|||..
T Consensus 503 pfl~~ 507 (586)
T KOG0667|consen 503 PFLTG 507 (586)
T ss_pred ccccc
Confidence 99974
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=266.76 Aligned_cols=184 Identities=24% Similarity=0.382 Sum_probs=144.0
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC-
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ- 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~- 79 (262)
|||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||+++.......
T Consensus 165 ~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~--~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 165 MPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPE--NAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred ehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC--CEEEccCccccccCccccc
Confidence 67886 59999997778899999999999999999999999999999999999998776 899999999875433221
Q ss_pred --CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh---hHHHHHhcccccc-----------
Q 024809 80 --PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP---KNFRKTIGRILSV----------- 143 (262)
Q Consensus 80 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~~~~~~~~~----------- 143 (262)
.....||+.|+|||++....++.+ +|||||||++|+|++|+.||.+.... ..+..++......
T Consensus 242 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 242 PQCYGWSGTLETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred ccccccccccCccCHhHhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 234579999999999988777655 89999999999999999999764422 2222222111100
Q ss_pred --------------cccCCC---cccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 024809 144 --------------HYSFPD---YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL 188 (262)
Q Consensus 144 --------------~~~~~~---~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 188 (262)
.+..+. ....+.++++||++||..||.+|||+.++|.||||.+..
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence 011111 113567899999999999999999999999999997643
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=259.03 Aligned_cols=184 Identities=26% Similarity=0.463 Sum_probs=144.3
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (262)
|||+++ +|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++......
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERG--ELKLADFGLARAKSVPTK 159 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--CEEECccccceecCCCcc
Confidence 789986 8888887654 589999999999999999999999999999999999998776 89999999987543222
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccc---------------c
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS---------------V 143 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------------~ 143 (262)
......+|+.|+|||.+.+....+.++||||+||++|+|++|+.||.+.+..+.+......... .
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 2234568999999999876544455699999999999999999999876654443333221110 0
Q ss_pred cccCC---------CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 144 HYSFP---------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 144 ~~~~~---------~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
...++ ....++.++++||.+||..||.+|||+.++++||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 01111 113478899999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=256.01 Aligned_cols=182 Identities=29% Similarity=0.495 Sum_probs=148.6
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||++||+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++ .++|+|||++.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~--~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG--HIRISDLGLAVKIPEGE 156 (285)
T ss_pred EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCC--CEEEecCCcceecCCCC
Confidence 6899999999888653 3699999999999999999999999999999999999998776 89999999987543333
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 158 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (262)
......|+..|+|||.+.+..+..+ +|+||+||++|+|++|..||...............+......++ ..++.++.
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 233 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLS-PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYS--AKFSEEAK 233 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccC--ccCCHHHH
Confidence 3345679999999999987776554 89999999999999999999876544333333333333222333 25788999
Q ss_pred HHHHHhcccCCCCCCC-----HhHHhcCcccccc
Q 024809 159 HLLSRIFVANSEKRIT-----IPEIKNHPWFLRN 187 (262)
Q Consensus 159 ~li~~~L~~dp~~R~s-----~~e~l~hp~~~~~ 187 (262)
+|+.+||+.+|.+||+ +.+++.|+||...
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 234 SICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 9999999999999999 8899999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=255.86 Aligned_cols=218 Identities=33% Similarity=0.562 Sum_probs=174.9
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-C
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-Q 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (262)
|||+.||+|--.|+.-++|.|..+..++..|+.||-|||++||+.||||.+||+++..+ ++||+|||+++...... .
T Consensus 429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eG--HiKi~DFGmcKEni~~~~T 506 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENIFDGVT 506 (683)
T ss_pred EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCC--ceEeeecccccccccCCcc
Confidence 89999999999999999999999999999999999999999999999999999998877 99999999998655443 3
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
..+++|||.|+|||++...+| ++.+|+||+||+||||+.|+.||.+.+..+.++.+ ...+..+|. .+|.++.+
T Consensus 507 TkTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI----~ehnvsyPK--slSkEAv~ 579 (683)
T KOG0696|consen 507 TKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI----MEHNVSYPK--SLSKEAVA 579 (683)
T ss_pred eeeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH----HHccCcCcc--cccHHHHH
Confidence 467899999999999988877 56689999999999999999999998776666554 444566777 79999999
Q ss_pred HHHHhcccCCCCCCCH-----hHHhcCccccccCCccccCCCCccccC-C-CCCCCCHHHHHHHhHHhcCCCCCCc
Q 024809 160 LLSRIFVANSEKRITI-----PEIKNHPWFLRNLPIELTEGGSWQSHD-V-NNPSQSLEEVLSLIHEATKPLEAPR 228 (262)
Q Consensus 160 li~~~L~~dp~~R~s~-----~e~l~hp~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (262)
+.+.+|.+.|.+|..+ .++-.||||+.-....+ +....+..- . .+...+.+.....+-.....+.+|.
T Consensus 580 ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~-E~~eiqPPfkPk~k~~r~~eNFD~~Ft~~~~~lTPpD 654 (683)
T KOG0696|consen 580 ICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKL-ERREIQPPFKPKIKCGRDAENFDKFFTREPTDLTPPD 654 (683)
T ss_pred HHHHHhhcCCccccCCCCccccchhhCcchhhccHHHH-hhccCCCCCCCccccCCchhhhhHHHhcCCCCCCCch
Confidence 9999999999999855 68999999976433222 222222111 1 1223456666666666655555553
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=249.65 Aligned_cols=190 Identities=34% Similarity=0.606 Sum_probs=157.0
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-CCCCcEEEeccCCCcCCCCCC-
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG-STAPRVKICDFGYSKSSVLHS- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~-~~~~~~kl~Dfg~a~~~~~~~- 78 (262)
||-|.||+|.++|.++..|+|.++..+++.|+.||.|||.+||.||||||+|||-.. +.-..||||||.+........
T Consensus 155 fEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 155 FEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred EecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 688999999999999999999999999999999999999999999999999999843 222358999998876443221
Q ss_pred -------CCCccccCCCCCCccccc----CCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh-----------hHHHHH
Q 024809 79 -------QPKSTVGTPAYIAPEVLT----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP-----------KNFRKT 136 (262)
Q Consensus 79 -------~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----------~~~~~~ 136 (262)
...+.+|+-.|||||+.. ...++.++.|.||||||+|-|++|..||.+.-.. .=..+.
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~L 314 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL 314 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHH
Confidence 123457888999999863 2345567799999999999999999999764321 123455
Q ss_pred hcccccccccCCC--cccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCCc
Q 024809 137 IGRILSVHYSFPD--YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPI 190 (262)
Q Consensus 137 ~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 190 (262)
+..|..+.+.||+ |..+|.+++++|+.+|..++.+|.++.++++|||++.-.+.
T Consensus 315 FesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 315 FESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 6678888899885 78899999999999999999999999999999999875443
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=253.66 Aligned_cols=181 Identities=32% Similarity=0.525 Sum_probs=146.7
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||+.||+|.+++.+.+.+++..++.++.|++.||.|||+.+++||||||+||+++.++ .++|+|||++..... ...
T Consensus 76 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~--~~kl~dfg~~~~~~~-~~~ 152 (278)
T cd05606 76 LDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSK-KKP 152 (278)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCC--CEEEccCcCccccCc-cCC
Confidence 79999999999998888899999999999999999999999999999999999998776 899999999875432 223
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 160 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 160 (262)
....|+..|+|||.+.+....+.++||||+||++|+|++|+.||........ .............+|. ..+.++.++
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~--~~s~~~~~l 229 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVELPD--SFSPELRSL 229 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch-HHHHHHhhccCCCCCC--cCCHHHHHH
Confidence 4567999999999987543334558999999999999999999986533211 1111112222233333 468999999
Q ss_pred HHHhcccCCCCCC-----CHhHHhcCcccccc
Q 024809 161 LSRIFVANSEKRI-----TIPEIKNHPWFLRN 187 (262)
Q Consensus 161 i~~~L~~dp~~R~-----s~~e~l~hp~~~~~ 187 (262)
+.+||..+|.+|| ++.++++||||...
T Consensus 230 i~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 230 LEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred HHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence 9999999999999 99999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=249.68 Aligned_cols=177 Identities=35% Similarity=0.558 Sum_probs=145.6
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||++||+|.+.+...+.+++..++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||+++........
T Consensus 83 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~--~~~l~dfg~~~~~~~~~~~ 160 (263)
T cd06625 83 MEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAG--NVKLGDFGASKRLQTICSS 160 (263)
T ss_pred EEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEeecccceeccccccc
Confidence 68999999999999888899999999999999999999999999999999999998776 8999999998754322111
Q ss_pred ----CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHH
Q 024809 81 ----KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 156 (262)
Q Consensus 81 ----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (262)
....|+..|+|||.+.+..++ .++||||+|+++|+|++|+.||...+........... .....++. .++..
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~--~~~~~ 235 (263)
T cd06625 161 GTGMKSVTGTPYWMSPEVISGEGYG-RKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ--PTNPQLPS--HVSPD 235 (263)
T ss_pred cccccCCCcCccccCcceeccCCCC-chhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhcc--CCCCCCCc--cCCHH
Confidence 235688899999999887655 4489999999999999999999876544333322211 11222333 57889
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
+.++|.+||..+|.+|||+.++++||||
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 236 ARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=263.16 Aligned_cols=178 Identities=30% Similarity=0.457 Sum_probs=139.3
Q ss_pred CCCCCCCchHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-
Q 024809 1 MEYAAGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l-~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (262)
|||=+ .||.++|.+.... +.-.++.|++|++.|+.++|..||||.||||.|+|+-.+ .+||+|||+|..+....
T Consensus 439 mE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG---~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 439 MECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKG---RLKLIDFGIANAIQPDTT 514 (677)
T ss_pred eeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEee---eEEeeeechhcccCcccc
Confidence 56654 4899999877654 435999999999999999999999999999999999543 79999999998664332
Q ss_pred --CCCccccCCCCCCcccccCCcCC----------CCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccc--
Q 024809 79 --QPKSTVGTPAYIAPEVLTKKEYD----------GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH-- 144 (262)
Q Consensus 79 --~~~~~~gt~~y~aPE~~~~~~~~----------~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-- 144 (262)
.....+||+.||+||.+....+. ++++||||||||||+|+.|+.||.... ++...+..+....
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~---n~~aKl~aI~~P~~~ 591 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII---NQIAKLHAITDPNHE 591 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH---HHHHHHHhhcCCCcc
Confidence 23457899999999998543222 345899999999999999999997532 2333344454443
Q ss_pred ccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 145 YSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 145 ~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
..||..+. ..++.++++.||.+||++|||+.++|+|||+..
T Consensus 592 Iefp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 592 IEFPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred ccccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 35665432 234999999999999999999999999999864
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=252.55 Aligned_cols=181 Identities=36% Similarity=0.568 Sum_probs=148.2
Q ss_pred CCCCCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||++||+|.+++.+.+ .+++..+..++.|++.||.|||++|++||||+|+||+++.++ .++|+|||++.......
T Consensus 72 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~--~~~l~dfg~~~~~~~~~ 149 (277)
T cd05577 72 MTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHG--NVRISDLGLAVELKGGK 149 (277)
T ss_pred EecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC--CEEEccCcchhhhccCC
Confidence 69999999999998766 799999999999999999999999999999999999998776 89999999987654333
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 158 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (262)
......++..|+|||.+.+..++. ++|+||+||++|+|++|+.||...............+.......+. ..+++++
T Consensus 150 ~~~~~~~~~~y~~PE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 226 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQGEVYDF-SVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPD--KFSPEAK 226 (277)
T ss_pred ccccccCCCCcCCHHHhcCCCCCc-hhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCc--cCCHHHH
Confidence 334557888999999987766554 4899999999999999999998765432222332222222223333 5789999
Q ss_pred HHHHHhcccCCCCCC-----CHhHHhcCccccc
Q 024809 159 HLLSRIFVANSEKRI-----TIPEIKNHPWFLR 186 (262)
Q Consensus 159 ~li~~~L~~dp~~R~-----s~~e~l~hp~~~~ 186 (262)
++|.+||+.+|.+|| ++.++++||||.+
T Consensus 227 ~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 227 DLCEALLQKDPEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred HHHHHHccCChhHccCCCcccHHHHHhChhhhc
Confidence 999999999999999 8888999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=253.19 Aligned_cols=182 Identities=34% Similarity=0.549 Sum_probs=143.3
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCC-CCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSS-VLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~-~~~~~ 79 (262)
|||++||+|.+++...+.+++..+..++.||+.||.+||++|++||||||+||+++.++ .++|+|||.+... .....
T Consensus 77 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~--~~~l~Dfg~~~~~~~~~~~ 154 (260)
T PF00069_consen 77 MEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENG--EVKLIDFGSSVKLSENNEN 154 (260)
T ss_dssp EEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTS--EEEESSGTTTEESTSTTSE
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccc
Confidence 68999999999999777899999999999999999999999999999999999998666 8999999998742 22233
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccc-cccccCCCcccCCHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIL-SVHYSFPDYVRVSLECK 158 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 158 (262)
.....++..|+|||++......+.++|+||||+++|+|++|..||................. ............+.++.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELR 234 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHH
Confidence 44567899999999998333345559999999999999999999997632222211111111 11111112122348999
Q ss_pred HHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 159 HLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 159 ~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
++|.+||..||++|||+.++++||||
T Consensus 235 ~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 235 DLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHHccCChhHCcCHHHHhcCCCC
Confidence 99999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=261.76 Aligned_cols=182 Identities=29% Similarity=0.496 Sum_probs=137.5
Q ss_pred CCCCCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||+. |+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++..+ .+||+|||+++.......
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~--~~kl~DfG~a~~~~~~~~ 212 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVD--QVCIGDLGAAQFPVVAPA 212 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--CEEEecCccccccccCcc
Confidence 57885 589888865 45699999999999999999999999999999999999998777 899999999975433333
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCC-CCCCCCh---------hHHHHHhcccccccccCC-
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYP-FEDPEDP---------KNFRKTIGRILSVHYSFP- 148 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~---------~~~~~~~~~~~~~~~~~~- 148 (262)
.....||+.|+|||++.+..+..+ +|||||||++|+|+++..| |...... ..+...+.........++
T Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 213 FLGLAGTVETNAPEVLARDKYNSK-ADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred cccccccccccCCeecCCCCCCch-hhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 345679999999999988777655 8999999999999985544 4432111 011111111100000011
Q ss_pred ---------------------------CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 149 ---------------------------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 149 ---------------------------~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
....++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 11246778889999999999999999999999999974
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=247.30 Aligned_cols=170 Identities=27% Similarity=0.461 Sum_probs=143.0
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCCCccccCCCCCCccc
Q 024809 16 AGRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 94 (262)
Q Consensus 16 ~~~l~e~~~~~~~~ql~~aL~~LH~-~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~ 94 (262)
.+.++|..+-++..-+++||.||.. +||+|||+||+|||++..+ ++||||||++.+...........|.+.|||||.
T Consensus 185 k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G--niKlCDFGIsGrlvdSkAhtrsAGC~~YMaPER 262 (391)
T KOG0983|consen 185 KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG--NIKLCDFGISGRLVDSKAHTRSAGCAAYMAPER 262 (391)
T ss_pred cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC--CEEeecccccceeecccccccccCCccccCccc
Confidence 4579999999999999999999986 5899999999999998877 999999999988877766777889999999999
Q ss_pred ccC---CcCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh-hHHHHHhcccccccccCCCcccCCHHHHHHHHHhcccCCC
Q 024809 95 LTK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP-KNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSE 170 (262)
Q Consensus 95 ~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~ 170 (262)
+.- ..|+.. +||||||+.++||.||+.||.+.+.. +.+.++++ .....+|....+|+++++|+..||++|+.
T Consensus 263 idp~~~~kYDiR-aDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln---~ePP~L~~~~gFSp~F~~fv~~CL~kd~r 338 (391)
T KOG0983|consen 263 IDPPDKPKYDIR-ADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN---EEPPLLPGHMGFSPDFQSFVKDCLTKDHR 338 (391)
T ss_pred cCCCCCCccchh-hhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh---cCCCCCCcccCcCHHHHHHHHHHhhcCcc
Confidence 853 456655 89999999999999999999986543 33333333 22244555556999999999999999999
Q ss_pred CCCCHhHHhcCccccccCCcc
Q 024809 171 KRITIPEIKNHPWFLRNLPIE 191 (262)
Q Consensus 171 ~R~s~~e~l~hp~~~~~~~~~ 191 (262)
+||...++|+|||+..+.+.+
T Consensus 339 ~RP~Y~~Ll~h~Fi~~ye~a~ 359 (391)
T KOG0983|consen 339 KRPKYNKLLEHPFIKRYETAE 359 (391)
T ss_pred cCcchHHHhcCcceeecchhh
Confidence 999999999999998765544
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=248.95 Aligned_cols=179 Identities=34% Similarity=0.549 Sum_probs=145.7
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||++||+|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++ .++|+|||+++.... .
T Consensus 76 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~---~ 150 (260)
T cd05611 76 MEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTG--HLKLTDFGLSRNGLE---N 150 (260)
T ss_pred EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC--cEEEeecccceeccc---c
Confidence 69999999999999888899999999999999999999999999999999999998766 899999999875332 3
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 160 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 160 (262)
....|++.|+|||.+.+..+. .++|+||+|+++|+|++|..||...+....+........ .+.......+++++.++
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 227 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDD-KMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRI--NWPEEVKEFCSPEAVDL 227 (260)
T ss_pred ccCCCCcCccChhhhcCCCCc-chhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc--CCCCcccccCCHHHHHH
Confidence 345688999999998876654 458999999999999999999987655433332221111 11111122578999999
Q ss_pred HHHhcccCCCCCCCH---hHHhcCcccccc
Q 024809 161 LSRIFVANSEKRITI---PEIKNHPWFLRN 187 (262)
Q Consensus 161 i~~~L~~dp~~R~s~---~e~l~hp~~~~~ 187 (262)
+.+||+.+|++||++ +|++.||||.+.
T Consensus 228 i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 228 INRLLCMDPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred HHHHccCCHHHccCCCcHHHHHcChHhhcC
Confidence 999999999999955 799999999753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=289.95 Aligned_cols=179 Identities=30% Similarity=0.456 Sum_probs=150.5
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
||||+||+|.+.+...+-.+|-..+.+..|++.|+.|||+.|||||||||+||+++.++ .+|++|||.|.......
T Consensus 1313 MEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g--~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNG--LIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCC--cEEeecccceeEecCchhc
Confidence 89999999999999888889999999999999999999999999999999999999888 89999999997654332
Q ss_pred ---CCCccccCCCCCCcccccCCc--CCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccC
Q 024809 79 ---QPKSTVGTPAYIAPEVLTKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRV 153 (262)
Q Consensus 79 ---~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (262)
..+...||+.|||||++.+.. -...++|||||||+..||+||+.||...++.-+++-. .-......+|+ .+
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~--V~~gh~Pq~P~--~l 1466 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYH--VAAGHKPQIPE--RL 1466 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhH--HhccCCCCCch--hh
Confidence 223568999999999997643 2244589999999999999999999887654333222 22233445666 49
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhcCcccc
Q 024809 154 SLECKHLLSRIFVANSEKRITIPEIKNHPWFL 185 (262)
Q Consensus 154 ~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~ 185 (262)
|++.++||.+||+.||++|.++.|+++|-|-+
T Consensus 1467 s~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1467 SSEGRDFLEHCLEQDPKMRWTASQLLEHAFGK 1498 (1509)
T ss_pred hHhHHHHHHHHHhcCchhhhHHHHHHHhhccc
Confidence 99999999999999999999999999998865
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=248.63 Aligned_cols=177 Identities=27% Similarity=0.431 Sum_probs=141.6
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH- 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~- 77 (262)
|||+.||+|.+++... ..+++..++.++.|++.||.|||+++|+||||||+||+++.++ .++|+|||+++.....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~--~~~l~Dfg~~~~~~~~~ 165 (272)
T cd06637 88 MEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA--EVKLVDFGVSAQLDRTV 165 (272)
T ss_pred EEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCC--CEEEccCCCceeccccc
Confidence 7999999999999863 3689999999999999999999999999999999999998776 8999999998754322
Q ss_pred CCCCccccCCCCCCcccccC-----CcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCccc
Q 024809 78 SQPKSTVGTPAYIAPEVLTK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR 152 (262)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (262)
.......|++.|+|||++.. ..++ .++|+||+||++|+|++|+.||.............. ..........
T Consensus 166 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~-~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~ 240 (272)
T cd06637 166 GRRNTFIGTPYWMAPEVIACDENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR----NPAPRLKSKK 240 (272)
T ss_pred ccCCcccccccccCHhHhccccCcCCCCC-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc----CCCCCCCCCC
Confidence 22344678999999999863 2343 448999999999999999999976543332222111 1111112235
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 153 VSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 153 ~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
++.++++|+.+||..+|.+|||+.+++.||||
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 241 WSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 78899999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=248.40 Aligned_cols=181 Identities=31% Similarity=0.466 Sum_probs=145.7
Q ss_pred CCCCCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC
Q 024809 1 MEYAAGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~---~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~ 77 (262)
|||++|++|.+++... +.+++..++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~--~~~l~df~~~~~~~~~ 155 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDG--SVKIADFGVSASLADG 155 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC--CEEEcccchHHHhccC
Confidence 6899999999999764 4599999999999999999999999999999999999998776 8999999998654432
Q ss_pred CC-----CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccC-CCcc
Q 024809 78 SQ-----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF-PDYV 151 (262)
Q Consensus 78 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 151 (262)
.. .....|+..|+|||.+......+.++|+||+||++|+|++|+.||........+.+....... .... ....
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 234 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPP-SLETGADYK 234 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCC-CcCCccccc
Confidence 22 133468999999999877633345589999999999999999999876554444443332111 1111 1123
Q ss_pred cCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 152 RVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 152 ~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
.+++++++++.+||..+|.+|||++++++||||
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 235 KYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred cccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 678899999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=250.49 Aligned_cols=182 Identities=25% Similarity=0.403 Sum_probs=144.2
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-C
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-Q 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (262)
|||++|++|..++.....+++..++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++....... .
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG--QIKLCDFGFARILTGPGDD 156 (286)
T ss_pred EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCC--cEEECccccceecCCCccc
Confidence 79999999988887777899999999999999999999999999999999999998776 89999999997554332 2
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccc---cc------------c
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIL---SV------------H 144 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~---~~------------~ 144 (262)
.....++..|+|||.+.+....+.++|+||+|+++|+|++|+.||.+....+.......... .. .
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence 23456888999999987644444558999999999999999999987665443322211100 00 0
Q ss_pred ccCC----------CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 145 YSFP----------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 145 ~~~~----------~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
...+ ....++..+.+|+.+||..+|++|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0001 012467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=256.28 Aligned_cols=183 Identities=25% Similarity=0.367 Sum_probs=134.1
Q ss_pred CCCCCCCchHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC--CCCcEEEeccC
Q 024809 1 MEYAAGGELFERICNA---------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS--TAPRVKICDFG 69 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~---------~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~--~~~~~kl~Dfg 69 (262)
|||+.+ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+... ..+++||+|||
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 79 FDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 688875 888877521 248999999999999999999999999999999999999432 23379999999
Q ss_pred CCcCCCCCC----CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh---------hHHHHH
Q 024809 70 YSKSSVLHS----QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP---------KNFRKT 136 (262)
Q Consensus 70 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------~~~~~~ 136 (262)
+++...... ......||+.|+|||++.+....+.++||||+||++|+|+||+.||...... ..+...
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 997543221 1234578999999999877554456689999999999999999999754321 111111
Q ss_pred hccccc------------------------cccc--------CCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 137 IGRILS------------------------VHYS--------FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 137 ~~~~~~------------------------~~~~--------~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
...... .... .......+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 100000 0000 00011245678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=259.21 Aligned_cols=182 Identities=31% Similarity=0.585 Sum_probs=144.4
Q ss_pred CCCCCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||++||+|.+++.. .+.+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~--~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNG--HIRLADFGSCLKMNQDGT 157 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCC--CEEEEeccceeeccCCCc
Confidence 799999999999987 46799999999999999999999999999999999999998776 899999999875433221
Q ss_pred --CCccccCCCCCCcccccCC----cCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCC-ccc
Q 024809 80 --PKSTVGTPAYIAPEVLTKK----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD-YVR 152 (262)
Q Consensus 80 --~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 152 (262)
.....||+.|+|||++.+. ...+.++||||+||++|+|++|+.||........+.++.... ....+|. ...
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~~~ 235 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHE--ERFQFPSHITD 235 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCC--CcccCCCcccc
Confidence 1235799999999998652 222445899999999999999999998765544444433221 1122332 235
Q ss_pred CCHHHHHHHHHhcccCCCC--CCCHhHHhcCccccc
Q 024809 153 VSLECKHLLSRIFVANSEK--RITIPEIKNHPWFLR 186 (262)
Q Consensus 153 ~~~~~~~li~~~L~~dp~~--R~s~~e~l~hp~~~~ 186 (262)
++.+++++|.+||..++.+ |++++++++||||..
T Consensus 236 ~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 236 VSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred CCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 7899999999999876654 569999999999974
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=247.30 Aligned_cols=179 Identities=36% Similarity=0.648 Sum_probs=148.7
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||++||+|.+++.+...+++..+..++.||+.||.|||++|++|+||||+||+++.++ .++|+|||+++........
T Consensus 72 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~--~~~l~df~~~~~~~~~~~~ 149 (262)
T cd05572 72 MEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNG--YVKLVDFGFAKKLKSGQKT 149 (262)
T ss_pred EecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCC--CEEEeeCCcccccCccccc
Confidence 68999999999999888899999999999999999999999999999999999998776 8999999999865443333
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCC--hhHHHHHhcccccccccCCCcccCCHHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPED--PKNFRKTIGRILSVHYSFPDYVRVSLECK 158 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (262)
....|++.|++||.+....++.+ +|+||+|+++|+|++|..||..... ......... ......+|. ..+.+++
T Consensus 150 ~~~~~~~~~~~PE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~--~~~~~~~ 224 (262)
T cd05572 150 WTFCGTPEYVAPEIILNKGYDFS-VDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK--GNGKLEFPN--YIDKAAK 224 (262)
T ss_pred ccccCCcCccChhHhcCCCCCCh-hhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhc--cCCCCCCCc--ccCHHHH
Confidence 44678999999999877666554 8999999999999999999987652 222222221 122333444 3488999
Q ss_pred HHHHHhcccCCCCCCC-----HhHHhcCccccc
Q 024809 159 HLLSRIFVANSEKRIT-----IPEIKNHPWFLR 186 (262)
Q Consensus 159 ~li~~~L~~dp~~R~s-----~~e~l~hp~~~~ 186 (262)
++|.+||..+|.+||+ ++|+++||||+.
T Consensus 225 ~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 225 DLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred HHHHHHccCChhhCcCCcccCHHHHhcChhhhC
Confidence 9999999999999999 999999999975
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=244.69 Aligned_cols=176 Identities=27% Similarity=0.495 Sum_probs=143.7
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH- 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~- 77 (262)
|||++||+|.+++... ..+++..++.++.|++.||.+||++|++||||||+||+++.++ .++|+|||++......
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~--~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTN--IIKVGDLGIARVLENQC 156 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCC--cEEEecccceEEecccC
Confidence 7999999999999763 3589999999999999999999999999999999999998766 8999999998754322
Q ss_pred CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHH
Q 024809 78 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 157 (262)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (262)
.......|++.|+|||++.+..++.+ +|+||+|+++|+|++|+.||...+............. ...+ ...++++
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~---~~~~--~~~~~~~ 230 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYK-SDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL---PPMP--KDYSPEL 230 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC---CCCc--cccCHHH
Confidence 22334568999999999987766544 8999999999999999999986554333222222111 1122 3578899
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 158 KHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
.+++.+||..+|.+|||+.+++.||||
T Consensus 231 ~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 231 GELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=273.16 Aligned_cols=172 Identities=32% Similarity=0.561 Sum_probs=147.1
Q ss_pred CCCCCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC
Q 024809 1 MEYAAGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQ--ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~aL~~LH~~~--ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (262)
||||.||.|-+++.. ..+|+|.++++|++|+++|+.+||... |||||||-+||||..++ ++||||||.|.....
T Consensus 121 mEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g--~~KLCDFGSatt~~~ 198 (738)
T KOG1989|consen 121 MEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG--NYKLCDFGSATTKIL 198 (738)
T ss_pred hhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC--CEEeCcccccccccC
Confidence 899999999999974 346999999999999999999999998 99999999999998887 899999999864332
Q ss_pred CCCCC----------ccccCCCCCCccccc---CCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc
Q 024809 77 HSQPK----------STVGTPAYIAPEVLT---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV 143 (262)
Q Consensus 77 ~~~~~----------~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 143 (262)
..... ....|+.|+|||++. +...+.+ +|||+|||+||.|+....||+.... ..|...
T Consensus 199 ~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eK-sDIWALGclLYkLCy~t~PFe~sg~--------laIlng 269 (738)
T KOG1989|consen 199 SPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEK-SDIWALGCLLYKLCYFTTPFEESGK--------LAILNG 269 (738)
T ss_pred CCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcch-hHHHHHHHHHHHHHHhCCCcCcCcc--------eeEEec
Confidence 22111 135799999999974 4556555 8999999999999999999987543 247788
Q ss_pred cccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcc
Q 024809 144 HYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPW 183 (262)
Q Consensus 144 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~ 183 (262)
.|.+|.+.+++..+++||+.||+.||.+||++-|++.+-+
T Consensus 270 ~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 270 NYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred cccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 9999999999999999999999999999999999887533
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=247.12 Aligned_cols=179 Identities=28% Similarity=0.450 Sum_probs=141.5
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-CC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (262)
|||++||+|.+++...+.+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||++...... ..
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~--~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNG--HVKLADFGVSAQITATIAK 162 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--CEEECcceeeeEccCcccc
Confidence 79999999999999888999999999999999999999999999999999999998776 8999999998654322 12
Q ss_pred CCccccCCCCCCccccc---CCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHH
Q 024809 80 PKSTVGTPAYIAPEVLT---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 156 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (262)
.....|+..|+|||.+. ...+ ..++|+||+||++|+|++|..||................. ..........++..
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~-~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 240 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNF-QPPKLKDKMKWSNS 240 (267)
T ss_pred cccccCcccccChhhhccccCCCC-CchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCC-CCCcccccCCCCHH
Confidence 23457999999999974 2334 3458999999999999999999975443222221111100 01111222357788
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcCcc
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKNHPW 183 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~hp~ 183 (262)
+.++|.+||..+|++|||+.++++|||
T Consensus 241 ~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 241 FHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=246.52 Aligned_cols=176 Identities=35% Similarity=0.560 Sum_probs=144.8
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
|||++|++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||.++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~--~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06628 85 LEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKG--GIKISDFGISKKLEANSLS 162 (267)
T ss_pred EEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCC--CEEecccCCCccccccccc
Confidence 68999999999999888899999999999999999999999999999999999998776 89999999987553211
Q ss_pred -----CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccC
Q 024809 79 -----QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRV 153 (262)
Q Consensus 79 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (262)
......|+..|+|||.+.+..++.. +|+||+||++|+|++|+.||.............. ......+. .+
T Consensus 163 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~--~~ 236 (267)
T cd06628 163 TKTNGARPSLQGSVFWMAPEVVKQTSYTRK-ADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE---NASPEIPS--NI 236 (267)
T ss_pred CCccccccccCCCcCccChhHhccCCCCch-hhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc---cCCCcCCc--cc
Confidence 1123458889999999987766544 8999999999999999999987654333322211 11112222 57
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 154 SLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 154 ~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
+.+++++|++||+.+|.+||++.++++||||
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 237 SSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 8899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=250.04 Aligned_cols=175 Identities=41% Similarity=0.722 Sum_probs=147.7
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||++||+|.+++...+.+++..+..++.||+.||.|||++|++||||+|.||+++.++ .+||+|||+++..... .
T Consensus 80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~--~~kl~dfg~~~~~~~~--~ 155 (290)
T cd05580 80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG--YIKITDFGFAKRVKGR--T 155 (290)
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC--CEEEeeCCCccccCCC--C
Confidence 79999999999999888999999999999999999999999999999999999998776 8999999999865332 3
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 160 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 160 (262)
....|++.|+|||.+.+...+ .++|+||||+++|+|++|+.||............ ......+|. ..+..++++
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~--~~~~~l~~l 228 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGYG-KAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI----LEGKVRFPS--FFSPDAKDL 228 (290)
T ss_pred CCCCCCccccChhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----hcCCccCCc--cCCHHHHHH
Confidence 445789999999998776654 4489999999999999999999876533323322 222333444 468899999
Q ss_pred HHHhcccCCCCCC-----CHhHHhcCccccc
Q 024809 161 LSRIFVANSEKRI-----TIPEIKNHPWFLR 186 (262)
Q Consensus 161 i~~~L~~dp~~R~-----s~~e~l~hp~~~~ 186 (262)
|.+||..+|.+|+ +++++++||||..
T Consensus 229 i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 259 (290)
T cd05580 229 IRNLLQVDLTKRLGNLKNGVNDIKNHPWFAG 259 (290)
T ss_pred HHHHccCCHHHccCcccCCHHHHHcCccccc
Confidence 9999999999999 9999999999965
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=252.92 Aligned_cols=179 Identities=36% Similarity=0.623 Sum_probs=147.8
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||+.||+|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESG--HIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCC--CEEEeecchhhcccccc
Confidence 6899999999998754 4699999999999999999999999999999999999998776 89999999986432211
Q ss_pred ------------------------------CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 024809 79 ------------------------------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 128 (262)
Q Consensus 79 ------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 128 (262)
......||..|+|||++.+..++ .++||||||+++|+|++|..||.+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHG-SAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCC-chHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 01134688899999999877665 45899999999999999999998776
Q ss_pred ChhHHHHHhcccccccccCCCcccCCHHHHHHHHHhcccCCCCCCC----HhHHhcCccccc
Q 024809 129 DPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRIT----IPEIKNHPWFLR 186 (262)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s----~~e~l~hp~~~~ 186 (262)
....+..... ....++....++.+++++|.+||..+|++||| +++++.||||+.
T Consensus 237 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~ 294 (316)
T cd05574 237 RDETFSNILK----KEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294 (316)
T ss_pred hHHHHHHHhc----CCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence 6555444332 22334444447899999999999999999999 999999999974
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=254.59 Aligned_cols=156 Identities=24% Similarity=0.413 Sum_probs=123.0
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC---CCCccccCCCCCCccc
Q 024809 18 RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEV 94 (262)
Q Consensus 18 ~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~ 94 (262)
.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...... ......+++.|+|||+
T Consensus 170 ~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~--~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 247 (338)
T cd05102 170 PLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPES 247 (338)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC--cEEEeecccccccccCcchhcccCCCCCccccCcHH
Confidence 478889999999999999999999999999999999998776 89999999997543211 1123346678999999
Q ss_pred ccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHHHHHhcccCCCCCC
Q 024809 95 LTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI 173 (262)
Q Consensus 95 ~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~ 173 (262)
+.+..++.+ +||||+||++|+|++ |..||.+......+...+... .....+ ...++++.+++.+||..||.+||
T Consensus 248 ~~~~~~~~~-sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~--~~~~~~l~~li~~cl~~dp~~RP 322 (338)
T cd05102 248 IFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDG--TRMRAP--ENATPEIYRIMLACWQGDPKERP 322 (338)
T ss_pred hhcCCCCcc-cCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcC--CCCCCC--CCCCHHHHHHHHHHccCChhhCc
Confidence 987777655 899999999999997 999998755433333322211 111222 25788999999999999999999
Q ss_pred CHhHHhc
Q 024809 174 TIPEIKN 180 (262)
Q Consensus 174 s~~e~l~ 180 (262)
|+.++++
T Consensus 323 s~~el~~ 329 (338)
T cd05102 323 TFSALVE 329 (338)
T ss_pred CHHHHHH
Confidence 9999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=255.23 Aligned_cols=216 Identities=23% Similarity=0.356 Sum_probs=160.5
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||+ |++|.+++.. +++++..++.++.|++.||.|||+.||+||||||+||+++.++ .++|+|||++..... ..
T Consensus 99 ~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~--~~kL~dfg~~~~~~~--~~ 172 (343)
T cd07851 99 THLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC--ELKILDFGLARHTDD--EM 172 (343)
T ss_pred EecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC--CEEEccccccccccc--cc
Confidence 5777 6799998876 4699999999999999999999999999999999999998776 899999999975432 23
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccc----------------
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH---------------- 144 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---------------- 144 (262)
....++..|+|||.+.+....+.++||||+||++|+|++|+.||.+......+..+........
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 252 (343)
T cd07851 173 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYI 252 (343)
T ss_pred cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHH
Confidence 4457889999999986643444558999999999999999999987665444333222111000
Q ss_pred --------ccC-CCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCCccccCCCCccccCCCCCCCCHHHHHH
Q 024809 145 --------YSF-PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLS 215 (262)
Q Consensus 145 --------~~~-~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (262)
..+ ......+.++.+||.+||..+|.+|||+.++++||||.+....+...........+.+..-.+.++..
T Consensus 253 ~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (343)
T cd07851 253 QSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPVAPPYDQSFESRDLTVDEWKE 332 (343)
T ss_pred HhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcccccccccCcchhhhhcCHHHHHH
Confidence 000 01124688999999999999999999999999999998765544322222222334444556677777
Q ss_pred HhHHhcC
Q 024809 216 LIHEATK 222 (262)
Q Consensus 216 ~~~~~~~ 222 (262)
+++....
T Consensus 333 ~~~~~~~ 339 (343)
T cd07851 333 LVYKEIM 339 (343)
T ss_pred HhHHHHH
Confidence 7766543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=268.26 Aligned_cols=183 Identities=32% Similarity=0.534 Sum_probs=152.5
Q ss_pred CCCCCCCchHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC-
Q 024809 1 MEYAAGGELFERICNA-GRF--SEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL- 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l--~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~- 76 (262)
||-++||+|.+++... |++ +|..+.+|.+||++||.|||.+.|||||||.+|+||+.- .+.+||+|||-+++...
T Consensus 651 MEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTy-SGvlKISDFGTsKRLAgi 729 (1226)
T KOG4279|consen 651 MEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTY-SGVLKISDFGTSKRLAGI 729 (1226)
T ss_pred eecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeec-cceEEecccccchhhccC
Confidence 8999999999999754 677 899999999999999999999999999999999999643 34899999999886543
Q ss_pred CCCCCccccCCCCCCcccccCCc-CCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 77 HSQPKSTVGTPAYIAPEVLTKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 77 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
.....++.||..|||||++..+. -+++++|||||||++.||.||++||.....++..+..+.. .+.....|. .+|.
T Consensus 730 nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGm-yKvHP~iPe--elsa 806 (1226)
T KOG4279|consen 730 NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGM-YKVHPPIPE--ELSA 806 (1226)
T ss_pred CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcc-eecCCCCcH--HHHH
Confidence 33456788999999999997643 3578899999999999999999999887776554332221 223334454 6889
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
+++.||.+|++.+|.+||+|+++|+.||++..
T Consensus 807 eak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 807 EAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred HHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 99999999999999999999999999999754
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=251.00 Aligned_cols=183 Identities=25% Similarity=0.471 Sum_probs=142.9
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (262)
|||+. |+|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++ .++|+|||++.......
T Consensus 83 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 83 FEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERG--ELKLADFGLARAKSIPTK 159 (301)
T ss_pred Eeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCC--cEEECcCcchhccCCCCC
Confidence 68997 4999988764 4699999999999999999999999999999999999998776 89999999987543222
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccc---------------c
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS---------------V 143 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------------~ 143 (262)
......+++.|+|||.+.+....+.++|||||||++|+|++|+.||...+..+........... .
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 2233567899999999876554455689999999999999999999876544333222111100 0
Q ss_pred cccCCC---------cccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 144 HYSFPD---------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 144 ~~~~~~---------~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
...++. ...+++++++||.+||+.||.+|||++++++||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 011111 1247889999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=266.41 Aligned_cols=181 Identities=41% Similarity=0.711 Sum_probs=162.0
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||+.||++++|+.+++++.+..++.++.|+++|++|||+++|||||||.+|||++.+. ++||+|||++..+......
T Consensus 134 ~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~m--nikIaDfgfS~~~~~~~~l 211 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENM--NIKIADFGFSTFFDYGLML 211 (596)
T ss_pred EEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccccc--ceeeeccccceeecccccc
Confidence 79999999999999999999999999999999999999999999999999999998776 7999999999988777778
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 160 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 160 (262)
.+.+|++.|.|||++.+..|+++.+|+||+|+++|.|++|..||.+..-+. .-.+.....+..|. .++.+|.++
T Consensus 212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~----Lr~rvl~gk~rIp~--~ms~dce~l 285 (596)
T KOG0586|consen 212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE----LRPRVLRGKYRIPF--YMSCDCEDL 285 (596)
T ss_pred cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc----ccchheeeeecccc--eeechhHHH
Confidence 899999999999999999999999999999999999999999999854332 22233444555555 588899999
Q ss_pred HHHhcccCCCCCCCHhHHhcCccccccCC
Q 024809 161 LSRIFVANSEKRITIPEIKNHPWFLRNLP 189 (262)
Q Consensus 161 i~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 189 (262)
|+++|..+|.+|++.++++.|.|......
T Consensus 286 Lrk~lvl~Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 286 LRKFLVLNPSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred HHHhhccCccccCCHHHhhhhcccchhhh
Confidence 99999999999999999999999975443
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=245.24 Aligned_cols=178 Identities=25% Similarity=0.432 Sum_probs=144.3
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC----
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL---- 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~---- 76 (262)
|||++||+|.+++.+.+.+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG--IIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCC--eEEeccchhhHhhhhcccc
Confidence 69999999999999888899999999999999999999999999999999999998776 899999999864321
Q ss_pred ---CCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccC
Q 024809 77 ---HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRV 153 (262)
Q Consensus 77 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (262)
........|+..|+|||.+.+..++.. +|+||+||++|+|++|+.||...+........... .......+ ..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~--~~~ 234 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVINESGYGRK-SDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAH-RGLMPRLP--DSF 234 (265)
T ss_pred ccccccccccCCCccccChhhhcCCCCcch-hhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhc-cCCCCCCC--CCC
Confidence 111233568999999999987766544 89999999999999999999865543332221111 01111122 257
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 154 SLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 154 ~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
+.++.++|++||..+|.+||++.++++||||
T Consensus 235 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 8899999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=249.58 Aligned_cols=171 Identities=23% Similarity=0.274 Sum_probs=141.0
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~-~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
||||+||+|.+++.+.+.+++.....++.|++.||.|||+. +++||||||+||+++.++ .+||+|||+++.... .
T Consensus 101 ~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~--~~kl~dfg~~~~~~~--~ 176 (283)
T PHA02988 101 LEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY--KLKIICHGLEKILSS--P 176 (283)
T ss_pred EEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC--cEEEcccchHhhhcc--c
Confidence 79999999999999888899999999999999999999984 999999999999998877 899999999875422 2
Q ss_pred CCccccCCCCCCcccccC--CcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHH
Q 024809 80 PKSTVGTPAYIAPEVLTK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 157 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (262)
.....|++.|+|||++.+ ..++ .++|||||||++|+|++|+.||.+....+.+....... ....+| ...++++
T Consensus 177 ~~~~~~~~~y~aPE~~~~~~~~~~-~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~--~~~~~~l 251 (283)
T PHA02988 177 PFKNVNFMVYFSYKMLNDIFSEYT-IKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKN--NSLKLP--LDCPLEI 251 (283)
T ss_pred cccccCcccccCHHHhhhcccccc-chhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcC--CCCCCC--CcCcHHH
Confidence 234578999999999975 4554 45899999999999999999998765544433332221 112222 2578999
Q ss_pred HHHHHHhcccCCCCCCCHhHHhc
Q 024809 158 KHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
++|+.+||+.||++|||+.++++
T Consensus 252 ~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 252 KCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHHHHHhcCCcccCcCHHHHHH
Confidence 99999999999999999999986
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=253.75 Aligned_cols=183 Identities=24% Similarity=0.417 Sum_probs=138.3
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||++||+|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.++ .++++||+.+.......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~--~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 78 TSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG--KVYLSGLRSNLSMINHG 155 (327)
T ss_pred EeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCC--cEEEcccchhhcccccc
Confidence 7999999999999753 4599999999999999999999999999999999999998776 89999998654322111
Q ss_pred C--------CCccccCCCCCCcccccCC--cCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc-----
Q 024809 79 Q--------PKSTVGTPAYIAPEVLTKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV----- 143 (262)
Q Consensus 79 ~--------~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----- 143 (262)
. .....++..|+|||++.+. .++ .++||||+||++|+|++|+.||...................
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTT 234 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCC-chhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCcccccccc
Confidence 1 1223567789999998763 344 45899999999999999999997644332222211110000
Q ss_pred -----------------------------------cccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 144 -----------------------------------HYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 144 -----------------------------------~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
....+....+++++++||.+||+.||++|||+.++++||||++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 0000111235678999999999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=247.95 Aligned_cols=181 Identities=25% Similarity=0.441 Sum_probs=138.6
Q ss_pred CCCCCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-
Q 024809 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (262)
|||+.| +|.+++.+ .+.+++..++.++.||++||.|||++|++||||||+||+++.++ .++|+|||+++......
T Consensus 78 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~--~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 78 FEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNG--ELKLADFGLARAFGIPVR 154 (284)
T ss_pred EecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCC--cEEECccchhhccCCCCC
Confidence 689975 88888765 56799999999999999999999999999999999999998776 89999999987543221
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCC-hhHHHHHhccccc-------------cc
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPED-PKNFRKTIGRILS-------------VH 144 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~~~~~~~~-------------~~ 144 (262)
......+++.|+|||.+.+....+.++||||+||++|+|++|..||....+ ...+..+...... ..
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 223456789999999987655445558999999999999999888644333 2222222111100 00
Q ss_pred ccCC----------CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 145 YSFP----------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 145 ~~~~----------~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
..++ ....+++++++||.+||..||.+|||+++++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0000 112478899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=255.50 Aligned_cols=180 Identities=33% Similarity=0.597 Sum_probs=164.7
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
||-|-||+|+..+..++.|.+..++.|+..++.|++|||++|||+|||||+|++++.++ -+||.|||+|+......+.
T Consensus 499 mEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~G--y~KLVDFGFAKki~~g~KT 576 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRG--YLKLVDFGFAKKIGSGRKT 576 (732)
T ss_pred HHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCC--ceEEeehhhHHHhccCCce
Confidence 78899999999999999999999999999999999999999999999999999998887 8999999999999888899
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 160 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 160 (262)
++++|||.|.|||++.+.+.+.. +|.||||+++|||++|.+||.+.+....+..+++.+-. ..+|. .++..+.+|
T Consensus 577 wTFcGTpEYVAPEIILnKGHD~a-vDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~--i~~Pr--~I~k~a~~L 651 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHDRA-VDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK--IEFPR--RITKTATDL 651 (732)
T ss_pred eeecCCcccccchhhhccCcchh-hHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh--hhccc--ccchhHHHH
Confidence 99999999999999999998755 89999999999999999999999888888777766543 34554 788899999
Q ss_pred HHHhcccCCCCCCC-----HhHHhcCcccccc
Q 024809 161 LSRIFVANSEKRIT-----IPEIKNHPWFLRN 187 (262)
Q Consensus 161 i~~~L~~dp~~R~s-----~~e~l~hp~~~~~ 187 (262)
|+++-..+|.+|.. +.+|..|.||...
T Consensus 652 ik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gf 683 (732)
T KOG0614|consen 652 IKKLCRDNPTERLGYQKGGINDIKKHRWFEGF 683 (732)
T ss_pred HHHHHhcCcHhhhccccCChHHHHhhhhhhcC
Confidence 99999999999985 7899999999643
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=261.74 Aligned_cols=179 Identities=29% Similarity=0.457 Sum_probs=146.3
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC-CC
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~ 78 (262)
.|||.||-...++..-+ .|++.++..+++|++.||.|||+++|||||||..|||++.+| .++|+|||.+..... ..
T Consensus 108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldG--dirLADFGVSAKn~~t~q 185 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDG--DIRLADFGVSAKNKSTRQ 185 (1187)
T ss_pred EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecC--cEeeecccccccchhHHh
Confidence 48999999988876543 699999999999999999999999999999999999998888 899999999754332 23
Q ss_pred CCCccccCCCCCCcccccC-----CcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc-cccCCCccc
Q 024809 79 QPKSTVGTPAYIAPEVLTK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-HYSFPDYVR 152 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 152 (262)
...+++|||+|||||+..+ .+|+.+ +||||||+.|.+|.-+.+|-...+....+.+ +.+. ...+-....
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDyk-aDiWSlGITLIEMAqiEPPHhelnpMRVllK----iaKSePPTLlqPS~ 260 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYK-ADIWSLGITLIEMAQIEPPHHELNPMRVLLK----IAKSEPPTLLQPSH 260 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhh-hhHHhhhhHHHHHhccCCCccccchHHHHHH----HhhcCCCcccCcch
Confidence 4567899999999999743 456655 8999999999999999999876544333322 2222 112222337
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 153 VSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 153 ~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
++..+.||+.+||.+||..||++.++|.||||..
T Consensus 261 Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~ 294 (1187)
T KOG0579|consen 261 WSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQN 294 (1187)
T ss_pred hhhHHHHHHHHHHhcCCccCCCHHHHhhCccccc
Confidence 8899999999999999999999999999999974
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=249.42 Aligned_cols=181 Identities=28% Similarity=0.497 Sum_probs=145.9
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-CC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (262)
|||++||+|.+++.. +++++..++.++.||+.||.|||++|++||||||+||+++.++ .++|+|||++...... ..
T Consensus 98 ~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~--~~kL~dfg~~~~~~~~~~~ 174 (292)
T cd06658 98 MEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDG--RIKLSDFGFCAQVSKEVPK 174 (292)
T ss_pred EeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC--CEEEccCcchhhccccccc
Confidence 799999999998754 4699999999999999999999999999999999999998776 8999999998654322 12
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....|+..|+|||.+.+..++. ++|+||+|+++|+|++|+.||........+.... ... ....+.....+..+.+
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~ 250 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGT-EVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIR-DNL--PPRVKDSHKVSSVLRG 250 (292)
T ss_pred CceeecCccccCHHHHccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hcC--CCccccccccCHHHHH
Confidence 23457899999999997766654 4899999999999999999998755443332221 111 1122233357889999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCccccccC
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWFLRNL 188 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 188 (262)
++.+||..+|.+|||++++++||||....
T Consensus 251 li~~~l~~~P~~Rpt~~~il~~~~~~~~~ 279 (292)
T cd06658 251 FLDLMLVREPSQRATAQELLQHPFLKLAG 279 (292)
T ss_pred HHHHHccCChhHCcCHHHHhhChhhhccC
Confidence 99999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=247.86 Aligned_cols=181 Identities=24% Similarity=0.398 Sum_probs=139.9
Q ss_pred CCCCCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC
Q 024809 1 MEYAAGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~---~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~ 77 (262)
|||++ |+|.+++... +.+++..++.++.||+.||.|||++|++||||||+||+++.++ .++|+|||++......
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 78 FEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKG--VIKLADFGLARAFGIP 154 (285)
T ss_pred EecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCC--cEEECcccceeecCCC
Confidence 68998 5898888643 4699999999999999999999999999999999999998777 8999999998754322
Q ss_pred C-CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccc--------------
Q 024809 78 S-QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS-------------- 142 (262)
Q Consensus 78 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-------------- 142 (262)
. ......+++.|+|||.+.+....+.++|+|||||++|+|+||+.||.+................
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 1 1233467899999999876544345589999999999999999999875543332222111100
Q ss_pred ccccC---------CCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 143 VHYSF---------PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 143 ~~~~~---------~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
....+ .....++++++++|++||..||.+|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 00000 0123478899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=251.04 Aligned_cols=216 Identities=24% Similarity=0.328 Sum_probs=155.1
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
|||+. ++|.+.+.....+++..++.++.||+.||.|||++|++||||||+||+++.++ .+||+|||+++......
T Consensus 85 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~--~~kl~Dfg~a~~~~~~~~~ 161 (332)
T cd07857 85 EELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADC--ELKICDFGLARGFSENPGE 161 (332)
T ss_pred Eeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCC--CEEeCcCCCceeccccccc
Confidence 46775 69999998888899999999999999999999999999999999999998776 89999999997543221
Q ss_pred ---CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccc-----------c--
Q 024809 79 ---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIL-----------S-- 142 (262)
Q Consensus 79 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-----------~-- 142 (262)
......|++.|+|||.+.+....+.++||||+||++|+|++|..||........+...+.... .
T Consensus 162 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (332)
T cd07857 162 NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPK 241 (332)
T ss_pred ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhh
Confidence 122357899999999876643334558999999999999999999987553332222111100 0
Q ss_pred -----------ccccCC-CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCCccccCCCCccccCCCCCCCCH
Q 024809 143 -----------VHYSFP-DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSL 210 (262)
Q Consensus 143 -----------~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (262)
....++ .....+..+.+|+.+||+.+|.+|||+.+++.|||+.+..........+...+..-....++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (332)
T cd07857 242 AQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFDFSFESEDSM 321 (332)
T ss_pred HHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccccccccccCCccccccH
Confidence 000011 12246788999999999999999999999999999987654322222111111112233556
Q ss_pred HHHHHHhHH
Q 024809 211 EEVLSLIHE 219 (262)
Q Consensus 211 ~~~~~~~~~ 219 (262)
+++...|.+
T Consensus 322 ~~~~~~~~~ 330 (332)
T cd07857 322 EELRDMIIE 330 (332)
T ss_pred HHHHHHHhh
Confidence 666665543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=249.46 Aligned_cols=181 Identities=31% Similarity=0.548 Sum_probs=143.9
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~-~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||++||+|.+++.+.+.+++..+..++.|++.||.|||+ .+++||||||+||+++.++ .++|+|||++..... ..
T Consensus 78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~-~~ 154 (308)
T cd06615 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLID-SM 154 (308)
T ss_pred eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC--cEEEccCCCcccccc-cc
Confidence 7999999999999988889999999999999999999998 5999999999999998776 899999999875432 22
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccc-----------------
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS----------------- 142 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~----------------- 142 (262)
.....|++.|+|||.+.+..+. .++|+||+||++|+|++|+.||...+.. .....+.....
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYT-VQSDIWSLGLSLVEMAIGRYPIPPPDAK-ELEAMFGRPVSEGEAKESHRPVSGHPPD 232 (308)
T ss_pred cccCCCCcCccChhHhcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCcchh-hHHHhhcCccccccccCCcccccCCCCC
Confidence 3456789999999998776665 4489999999999999999999754422 11111111000
Q ss_pred -----------------ccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 143 -----------------VHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 143 -----------------~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
.....|. ..++.++++|+.+||..+|++|||+.++++||||.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 233 SPRPMAIFELLDYIVNEPPPKLPS-GAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred ccchhhHHHHHHHHhcCCCccCcC-cccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 0001111 1367889999999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=246.16 Aligned_cols=181 Identities=28% Similarity=0.518 Sum_probs=143.8
Q ss_pred CCCCCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC
Q 024809 1 MEYAAGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~---~~l~e~~~~~~~~ql~~aL~~LH~-~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (262)
|||++||+|.+++... +.+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .++|+|||++.....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~ 155 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG--QVKLCDFGVSGNLVA 155 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC--CEEEeecCCcccccC
Confidence 7999999999988763 379999999999999999999997 5999999999999998766 899999999875432
Q ss_pred CCCCCccccCCCCCCcccccCCcC-----CCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccc-ccccCCCc
Q 024809 77 HSQPKSTVGTPAYIAPEVLTKKEY-----DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS-VHYSFPDY 150 (262)
Q Consensus 77 ~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~ 150 (262)
.......+++.|+|||.+.+... .+.++|+||+||++|+|++|+.||........+.. +..+.. .....+.
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~- 232 (286)
T cd06622 156 -SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQ-LSAIVDGDPPTLPS- 232 (286)
T ss_pred -CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHH-HHHHhhcCCCCCCc-
Confidence 23344568889999999855332 23458999999999999999999976544332222 122221 1122332
Q ss_pred ccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 151 VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 151 ~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
.++.++.+||.+||+.+|.+||++.++++||||...
T Consensus 233 -~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 233 -GYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred -ccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 488999999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=247.54 Aligned_cols=180 Identities=26% Similarity=0.391 Sum_probs=142.4
Q ss_pred CCCCCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC
Q 024809 1 MEYAAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (262)
|||++||+|.+++.. .+.+++..++.++.|++.||.|||+.|++||||||+||+++.++ .+||+|||++.....
T Consensus 103 ~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~--~~kl~dfg~~~~~~~ 180 (291)
T cd06639 103 LELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEG--GVKLVDFGVSAQLTS 180 (291)
T ss_pred EEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC--CEEEeecccchhccc
Confidence 689999999998853 45699999999999999999999999999999999999998776 899999999875433
Q ss_pred CC-CCCccccCCCCCCcccccCCcC----CCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcc
Q 024809 77 HS-QPKSTVGTPAYIAPEVLTKKEY----DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV 151 (262)
Q Consensus 77 ~~-~~~~~~gt~~y~aPE~~~~~~~----~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (262)
.. ......|+..|+|||.+..... .+.++||||+||++|+|++|+.||................ ........
T Consensus 181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~ 257 (291)
T cd06639 181 TRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP---PPTLLHPE 257 (291)
T ss_pred ccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC---CCCCCccc
Confidence 22 2234568899999999864321 2345899999999999999999998765444333322111 11111122
Q ss_pred cCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccc
Q 024809 152 RVSLECKHLLSRIFVANSEKRITIPEIKNHPWFL 185 (262)
Q Consensus 152 ~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~ 185 (262)
..+..+.++|.+||+.+|++||++.++++||||+
T Consensus 258 ~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 258 KWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred ccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 4677899999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=245.89 Aligned_cols=181 Identities=30% Similarity=0.448 Sum_probs=143.9
Q ss_pred CCCCCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-C
Q 024809 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-S 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~ 78 (262)
|||++||+|..++.+ .+.+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++...... .
T Consensus 81 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~--~~kl~dfg~~~~~~~~~~ 158 (282)
T cd06643 81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG--DIKLADFGVSAKNTRTIQ 158 (282)
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCC--CEEEcccccccccccccc
Confidence 689999999988765 45799999999999999999999999999999999999998776 8999999998654322 1
Q ss_pred CCCccccCCCCCCcccccC-----CcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccC
Q 024809 79 QPKSTVGTPAYIAPEVLTK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRV 153 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (262)
......+++.|+|||++.. ..++ .++|+||+||++|+|++|+.||............... .. ...+....+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~-~~--~~~~~~~~~ 234 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYD-YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-EP--PTLAQPSRW 234 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCC-ccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhc-CC--CCCCCcccc
Confidence 2334578999999999842 2233 4589999999999999999999875543333332211 11 111222357
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 154 SLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 154 ~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
+.++++||.+||..+|.+|||+.++++||||...
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 235 SSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 8899999999999999999999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=246.53 Aligned_cols=177 Identities=26% Similarity=0.414 Sum_probs=140.4
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH- 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~- 77 (262)
|||+.+|+|.+++... ..+++..+..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++......
T Consensus 98 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~--~~~l~dfg~~~~~~~~~ 175 (282)
T cd06636 98 MEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENA--EVKLVDFGVSAQLDRTV 175 (282)
T ss_pred EEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEeeCcchhhhhccc
Confidence 7999999999999753 3589999999999999999999999999999999999998776 8999999998754321
Q ss_pred CCCCccccCCCCCCcccccC-----CcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCccc
Q 024809 78 SQPKSTVGTPAYIAPEVLTK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR 152 (262)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (262)
.......|++.|+|||.+.. ..++ .++|+|||||++|+|++|..||............ ............
T Consensus 176 ~~~~~~~~~~~y~aPE~l~~~~~~~~~~~-~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~ 250 (282)
T cd06636 176 GRRNTFIGTPYWMAPEVIACDENPDATYD-YRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI----PRNPPPKLKSKK 250 (282)
T ss_pred cCCCcccccccccCHhhcCcccCcCcCCC-cccchhHHHHHHHHHHhCCCCccccCHHhhhhhH----hhCCCCCCcccc
Confidence 22344678999999999853 2344 3489999999999999999999765433222211 111111111235
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 153 VSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 153 ~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
++.++.+||.+||..||.+|||+.+++.||||
T Consensus 251 ~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 251 WSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred cCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 78899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=254.21 Aligned_cols=184 Identities=27% Similarity=0.426 Sum_probs=144.7
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||+.| +|.+.+... +++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++........
T Consensus 100 ~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~--~~kL~Dfg~~~~~~~~~~~ 174 (353)
T cd07850 100 MELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAGTSFMM 174 (353)
T ss_pred EeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC--CEEEccCccceeCCCCCCC
Confidence 688965 898888654 99999999999999999999999999999999999998777 8999999999865443334
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc-----------------
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV----------------- 143 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----------------- 143 (262)
....+++.|+|||.+.+..+..+ +||||+||++|+|++|+.||...+....+..+.......
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (353)
T cd07850 175 TPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVE 253 (353)
T ss_pred CCCcccccccCHHHHhCCCCCCc-hhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhh
Confidence 45678999999999988777644 899999999999999999998765444333322111100
Q ss_pred -c--------------ccCCC-----cccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCCc
Q 024809 144 -H--------------YSFPD-----YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPI 190 (262)
Q Consensus 144 -~--------------~~~~~-----~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 190 (262)
. ..++. ....+..++++|.+||..||++|||+.++|.||||..+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~ 320 (353)
T cd07850 254 NRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDP 320 (353)
T ss_pred cCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCC
Confidence 0 00000 11245678999999999999999999999999999866543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=250.91 Aligned_cols=186 Identities=26% Similarity=0.403 Sum_probs=147.5
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
|||+.+ +|.+++.+...+++..++.++.||+.||.|||++||+||||||.||+++.++ .++|+|||++.......
T Consensus 83 ~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~--~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 83 TELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNC--DLKICDFGLARGVDPDEDE 159 (330)
T ss_pred ecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEcccCceEeecccccc
Confidence 688874 8999998888899999999999999999999999999999999999998876 89999999998654432
Q ss_pred --CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccc------------
Q 024809 79 --QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH------------ 144 (262)
Q Consensus 79 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------------ 144 (262)
......+++.|+|||.+.+....+.++|+||+|+++|+|++|..||.+....+.+..+........
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 233456899999999998773344558999999999999999999987665443333222111000
Q ss_pred ------------ccC-CCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCC
Q 024809 145 ------------YSF-PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLP 189 (262)
Q Consensus 145 ------------~~~-~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 189 (262)
..+ .....++.++.++|.+||+.+|.+|||+.+++.||||.....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 000 011236888999999999999999999999999999986544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=261.79 Aligned_cols=182 Identities=23% Similarity=0.368 Sum_probs=137.6
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (262)
|||+. |+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~--~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE--DICLGDFGAACFARGSWS 315 (461)
T ss_pred EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCC--CEEEcccCCceecccccc
Confidence 57775 6899988764 4699999999999999999999999999999999999998776 89999999987543221
Q ss_pred --CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCC-CCC------hhHHHHHhcccccc------
Q 024809 79 --QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFED-PED------PKNFRKTIGRILSV------ 143 (262)
Q Consensus 79 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~------~~~~~~~~~~~~~~------ 143 (262)
......||+.|+|||++.+..++.+ +|||||||++|+|++|..|+-. ... ...+.+++......
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~-sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPS-VDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCch-HHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 1223569999999999988777544 8999999999999998765422 111 12222222211100
Q ss_pred --------------------cc---cCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 144 --------------------HY---SFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 144 --------------------~~---~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
.. .+..+..++.++++||.+||+.||.+|||+.|+|+||||+.
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 00 01112246678999999999999999999999999999964
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=246.25 Aligned_cols=182 Identities=28% Similarity=0.451 Sum_probs=143.9
Q ss_pred CCCCCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||+ |++|.+++.. .+.+++..++.++.||+.||.|||+.|++|+||||+||+++.++ .++|+|||++........
T Consensus 78 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~--~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 78 MEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADG--VLKIADFGLARLFSEEEP 154 (286)
T ss_pred eccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCC--cEEEeeeeecccccCCCC
Confidence 6899 9999999865 35699999999999999999999999999999999999998766 899999999875543321
Q ss_pred --CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc--------------
Q 024809 80 --PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-------------- 143 (262)
Q Consensus 80 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------------- 143 (262)
.....|+..|+|||.+.+......++||||+||++|+|++|+.||.+......+..........
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 2345789999999998765554566999999999999999988887766544444333221110
Q ss_pred -cccCCC---------cccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccc
Q 024809 144 -HYSFPD---------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFL 185 (262)
Q Consensus 144 -~~~~~~---------~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~ 185 (262)
...++. ....+.++.+||.+||..+|.+|||++++++||||.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 000110 124568899999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=243.76 Aligned_cols=177 Identities=32% Similarity=0.511 Sum_probs=142.4
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC---
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH--- 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~--- 77 (262)
|||++|++|.+++.+.+.+++..++.++.|++.||.|||+.+++||||||+||+++.++ .++|+|||+++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~--~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd06651 85 MEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAG--NVKLGDFGASKRLQTICMS 162 (266)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC--CEEEccCCCcccccccccc
Confidence 68999999999999888899999999999999999999999999999999999998776 8999999998754321
Q ss_pred -CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHH
Q 024809 78 -SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 156 (262)
Q Consensus 78 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (262)
.......++..|+|||.+.+..++. ++|+||+||++|+|++|+.||............... .....+|. .++..
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~--~~~~~ 237 (266)
T cd06651 163 GTGIRSVTGTPYWMSPEVISGEGYGR-KADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQ--PTNPQLPS--HISEH 237 (266)
T ss_pred CCccccCCccccccCHHHhCCCCCCc-hhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcC--CCCCCCch--hcCHH
Confidence 1112345888999999998766654 489999999999999999999876544433322211 11122222 46788
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcCcccc
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKNHPWFL 185 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~ 185 (262)
+++++ +||..+|++||+++++++||||+
T Consensus 238 ~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 238 ARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 99999 57778999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=246.03 Aligned_cols=180 Identities=26% Similarity=0.437 Sum_probs=141.8
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||++| +|.+.+... +.+++..++.++.|++.||.|||++|++||||||+||+++. + .+||+|||+++.......
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~--~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-D--ILKLADFGSCRGIYSKPP 154 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-C--CeEEEecccccccccCCC
Confidence 689975 888888764 46899999999999999999999999999999999999987 4 899999999976543333
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccc--------------ccccc
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRI--------------LSVHY 145 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--------------~~~~~ 145 (262)
.....+++.|+|||.+......+.++||||+||++|+|++|..||.+.+..+.+....... ....+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07831 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234 (282)
T ss_pred cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence 3445689999999987655554566999999999999999999998765433322221110 00111
Q ss_pred cCCC---------cccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 146 SFPD---------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 146 ~~~~---------~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
.++. ...++.+++++|.+||..+|++|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1221 12467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=241.03 Aligned_cols=176 Identities=31% Similarity=0.480 Sum_probs=143.8
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||++|++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||+++......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~--~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYD--NVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCC--CEEEcccccceeccCcc
Confidence 6899999999999764 5799999999999999999999999999999999999998776 89999999987544322
Q ss_pred -CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHH
Q 024809 79 -QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 157 (262)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (262)
......|++.|+|||++.+..++.+ +|+|||||++|+|++|+.||................ ....+. .++.++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~--~~~~~~ 229 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEK-SDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV---FPPVSQ--MYSQQL 229 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC---CCCCcc--ccCHHH
Confidence 2234568899999999987776544 899999999999999999998765433332222111 111222 578899
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 158 KHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
.+++.+||+.+|++||++.+++.|||+
T Consensus 230 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 230 AQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=242.78 Aligned_cols=180 Identities=33% Similarity=0.497 Sum_probs=144.1
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
|||+.||+|.+++.+.+.+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||+++......
T Consensus 87 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~--~~~l~d~~~~~~~~~~~~~ 164 (272)
T cd06629 87 LEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADG--ICKISDFGISKKSDDIYDN 164 (272)
T ss_pred EecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCC--eEEEeeccccccccccccc
Confidence 69999999999999888899999999999999999999999999999999999998776 89999999987543211
Q ss_pred -CCCccccCCCCCCcccccCCc-CCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCC--cccCC
Q 024809 79 -QPKSTVGTPAYIAPEVLTKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVS 154 (262)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 154 (262)
......|+..|+|||.+.... ..+.++|+||+|+++|++++|..||................ ....++. ...++
T Consensus 165 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 242 (272)
T cd06629 165 DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKR--SAPPIPPDVSMNLS 242 (272)
T ss_pred cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccc--cCCcCCccccccCC
Confidence 123346889999999987654 23445899999999999999999997654433332222111 1112222 23578
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 155 LECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
.+++++|.+||..+|.+|||+.++++||||
T Consensus 243 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 243 PVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 899999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=276.18 Aligned_cols=183 Identities=27% Similarity=0.440 Sum_probs=145.6
Q ss_pred CCCCCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHc-------CCeecCCCCCcEEecCC-----------
Q 024809 1 MEYAAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSM-------QICHRDLKLENTLLDGS----------- 58 (262)
Q Consensus 1 mE~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~aL~~LH~~-------~ivHrDlkp~Nili~~~----------- 58 (262)
||||+||+|.++|.. .+.+++..++.|+.||+.||.|||+. +||||||||+|||++..
T Consensus 93 MEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~ 172 (1021)
T PTZ00266 93 MEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172 (1021)
T ss_pred EeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccc
Confidence 799999999999875 35699999999999999999999984 49999999999999642
Q ss_pred ----CCCcEEEeccCCCcCCCCCCCCCccccCCCCCCcccccCCc-CCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHH
Q 024809 59 ----TAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNF 133 (262)
Q Consensus 59 ----~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 133 (262)
+.+.+||+|||+++............||+.|+|||++.+.. ..+.++|||||||+||+|+||..||........+
T Consensus 173 ~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~ql 252 (1021)
T PTZ00266 173 NNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQL 252 (1021)
T ss_pred cccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHH
Confidence 22358999999998654433444567999999999986432 2345589999999999999999999876654444
Q ss_pred HHHhcccccccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 024809 134 RKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL 188 (262)
Q Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 188 (262)
...+... ...+ ....+.++.+||.+||..+|.+||++.++|.|||+....
T Consensus 253 i~~lk~~----p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 253 ISELKRG----PDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred HHHHhcC----CCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 3332221 1122 134688999999999999999999999999999997543
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=240.61 Aligned_cols=178 Identities=28% Similarity=0.466 Sum_probs=143.4
Q ss_pred CCCCCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-
Q 024809 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (262)
|||+.|++|.+++.. ...+++..++.++.|++.||.|||+.|++||||+|.||+++.++ .++|+|||++.......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~--~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEG--QAKLADFGVSGQLTDTMA 154 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCC--cEEEcccccchhcccCcc
Confidence 689999999999975 44689999999999999999999999999999999999998776 89999999987654332
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 158 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (262)
......|+..|+|||.+.+..++.+ +||||+|+++|+|++|+.||............ ..... ..+.....++.++.
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~ 230 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNK-ADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI-PNKPP--PTLSDPEKWSPEFN 230 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCch-hhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh-ccCCC--CCCCchhhcCHHHH
Confidence 2334568899999999887766544 89999999999999999999865433222111 11111 11122225778999
Q ss_pred HHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 159 HLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 159 ~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
++|.+||+.+|.+|||+.+++.||||
T Consensus 231 ~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 231 DFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=246.79 Aligned_cols=185 Identities=26% Similarity=0.381 Sum_probs=145.4
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (262)
|||+ +|+|.+++.... .+++..++.++.||++||.|||++|++||||||+||+++.++ .++|+|||+++......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~--~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDG--VLKLADFGLARSFGSPNR 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCC--CEEEccceeeeeccCCCc
Confidence 7999 899999998776 799999999999999999999999999999999999998776 89999999997554322
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc------------cc-
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV------------HY- 145 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------------~~- 145 (262)
......+++.|+|||.+.+......++|+||+||++|+|++|..||.+......+.+........ ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 22334578889999998654444566999999999999999988887766544433332211000 00
Q ss_pred ------cCC---CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 024809 146 ------SFP---DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL 188 (262)
Q Consensus 146 ------~~~---~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 188 (262)
..+ .....+..+.+||.+||..+|++|||+.+++.||||.+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 000 0123578899999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=260.04 Aligned_cols=174 Identities=32% Similarity=0.450 Sum_probs=149.4
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
||||..|-|..+|+..+.++...+..|.++|+.|+.|||.+.|||||||.-||||..+. .|||+|||-++........
T Consensus 191 MEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d--~VKIsDFGTS~e~~~~STk 268 (904)
T KOG4721|consen 191 MEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDD--VVKISDFGTSKELSDKSTK 268 (904)
T ss_pred eeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccc--eEEeccccchHhhhhhhhh
Confidence 89999999999999999999999999999999999999999999999999999998777 8999999998855444445
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 160 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 160 (262)
..++||..|||||++++...+.+ +||||+||+|||||||..||..-+... ++-.+......+|-...++..++-|
T Consensus 269 MSFaGTVaWMAPEvIrnePcsEK-VDIwSfGVVLWEmLT~EiPYkdVdssA----IIwGVGsNsL~LpvPstcP~GfklL 343 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRNEPCSEK-VDIWSFGVVLWEMLTGEIPYKDVDSSA----IIWGVGSNSLHLPVPSTCPDGFKLL 343 (904)
T ss_pred hhhhhhHhhhCHHHhhcCCcccc-cceehhHHHHHHHHhcCCCccccchhe----eEEeccCCcccccCcccCchHHHHH
Confidence 67899999999999998888766 899999999999999999998754422 2222222333333333688899999
Q ss_pred HHHhcccCCCCCCCHhHHhcC
Q 024809 161 LSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 161 i~~~L~~dp~~R~s~~e~l~h 181 (262)
|++||...|..|||+.++|.|
T Consensus 344 ~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 344 LKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred HHHHHhcCCCCCccHHHHHHH
Confidence 999999999999999999998
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=246.40 Aligned_cols=180 Identities=27% Similarity=0.457 Sum_probs=144.7
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-C
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-Q 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (262)
|||++||+|.+++... .+++.++..++.|++.||.|||+.||+||||||+||+++.++ .++|+|||++....... .
T Consensus 96 ~e~~~~~~L~~~~~~~-~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~--~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 96 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred ecccCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC--CEEECccccchhccccccc
Confidence 7999999999998654 689999999999999999999999999999999999998776 89999999987543222 2
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....|++.|+|||.+.+..++. ++|+||+||++|+|++|+.||.............. ......+....++..+.+
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~ 248 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGP-KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT---NGTPELQNPEKLSAIFRD 248 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCc-cchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc---CCCCCCCCccccCHHHHH
Confidence 23457899999999998766654 48999999999999999999987554332222111 111112222357888999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
++.+||..+|.+|||+.++++||||...
T Consensus 249 li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 249 FLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 9999999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=240.57 Aligned_cols=169 Identities=25% Similarity=0.376 Sum_probs=138.9
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||++||+|.+++.+...+++..+..++.|++.||.|||++|++||||||+||+++.++ .++++|||.+..... ..
T Consensus 64 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~~l~df~~~~~~~~--~~ 139 (237)
T cd05576 64 LQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRG--HIQLTYFSRWSEVED--SC 139 (237)
T ss_pred EecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC--CEEEecccchhcccc--cc
Confidence 79999999999998887899999999999999999999999999999999999998776 899999998764432 22
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 160 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 160 (262)
....++..|+|||.+....++. ++|+||+|+++|+|++|+.||....... .. ......|. .+++.++++
T Consensus 140 ~~~~~~~~y~aPE~~~~~~~~~-~~DvwslG~il~el~~g~~~~~~~~~~~------~~--~~~~~~~~--~~~~~~~~l 208 (237)
T cd05576 140 DGEAVENMYCAPEVGGISEETE-ACDWWSLGAILFELLTGKTLVECHPSGI------NT--HTTLNIPE--WVSEEARSL 208 (237)
T ss_pred ccCCcCccccCCcccCCCCCCc-hhhHHHHHHHHHHHHHCcchhhcCchhc------cc--ccccCCcc--cCCHHHHHH
Confidence 3445677899999987766654 4899999999999999998876432110 00 01112333 478899999
Q ss_pred HHHhcccCCCCCCCH-----hHHhcCccc
Q 024809 161 LSRIFVANSEKRITI-----PEIKNHPWF 184 (262)
Q Consensus 161 i~~~L~~dp~~R~s~-----~e~l~hp~~ 184 (262)
|.+||+.||++|+++ +++++||||
T Consensus 209 i~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 209 LQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred HHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 999999999999986 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=250.39 Aligned_cols=184 Identities=28% Similarity=0.420 Sum_probs=143.6
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-CC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (262)
|||+. ++|.+++...+.+++..++.++.|++.||.|||+++++||||||+||+++.++ .+||+|||+++..... ..
T Consensus 88 ~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~--~~kL~Dfg~~~~~~~~~~~ 164 (337)
T cd07858 88 YELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC--DLKICDFGLARTTSEKGDF 164 (337)
T ss_pred EeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC--CEEECcCccccccCCCccc
Confidence 68886 69999998888899999999999999999999999999999999999998776 8999999999755432 22
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccc------------------
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIL------------------ 141 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~------------------ 141 (262)
.....++..|+|||.+......+.++|+|||||++|+|++|+.||.+.+....+........
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (337)
T cd07858 165 MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRY 244 (337)
T ss_pred ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHH
Confidence 33457899999999986543344558999999999999999999976543222111110000
Q ss_pred -----cc-cccC-CCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 142 -----SV-HYSF-PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 142 -----~~-~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
.. ...+ .....++++++++|++||+.+|.+|||++++++||||...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 245 IRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred HHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00 0000 0123578899999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=239.54 Aligned_cols=177 Identities=34% Similarity=0.511 Sum_probs=144.8
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||++||+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++ ..++|+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~-~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHK-MVVKIGDFGISKILSSKS 156 (256)
T ss_pred EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEEccCCCceecCCCc
Confidence 7999999999999764 3589999999999999999999999999999999999997543 258999999998654444
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 158 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (262)
......|+..|+|||.+.+..++. ++|+||+|+++|+|++|..||...+........... .....+. .++.+++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~--~~~~~l~ 230 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPYNQ-KSDIWALGCVLYELASLKRAFEAANLPALVLKIMSG---TFAPISD--RYSPDLR 230 (256)
T ss_pred cccccccCCcccCchhccCCCCCc-ccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhc---CCCCCCC--CcCHHHH
Confidence 444567899999999998766554 489999999999999999999876554433332221 1112222 5788999
Q ss_pred HHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 159 HLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 159 ~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
+++.+||..+|.+|||+.++++||||
T Consensus 231 ~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 231 QLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHHHccCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=244.86 Aligned_cols=182 Identities=26% Similarity=0.375 Sum_probs=141.7
Q ss_pred CCCCCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-CCCCcEEEeccCCCcCC
Q 024809 1 MEYAAGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG-STAPRVKICDFGYSKSS 74 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-----~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~-~~~~~~kl~Dfg~a~~~ 74 (262)
|||++| +|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++. ++ .+||+|||+++..
T Consensus 85 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~--~~kl~dfg~~~~~ 161 (295)
T cd07837 85 FEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKG--LLKIADLGLGRAF 161 (295)
T ss_pred eeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCC--eEEEeecccceec
Confidence 789986 898888643 35899999999999999999999999999999999999987 44 8999999998754
Q ss_pred CCC-CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccc-c-------
Q 024809 75 VLH-SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH-Y------- 145 (262)
Q Consensus 75 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-~------- 145 (262)
... .......+++.|+|||.+.+....+.++|+||+|+++|+|++|..||.+.+....+.++...+.... .
T Consensus 162 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (295)
T cd07837 162 SIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSK 241 (295)
T ss_pred CCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhh
Confidence 322 1223346788999999886644434558999999999999999999987665554444332211000 0
Q ss_pred -----cCCC---------cccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccc
Q 024809 146 -----SFPD---------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFL 185 (262)
Q Consensus 146 -----~~~~---------~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~ 185 (262)
.++. ...++.++.+||.+||..+|.+|||+.+++.||||+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 242 LRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred ccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 0010 124788999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=241.86 Aligned_cols=176 Identities=32% Similarity=0.576 Sum_probs=147.4
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||+.|++|.+++.....+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++.........
T Consensus 79 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~--~~~l~d~~~~~~~~~~~~~ 156 (258)
T cd05578 79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQG--HVHITDFNIATKVTPDTLT 156 (258)
T ss_pred EeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCC--CEEEeecccccccCCCccc
Confidence 68999999999998887899999999999999999999999999999999999998776 8999999998765444344
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCC--hhHHHHHhcccccccccCCCcccCCHHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPED--PKNFRKTIGRILSVHYSFPDYVRVSLECK 158 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (262)
....|+..|+|||.+....+.. ++|+||+|+++|+|++|+.||..... ...+...... .....|. .++.++.
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~-~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~--~~~~~~~ 230 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSV-AVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET---ADVLYPA--TWSTEAI 230 (258)
T ss_pred cccCCChhhcCHHHHcccCCCC-cccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc---ccccCcc--cCcHHHH
Confidence 4567889999999998766554 48999999999999999999987654 2322222221 2222333 5789999
Q ss_pred HHHHHhcccCCCCCCCH--hHHhcCccc
Q 024809 159 HLLSRIFVANSEKRITI--PEIKNHPWF 184 (262)
Q Consensus 159 ~li~~~L~~dp~~R~s~--~e~l~hp~~ 184 (262)
++|.+||..+|.+||++ +++++||||
T Consensus 231 ~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 231 DAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 99999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=244.22 Aligned_cols=181 Identities=28% Similarity=0.539 Sum_probs=145.5
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-C
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-Q 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (262)
|||+.|++|.+++.. +++++..+..++.|++.||.|||++|++||||+|+||+++.++ .++|+|||++....... .
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~~l~d~g~~~~~~~~~~~ 171 (285)
T cd06648 95 MEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDG--RVKLSDFGFCAQVSKEVPR 171 (285)
T ss_pred EeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCC--cEEEcccccchhhccCCcc
Confidence 689999999999987 5799999999999999999999999999999999999998776 89999999886443221 2
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....|++.|+|||.+.+..+..+ +|+||+||++|+|++|+.||............... . .........++..+.+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~l~~ 247 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-L--PPKLKNLHKVSPRLRS 247 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCc-ccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-C--CCCCcccccCCHHHHH
Confidence 233568999999999977666554 89999999999999999999765433332222111 1 1112222247889999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCccccccC
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWFLRNL 188 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 188 (262)
|+.+||..+|++|||+.++++||||.+..
T Consensus 248 li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 248 FLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred HHHHHcccChhhCcCHHHHccCcccccCC
Confidence 99999999999999999999999997644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=243.87 Aligned_cols=179 Identities=28% Similarity=0.462 Sum_probs=146.0
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-CC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (262)
|||++||+|.+++... .+++..++.++.|++.||.|||+.+++||||+|+||+++.++ .++|+|||+++..... ..
T Consensus 78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~--~~~l~d~g~~~~~~~~~~~ 154 (274)
T cd06609 78 MEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEG--DVKLADFGVSGQLTSTMSK 154 (274)
T ss_pred EEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC--CEEEcccccceeecccccc
Confidence 5899999999999876 799999999999999999999999999999999999998877 8999999999765433 23
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....+++.|+|||.+.+..++.+ +||||+||++|+|++|+.||............... .....+. ..++.++.+
T Consensus 155 ~~~~~~~~~y~~PE~~~~~~~~~~-sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~---~~~~~~~-~~~~~~~~~ 229 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQSGYDEK-ADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN---NPPSLEG-NKFSKPFKD 229 (274)
T ss_pred cccccCCccccChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc---CCCCCcc-cccCHHHHH
Confidence 345678899999999987776544 89999999999999999999765433222221111 1111222 127889999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
++.+||..+|++|||++++++||||.+.
T Consensus 230 ~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 230 FVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred HHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 9999999999999999999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=240.79 Aligned_cols=179 Identities=40% Similarity=0.684 Sum_probs=148.3
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
|||++||+|.+++.+.+.+++..+..++.||+.||.|||++|++||||+|+||+++.++ .++|+|||++.......
T Consensus 72 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~--~~~l~dfg~~~~~~~~~~~ 149 (265)
T cd05579 72 MEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNG--HLKLTDFGLSKVGLVRRQI 149 (265)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCC--CEEEEecccchhcccCccc
Confidence 68999999999999877899999999999999999999999999999999999998877 89999999987543221
Q ss_pred -------CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcc
Q 024809 79 -------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV 151 (262)
Q Consensus 79 -------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (262)
......++..|+|||.+.....+ .++|+||||+++|++++|..||........+.... .....++...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~ 224 (265)
T cd05579 150 NLNDDEKEDKRIVGTPDYIAPEVILGQGHS-KTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNIL----NGKIEWPEDV 224 (265)
T ss_pred ccccccccccCcccCccccCHHHhcCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh----cCCcCCCccc
Confidence 12234688899999998776654 44899999999999999999998765444333322 2233445444
Q ss_pred cCCHHHHHHHHHhcccCCCCCCCH---hHHhcCccccc
Q 024809 152 RVSLECKHLLSRIFVANSEKRITI---PEIKNHPWFLR 186 (262)
Q Consensus 152 ~~~~~~~~li~~~L~~dp~~R~s~---~e~l~hp~~~~ 186 (262)
..+..+.+++.+||+.+|.+|||+ .++++||||..
T Consensus 225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 225 EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence 468999999999999999999999 99999999964
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=246.42 Aligned_cols=180 Identities=28% Similarity=0.476 Sum_probs=145.7
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-C
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-Q 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (262)
|||++||+|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++....... .
T Consensus 95 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~--~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 95 MEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDG--SVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred EEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEccCccchhccccccc
Confidence 6899999999988755 699999999999999999999999999999999999998766 89999999987543322 2
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....|+..|+|||.+.+..+..+ +|+||+||++|+|++|+.||...+........... ..........+++.+.+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 247 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN---GTPELQNPEKLSPIFRD 247 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---CCcccCCcccCCHHHHH
Confidence 234568899999999987766544 89999999999999999999876543332222111 11112222367889999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
||.+||..+|.+|||+.+++.||||+..
T Consensus 248 li~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 248 FLNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred HHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 9999999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=242.65 Aligned_cols=176 Identities=27% Similarity=0.439 Sum_probs=140.5
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-C
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-Q 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (262)
|||++||+|.+++...+.+++..+..++.|++.||.|||+.||+||||||+||+++.++ .++|+|||+++...... .
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~--~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06646 85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNG--DVKLADFGVAAKITATIAK 162 (267)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC--CEEECcCccceeecccccc
Confidence 69999999999998888899999999999999999999999999999999999998776 79999999987543222 2
Q ss_pred CCccccCCCCCCcccccC---CcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccccc---CCCcccC
Q 024809 80 PKSTVGTPAYIAPEVLTK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYS---FPDYVRV 153 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 153 (262)
.....|++.|+|||.+.. ..+ ..++|+||+||++|+|++|+.||........... +...... .+....+
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~-~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 237 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFL----MSKSNFQPPKLKDKTKW 237 (267)
T ss_pred cCccccCccccCHhHcccccCCCC-cchhhHHHHHHHHHHHHhCCCCccccchhhhhee----eecCCCCCCCCcccccc
Confidence 334578999999998753 223 3458999999999999999999965432221111 1111111 1222357
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhcCcc
Q 024809 154 SLECKHLLSRIFVANSEKRITIPEIKNHPW 183 (262)
Q Consensus 154 ~~~~~~li~~~L~~dp~~R~s~~e~l~hp~ 183 (262)
+..+.+||++||..+|.+|||++++++|+|
T Consensus 238 ~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 238 SSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 889999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=239.36 Aligned_cols=179 Identities=34% Similarity=0.551 Sum_probs=146.1
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC-
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ- 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~- 79 (262)
|||++|++|.+++.+.+.+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .+||+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~--~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 78 MEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNG--VIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred EecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEcccccccccCCCCCc
Confidence 68999999999999887899999999999999999999999999999999999998866 899999999875433222
Q ss_pred ----CCccccCCCCCCcccccCCc---CCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCccc
Q 024809 80 ----PKSTVGTPAYIAPEVLTKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR 152 (262)
Q Consensus 80 ----~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (262)
.....+++.|+|||.+.... +. .++||||+|+++|++++|+.||.............. ......+|....
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~-~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~ 232 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHG-RAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG--AGHKPPIPDSLQ 232 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCC-cccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHh--cCCCCCCCcccc
Confidence 11346788999999987654 43 448999999999999999999976543322221111 122334555556
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 153 VSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 153 ~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
++..+.++|.+||+.+|.+|||+.+++.|||+
T Consensus 233 ~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 233 LSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 78999999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=247.57 Aligned_cols=184 Identities=27% Similarity=0.392 Sum_probs=144.0
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (262)
|||+.+ +|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||++.......
T Consensus 87 ~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~--~~kL~dfg~~~~~~~~~~ 163 (309)
T cd07845 87 MEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG--CLKIADFGLARTYGLPAK 163 (309)
T ss_pred EecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--CEEECccceeeecCCccC
Confidence 689975 888888753 5799999999999999999999999999999999999998776 89999999987654321
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc---------------
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV--------------- 143 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------------- 143 (262)
......+++.|+|||.+.+....+.++|+||+||++|+|++|+.||...+....+..........
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243 (309)
T ss_pred CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence 22234568889999998764444455899999999999999999998776655544433321100
Q ss_pred cccCCC---------cccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 144 HYSFPD---------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 144 ~~~~~~---------~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
.+..+. ....++++.+||.+||..||++|||+.+++.||||.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred cccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 000110 11257889999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=241.91 Aligned_cols=181 Identities=29% Similarity=0.473 Sum_probs=143.7
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC-
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ- 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~- 79 (262)
|||++||+|.+++...+.+++..++.++.||+.||.|||++|++||||||+||+++.++. .++|+|||.+........
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~-~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 82 VEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ-RLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEccccccccccccccc
Confidence 689999999999998888999999999999999999999999999999999999975542 589999999875543211
Q ss_pred ----CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccc-ccccccCCCcccCC
Q 024809 80 ----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRI-LSVHYSFPDYVRVS 154 (262)
Q Consensus 80 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 154 (262)
.....|+..|+|||.+.+..++. ++|+||+|+++|+|++|..||................ .......+. .++
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~~~-~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 237 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQYGR-SCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPE--HLS 237 (268)
T ss_pred CCccccccccccceeCHhHhccCCCCc-ccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCch--hhC
Confidence 12346888999999987766654 4899999999999999999997544332222221111 011112222 578
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhcCcccc
Q 024809 155 LECKHLLSRIFVANSEKRITIPEIKNHPWFL 185 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~ 185 (262)
+++.+++.+||..+|.+|||+.++++||||+
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 8999999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=245.72 Aligned_cols=179 Identities=35% Similarity=0.618 Sum_probs=143.7
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
|||++||+|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||+++......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~--~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMG--HIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCC--CEEEeeCCCccccCcCccc
Confidence 79999999999998888899999999999999999999999999999999999998776 89999999986321100
Q ss_pred --------------CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccc
Q 024809 79 --------------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH 144 (262)
Q Consensus 79 --------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 144 (262)
......|+..|+|||.+.+..+..+ +|+|||||++|+|++|..||.+....+.+.... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~----~~~ 232 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI----SDD 232 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----hcc
Confidence 0112357889999999887666544 899999999999999999998654433232221 111
Q ss_pred ccCCCc-ccCCHHHHHHHHHhcccCCCCCCC---HhHHhcCccccc
Q 024809 145 YSFPDY-VRVSLECKHLLSRIFVANSEKRIT---IPEIKNHPWFLR 186 (262)
Q Consensus 145 ~~~~~~-~~~~~~~~~li~~~L~~dp~~R~s---~~e~l~hp~~~~ 186 (262)
...|.. ..++.+++++|.+||+.+|.+||+ +.++++||||..
T Consensus 233 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 233 IEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred cCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 222221 257889999999999999999998 789999999965
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=242.85 Aligned_cols=182 Identities=26% Similarity=0.412 Sum_probs=143.9
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (262)
|||++||+|.+++.+. +.+++..++.++.|++.||.|||++||+||||||+||+++.++ .++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~--~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDG--DVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCC--CEEEccCccchhhccccc
Confidence 7999999999998764 4699999999999999999999999999999999999998776 89999999886543221
Q ss_pred CCCccccCCCCCCcccccCC----cCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCC
Q 024809 79 QPKSTVGTPAYIAPEVLTKK----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS 154 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (262)
......+++.|+|||.+... ...+.++|+||+|+++|+|++|+.||..........+.... . ...+.....++
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~ 235 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS-E--PPTLDQPSKWS 235 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC-C--CCCcCCcccCC
Confidence 22345689999999997532 12234489999999999999999999876543333222111 1 11111223578
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 155 LECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
.++.++|.+||..+|.+|||+.++++||||...
T Consensus 236 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 236 SSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 899999999999999999999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=239.49 Aligned_cols=187 Identities=27% Similarity=0.372 Sum_probs=145.9
Q ss_pred CCCCCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC--CCcEEEeccCCCcC
Q 024809 1 MEYAAGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST--APRVKICDFGYSKS 73 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-----~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~--~~~~kl~Dfg~a~~ 73 (262)
+||++. ||..+|+-. ..++...++.|+.||+.|+.|||++=|+||||||.|||+..++ .+.|||+|||+++.
T Consensus 107 fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~ 185 (438)
T KOG0666|consen 107 FDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARL 185 (438)
T ss_pred ehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHH
Confidence 588886 999998632 3599999999999999999999999999999999999996552 35899999999986
Q ss_pred CCCCC----CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCC---------hhHHHHHhccc
Q 024809 74 SVLHS----QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPED---------PKNFRKTIGRI 140 (262)
Q Consensus 74 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~~~~~~~ 140 (262)
+...- .....+.|.+|+|||++.+...++++.|||++|||+.||+|-++.|.+.+. .+++.+++...
T Consensus 186 ~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vL 265 (438)
T KOG0666|consen 186 FNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVL 265 (438)
T ss_pred hhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHc
Confidence 64332 223467899999999999988888989999999999999999998876442 12333333222
Q ss_pred ccc-------cccCCCc------------------------ccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 024809 141 LSV-------HYSFPDY------------------------VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL 188 (262)
Q Consensus 141 ~~~-------~~~~~~~------------------------~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 188 (262)
... -..+|++ ..-++.+.+|+.+||++||.+|+|++++|+|+||....
T Consensus 266 G~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~ 344 (438)
T KOG0666|consen 266 GTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDP 344 (438)
T ss_pred CCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCC
Confidence 111 0011221 11345588999999999999999999999999998753
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=249.88 Aligned_cols=188 Identities=27% Similarity=0.410 Sum_probs=145.2
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC-
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ- 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~- 79 (262)
|||+. |+|.+++...+.+++..++.++.||+.||.|||++|++||||||+||+++.++ .+||+|||++........
T Consensus 87 ~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~--~~kl~dfg~~~~~~~~~~~ 163 (334)
T cd07855 87 MDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDC--ELRIGDFGMARGLSSSPTE 163 (334)
T ss_pred Eehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC--cEEecccccceeecccCcC
Confidence 68996 59999998888899999999999999999999999999999999999998777 899999999875432221
Q ss_pred ----CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccc-------------
Q 024809 80 ----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS------------- 142 (262)
Q Consensus 80 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~------------- 142 (262)
.....|+..|+|||.+.+....+.++||||+||++|+|++|+.||...+....+.........
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~ 243 (334)
T cd07855 164 HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243 (334)
T ss_pred CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhh
Confidence 123478999999999866443455589999999999999999999775543322211111000
Q ss_pred ---------ccccCC---CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCCcc
Q 024809 143 ---------VHYSFP---DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIE 191 (262)
Q Consensus 143 ---------~~~~~~---~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~ 191 (262)
.....+ .....+.++.++|++||+.+|.+|||+.+++.||||.+.....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~ 304 (334)
T cd07855 244 VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPD 304 (334)
T ss_pred HHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCc
Confidence 000000 0124688999999999999999999999999999997654433
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=243.00 Aligned_cols=182 Identities=28% Similarity=0.538 Sum_probs=144.6
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~-~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||+.|++|.+++... ..+++..+..++.|++.||.|||+ .|++||||||+||+++.++ .++|+|||.+.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~--~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG--QIKLCDFGVSGQLVNSL 155 (265)
T ss_pred EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC--CEEEeecccchhhHHHH
Confidence 6899999999999876 689999999999999999999999 9999999999999998866 89999999987543222
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCC-hhHHHHHhccccc-ccccCCCcccCCHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPED-PKNFRKTIGRILS-VHYSFPDYVRVSLE 156 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 156 (262)
.....++..|+|||.+.+..+.. ++|+||+|+++|+|++|..||..... ..........+.. .....+.. .++.+
T Consensus 156 -~~~~~~~~~y~~PE~~~~~~~~~-~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 232 (265)
T cd06605 156 -AKTFVGTSSYMAPERIQGNDYSV-KSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSG-KFSPD 232 (265)
T ss_pred -hhcccCChhccCHHHHcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChh-hcCHH
Confidence 12267889999999997776654 48999999999999999999976421 1111111221111 11122221 27889
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
++++|.+||..+|.+|||+.+++.||||+++
T Consensus 233 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 233 FQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 9999999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=239.77 Aligned_cols=179 Identities=27% Similarity=0.417 Sum_probs=143.1
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (262)
|||+.|++|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~--~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDG--DVKLADFGVSAQLTATIA 156 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCC--CEEECccccchhhhhhhh
Confidence 7999999999999876 6899999999999999999999999999999999999998776 89999999987543322
Q ss_pred CCCccccCCCCCCcccccCC---cCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 79 QPKSTVGTPAYIAPEVLTKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
......++..|+|||.+... .++ .++|+||+|+++|+|++|+.||.................. ..........+.
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~-~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 234 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYD-GKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFP-PPKLKDKEKWSP 234 (262)
T ss_pred ccccccCCccccCchhhcccccCCcC-chhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-CccccchhhhhH
Confidence 23445788899999998765 555 4489999999999999999999876543332222111000 011112224678
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhcCcc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKNHPW 183 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~hp~ 183 (262)
++++|+.+||..+|.+|||+.+++.|+|
T Consensus 235 ~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 235 VFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 8999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=242.96 Aligned_cols=180 Identities=28% Similarity=0.449 Sum_probs=142.2
Q ss_pred CCCCCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-C
Q 024809 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-S 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~ 78 (262)
|||++||+|..++.+ ...+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||++...... .
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG--DIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCC--CEEEccCccceecccccc
Confidence 799999999988764 45699999999999999999999999999999999999998766 8999999998653222 1
Q ss_pred CCCccccCCCCCCcccccC-----CcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccC
Q 024809 79 QPKSTVGTPAYIAPEVLTK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRV 153 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (262)
......+++.|+|||.+.. ..+ +.++|+|||||++|+|++|..||..........+.... .....+....+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 241 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---EPPTLSQPSKW 241 (292)
T ss_pred ccceecCCccccCceeeccccccCCCC-CchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC---CCccCCCCccc
Confidence 2234568899999999853 223 34489999999999999999999775543333222111 11112222357
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 154 SLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 154 ~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
+.++.++|.+||..+|++||+++++++||||..
T Consensus 242 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 242 SMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 889999999999999999999999999999964
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=238.87 Aligned_cols=175 Identities=31% Similarity=0.511 Sum_probs=144.1
Q ss_pred CCCCCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----HcCCeecCCCCCcEEecCCCCCcEEEeccCCC
Q 024809 1 MEYAAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCH-----SMQICHRDLKLENTLLDGSTAPRVKICDFGYS 71 (262)
Q Consensus 1 mE~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~aL~~LH-----~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a 71 (262)
|||++||+|.+++.. ...+++..++.++.||+.||.||| +.+++|+||||+||+++.++ .+||+|||++
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~--~~kl~d~g~~ 157 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN--NVKLGDFGLA 157 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC--CEEEeccccc
Confidence 799999999999975 357999999999999999999999 99999999999999998766 8999999999
Q ss_pred cCCCCCCC-CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccc-cCCC
Q 024809 72 KSSVLHSQ-PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY-SFPD 149 (262)
Q Consensus 72 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~ 149 (262)
........ .....+++.|+|||.+....++ .++|+||||+++|+|++|+.||....... +...+ ..... .++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~---~~~~~~~~~~ 232 (265)
T cd08217 158 KILGHDSSFAKTYVGTPYYMSPEQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQ-LASKI---KEGKFRRIPY 232 (265)
T ss_pred ccccCCcccccccccCCCccChhhhcCCCCC-chhHHHHHHHHHHHHHHCCCcccCcCHHH-HHHHH---hcCCCCCCcc
Confidence 86544332 3445789999999999876665 44899999999999999999998765322 22222 11111 2222
Q ss_pred cccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 150 YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 150 ~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
..+.++.+++.+||..+|.+|||+.++++|||+
T Consensus 233 --~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 233 --RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred --ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 578899999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=244.96 Aligned_cols=182 Identities=26% Similarity=0.426 Sum_probs=152.4
Q ss_pred CCCCCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-C
Q 024809 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-S 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~ 78 (262)
||||-.|++.++++. ++.|+|+++..+++.-++||+|||..+=+|||||..|||++.++ ..||+|||.|...... .
T Consensus 107 MEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G--~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDG--IAKLADFGVAGQLTDTMA 184 (502)
T ss_pred hhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccc--hhhhhhccccchhhhhHH
Confidence 899999999999974 55799999999999999999999999999999999999997666 8999999999865443 2
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 158 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (262)
+.++.+|||.|||||++..-+|+.. +||||||+...+|..|++||.....-. .++-...+....|...-.+|+++.
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~-ADIWSLGITaIEMAEG~PPYsDIHPMR---AIFMIPT~PPPTF~KPE~WS~~F~ 260 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTK-ADIWSLGITAIEMAEGRPPYSDIHPMR---AIFMIPTKPPPTFKKPEEWSSEFN 260 (502)
T ss_pred hhCccccCcccccHHHHHHhccchh-hhHhhhcchhhhhhcCCCCcccccccc---eeEeccCCCCCCCCChHhhhhHHH
Confidence 4577899999999999999999877 799999999999999999998654321 111111222233333336899999
Q ss_pred HHHHHhcccCCCCCCCHhHHhcCccccccC
Q 024809 159 HLLSRIFVANSEKRITIPEIKNHPWFLRNL 188 (262)
Q Consensus 159 ~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 188 (262)
+||++||.++|++|.||.++++|||++...
T Consensus 261 DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 261 DFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred HHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 999999999999999999999999997643
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=241.80 Aligned_cols=179 Identities=27% Similarity=0.434 Sum_probs=141.4
Q ss_pred CCCCCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC
Q 024809 1 MEYAAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (262)
|||++||+|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~--~~~l~d~~~~~~~~~ 165 (275)
T cd06608 88 MELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNA--EVKLVDFGVSAQLDS 165 (275)
T ss_pred EEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCC--eEEECCCccceeccc
Confidence 699999999998864 34799999999999999999999999999999999999998776 899999999865432
Q ss_pred C-CCCCccccCCCCCCcccccCCc----CCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcc
Q 024809 77 H-SQPKSTVGTPAYIAPEVLTKKE----YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV 151 (262)
Q Consensus 77 ~-~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (262)
. .......|+..|+|||.+.... ....++||||+||++|+|++|+.||................ ........
T Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~ 242 (275)
T cd06608 166 TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP---PPTLKSPE 242 (275)
T ss_pred chhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC---CCCCCchh
Confidence 2 2234467899999999875422 12344899999999999999999997654433333322211 11112222
Q ss_pred cCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 152 RVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 152 ~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
.++.++++||.+||..||++|||+.++++|||+
T Consensus 243 ~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 243 NWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred hcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 477899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=243.09 Aligned_cols=178 Identities=26% Similarity=0.413 Sum_probs=140.1
Q ss_pred CCCCCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC
Q 024809 1 MEYAAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (262)
|||++||+|.+++.. .+.+++..++.++.|++.||.|||+.+++||||||+||+++.++ .++|+|||+++....
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~--~~kl~dfg~~~~~~~ 176 (286)
T cd06638 99 LELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEG--GVKLVDFGVSAQLTS 176 (286)
T ss_pred EeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCC--CEEEccCCceeeccc
Confidence 799999999998753 34689999999999999999999999999999999999998776 799999999875433
Q ss_pred CC-CCCccccCCCCCCcccccCC-----cCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCc
Q 024809 77 HS-QPKSTVGTPAYIAPEVLTKK-----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDY 150 (262)
Q Consensus 77 ~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (262)
.. ......|++.|+|||.+... .+ +.++||||+||++|+|++|+.||............... .......+
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~-- 252 (286)
T cd06638 177 TRLRRNTSVGTPFWMAPEVIACEQQLDSTY-DARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN-PPPTLHQP-- 252 (286)
T ss_pred CCCccccccCCCcccChhhhchhhhccccc-cchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc-CCCcccCC--
Confidence 22 22345799999999998532 23 34589999999999999999999875543332221111 11111112
Q ss_pred ccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 151 VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 151 ~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
...+.+++++|.+||..+|++|||+.++++|+||
T Consensus 253 ~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 253 ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 2357789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=243.03 Aligned_cols=179 Identities=26% Similarity=0.468 Sum_probs=139.6
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||++||+|..+ ..+++..+..++.|++.||.|||++||+|+||||+||+++.++ .++|+|||++..... ...
T Consensus 78 ~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~--~~~l~dfg~~~~~~~-~~~ 150 (279)
T cd06619 78 TEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRG--QVKLCDFGVSTQLVN-SIA 150 (279)
T ss_pred EecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCC--CEEEeeCCcceeccc-ccc
Confidence 699999999654 3588999999999999999999999999999999999998776 899999999875432 233
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhH---HHHHhcccccccccCCCcccCCHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKN---FRKTIGRILSVHYSFPDYVRVSLEC 157 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (262)
....|+..|+|||.+.+..++.+ +|+||+||++|+|++|+.||........ .......+.............++++
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIH-SDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKF 229 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCc-chHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHH
Confidence 45679999999999987776544 8999999999999999999965322111 0111111111111111122477899
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 158 KHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
++++.+||..+|.+||++++++.||||...
T Consensus 230 ~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 230 VHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 999999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=240.27 Aligned_cols=177 Identities=34% Similarity=0.546 Sum_probs=142.7
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC---
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH--- 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~--- 77 (262)
|||++||+|.+++.+.+.+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||+++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~--~~~l~Dfg~~~~~~~~~~~ 162 (265)
T cd06652 85 MEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVG--NVKLGDFGASKRLQTICLS 162 (265)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCC--CEEECcCcccccccccccc
Confidence 68999999999998888899999999999999999999999999999999999998776 8999999998754321
Q ss_pred -CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHH
Q 024809 78 -SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 156 (262)
Q Consensus 78 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (262)
.......|+..|+|||.+.+..++ .++|+|||||++|+|++|+.||............... ......|. ..+..
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~--~~~~~ 237 (265)
T cd06652 163 GTGMKSVTGTPYWMSPEVISGEGYG-RKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ--PTNPVLPP--HVSDH 237 (265)
T ss_pred ccccccCCCCccccChhhhcCCCCC-cchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcC--CCCCCCch--hhCHH
Confidence 112335688999999998776664 4489999999999999999999865444333222111 11112222 56788
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcCcccc
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKNHPWFL 185 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~ 185 (262)
+.++|.+|+. +|++||+++++++|||+.
T Consensus 238 ~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 238 CRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 9999999995 999999999999999973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=243.67 Aligned_cols=183 Identities=33% Similarity=0.587 Sum_probs=146.7
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
|||++||+|.+++.....+++..+..++.|++.||.|||+.|++||||||+||+++.++ .+||+|||+++......
T Consensus 84 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~~~~~~ 161 (290)
T cd05613 84 LDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG--HVVLTDFGLSKEFHEDEVE 161 (290)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCC--CEEEeeCccceeccccccc
Confidence 69999999999999888899999999999999999999999999999999999998776 89999999987543321
Q ss_pred CCCccccCCCCCCcccccCCc-CCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 157 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (262)
......|+..|+|||.+.+.. ....++||||+|+++|+|++|..||...............+......++. .+++.+
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 239 (290)
T cd05613 162 RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EMSALA 239 (290)
T ss_pred ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCc--cCCHHH
Confidence 122456899999999986532 23445899999999999999999997543332223333333222223333 578899
Q ss_pred HHHHHHhcccCCCCCC-----CHhHHhcCcccccc
Q 024809 158 KHLLSRIFVANSEKRI-----TIPEIKNHPWFLRN 187 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~-----s~~e~l~hp~~~~~ 187 (262)
.+++.+||..+|.+|| ++.+++.||||.+.
T Consensus 240 ~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 9999999999999997 88999999999754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=246.82 Aligned_cols=183 Identities=23% Similarity=0.397 Sum_probs=139.5
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||+++|+|.+++... ..+++..++.+++|++.||.|||++||+||||||+||+++.++ .++|+|||.+.......
T Consensus 78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~--~~kl~d~~~~~~~~~~~ 155 (314)
T cd08216 78 SPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDG--KVVLSGLRYSVSMIKHG 155 (314)
T ss_pred EeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCC--ceEEecCccceeecccc
Confidence 6999999999999763 4689999999999999999999999999999999999998776 89999999886432211
Q ss_pred C--------CCccccCCCCCCcccccCC--cCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccc------
Q 024809 79 Q--------PKSTVGTPAYIAPEVLTKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS------ 142 (262)
Q Consensus 79 ~--------~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~------ 142 (262)
. .....++..|+|||++... .+. .++|+||+||++|+|++|..||..................
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (314)
T cd08216 156 KRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYN-EKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKS 234 (314)
T ss_pred ccccccccccccccccccccCHHHhcCCCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccC
Confidence 1 1234577889999998653 343 4589999999999999999999865443322211110000
Q ss_pred ----------------------ccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 143 ----------------------VHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 143 ----------------------~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
.....+....++.++.+|+.+||..||++|||+.++|+||||+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~ 300 (314)
T cd08216 235 TYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQ 300 (314)
T ss_pred chhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhh
Confidence 00000111124567899999999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=247.42 Aligned_cols=215 Identities=25% Similarity=0.367 Sum_probs=152.2
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||+.+ +|..++ ...+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||+++... ...
T Consensus 99 ~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~--~~kL~dfg~~~~~~--~~~ 171 (342)
T cd07879 99 MPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC--ELKILDFGLARHAD--AEM 171 (342)
T ss_pred eccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEeeCCCCcCCC--CCC
Confidence 467754 776665 23699999999999999999999999999999999999998776 89999999987542 223
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccc-------------------
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIL------------------- 141 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~------------------- 141 (262)
....+++.|+|||.+.+....+.++|+||+||++|+|++|+.||.+......+...+....
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (342)
T cd07879 172 TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYI 251 (342)
T ss_pred CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHH
Confidence 3457889999999987644344558999999999999999999987554333322221100
Q ss_pred cccccCC------CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCCccccCCCCccccCCCCCCCCHHHHHH
Q 024809 142 SVHYSFP------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLS 215 (262)
Q Consensus 142 ~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (262)
......+ .+...+.++.+||.+||+.||.+||++.+++.||||....+.+......-..........+.+++..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (342)
T cd07879 252 KSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQQPYDDSLENEKLSVDEWKK 331 (342)
T ss_pred hhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccCCCCcccchhhhhhCCHHHHHH
Confidence 0000000 1234678899999999999999999999999999998765443322211111111222344566666
Q ss_pred HhHHhcC
Q 024809 216 LIHEATK 222 (262)
Q Consensus 216 ~~~~~~~ 222 (262)
.+.+..+
T Consensus 332 ~~~~~~~ 338 (342)
T cd07879 332 HIYKEVK 338 (342)
T ss_pred Hhhhhhh
Confidence 6655533
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=242.80 Aligned_cols=180 Identities=29% Similarity=0.421 Sum_probs=142.2
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-C
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-S 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~ 78 (262)
|||+.+ +|.+++.... .+++..++.++.||+.||.|||++|++||||||+||+++.++ .++|+|||++...... .
T Consensus 85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~--~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRG--ILKICDFGLAREYGSPLK 161 (293)
T ss_pred ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC--cEEEeecCceeeccCCcc
Confidence 689975 9999887644 599999999999999999999999999999999999998776 8999999998765433 2
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccc----------------
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS---------------- 142 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------------- 142 (262)
......+++.|+|||.+.+....+.++|+||+|+++|+|++|..||..........+.......
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK 241 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence 2334567889999999876554445589999999999999999999876654444333221100
Q ss_pred -c----------cccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 143 -V----------HYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 143 -~----------~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
. ...++. ..+++.+.++|++||+.+|++|||+.|++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 242 KKTFTKYPYNQLRKKFPA-LSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred ccccccccchhhhccccc-cCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0 001111 0148889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=246.43 Aligned_cols=186 Identities=28% Similarity=0.445 Sum_probs=141.3
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
|||+.+ +|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++......
T Consensus 87 ~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~--~~kl~dfg~~~~~~~~~~~ 162 (336)
T cd07849 87 QELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNC--DLKICDFGLARIADPEHDH 162 (336)
T ss_pred ehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC--CEEECcccceeeccccccc
Confidence 588875 88888754 4699999999999999999999999999999999999998777 89999999987543221
Q ss_pred --CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccc-----------c---
Q 024809 79 --QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIL-----------S--- 142 (262)
Q Consensus 79 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-----------~--- 142 (262)
......|++.|+|||.+.+....+.++||||+||++|+|++|+.||.+.+.......+..... .
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (336)
T cd07849 163 TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRA 242 (336)
T ss_pred cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhh
Confidence 112357899999999876544344568999999999999999999976543222211111000 0
Q ss_pred --------ccccCC---CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCCc
Q 024809 143 --------VHYSFP---DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPI 190 (262)
Q Consensus 143 --------~~~~~~---~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 190 (262)
.....+ .....++++.++|.+||+.+|.+|||+.++++||||......
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 243 RNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred hhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 000000 012467889999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=256.64 Aligned_cols=177 Identities=27% Similarity=0.507 Sum_probs=149.9
Q ss_pred CCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 2 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 2 E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~--ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|++.+|+|+.|+++.++++.+.++.|++||++||.|||++. |+|||||.+||||+.+. |.|||+|+|+|+.... ..
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~-G~VKIGDLGLAtl~r~-s~ 200 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNL-GEVKIGDLGLATLLRK-SH 200 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCc-CceeecchhHHHHhhc-cc
Confidence 78999999999999999999999999999999999999985 99999999999998653 5899999999985532 23
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhH-HHHHhcccccccccCCCcccCCHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKN-FRKTIGRILSVHYSFPDYVRVSLECK 158 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (262)
....+|||.|||||++. ..|+.. +||||||++|.||+|+..||....++.+ +.+....+.+..+.. --.++++
T Consensus 201 aksvIGTPEFMAPEmYE-E~YnE~-VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~k----V~dPevr 274 (632)
T KOG0584|consen 201 AKSVIGTPEFMAPEMYE-ENYNEL-VDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSK----VKDPEVR 274 (632)
T ss_pred cceeccCccccChHHHh-hhcchh-hhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhc----cCCHHHH
Confidence 34579999999999987 677766 8999999999999999999998777654 444444443332221 2368899
Q ss_pred HHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 159 HLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 159 ~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
+||.+||.. .+.|+|+.|+|.||||..+
T Consensus 275 ~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 275 EFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 999999999 9999999999999999875
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=241.61 Aligned_cols=182 Identities=30% Similarity=0.487 Sum_probs=142.6
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
|||++++.+..++.+...+++..+..++.||+.||.|||++|++||||+|+||+++.++ .+||+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~--~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESG--VLKLCDFGFARALRARPAS 156 (288)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC--CEEEEeeecccccCCCccc
Confidence 68999988877777767799999999999999999999999999999999999998766 89999999987654433
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccc------------c---
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS------------V--- 143 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~------------~--- 143 (262)
......++..|+|||++......+.++|+||+|+++|+|++|+.||.+....+.+......... .
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence 2334678899999999987733345589999999999999999999876544332221110000 0
Q ss_pred cccCCC----------c-ccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 144 HYSFPD----------Y-VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 144 ~~~~~~----------~-~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
...++. + ..++.++++||++||..+|++|||+++++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 000000 0 1247889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=239.22 Aligned_cols=178 Identities=31% Similarity=0.534 Sum_probs=146.0
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~-~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||++||+|.+++.....+++..+..++.|++.||.|||+ .|++||||+|+||+++.++ .++|+|||++........
T Consensus 78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~--~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG--EVKIADFGISKVLENTLD 155 (264)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCC--CEEEccCccceecccCCC
Confidence 6899999999999988889999999999999999999999 9999999999999998877 899999999876543332
Q ss_pred C-CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCC--ChhHHHHHhcccccc-cccCCCccc-CC
Q 024809 80 P-KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE--DPKNFRKTIGRILSV-HYSFPDYVR-VS 154 (262)
Q Consensus 80 ~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~-~~ 154 (262)
. ....++..|+|||.+....++. ++|+||||+++|+|++|+.||.... ...... ..+... ....+ .. ++
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~-~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~---~~~~~~~~~~~~--~~~~~ 229 (264)
T cd06623 156 QCNTFVGTVTYMSPERIQGESYSY-AADIWSLGLTLLECALGKFPFLPPGQPSFFELM---QAICDGPPPSLP--AEEFS 229 (264)
T ss_pred cccceeecccccCHhhhCCCCCCc-hhhHHHHHHHHHHHHhCCCCCccccccCHHHHH---HHHhcCCCCCCC--cccCC
Confidence 2 2456889999999987776554 4899999999999999999998765 222222 222211 11122 23 78
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 155 LECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
..+.++|.+||..+|++|||+.++++||||+.
T Consensus 230 ~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 230 PEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 89999999999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=243.84 Aligned_cols=180 Identities=27% Similarity=0.524 Sum_probs=144.8
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-C
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-Q 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (262)
|||++||+|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||++....... .
T Consensus 97 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~--~~kL~dfg~~~~~~~~~~~ 173 (297)
T cd06659 97 MEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDG--RVKLSDFGFCAQISKDVPK 173 (297)
T ss_pred EecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCC--cEEEeechhHhhccccccc
Confidence 689999999987755 4699999999999999999999999999999999999998777 89999999986443221 2
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....|+..|+|||.+.+..+. .++|+||+||++|+|++|+.||............. .... ........++..+.+
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~l~~ 249 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYG-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR-DSPP--PKLKNAHKISPVLRD 249 (297)
T ss_pred ccceecCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-ccCC--CCccccCCCCHHHHH
Confidence 2346789999999999876665 44899999999999999999998655443332221 1111 111222357889999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
+|.+||+.+|.+||+++++++||||.+.
T Consensus 250 ~i~~~l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 250 FLERMLTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred HHHHHhcCCcccCcCHHHHhhChhhccC
Confidence 9999999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=241.38 Aligned_cols=173 Identities=22% Similarity=0.364 Sum_probs=139.3
Q ss_pred CCCCCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEE
Q 024809 1 MEYAAGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVK 64 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~k 64 (262)
|||++||+|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++ .++
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~--~~~ 164 (283)
T cd05048 87 FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL--TVK 164 (283)
T ss_pred EecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC--cEE
Confidence 6899999999999764 4588999999999999999999999999999999999998776 899
Q ss_pred EeccCCCcCCCCCC---CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhccc
Q 024809 65 ICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRI 140 (262)
Q Consensus 65 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~ 140 (262)
|+|||+++...... ......+++.|+|||.+.+..++. ++|||||||++|+|++ |..||.+....+....+....
T Consensus 165 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~ 243 (283)
T cd05048 165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTT-ESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ 243 (283)
T ss_pred ECCCcceeeccccccccccCCCcccccccCHHHhccCcCch-hhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999987543221 123345688899999988777654 4899999999999998 999998765544333222111
Q ss_pred ccccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 141 LSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
....+ ..++.++.+|+.+||..+|.+||++.+++++
T Consensus 244 ---~~~~~--~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 244 ---LLPCP--EDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred ---cCCCc--ccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 11122 3688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=237.05 Aligned_cols=178 Identities=31% Similarity=0.479 Sum_probs=145.1
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||++|++|.+++.+.+.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++ .+||+|||++.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~--~~kl~d~~~~~~~~~~~~~ 158 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNG--VVKLADFGMAKQVVEFSFA 158 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEccCccceeccccccc
Confidence 68999999999999888899999999999999999999999999999999999998776 8999999998765433334
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 160 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 160 (262)
....|+..|++||.+......+.++|+||+||++|+|++|+.||............... .....++ ..++++++++
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~~l 234 (258)
T cd06632 159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS--KELPPIP--DHLSDEAKDF 234 (258)
T ss_pred cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhc--ccCCCcC--CCcCHHHHHH
Confidence 45678999999999876552334589999999999999999999876533322221110 1111222 2578899999
Q ss_pred HHHhcccCCCCCCCHhHHhcCccc
Q 024809 161 LSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 161 i~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
+.+||..+|.+||++.+++.|||+
T Consensus 235 i~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 235 ILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=242.47 Aligned_cols=181 Identities=24% Similarity=0.357 Sum_probs=137.4
Q ss_pred CCCCCCCchHHH---HH--hCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCCcEEEeccCCCcCC
Q 024809 1 MEYAAGGELFER---IC--NAGRFSEDEARFFFQQLISGVSYCHSM-QICHRDLKLENTLLDGSTAPRVKICDFGYSKSS 74 (262)
Q Consensus 1 mE~~~gg~L~~~---i~--~~~~l~e~~~~~~~~ql~~aL~~LH~~-~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~ 74 (262)
|||+.+ +|.++ +. ..+.+++..+..++.|++.||+|||+. |++||||||+||+++.++ .++|+|||+++..
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~--~~kl~dfg~~~~~ 158 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG--NIKLCDFGISGQL 158 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC--cEEEeecchhHHh
Confidence 577764 55443 32 245799999999999999999999975 999999999999998776 8999999998755
Q ss_pred CCCCCCCccccCCCCCCcccccCC--cCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCC--Cc
Q 024809 75 VLHSQPKSTVGTPAYIAPEVLTKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP--DY 150 (262)
Q Consensus 75 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~ 150 (262)
..........|++.|+|||.+... ...+.++||||+||++|+|++|+.||...... ...............+ ..
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd06616 159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV--FDQLTQVVKGDPPILSNSEE 236 (288)
T ss_pred ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH--HHHHhhhcCCCCCcCCCcCC
Confidence 433333445789999999998765 23345589999999999999999999765421 1111111111111111 12
Q ss_pred ccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 151 VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 151 ~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
..++.++.+||.+||..+|.+|||+++++.||||..
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 237 REFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred CccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 357889999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=243.27 Aligned_cols=180 Identities=27% Similarity=0.476 Sum_probs=143.8
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-C
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-Q 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (262)
|||++||+|.+++.+. .+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++....... .
T Consensus 95 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~--~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 95 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred ecccCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEECcCccceEccCCccC
Confidence 7999999999998654 589999999999999999999999999999999999998776 89999999987543222 2
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....+++.|+|||.+.+..+. .++|+||+||++|+|++|+.||...+........ .............++..+++
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 247 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---ATNGTPELQNPERLSAVFRD 247 (297)
T ss_pred cCcccCCccccCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee---ccCCCCCCCCccccCHHHHH
Confidence 2345788999999999876665 4489999999999999999999765432221111 11111111122357788999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
|+.+||..+|++|||+.++++||||...
T Consensus 248 li~~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 248 FLNRCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred HHHHHccCChhhCcCHHHHhcCchhccc
Confidence 9999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=236.60 Aligned_cols=176 Identities=32% Similarity=0.527 Sum_probs=144.9
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
||||+||+|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++ .+||+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~--~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAG--LIKLGDFGISKILGSEY 155 (256)
T ss_pred EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCC--CEEECcCcceEEccccc
Confidence 6999999999999765 4689999999999999999999999999999999999998776 89999999987543322
Q ss_pred -CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHH
Q 024809 79 -QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 157 (262)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (262)
......|++.|+|||.+.+..++.. +|+||+|+++|+|++|..||......+....... ..+. +....++.++
T Consensus 156 ~~~~~~~~~~~y~ape~~~~~~~~~~-~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~----~~~~-~~~~~~~~~~ 229 (256)
T cd08221 156 SMAETVVGTPYYMSPELCQGVKYNFK-SDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ----GNYT-PVVSVYSSEL 229 (256)
T ss_pred ccccccCCCccccCHhhcCCCCCCCc-chhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc----CCCC-CCccccCHHH
Confidence 2344678999999999887665544 8999999999999999999987554443333221 1111 1123578899
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 158 KHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
.+++.+||..+|.+|||++++++|||+
T Consensus 230 ~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 230 ISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=241.95 Aligned_cols=182 Identities=26% Similarity=0.442 Sum_probs=143.3
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-C
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-Q 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (262)
|||++|++|.+++...+.+++..++.++.|++.||.|||+.|++||||+|+||+++.++ .++|+|||++....... .
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~--~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07846 79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSG--VVKLCDFGFARTLAAPGEV 156 (286)
T ss_pred EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC--cEEEEeeeeeeeccCCccc
Confidence 69999999988887777799999999999999999999999999999999999998776 89999999987543322 2
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccc---------------cc
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS---------------VH 144 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------------~~ 144 (262)
.....++..|+|||.+.+....+.++||||+|+++|+|++|+.||......+........... ..
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence 234568899999999876544445689999999999999999999765543332222211000 00
Q ss_pred ccCC----------CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 145 YSFP----------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 145 ~~~~----------~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
...+ ....++..+++|+.+||..+|.+||++.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0011 123578889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=240.26 Aligned_cols=180 Identities=27% Similarity=0.498 Sum_probs=143.8
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-C
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-Q 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (262)
|||++||+|.+++... .+++..+..++.|++.||.|||+.|++||||+|+||+++.++ .++|+|||++....... .
T Consensus 81 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~--~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06917 81 MEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG--NVKLCDFGVAALLNQNSSK 157 (277)
T ss_pred EecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC--CEEEccCCceeecCCCccc
Confidence 7999999999998664 799999999999999999999999999999999999998766 89999999987554322 2
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....|+..|+|||.+.+....+.++|+||+||++|+|++|..||........... .... ....++. ...+.++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~-~~~~--~~~~~~~-~~~~~~~~~ 233 (277)
T cd06917 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML-IPKS--KPPRLED-NGYSKLLRE 233 (277)
T ss_pred cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc-cccC--CCCCCCc-ccCCHHHHH
Confidence 33457899999999987654444558999999999999999999987543322211 1111 0111111 137789999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
++.+||..+|++||++.+++.||||++.
T Consensus 234 ~i~~~l~~~p~~R~~~~~il~~~~~~~~ 261 (277)
T cd06917 234 FVAACLDEEPKERLSAEELLKSKWIKAH 261 (277)
T ss_pred HHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence 9999999999999999999999999753
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=240.07 Aligned_cols=181 Identities=25% Similarity=0.414 Sum_probs=141.1
Q ss_pred CCCCCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||+. ++|.+++.. .+.+++..++.++.|++.||.|||+.|++||||+|+||+++.++ .+||+|||++.......
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~--~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG--AIKLADFGLARAFGVPV 154 (284)
T ss_pred eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--CEEEeeccchhhcccCc
Confidence 68996 589998865 34689999999999999999999999999999999999998777 89999999987543221
Q ss_pred -CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccc--------------c
Q 024809 79 -QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS--------------V 143 (262)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--------------~ 143 (262)
......+++.|+|||.+.+....+.++|||||||++|+|+||+.||...+......+....... .
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 2233457889999999876554455689999999999999999999876554433332211100 0
Q ss_pred cccCCC---------cccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 144 HYSFPD---------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 144 ~~~~~~---------~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
...++. ...++++++++|.+||..||.+|||+++++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 001111 12467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=247.15 Aligned_cols=214 Identities=26% Similarity=0.364 Sum_probs=156.4
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||+ |++|.+++.. +.+++..++.++.|++.||.|||+.||+||||||+||+++.++ .++|+|||++..... ..
T Consensus 99 ~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~--~~kl~dfg~~~~~~~--~~ 172 (343)
T cd07880 99 MPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC--ELKILDFGLARQTDS--EM 172 (343)
T ss_pred EecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEeeccccccccc--Cc
Confidence 5787 7799888764 4699999999999999999999999999999999999998766 899999999875432 22
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc-----------------
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV----------------- 143 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----------------- 143 (262)
....+++.|+|||.+.+....+.++|+||+||++|++++|+.||........+..........
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (343)
T cd07880 173 TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYV 252 (343)
T ss_pred cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHH
Confidence 345678999999998764434556899999999999999999998765443333322110000
Q ss_pred ----ccc---CC-CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCCccccCCCCccccCCCCCCCCHHHHHH
Q 024809 144 ----HYS---FP-DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLS 215 (262)
Q Consensus 144 ----~~~---~~-~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (262)
... +. ....+++++.++|.+||..||.+|||+.+++.||||+.....+......-.........+.++++..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (343)
T cd07880 253 KKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAPPYDDSFDEVDQSLEEWKR 332 (343)
T ss_pred HhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCCCCccccHHhhccchHHHHH
Confidence 000 00 0135788899999999999999999999999999998754432221111112223455577777766
Q ss_pred HhHHh
Q 024809 216 LIHEA 220 (262)
Q Consensus 216 ~~~~~ 220 (262)
+-...
T Consensus 333 ~~~~~ 337 (343)
T cd07880 333 LTFTE 337 (343)
T ss_pred HHHHH
Confidence 65443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=239.89 Aligned_cols=182 Identities=24% Similarity=0.436 Sum_probs=144.6
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~-~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||++||+|.+++.+.+.+++..+..++.|++.||.|||+ .+++||||||+||+++.++ .++|+|||++..... ..
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~--~~~l~d~gl~~~~~~-~~ 158 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG--QIKLCDFGVSGELIN-SI 158 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC--cEEEccCCcccchhh-hc
Confidence 7999999999999888889999999999999999999997 5899999999999998776 899999999864322 22
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh-------hHHHHHhccccccc-ccCCCcc
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP-------KNFRKTIGRILSVH-YSFPDYV 151 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~ 151 (262)
.....|+..|+|||.+.+..++.+ +|+||+||++|+|++|+.||...... .........+.... ..++. .
T Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~-~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 236 (284)
T cd06620 159 ADTFVGTSTYMSPERIQGGKYTVK-SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS-S 236 (284)
T ss_pred cCccccCcccCCHHHHccCCCCcc-chHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCc-h
Confidence 334578999999999877666544 89999999999999999999864432 11111112221111 11111 2
Q ss_pred cCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 152 RVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 152 ~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
.++.++.+|+.+||..||.+|||+.++++|+||.+.
T Consensus 237 ~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 237 DFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred hcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 377889999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=262.43 Aligned_cols=187 Identities=20% Similarity=0.236 Sum_probs=131.0
Q ss_pred CCCCCCCchHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC
Q 024809 1 MEYAAGGELFERICNAGR--------------------FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~--------------------l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~ 60 (262)
|||+.+|+|.+++..... ..+..+..++.||+.||.|||++||+||||||+|||++.+.
T Consensus 214 ~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~- 292 (566)
T PLN03225 214 WRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGS- 292 (566)
T ss_pred EEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCCC-
Confidence 689999999999875421 12445778999999999999999999999999999997532
Q ss_pred CcEEEeccCCCcCCCCC--CCCCccccCCCCCCcccccCCcCC---------------------CCchhHHHHHHHHHHH
Q 024809 61 PRVKICDFGYSKSSVLH--SQPKSTVGTPAYIAPEVLTKKEYD---------------------GKIADVWSCGVTLYVM 117 (262)
Q Consensus 61 ~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~---------------------~~~~DiwslG~il~~l 117 (262)
+.+||+|||+|+..... .......+++.|+|||.+...... ..++||||+||+||+|
T Consensus 293 ~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el 372 (566)
T PLN03225 293 GSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 372 (566)
T ss_pred CcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHH
Confidence 27999999999754322 223456899999999976432211 1235999999999999
Q ss_pred HhCCCCCCCCCChhHHHHHhccccc----------ccc------cCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 118 LVGAYPFEDPEDPKNFRKTIGRILS----------VHY------SFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 118 l~g~~pf~~~~~~~~~~~~~~~~~~----------~~~------~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
+++..++.. ....+...+..... ... .+.........+.+||.+||++||.+|||+.++|+|
T Consensus 373 ~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 373 AFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCC
Confidence 997766542 22222222211100 000 000001123345689999999999999999999999
Q ss_pred ccccccCCc
Q 024809 182 PWFLRNLPI 190 (262)
Q Consensus 182 p~~~~~~~~ 190 (262)
|||......
T Consensus 451 pff~~~~~~ 459 (566)
T PLN03225 451 PYFDREGLL 459 (566)
T ss_pred cCcCCCCcc
Confidence 999875543
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=233.70 Aligned_cols=175 Identities=43% Similarity=0.736 Sum_probs=146.4
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-CC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (262)
|||++|++|.+++...+.+++..+..++.|++.||.|||+.+++|+||||+||+++.++ .++|+|||++...... ..
T Consensus 72 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~--~~~l~d~~~~~~~~~~~~~ 149 (250)
T cd05123 72 LEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADG--HIKLTDFGLAKELSSEGSR 149 (250)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCC--cEEEeecCcceecccCCCc
Confidence 68999999999999888899999999999999999999999999999999999998776 8999999998755332 23
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....++..|++||.+.+.... ..+|+||||+++|++++|+.||............ ......++. ..+..+.+
T Consensus 150 ~~~~~~~~~~~~Pe~~~~~~~~-~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~--~~~~~l~~ 222 (250)
T cd05123 150 TNTFCGTPEYLAPEVLLGKGYG-KAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI----LKDPLRFPE--FLSPEARD 222 (250)
T ss_pred ccCCcCCccccChHHhCCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH----hcCCCCCCC--CCCHHHHH
Confidence 3456788999999998776654 4489999999999999999999765543322222 223333444 46889999
Q ss_pred HHHHhcccCCCCCCCH---hHHhcCccc
Q 024809 160 LLSRIFVANSEKRITI---PEIKNHPWF 184 (262)
Q Consensus 160 li~~~L~~dp~~R~s~---~e~l~hp~~ 184 (262)
++++||..||.+||++ .++++||||
T Consensus 223 ~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 223 LISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 9999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=233.53 Aligned_cols=177 Identities=32% Similarity=0.510 Sum_probs=144.4
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||++|++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+++.++ .++|+|||.+........
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 76 MEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDG--EVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred EecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCC--eEEEeecccccccccccc
Confidence 6899999999999876 5799999999999999999999999999999999999998766 899999999876544332
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....++..|+|||.+....++ .++|+||+|+++|+|++|+.||...+.......... ......+....++..+.+
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 229 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYD-YKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT---NGPPGLRNPEKWSDEFKD 229 (253)
T ss_pred ccceecCCcccCHHHHcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh---cCCCCcCcccccCHHHHH
Confidence 3456789999999998776654 448999999999999999999987643333222211 111122332235889999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCcc
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPW 183 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~ 183 (262)
+|.+||..||++|||+.++++|||
T Consensus 230 ~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 230 FLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHHHccCChhhCCCHHHHhcCCC
Confidence 999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=235.39 Aligned_cols=173 Identities=26% Similarity=0.403 Sum_probs=142.3
Q ss_pred CCCCCCCchHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCC
Q 024809 1 MEYAAGGELFERICNA---------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYS 71 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~---------~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a 71 (262)
|||++||+|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||.+
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~--~~~l~dfg~~ 152 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDL--VVKISDFGLS 152 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCC--cEEEcccccc
Confidence 6899999999999875 6799999999999999999999999999999999999998876 8999999999
Q ss_pred cCCCCCC---CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccC
Q 024809 72 KSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSF 147 (262)
Q Consensus 72 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 147 (262)
....... ......+++.|+|||.+....++. ++||||||+++|+|++ |..||.............. ......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~---~~~~~~ 228 (262)
T cd00192 153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTS-KSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK---GYRLPK 228 (262)
T ss_pred cccccccccccccCCCcCccccCHHHhccCCcch-hhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---CCCCCC
Confidence 8654332 233456788999999988766554 4899999999999999 6999988754443333322 111222
Q ss_pred CCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 148 PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 148 ~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
+ ..+++++.+++.+||..+|.+|||+.+++.+
T Consensus 229 ~--~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 229 P--EYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred C--ccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 2 3578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=238.14 Aligned_cols=181 Identities=27% Similarity=0.419 Sum_probs=143.6
Q ss_pred CCCCCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||+ +|+|.+++.... .+++..+..++.|++.||.|||++|++|+||+|.||+++.++ .++|+|||+++......
T Consensus 77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~--~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 77 FEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPE--VVKIADFGLAREIRSRP 153 (283)
T ss_pred EecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC--CEEEeecccceeccCCC
Confidence 7899 789999998764 789999999999999999999999999999999999998876 89999999998654443
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccc---------------c
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS---------------V 143 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------------~ 143 (262)
......++..|+|||.+......+.++|+||+|+++++|++|+.||......+.+.+....... .
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 4445678999999998865443445589999999999999999999876654444332211100 0
Q ss_pred cccCC---------CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 144 HYSFP---------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 144 ~~~~~---------~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
...++ .....+.+++++|++||+.+|.+|||++|++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00000 011246789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=235.43 Aligned_cols=172 Identities=23% Similarity=0.317 Sum_probs=138.3
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC-
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ- 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~- 79 (262)
|||+++|+|.+++...+.+++..+..++.|++.||.|||++|++||||||.||+++.++ .+||+|||+++.......
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~--~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 74 MELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH--YAKISDFGLSKALGADENY 151 (257)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCC--eEEECCCccccccCCCCCe
Confidence 79999999999998888899999999999999999999999999999999999998766 899999999975533221
Q ss_pred ---CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 80 ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 80 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
.....++..|+|||.+....++. ++|+|||||++|+|++ |..||...........+ ... .....|. .+++
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i-~~~--~~~~~~~--~~~~ 225 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYYKFSS-KSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI-ESG--ERMECPQ--RCPP 225 (257)
T ss_pred eeecCCCCCCccccCHhHhccCCcCc-hhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HCC--CCCCCCC--CCCH
Confidence 11223457899999987666554 4899999999999998 99999875543332222 211 1122333 5889
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
++.++|.+||+.||++||++.+|..
T Consensus 226 ~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 226 EMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHHHHHHHhccCchhCcCHHHHHH
Confidence 9999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=240.26 Aligned_cols=183 Identities=34% Similarity=0.589 Sum_probs=144.1
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC-
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ- 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~- 79 (262)
|||+.||+|.+++...+.+++..++.++.|++.||.|||+.|++||||||.||+++.++ .++|+|||+++.......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~~~~ 161 (288)
T cd05583 84 LDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEG--HVVLTDFGLSKEFLAEEEE 161 (288)
T ss_pred EecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC--CEEEEECcccccccccccc
Confidence 79999999999998888899999999999999999999999999999999999998776 899999999875433221
Q ss_pred -CCccccCCCCCCcccccCCc-CCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHH
Q 024809 80 -PKSTVGTPAYIAPEVLTKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 157 (262)
Q Consensus 80 -~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (262)
.....|+..|+|||.+.+.. ....++|+||+|+++|+|++|..||...............+.......+. .++..+
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l 239 (288)
T cd05583 162 RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPK--TMSAEA 239 (288)
T ss_pred ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCc--ccCHHH
Confidence 22346899999999986644 22345899999999999999999996533222222222222222222332 578899
Q ss_pred HHHHHHhcccCCCCCCC---HhHHhcCcccccc
Q 024809 158 KHLLSRIFVANSEKRIT---IPEIKNHPWFLRN 187 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s---~~e~l~hp~~~~~ 187 (262)
.++|.+||+.+|++||| +.++|+||||+..
T Consensus 240 ~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 240 RDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred HHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 99999999999999998 5677999999754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=259.02 Aligned_cols=183 Identities=25% Similarity=0.383 Sum_probs=134.9
Q ss_pred CCCCCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCC
Q 024809 1 MEYAAGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV 75 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-----~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~ 75 (262)
||++. ++|.+++... .......++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 242 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~--~vkL~DFGla~~~~ 318 (501)
T PHA03210 242 TQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG--KIVLGDFGTAMPFE 318 (501)
T ss_pred Eeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--CEEEEeCCCceecC
Confidence 45664 5788877543 2345678889999999999999999999999999999998776 89999999997654
Q ss_pred CCCC--CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCC-CCCCC--ChhHHHHHhcccccccccCC--
Q 024809 76 LHSQ--PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYP-FEDPE--DPKNFRKTIGRILSVHYSFP-- 148 (262)
Q Consensus 76 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~--~~~~~~~~~~~~~~~~~~~~-- 148 (262)
.... .....||+.|+|||++.+..++.. +|||||||++|+|++|..+ |.... ....+.+.+..+......+|
T Consensus 319 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 397 (501)
T PHA03210 319 KEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDP 397 (501)
T ss_pred cccccccccccCCcCCCCchhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCc
Confidence 3221 224579999999999988777654 8999999999999998754 43322 12222222221110000011
Q ss_pred ------------------------CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 149 ------------------------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 149 ------------------------~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
....++.++.++|.+||.+||.+|||+.|+|.||||...
T Consensus 398 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 398 PCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 112356778899999999999999999999999999753
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=243.36 Aligned_cols=183 Identities=31% Similarity=0.421 Sum_probs=143.4
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
|||+.+ +|..++... .+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++......
T Consensus 88 ~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~--~~kl~d~g~~~~~~~~~~~ 163 (337)
T cd07852 88 FEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDC--RVKLADFGLARSLSELEEN 163 (337)
T ss_pred eccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC--cEEEeeccchhcccccccc
Confidence 689974 999998776 789999999999999999999999999999999999998777 89999999987553322
Q ss_pred ----CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccc--------------
Q 024809 79 ----QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRI-------------- 140 (262)
Q Consensus 79 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-------------- 140 (262)
......|++.|+|||.+.+......++|+||+|+++|+|++|+.||.+........+.....
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (337)
T cd07852 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSP 243 (337)
T ss_pred ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhh
Confidence 12235689999999988665544556899999999999999999998765443332221110
Q ss_pred ---------ccccc-cC-CCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 141 ---------LSVHY-SF-PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 141 ---------~~~~~-~~-~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
..... .. .....++.++.++|.+||+.+|.+|||+.++++|||+.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 244 FAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred hHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 00000 00 0112368899999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=237.69 Aligned_cols=175 Identities=38% Similarity=0.687 Sum_probs=146.4
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
|||++||+|.+++.+.+.+++..++.++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~--~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDM--HIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC--CEEecCCccccccCCcccc
Confidence 79999999999999888899999999999999999999999999999999999998766 89999999987543221
Q ss_pred -------------------CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcc
Q 024809 79 -------------------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGR 139 (262)
Q Consensus 79 -------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~ 139 (262)
......++..|+|||.+....+. .++|+||||++++++++|+.||........+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-- 235 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAG-KSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL-- 235 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCC-hhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH--
Confidence 11234578899999998776654 44899999999999999999999876544333322
Q ss_pred cccccccCCCcccCCHHHHHHHHHhcccCCCCCCCH----hHHhcCccc
Q 024809 140 ILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITI----PEIKNHPWF 184 (262)
Q Consensus 140 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~----~e~l~hp~~ 184 (262)
.....++. .+++.+.+||.+||..+|.+|||+ +++++||||
T Consensus 236 --~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 236 --KLEYSFPP--NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred --hcCCCCCC--ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 23334443 568899999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=240.90 Aligned_cols=181 Identities=23% Similarity=0.374 Sum_probs=137.4
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||+.+ +|.+.+.... .+++..++.++.|++.||.|||++|++|+||||+||+++.++ .+||+|||++........
T Consensus 98 ~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~~~~~ 174 (310)
T cd07865 98 FEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG--ILKLADFGLARAFSLSKN 174 (310)
T ss_pred EcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC--cEEECcCCCcccccCCcc
Confidence 689875 8888887553 699999999999999999999999999999999999998776 899999999875433221
Q ss_pred -----CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc-----------
Q 024809 80 -----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV----------- 143 (262)
Q Consensus 80 -----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----------- 143 (262)
.....++..|+|||.+.+....+.++|+||+|+++|+|++|+.||.+.........+.......
T Consensus 175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (310)
T cd07865 175 SKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKL 254 (310)
T ss_pred cCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccch
Confidence 1234678899999988765433455899999999999999999998755433222111100000
Q ss_pred ----cccCCC-----------cccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 144 ----HYSFPD-----------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 144 ----~~~~~~-----------~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
...++. ....+..+++||.+||..||.+|||++++++||||
T Consensus 255 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 255 ELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 000010 00135678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=233.83 Aligned_cols=178 Identities=34% Similarity=0.550 Sum_probs=145.9
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC-
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ- 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~- 79 (262)
|||++|++|.+++.+...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||.+........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDG--VVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC--CEEEcccccEEeccccccc
Confidence 68999999999999888899999999999999999999999999999999999998766 899999999876544332
Q ss_pred --CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHH
Q 024809 80 --PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 157 (262)
Q Consensus 80 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (262)
.....++..|+|||.+.......+ +|+||||+++|+|++|..||............... .......+. ..+..+
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~l 233 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRA-ADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS-SGEPPEIPE--HLSEEA 233 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc-cCCCcCCCc--ccCHHH
Confidence 345678899999999877665444 89999999999999999999876632222111111 011122333 468899
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 158 KHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
+++|.+||+.+|.+||++.+++.||||
T Consensus 234 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 234 KDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=238.05 Aligned_cols=181 Identities=29% Similarity=0.454 Sum_probs=142.5
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (262)
|||+++ +|.+++... +.+++..+..++.|++.||.|||++||+|+||||+||+++.++ .++|+|||.+.......
T Consensus 77 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~--~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 77 FEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG--VLKLADFGLARSFGSPVR 153 (283)
T ss_pred EeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCC--cEEEeeeeeeEecCCCcc
Confidence 689975 888888764 5799999999999999999999999999999999999998766 89999999987554332
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc---------------
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV--------------- 143 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------------- 143 (262)
......++..|+|||.+.+....+.++|+||+|+++|+|++|+.||...+..+.+.+........
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence 22335688899999998776334555899999999999999999998766544443332221110
Q ss_pred cccCCC---------cccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 144 HYSFPD---------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 144 ~~~~~~---------~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
...++. ...++.++++||.+||..+|.+||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 000110 12367889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=238.79 Aligned_cols=180 Identities=26% Similarity=0.432 Sum_probs=140.0
Q ss_pred CCCCCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCCcEEEeccCCCcCCC
Q 024809 1 MEYAAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSM-QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV 75 (262)
Q Consensus 1 mE~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~aL~~LH~~-~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~ 75 (262)
|||++ |+|.+++.. ...+++..++.++.|++.||.|||++ +++||||||+||+++.++ .+||+|||+++...
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~--~~kl~dfg~~~~~~ 155 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG--QVKLCDFGISGYLV 155 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC--CEEEeecccccccc
Confidence 68997 588877754 24699999999999999999999997 999999999999998776 89999999987654
Q ss_pred CCCCCCccccCCCCCCcccccCCc---CCCCchhHHHHHHHHHHHHhCCCCCCCCCCh-hHHHHHhcccccccccCCCcc
Q 024809 76 LHSQPKSTVGTPAYIAPEVLTKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEDP-KNFRKTIGRILSVHYSFPDYV 151 (262)
Q Consensus 76 ~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 151 (262)
.........|+..|+|||.+.+.. ..+.++|+||+||++|+|++|+.||...... +.+.... .......+. .
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~-~ 231 (283)
T cd06617 156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV---EEPSPQLPA-E 231 (283)
T ss_pred cccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH---hcCCCCCCc-c
Confidence 332333457899999999886421 1234589999999999999999999754322 2222221 111122222 2
Q ss_pred cCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 152 RVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 152 ~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
.++.++++||.+||..+|.+|||+.++++||||...
T Consensus 232 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 232 KFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 478899999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=244.09 Aligned_cols=184 Identities=24% Similarity=0.359 Sum_probs=144.9
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC----
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL---- 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~---- 76 (262)
|||+. |+|.+++.....+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||+++....
T Consensus 99 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~--~~kl~dfg~~~~~~~~~~~ 175 (335)
T PTZ00024 99 MDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKG--ICKIADFGLARRYGYPPYS 175 (335)
T ss_pred Eeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCC--CEEECCccceeeccccccc
Confidence 78997 59999998888899999999999999999999999999999999999998776 899999999875431
Q ss_pred -----------CCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc-c
Q 024809 77 -----------HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-H 144 (262)
Q Consensus 77 -----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-~ 144 (262)
........+++.|+|||.+.+....+.++|+|||||++|+|++|..||...+....+..+....... .
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~ 255 (335)
T PTZ00024 176 DTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNE 255 (335)
T ss_pred ccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCch
Confidence 0111223568889999998765544556899999999999999999998776554443332211100 0
Q ss_pred ccCC---------------------CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 145 YSFP---------------------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 145 ~~~~---------------------~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
..++ .....+.++.++|.+||..+|++|||+++++.||||+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 256 DNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred hhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 0000 012357889999999999999999999999999999865
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=237.56 Aligned_cols=181 Identities=25% Similarity=0.409 Sum_probs=141.1
Q ss_pred CCCCCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||++ ++|.+++.... .+++..+..++.|++.||.|||+++++||||+|+||+++.++ .++|+|||++.......
T Consensus 77 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~--~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 77 FEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG--ALKLADFGLARAFGVPV 153 (283)
T ss_pred EeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC--cEEEeecccccccCCCc
Confidence 68985 69999998765 699999999999999999999999999999999999998766 89999999987543221
Q ss_pred -CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccc--------------c
Q 024809 79 -QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS--------------V 143 (262)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--------------~ 143 (262)
......++..|+|||++.+......++|+||+|+++|+|++|+.||...+....+.+....... .
T Consensus 154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence 1233457889999998876543345589999999999999999999876554333332211000 0
Q ss_pred cccCC---------CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 144 HYSFP---------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 144 ~~~~~---------~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
...++ ....++..+.++|.+||+.+|.+|||+++++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 00011 123577899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=237.26 Aligned_cols=180 Identities=29% Similarity=0.439 Sum_probs=143.9
Q ss_pred CCCCCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||+.+ +|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~--~~~l~dfg~~~~~~~~~ 161 (287)
T cd07838 85 FEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG--QVKIADFGLARIYSFEM 161 (287)
T ss_pred ehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCC--CEEEeccCcceeccCCc
Confidence 688875 8999887643 599999999999999999999999999999999999998876 89999999987654433
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc-ccc-----------
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-HYS----------- 146 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-~~~----------- 146 (262)
......++..|+|||.+.+..+..+ +|+||+||++|+|++|..||......+.+.+........ ...
T Consensus 162 ~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (287)
T cd07838 162 ALTSVVVTLWYRAPEVLLQSSYATP-VDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSS 240 (287)
T ss_pred ccccccccccccChHHhccCCCCCc-chhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhh
Confidence 3344568889999999987776554 899999999999999999998766655554443322110 000
Q ss_pred CCC---------cccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 147 FPD---------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 147 ~~~---------~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
++. ...++..+.++|.+||..||.+||++.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 241 FPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred cccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 000 11356788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=239.88 Aligned_cols=173 Identities=23% Similarity=0.350 Sum_probs=136.6
Q ss_pred CCCCCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEE
Q 024809 1 MEYAAGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVK 64 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~k 64 (262)
|||+++|+|.+++.+.+ .+++..++.++.|++.||+|||++|++||||||+||+++.++ .+|
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~--~~k 159 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL--ASK 159 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC--eEE
Confidence 68999999999997542 488999999999999999999999999999999999998776 899
Q ss_pred EeccCCCcCCCCCCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccc
Q 024809 65 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSV 143 (262)
Q Consensus 65 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 143 (262)
|+|||++..............+..|+|||.+.+..++. ++|||||||++|+|++ |..||..........+....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~---- 234 (297)
T cd05089 160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTT-KSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---- 234 (297)
T ss_pred ECCcCCCccccceeccCCCCcCccccCchhhccCCCCc-hhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC----
Confidence 99999986432211122223355799999987776654 4899999999999997 99999876554443333221
Q ss_pred cccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 144 HYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 144 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
...+....++..+++|+.+||..+|.+|||+.++++.
T Consensus 235 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 235 -YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1111223588999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=252.28 Aligned_cols=180 Identities=34% Similarity=0.600 Sum_probs=148.6
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
|+|++|||+-.+|.+.+-|+|..+++|+..|..|+++.|+.|+|||||||+||||+.++ ++||+|||+++.+...-
T Consensus 708 MdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdG--HIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG--HIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred EeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCC--ceeeeeccccccceecccc
Confidence 89999999999999999999999999999999999999999999999999999999888 99999999986432100
Q ss_pred ------CC-----------------------------------CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHH
Q 024809 79 ------QP-----------------------------------KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVM 117 (262)
Q Consensus 79 ------~~-----------------------------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 117 (262)
.. ...+||+.|+|||++.+.+|+-. +|+||.|||||+|
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~-cdwws~gvil~em 864 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL-CDWWSVGVILYEM 864 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc-chhhHhhHHHHHH
Confidence 00 12369999999999999888655 8999999999999
Q ss_pred HhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHHHHHhcccCCCCCC---CHhHHhcCccccc
Q 024809 118 LVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI---TIPEIKNHPWFLR 186 (262)
Q Consensus 118 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~---s~~e~l~hp~~~~ 186 (262)
+.|+.||..........++++. .....++...++|.++.++|.++- ..++.|. .+.++..||||+.
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~nw--~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVINW--RNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred hhCCCCccCCCCCcceeeeeeh--hhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccc
Confidence 9999999876654443333222 223456666789999999999873 5788887 4568999999964
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=238.12 Aligned_cols=183 Identities=31% Similarity=0.492 Sum_probs=141.7
Q ss_pred CCCCCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC
Q 024809 1 MEYAAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (262)
|||++||+|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|.||+++.++ .++|+|||++.....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~--~~~l~dfg~~~~~~~ 157 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKG--QVKLCDFGVSGELVN 157 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCC--eEEEeeccccccccc
Confidence 699999999988753 34689999999999999999999999999999999999998776 799999999875432
Q ss_pred CCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCC----hhHHHHHhcccccccc--cCCCc
Q 024809 77 HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPED----PKNFRKTIGRILSVHY--SFPDY 150 (262)
Q Consensus 77 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~~~~~~~~~~~--~~~~~ 150 (262)
. ......++..|+|||.+.+..++.. +|||||||++|+|++|+.||..... .......+........ ..+..
T Consensus 158 ~-~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd06621 158 S-LAGTFTGTSFYMAPERIQGKPYSIT-SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNG 235 (287)
T ss_pred c-ccccccCCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCC
Confidence 2 2234567889999999987777655 8999999999999999999986522 1111111111111000 11111
Q ss_pred ccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 151 VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 151 ~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
...++.+++||.+||..+|.+|||+.+++.||||++.
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 236 IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred CchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 2356789999999999999999999999999999643
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=243.22 Aligned_cols=182 Identities=25% Similarity=0.440 Sum_probs=140.2
Q ss_pred CCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCCCccc
Q 024809 5 AGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTV 84 (262)
Q Consensus 5 ~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 84 (262)
.|++|.+++... .+++..++.++.|++.||.|||+.||+||||||+||+++.++ .+||+|||+++... .......
T Consensus 104 ~~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~--~~kl~dfg~~~~~~--~~~~~~~ 178 (345)
T cd07877 104 MGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARHTD--DEMTGYV 178 (345)
T ss_pred cccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCC--CEEEeccccccccc--ccccccc
Confidence 478998877654 699999999999999999999999999999999999998877 89999999987542 2233457
Q ss_pred cCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccc----------------------
Q 024809 85 GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS---------------------- 142 (262)
Q Consensus 85 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------------------- 142 (262)
+++.|+|||.+.+....+.++||||+||++|+|++|+.||........+.........
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (345)
T cd07877 179 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 258 (345)
T ss_pred cCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhc
Confidence 8999999999866433345589999999999999999999765543333222111000
Q ss_pred c--cccCC-CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCCcc
Q 024809 143 V--HYSFP-DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIE 191 (262)
Q Consensus 143 ~--~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~ 191 (262)
. ...+. .....++++++||.+||..+|.+|||+.++++||||++...++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~ 310 (345)
T cd07877 259 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 310 (345)
T ss_pred ccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCC
Confidence 0 00000 0123678899999999999999999999999999998755443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=235.17 Aligned_cols=180 Identities=32% Similarity=0.543 Sum_probs=139.0
Q ss_pred CCCCCCCchHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRF--SEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l--~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~ 77 (262)
|||++||+|.+++... +.+ ++..+..++.||+.||.|||++||+||||||+||+++... +.++|+|||++......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~-~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYS-GVVKISDFGTSKRLAGI 162 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CeEEEecchhheecccC
Confidence 6899999999999864 455 8899999999999999999999999999999999997522 27999999998754322
Q ss_pred C-CCCccccCCCCCCcccccCCc-CCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 78 S-QPKSTVGTPAYIAPEVLTKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 78 ~-~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
. ......|++.|+|||.+.+.. ..+.++|+||+|+++|+|++|+.||............. ........+|. .+++
T Consensus 163 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~ 239 (268)
T cd06624 163 NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV-GMFKIHPEIPE--SLSA 239 (268)
T ss_pred CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhh-hhhccCCCCCc--ccCH
Confidence 1 223346889999999986543 23455899999999999999999997644322111100 11111122332 5788
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
++++|+.+||..+|.+|||+.+++.||||
T Consensus 240 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 240 EAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 99999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=238.61 Aligned_cols=181 Identities=29% Similarity=0.508 Sum_probs=137.1
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (262)
|||+.| +|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++......
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERG--ELKLADFGLARAKSVPSK 158 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCC--CEEECccccccccCCCCc
Confidence 799985 999988764 4689999999999999999999999999999999999998877 89999999987543221
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh-hHHHHHhccccc---------------
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP-KNFRKTIGRILS--------------- 142 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~--------------- 142 (262)
......++..|+|||.+.+......++||||+|+++|+|++|+.||...... +.+.........
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 1223357889999999876443345589999999999999999999765532 222211111000
Q ss_pred ccccCC---------CcccCC--HHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 143 VHYSFP---------DYVRVS--LECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 143 ~~~~~~---------~~~~~~--~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
....++ ....++ .++.+++.+||..+|.+|||+.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000000 001233 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=238.19 Aligned_cols=177 Identities=28% Similarity=0.465 Sum_probs=142.5
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-C
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-Q 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (262)
|||++||+|.+++.. +++++..+..++.|++.||.|||+++++|+||+|+||+++.++ .++|+|||++....... .
T Consensus 81 ~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~--~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06640 81 MEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG--DVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred EecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCC--CEEEcccccceeccCCccc
Confidence 799999999999875 4699999999999999999999999999999999999998766 89999999987553322 1
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....++..|+|||.+.+..++.+ +|+|||||++|+|++|..||............ .. ...... ...++..+.+
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-~~--~~~~~~--~~~~~~~~~~ 231 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSK-ADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-PK--NNPPTL--TGEFSKPFKE 231 (277)
T ss_pred cccccCcccccCHhHhccCCCccH-HHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-hc--CCCCCC--chhhhHHHHH
Confidence 233468889999999887666544 89999999999999999999865433222211 11 001111 1246788999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
++.+||..+|++||++.+++.||||.+
T Consensus 232 li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06640 232 FIDACLNKDPSFRPTAKELLKHKFIVK 258 (277)
T ss_pred HHHHHcccCcccCcCHHHHHhChHhhh
Confidence 999999999999999999999999964
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=234.67 Aligned_cols=176 Identities=27% Similarity=0.487 Sum_probs=143.2
Q ss_pred CCCCCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||+.||+|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~--~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG--TIKLGDFGIARVLNSTV 155 (256)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC--CEEEeeccceeecCcch
Confidence 69999999999997643 589999999999999999999999999999999999998776 89999999987543221
Q ss_pred C-CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHH
Q 024809 79 Q-PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 157 (262)
Q Consensus 79 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (262)
. .....|++.|+|||.+.+..++. ++|+||+||++|+|++|+.||................ ....+ ...+.++
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~-~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~---~~~~~--~~~~~~~ 229 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNN-KSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS---YPPVS--SHYSYDL 229 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCC-ccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC---CCCCc--ccCCHHH
Confidence 1 22346888999999987766654 4899999999999999999998755444333332211 11122 2578899
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 158 KHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
.++|.+||+.+|.+||++.++++||||
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 230 RNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=245.19 Aligned_cols=185 Identities=21% Similarity=0.295 Sum_probs=138.2
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||+.+|+|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++ .++++||+.+.......
T Consensus 78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~--~~~~~~~~~~~~~~~~~ 155 (328)
T cd08226 78 SPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDG--LVSLSGLSHLYSLVRNG 155 (328)
T ss_pred EecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCC--cEEEechHHHhhhhccC
Confidence 6899999999998864 3599999999999999999999999999999999999998776 89999998653221111
Q ss_pred C--------CCccccCCCCCCcccccCCcC-CCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccc--------
Q 024809 79 Q--------PKSTVGTPAYIAPEVLTKKEY-DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIL-------- 141 (262)
Q Consensus 79 ~--------~~~~~gt~~y~aPE~~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-------- 141 (262)
. .....++..|+|||++.+... .+.++||||+||++|+|++|+.||.................
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITT 235 (328)
T ss_pred ccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccc
Confidence 1 111235667999999876421 24558999999999999999999987654333222211100
Q ss_pred ---------------------------------cccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 142 ---------------------------------SVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 142 ---------------------------------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
......+.....++++++|+++||..||++|||+.++++||||...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 0000111122356789999999999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=243.24 Aligned_cols=181 Identities=27% Similarity=0.353 Sum_probs=136.2
Q ss_pred CCCCCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC----CCCCcEEEeccCCC
Q 024809 1 MEYAAGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG----STAPRVKICDFGYS 71 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-----~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~----~~~~~~kl~Dfg~a 71 (262)
|||+++ +|.+.+... ..+++..++.++.|++.||.|||+++|+||||||+||+++. ++ .+||+|||++
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~--~~kl~Dfg~~ 159 (316)
T cd07842 83 FDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERG--VVKIGDLGLA 159 (316)
T ss_pred EeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccc--eEEECCCccc
Confidence 689975 777776532 26899999999999999999999999999999999999987 44 8999999998
Q ss_pred cCCCCCCC----CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChh---------HHHHHhc
Q 024809 72 KSSVLHSQ----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPK---------NFRKTIG 138 (262)
Q Consensus 72 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---------~~~~~~~ 138 (262)
+....... .....+++.|+|||.+.+....+.++|||||||++|+|++|+.||.+..... .+...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 75433221 2345688999999988765444455899999999999999999998654321 1111100
Q ss_pred ccc----------------------cccccCC---------CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 139 RIL----------------------SVHYSFP---------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 139 ~~~----------------------~~~~~~~---------~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
.+. .....++ .....+.++.+++.+||+.||++|||+.++++||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 000 0000011 011467789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=238.35 Aligned_cols=178 Identities=28% Similarity=0.436 Sum_probs=142.5
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-C
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-Q 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (262)
|||++||+|.+++.. +.+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++....... .
T Consensus 81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~--~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06642 81 MEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQG--DVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred EEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCC--CEEEccccccccccCcchh
Confidence 699999999998865 4699999999999999999999999999999999999998766 89999999987544322 1
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....|+..|+|||.+.+..++.+ +|+||+||++|+|++|+.||............. . ......+ ...+.++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~--~~~~~~~--~~~~~~~~~ 231 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFK-ADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP-K--NSPPTLE--GQYSKPFKE 231 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchh-hhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh-c--CCCCCCC--cccCHHHHH
Confidence 223468889999999987766544 899999999999999999997544322221111 0 0111111 246788999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
+|.+||..+|.+|||+.++++||||...
T Consensus 232 li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 232 FVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred HHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 9999999999999999999999999753
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=238.46 Aligned_cols=182 Identities=29% Similarity=0.519 Sum_probs=145.4
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-C
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-Q 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (262)
|||++|++|.+++.. +++++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||++....... .
T Consensus 96 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~--~~~l~dfg~~~~~~~~~~~ 172 (292)
T cd06657 96 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDG--RVKLSDFGFCAQVSKEVPR 172 (292)
T ss_pred EecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--CEEEcccccceeccccccc
Confidence 799999999988754 4689999999999999999999999999999999999998776 89999999886543221 2
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....|++.|+|||.+.+..+. .++|+||+|+++|+|++|..||........... +.... ...++....++..+.+
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~l~~ 248 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM-IRDNL--PPKLKNLHKVSPSLKG 248 (292)
T ss_pred ccccccCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhhC--CcccCCcccCCHHHHH
Confidence 2345689999999998766664 448999999999999999999986544333222 21111 1122233357889999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCccccccCC
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWFLRNLP 189 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 189 (262)
++.+||..+|.+||++.++++||||.+..+
T Consensus 249 li~~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 249 FLDRLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred HHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence 999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=246.93 Aligned_cols=172 Identities=26% Similarity=0.396 Sum_probs=143.6
Q ss_pred CCCCCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
||||+.|+|.++|+. +..++..+...++.||++|++||+++++|||||...|||++.+. .+||+|||+|+......
T Consensus 280 tE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~--~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDL--VVKISDFGLARLIGDDE 357 (468)
T ss_pred EEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCc--eEEEcccccccccCCCc
Confidence 799999999999997 45699999999999999999999999999999999999998877 89999999999432211
Q ss_pred C--CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 79 Q--PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 79 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
. .....-...|+|||.+....++.+ |||||+||+|+||+| |+.||.+.+..+.+..+. ..+.+|....+++
T Consensus 358 Y~~~~~~kfPIkWtAPEa~~~~~FS~k-SDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le-----~GyRlp~P~~CP~ 431 (468)
T KOG0197|consen 358 YTASEGGKFPIKWTAPEALNYGKFSSK-SDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE-----RGYRLPRPEGCPD 431 (468)
T ss_pred eeecCCCCCCceecCHHHHhhCCcccc-cceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh-----ccCcCCCCCCCCH
Confidence 1 111223456999999999998877 899999999999999 999999987766554432 2345555558999
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
++.+++..||..+|++|||++.+..
T Consensus 432 ~vY~lM~~CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 432 EVYELMKSCWHEDPEDRPTFETLRE 456 (468)
T ss_pred HHHHHHHHHhhCCcccCCCHHHHHH
Confidence 9999999999999999999986653
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=247.74 Aligned_cols=156 Identities=26% Similarity=0.397 Sum_probs=121.9
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC---CCccccCCCCCCccc
Q 024809 18 RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEV 94 (262)
Q Consensus 18 ~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~ 94 (262)
++++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....... .....+++.|+|||+
T Consensus 208 ~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~--~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~ 285 (374)
T cd05106 208 PLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR--VAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPES 285 (374)
T ss_pred CcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC--eEEEeeceeeeeccCCcceeeccCCCCccceeCHHH
Confidence 478889999999999999999999999999999999998766 899999999875432211 112335667999999
Q ss_pred ccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHHHHHhcccCCCCCC
Q 024809 95 LTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI 173 (262)
Q Consensus 95 ~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~ 173 (262)
+.+..++.+ +||||+||++|+|++ |+.||........+....... .....+. ..++++++++.+||+.+|.+||
T Consensus 286 ~~~~~~~~~-~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~--~~~~~~~--~~~~~l~~li~~cl~~dp~~RP 360 (374)
T cd05106 286 IFDCVYTVQ-SDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRG--YQMSRPD--FAPPEIYSIMKMCWNLEPTERP 360 (374)
T ss_pred hcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcc--cCccCCC--CCCHHHHHHHHHHcCCChhhCc
Confidence 987776554 899999999999997 999998755433333322211 1112222 4689999999999999999999
Q ss_pred CHhHHhc
Q 024809 174 TIPEIKN 180 (262)
Q Consensus 174 s~~e~l~ 180 (262)
|+.++++
T Consensus 361 s~~~l~~ 367 (374)
T cd05106 361 TFSQISQ 367 (374)
T ss_pred CHHHHHH
Confidence 9999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=237.22 Aligned_cols=172 Identities=24% Similarity=0.370 Sum_probs=137.0
Q ss_pred CCCCCCCchHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEec
Q 024809 1 MEYAAGGELFERICNAG-------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICD 67 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-------------~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~D 67 (262)
|||++||+|.+++...+ .+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~--~~kl~d 163 (288)
T cd05093 86 FEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL--LVKIGD 163 (288)
T ss_pred EEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC--cEEecc
Confidence 69999999999997543 489999999999999999999999999999999999998776 899999
Q ss_pred cCCCcCCCCCC---CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccc
Q 024809 68 FGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSV 143 (262)
Q Consensus 68 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 143 (262)
||+++...... ......+++.|+|||.+.+..++. ++|+|||||++|+|++ |..||...........+.. .
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~----~ 238 (288)
T cd05093 164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTT-ESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ----G 238 (288)
T ss_pred CCccccccCCceeecCCCCCccccccCHHHhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc----C
Confidence 99987543221 112334577899999998766654 4899999999999998 9999977654433333222 1
Q ss_pred cccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 144 HYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 144 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
.. .+.....+.++.+|+.+||+.||.+|||+.+++.
T Consensus 239 ~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 239 RV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred Cc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11 1112257889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=226.86 Aligned_cols=184 Identities=23% Similarity=0.367 Sum_probs=146.8
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|.+|+. ||+.++.+. .+|+..+++.+|++++.||.|+|.+.|+|||+||+|+||+.++ .+||+|||+++.+.....
T Consensus 103 f~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dg--ilklADFGlar~fs~~~n 179 (376)
T KOG0669|consen 103 FDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDG--ILKLADFGLARAFSTSKN 179 (376)
T ss_pred HHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCc--eEEeeccccccceecccc
Confidence 456775 899998876 5899999999999999999999999999999999999998777 899999999976543321
Q ss_pred -----CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccc-cCCCc---
Q 024809 80 -----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY-SFPDY--- 150 (262)
Q Consensus 80 -----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~--- 150 (262)
.+..+.|.+|++||.+.+...+++..|||..|||+.+|+||.+.+++.++..++..+..-...... .+|+-
T Consensus 180 ~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~l 259 (376)
T KOG0669|consen 180 VVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNL 259 (376)
T ss_pred cCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccc
Confidence 234567999999999999887788899999999999999999999987766555433221111100 01100
Q ss_pred ---c----------------------cCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 151 ---V----------------------RVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 151 ---~----------------------~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
. .-.+++.+|+.++|..||.+|+++.++++|.||.+.
T Consensus 260 pL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 260 PLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred hHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 0 123578899999999999999999999999999754
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=242.61 Aligned_cols=157 Identities=25% Similarity=0.404 Sum_probs=125.1
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC---CCCccccCCCCCCccc
Q 024809 18 RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEV 94 (262)
Q Consensus 18 ~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~ 94 (262)
.+++..+..++.||+.||.|||++||+||||||+||+++.++ .++|+|||+++...... ......++..|+|||+
T Consensus 169 ~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~--~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 246 (337)
T cd05054 169 PLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPES 246 (337)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC--cEEEeccccchhcccCcchhhccCCCCCccccCcHH
Confidence 578999999999999999999999999999999999998766 89999999997643221 1223456778999999
Q ss_pred ccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHHHHHhcccCCCCCC
Q 024809 95 LTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI 173 (262)
Q Consensus 95 ~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~ 173 (262)
+.+..++.+ +||||+||++|+|++ |..||.+....+.+...+.... ....+ ...++++.+++.+||+.+|.+||
T Consensus 247 ~~~~~~~~~-~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~--~~~~~~~~~l~~~cl~~~p~~RP 321 (337)
T cd05054 247 IFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT--RMRAP--EYATPEIYSIMLDCWHNNPEDRP 321 (337)
T ss_pred hcCCCCCcc-ccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccC--CCCCC--ccCCHHHHHHHHHHccCChhhCc
Confidence 988777655 899999999999998 9999987544343333322211 11122 25778999999999999999999
Q ss_pred CHhHHhcC
Q 024809 174 TIPEIKNH 181 (262)
Q Consensus 174 s~~e~l~h 181 (262)
++.++++|
T Consensus 322 s~~ell~~ 329 (337)
T cd05054 322 TFSELVEI 329 (337)
T ss_pred CHHHHHHH
Confidence 99999885
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=231.74 Aligned_cols=176 Identities=31% Similarity=0.526 Sum_probs=145.3
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC-
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ- 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~- 79 (262)
|||++|++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG--VVKLADFGVATKLNDVSKD 155 (254)
T ss_pred EecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCC--CEEEeccccceecCCCccc
Confidence 68999999999999888899999999999999999999999999999999999998765 899999999976543322
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....++..|+|||.+.+..+. .++|+||+|+++|+|++|+.||............. ......++. .++..+++
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~--~~~~~~~~ 229 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGAS-TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV---QDDHPPLPE--GISPELKD 229 (254)
T ss_pred ccccccchhhcCHhhhcCCCCC-cchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh---ccCCCCCCC--CCCHHHHH
Confidence 2345688999999998776654 45899999999999999999998655333222221 112222332 57889999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCccc
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
++.+||..+|++|||+.+++.||||
T Consensus 230 ~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 230 FLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHHHHhCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=232.72 Aligned_cols=176 Identities=35% Similarity=0.535 Sum_probs=144.8
Q ss_pred CCCCCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC
Q 024809 1 MEYAAGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~----~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (262)
|||++|++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~--~~~l~d~~~~~~~~~ 155 (258)
T cd08215 78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNG--LVKLGDFGISKVLSS 155 (258)
T ss_pred EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCC--cEEECCccceeeccc
Confidence 6899999999999764 6799999999999999999999999999999999999998766 899999999875433
Q ss_pred CC-CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 77 HS-QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 77 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
.. ......|++.|+|||.+....+..+ +|+||+|+++++|++|..||................ ....+. .++.
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~--~~~~ 229 (258)
T cd08215 156 TVDLAKTVVGTPYYLSPELCQNKPYNYK-SDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ---YPPIPS--QYSS 229 (258)
T ss_pred CcceecceeeeecccChhHhccCCCCcc-ccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC---CCCCCC--CCCH
Confidence 32 2334578999999999877766544 899999999999999999998765433333322211 112222 5788
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
++.+++.+||..+|.+|||+.++++||||
T Consensus 230 ~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 230 ELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=236.48 Aligned_cols=181 Identities=27% Similarity=0.431 Sum_probs=135.4
Q ss_pred CCCCCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-
Q 024809 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (262)
|||+. ++|.+.+.. .+.+++..++.++.|++.||.|||++||+||||||+||+++.++ .++|+|||+++......
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~--~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLG--ELKLADFGLARAKSIPSQ 158 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCC--cEEEeccccccccCCCCC
Confidence 68996 577777654 35689999999999999999999999999999999999998776 89999999987543221
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChh-HHHHHhcccc-----------cc-c-
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPK-NFRKTIGRIL-----------SV-H- 144 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~~-----------~~-~- 144 (262)
......+++.|+|||.+.+......++|+|||||++|+|++|+.||....... .+.+...... .. .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY 238 (291)
T ss_pred CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence 22345678999999998764433345899999999999999999998654421 1111111000 00 0
Q ss_pred --ccC----C-------CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 145 --YSF----P-------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 145 --~~~----~-------~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
..+ + .....+.++.+++.+||+.||.+|||+.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 000 0 011235789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=233.46 Aligned_cols=176 Identities=35% Similarity=0.561 Sum_probs=143.2
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC---
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH--- 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~--- 77 (262)
|||++||+|.+++.+.+.+++..++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||+++.....
T Consensus 85 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~--~~~l~dfg~~~~~~~~~~~ 162 (264)
T cd06653 85 VEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAG--NVKLGDFGASKRIQTICMS 162 (264)
T ss_pred EEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC--CEEECcccccccccccccc
Confidence 68999999999999888899999999999999999999999999999999999998776 8999999999754321
Q ss_pred -CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHH
Q 024809 78 -SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 156 (262)
Q Consensus 78 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (262)
.......|+..|+|||.+.+...+ .++|+||+||++|+|++|+.||..........+... .+....+|. .++..
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~p~--~~~~~ 237 (264)
T cd06653 163 GTGIKSVTGTPYWMSPEVISGEGYG-RKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT--QPTKPMLPD--GVSDA 237 (264)
T ss_pred CccccccCCcccccCHhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc--CCCCCCCCc--ccCHH
Confidence 111235688999999999876655 448999999999999999999987554443332221 111222333 68899
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
+.++|.+||+ +|.+||++.+++.|||.
T Consensus 238 ~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 238 CRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 9999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=240.51 Aligned_cols=173 Identities=24% Similarity=0.361 Sum_probs=136.6
Q ss_pred CCCCCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEE
Q 024809 1 MEYAAGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVK 64 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~k 64 (262)
|||++||+|.+++...+ .+++..++.++.|++.||+|||++|++||||||+|||++.++ .+|
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~--~~k 164 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY--VAK 164 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC--cEE
Confidence 68999999999997542 478999999999999999999999999999999999998776 899
Q ss_pred EeccCCCcCCCCCCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccc
Q 024809 65 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSV 143 (262)
Q Consensus 65 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 143 (262)
|+|||+++............++..|+|||.+.+..++ .++|||||||++|+|+| |..||......+.+.....
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~----- 238 (303)
T cd05088 165 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ----- 238 (303)
T ss_pred eCccccCcccchhhhcccCCCcccccCHHHHhccCCc-ccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc-----
Confidence 9999998643222222223346679999998776654 45899999999999998 9999976554433332211
Q ss_pred cccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 144 HYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 144 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
....+.....++++.+|+.+||..+|++||++.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 239 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11112223578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=234.60 Aligned_cols=172 Identities=23% Similarity=0.355 Sum_probs=138.1
Q ss_pred CCCCCCCchHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEe
Q 024809 1 MEYAAGGELFERICNAG--------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKIC 66 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~--------------~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~ 66 (262)
|||++||+|.+++...+ .+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+
T Consensus 87 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~--~~kl~ 164 (280)
T cd05049 87 FEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL--VVKIG 164 (280)
T ss_pred EecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC--eEEEC
Confidence 79999999999997542 478999999999999999999999999999999999998776 89999
Q ss_pred ccCCCcCCCCCC---CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhccccc
Q 024809 67 DFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILS 142 (262)
Q Consensus 67 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 142 (262)
|||+++...... ......+++.|+|||++.+..++.+ +|||||||++|+|++ |..||............. .
T Consensus 165 d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~----~ 239 (280)
T cd05049 165 DFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT----Q 239 (280)
T ss_pred CcccceecccCcceecCCCCcccceecChhhhccCCcchh-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH----c
Confidence 999987542221 1223456788999999987776544 899999999999998 999998765544333322 1
Q ss_pred ccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 143 VHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 143 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
.....+ ....+..+++++.+||..||.+|||+.++++
T Consensus 240 ~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 240 GRLLQR-PRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCcCCC-CCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 111111 1257889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=252.83 Aligned_cols=179 Identities=37% Similarity=0.679 Sum_probs=152.5
Q ss_pred CCCCCCCchHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-CCCcEEEeccCCCcCCCCC
Q 024809 1 MEYAAGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS-TAPRVKICDFGYSKSSVLH 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~--~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~-~~~~~kl~Dfg~a~~~~~~ 77 (262)
||-+.| |..+.|- ..++|++..-+.++.||+.||+|||-+||+|+||||+|||+.+. ..+.+||||||+|+.+...
T Consensus 642 MEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 642 MEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred ehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence 777875 7666664 45689999999999999999999999999999999999999643 3568999999999988777
Q ss_pred CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc--cccCCCcccCCH
Q 024809 78 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV--HYSFPDYVRVSL 155 (262)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 155 (262)
....+.+|||.|.|||++++.+|+.. -|+||+|||+|.-+.|.+||...++... +|... .+....|..+++
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrS-LDMWSVGVIiYVsLSGTFPFNEdEdInd------QIQNAaFMyPp~PW~eis~ 793 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRS-LDMWSVGVIIYVSLSGTFPFNEDEDIND------QIQNAAFMYPPNPWSEISP 793 (888)
T ss_pred hhhhhhcCCccccCHHHHhhcccccc-ccceeeeEEEEEEecccccCCCccchhH------HhhccccccCCCchhhcCH
Confidence 77788999999999999999999755 7999999999999999999987654322 12222 333335778999
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
++.+||..+|+..-.+|.|+.+.|.|||++.+
T Consensus 794 ~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 794 EAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 99999999999999999999999999999864
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=236.67 Aligned_cols=172 Identities=23% Similarity=0.355 Sum_probs=137.0
Q ss_pred CCCCCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEE
Q 024809 1 MEYAAGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVK 64 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~k 64 (262)
|||++||+|.+++... +.+++..++.++.||+.||.|||++|++||||||+||+++.++ .++
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~--~~~ 163 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL--LVK 163 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC--cEE
Confidence 7999999999999754 2489999999999999999999999999999999999998776 899
Q ss_pred EeccCCCcCCCCCC---CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhccc
Q 024809 65 ICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRI 140 (262)
Q Consensus 65 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~ 140 (262)
|+|||++....... ......++..|+|||.+.+..++.+ +||||+||++|+|+| |+.||..............
T Consensus 164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-- 240 (291)
T cd05094 164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ-- 240 (291)
T ss_pred ECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhC--
Confidence 99999987543221 1223456788999999887766544 899999999999998 9999977554433322211
Q ss_pred ccccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 141 LSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
.... ......+..+.+++.+||+.+|++|||+.++++
T Consensus 241 --~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 241 --GRVL-ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred --CCCC-CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 1111 112246789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=235.21 Aligned_cols=181 Identities=25% Similarity=0.445 Sum_probs=141.7
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (262)
|||+++ +|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++ .++|+|||++.......
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~--~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 79 FEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDG--VLKLADFGLARPYTKRNS 155 (287)
T ss_pred eccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCC--CEEEccccceeeccCCCc
Confidence 689975 999998765 5799999999999999999999999999999999999998877 89999999987554332
Q ss_pred -CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccc-ccCCC-------
Q 024809 79 -QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH-YSFPD------- 149 (262)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~------- 149 (262)
......++..|+|||.+.+....+.++||||||+++|+|++|+.||.................... ..++.
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence 123346788899999876644445568999999999999999999987665444433322111000 00000
Q ss_pred ----------------ccc-CCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 150 ----------------YVR-VSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 150 ----------------~~~-~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
... .+..+.+++++||..+|.+||++++++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 011 38889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=240.94 Aligned_cols=178 Identities=29% Similarity=0.478 Sum_probs=141.6
Q ss_pred CCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC------------------CCcEEE
Q 024809 6 GGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST------------------APRVKI 65 (262)
Q Consensus 6 gg~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~------------------~~~~kl 65 (262)
|-|+++++++++ +++...++.+.+||+.+++|||+++++|.||||+|||+-++. ...|+|
T Consensus 174 G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~v 253 (415)
T KOG0671|consen 174 GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKV 253 (415)
T ss_pred ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEE
Confidence 448999998865 699999999999999999999999999999999999983211 236899
Q ss_pred eccCCCcCCCCCCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc--
Q 024809 66 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-- 143 (262)
Q Consensus 66 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-- 143 (262)
+|||.|+... ......+.|..|+|||++.+-+++.+ +||||+||||+|+.||...|+..++.+.+ .++.++...
T Consensus 254 IDFGsAtf~~--e~hs~iVsTRHYRAPEViLgLGwS~p-CDvWSiGCIL~ElytG~~LFqtHen~EHL-aMMerIlGp~P 329 (415)
T KOG0671|consen 254 IDFGSATFDH--EHHSTIVSTRHYRAPEVILGLGWSQP-CDVWSIGCILVELYTGETLFQTHENLEHL-AMMERILGPIP 329 (415)
T ss_pred EecCCcceec--cCcceeeeccccCCchheeccCcCCc-cCceeeeeEEEEeeccceecccCCcHHHH-HHHHHhhCCCc
Confidence 9999998543 33466789999999999999999877 89999999999999999999988876654 333332211
Q ss_pred ----------------cccCCCcc-----------------------cCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 144 ----------------HYSFPDYV-----------------------RVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 144 ----------------~~~~~~~~-----------------------~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
...+++.. ....++.+||++||++||.+|+|+.|+|.||||
T Consensus 330 ~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF 409 (415)
T KOG0671|consen 330 SRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFF 409 (415)
T ss_pred HHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHh
Confidence 11111100 011347899999999999999999999999999
Q ss_pred ccc
Q 024809 185 LRN 187 (262)
Q Consensus 185 ~~~ 187 (262)
+..
T Consensus 410 ~~~ 412 (415)
T KOG0671|consen 410 ARL 412 (415)
T ss_pred hcC
Confidence 754
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=244.67 Aligned_cols=157 Identities=26% Similarity=0.369 Sum_probs=122.4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC---CCccccCCCCCCccc
Q 024809 18 RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEV 94 (262)
Q Consensus 18 ~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~ 94 (262)
.+++..+..++.||+.||.|||++||+||||||+|||++.+. .+||+|||+++....... .....++..|+|||+
T Consensus 210 ~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~--~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 287 (375)
T cd05104 210 ALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR--ITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPES 287 (375)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC--cEEEecCccceeccCcccccccCCCCCCcceeChhH
Confidence 478889999999999999999999999999999999998766 899999999975432221 112335667999999
Q ss_pred ccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHHHHHhcccCCCCCC
Q 024809 95 LTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI 173 (262)
Q Consensus 95 ~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~ 173 (262)
+.+..++.+ +|||||||++|+|++ |..||........+.+.+.... ....| ...+.++++|+.+||..||++||
T Consensus 288 ~~~~~~~~~-sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~--~~~~~--~~~~~~l~~li~~cl~~dP~~RP 362 (375)
T cd05104 288 IFNCVYTFE-SDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY--RMLSP--ECAPSEMYDIMKSCWDADPLKRP 362 (375)
T ss_pred hcCCCCCCC-CCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCc--cCCCC--CCCCHHHHHHHHHHccCChhHCc
Confidence 987776544 899999999999998 8999987554443333322211 11112 24678999999999999999999
Q ss_pred CHhHHhcC
Q 024809 174 TIPEIKNH 181 (262)
Q Consensus 174 s~~e~l~h 181 (262)
|+.++++.
T Consensus 363 s~~eil~~ 370 (375)
T cd05104 363 TFKQIVQL 370 (375)
T ss_pred CHHHHHHH
Confidence 99999873
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=235.73 Aligned_cols=181 Identities=27% Similarity=0.471 Sum_probs=141.6
Q ss_pred CCCCCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC
Q 024809 1 MEYAAGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~---~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~ 77 (262)
|||++| +|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||+++.....
T Consensus 77 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~--~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 77 FEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRG--ELKLADFGLARAFGIP 153 (284)
T ss_pred EecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC--cEEEeecchhhhhcCC
Confidence 689985 898888754 3589999999999999999999999999999999999998776 8999999998754322
Q ss_pred C-CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccc--------------c
Q 024809 78 S-QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIL--------------S 142 (262)
Q Consensus 78 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--------------~ 142 (262)
. ......++..|++||++.+......++|+||+||++|+|++|+.||.+.+..+...+...... .
T Consensus 154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 1 223456788999999986654445568999999999999999999988765544443322110 0
Q ss_pred ccccCCC---------cccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 143 VHYSFPD---------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 143 ~~~~~~~---------~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
....++. ....+.+++++|.+||+.+|.+||++.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0001111 12357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=236.51 Aligned_cols=180 Identities=31% Similarity=0.536 Sum_probs=145.7
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (262)
|||++|++|.+++...+ .+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++.......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDG--SVKLADFGFAAQLTKEKS 171 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCC--CEEECccchhhhhccchh
Confidence 68999999999999876 799999999999999999999999999999999999998776 89999999876443221
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 158 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (262)
......++..|++||.+.+..++.+ +|+||+||++|+|++|+.||............... .....+....++.+++
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~ 247 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRKDYGPK-VDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK---GIPPLKNPEKWSPEFK 247 (286)
T ss_pred hhccccCCcccCCHhHhcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---CCCCCcchhhCCHHHH
Confidence 1233457889999999887766544 89999999999999999999865443322222111 1112222224788999
Q ss_pred HHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 159 HLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 159 ~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
++|.+||+.+|.+|||+.++++||||.+
T Consensus 248 ~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 248 DFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred HHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 9999999999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=234.13 Aligned_cols=172 Identities=24% Similarity=0.364 Sum_probs=135.4
Q ss_pred CCCCCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEE
Q 024809 1 MEYAAGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVK 64 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~k 64 (262)
|||++||+|.+++.... .+++..++.++.|++.||+|||++|++||||||+||+++.++ .+|
T Consensus 75 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~--~~k 152 (270)
T cd05047 75 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY--VAK 152 (270)
T ss_pred EEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCC--eEE
Confidence 79999999999997543 478999999999999999999999999999999999998776 899
Q ss_pred EeccCCCcCCCCCCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccc
Q 024809 65 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSV 143 (262)
Q Consensus 65 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 143 (262)
|+|||++..............+..|+|||.+....++ .++|||||||++|+|++ |..||.+......+......
T Consensus 153 l~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~---- 227 (270)
T cd05047 153 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---- 227 (270)
T ss_pred ECCCCCccccchhhhccCCCCccccCChHHHccCCCC-chhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC----
Confidence 9999998643222122223345679999998776665 44899999999999997 99999765543333322111
Q ss_pred cccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 144 HYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 144 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
...+.....+.++.+++.+||..+|.+|||+.+++.
T Consensus 228 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 228 -YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred -CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 111222357789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=238.69 Aligned_cols=181 Identities=24% Similarity=0.398 Sum_probs=138.6
Q ss_pred CCCCCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||+.+ +|...+.. ...+++..++.++.|+++||.|||++|++||||||+||+++.++ .++|+|||+++.......
T Consensus 94 ~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~~~ 170 (311)
T cd07866 94 TPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQG--ILKIADFGLARPYDGPPP 170 (311)
T ss_pred EecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--CEEECcCccchhccCCCc
Confidence 578775 77777764 44799999999999999999999999999999999999998877 899999999875432211
Q ss_pred ------------CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccc---
Q 024809 80 ------------PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH--- 144 (262)
Q Consensus 80 ------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--- 144 (262)
.....+++.|+|||.+.+....+.++||||+||++|+|++|+.||.+.........+........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (311)
T cd07866 171 NPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEET 250 (311)
T ss_pred ccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 12235788899999987654344558999999999999999999987665544443322111000
Q ss_pred ----------------ccCC-----CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 145 ----------------YSFP-----DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 145 ----------------~~~~-----~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
...+ .....++.+.+||.+||+.+|.+|||+.+++.||||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 251 WPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred chhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 0000 112355788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=233.70 Aligned_cols=173 Identities=22% Similarity=0.335 Sum_probs=136.5
Q ss_pred CCCCCCCchHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCC
Q 024809 1 MEYAAGGELFERICN------AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSS 74 (262)
Q Consensus 1 mE~~~gg~L~~~i~~------~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~ 74 (262)
|||+.||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .++|+|||+++..
T Consensus 85 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~ 162 (272)
T cd05075 85 LPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENM--NVCVADFGLSKKI 162 (272)
T ss_pred EEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCC--CEEECCCCccccc
Confidence 689999999998742 23489999999999999999999999999999999999998766 8999999999865
Q ss_pred CCCCC---CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCc
Q 024809 75 VLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDY 150 (262)
Q Consensus 75 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (262)
..... .....+++.|+|||.+.+..++. ++||||+||++|+|++ |+.||............... . ..+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~-~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~----~-~~~~~ 236 (272)
T cd05075 163 YNGDYYRQGRIAKMPVKWIAIESLADRVYTT-KSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG----N-RLKQP 236 (272)
T ss_pred CcccceecCCcccCCcccCCHHHccCCCcCh-HHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC----C-CCCCC
Confidence 33221 12234677899999998776654 4899999999999999 89999875543333222211 1 11222
Q ss_pred ccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 151 VRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 151 ~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
..++..++++|.+||+.+|.+|||+.+++++
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 237 PDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 3578889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=237.59 Aligned_cols=180 Identities=28% Similarity=0.471 Sum_probs=144.1
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-C
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-Q 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (262)
|||++||+|.+++.+. .+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++....... .
T Consensus 95 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~--~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 95 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred EecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCC--CEEEccCcceecccccccc
Confidence 6899999999998765 589999999999999999999999999999999999998776 89999999886443222 2
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....|++.|+|||.+.+..++. ++|+||+||++|++++|+.||............ .......++....++..+++
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~-~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~ 247 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGP-KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---ATNGTPELQNPEKLSAIFRD 247 (293)
T ss_pred cccccCChhhcCchhhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh---hcCCCCCCCCccccCHHHHH
Confidence 23456889999999988766654 489999999999999999999865433221111 11111222233357788999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
+|.+||..+|.+||++.+++.||||+..
T Consensus 248 li~~~l~~~p~~Rp~~~~il~h~~~~~~ 275 (293)
T cd06647 248 FLNRCLEMDVEKRGSAKELLQHPFLKIA 275 (293)
T ss_pred HHHHHccCChhhCcCHHHHhcCHHHhcC
Confidence 9999999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=233.06 Aligned_cols=181 Identities=30% Similarity=0.467 Sum_probs=142.0
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (262)
|||+++ +|.+++... ..+++..++.++.|++.||.|||++||+||||+|+||+++.++ .++|+|||+++......
T Consensus 77 ~e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~--~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 77 FEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDG--VLKLADFGLARAFGIPLR 153 (282)
T ss_pred ecCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCC--CEEEecCCcccccCCCcc
Confidence 689984 999999876 5799999999999999999999999999999999999998876 89999999987553322
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccc--------------cc
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS--------------VH 144 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--------------~~ 144 (262)
......++..|+|||.+......+.++|+||+||++|+|++|+.||........+.++...... ..
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 2233456788999999876633445589999999999999999999876554443332221100 00
Q ss_pred ccCCC---------cccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 145 YSFPD---------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 145 ~~~~~---------~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
..++. ....+..+.++|.+||..+|.+||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 01111 12357789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=230.84 Aligned_cols=177 Identities=31% Similarity=0.515 Sum_probs=142.0
Q ss_pred CCCCCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||++|++|.+++.... .+++..+..++.|++.||.|||+++++|+||||+||+++.++. .++|+|||.+.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM-VAKLGDFGIARQLNDSM 156 (257)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC-eEEecccccchhccCCc
Confidence 68999999999997654 4899999999999999999999999999999999999976642 47999999987543322
Q ss_pred -CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHH
Q 024809 79 -QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 157 (262)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (262)
......|++.|+|||.+.+..++.+ +|+||+|+++|+|++|..||............... .. .+.....+.++
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~-~~~~~~~~~~~ 230 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNK-TDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQG----YF-APISPNFSRDL 230 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc----cC-CCCCCCCCHHH
Confidence 1223468999999999877666544 89999999999999999999865543333322211 11 11223578899
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 158 KHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
+++|.+||..+|++|||+.+++.||||
T Consensus 231 ~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 231 RSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=235.90 Aligned_cols=185 Identities=25% Similarity=0.370 Sum_probs=141.1
Q ss_pred CCCCCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~--l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||++ ++|.+++..... +++..++.++.||+.||.|||++|++||||||+||+++..+ ..+||+|||++.......
T Consensus 80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~-~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT-NALKLADFGLARAFGIPV 157 (294)
T ss_pred Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCC-CEEEEcccccccccCCCc
Confidence 68996 588888876543 68899999999999999999999999999999999997533 268999999997543221
Q ss_pred -CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc--------------
Q 024809 79 -QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-------------- 143 (262)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------------- 143 (262)
......+++.|+|||.+.+......++||||+||++|+|++|+.||..........+........
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (294)
T PLN00009 158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY 237 (294)
T ss_pred cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhh
Confidence 22345678999999998765444455899999999999999999998765544443332211100
Q ss_pred cccCC---------CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 144 HYSFP---------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 144 ~~~~~---------~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
...++ ....+++++.++|.+||..+|.+||++.++++||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 238 KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 00001 012478889999999999999999999999999999753
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=230.97 Aligned_cols=172 Identities=26% Similarity=0.377 Sum_probs=138.3
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||++||+|.+++.+.+.+++..+..++.|++.||.|||+.|++||||||+||+++.++ .+||+|||+++........
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~--~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 74 MELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRH--QAKISDFGMSRALGAGSDY 151 (257)
T ss_pred EEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCC--cEEeccccccceeecCCcc
Confidence 68999999999999888899999999999999999999999999999999999998776 8999999998755332211
Q ss_pred ----CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 81 ----KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 81 ----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
....++..|+|||.+.+..++.+ +|||||||++|+|++ |..||......+.. ..+... ...+....++.
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~~~~~g~~p~~~~~~~~~~-~~~~~~----~~~~~~~~~~~ 225 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSK-SDVWSYGVTLWEAFSYGAKPYGEMKGAEVI-AMLESG----ERLPRPEECPQ 225 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCcc-chHHHHHHHHHHHHcCCCCCcccCCHHHHH-HHHHcC----CcCCCCCCCCH
Confidence 11223467999999977776544 899999999999998 99999876543322 222211 11122235788
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
.++++|.+||..+|++|||+.++++
T Consensus 226 ~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 226 EIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=234.45 Aligned_cols=172 Identities=21% Similarity=0.400 Sum_probs=136.9
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||+++|+|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++.......
T Consensus 87 ~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~--~~kL~dfG~~~~~~~~~~ 164 (279)
T cd05109 87 TQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPN--HVKITDFGLARLLDIDET 164 (279)
T ss_pred EEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC--cEEECCCCceeecccccc
Confidence 6899999999999764 4699999999999999999999999999999999999998766 799999999875532221
Q ss_pred C---CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 80 P---KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 80 ~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
. ....+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||....... ....+... ...+.....+.
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~----~~~~~~~~~~~ 238 (279)
T cd05109 165 EYHADGGKVPIKWMALESILHRRFTHQ-SDVWSYGVTVWELMTFGAKPYDGIPARE-IPDLLEKG----ERLPQPPICTI 238 (279)
T ss_pred eeecCCCccchhhCCHHHhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHHCC----CcCCCCccCCH
Confidence 1 12234678999999987776554 899999999999998 999997654322 22222211 11222336788
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
++.+++.+||..||++||++.+++.
T Consensus 239 ~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 239 DVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=242.43 Aligned_cols=184 Identities=27% Similarity=0.392 Sum_probs=139.2
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
|||+. ++|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+||+++..+ ..++|+|||+++......
T Consensus 95 ~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~-~~~kl~dfg~~~~~~~~~~~ 171 (342)
T cd07854 95 QEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTED-LVLKIGDFGLARIVDPHYSH 171 (342)
T ss_pred eeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC-ceEEECCcccceecCCcccc
Confidence 68997 499888864 4699999999999999999999999999999999999997433 268999999987542211
Q ss_pred --CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccc--------------
Q 024809 79 --QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS-------------- 142 (262)
Q Consensus 79 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-------------- 142 (262)
......++..|+|||.+........++|||||||++|+|++|+.||..................
T Consensus 172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (342)
T cd07854 172 KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIP 251 (342)
T ss_pred ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhh
Confidence 1123467889999998765444455689999999999999999999876544333322211100
Q ss_pred -------ccccCC---CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 143 -------VHYSFP---DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 143 -------~~~~~~---~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
.....+ ....++.++++||.+||..||.+|||+.+++.||||+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 252 SFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred hhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 000000 012477889999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=229.08 Aligned_cols=175 Identities=33% Similarity=0.418 Sum_probs=142.9
Q ss_pred CCCCCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC
Q 024809 1 MEYAAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (262)
|||++|++|.+++.. ...+++..+..++.|++.||.|||++|++|+||+|.||+++.++ .+||+|||++.....
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~--~~kl~d~g~~~~~~~ 155 (256)
T cd08530 78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND--LVKIGDLGISKVLKK 155 (256)
T ss_pred ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCC--cEEEeeccchhhhcc
Confidence 689999999999876 34689999999999999999999999999999999999998766 899999999876543
Q ss_pred CCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHH
Q 024809 77 HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 156 (262)
Q Consensus 77 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (262)
. ......+++.|++||.+.+..++. ++|+||+|+++|+|++|+.||...+........... .....+ ...+.+
T Consensus 156 ~-~~~~~~~~~~~~~Pe~~~~~~~~~-~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~--~~~~~~ 228 (256)
T cd08530 156 N-MAKTQIGTPHYMAPEVWKGRPYSY-KSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG---KYPPIP--PIYSQD 228 (256)
T ss_pred C-CcccccCCccccCHHHHCCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---CCCCCc--hhhCHH
Confidence 3 333456889999999997766654 489999999999999999999876543322221111 111122 257889
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
+++++.+||..+|.+|||+.++++||++
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 229 LQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=234.02 Aligned_cols=175 Identities=21% Similarity=0.332 Sum_probs=137.1
Q ss_pred CCCCCCCchHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCcEEEeccCCCc
Q 024809 1 MEYAAGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-APRVKICDFGYSK 72 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-------~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~-~~~~kl~Dfg~a~ 72 (262)
|||++||+|.+++...+ .+++..+..++.||+.||.|||+++++||||||+||+++.++ ...+||+|||+++
T Consensus 88 ~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~ 167 (277)
T cd05036 88 LELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167 (277)
T ss_pred EecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCcccc
Confidence 79999999999997653 489999999999999999999999999999999999997654 2358999999997
Q ss_pred CCCCCCC---CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCC
Q 024809 73 SSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFP 148 (262)
Q Consensus 73 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 148 (262)
....... ......+..|+|||.+.+..++.+ +|||||||++|+|++ |..||........... +... ....+|
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~~g~~pf~~~~~~~~~~~-~~~~--~~~~~~ 243 (277)
T cd05036 168 DIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSK-TDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF-VTGG--GRLDPP 243 (277)
T ss_pred ccCCccceecCCCCCccHhhCCHHHHhcCCcCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HHcC--CcCCCC
Confidence 5422111 112233567999999987776544 899999999999997 9999987654433222 2111 112222
Q ss_pred CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 149 DYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 149 ~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
..++..+.+++.+||+.+|++|||+.++++|
T Consensus 244 --~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 244 --KGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred --CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 3578899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=214.30 Aligned_cols=184 Identities=24% Similarity=0.442 Sum_probs=150.9
Q ss_pred CCCCCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-
Q 024809 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (262)
+|||.. +|.+++.+ ++.++.+.++.+|.|+++||.|+|++++.||||||.|+||+.++ .+||+|||+++.+...-
T Consensus 80 fe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ng--elkladfglarafgipvr 156 (292)
T KOG0662|consen 80 FEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNG--ELKLADFGLARAFGIPVR 156 (292)
T ss_pred HHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCC--cEEecccchhhhcCCceE
Confidence 588876 89888875 45699999999999999999999999999999999999998888 89999999998654433
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhccccccc-------ccCCCc
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVH-------YSFPDY 150 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~-------~~~~~~ 150 (262)
.....+.|.+|++|.++.+...+....|+||.|||+.|+.. |++.|.+.+-.+++.+++....... ...|++
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence 23446789999999999987766666899999999999986 8888999888888877765443211 011111
Q ss_pred ----------------ccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 151 ----------------VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 151 ----------------~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
+.++..-+++++++|.-+|.+|++++.+++||||...
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 1244567899999999999999999999999999754
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=239.01 Aligned_cols=173 Identities=19% Similarity=0.357 Sum_probs=138.9
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||+++.......
T Consensus 87 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~--~~kl~DfG~a~~~~~~~~ 164 (316)
T cd05108 87 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQ--HVKITDFGLAKLLGADEK 164 (316)
T ss_pred eecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCC--cEEEccccccccccCCCc
Confidence 68999999999998754 689999999999999999999999999999999999998776 899999999986543322
Q ss_pred C---CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 80 P---KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 80 ~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
. ....++..|+|||.+.+..++.+ +|||||||++|+|++ |..||.+....+ +...... ....+.....+.
T Consensus 165 ~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slGv~l~el~t~g~~p~~~~~~~~-~~~~~~~----~~~~~~~~~~~~ 238 (316)
T cd05108 165 EYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEK----GERLPQPPICTI 238 (316)
T ss_pred ceeccCCccceeecChHHhccCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHhC----CCCCCCCCCCCH
Confidence 2 12234667999999987777655 899999999999997 999998654332 2222221 122233345788
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
++.+++.+||..+|.+|||+.+++.+
T Consensus 239 ~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 239 DVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=233.37 Aligned_cols=173 Identities=21% Similarity=0.289 Sum_probs=135.5
Q ss_pred CCCCCCCchHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCC
Q 024809 1 MEYAAGGELFERICNAG----------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGY 70 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~----------~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~ 70 (262)
|||++||+|.+++.+.. .++...+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||+
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~--~~~l~dfg~ 165 (277)
T cd05062 88 MELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF--TVKIGDFGM 165 (277)
T ss_pred EecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCC--CEEECCCCC
Confidence 79999999999997532 357788999999999999999999999999999999998776 899999999
Q ss_pred CcCCCCCCC---CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhccccccccc
Q 024809 71 SKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYS 146 (262)
Q Consensus 71 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 146 (262)
++....... .....+++.|+|||.+.+..++. ++|||||||++|+|++ |..||.+............. ....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~---~~~~ 241 (277)
T cd05062 166 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTT-YSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG---GLLD 241 (277)
T ss_pred ccccCCcceeecCCCCccCHhhcChhHhhcCCcCc-hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC---CcCC
Confidence 875432211 12234577899999998766654 4899999999999999 78999876543333222111 1112
Q ss_pred CCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 147 FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 147 ~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
.+ ...+..+++++.+||+.+|++|||+.+++++
T Consensus 242 ~~--~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 242 KP--DNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 22 2577889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=223.43 Aligned_cols=174 Identities=27% Similarity=0.420 Sum_probs=139.7
Q ss_pred CCCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC
Q 024809 3 YAAGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQ--ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL 76 (262)
Q Consensus 3 ~~~gg~L~~~i~~~----~~l~e~~~~~~~~ql~~aL~~LH~~~--ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (262)
|...|+|.+.|... .-++|.++..|+.+|++||++||+.. ++||||||.|||+.+.+ ..+|.|||.++....
T Consensus 104 yy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~--~~vl~D~GS~~~a~i 181 (302)
T KOG2345|consen 104 YYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSG--LPVLMDLGSATQAPI 181 (302)
T ss_pred hhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCC--ceEEEeccCccccce
Confidence 56678999998643 25999999999999999999999998 99999999999998766 889999999875432
Q ss_pred CCCC----------CccccCCCCCCcccccCCc---CCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc
Q 024809 77 HSQP----------KSTVGTPAYIAPEVLTKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV 143 (262)
Q Consensus 77 ~~~~----------~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 143 (262)
.-.. .....|..|+|||++.-.. .+.+ +|||||||+||.|+.|..||...-. .-....-.+...
T Consensus 182 ~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~er-tDIWSLGCtLYa~mf~~sPfe~~~~--~GgSlaLAv~n~ 258 (302)
T KOG2345|consen 182 QIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITER-TDIWSLGCTLYAMMFGESPFERIYQ--QGGSLALAVQNA 258 (302)
T ss_pred EeechHHHHHHHHHHHHhCCCcccCchheecccCcccccc-cchhhhhHHHHHHHHcCCcchHHhh--cCCeEEEeeecc
Confidence 2111 1235899999999986543 3344 8999999999999999999974221 001112235566
Q ss_pred cccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 144 HYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 144 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
.+.+|+...+|..+.++|+.||+.||.+||++.+++.+
T Consensus 259 q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 259 QISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred ccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 78899988999999999999999999999999999874
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=236.60 Aligned_cols=177 Identities=21% Similarity=0.313 Sum_probs=134.5
Q ss_pred CCCCCCCchHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCC
Q 024809 1 MEYAAGGELFERICNAG-------------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAP 61 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-------------------~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~ 61 (262)
|||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~-- 175 (304)
T cd05096 98 TEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENL-- 175 (304)
T ss_pred EecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCCc--
Confidence 79999999999986532 367788999999999999999999999999999999998776
Q ss_pred cEEEeccCCCcCCCCCC---CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh--CCCCCCCCCChhHHHHH
Q 024809 62 RVKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV--GAYPFEDPEDPKNFRKT 136 (262)
Q Consensus 62 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~--g~~pf~~~~~~~~~~~~ 136 (262)
.+||+|||+++...... ......++..|+|||++....++.+ +|||||||++|+|++ +..||......+.....
T Consensus 176 ~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~ 254 (304)
T cd05096 176 TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTA-SDVWAFGVTLWEILMLCKEQPYGELTDEQVIENA 254 (304)
T ss_pred cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCch-hhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHH
Confidence 89999999987543221 1123345788999999887776544 899999999999986 66788776544333222
Q ss_pred hcccccc--cccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 137 IGRILSV--HYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 137 ~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
....... .........++..+.+|+.+||..+|.+|||+.++..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 255 GEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred HHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 1111110 0111112357889999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=230.42 Aligned_cols=172 Identities=22% Similarity=0.330 Sum_probs=137.1
Q ss_pred CCCCCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||++||+|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~--~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC--cEEeCCCccccccccce
Confidence 68999999999997543 589999999999999999999999999999999999998776 89999999987543321
Q ss_pred CC--CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 79 QP--KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 79 ~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
.. ....++..|+|||.+.+..++.. +|||||||++|+|++ |..||.+....+......... ....+ ..++.
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~--~~~~~ 232 (263)
T cd05052 159 YTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY---RMERP--EGCPP 232 (263)
T ss_pred eeccCCCCCccccCCHHHhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC---CCCCC--CCCCH
Confidence 11 12234567999999877776554 899999999999998 999998755443333322211 12222 36789
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
++.+++.+||..+|++|||+.++++
T Consensus 233 ~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 233 KVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHHHHHHccCCcccCCCHHHHHH
Confidence 9999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=235.52 Aligned_cols=181 Identities=28% Similarity=0.467 Sum_probs=139.9
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||++| +|.+.+... ..+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||++........
T Consensus 95 ~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~--~~kl~dfg~~~~~~~~~~ 171 (302)
T cd07864 95 FEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG--QIKLADFGLARLYNSEES 171 (302)
T ss_pred EcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--cEEeCcccccccccCCcc
Confidence 689986 777777654 4699999999999999999999999999999999999998777 899999999875433221
Q ss_pred --CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccc-ccC---------
Q 024809 80 --PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH-YSF--------- 147 (262)
Q Consensus 80 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~--------- 147 (262)
.....++..|+|||.+.+....+.++||||+||++|+|++|+.||...+....+..+........ ..+
T Consensus 172 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T cd07864 172 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYF 251 (302)
T ss_pred cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccc
Confidence 12235678899999886544334558999999999999999999987655444333322111100 000
Q ss_pred --------------CCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 148 --------------PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 148 --------------~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
.....++..+.+++.+||..+|.+|||+.+++.||||
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 252 NTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0122468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=229.89 Aligned_cols=173 Identities=24% Similarity=0.397 Sum_probs=138.0
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||+.||+|.+++... ..+++..++.++.|++.||.|||++|++|+||||.||+++.++ .+||+|||.++.......
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~--~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQG--CVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC--CEEECCCccceecCCCce
Confidence 7999999999999764 3689999999999999999999999999999999999998766 899999999875432211
Q ss_pred --CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCHH
Q 024809 80 --PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 156 (262)
Q Consensus 80 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (262)
.....++..|+|||.+.+..++.+ +|||||||++|+|++ |..||................ ....+ ...+..
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~-~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~--~~~~~~ 229 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSK-SDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGL---RLYRP--HLASEK 229 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccch-hHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCC---CCCCC--CCCCHH
Confidence 112235667999999987666544 899999999999998 999998766544333332221 11112 246789
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
+++++.+||..+|.+|||+.+++.+
T Consensus 230 ~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 230 VYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHHHcCCCcccCCCHHHHHHh
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=229.32 Aligned_cols=171 Identities=19% Similarity=0.237 Sum_probs=133.9
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC------CcEEEeccCCCcC
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA------PRVKICDFGYSKS 73 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~------~~~kl~Dfg~a~~ 73 (262)
|||++||+|.+++..++ .+++..++.++.||+.||.|||++||+||||||+||+++.++. +.++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 79999999999997654 5899999999999999999999999999999999999976542 1379999999864
Q ss_pred CCCCCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCC-CCCCCCCChhHHHHHhcccccccccCCCccc
Q 024809 74 SVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGA-YPFEDPEDPKNFRKTIGRILSVHYSFPDYVR 152 (262)
Q Consensus 74 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (262)
... .....+++.|+|||++.+....+.++||||+||++|+|++|. .||......... ... .....+|. .
T Consensus 158 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~~----~~~~~~~~--~ 227 (258)
T cd05078 158 VLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFY----EDRHQLPA--P 227 (258)
T ss_pred cCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HHH----HccccCCC--C
Confidence 432 234568889999999976544345589999999999999985 666554332221 111 11222333 4
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 153 VSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 153 ~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
.+.++.+++.+||+.+|++|||++++++.
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 228 KWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred CcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 56789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=231.31 Aligned_cols=172 Identities=19% Similarity=0.317 Sum_probs=137.1
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||++||+|.+++... +.+++..++.++.|++.||.|||++|++||||||+||+++.++ .++++|||.+........
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~--~~~l~dfg~~~~~~~~~~ 162 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL--VCKISGFRRLQEDKSEAI 162 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCC--cEEECCCcccccccccch
Confidence 7999999999999864 4799999999999999999999999999999999999998776 899999998764322211
Q ss_pred C--CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCHH
Q 024809 80 P--KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 156 (262)
Q Consensus 80 ~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (262)
. ....++..|+|||.+.+..++.+ +||||+||++|++++ |..||...........+... ...+....++..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 236 (266)
T cd05064 163 YTTMSGKSPVLWAAPEAIQYHHFSSA-SDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG-----FRLPAPRNCPNL 236 (266)
T ss_pred hcccCCCCceeecCHHHHhhCCccch-hHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC-----CCCCCCCCCCHH
Confidence 1 12345678999999987776544 899999999999775 99999876554433322111 122333467889
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhc
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
+.+++.+||..+|.+|||+.++++
T Consensus 237 ~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 237 LHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHHHcCCCchhCCCHHHHHH
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=229.75 Aligned_cols=170 Identities=21% Similarity=0.356 Sum_probs=135.9
Q ss_pred CCCCCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||++||+|.+++.+.+ .+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~--~~kl~dfg~~~~~~~~- 155 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN--VAKVSDFGLTKEASST- 155 (256)
T ss_pred EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCC--cEEecCCccceecccc-
Confidence 69999999999998654 489999999999999999999999999999999999998777 8999999998754322
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 157 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (262)
.....++..|+|||.+....++.+ +||||+||++|+|++ |+.||............... ........+++.+
T Consensus 156 -~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~ 228 (256)
T cd05082 156 -QDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-----YKMDAPDGCPPVV 228 (256)
T ss_pred -CCCCccceeecCHHHHccCCCCch-hhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-----CCCCCCCCCCHHH
Confidence 223445678999999877766544 899999999999997 99999765433322222111 1111123578899
Q ss_pred HHHHHHhcccCCCCCCCHhHHhc
Q 024809 158 KHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
.+++.+||..+|++|||+.++++
T Consensus 229 ~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 229 YDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHHHhcCChhhCcCHHHHHH
Confidence 99999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=233.10 Aligned_cols=174 Identities=29% Similarity=0.415 Sum_probs=134.7
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC-
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ- 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~- 79 (262)
|||++||+|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++.++ .++|+|||+++.......
T Consensus 87 ~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~~l~dfg~~~~~~~~~~~ 163 (283)
T cd05080 87 MEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR--LVKIGDFGLAKAVPEGHEY 163 (283)
T ss_pred ecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCC--cEEEeecccccccCCcchh
Confidence 7999999999999765 599999999999999999999999999999999999998776 899999999875543221
Q ss_pred ---CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcc------------ccccc
Q 024809 80 ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGR------------ILSVH 144 (262)
Q Consensus 80 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~------------~~~~~ 144 (262)
.....++..|+|||.+....++. ++||||||+++|+|++|..||...... +...... .....
T Consensus 164 ~~~~~~~~~~~~~~~PE~~~~~~~~~-~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 164 YRVREDGDSPVFWYAVECLKENKFSY-ASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred hccCCCCCCCceeeCHhHhcccCCCc-ccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhhhhhhhhcC
Confidence 12234566799999987766654 489999999999999999998654321 1111000 00001
Q ss_pred ccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 145 YSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 145 ~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
...+.....+.++.+++.+||+.+|++|||++++++
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 111222357789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=232.67 Aligned_cols=177 Identities=24% Similarity=0.354 Sum_probs=138.2
Q ss_pred CCCCCCCchHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCC
Q 024809 1 MEYAAGGELFERICNAG----------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGY 70 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~----------~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~ 70 (262)
|||+.||+|.+++...+ .++...+..++.|++.||.|||++||+||||||+||+++.++ .++|+|||+
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~--~~~L~Dfg~ 165 (288)
T cd05061 88 MELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF--TVKIGDFGM 165 (288)
T ss_pred EeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCC--cEEECcCCc
Confidence 79999999999997532 346678999999999999999999999999999999998766 899999999
Q ss_pred CcCCCCCCC---CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhccccccccc
Q 024809 71 SKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYS 146 (262)
Q Consensus 71 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 146 (262)
++....... .....++..|+|||.+.+..++. ++|+||+||++|+|++ |..||.+....+....... .....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~-~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~---~~~~~ 241 (288)
T cd05061 166 TRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTT-SSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD---GGYLD 241 (288)
T ss_pred cccccccccccccCCCcccccccCHHHhccCCCCh-HhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---CCCCC
Confidence 875432211 12234567899999988776654 4899999999999998 7889987554433222211 11112
Q ss_pred CCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhc------Ccccc
Q 024809 147 FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN------HPWFL 185 (262)
Q Consensus 147 ~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~------hp~~~ 185 (262)
.+. ..++.+++++.+||..+|++|||+.++++ ||||.
T Consensus 242 ~~~--~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~ 284 (288)
T cd05061 242 QPD--NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 284 (288)
T ss_pred CCC--CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCC
Confidence 222 56789999999999999999999999986 78875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=228.69 Aligned_cols=172 Identities=23% Similarity=0.385 Sum_probs=137.3
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||++||+|.+++... +.+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||.++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~--~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG--VVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCC--eEEECCCCCccccCCCce
Confidence 7999999999999754 4689999999999999999999999999999999999998776 899999999875432211
Q ss_pred --CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCHH
Q 024809 80 --PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 156 (262)
Q Consensus 80 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (262)
.....++..|+|||.+.+..+.. ++|+||+|+++|+|++ |+.||......+......... ....|. ..+..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~---~~~~~~--~~~~~ 229 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSS-KSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF---RLYRPK--LASMT 229 (256)
T ss_pred eccCCCCCchhhCChhhcccCccch-hhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC---CCCCCC--CCCHH
Confidence 12234566799999998776654 4899999999999999 999998765544433332211 111222 46788
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhc
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
+.+++.+||..+|.+|||+.++++
T Consensus 230 ~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 230 VYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHHHHccCCcccCcCHHHHHH
Confidence 999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=235.27 Aligned_cols=173 Identities=24% Similarity=0.364 Sum_probs=137.6
Q ss_pred CCCCCCCchHHHHHh----------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEE
Q 024809 1 MEYAAGGELFERICN----------------AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVK 64 (262)
Q Consensus 1 mE~~~gg~L~~~i~~----------------~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~k 64 (262)
|||+++|+|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||+++.++ .+|
T Consensus 95 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~--~~k 172 (293)
T cd05053 95 VEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH--VMK 172 (293)
T ss_pred EEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCC--eEE
Confidence 699999999999964 24689999999999999999999999999999999999998776 899
Q ss_pred EeccCCCcCCCCCCC---CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhccc
Q 024809 65 ICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRI 140 (262)
Q Consensus 65 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~ 140 (262)
|+|||+++....... .....++..|+|||.+.+..++.+ +||||+||++|+|++ |..||.+....+.+.......
T Consensus 173 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 251 (293)
T cd05053 173 IADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGY 251 (293)
T ss_pred eCccccccccccccceeccCCCCCCccccCHHHhccCCcCcc-cceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999975433211 112235677999999877766544 899999999999997 999998765444333322211
Q ss_pred ccccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 141 LSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
..+.....+.++.+|+.+||..+|++|||+.+++++
T Consensus 252 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 252 -----RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred -----cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 111223578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=233.48 Aligned_cols=180 Identities=28% Similarity=0.449 Sum_probs=140.1
Q ss_pred CCCCCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~aL~~LH~-~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||+. ++|.+++.. .+.+++..+..++.|++.||.|||+ .||+||||+|+||+++.++ .+||+|||++.......
T Consensus 93 ~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~--~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 93 MELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG--NVKLCDFGISGRLVDSK 169 (296)
T ss_pred eeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC--CEEECccccchhccCCC
Confidence 68875 477777765 4579999999999999999999997 5999999999999998766 89999999987654333
Q ss_pred CCCccccCCCCCCcccccCCc----CCCCchhHHHHHHHHHHHHhCCCCCCCCCCh-hHHHHHhcccccccccCCCcccC
Q 024809 79 QPKSTVGTPAYIAPEVLTKKE----YDGKIADVWSCGVTLYVMLVGAYPFEDPEDP-KNFRKTIGRILSVHYSFPDYVRV 153 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 153 (262)
......++..|+|||.+.+.. ++ .++|+||+|+++|+|++|+.||...... +.+...... .....+....+
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 245 (296)
T cd06618 170 AKTRSAGCAAYMAPERIDPPDPNPKYD-IRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE---EPPSLPPNEGF 245 (296)
T ss_pred cccCCCCCccccCHhhcCCCCCccccc-cchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC---CCCCCCCCCCC
Confidence 333456788999999986543 43 4489999999999999999999764332 222222211 11223333357
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 154 SLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 154 ~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
+.++++|+.+||..+|.+||++.+++.||||...
T Consensus 246 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 246 SPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 8899999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=229.13 Aligned_cols=172 Identities=23% Similarity=0.385 Sum_probs=136.2
Q ss_pred CCCCCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||++||+|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++.......
T Consensus 73 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~--~~kl~dfg~~~~~~~~~~ 150 (257)
T cd05115 73 MEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH--YAKISDFGLSKALGADDS 150 (257)
T ss_pred EEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCC--cEEeccCCccccccCCcc
Confidence 799999999999975 45799999999999999999999999999999999999998776 899999999874432211
Q ss_pred ----CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCC
Q 024809 80 ----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS 154 (262)
Q Consensus 80 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (262)
.....++..|+|||.+....++. ++|||||||++|++++ |..||............... .....+ ...+
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~--~~~~ 224 (257)
T cd05115 151 YYKARSAGKWPLKWYAPECINFRKFSS-RSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG---KRLDCP--AECP 224 (257)
T ss_pred ceeccCCCCCCcccCCHHHHccCCCCc-hhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC---CCCCCC--CCCC
Confidence 11122356899999987766654 4899999999999996 99999876554433222111 111222 2578
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 155 LECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
+++.+++.+||..+|++||++.++.+
T Consensus 225 ~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 225 PEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=230.71 Aligned_cols=173 Identities=22% Similarity=0.344 Sum_probs=137.3
Q ss_pred CCCCCCCchHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCC
Q 024809 1 MEYAAGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSS 74 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~------~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~ 74 (262)
|||+++|+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++..
T Consensus 86 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~dfg~~~~~ 163 (273)
T cd05035 86 LPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDM--TVCVADFGLSKKI 163 (273)
T ss_pred EeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCC--eEEECCccceeec
Confidence 6899999999998532 3589999999999999999999999999999999999998776 8999999998754
Q ss_pred CCCCC---CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCc
Q 024809 75 VLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDY 150 (262)
Q Consensus 75 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (262)
..... .....++..|+|||.+....++.+ +||||+||++|+|++ |..||.+....+.+...... .....+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~-- 237 (273)
T cd05035 164 YSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG---NRLKQP-- 237 (273)
T ss_pred cccccccccccccCCccccCHhhcccCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---CCCCCC--
Confidence 32221 112335678999999877666544 899999999999999 89999876554443332221 112222
Q ss_pred ccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 151 VRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 151 ~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
...+.++.+++.+||+.||++|||+.+++.+
T Consensus 238 ~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 238 EDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=238.64 Aligned_cols=186 Identities=30% Similarity=0.447 Sum_probs=153.4
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc--CCeecCCCCCcEEec-CCCCCcEEEeccCCCcCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM--QICHRDLKLENTLLD-GSTAPRVKICDFGYSKSSVLH 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~--~ivHrDlkp~Nili~-~~~~~~~kl~Dfg~a~~~~~~ 77 (262)
+|||+|-+|.-|++.++.++|++++.|+.||+.||.||... .|||-||||.|||+- .+..+.+||+|||+++.+...
T Consensus 547 LEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMddd 626 (775)
T KOG1151|consen 547 LEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDD 626 (775)
T ss_pred eeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCC
Confidence 59999999999999999999999999999999999999986 499999999999984 344568999999999876433
Q ss_pred CCC--------CccccCCCCCCcccccCC---cCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccccc
Q 024809 78 SQP--------KSTVGTPAYIAPEVLTKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYS 146 (262)
Q Consensus 78 ~~~--------~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 146 (262)
... ....||.||++||++.-. +--+.++||||+|||+|.++.|+.||........+...-..+......
T Consensus 627 Sy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVq 706 (775)
T KOG1151|consen 627 SYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQ 706 (775)
T ss_pred ccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceecc
Confidence 211 235799999999998543 112344899999999999999999998755443333322233345667
Q ss_pred CCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 147 FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 147 ~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
||..+.+++++++||++||++.-++|..+.++..||||..
T Consensus 707 FP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 707 FPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred CCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 8888899999999999999999999999999999999974
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=231.97 Aligned_cols=172 Identities=23% Similarity=0.391 Sum_probs=137.3
Q ss_pred CCCCCCCchHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEE
Q 024809 1 MEYAAGGELFERICNAG---------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKI 65 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~---------------~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl 65 (262)
|||++||+|.+++...+ .+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~--~~kL 163 (280)
T cd05092 86 FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL--VVKI 163 (280)
T ss_pred EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC--CEEE
Confidence 69999999999997643 489999999999999999999999999999999999998766 8999
Q ss_pred eccCCCcCCCCCC---CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccc
Q 024809 66 CDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRIL 141 (262)
Q Consensus 66 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 141 (262)
+|||+++...... ......+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||................
T Consensus 164 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~- 241 (280)
T cd05092 164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR- 241 (280)
T ss_pred CCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCch-hhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc-
Confidence 9999986443221 1222345778999999887776554 899999999999998 999997655544433332211
Q ss_pred cccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 142 SVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
....+ ..+++.+.+++.+||..+|.+||++++++.
T Consensus 242 --~~~~~--~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 242 --ELERP--RTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred --cCCCC--CCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11222 357889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=229.57 Aligned_cols=171 Identities=20% Similarity=0.238 Sum_probs=132.6
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC-----CcEEEeccCCCcCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA-----PRVKICDFGYSKSS 74 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~-----~~~kl~Dfg~a~~~ 74 (262)
|||+++|+|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++. +.++++|||++...
T Consensus 83 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~ 162 (262)
T cd05077 83 EEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV 162 (262)
T ss_pred EecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccc
Confidence 7999999999988754 56999999999999999999999999999999999999975442 13899999998643
Q ss_pred CCCCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHH-hCCCCCCCCCChhHHHHHhcccccccccCCCcccC
Q 024809 75 VLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRV 153 (262)
Q Consensus 75 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (262)
. ......++..|+|||.+......+.++|||||||++|+|+ +|..||......+. ..... .. +......
T Consensus 163 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~~----~~--~~~~~~~ 232 (262)
T cd05077 163 L---SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-ERFYE----GQ--CMLVTPS 232 (262)
T ss_pred c---CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-HHHHh----cC--ccCCCCC
Confidence 2 2234568889999999875444455589999999999998 58888876433221 11111 11 1111235
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 154 SLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 154 ~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
+.++.+||.+||..||.+||++.+|+++
T Consensus 233 ~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 233 CKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred hHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 6789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=229.53 Aligned_cols=171 Identities=30% Similarity=0.502 Sum_probs=138.3
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||++||+|.+++... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++ .++|+|||.++......
T Consensus 77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~--~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNG--KVKLGDFGSARLLTSPG 154 (255)
T ss_pred EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCC--cEEEcccCcceeecccc
Confidence 6999999999998753 3589999999999999999999999999999999999998776 89999999987543322
Q ss_pred -CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccc-cCCCcccCCHH
Q 024809 79 -QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY-SFPDYVRVSLE 156 (262)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 156 (262)
......|++.|+|||++.+..++. ++|+||+|+++|+|++|..||...+........ ..... ..+ ..++..
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~-~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~--~~~~~~ 227 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNN-KSDIWSLGCILYELCTLKHPFQANSWKNLILKV----CQGSYKPLP--SHYSYE 227 (255)
T ss_pred cccccccCCccccCHHHHccCCcCc-hhhhhhhchhheehhhccCCCCCCCHHHHHHHH----hcCCCCCCC--cccCHH
Confidence 223457899999999998776654 489999999999999999999865433322222 11111 122 257889
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhc
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
+++||.+||+.+|.+|||+.+++.
T Consensus 228 ~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 228 LRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred HHHHHHHHHhCCcccCCCHHHHhh
Confidence 999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=227.65 Aligned_cols=173 Identities=24% Similarity=0.372 Sum_probs=139.3
Q ss_pred CCCCCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||++||+|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++......
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~--~~kl~dfg~~~~~~~~~ 151 (257)
T cd05040 74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD--KVKIGDFGLMRALPQNE 151 (257)
T ss_pred EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC--EEEeccccccccccccc
Confidence 68999999999998764 689999999999999999999999999999999999998776 89999999987654321
Q ss_pred C----CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccC
Q 024809 79 Q----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRV 153 (262)
Q Consensus 79 ~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (262)
. .....++..|+|||.+....++.. +|||||||++|+|++ |..||......+....... .....+.....
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~ 226 (257)
T cd05040 152 DHYVMEEHLKVPFAWCAPESLRTRTFSHA-SDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK----EGERLERPEAC 226 (257)
T ss_pred cceecccCCCCCceecCHHHhcccCcCch-hhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh----cCCcCCCCccC
Confidence 1 123457788999999877776554 899999999999998 9999976554443333221 11112222257
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 154 SLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 154 ~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
+..+.+++.+||..+|++|||+.++++
T Consensus 227 ~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 227 PQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred CHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=246.87 Aligned_cols=179 Identities=28% Similarity=0.389 Sum_probs=148.0
Q ss_pred CCCCCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
||||-| +-.+++.- .+++-|-++..|..+.+.||.|||+.+.||||||..|||++..+ .|||+|||.|... ..
T Consensus 105 MEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g--~VKLaDFGSAsi~---~P 178 (948)
T KOG0577|consen 105 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPG--LVKLADFGSASIM---AP 178 (948)
T ss_pred HHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCC--eeeeccccchhhc---Cc
Confidence 899986 77787753 44799999999999999999999999999999999999998887 8999999988643 34
Q ss_pred CCccccCCCCCCccccc---CCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHH
Q 024809 80 PKSTVGTPAYIAPEVLT---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 156 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (262)
.++++|||+|||||++. .+.|+++ +||||||++..++.-.++|.-+.+....+..+...- ....+ ...+|..
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgk-vDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe---sPtLq-s~eWS~~ 253 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE---SPTLQ-SNEWSDY 253 (948)
T ss_pred hhcccCCccccchhHheeccccccCCc-cceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC---CCCCC-CchhHHH
Confidence 57899999999999985 4677777 899999999999999999977655444443333221 11222 3468899
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcCccccccCCc
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPI 190 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 190 (262)
++.||..||++-|.+|||.+++|.|+|+.+..|.
T Consensus 254 F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~ 287 (948)
T KOG0577|consen 254 FRNFVDSCLQKIPQERPTSEELLKHRFVLRERPP 287 (948)
T ss_pred HHHHHHHHHhhCcccCCcHHHHhhcchhccCCCc
Confidence 9999999999999999999999999999876654
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=228.31 Aligned_cols=172 Identities=23% Similarity=0.373 Sum_probs=137.6
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||++||+|.+++... ..+++..+..++.|++.||.|||+++++||||||+||+++.++ .++|+|||+++......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~--~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESL--MCKIADFGLARVIEDNE 157 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCC--cEEECCCccceecCCCc
Confidence 6899999999999753 4689999999999999999999999999999999999998776 89999999997543221
Q ss_pred C--CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 79 Q--PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 79 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
. .....++..|+|||.+....++. ++|||||||++|+|++ |..||............... ...+....++.
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 231 (261)
T cd05072 158 YTAREGAKFPIKWTAPEAINFGSFTI-KSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-----YRMPRMENCPD 231 (261)
T ss_pred eeccCCCccceecCCHHHhccCCCCh-hhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-----CCCCCCCCCCH
Confidence 1 12234567899999987766654 4899999999999998 99999875543333322211 22333346888
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
++.+++.+||..+|++|||++++++
T Consensus 232 ~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 232 ELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=218.03 Aligned_cols=182 Identities=24% Similarity=0.435 Sum_probs=143.9
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
+||+++-+...+ . +.|+...++.+++++++||.|||+.||+|||+||.|++|+.... .++|+|+|+|........-
T Consensus 114 FE~v~n~Dfk~l-y--~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~r-kLrlIDWGLAEFYHp~~eY 189 (338)
T KOG0668|consen 114 FEYVNNTDFKQL-Y--PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEY 189 (338)
T ss_pred hhhhccccHHHH-h--hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhc-eeeeeecchHhhcCCCcee
Confidence 466666554332 2 24889999999999999999999999999999999999986553 7999999999988877777
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCC-CCCCChhHHHHHhcccccc----------------
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEDPKNFRKTIGRILSV---------------- 143 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~~~~~~~~~---------------- 143 (262)
+..+.+..|--||++.....+...-|+|||||+|..|++.+.|| .+.++.+++.++.+.....
T Consensus 190 nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~ 269 (338)
T KOG0668|consen 190 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQ 269 (338)
T ss_pred eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChh
Confidence 77889999999999977655555579999999999999988776 5666667766654322110
Q ss_pred ------ccc------C--C-CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 144 ------HYS------F--P-DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 144 ------~~~------~--~-~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
..+ | + +..-.++++.||+.++|.+|..+|+||+|++.||||..
T Consensus 270 ~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 270 FEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred HhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 000 0 1 11125699999999999999999999999999999964
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=228.05 Aligned_cols=175 Identities=31% Similarity=0.494 Sum_probs=140.4
Q ss_pred CCCCCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC
Q 024809 1 MEYAAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (262)
|||++|++|.+++.. ...+++..++.++.|++.||.|||++|++|+||||+||+++.+ .++|+|||++.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~---~~~l~d~g~~~~~~~ 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN---LLKIGDFGVSRLLMG 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecC---CEeecccCceeecCC
Confidence 689999999988853 3469999999999999999999999999999999999999743 699999999875432
Q ss_pred CC-CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 77 HS-QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 77 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
.. ......|++.|+|||.+.+..++.+ +|+||+|+++|+|++|..||.............. ......+. .++.
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~--~~~~ 231 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYDSK-SDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE---GPTPSLPE--TYSR 231 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc---CCCCCCcc--hhcH
Confidence 22 2234568899999999877666555 8999999999999999999976543332222211 11112222 5788
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
++.++|.+||..+|++||++.++++||||
T Consensus 232 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 232 QLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 99999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-32 Score=230.05 Aligned_cols=172 Identities=20% Similarity=0.344 Sum_probs=136.3
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||+++|+|.+++... +.+++..+..++.||+.||.|||++|++||||||+||+++.++ .+||+|||+++.......
T Consensus 87 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~--~~kl~Dfg~~~~~~~~~~ 164 (279)
T cd05111 87 TQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDS--IVQIADFGVADLLYPDDK 164 (279)
T ss_pred EEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC--cEEEcCCccceeccCCCc
Confidence 6899999999999764 4699999999999999999999999999999999999998776 899999999975432221
Q ss_pred ---CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 80 ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 80 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
.....++..|+|||.+.+..++.+ +|||||||++|+|++ |..||.+..... ....+.. . ...+.....+.
T Consensus 165 ~~~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~el~t~g~~p~~~~~~~~-~~~~~~~---~-~~~~~~~~~~~ 238 (279)
T cd05111 165 KYFYSEHKTPIKWMALESILFGRYTHQ-SDVWSYGVTVWEMMSYGAEPYAGMRPHE-VPDLLEK---G-ERLAQPQICTI 238 (279)
T ss_pred ccccCCCCCcccccCHHHhccCCcCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHHC---C-CcCCCCCCCCH
Confidence 123456778999999987776544 899999999999998 999997654322 2222211 1 11111224677
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
++.+++.+||..+|.+|||+.++++
T Consensus 239 ~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 239 DVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHH
Confidence 8999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=233.27 Aligned_cols=167 Identities=17% Similarity=0.190 Sum_probs=130.6
Q ss_pred chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--------C
Q 024809 8 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS--------Q 79 (262)
Q Consensus 8 ~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~--------~ 79 (262)
++.+.+.....+++..++.++.|++.||.|||+++|+||||||+|||++.++ .++|+|||+|+...... .
T Consensus 112 ~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~--~~~l~DFGla~~~~~~~~~~~~~~~~ 189 (294)
T PHA02882 112 NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN--RGYIIDYGIASHFIIHGKHIEYSKEQ 189 (294)
T ss_pred CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--cEEEEEcCCceeeccCCccccccccc
Confidence 6666666655678999999999999999999999999999999999998766 89999999997543211 1
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHH-----HhcccccccccCCCcccCC
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRK-----TIGRILSVHYSFPDYVRVS 154 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 154 (262)
.....||+.|+|||++.+..++ .++||||+||++|+|++|+.||.+......... ....+....... ...+
T Consensus 190 ~~~~~gt~~y~ape~~~~~~~~-~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 265 (294)
T PHA02882 190 KDLHRGTLYYAGLDAHNGACVT-RRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKI---KNAN 265 (294)
T ss_pred ccccCCCccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhhhcc---CCCC
Confidence 1234699999999999887775 448999999999999999999987643222111 112222222222 2467
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 155 LECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
.++.+++..|+..+|.+||++.++++
T Consensus 266 ~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 266 KFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 88999999999999999999999875
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=229.48 Aligned_cols=176 Identities=20% Similarity=0.341 Sum_probs=132.9
Q ss_pred CCCCCCCchHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCC
Q 024809 1 MEYAAGGELFERICNAG-----RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV 75 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-----~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~ 75 (262)
|||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~--~~kl~dfg~~~~~~ 151 (269)
T cd05042 74 LEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADL--SVKIGDYGLALEQY 151 (269)
T ss_pred EEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCC--cEEEeccccccccc
Confidence 79999999999997643 246788999999999999999999999999999999998776 89999999986432
Q ss_pred CCC---CCCccccCCCCCCcccccCC------cCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccc
Q 024809 76 LHS---QPKSTVGTPAYIAPEVLTKK------EYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHY 145 (262)
Q Consensus 76 ~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 145 (262)
... ......+++.|+|||++... ...+.++||||+||++|+|++ |..||......+.+........ ...
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~-~~~ 230 (269)
T cd05042 152 PEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQD-IKL 230 (269)
T ss_pred cchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccC-ccC
Confidence 211 11233456789999997532 223455899999999999999 7889987655544443332211 111
Q ss_pred cCC-CcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 146 SFP-DYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 146 ~~~-~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
..+ ....++..+.+++..|+ .||.+|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 231 PKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 111 12257788999999998 59999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=229.75 Aligned_cols=172 Identities=23% Similarity=0.347 Sum_probs=136.9
Q ss_pred CCCCCCCchHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCC
Q 024809 1 MEYAAGGELFERICNAG----------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGY 70 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~----------~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~ 70 (262)
|||+++|+|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||+
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~--~~kl~dfg~ 165 (277)
T cd05032 88 MELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL--TVKIGDFGM 165 (277)
T ss_pred EecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCC--CEEECCccc
Confidence 79999999999996432 368889999999999999999999999999999999998777 899999999
Q ss_pred CcCCCCCC---CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhccccccccc
Q 024809 71 SKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYS 146 (262)
Q Consensus 71 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 146 (262)
++...... ......++..|+|||.+.+..++.+ +|||||||++|++++ |..||.......... ... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~~-~~~--~~~~~~ 241 (277)
T cd05032 166 TRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTK-SDVWSFGVVLWEMATLAEQPYQGLSNEEVLK-FVI--DGGHLD 241 (277)
T ss_pred chhhccCcccccCCCCCccccccCHHHHhcCCCCcc-cchHHHHHHHHHhhccCCCCCccCCHHHHHH-HHh--cCCCCC
Confidence 87543222 1223456788999999877666544 899999999999998 999998655433322 222 111222
Q ss_pred CCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 147 FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 147 ~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
.|. ..+.++.+++.+||..+|++|||+.++++
T Consensus 242 ~~~--~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 242 LPE--NCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCC--CCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 333 46889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=227.47 Aligned_cols=173 Identities=21% Similarity=0.358 Sum_probs=137.2
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||++||+|.+++... +.+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++.......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~--~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDN--VVKVSDFGLARYVLDDQY 155 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCC--cEEECCcccceecccccc
Confidence 6999999999999764 4689999999999999999999999999999999999998776 899999999875432211
Q ss_pred C--CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCHH
Q 024809 80 P--KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 156 (262)
Q Consensus 80 ~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (262)
. ....++..|+|||.+.+..+..+ +|+||+|+++|+|++ |+.||......+........ ...+.....+.+
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 229 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSK-SDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG-----YRLYRPKLAPTE 229 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCch-hhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC-----CcCCCCCCCCHH
Confidence 1 11223457999999987776544 899999999999999 89999875544333322211 111222357899
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
+.+++.+||..+|++|||+.++++.
T Consensus 230 ~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 230 VYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHH
Confidence 9999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=231.59 Aligned_cols=177 Identities=24% Similarity=0.341 Sum_probs=138.8
Q ss_pred CCCCCCCchHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccC
Q 024809 1 MEYAAGGELFERICNAG-----------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFG 69 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-----------~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg 69 (262)
|||+.||+|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~--~~~l~dfg 175 (296)
T cd05051 98 MEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNY--TIKIADFG 175 (296)
T ss_pred EecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCCC--ceEEcccc
Confidence 68999999999998765 689999999999999999999999999999999999998776 89999999
Q ss_pred CCcCCCCCC---CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh--CCCCCCCCCChhHHHHHhcccc--c
Q 024809 70 YSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV--GAYPFEDPEDPKNFRKTIGRIL--S 142 (262)
Q Consensus 70 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~--g~~pf~~~~~~~~~~~~~~~~~--~ 142 (262)
+++...... ......+++.|+|||.+.+..+. .++||||+||++|+|++ |..||........+........ .
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 254 (296)
T cd05051 176 MSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFT-TKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDG 254 (296)
T ss_pred ceeecccCcceeecCcCCCCceecCHHHhhcCCCC-ccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhcccccc
Confidence 987543221 12234567789999998776665 44899999999999998 7788876655444333322111 1
Q ss_pred ccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 143 VHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 143 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
.....+.....+.++.+++.+||+.+|.+|||+.++++
T Consensus 255 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 255 RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 11112222356789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=226.67 Aligned_cols=172 Identities=24% Similarity=0.388 Sum_probs=134.2
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||++||+|.+++...+ .+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||++........
T Consensus 72 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~~~~~ 149 (252)
T cd05084 72 MELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKN--VLKISDFGMSREEEDGVY 149 (252)
T ss_pred EeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCC--cEEECccccCcccccccc
Confidence 79999999999997654 589999999999999999999999999999999999998766 899999999875432111
Q ss_pred C---CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 80 P---KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 80 ~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
. ....++..|+|||.+.+..+..+ +|+|||||++|+|++ |..||............... .....+ ...+.
T Consensus 150 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~---~~~~~~--~~~~~ 223 (252)
T cd05084 150 ASTGGMKQIPVKWTAPEALNYGRYSSE-SDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG---VRLPCP--ELCPD 223 (252)
T ss_pred cccCCCCCCceeecCchhhcCCCCChH-HHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC---CCCCCc--ccCCH
Confidence 1 11123456999999987776544 899999999999998 88999765443322222111 111222 25788
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
.+.+|+.+||+.+|++|||+.++++
T Consensus 224 ~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 224 AVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=230.89 Aligned_cols=173 Identities=18% Similarity=0.310 Sum_probs=136.8
Q ss_pred CCCCCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEE
Q 024809 1 MEYAAGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVK 64 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~k 64 (262)
|||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.+. .+|
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~--~~k 164 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL--NVK 164 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC--ceE
Confidence 5899999999998532 2488899999999999999999999999999999999998766 799
Q ss_pred EeccCCCcCCCCCCC---CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhccc
Q 024809 65 ICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRI 140 (262)
Q Consensus 65 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~ 140 (262)
|+|||+++....... .....+++.|+|||.+.+..++.. +|||||||++|+|++ |..||.+....+....+....
T Consensus 165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~ 243 (283)
T cd05091 165 ISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ 243 (283)
T ss_pred ecccccccccccchheeeccCccCCccccCHHHHhcCCCCcc-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999875432221 123456788999999877766544 899999999999998 888998765544333322221
Q ss_pred ccccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 141 LSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
....+ ..++..+.+|+.+||+.+|.+||++.+++..
T Consensus 244 ---~~~~~--~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 244 ---VLPCP--DDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred ---cCCCC--CCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 11222 2688899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=232.43 Aligned_cols=173 Identities=26% Similarity=0.397 Sum_probs=138.2
Q ss_pred CCCCCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||+.||+|.+++.... .+++..+..++.|++.||.|||+++++|+||||+||+++.++ .++|+|||+++......
T Consensus 118 ~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~~l~dfg~~~~~~~~~ 195 (302)
T cd05055 118 TEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK--IVKICDFGLARDIMNDS 195 (302)
T ss_pred EEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC--eEEECCCcccccccCCC
Confidence 69999999999997643 389999999999999999999999999999999999998766 89999999987543221
Q ss_pred C---CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCC
Q 024809 79 Q---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS 154 (262)
Q Consensus 79 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (262)
. .....++..|+|||.+....++.+ +||||+||++|+|++ |..||........+.+..... ...+.....+
T Consensus 196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 270 (302)
T cd05055 196 NYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG----YRMAQPEHAP 270 (302)
T ss_pred ceeecCCCCcccccCCHhhhccCCCCcH-hHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcC----CcCCCCCCCC
Confidence 1 122346778999999887776544 899999999999998 999998765544443332211 1112223578
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 155 LECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
.++.+++.+||..+|++|||+.+++.
T Consensus 271 ~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 271 AEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 89999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-32 Score=227.36 Aligned_cols=172 Identities=22% Similarity=0.327 Sum_probs=137.9
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||+.||+|.+++.+. ..+++..+..++.|++.||.|||+++++||||||+||+++.++ .++|+|||.++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~--~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL--VCKVADFGLARLIEDNE 156 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCC--cEEeccCCceeeccccc
Confidence 7999999999999763 3589999999999999999999999999999999999998776 89999999987543322
Q ss_pred CC--CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 79 QP--KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 79 ~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
.. ....++..|+|||.+.+..++.. +|+|||||++|+|++ |..||............... ...+....++.
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 230 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-----YRMPCPPECPE 230 (262)
T ss_pred cccccCCcccceecCHhHhccCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcC-----CCCCCccccCH
Confidence 11 12345678999999877776544 899999999999999 88899876554433332211 11222336788
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
.+.+++.+||+.+|.+|||+.++++
T Consensus 231 ~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 231 SLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHHHHHccCCcccCCCHHHHHH
Confidence 9999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=265.50 Aligned_cols=177 Identities=16% Similarity=0.181 Sum_probs=132.2
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-----------------CCCc
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS-----------------TAPR 62 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~-----------------~~~~ 62 (262)
|||+ +++|.++|... ..+++..++.+++||+.||.|||++||+||||||+|||++.. ....
T Consensus 59 ~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~ 137 (793)
T PLN00181 59 LECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDAT 137 (793)
T ss_pred hccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCc
Confidence 5776 56999999753 469999999999999999999999999999999999999532 2235
Q ss_pred EEEeccCCCcCCCCCC-----------------CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCC
Q 024809 63 VKICDFGYSKSSVLHS-----------------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFE 125 (262)
Q Consensus 63 ~kl~Dfg~a~~~~~~~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 125 (262)
+|++|||+++...... ......||++|||||++.+..+.. ++|||||||+||||++|..|+.
T Consensus 138 ~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~-~sDVwSlGviL~ELl~~~~~~~ 216 (793)
T PLN00181 138 TKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNC-ASDVYRLGVLLFELFCPVSSRE 216 (793)
T ss_pred ccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCc-hhhhhhHHHHHHHHhhCCCchh
Confidence 7788888876421100 011246899999999998877754 4899999999999999988875
Q ss_pred CCCChhHHHHHhcccccccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 126 DPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
.... .......... .+......+...+++.+||..+|.+|||+.++++||||..
T Consensus 217 ~~~~--~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 217 EKSR--TMSSLRHRVL-----PPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINE 270 (793)
T ss_pred hHHH--HHHHHHHhhc-----ChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence 3211 1111111111 1111123456789999999999999999999999999975
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-32 Score=227.26 Aligned_cols=172 Identities=21% Similarity=0.353 Sum_probs=138.5
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||++||+|.+++.+. +.+++..+..++.||+.||.|||++|++||||||+||+++.++ .+||+|||.+.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~--~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDL--VCKVADFGLARLIKEDV 158 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCc--eEEEccccchhhcCCcc
Confidence 7999999999999853 3689999999999999999999999999999999999998776 89999999987543221
Q ss_pred C-CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCHH
Q 024809 79 Q-PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 156 (262)
Q Consensus 79 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (262)
. .....++..|+|||.+....+..+ +||||||+++|+|++ |+.||......+.+..... ....+.....+..
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~~~~-~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~ 232 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTFSTK-SDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA-----GYRMPCPAKCPQE 232 (261)
T ss_pred ccccCCCCceEecCHHHHccCCCCch-hhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHh-----CCcCCCCCCCCHH
Confidence 1 122345678999999877666544 899999999999998 8999987654444433321 1222233468899
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhc
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
+.+++.+||..+|.+|||+.++++
T Consensus 233 ~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 233 IYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHHHcCCCchhCcCHHHHHH
Confidence 999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=230.95 Aligned_cols=178 Identities=27% Similarity=0.423 Sum_probs=142.7
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-C
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-Q 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (262)
|||+.||+|.+++.+. .+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++....... .
T Consensus 81 ~e~~~~~~l~~~i~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~--~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06641 81 MEYLGGGSALDLLEPG-PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG--EVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred EEeCCCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCC--CEEEeecccceecccchhh
Confidence 6999999999998654 699999999999999999999999999999999999998776 89999999987543221 1
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....++..|+|||.+.....+. ++|+||+||++|+|++|..||............... .....+ ..++.++.+
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~-~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~--~~~~~~~~~ 231 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDS-KADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN---NPPTLE--GNYSKPLKE 231 (277)
T ss_pred hccccCCccccChhhhccCCCCc-hhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC---CCCCCC--cccCHHHHH
Confidence 23356888999999987766654 489999999999999999999765433222221111 111112 247788999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
++.+||..+|.+||++.++++||||.+.
T Consensus 232 ~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 232 FVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred HHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 9999999999999999999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=233.33 Aligned_cols=172 Identities=24% Similarity=0.344 Sum_probs=135.8
Q ss_pred CCCCCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEE
Q 024809 1 MEYAAGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVK 64 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~k 64 (262)
|||++||+|.+++... ..++...+..++.|++.||.|||++|++||||||+||+++.++ .+|
T Consensus 97 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~--~~k 174 (314)
T cd05099 97 VEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN--VMK 174 (314)
T ss_pred EecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCC--cEE
Confidence 6999999999999753 3488999999999999999999999999999999999998776 899
Q ss_pred EeccCCCcCCCCCCC---CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhccc
Q 024809 65 ICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRI 140 (262)
Q Consensus 65 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~ 140 (262)
|+|||+++....... .....++..|+|||.+.+..++. ++|||||||++|+|++ |..||.+......+......
T Consensus 175 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~- 252 (314)
T cd05099 175 IADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTH-QSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREG- 252 (314)
T ss_pred EccccccccccccccccccccCCCCccccCHHHHccCCcCc-cchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-
Confidence 999999975432211 11223456799999998766654 4899999999999999 89999775543333322211
Q ss_pred ccccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 141 LSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
.....+ ..++.++++++.+||..+|.+|||+.++++
T Consensus 253 --~~~~~~--~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 253 --HRMDKP--SNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred --CCCCCC--CCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 111222 357889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=226.98 Aligned_cols=172 Identities=20% Similarity=0.318 Sum_probs=137.5
Q ss_pred CCCCCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||+.||+|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||+++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~--~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNL--VCKIADFGLARLIEDNE 156 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC--eEEECCCccceEccCCc
Confidence 79999999999997643 489999999999999999999999999999999999998776 89999999987543222
Q ss_pred C--CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 79 Q--PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 79 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
. .....++..|+|||.+.+..++ .++|+||||+++|+|++ |..||.+............. ...+.....+.
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 230 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG-----YRMPCPQGCPE 230 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCcC-hHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----CCCCCCcccCH
Confidence 1 1223456789999998776665 44899999999999999 99999876554433332221 11222235788
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
.+++++.+||..+|.+||+++++++
T Consensus 231 ~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 231 SLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHH
Confidence 9999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-32 Score=232.23 Aligned_cols=178 Identities=25% Similarity=0.322 Sum_probs=138.8
Q ss_pred CCCCCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||+.| +|.+.+.. .+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++ .++|+|||++.... .
T Consensus 94 ~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~--~~kL~dfg~~~~~~---~ 167 (307)
T cd06607 94 MEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPG--TVKLADFGSASLVS---P 167 (307)
T ss_pred HHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCC--CEEEeecCcceecC---C
Confidence 689875 77777654 45799999999999999999999999999999999999998776 89999999986442 2
Q ss_pred CCccccCCCCCCcccccC--CcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHH
Q 024809 80 PKSTVGTPAYIAPEVLTK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 157 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (262)
.....+++.|+|||++.+ ....+.++||||+|+++|+|++|+.||............... .....+ ...++..+
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~---~~~~~~-~~~~~~~~ 243 (307)
T cd06607 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN---DSPTLS-SNDWSDYF 243 (307)
T ss_pred CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC---CCCCCC-chhhCHHH
Confidence 234578889999998742 222334589999999999999999999865443322221111 111111 12467889
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 024809 158 KHLLSRIFVANSEKRITIPEIKNHPWFLRNL 188 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 188 (262)
+++|.+||..+|++||++.+++.||||....
T Consensus 244 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 244 RNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred HHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 9999999999999999999999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=227.60 Aligned_cols=176 Identities=23% Similarity=0.339 Sum_probs=131.8
Q ss_pred CCCCCCCchHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCC
Q 024809 1 MEYAAGGELFERICNAG-----RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV 75 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-----~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~ 75 (262)
|||++||+|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.++ ++||+|||+++...
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~--~~kL~dfg~~~~~~ 151 (269)
T cd05087 74 MEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL--TVKIGDYGLSHNKY 151 (269)
T ss_pred EECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC--cEEECCcccccccc
Confidence 79999999999997532 357778899999999999999999999999999999998766 89999999986432
Q ss_pred CCC---CCCccccCCCCCCcccccCCc------CCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccc
Q 024809 76 LHS---QPKSTVGTPAYIAPEVLTKKE------YDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHY 145 (262)
Q Consensus 76 ~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 145 (262)
... ......++..|+|||++.+.. ..+.++|+||+|+++|+|++ |+.||......+......... ....
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~ 230 (269)
T cd05087 152 KEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQ-QLKL 230 (269)
T ss_pred CcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcc-cCCC
Confidence 221 112345778899999986432 12345899999999999996 999998765544332222111 1111
Q ss_pred cCCC-cccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 146 SFPD-YVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 146 ~~~~-~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
..|. ....+..+.+++.+|+ .+|.+|||+++++.
T Consensus 231 ~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 231 PKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 1111 1246788999999998 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=226.86 Aligned_cols=172 Identities=21% Similarity=0.339 Sum_probs=137.0
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||++||+|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||++.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~--~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGL--VCKIADFGLARLIEDNE 156 (260)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCc--eEEeCCceeeeeccCcc
Confidence 7899999999999753 3589999999999999999999999999999999999998776 89999999987543222
Q ss_pred CC--CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 79 QP--KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 79 ~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
.. ....++..|+|||.+.+..++. ++|+||||+++|+|++ |..||......+....+... ...+.....+.
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 230 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALYGRFTI-KSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG-----YRMPCPQDCPI 230 (260)
T ss_pred cccccCCCCCccccChHHHhcCCCcc-hhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----CCCCCCCcCCH
Confidence 11 1233556799999987766654 4899999999999999 89999875544433332211 12222236788
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
.+++|+.+||..+|++|||+.++.+
T Consensus 231 ~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 231 SLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHH
Confidence 9999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8e-32 Score=232.09 Aligned_cols=173 Identities=23% Similarity=0.344 Sum_probs=136.7
Q ss_pred CCCCCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEE
Q 024809 1 MEYAAGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVK 64 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~k 64 (262)
|||+++|+|.+++.+. ..++...+..++.||+.||.|||++|++||||||+||+++.++ .+|
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~--~~k 177 (304)
T cd05101 100 VEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENN--VMK 177 (304)
T ss_pred EecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCC--cEE
Confidence 7999999999999764 2478889999999999999999999999999999999998766 899
Q ss_pred EeccCCCcCCCCCCC---CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhccc
Q 024809 65 ICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRI 140 (262)
Q Consensus 65 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~ 140 (262)
|+|||+++....... .....+++.|+|||++.+..++.+ +||||||+++|+|++ |..||.+....+........
T Consensus 178 l~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~- 255 (304)
T cd05101 178 IADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG- 255 (304)
T ss_pred ECCCccceecccccccccccCCCCCceeeCchhhccCCCCch-hhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-
Confidence 999999975532211 122345678999999987776555 899999999999998 78888765443333222111
Q ss_pred ccccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 141 LSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
.....+ ..++.++++|+.+||..+|.+|||+.++++.
T Consensus 256 --~~~~~~--~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 256 --HRMDKP--ANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred --CcCCCC--CCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 111122 3678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-32 Score=227.33 Aligned_cols=173 Identities=23% Similarity=0.407 Sum_probs=138.5
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||++||+|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.++ .++|+|||+++.......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~--~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNL--VCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC--CEEECccchhhccccccc
Confidence 7999999999999764 4699999999999999999999999999999999999998776 899999999986542111
Q ss_pred C---CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 80 P---KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 80 ~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
. ....++..|+|||.+.+..++.+ +||||||+++|+|++ |..||............... ...+.....+.
T Consensus 162 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 235 (266)
T cd05033 162 TYTTKGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG-----YRLPPPMDCPS 235 (266)
T ss_pred ceeccCCCCCccccChhhhccCCCccc-cchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-----CCCCCCCCCCH
Confidence 1 12234678999999987776544 899999999999998 99999765544333222211 12222336789
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
.+.+++.+||+.+|++||++.+++++
T Consensus 236 ~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 236 ALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 99999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=225.36 Aligned_cols=172 Identities=20% Similarity=0.305 Sum_probs=137.1
Q ss_pred CCCCCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||+.||+|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||+++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENN--ICKVADFGLARVIKEDI 157 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCC--CEEECCcceEEEccCCc
Confidence 79999999999997654 699999999999999999999999999999999999998776 89999999987654221
Q ss_pred CC--CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 79 QP--KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 79 ~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
.. .....+..|+|||.+.+..++.+ +|+||||+++|+|++ |+.||.+......+..+... ...+.....+.
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 231 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIK-SDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG-----YRMPCPPGCPK 231 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCch-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----CCCCCCCcCCH
Confidence 11 11223457999999887766555 899999999999999 99999876544333332211 11222235788
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
.+.+++.+||..+|.+||++.+++.
T Consensus 232 ~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 232 ELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHHHHhhcCcccCCCHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=216.10 Aligned_cols=164 Identities=20% Similarity=0.204 Sum_probs=126.8
Q ss_pred CchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCCCcccc
Q 024809 7 GELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVG 85 (262)
Q Consensus 7 g~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~g 85 (262)
|+|.+++... +.+++..++.++.|++.||.|||+.+ ||+|||++.++ .+|+ ||+++.... ....|
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~--~~~~--fG~~~~~~~----~~~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDG--LLKL--DGSVAFKTP----EQSRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCcc--ceee--ccceEeecc----ccCCC
Confidence 7999999874 46999999999999999999999998 99999998776 7888 999875432 22368
Q ss_pred CCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChh-HHHHHhccccccccc-CCCcccCCH--HHHHHH
Q 024809 86 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPK-NFRKTIGRILSVHYS-FPDYVRVSL--ECKHLL 161 (262)
Q Consensus 86 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~li 161 (262)
|+.|+|||++.+..++.+ +||||+||++|+|++|+.||....... .+............. .+....++. +++++|
T Consensus 67 ~~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEK-ADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred cccccChHHhcCCCCcch-hhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 999999999988877654 899999999999999999997654322 222222221111100 011112333 699999
Q ss_pred HHhcccCCCCCCCHhHHhcCcccc
Q 024809 162 SRIFVANSEKRITIPEIKNHPWFL 185 (262)
Q Consensus 162 ~~~L~~dp~~R~s~~e~l~hp~~~ 185 (262)
.+||..+|.+|||+.+++.|+|+.
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHH
Confidence 999999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-32 Score=233.07 Aligned_cols=173 Identities=24% Similarity=0.342 Sum_probs=135.5
Q ss_pred CCCCCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEE
Q 024809 1 MEYAAGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVK 64 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~k 64 (262)
|||+.+|+|.+++...+ .++...++.++.|++.||.|||++|++||||||+||+++.++ .+|
T Consensus 103 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~--~~k 180 (307)
T cd05098 103 VEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN--VMK 180 (307)
T ss_pred EecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCC--cEE
Confidence 79999999999997642 488999999999999999999999999999999999998776 899
Q ss_pred EeccCCCcCCCCCCC---CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhccc
Q 024809 65 ICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRI 140 (262)
Q Consensus 65 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~ 140 (262)
|+|||+++....... .....+++.|+|||.+.+..++. ++|+||+||++|+|++ |..||..... ......+...
T Consensus 181 L~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwslG~~l~el~~~g~~p~~~~~~-~~~~~~~~~~ 258 (307)
T cd05098 181 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH-QSDVWSFGVLLWEIFTLGGSPYPGVPV-EELFKLLKEG 258 (307)
T ss_pred ECCCcccccccccchhhccccCCCccceeChHHhccCCCCc-HHHHHHHHHHHHHHHcCCCCCCCcCCH-HHHHHHHHcC
Confidence 999999875432211 11223456899999988766654 4899999999999998 8899876443 2222222111
Q ss_pred ccccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 141 LSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
.....+ ...+.++.+|+.+||..+|.+|||+.+++.+
T Consensus 259 --~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 259 --HRMDKP--SNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred --CCCCCC--CcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 111222 3578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.1e-32 Score=229.26 Aligned_cols=173 Identities=20% Similarity=0.353 Sum_probs=136.3
Q ss_pred CCCCCCCchHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcE
Q 024809 1 MEYAAGGELFERICNA-----------------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRV 63 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-----------------~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~ 63 (262)
|||+.+|+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.+. .+
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~--~~ 163 (283)
T cd05090 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL--HV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC--cE
Confidence 7999999999998532 2478999999999999999999999999999999999998776 89
Q ss_pred EEeccCCCcCCCCCC---CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcc
Q 024809 64 KICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGR 139 (262)
Q Consensus 64 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~ 139 (262)
||+|||+++...... ......++..|+|||.+.+..++. ++|+|||||++|+|++ |..||.+......... ...
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~-~~~ 241 (283)
T cd05090 164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSS-DSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM-VRK 241 (283)
T ss_pred EeccccccccccCCcceecccCCCccceecChHHhccCCCCc-hhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HHc
Confidence 999999997543221 123344667899999987766654 4899999999999998 9999976543322222 211
Q ss_pred cccccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 140 ILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 140 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
....+....+++.+.+++.+||+.+|.+||++.+++++
T Consensus 242 ----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 242 ----RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred ----CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 11122223678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=226.77 Aligned_cols=175 Identities=28% Similarity=0.397 Sum_probs=136.8
Q ss_pred CCCCCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC
Q 024809 1 MEYAAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (262)
|||++||+|.+++.. .+.+++..++.++.||+.||.|||++|++|+||||+||+++.++ .++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~--~~~l~dfg~~~~~~~ 158 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG--VVKLGDLGLGRFFSS 158 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC--CEEECcchhhhcccc
Confidence 689999999998863 34689999999999999999999999999999999999998766 899999999875433
Q ss_pred CCC-CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 77 HSQ-PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 77 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
... .....|+..|+|||.+.+..++.+ +|+||+|+++|+|++|..||.+.... .......+....+........+.
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHYSE 235 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCccch-hhHHHHHHHHHHHHhCCCCcccccch--HHHHhhhhhcCCCCCCCcccccH
Confidence 221 234568999999999987776544 89999999999999999999754321 11111222211111111224788
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
++++++.+||..+|.+|||+.++++
T Consensus 236 ~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 236 ELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHHH
Confidence 9999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=224.69 Aligned_cols=170 Identities=23% Similarity=0.362 Sum_probs=136.4
Q ss_pred CCCCCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||++||+|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||.++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~--~~~l~d~g~~~~~~~~- 155 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDL--VAKVSDFGLAKEASQG- 155 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCC--CEEEcccccccccccc-
Confidence 68999999999998765 699999999999999999999999999999999999998776 8999999999865321
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 157 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (262)
.....++..|+|||.+....+.. ++|+||+|+++|+|++ |+.||............... .....+ ...++++
T Consensus 156 -~~~~~~~~~~~ape~~~~~~~~~-~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~--~~~~~~~ 228 (256)
T cd05039 156 -QDSGKLPVKWTAPEALREKKFST-KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG---YRMEAP--EGCPPEV 228 (256)
T ss_pred -cccCCCcccccCchhhcCCcCCc-HHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC---CCCCCc--cCCCHHH
Confidence 12334566799999987766654 4899999999999997 99999765433322221111 111222 2578899
Q ss_pred HHHHHHhcccCCCCCCCHhHHhc
Q 024809 158 KHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
.++|.+||..+|++|||+.+++.
T Consensus 229 ~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 229 YKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHHHhccChhhCcCHHHHHH
Confidence 99999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=224.34 Aligned_cols=170 Identities=21% Similarity=0.222 Sum_probs=133.0
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCC-----cEEEeccCCCcCC
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAP-----RVKICDFGYSKSS 74 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~-----~~kl~Dfg~a~~~ 74 (262)
|||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||+++..+.. .+||+|||++...
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~ 158 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV 158 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccc
Confidence 69999999999998766 79999999999999999999999999999999999999765422 6999999998754
Q ss_pred CCCCCCCccccCCCCCCcccccCC-cCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCccc
Q 024809 75 VLHSQPKSTVGTPAYIAPEVLTKK-EYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR 152 (262)
Q Consensus 75 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (262)
.. .....++..|+|||.+... ...+.++||||+||++|+|++ |..||........ ..... .....+. .
T Consensus 159 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~-~~~~~----~~~~~~~--~ 228 (259)
T cd05037 159 LS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK-ERFYQ----DQHRLPM--P 228 (259)
T ss_pred cc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH-HHHHh----cCCCCCC--C
Confidence 32 2344577889999998776 233455899999999999999 5788876542221 11111 0111111 2
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 153 VSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 153 ~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
....+.+++.+||..+|.+|||+.++++
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 229 DCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 3378999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=225.31 Aligned_cols=174 Identities=30% Similarity=0.439 Sum_probs=136.8
Q ss_pred CCCCCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC
Q 024809 1 MEYAAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (262)
|||++||+|.+++.. ...+++..++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~--~~~l~d~~~~~~~~~ 158 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATG--VVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCC--cEEEeccceeeeccC
Confidence 799999999999864 34589999999999999999999999999999999999998776 899999999875433
Q ss_pred CC-CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccc-cCCCcccCC
Q 024809 77 HS-QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY-SFPDYVRVS 154 (262)
Q Consensus 77 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 154 (262)
.. ......+++.|+|||.+.+..++.+ +|+||+||++|+|++|+.||...... .......+..... ..| ....+
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~-~~~~~ 234 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEKCDYPPLP-ADHYS 234 (267)
T ss_pred CCcccceecCCccccCHHHhccCCCCch-hcHHHHHHHHHHHHHCCCCcccCCcc--HHHHHhhhhcCCCCCCC-hhhcC
Confidence 22 2234568999999999987776544 89999999999999999999654321 1111111111111 112 12577
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 155 LECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
.++.++|.+||..+|++|||+.++++
T Consensus 235 ~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 235 EELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 88999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=230.29 Aligned_cols=177 Identities=25% Similarity=0.337 Sum_probs=139.5
Q ss_pred CCCCCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||+.| +|.+.+.. .+.+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++... ..
T Consensus 100 ~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~--~~kL~dfg~~~~~---~~ 173 (313)
T cd06633 100 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG--QVKLADFGSASKS---SP 173 (313)
T ss_pred EecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCC--CEEEeecCCCccc---CC
Confidence 689964 78777764 45699999999999999999999999999999999999998766 8999999988643 22
Q ss_pred CCccccCCCCCCcccccC--CcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHH
Q 024809 80 PKSTVGTPAYIAPEVLTK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 157 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (262)
.....|+..|+|||.+.. ......++|+||+||++|+|++|..||...+........... .........++..+
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l 249 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----DSPTLQSNEWTDSF 249 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc----CCCCCCccccCHHH
Confidence 345678999999999842 222344589999999999999999999876543333332211 11111122467789
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 158 KHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
++|+.+||+.+|.+||++.+++.||||...
T Consensus 250 ~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 250 RGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-31 Score=224.73 Aligned_cols=177 Identities=22% Similarity=0.293 Sum_probs=132.6
Q ss_pred CCCCCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC
Q 024809 1 MEYAAGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~----~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (262)
|||++||+|.+++.+. ..+++..++.++.||+.||.|||+++++||||||+|||++.++ .++|+|||++.....
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~--~~~l~Dfg~~~~~~~ 151 (268)
T cd05086 74 FEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDL--TVKVGDYGIGPSRYK 151 (268)
T ss_pred EecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCc--cEEecccccccccCc
Confidence 7999999999999754 2467788899999999999999999999999999999998776 899999999864221
Q ss_pred C---CCCCccccCCCCCCcccccCCc------CCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhccccccccc
Q 024809 77 H---SQPKSTVGTPAYIAPEVLTKKE------YDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYS 146 (262)
Q Consensus 77 ~---~~~~~~~gt~~y~aPE~~~~~~------~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 146 (262)
. .......++..|+|||++.... ..+.++||||+||++|+|++ |..||......+.+.............
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (268)
T cd05086 152 EDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFK 231 (268)
T ss_pred chhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCC
Confidence 1 1123456888999999985321 12345899999999999997 577887665554444433221111111
Q ss_pred CCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 147 FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 147 ~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
......+++.+.+++.+|+ .+|.+|||+.+++.
T Consensus 232 ~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 232 PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 1111247888999999999 67999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=227.35 Aligned_cols=171 Identities=23% Similarity=0.302 Sum_probs=133.5
Q ss_pred CCCCCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-----CCcEEEeccCCCcCC
Q 024809 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-----APRVKICDFGYSKSS 74 (262)
Q Consensus 1 mE~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~-----~~~~kl~Dfg~a~~~ 74 (262)
||||+||+|..++.. .+.+++..+..++.|++.||.|||++||+||||||+||+++..+ .+.+|++|||++...
T Consensus 95 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~ 174 (274)
T cd05076 95 EEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTA 174 (274)
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCcccccc
Confidence 799999999999875 45799999999999999999999999999999999999997533 224899999987643
Q ss_pred CCCCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHH-hCCCCCCCCCChhHHHHHhcccccccccCCCcccC
Q 024809 75 VLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRV 153 (262)
Q Consensus 75 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (262)
. ......++..|+|||.+.+....+.++|||||||++|+|+ +|+.||......... .... .....+. ..
T Consensus 175 ~---~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~----~~~~~~~--~~ 244 (274)
T cd05076 175 L---SREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE-RFYE----KKHRLPE--PS 244 (274)
T ss_pred c---cccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH-HHHH----hccCCCC--CC
Confidence 2 1223457888999999876443455589999999999985 699999875443221 1111 1122232 35
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 154 SLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 154 ~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
++++.++|.+||+.+|.+|||+.+++++
T Consensus 245 ~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 245 CKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred ChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 6789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=223.01 Aligned_cols=172 Identities=27% Similarity=0.410 Sum_probs=137.5
Q ss_pred CCCCCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~--l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||++||+|.+++..... +++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||+++......
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~--~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL--VVKISDFGLSRDLYDDD 157 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCC--eEEEcccCCceeccccc
Confidence 799999999999986554 99999999999999999999999999999999999998777 89999999987554331
Q ss_pred CCC--ccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 79 QPK--STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 79 ~~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
... ...+++.|+|||.+....++ .++|+||+|+++|+|++ |..||................ ....+ ...+.
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~--~~~~~ 231 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFT-SKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY---RLPKP--ENCPP 231 (258)
T ss_pred ccccccCCCcccccChHHhccCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC---CCCCC--CcCCH
Confidence 111 13367899999998665554 45899999999999998 888988754433333322211 11222 24789
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
++.+++.+||..+|.+|||+.++++
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 232 EIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHHHCcCChhhCcCHHHHHh
Confidence 9999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=228.91 Aligned_cols=177 Identities=25% Similarity=0.348 Sum_probs=134.8
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||++||+|.+++.+.. .+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||+++.......
T Consensus 87 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~--~~~l~dfg~~~~~~~~~~ 164 (284)
T cd05079 87 MEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH--QVKIGDFGLTKAIETDKE 164 (284)
T ss_pred EEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCC--CEEECCCccccccccCcc
Confidence 79999999999997653 589999999999999999999999999999999999998766 899999999986543221
Q ss_pred ----CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh-----------hHHHHHhccccccc
Q 024809 80 ----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP-----------KNFRKTIGRILSVH 144 (262)
Q Consensus 80 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----------~~~~~~~~~~~~~~ 144 (262)
.....++..|+|||.+.+..+.. ++||||+||++|+|++++.|+...... .........+. ..
T Consensus 165 ~~~~~~~~~~~~~y~apE~~~~~~~~~-~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 242 (284)
T cd05079 165 YYTVKDDLDSPVFWYAPECLIQSKFYI-ASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE-EG 242 (284)
T ss_pred ceeecCCCCCCccccCHHHhccCCCCc-cccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH-cC
Confidence 12345677899999988776654 489999999999999987665321110 00000110011 11
Q ss_pred ccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 145 YSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 145 ~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
...+....++..+.+|+.+||+.+|.+|||+.+++.+
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 1223334688999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=223.87 Aligned_cols=173 Identities=24% Similarity=0.315 Sum_probs=133.0
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (262)
|||+.+|+|.+++.+. ..+++..+..++.|++.||.|||+.+++||||||+|||++.++ .+||+|||+++......
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~--~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 76 LPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESF--TVKVADFGLARDIYDKEY 153 (262)
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC--cEEECCccccccccCCcc
Confidence 6899999999999764 3577888999999999999999999999999999999998776 89999999987542211
Q ss_pred ----CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhC-CCCCCCCCChhHHHHHhcccccccccCCCcccC
Q 024809 79 ----QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRV 153 (262)
Q Consensus 79 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (262)
......++..|+|||.+.+..++.+ +|||||||++|+|++| ..||.............. ......+ ...
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~--~~~ 227 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ---GRRLLQP--EYC 227 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchH-HHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc---CCCCCCC--CcC
Confidence 1123345778999999877766544 8999999999999995 566665433222222111 1111222 246
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 154 SLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 154 ~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
+..+.+++.+||..+|++||++.+++..
T Consensus 228 ~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 228 PDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 7889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=228.11 Aligned_cols=172 Identities=26% Similarity=0.393 Sum_probs=135.5
Q ss_pred CCCCCCCchHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec
Q 024809 1 MEYAAGGELFERICNA------------------------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD 56 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~------------------------~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~ 56 (262)
|||+.||+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~ 161 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVA 161 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEc
Confidence 6899999999998642 2478899999999999999999999999999999999998
Q ss_pred CCCCCcEEEeccCCCcCCCCCC---CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhH
Q 024809 57 GSTAPRVKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKN 132 (262)
Q Consensus 57 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 132 (262)
.++ .+||+|||+++...... ......++..|+|||.+.+..++ .++||||||+++|+|++ |..||.+......
T Consensus 162 ~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~ 238 (290)
T cd05045 162 EGR--KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIAPERL 238 (290)
T ss_pred CCC--cEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcc-hHhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 776 89999999987543221 11223456789999998776665 44899999999999998 9999977554332
Q ss_pred HHHHhcccccccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 133 FRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
. ..... ....+....++.++.+++.+||+.+|.+||++.+++.
T Consensus 239 ~-~~~~~----~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 239 F-NLLKT----GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred H-HHHhC----CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 2 22221 1122222367889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=225.05 Aligned_cols=173 Identities=23% Similarity=0.346 Sum_probs=138.1
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||+++|+|.+++.+.+ .+++..++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||+++.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~--~~~l~d~g~~~~~~~~~~ 162 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD--CVKLGDFGLSRYLEDESY 162 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCC--CeEEccCceeeecccccc
Confidence 79999999999998754 589999999999999999999999999999999999998776 899999999875433221
Q ss_pred C--CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCHH
Q 024809 80 P--KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 156 (262)
Q Consensus 80 ~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (262)
. ....++..|+|||.+....+..+ +||||||+++|++++ |..||............... ... +....++.+
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~---~~~--~~~~~~~~~ 236 (270)
T cd05056 163 YKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENG---ERL--PMPPNCPPT 236 (270)
T ss_pred eecCCCCccccccChhhhccCCCCch-hhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC---CcC--CCCCCCCHH
Confidence 1 12234567999999877766544 899999999999986 99999876654443332211 111 222367899
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
+.+++.+|+..+|.+|||+.+++..
T Consensus 237 ~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 237 LYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=230.46 Aligned_cols=177 Identities=25% Similarity=0.338 Sum_probs=139.2
Q ss_pred CCCCCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||+. |+|.+.+.. ...+++..+..++.|++.||.|||+++++||||||+||+++.++ .++|+|||++.... .
T Consensus 94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~---~ 167 (308)
T cd06634 94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG--LVKLGDFGSASIMA---P 167 (308)
T ss_pred EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCC--cEEECCcccceeec---C
Confidence 68997 588777754 44699999999999999999999999999999999999998766 89999999986432 2
Q ss_pred CCccccCCCCCCcccccC---CcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHH
Q 024809 80 PKSTVGTPAYIAPEVLTK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 156 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (262)
.....|++.|+|||.+.+ ..++ .++|||||||++|+|++|..||............... ..........+..
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~ 242 (308)
T cd06634 168 ANXFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----ESPALQSGHWSEY 242 (308)
T ss_pred cccccCCccccCHHHHhhcccCCCC-cccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhc----CCCCcCcccccHH
Confidence 334578899999999753 2333 4589999999999999999999765433332222211 1111112257788
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKNHPWFLRNL 188 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 188 (262)
+++||.+||..+|.+||++.+++.|||+....
T Consensus 243 ~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~ 274 (308)
T cd06634 243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (308)
T ss_pred HHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence 99999999999999999999999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-32 Score=254.07 Aligned_cols=176 Identities=31% Similarity=0.471 Sum_probs=136.0
Q ss_pred CCCCCCCchHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCC----
Q 024809 1 MEYAAGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV---- 75 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l-~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~---- 75 (262)
||||+.-.|.++|..+... ..+.++++++||+.||.|+|+.|||||||||.|||++... .|||+|||+|+...
T Consensus 675 MEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~--~VKIGDFGLAt~~~~~~~ 752 (1351)
T KOG1035|consen 675 MEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRN--SVKIGDFGLATDLKENLE 752 (1351)
T ss_pred HhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCC--Ceeecccccchhhhhhhh
Confidence 8999996666666655433 4889999999999999999999999999999999999776 89999999997511
Q ss_pred ---------------CCCCCCccccCCCCCCcccccCCc---CCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHh
Q 024809 76 ---------------LHSQPKSTVGTPAYIAPEVLTKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTI 137 (262)
Q Consensus 76 ---------------~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~ 137 (262)
.....+..+||-.|+|||++.+.. |+.+ +||||||+||+||+ .||...-. ...++
T Consensus 753 ~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K-iDmYSLGIVlFEM~---yPF~TsME---Ra~iL 825 (1351)
T KOG1035|consen 753 SIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK-IDMYSLGIVLFEML---YPFGTSME---RASIL 825 (1351)
T ss_pred hHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch-hhhHHHHHHHHHHh---ccCCchHH---HHHHH
Confidence 001223468999999999998755 5544 89999999999998 45765322 23344
Q ss_pred cccccccccCCC--cccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccc
Q 024809 138 GRILSVHYSFPD--YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFL 185 (262)
Q Consensus 138 ~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~ 185 (262)
..+.++..+++. +.+--+.-..+|+.||..||.+||||.|+|++.||.
T Consensus 826 ~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 826 TNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 444544444441 123335567999999999999999999999999986
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=222.90 Aligned_cols=170 Identities=23% Similarity=0.368 Sum_probs=135.9
Q ss_pred CCCCCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||+.||+|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++.....
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~--~~kl~Dfg~~~~~~~-- 152 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG--VAKVSDFGLARVGSM-- 152 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC--cEEECCCccceeccc--
Confidence 79999999999997654 589999999999999999999999999999999999998776 899999999875322
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 157 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (262)
.......+..|+|||.+.+..+..+ +|+|||||++|+|++ |+.||............... ...+....++..+
T Consensus 153 ~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~ 226 (254)
T cd05083 153 GVDNSKLPVKWTAPEALKHKKFSSK-SDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG-----YRMEPPEGCPADV 226 (254)
T ss_pred cCCCCCCCceecCHHHhccCCcCch-hhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC-----CCCCCCCcCCHHH
Confidence 1223344667999999877666544 899999999999998 99999876543332222111 1111223578899
Q ss_pred HHHHHHhcccCCCCCCCHhHHhc
Q 024809 158 KHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
.+++.+||..+|.+||++.+++.
T Consensus 227 ~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 227 YVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=223.72 Aligned_cols=172 Identities=21% Similarity=0.342 Sum_probs=137.8
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||+.||+|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++ .++|+|||++.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~--~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETL--CCKIADFGLARLIEDNE 156 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCC--CEEEccCcceeecCCCC
Confidence 6899999999998753 3689999999999999999999999999999999999998776 89999999987543221
Q ss_pred C--CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 79 Q--PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 79 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
. .....++..|+|||.+....+. .++||||+|+++|+|++ |+.||.+............. ...+.....+.
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 230 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG-----YRMPRPDNCPE 230 (260)
T ss_pred cccccCCcccccccCHHHhccCCcC-cccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC-----CCCCCCCCCCH
Confidence 1 1223456789999998776665 44899999999999999 99999876654433332111 11222235778
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
++.+++.+||..+|++|||+++++.
T Consensus 231 ~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 231 ELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHHHHHccCChhhCCCHHHHHH
Confidence 9999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=225.91 Aligned_cols=175 Identities=27% Similarity=0.388 Sum_probs=136.2
Q ss_pred CCCCCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC
Q 024809 1 MEYAAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (262)
|||++||+|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~--~~~l~d~g~~~~~~~ 158 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG--VVKLGDLGLGRFFSS 158 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCC--CEEECccccceeccc
Confidence 689999999988853 34589999999999999999999999999999999999998776 899999999875432
Q ss_pred CC-CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCC-hhHHHHHhcccccccccCCCcccCC
Q 024809 77 HS-QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPED-PKNFRKTIGRILSVHYSFPDYVRVS 154 (262)
Q Consensus 77 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (262)
.. ......|++.|+|||.+.+..++.+ +|+||+|+++|+|++|+.||..... ...+...+.. ...........+
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 234 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ---CDYPPLPTEHYS 234 (267)
T ss_pred hhHHHhcCCCCccccChhhhccCCCCch-hhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhc---CCCCCCChhhcC
Confidence 21 1223568889999999987766544 8999999999999999999965432 1222222211 111111112467
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 155 LECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
..+.+++.+||..+|.+|||+.++++.
T Consensus 235 ~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 235 EKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 889999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=221.16 Aligned_cols=172 Identities=23% Similarity=0.373 Sum_probs=135.7
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||++||+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++........
T Consensus 71 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~--~~~l~d~g~~~~~~~~~~ 148 (250)
T cd05085 71 MELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENN--VLKISDFGMSRQEDDGIY 148 (250)
T ss_pred EECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCC--eEEECCCccceecccccc
Confidence 7999999999998754 4689999999999999999999999999999999999998776 899999999875332211
Q ss_pred --CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCHH
Q 024809 80 --PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 156 (262)
Q Consensus 80 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (262)
.....++..|+|||++....+..+ +||||+|+++|++++ |..||............... .....+ ..++.+
T Consensus 149 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~--~~~~~~ 222 (250)
T cd05085 149 SSSGLKQIPIKWTAPEALNYGRYSSE-SDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG---YRMSCP--QKCPDD 222 (250)
T ss_pred ccCCCCCCcccccCHHHhccCCCCch-hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC---CCCCCC--CCCCHH
Confidence 112244567999999977666544 899999999999998 99999875443322222111 111222 357899
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhc
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
+.+++.+||..+|++|||+.++++
T Consensus 223 ~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 223 VYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred HHHHHHHHcccCcccCCCHHHHHH
Confidence 999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=232.51 Aligned_cols=173 Identities=23% Similarity=0.339 Sum_probs=136.8
Q ss_pred CCCCCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEE
Q 024809 1 MEYAAGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVK 64 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~k 64 (262)
|||+.||+|.+++.... .++...+..++.|++.||.|||++|++||||||+||+++.++ .+|
T Consensus 97 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~--~~k 174 (334)
T cd05100 97 VEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDN--VMK 174 (334)
T ss_pred EecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC--cEE
Confidence 68999999999997532 377889999999999999999999999999999999998776 899
Q ss_pred EeccCCCcCCCCCCC---CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhccc
Q 024809 65 ICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRI 140 (262)
Q Consensus 65 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~ 140 (262)
|+|||+++....... .....++..|+|||++.+..++.+ +|||||||++|+|++ |..||.+....+.+......
T Consensus 175 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~- 252 (334)
T cd05100 175 IADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG- 252 (334)
T ss_pred ECCcccceecccccccccccCCCcCceEcCHHHhccCCcCch-hhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-
Confidence 999999875432211 122334567999999987777655 899999999999998 88999876543333322211
Q ss_pred ccccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 141 LSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
...+.....+.++.+++.+||..+|.+|||+.+++.+
T Consensus 253 ----~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 253 ----HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 1112223578899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=230.13 Aligned_cols=183 Identities=27% Similarity=0.463 Sum_probs=139.5
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||+ |++|.+++... .+++..+..++.|++.||.|||++||+||||||.||+++.++ .++|+|||+++... ...
T Consensus 89 ~e~~-~~~L~~~~~~~-~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~--~~~l~dfg~~~~~~--~~~ 162 (328)
T cd07856 89 TELL-GTDLHRLLTSR-PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENC--DLKICDFGLARIQD--PQM 162 (328)
T ss_pred eehh-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCC--CEEeCccccccccC--CCc
Confidence 6888 56898887653 689999999999999999999999999999999999998766 89999999987432 222
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccc--------------------
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRI-------------------- 140 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-------------------- 140 (262)
....++..|+|||.+......+.++|+||+||++|+|++|+.||........+.......
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd07856 163 TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFV 242 (328)
T ss_pred CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHH
Confidence 345678899999998664434556999999999999999999997654322111111000
Q ss_pred --ccccccCC---CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCC
Q 024809 141 --LSVHYSFP---DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLP 189 (262)
Q Consensus 141 --~~~~~~~~---~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 189 (262)
.......| ....++..++++|++||+.+|++|||+.+++.||||.....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~ 296 (328)
T cd07856 243 QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHD 296 (328)
T ss_pred hhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccC
Confidence 00000011 11246789999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=223.23 Aligned_cols=172 Identities=22% Similarity=0.400 Sum_probs=136.9
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||++||+|.+++... +.+++..+..++.|++.||.|||+.|++||||||+||+++.+. .+||+|||++........
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~--~~kl~dfg~~~~~~~~~~ 162 (268)
T cd05063 85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNL--ECKVSDFGLSRVLEDDPE 162 (268)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCC--cEEECCCccceecccccc
Confidence 7999999999999764 5799999999999999999999999999999999999998766 899999999875432211
Q ss_pred CC----ccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCC
Q 024809 80 PK----STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS 154 (262)
Q Consensus 80 ~~----~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (262)
.. ....+..|+|||.+.+..++.+ +||||+||++|+|++ |..||...........+. .. ...|.....+
T Consensus 163 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~-~~----~~~~~~~~~~ 236 (268)
T cd05063 163 GTYTTSGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN-DG----FRLPAPMDCP 236 (268)
T ss_pred cceeccCCCcCceecCHHHhhcCCcChH-hHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh-cC----CCCCCCCCCC
Confidence 11 1123456999999987766544 899999999999997 999997655443333222 11 1223333678
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 155 LECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
.++.+++.+||..+|++||++.++++
T Consensus 237 ~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 237 SAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 89999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=224.86 Aligned_cols=174 Identities=21% Similarity=0.359 Sum_probs=138.8
Q ss_pred CCCCCCCchHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCC
Q 024809 1 MEYAAGGELFERICNAG---------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYS 71 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~---------~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a 71 (262)
|||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++..+ .++++|||++
T Consensus 87 ~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~--~~~l~~~~~~ 164 (275)
T cd05046 87 LEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQR--EVKVSLLSLS 164 (275)
T ss_pred EEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCC--cEEEcccccc
Confidence 69999999999998665 699999999999999999999999999999999999998776 8999999998
Q ss_pred cCCCCCC--CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCC
Q 024809 72 KSSVLHS--QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFP 148 (262)
Q Consensus 72 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 148 (262)
+...... ......++..|+|||.+.+.... .++||||||+++|+|++ |..||............ ......++
T Consensus 165 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~----~~~~~~~~ 239 (275)
T cd05046 165 KDVYNSEYYKLRNALIPLRWLAPEAVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL----QAGKLELP 239 (275)
T ss_pred cccCcccccccCCceeEEeecChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCccccchHHHHHHH----HcCCcCCC
Confidence 6432211 12234567789999998776654 44899999999999998 88899765543333222 21222233
Q ss_pred CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 149 DYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 149 ~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
....++..+.+++.+||..+|.+|||+.+++.+
T Consensus 240 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 240 VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 333678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=228.11 Aligned_cols=173 Identities=18% Similarity=0.372 Sum_probs=137.1
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++.......
T Consensus 87 ~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~--~~kL~Dfg~~~~~~~~~~ 164 (303)
T cd05110 87 TQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPN--HVKITDFGLARLLEGDEK 164 (303)
T ss_pred ehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCC--ceEEccccccccccCccc
Confidence 68999999999997654 689999999999999999999999999999999999998766 799999999975432221
Q ss_pred ---CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 80 ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 80 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
.....++..|+|||.+.+..++.+ +|||||||++|+|++ |..||.+... ......+.. ....+.....+.
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DiwslG~~l~el~t~g~~p~~~~~~-~~~~~~~~~----~~~~~~~~~~~~ 238 (303)
T cd05110 165 EYNADGGKMPIKWMALECIHYRKFTHQ-SDVWSYGVTIWELMTFGGKPYDGIPT-REIPDLLEK----GERLPQPPICTI 238 (303)
T ss_pred ccccCCCccccccCCHHHhccCCCChH-HHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHC----CCCCCCCCCCCH
Confidence 122345678999999877666544 899999999999997 9999976432 222222221 112233335778
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
++.+++.+||..+|++||++.+++..
T Consensus 239 ~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 239 DVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=226.51 Aligned_cols=177 Identities=24% Similarity=0.345 Sum_probs=135.2
Q ss_pred CCCCCCCchHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccC
Q 024809 1 MEYAAGGELFERICNAG-----------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFG 69 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-----------~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg 69 (262)
|||+.||+|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~--~~~l~dfg 175 (296)
T cd05095 98 TEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNY--TIKIADFG 175 (296)
T ss_pred EEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCCC--CEEeccCc
Confidence 69999999999997642 367789999999999999999999999999999999998766 89999999
Q ss_pred CCcCCCCCCC---CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh--CCCCCCCCCChhHHHHHhcccc--c
Q 024809 70 YSKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV--GAYPFEDPEDPKNFRKTIGRIL--S 142 (262)
Q Consensus 70 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~--g~~pf~~~~~~~~~~~~~~~~~--~ 142 (262)
+++....... .....+++.|++||...+..++. ++|+|||||++|+|++ |..||......+.......... .
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~-~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 254 (296)
T cd05095 176 MSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTT-ASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQG 254 (296)
T ss_pred ccccccCCcceeccCcCcCccccCCHHHHhcCCccc-hhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhcc
Confidence 9875432211 12234467899999887766654 4899999999999998 7789976554433322111100 0
Q ss_pred ccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 143 VHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 143 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
.....+....+++.+.+|+.+||..||.+|||+.++++
T Consensus 255 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 255 RQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 11112333457789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=226.37 Aligned_cols=175 Identities=25% Similarity=0.388 Sum_probs=133.6
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||++||+|.+++.+. ..+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++.......
T Consensus 86 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~--~~~l~dfg~~~~~~~~~~ 163 (284)
T cd05081 86 MEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESEN--RVKIGDFGLTKVLPQDKE 163 (284)
T ss_pred EEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCC--eEEECCCcccccccCCCc
Confidence 6899999999999764 4689999999999999999999999999999999999998776 899999999985432221
Q ss_pred C----CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHH-------------hccccc
Q 024809 80 P----KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKT-------------IGRILS 142 (262)
Q Consensus 80 ~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~-------------~~~~~~ 142 (262)
. ....++..|+|||.+.+..++ .++||||+||++|+|++|..++...... +... +.....
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05081 164 YYKVREPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYSDKSCSPPAE--FMRMMGNDKQGQMIVYHLIELLK 240 (284)
T ss_pred ceeecCCCCCceEeeCHHHhccCCcC-hHHHHHHHHHHHHHHhhcCCcCCCcchh--hhhhcccccccccchHHHHHHHh
Confidence 1 112234469999999776665 4489999999999999988776433211 1000 001111
Q ss_pred ccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 143 VHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 143 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
....++....++.++.+|+.+||..+|++|||+.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 12223333467889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=222.48 Aligned_cols=172 Identities=22% Similarity=0.328 Sum_probs=137.7
Q ss_pred CCCCCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||++||+|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||+++......
T Consensus 80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~--~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENL--VCKIADFGLARLIEDDE 157 (261)
T ss_pred EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCC--CEEECccccceeccchh
Confidence 68999999999997653 689999999999999999999999999999999999998776 89999999987543211
Q ss_pred C--CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 79 Q--PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 79 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
. .....++..|+|||.+.+..+. .++|+||+|+++|+|++ |+.||.+............. +..+.....+.
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 231 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFT-IKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG-----YRMPRPPNCPE 231 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----CCCCCCCCCCH
Confidence 1 1122345689999999876664 44899999999999998 99999876554444433221 12222235688
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
++.+++.+||..+|.+||+++++++
T Consensus 232 ~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 232 ELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHHHHHcccCcccCCCHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=227.75 Aligned_cols=176 Identities=26% Similarity=0.362 Sum_probs=139.3
Q ss_pred CCCCCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||+.| +|.+.+.. ...+++..+..++.|++.||.|||++||+||||+|+||+++.++ .++|+|||++.... .
T Consensus 104 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~--~~kl~dfg~~~~~~---~ 177 (317)
T cd06635 104 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG--QVKLADFGSASIAS---P 177 (317)
T ss_pred EeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCC--CEEEecCCCccccC---C
Confidence 689975 78777754 45699999999999999999999999999999999999998766 89999999886432 2
Q ss_pred CCccccCCCCCCcccccC---CcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHH
Q 024809 80 PKSTVGTPAYIAPEVLTK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 156 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (262)
.....|++.|+|||.+.. ..+ ..++|+||+||++|+|++|+.||............... ..........++.
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~ 252 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----ESPTLQSNEWSDY 252 (317)
T ss_pred cccccCCccccChhhhhcCCCCCC-CccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc----cCCCCCCccccHH
Confidence 334578999999999742 334 44589999999999999999999775443333322211 1111122357788
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
+++++.+||+.+|.+||++.++++|+|+...
T Consensus 253 l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 253 FRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred HHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 9999999999999999999999999999654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=216.84 Aligned_cols=178 Identities=44% Similarity=0.731 Sum_probs=146.8
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||+.+|+|.+++.....++...+..++.+++.++.|||+.|++|+||+|.||+++.++ .++|+|||.+.........
T Consensus 66 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~--~~~l~d~~~~~~~~~~~~~ 143 (244)
T smart00220 66 MEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDG--HVKLADFGLARQLDPGGLL 143 (244)
T ss_pred EeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC--cEEEccccceeeecccccc
Confidence 68999999999998876799999999999999999999999999999999999998776 8999999999866544344
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcc-cCCHHHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV-RVSLECKH 159 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 159 (262)
....++..|++||.+....++. ++|+||+|++++++++|..||.............. .......... .++.++.+
T Consensus 144 ~~~~~~~~~~~pE~~~~~~~~~-~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 219 (244)
T smart00220 144 TTFVGTPEYMAPEVLLGKGYGK-AVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG---KPKPPFPPPEWKISPEAKD 219 (244)
T ss_pred ccccCCcCCCCHHHHccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh---ccCCCCccccccCCHHHHH
Confidence 5667899999999998766655 58999999999999999999987444333333222 1222222211 17889999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCccc
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
++.+||..+|++||++.++++||||
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred HHHHHccCCchhccCHHHHhhCCCC
Confidence 9999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=236.51 Aligned_cols=156 Identities=26% Similarity=0.430 Sum_probs=122.2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC---CCCccccCCCCCCccc
Q 024809 18 RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEV 94 (262)
Q Consensus 18 ~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~ 94 (262)
.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...... ......+++.|+|||.
T Consensus 233 ~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~--~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~ 310 (400)
T cd05105 233 GLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGK--IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPES 310 (400)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCC--EEEEEeCCcceeccccccccccCCcCCCcceEChhh
Confidence 478888999999999999999999999999999999998776 89999999987543221 1223456788999999
Q ss_pred ccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHHHHHhcccCCCCCC
Q 024809 95 LTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI 173 (262)
Q Consensus 95 ~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~ 173 (262)
+.+..+.. ++|||||||++|+|++ |..||........+...+.. ....+....++.++.+++.+||..+|++||
T Consensus 311 ~~~~~~~~-~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 385 (400)
T cd05105 311 IFDNLYTT-LSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKS----GYRMAKPDHATQEVYDIMVKCWNSEPEKRP 385 (400)
T ss_pred hcCCCCCc-hhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhc----CCCCCCCccCCHHHHHHHHHHCccCHhHCc
Confidence 98776654 4899999999999997 99999865433333222211 112222236788999999999999999999
Q ss_pred CHhHHhc
Q 024809 174 TIPEIKN 180 (262)
Q Consensus 174 s~~e~l~ 180 (262)
|+.++.+
T Consensus 386 t~~~l~~ 392 (400)
T cd05105 386 SFLHLSD 392 (400)
T ss_pred CHHHHHH
Confidence 9998876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=239.35 Aligned_cols=184 Identities=21% Similarity=0.262 Sum_probs=136.7
Q ss_pred CCCCCCCchHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec
Q 024809 1 MEYAAGGELFERICNAG------------------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD 56 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~------------------------~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~ 56 (262)
|||++||+|.+++.... .+++..++.++.|++.||.|||+.+|+||||||+|||++
T Consensus 264 ~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~ 343 (507)
T PLN03224 264 WKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVT 343 (507)
T ss_pred EEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEEC
Confidence 68999999999886421 245678899999999999999999999999999999998
Q ss_pred CCCCCcEEEeccCCCcCCCCCCCCC--ccccCCCCCCcccccCCcC--------------------C-CCchhHHHHHHH
Q 024809 57 GSTAPRVKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVLTKKEY--------------------D-GKIADVWSCGVT 113 (262)
Q Consensus 57 ~~~~~~~kl~Dfg~a~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~--------------------~-~~~~DiwslG~i 113 (262)
.++ .+||+|||+++......... ...+|+.|+|||.+..... . ....||||+||+
T Consensus 344 ~~~--~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvi 421 (507)
T PLN03224 344 VDG--QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVL 421 (507)
T ss_pred CCC--cEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHH
Confidence 776 89999999997543322222 2345889999999754221 1 112699999999
Q ss_pred HHHHHhCCC-CCCCCCChhH-------HHHHhcccccccccCCCcccCCHHHHHHHHHhcccCC---CCCCCHhHHhcCc
Q 024809 114 LYVMLVGAY-PFEDPEDPKN-------FRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANS---EKRITIPEIKNHP 182 (262)
Q Consensus 114 l~~ll~g~~-pf~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp---~~R~s~~e~l~hp 182 (262)
+|+|++|.. ||........ ....+.......+.++.+...++.+++|+.+||..+| .+|+|++|+|+||
T Consensus 422 l~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp 501 (507)
T PLN03224 422 LMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHR 501 (507)
T ss_pred HHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCC
Confidence 999999875 7754221111 0111122233445566566789999999999999876 6899999999999
Q ss_pred cccc
Q 024809 183 WFLR 186 (262)
Q Consensus 183 ~~~~ 186 (262)
||..
T Consensus 502 ~f~~ 505 (507)
T PLN03224 502 FFLP 505 (507)
T ss_pred CcCC
Confidence 9964
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=221.46 Aligned_cols=172 Identities=23% Similarity=0.361 Sum_probs=136.7
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||++||+|.+++.+. ..++...+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||.+.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL--VCKIADFGLARVIEDNE 156 (260)
T ss_pred EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC--cEEECCCcceeeccCCC
Confidence 6899999999999763 3578899999999999999999999999999999999998766 89999999987543221
Q ss_pred C--CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 79 Q--PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 79 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
. .....++..|+|||.+....++. ++|+|||||++|++++ |..||...+.......... .+..+.....+.
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~-~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 230 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTI-KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-----GYRMPRPENCPE 230 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCc-cccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC-----CCCCCCcccCCH
Confidence 1 12234567799999997766654 4899999999999998 9999987655433332221 112222346788
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
++.+++.+||..+|++||++.+++.
T Consensus 231 ~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 231 ELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHH
Confidence 9999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=224.02 Aligned_cols=172 Identities=22% Similarity=0.348 Sum_probs=136.2
Q ss_pred CCCCCCCchHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 1 MEYAAGGELFERICNA--------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--------~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
+||+.+|+|.+++... ..+++..+..++.|++.||.|||+++++||||||+||+++.++ .+||+|||+++
T Consensus 88 ~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~--~~kl~d~g~~~ 165 (280)
T cd05043 88 YPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL--QVKITDNALSR 165 (280)
T ss_pred EEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCC--cEEECCCCCcc
Confidence 4789999999999753 3589999999999999999999999999999999999998766 89999999997
Q ss_pred CCCCCCC---CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCC
Q 024809 73 SSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFP 148 (262)
Q Consensus 73 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 148 (262)
....... .....++..|+|||.+.+..++.+ +|||||||++|++++ |+.||....... ....+.. ....+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~----~~~~~ 239 (280)
T cd05043 166 DLFPMDYHCLGDNENRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVEIDPFE-MAAYLKD----GYRLA 239 (280)
T ss_pred cccCCceEEeCCCCCcchhccCHHHHhcCCCCch-hhHHHhHHHHHHHhcCCCCCcCcCCHHH-HHHHHHc----CCCCC
Confidence 5432211 122345677999999977766544 899999999999999 999998754332 2222111 12222
Q ss_pred CcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 149 DYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 149 ~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
....+++++.+++.+||..+|++|||+.++++
T Consensus 240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 240 QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 33357889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=223.09 Aligned_cols=182 Identities=25% Similarity=0.418 Sum_probs=144.7
Q ss_pred CCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC--
Q 024809 2 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ-- 79 (262)
Q Consensus 2 E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~-- 79 (262)
|++.. +|.++|.+-+.++...++-+++||++||+|||+.||.||||||.|+|++++. .+||||||+++.......
T Consensus 137 ELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNC--vLKICDFGLARvee~d~~~h 213 (449)
T KOG0664|consen 137 ELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNC--ILKICDFGLARTWDQRDRLN 213 (449)
T ss_pred HHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCc--eEEecccccccccchhhhhh
Confidence 44543 8889998889999999999999999999999999999999999999999988 899999999985443322
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccc------------------
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIL------------------ 141 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~------------------ 141 (262)
.+..+.|..|+|||++.+...++.++||||+|||+.|++..+..|+.....+++..+..-..
T Consensus 214 MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~ 293 (449)
T KOG0664|consen 214 MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHV 293 (449)
T ss_pred hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHh
Confidence 23457899999999999877667779999999999999999999998776665544322111
Q ss_pred -cccccCCC---cc------cCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 142 -SVHYSFPD---YV------RVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 142 -~~~~~~~~---~~------~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
.....-|. .. ....+..+++.++|.++|.+|++.++++.|+|..+
T Consensus 294 LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 294 LRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred hccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 11111111 11 22346789999999999999999999999999854
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=230.74 Aligned_cols=156 Identities=25% Similarity=0.425 Sum_probs=121.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC---CCCccccCCCCCCcccc
Q 024809 19 FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVL 95 (262)
Q Consensus 19 l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~ 95 (262)
++...+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++....... ......++..|+|||.+
T Consensus 176 ~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 253 (343)
T cd05103 176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 253 (343)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC--cEEEEecccccccccCcchhhcCCCCCCcceECcHHh
Confidence 67888899999999999999999999999999999998766 89999999987542211 11123456789999998
Q ss_pred cCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHHHHHhcccCCCCCCC
Q 024809 96 TKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRIT 174 (262)
Q Consensus 96 ~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s 174 (262)
.+..++.+ +||||+|+++|+|++ |..||........+....... .....|. ..++++.+++.+||+.+|.+|||
T Consensus 254 ~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~~~~~cl~~~p~~Rps 328 (343)
T cd05103 254 FDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG--TRMRAPD--YTTPEMYQTMLDCWHGEPSQRPT 328 (343)
T ss_pred cCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhcc--CCCCCCC--CCCHHHHHHHHHHccCChhhCcC
Confidence 77776554 899999999999997 999998755433333322211 1112222 46788999999999999999999
Q ss_pred HhHHhcC
Q 024809 175 IPEIKNH 181 (262)
Q Consensus 175 ~~e~l~h 181 (262)
+.++++|
T Consensus 329 ~~eil~~ 335 (343)
T cd05103 329 FSELVEH 335 (343)
T ss_pred HHHHHHH
Confidence 9999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=220.05 Aligned_cols=172 Identities=24% Similarity=0.351 Sum_probs=135.3
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||+.|++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++........
T Consensus 71 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~--~~~l~d~g~~~~~~~~~~ 148 (251)
T cd05041 71 MELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN--VLKISDFGMSREEEGGIY 148 (251)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCC--cEEEeeccccccccCCcc
Confidence 6899999999999764 4689999999999999999999999999999999999998776 899999999875431111
Q ss_pred ---CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 80 ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 80 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
.....++..|+|||.+.+..+. .++|+|||||++|+|++ |..||............... .....+ ...+.
T Consensus 149 ~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~---~~~~~~--~~~~~ 222 (251)
T cd05041 149 TVSDGLKQIPIKWTAPEALNYGRYT-SESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG---YRMPAP--QLCPE 222 (251)
T ss_pred eeccccCcceeccCChHhhccCCCC-cchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC---CCCCCC--ccCCH
Confidence 1122345679999998776654 45899999999999999 88999776543322222111 111222 35788
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
++.+++.+||..+|.+|||+.++++
T Consensus 223 ~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 223 EIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHHHHHHHHhccChhhCcCHHHHHH
Confidence 9999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=220.90 Aligned_cols=173 Identities=23% Similarity=0.384 Sum_probs=135.9
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||++||+|.+++... +.+++..++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||+++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~--~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ--VVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCC--eEEECCCcceeecccCcc
Confidence 6899999999999764 4689999999999999999999999999999999999998766 899999999875432111
Q ss_pred --CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCHH
Q 024809 80 --PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 156 (262)
Q Consensus 80 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (262)
.....++..|+|||.+.+..+.. ++|+||+|+++|+|++ |+.||...........+.... ....+ ...+..
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~-~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~--~~~~~~ 229 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSS-KSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF---RLYKP--RLASQS 229 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcCh-HHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC---CCCCC--CCCCHH
Confidence 11233556899999988766654 4899999999999998 999998655433332221111 11112 246788
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
+.+|+.+||+.+|++|||+.+++++
T Consensus 230 ~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 230 VYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHHHHcccChhhCCCHHHHHHh
Confidence 9999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=225.15 Aligned_cols=177 Identities=23% Similarity=0.325 Sum_probs=134.6
Q ss_pred CCCCCCCchHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEecc
Q 024809 1 MEYAAGGELFERICNAG------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDF 68 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~------------~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Df 68 (262)
|||+.||+|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+||
T Consensus 96 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~--~~kl~df 173 (295)
T cd05097 96 TEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHY--TIKIADF 173 (295)
T ss_pred EecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCCC--cEEeccc
Confidence 79999999999986532 368889999999999999999999999999999999998766 7999999
Q ss_pred CCCcCCCCCCC---CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh--CCCCCCCCCChhHHHHHhcccccc
Q 024809 69 GYSKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV--GAYPFEDPEDPKNFRKTIGRILSV 143 (262)
Q Consensus 69 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~--g~~pf~~~~~~~~~~~~~~~~~~~ 143 (262)
|+++....... .....++..|+|||.+.+..++ .++|+|||||++|+|++ |..||......+............
T Consensus 174 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 252 (295)
T cd05097 174 GMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQ 252 (295)
T ss_pred ccccccccCcceeccCcCcCceeecChhhhccCCcC-chhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhc
Confidence 99875432211 1223456789999998877765 44899999999999988 667887655443332221111100
Q ss_pred -c-ccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 144 -H-YSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 144 -~-~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
. .........++.+.+|+.+||..+|++|||+.++++
T Consensus 253 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 253 GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0 011122246789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=222.32 Aligned_cols=172 Identities=20% Similarity=0.381 Sum_probs=135.8
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||++||+|.+++... +.+++..++.++.|++.||.|||++|++||||||+||+++.+. .++|+|||++........
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~--~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL--VCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCC--cEEECCCccccccccCcc
Confidence 6999999999999764 4689999999999999999999999999999999999998766 899999999875433221
Q ss_pred CCcc---c---cCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCccc
Q 024809 80 PKST---V---GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR 152 (262)
Q Consensus 80 ~~~~---~---gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (262)
.... . ++..|+|||.+.+..++.+ +||||+||++|+|++ |..||............ . .....+....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i-~----~~~~~~~~~~ 235 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI-E----QDYRLPPPMD 235 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccch-hhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH-H----cCCcCCCccc
Confidence 1111 1 2346999999987776554 899999999999886 99999875543332222 1 1122333346
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 153 VSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 153 ~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
++..+.+++.+||..+|.+||++.+++.
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 236 CPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 7889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=251.23 Aligned_cols=174 Identities=25% Similarity=0.355 Sum_probs=133.5
Q ss_pred CCCCCCCchHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccC
Q 024809 1 MEYAAGGELFERICNA-----------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFG 69 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-----------~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg 69 (262)
|||++||+|.+++... ..++...+..++.||+.||.|||++||+||||||+||+++.++ .++|+|||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg--~vKLiDFG 158 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFG--EVVILDWG 158 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCC--CEEEEecC
Confidence 7999999999998641 2356678899999999999999999999999999999998777 89999999
Q ss_pred CCcCCCCCC-------------------CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh
Q 024809 70 YSKSSVLHS-------------------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP 130 (262)
Q Consensus 70 ~a~~~~~~~-------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 130 (262)
+++...... .....+||+.|+|||.+.+..++. ++||||+||++|+|+||+.||......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~-kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASE-STDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCc-HhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 997541110 111246999999999998777654 489999999999999999999874432
Q ss_pred hHHHHHhcccccccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 131 KNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
..... ..............+++.+.+++.+||..||++|++..+.+.
T Consensus 238 ki~~~---~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 238 KISYR---DVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred hhhhh---hhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 22111 111111112223468899999999999999999988766554
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-32 Score=227.28 Aligned_cols=172 Identities=33% Similarity=0.472 Sum_probs=132.3
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
||||++|+|.++|... ..+++..+..++.|++.||.|||+++++|++|++.||+++.++ .+||+|||++.......
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~--~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNG--QVKLSDFGLSRPISEKS 157 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTT--EEEEESTTTGEETTTSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccc
Confidence 6999999999999987 6799999999999999999999999999999999999999877 89999999987552111
Q ss_pred ---CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCC
Q 024809 79 ---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS 154 (262)
Q Consensus 79 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (262)
......+...|+|||.+....++ .++||||||+++|+|++ |+.||......+..... ... . ..+....++
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~-~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~--~--~~~~~~~~~ 231 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYT-KKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQG--Q--RLPIPDNCP 231 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEES-HHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTT--E--ETTSBTTSB
T ss_pred cccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccc-ccc--c--cceeccchh
Confidence 12234567789999999877764 45899999999999999 78999876443333332 111 1 122223578
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 155 LECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
..+.++|.+||..+|.+|||+.++++
T Consensus 232 ~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 232 KDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 99999999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=223.08 Aligned_cols=174 Identities=28% Similarity=0.422 Sum_probs=138.7
Q ss_pred CCCCCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCC
Q 024809 1 MEYAAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV 75 (262)
Q Consensus 1 mE~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~aL~~LH~-~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~ 75 (262)
|||++|++|.+++.. ...+++..++.++.|++.||.|||+ .|++||||||+||+++.++ .++|+|||++....
T Consensus 88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~--~~~l~dfg~~~~~~ 165 (269)
T cd08528 88 MDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD--KVTITDFGLAKQKQ 165 (269)
T ss_pred EecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC--cEEEecccceeecc
Confidence 799999999988742 3469999999999999999999996 6899999999999998776 89999999997654
Q ss_pred CCCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 76 LHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 76 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
.........|+..|+|||.+.+..+. .++|+||||+++|+|++|+.||............. ............+.
T Consensus 166 ~~~~~~~~~~~~~~~~Pe~~~~~~~~-~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~ 240 (269)
T cd08528 166 PESKLTSVVGTILYSCPEIVKNEPYG-EKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIV----EAVYEPLPEGMYSE 240 (269)
T ss_pred cccccccccCcccCcChhhhcCCCCc-hHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHh----hccCCcCCcccCCH
Confidence 44333456789999999999876664 45899999999999999999997654333222221 11111112225788
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
++.++|.+||..||++||++.++..+
T Consensus 241 ~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 241 DVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 99999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=222.75 Aligned_cols=172 Identities=24% Similarity=0.376 Sum_probs=136.0
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||++||+|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++ .+||+|||+++.......
T Consensus 87 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~--~~kL~dfg~~~~~~~~~~ 164 (279)
T cd05057 87 TQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQ--HVKITDFGLAKLLDVDEK 164 (279)
T ss_pred EecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCC--eEEECCCcccccccCccc
Confidence 6899999999999864 4699999999999999999999999999999999999998766 899999999975542221
Q ss_pred CCc---cccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 80 PKS---TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 80 ~~~---~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
... ..++..|+|||.+....++.. +|+||+||++|++++ |+.||......+.... +.. ....+.....+.
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~----~~~~~~~~~~~~ 238 (279)
T cd05057 165 EYHAEGGKVPIKWMALESILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEGIPAVEIPDL-LEK----GERLPQPPICTI 238 (279)
T ss_pred ceecCCCcccccccCHHHhhcCCcCch-hhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH-HhC----CCCCCCCCCCCH
Confidence 111 223567999999876666544 899999999999998 9999987654332222 211 111222235778
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
++.+++.+||..+|++|||+.++++
T Consensus 239 ~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 239 DVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHH
Confidence 8999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=221.60 Aligned_cols=172 Identities=21% Similarity=0.392 Sum_probs=137.5
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||++||+|.+++... +.+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++........
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~--~~~l~dfg~~~~~~~~~~ 161 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL--VCKVSDFGLSRVLEDDPE 161 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCC--eEEeCCCCcccccccccc
Confidence 7999999999999765 4689999999999999999999999999999999999998766 899999999875533221
Q ss_pred C----CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCC
Q 024809 80 P----KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS 154 (262)
Q Consensus 80 ~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (262)
. ....++..|+|||.+.+..++.+ +|+||+||++|++++ |..||...........+... ...+....++
T Consensus 162 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~ 235 (267)
T cd05066 162 AAYTTRGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-----YRLPAPMDCP 235 (267)
T ss_pred eeeecCCCccceeecCHhHhccCccCch-hhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-----CcCCCCCCCC
Confidence 1 11223567999999987766544 899999999999886 99999876544433332221 1233334678
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 155 LECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
+.+.+++.+||+.+|.+|||+.++++
T Consensus 236 ~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 236 AALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHHHHHcccCchhCCCHHHHHH
Confidence 89999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=223.05 Aligned_cols=180 Identities=31% Similarity=0.603 Sum_probs=148.1
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC-CCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (262)
.||++||+|--+++...+++|+.++.+-..|+.||.|||+.||+.||||..|+|++..+ ++||+|+|+.+.... ...
T Consensus 330 ieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeg--hikltdygmcke~l~~gd~ 407 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEG--HIKLTDYGMCKEGLGPGDT 407 (593)
T ss_pred EEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCC--ceeecccchhhcCCCCCcc
Confidence 38999999999999988999999999999999999999999999999999999998877 999999999975433 345
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCC--CCChh-HH-HHHhcccccccccCCCcccCCH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFED--PEDPK-NF-RKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~--~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
..+++|||.|.|||++++..|- ..+|+|+|||++++|+.|+.||.- .++++ +. .-.++.+.......|. .+|-
T Consensus 408 tstfcgtpnyiapeilrgeeyg-fsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr--slsv 484 (593)
T KOG0695|consen 408 TSTFCGTPNYIAPEILRGEEYG-FSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR--SLSV 484 (593)
T ss_pred cccccCCCcccchhhhcccccC-ceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc--eeeh
Confidence 5678999999999999998874 558999999999999999999963 22211 11 1112223334445555 5677
Q ss_pred HHHHHHHHhcccCCCCCC------CHhHHhcCcccc
Q 024809 156 ECKHLLSRIFVANSEKRI------TIPEIKNHPWFL 185 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~------s~~e~l~hp~~~ 185 (262)
.+..+++..|.+||.+|. ...++..|+||+
T Consensus 485 kas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr 520 (593)
T KOG0695|consen 485 KASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFR 520 (593)
T ss_pred hhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhh
Confidence 788999999999999996 457899999997
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-32 Score=239.41 Aligned_cols=173 Identities=25% Similarity=0.374 Sum_probs=135.4
Q ss_pred CCCCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC---
Q 024809 2 EYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH--- 77 (262)
Q Consensus 2 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~--- 77 (262)
-+|+|-+|..+|.- ..+|.....+.|++|+++|+.|||.++|||||||..|||+..+. +|||+|||++......
T Consensus 467 qwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~--kVkIgDFGLatvk~~w~g~ 544 (678)
T KOG0193|consen 467 QWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDL--KVKIGDFGLATVKTRWSGE 544 (678)
T ss_pred hhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCC--cEEEecccceeeeeeeccc
Confidence 37999999999864 34799999999999999999999999999999999999998776 8999999998644332
Q ss_pred CCCCccccCCCCCCcccccCC--cCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc---cccCCCccc
Q 024809 78 SQPKSTVGTPAYIAPEVLTKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV---HYSFPDYVR 152 (262)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 152 (262)
.......|...|||||+++.. ..++..+||||+|+++|||+||..||. ....++ ++-.+..+ .-.......
T Consensus 545 ~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dq---IifmVGrG~l~pd~s~~~s~ 620 (678)
T KOG0193|consen 545 QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQ---IIFMVGRGYLMPDLSKIRSN 620 (678)
T ss_pred cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhh---eEEEecccccCccchhhhcc
Confidence 122345688899999998642 223455999999999999999999999 333333 22222222 111112235
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 153 VSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 153 ~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
.+.++++|+..||.+++++||.+.+||.
T Consensus 621 ~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 621 CPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred CHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 6679999999999999999999999987
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=220.41 Aligned_cols=174 Identities=23% Similarity=0.387 Sum_probs=135.3
Q ss_pred CCCCCCCchHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC---CCcEEEeccCC
Q 024809 1 MEYAAGGELFERICNA-------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST---APRVKICDFGY 70 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-------~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~---~~~~kl~Dfg~ 70 (262)
|||++||+|.+++... ..+++..+..++.|++.||.|||+++++|+||||+||+++.+. ...++|+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 6899999999999742 2478999999999999999999999999999999999997644 22689999999
Q ss_pred CcCCCCCC---CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhccccccccc
Q 024809 71 SKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYS 146 (262)
Q Consensus 71 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 146 (262)
++...... ......++..|+|||.+.+..+. .++|||||||++|+|++ |..||......+....+.. .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~---~~~~~ 233 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFT-TQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA---GGRLQ 233 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcc-cchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhc---CCccC
Confidence 87543221 11223457789999999877765 45899999999999998 9999976554332222111 11112
Q ss_pred CCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 147 FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 147 ~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
.+ ..++..+.++|.+||..+|.+||++.++++
T Consensus 234 ~~--~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 234 KP--ENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred Cc--ccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 22 357889999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=223.51 Aligned_cols=172 Identities=23% Similarity=0.345 Sum_probs=134.3
Q ss_pred CCCCCCCchHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC
Q 024809 1 MEYAAGGELFERICNAG----------------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~----------------------~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~ 58 (262)
|||++||+|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~ 166 (288)
T cd05050 87 FEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGEN 166 (288)
T ss_pred EecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecCC
Confidence 68999999999997432 37888999999999999999999999999999999999876
Q ss_pred CCCcEEEeccCCCcCCCCCCC---CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHH
Q 024809 59 TAPRVKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFR 134 (262)
Q Consensus 59 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 134 (262)
+ .++|+|||++........ .....++..|+|||.+.+..++.+ +|||||||++|+|++ |..||.+....+...
T Consensus 167 ~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~~~~~p~~~~~~~~~~~ 243 (288)
T cd05050 167 M--VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGMQPYYGMAHEEVIY 243 (288)
T ss_pred C--ceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 6 899999999875432211 122345667999999887776544 899999999999997 888997655433332
Q ss_pred HHhcccccccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 135 KTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 135 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
... .... .+.....+.++.+|+.+||..+|.+|||+.|+++
T Consensus 244 ~~~----~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 244 YVR----DGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHh----cCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 221 1111 1112257889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=247.44 Aligned_cols=98 Identities=31% Similarity=0.627 Sum_probs=77.7
Q ss_pred ccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCC-cccCCHHHHHHHH
Q 024809 84 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD-YVRVSLECKHLLS 162 (262)
Q Consensus 84 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~ 162 (262)
+||+.|+|||++.+..+. .++||||+||++|+|++|+.||.+......+..++.. ...++. ...++..+.+++.
T Consensus 541 vGT~~Y~APE~l~~~~~~-~~~DiwSlG~il~ElltG~~pf~~~~~~~~~~~il~~----~~~~p~~~~~~~~~~~~~l~ 615 (669)
T cd05610 541 LGTPDYLAPELLLGKPHG-PAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNR----DIPWPEGEEKLSVNAQNAIE 615 (669)
T ss_pred eeCccccCHHHcCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc----CCCCCcccccCCHHHHHHHH
Confidence 468899999999887765 4489999999999999999999876554444443322 222222 1257788999999
Q ss_pred HhcccCCCCCCCHhHHhcCccccc
Q 024809 163 RIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 163 ~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
+||..+|.+||++.++++||||..
T Consensus 616 ~lL~~dP~~R~ta~e~l~h~~~~~ 639 (669)
T cd05610 616 ILLTMDPTKRAGLKELKQHPLFHG 639 (669)
T ss_pred HHcccChhHCcCHHHHHhCHhhcC
Confidence 999999999999999999999964
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=223.25 Aligned_cols=177 Identities=25% Similarity=0.364 Sum_probs=135.7
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||++||+|.+++.... .+++..+..++.||+.||.|||++|++||||||+||+++.++ .++|+|||++........
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~~~ 164 (284)
T cd05038 87 MEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED--LVKISDFGLAKVLPEDKD 164 (284)
T ss_pred EecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC--CEEEcccccccccccCCc
Confidence 69999999999998765 699999999999999999999999999999999999998776 899999999976542211
Q ss_pred ----CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhH----------HHHHhcccccccc
Q 024809 80 ----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKN----------FRKTIGRILSVHY 145 (262)
Q Consensus 80 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----------~~~~~~~~~~~~~ 145 (262)
.....++..|+|||.+....+.. ++|+||||+++|+|++|..||........ ....+........
T Consensus 165 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~-~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
T cd05038 165 YYYVKEPGESPIFWYAPECLRTSKFSS-ASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE 243 (284)
T ss_pred ceeccCCCCCcccccCcHHHccCCCCc-ccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCC
Confidence 11223456799999987766654 48999999999999999999865332110 0011111111122
Q ss_pred cCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 146 SFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 146 ~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
..+.....+.++.+++.+||..+|.+|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 244 RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 22333356788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=219.45 Aligned_cols=173 Identities=21% Similarity=0.349 Sum_probs=134.4
Q ss_pred CCCCCCCchHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCC
Q 024809 1 MEYAAGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSS 74 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~------~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~ 74 (262)
+||+.+|+|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.+. .+||+|||+++..
T Consensus 86 ~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~--~~kl~dfg~~~~~ 163 (273)
T cd05074 86 LPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENM--TVCVADFGLSKKI 163 (273)
T ss_pred EecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCC--CEEECcccccccc
Confidence 4789999999887532 1479999999999999999999999999999999999998766 8999999998854
Q ss_pred CCCC---CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCc
Q 024809 75 VLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDY 150 (262)
Q Consensus 75 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (262)
.... ......+++.|++||.+....++.+ +|||||||++|+|++ |+.||............... ... +..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~---~~~--~~~ 237 (273)
T cd05074 164 YSGDYYRQGCASKLPVKWLALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG---NRL--KQP 237 (273)
T ss_pred cCCcceecCCCccCchhhcCHhHHhcCccchh-hhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC---CcC--CCC
Confidence 3221 1223345678999999877766544 899999999999999 88999765543332222211 111 122
Q ss_pred ccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 151 VRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 151 ~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
...+..+.+++.+||..+|++|||+.+++.+
T Consensus 238 ~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 238 PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3577899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=238.42 Aligned_cols=174 Identities=29% Similarity=0.388 Sum_probs=135.7
Q ss_pred CCCCCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCC--cEEEeccCCCcCCC
Q 024809 1 MEYAAGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAP--RVKICDFGYSKSSV 75 (262)
Q Consensus 1 mE~~~gg~L~~~i~~---~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~--~~kl~Dfg~a~~~~ 75 (262)
||||.||||+.++.+ ..+|+|.+++.++..++.||.|||++||+||||||.||++..+.++ -.||+|||.|+...
T Consensus 96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~ 175 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELD 175 (732)
T ss_pred EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCC
Confidence 899999999999973 4479999999999999999999999999999999999999655433 45999999999888
Q ss_pred CCCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHh-----ccc----------
Q 024809 76 LHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTI-----GRI---------- 140 (262)
Q Consensus 76 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~-----~~~---------- 140 (262)
......+.+||+.|.+||+..+..+++..+|.||+||++|++.||..||.....+.+...++ ++.
T Consensus 176 d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~ 255 (732)
T KOG4250|consen 176 DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEE 255 (732)
T ss_pred CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecc
Confidence 77788889999999999999864555555899999999999999999998755543211111 110
Q ss_pred ----ccccccCCCcccCCHH----HHHHHHHhcccCCCCCCC
Q 024809 141 ----LSVHYSFPDYVRVSLE----CKHLLSRIFVANSEKRIT 174 (262)
Q Consensus 141 ----~~~~~~~~~~~~~~~~----~~~li~~~L~~dp~~R~s 174 (262)
......+|....+++. +-.++..+|+.+|.+|-.
T Consensus 256 eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~ 297 (732)
T KOG4250|consen 256 ENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGH 297 (732)
T ss_pred cCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCC
Confidence 0011223333344443 446778899999999983
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=229.90 Aligned_cols=156 Identities=26% Similarity=0.422 Sum_probs=122.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC---CCCccccCCCCCCcccc
Q 024809 19 FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVL 95 (262)
Q Consensus 19 l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~ 95 (262)
+++..+..++.||+.||.|||+.+++||||||+|||++.++ .+||+|||+++...... ......++..|+|||.+
T Consensus 236 l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~--~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~ 313 (401)
T cd05107 236 LSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGK--LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESI 313 (401)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCC--EEEEEecCcceecccccccccCCCcCCCCceeChHHh
Confidence 67778899999999999999999999999999999998766 89999999997543221 12234577889999999
Q ss_pred cCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHHHHHhcccCCCCCCC
Q 024809 96 TKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRIT 174 (262)
Q Consensus 96 ~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s 174 (262)
.+..+.. ++||||+||++|+|++ |..||......+.....+.. ....+....++.++.+|+.+||..+|.+||+
T Consensus 314 ~~~~~~~-~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~----~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs 388 (401)
T cd05107 314 FNNLYTT-LSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKR----GYRMAKPAHASDEIYEIMQKCWEEKFEIRPD 388 (401)
T ss_pred cCCCCCc-HhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHc----CCCCCCCCCCCHHHHHHHHHHcCCChhHCcC
Confidence 8776654 4899999999999998 89999765544433332221 1111222357899999999999999999999
Q ss_pred HhHHhcC
Q 024809 175 IPEIKNH 181 (262)
Q Consensus 175 ~~e~l~h 181 (262)
+.+++..
T Consensus 389 ~~ell~~ 395 (401)
T cd05107 389 FSQLVHL 395 (401)
T ss_pred HHHHHHH
Confidence 9999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=231.77 Aligned_cols=177 Identities=25% Similarity=0.421 Sum_probs=138.6
Q ss_pred CchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCCCcc
Q 024809 7 GELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST 83 (262)
Q Consensus 7 g~L~~~i~~~~---~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 83 (262)
.+|.++|++-| +|....++.|+.||+.||..|-..||+|.||||.|||++.+.. .+||||||.|..... ...+.+
T Consensus 518 lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~-iLKLCDfGSA~~~~e-neitPY 595 (752)
T KOG0670|consen 518 LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKN-ILKLCDFGSASFASE-NEITPY 595 (752)
T ss_pred chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcc-eeeeccCcccccccc-ccccHH
Confidence 47888888765 5899999999999999999999999999999999999987653 689999999875432 234456
Q ss_pred ccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccc--------ccccc---c------
Q 024809 84 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRI--------LSVHY---S------ 146 (262)
Q Consensus 84 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--------~~~~~---~------ 146 (262)
..+..|.|||++.+..|+.. .|+||+||+|||+.||+..|.+.++..-+.-.+..- .+..+ .
T Consensus 596 LVSRFYRaPEIiLG~~yd~~-iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~n 674 (752)
T KOG0670|consen 596 LVSRFYRAPEIILGLPYDYP-IDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLN 674 (752)
T ss_pred HHHHhccCcceeecCcccCC-ccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccc
Confidence 77889999999999999877 799999999999999999999887654332211100 00000 0
Q ss_pred ------------------------------------CC-CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 147 ------------------------------------FP-DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 147 ------------------------------------~~-~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
+| +...+-.++++|+.+||..||.+|+|+.++|.||||..
T Consensus 675 f~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 675 FLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred eEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 00 00012246889999999999999999999999999963
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=238.39 Aligned_cols=180 Identities=28% Similarity=0.458 Sum_probs=152.2
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC-C
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-H 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~ 77 (262)
||||.|||.-+++++. .++.|..+..|++.++.||.+||.+.++|||||-.|||++.++ .|||+|||++..... -
T Consensus 100 MEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~--~VKLvDFGvSaQldsT~ 177 (953)
T KOG0587|consen 100 MEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENA--EVKLVDFGVSAQLDSTV 177 (953)
T ss_pred eeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccC--cEEEeeeeeeeeeeccc
Confidence 8999999999999754 4799999999999999999999999999999999999998887 899999999876543 3
Q ss_pred CCCCccccCCCCCCcccccCC-----cCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCccc
Q 024809 78 SQPKSTVGTPAYIAPEVLTKK-----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR 152 (262)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (262)
...++.+|||.|||||++... .|+.. +|+||||++..||.-|.+|+-..... ..++............+..
T Consensus 178 grRnT~iGtP~WMAPEViac~e~~d~tyd~R-~D~WsLGITaIEladG~PPl~DmHPm---raLF~IpRNPPPkLkrp~k 253 (953)
T KOG0587|consen 178 GRRNTFIGTPYWMAPEVIACDESPDATYDYR-SDLWSLGITAIEMAEGAPPLCDMHPM---RALFLIPRNPPPKLKRPKK 253 (953)
T ss_pred ccccCcCCCcccccceeeecccCCCCCcccc-cchhhccceeehhcCCCCCccCcchh---hhhccCCCCCCccccchhh
Confidence 456788999999999999753 34444 89999999999999999999765543 3333334444444445557
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 153 VSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 153 ~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
++.++.+||..||.+|..+||+..++|.|||+.+
T Consensus 254 Ws~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 254 WSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred HHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 8999999999999999999999999999999973
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=215.90 Aligned_cols=183 Identities=25% Similarity=0.424 Sum_probs=141.4
Q ss_pred CCCCCCCchHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCcEEEeccCCCcCC
Q 024809 1 MEYAAGGELFERIC-----NAGRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSS 74 (262)
Q Consensus 1 mE~~~gg~L~~~i~-----~~~~l~e~~~~~~~~ql~~aL~~LH~-~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~ 74 (262)
||+|.- ||..+-+ .+..++|+.+-.|..-.+.||.||-. ..|||||+||+|||++..+ .+||||||++...
T Consensus 142 MELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G--~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 142 MELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG--DVKLCDFGICGQL 218 (361)
T ss_pred HHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC--CEeeecccchHhH
Confidence 566653 6644332 34579999999999999999999986 5899999999999998877 8999999998765
Q ss_pred CCCCCCCccccCCCCCCcccccC--CcCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh-hHHHHHhcccccccccCC-Cc
Q 024809 75 VLHSQPKSTVGTPAYIAPEVLTK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP-KNFRKTIGRILSVHYSFP-DY 150 (262)
Q Consensus 75 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~-~~ 150 (262)
...-..+.-.|...|||||.+.. .+|+.+ +|+||||++|||+.||+.|+.+.++. +++......- +....++ +.
T Consensus 219 v~SiAkT~daGCrpYmAPERi~p~~~gyDiR-SDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gd-pp~l~~~~~~ 296 (361)
T KOG1006|consen 219 VDSIAKTVDAGCRPYMAPERIDPSDKGYDIR-SDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGD-PPILLFDKEC 296 (361)
T ss_pred HHHHHhhhccCCccccChhccCCccCCcchh-hhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCC-CCeecCcccc
Confidence 54444455689999999999864 356666 89999999999999999999886542 2222221111 1111122 23
Q ss_pred ccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 024809 151 VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL 188 (262)
Q Consensus 151 ~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 188 (262)
...+..++.||.-||.+|-+.||...+++.+||++.+.
T Consensus 297 ~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 297 VHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred cccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 46889999999999999999999999999999997653
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=228.81 Aligned_cols=173 Identities=28% Similarity=0.395 Sum_probs=142.3
Q ss_pred CCCCCCCchHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~-l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
||+|+||+|.++|++.+. ++..+...++.+.+.||+|||+++++||||-.+|+|++.+. .+||+|||+++.......
T Consensus 240 mEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~--~vKISDFGLs~~~~~~~~ 317 (474)
T KOG0194|consen 240 MELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKG--VVKISDFGLSRAGSQYVM 317 (474)
T ss_pred EEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCC--eEEeCccccccCCcceee
Confidence 899999999999999874 99999999999999999999999999999999999998776 689999999986542222
Q ss_pred CC-ccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHH
Q 024809 80 PK-STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 157 (262)
Q Consensus 80 ~~-~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (262)
.. ...-...|+|||.+....|+.+ +||||+||++||+++ |..||.+....+...++ ....+..+.....+.++
T Consensus 318 ~~~~~klPirWLAPEtl~~~~~s~k-TDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI----~~~~~r~~~~~~~p~~~ 392 (474)
T KOG0194|consen 318 KKFLKKLPIRWLAPETLNTGIFSFK-TDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKI----VKNGYRMPIPSKTPKEL 392 (474)
T ss_pred ccccccCcceecChhhhccCccccc-cchhheeeeEEeeeccCCCCCCCCCHHHHHHHH----HhcCccCCCCCCCHHHH
Confidence 22 2234567999999998877655 899999999999998 88999987765444443 22233333333678889
Q ss_pred HHHHHHhcccCCCCCCCHhHHhc
Q 024809 158 KHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
..++.+|+..+|++|||+.++.+
T Consensus 393 ~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 393 AKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHhccCChhhccCHHHHHH
Confidence 99999999999999999998876
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=231.53 Aligned_cols=171 Identities=26% Similarity=0.405 Sum_probs=141.9
Q ss_pred CCCCCCCchHHHHHhCC----------C----CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEe
Q 024809 1 MEYAAGGELFERICNAG----------R----FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKIC 66 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~----------~----l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~ 66 (262)
+|||..|||.++|..++ . |+..+...|+.||+.|+.||-++.+|||||-.+|+||..+- .|||+
T Consensus 568 FEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l--~VKIs 645 (774)
T KOG1026|consen 568 FEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL--VVKIS 645 (774)
T ss_pred EEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce--EEEec
Confidence 69999999999996432 2 88999999999999999999999999999999999998777 89999
Q ss_pred ccCCCcCCCCCCCCC---ccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhccccc
Q 024809 67 DFGYSKSSVLHSQPK---STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILS 142 (262)
Q Consensus 67 Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 142 (262)
|||+++........+ ...-...|||||.|..+++++. |||||+||+|||+++ |+.||.+..+.+.+.-+.+.
T Consensus 646 DfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTte-SDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g--- 721 (774)
T KOG1026|consen 646 DFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTE-SDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG--- 721 (774)
T ss_pred ccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccch-hhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC---
Confidence 999998654332211 2234567999999999999877 899999999999998 99999998876554433222
Q ss_pred ccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHh
Q 024809 143 VHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIK 179 (262)
Q Consensus 143 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l 179 (262)
.-...|+ .++.++.+|+..||+.+|++||++++|=
T Consensus 722 ~lL~~Pe--~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 722 QLLSCPE--NCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred CcccCCC--CCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 1134455 7999999999999999999999999874
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-30 Score=235.41 Aligned_cols=176 Identities=31% Similarity=0.479 Sum_probs=132.5
Q ss_pred CCCCCCCchHHHHHhCC-C---CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC---CCCCcEEEeccCCCcC
Q 024809 1 MEYAAGGELFERICNAG-R---FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG---STAPRVKICDFGYSKS 73 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~---l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~---~~~~~~kl~Dfg~a~~ 73 (262)
.|.|.- +|.+++...+ . ...-..+.++.|++.||.+||+.+||||||||.||||.. ++..+++|+|||+++.
T Consensus 582 lELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 582 LELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred ehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 477874 9999998741 1 122456889999999999999999999999999999965 3445789999999987
Q ss_pred CCCCCC----CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhC-CCCCCCCCChhHHHHHhcccccccccCC
Q 024809 74 SVLHSQ----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEDPKNFRKTIGRILSVHYSFP 148 (262)
Q Consensus 74 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 148 (262)
...... .....||-+|+|||.+...... .++||+|+||++|+.++| ..||...-..+ ..|....+..-
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~-~avDiFslGCvfyYvltgG~HpFGd~~~R~------~NIl~~~~~L~ 733 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKT-QAVDIFSLGCVFYYVLTGGSHPFGDSLERQ------ANILTGNYTLV 733 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccccC-cccchhhcCceEEEEecCCccCCCchHHhh------hhhhcCcccee
Confidence 654332 2345799999999999876654 458999999999999985 89998643211 11222222211
Q ss_pred Ccc-cCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 149 DYV-RVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 149 ~~~-~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
... ....++++||.+|+..+|..||+|.++|.||+|
T Consensus 734 ~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlF 770 (903)
T KOG1027|consen 734 HLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLF 770 (903)
T ss_pred eeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCcc
Confidence 100 011189999999999999999999999999998
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=237.74 Aligned_cols=172 Identities=25% Similarity=0.414 Sum_probs=141.0
Q ss_pred CCCCCCCchHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcC
Q 024809 1 MEYAAGGELFERICNA-------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS 73 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-------~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (262)
+|||+||||.++|++. ..++-.++..++.||++|.+||+++++|||||..+|+|++... .|||+|||+|+.
T Consensus 774 leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r--~VKIaDFGlArD 851 (1025)
T KOG1095|consen 774 LEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERR--VVKIADFGLARD 851 (1025)
T ss_pred ehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccC--cEEEcccchhHh
Confidence 6999999999999876 2489999999999999999999999999999999999998764 899999999994
Q ss_pred CCCCCC---CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCC
Q 024809 74 SVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPD 149 (262)
Q Consensus 74 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (262)
+..... .....-...|||||.+....++++ +|||||||++||++| |..||.+..+.+.+.-.. ...+...|.
T Consensus 852 iy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtsk-SDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~---~ggRL~~P~ 927 (1025)
T KOG1095|consen 852 IYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSK-SDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL---EGGRLDPPS 927 (1025)
T ss_pred hhhchheeccCccccceecCCHHHHhhcccccc-cchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH---hCCccCCCC
Confidence 332211 111123357999999998777766 899999999999999 999999877655443222 122333344
Q ss_pred cccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 150 YVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 150 ~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
.++..+.++|.+||+.+|++||++..|++
T Consensus 928 --~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 928 --YCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred --CCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 78999999999999999999999999987
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=219.92 Aligned_cols=177 Identities=24% Similarity=0.360 Sum_probs=132.5
Q ss_pred CCCCCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcC---CeecCCCCCcEEecCCCCCcEEEeccCCCcCCC
Q 024809 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQ---ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV 75 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~---ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~ 75 (262)
+||+++|+|.++|.... .+++....+|+.++++||+|||... ||||||||+|||++.+. +.||+|||+|+...
T Consensus 151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~--~aKlsDFGLa~~~~ 228 (361)
T KOG1187|consen 151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF--NAKLSDFGLAKLGP 228 (361)
T ss_pred EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC--CEEccCccCcccCC
Confidence 59999999999998665 7999999999999999999999854 99999999999999887 88999999997554
Q ss_pred C-CCCCCcc-ccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCC--ChhHHHH----Hh-----ccccc
Q 024809 76 L-HSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE--DPKNFRK----TI-----GRILS 142 (262)
Q Consensus 76 ~-~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~----~~-----~~~~~ 142 (262)
. ....... .||.+|+|||.+..+..+.+ +||||+||+|.|++||+.+..... ....+.. .+ ..+..
T Consensus 229 ~~~~~~~~~~~gt~gY~~PEy~~~g~lt~K-sDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD 307 (361)
T KOG1187|consen 229 EGDTSVSTTVMGTFGYLAPEYASTGKLTEK-SDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVD 307 (361)
T ss_pred ccccceeeecCCCCccCChhhhccCCcCcc-cccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeC
Confidence 3 2222223 89999999999987666555 899999999999999998876432 1111111 11 11111
Q ss_pred ccccCCCcc--cCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 143 VHYSFPDYV--RVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 143 ~~~~~~~~~--~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
....-..+. ..-..+..+..+|+..+|.+||+..|++.
T Consensus 308 ~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 308 PRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 111101111 11223567788999999999999999754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-29 Score=232.10 Aligned_cols=184 Identities=36% Similarity=0.576 Sum_probs=151.6
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC-
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ- 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~- 79 (262)
||||++ ||+..+...+.++..++..+++||+.||+|||+.||.|||||++|+++..++ .+||+|||.+........
T Consensus 400 mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g--~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 400 MEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENG--ILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred hhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCC--ceEEeecCcceeeccCcch
Confidence 899999 9999999988899999999999999999999999999999999999998887 899999999875543322
Q ss_pred ----CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccc---cccccCCCccc
Q 024809 80 ----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIL---SVHYSFPDYVR 152 (262)
Q Consensus 80 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 152 (262)
....+|+..|+|||++....|+...+||||.|+++..|.+|+.||......++......... ......+-...
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSL 556 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHh
Confidence 23467999999999999999999999999999999999999999987655433211111000 00111122235
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 153 VSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 153 ~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
++.+.+.+|.+||+.+|.+|+|+++|++.+||+.-
T Consensus 557 lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 557 LPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred chhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 77889999999999999999999999999999753
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=219.57 Aligned_cols=172 Identities=24% Similarity=0.383 Sum_probs=141.5
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
||+++-|.|..|++.++ .|+...+..+++||+.||.|||++++|||||...|||+.+.. .|||+|||+++.......
T Consensus 469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~--CVKLaDFGLSR~~ed~~y 546 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQ--CVKLADFGLSRYLEDDAY 546 (974)
T ss_pred EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcc--eeeecccchhhhccccch
Confidence 89999999999998665 699999999999999999999999999999999999998777 799999999997654433
Q ss_pred CCccc--cCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCHH
Q 024809 80 PKSTV--GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 156 (262)
Q Consensus 80 ~~~~~--gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (262)
-.... -...|||||-+....+++. +|||.|||++||++. |..||.+-.+.+.+..+-+ ..+.+.| ..+++.
T Consensus 547 YkaS~~kLPIKWmaPESINfRrFTtA-SDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEn---GeRlP~P--~nCPp~ 620 (974)
T KOG4257|consen 547 YKASRGKLPIKWMAPESINFRRFTTA-SDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIEN---GERLPCP--PNCPPA 620 (974)
T ss_pred hhccccccceeecCccccchhcccch-hhHHHHHHHHHHHHHhcCCccccccccceEEEecC---CCCCCCC--CCCChH
Confidence 32223 3557999999988887655 899999999999886 9999998766554332211 1233334 479999
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhc
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
+..|+.+||.++|.+||++.++..
T Consensus 621 LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 621 LYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred HHHHHHHHhccCcccCCcHHHHHH
Confidence 999999999999999999977653
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=213.71 Aligned_cols=173 Identities=24% Similarity=0.375 Sum_probs=144.4
Q ss_pred CCCCCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
||+|++|+|.+.|.+ +..|--..+..|+.||+.|+.||.++++|||||-..|+|+.... .|||+|||+.+.....+
T Consensus 189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllaspr--tVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPR--TVKICDFGLMRALGENE 266 (1039)
T ss_pred hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccc--eeeeecccceeccCCCC
Confidence 699999999999987 33588899999999999999999999999999999999997655 89999999999766554
Q ss_pred CCCcc----ccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccC
Q 024809 79 QPKST----VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRV 153 (262)
Q Consensus 79 ~~~~~----~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (262)
..... .....|+|||.++...++.. +|+|++||++|||++ |+.||.+....+.+.++- ..-.++.-..+
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFSha-SDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-----~~erLpRPk~c 340 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHA-SDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-----AGERLPRPKYC 340 (1039)
T ss_pred cceEecCCCcCcccccCHhHhcccccccc-chhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-----ccccCCCCCCC
Confidence 44332 23457999999999998766 899999999999998 899999988766655543 11223333479
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 154 SLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 154 ~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
+.++.+++..||..+|.+|||+..|.+.
T Consensus 341 sedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 341 SEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred hHHHHHHHHHhccCCccccccHHHHHHh
Confidence 9999999999999999999999888643
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-27 Score=202.42 Aligned_cols=181 Identities=27% Similarity=0.418 Sum_probs=130.8
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCC-----
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV----- 75 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~----- 75 (262)
|||++.-+..++... ++-.+++.+++.++.||.++|++|||||||||.|+|.+.... +-.|.|||+|....
T Consensus 114 lp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~-rg~LvDFgLA~~~d~~~~~ 189 (418)
T KOG1167|consen 114 LPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQ-RGVLVDFGLAQRYDGYQQT 189 (418)
T ss_pred ecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccC-CceEEechhHHHHHhhhhh
Confidence 577777666555544 678999999999999999999999999999999999976553 57899999986100
Q ss_pred ------------C-CCC---------------------------CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHH
Q 024809 76 ------------L-HSQ---------------------------PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY 115 (262)
Q Consensus 76 ------------~-~~~---------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ 115 (262)
. .+. .-...||++|+|||++.+.+-.+.++||||.|||+.
T Consensus 190 ~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~L 269 (418)
T KOG1167|consen 190 EHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILL 269 (418)
T ss_pred hhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceee
Confidence 0 000 001359999999999987665566699999999999
Q ss_pred HHHhCCCCCCCCCC-hhHHHHHh---------------cc--ccc----------------c--------cc---cCCCc
Q 024809 116 VMLVGAYPFEDPED-PKNFRKTI---------------GR--ILS----------------V--------HY---SFPDY 150 (262)
Q Consensus 116 ~ll~g~~pf~~~~~-~~~~~~~~---------------~~--~~~----------------~--------~~---~~~~~ 150 (262)
.+++++.||-...+ ...+..+. .+ +.. . .. ....+
T Consensus 270 slls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~ 349 (418)
T KOG1167|consen 270 SLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIG 349 (418)
T ss_pred hhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccc
Confidence 99999999854332 11111110 00 000 0 00 00001
Q ss_pred -ccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccc
Q 024809 151 -VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFL 185 (262)
Q Consensus 151 -~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~ 185 (262)
-..+..+.+|+.+||+.||.+|+||+++|.||||.
T Consensus 350 ~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~ 385 (418)
T KOG1167|consen 350 SDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFD 385 (418)
T ss_pred cccccHHHHHHHHHHccCChhhcccHHHHhcCcCCc
Confidence 11345789999999999999999999999999997
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-27 Score=195.16 Aligned_cols=181 Identities=24% Similarity=0.428 Sum_probs=135.2
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
||||+-|||.+-+... ++.|...+.++.|+++||.|||++++||||||.+||||-.....+|||||||.++..... .
T Consensus 101 qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t--V 177 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT--V 177 (378)
T ss_pred eccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce--e
Confidence 7999999999998775 489999999999999999999999999999999999996666669999999998744321 1
Q ss_pred CccccCCCCCCcccccC---CcC-CCCchhHHHHHHHHHHHHhCCCCCCCCCChh-HHHHHhcccccccccCC-CcccCC
Q 024809 81 KSTVGTPAYIAPEVLTK---KEY-DGKIADVWSCGVTLYVMLVGAYPFEDPEDPK-NFRKTIGRILSVHYSFP-DYVRVS 154 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~---~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~ 154 (262)
...--+..|.+||++.. +.+ ..+.+|+|.+|+++|.++||++||+.....+ .+.+..+.........| .+..++
T Consensus 178 ~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs 257 (378)
T KOG1345|consen 178 KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFS 257 (378)
T ss_pred hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccC
Confidence 12224557899998743 222 2344799999999999999999998533222 22222222222222333 355799
Q ss_pred HHHHHHHHHhcccCCCCC---CCHhHHhcCccc
Q 024809 155 LECKHLLSRIFVANSEKR---ITIPEIKNHPWF 184 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R---~s~~e~l~hp~~ 184 (262)
+.+..+.++-|..+|++| -+++.....-|.
T Consensus 258 ~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 258 EKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred HHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 999999999999999999 455555555554
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=216.71 Aligned_cols=172 Identities=27% Similarity=0.459 Sum_probs=138.0
Q ss_pred CCCCCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEE
Q 024809 1 MEYAAGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVK 64 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~k 64 (262)
+|||..|+|.+++..++ .++..++..+++||+.|++||++.++|||||-.+|||+..+. .+|
T Consensus 381 ~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~--~~k 458 (609)
T KOG0200|consen 381 VEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNK--VIK 458 (609)
T ss_pred EEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCC--EEE
Confidence 58999999999998765 389999999999999999999999999999999999998876 899
Q ss_pred EeccCCCcCCCCCCCCC--cccc--CCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcc
Q 024809 65 ICDFGYSKSSVLHSQPK--STVG--TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGR 139 (262)
Q Consensus 65 l~Dfg~a~~~~~~~~~~--~~~g--t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~ 139 (262)
|+|||+|+......... ...| ...|||||.+....|+.+ +||||+|++|||+++ |..||.+......+.+.
T Consensus 459 IaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~k-SDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~--- 534 (609)
T KOG0200|consen 459 IADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSK-SDVWSFGILLWEIFTLGGTPYPGIPPTEELLEF--- 534 (609)
T ss_pred EccccceeccCCCCceEecCCCCccceeecCHHHhccCccccc-chhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHH---
Confidence 99999998543322211 1122 335999999998777666 899999999999998 89999884433333322
Q ss_pred cccc-cccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 140 ILSV-HYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 140 ~~~~-~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
+..+ ....|. .+++++.++++.||..+|++||++.++..
T Consensus 535 l~~G~r~~~P~--~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 535 LKEGNRMEQPE--HCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HhcCCCCCCCC--CCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 2222 223344 67999999999999999999999999876
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-27 Score=184.29 Aligned_cols=126 Identities=33% Similarity=0.514 Sum_probs=104.0
Q ss_pred CCCCCCCchHH----HHHhCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCCcEEEeccCCCcCCC
Q 024809 1 MEYAAGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHSM-QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV 75 (262)
Q Consensus 1 mE~~~gg~L~~----~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~-~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~ 75 (262)
||.|.. ||.. .+...+.++|..+-+|+..++.||.|||++ .++|||+||+||||+..+ +||+||||.+....
T Consensus 124 ME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G--qVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 124 MELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG--QVKICDFGISGYLV 200 (282)
T ss_pred HHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC--cEEEcccccceeeh
Confidence 556654 6644 345677899999999999999999999986 899999999999998777 99999999997654
Q ss_pred CCCCCCccccCCCCCCcccccC----CcCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh
Q 024809 76 LHSQPKSTVGTPAYIAPEVLTK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP 130 (262)
Q Consensus 76 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 130 (262)
..-..+...|...|||||.+.. .+|+.+ +||||||+.+.||.+++.||.....+
T Consensus 201 dSiAkt~daGCkpYmaPEri~~e~n~~gY~vk-sDvWSLGItmiElA~lr~PY~~w~tp 258 (282)
T KOG0984|consen 201 DSIAKTMDAGCKPYMAPERINPELNQKGYSVK-SDVWSLGITMIEMAILRFPYESWGTP 258 (282)
T ss_pred hhhHHHHhcCCCccCChhhcCcccCcccceee-hhhhhhhhhhhhhhhccccccccCCH
Confidence 4433344678999999999853 356655 89999999999999999999887654
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=216.39 Aligned_cols=173 Identities=23% Similarity=0.418 Sum_probs=146.0
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (262)
.|||++|+|..+|+.+ ++|+.-++..+++.|+.|++||-+.|+|||||...|||++.+- .+|++|||++|......
T Consensus 709 TEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnL--vCKVsDFGLSRvledd~~ 786 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNL--VCKVSDFGLSRVLEDDPE 786 (996)
T ss_pred hhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccce--EEEeccccceeecccCCC
Confidence 3899999999999854 5799999999999999999999999999999999999998887 89999999999654332
Q ss_pred CCCcccc---CCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCC
Q 024809 79 QPKSTVG---TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS 154 (262)
Q Consensus 79 ~~~~~~g---t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (262)
...+..| ...|.|||.+...++++. +||||+|++|||.++ |..||....+.+.+..+. ..+.+|...+++
T Consensus 787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsA-SDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe-----~gyRLPpPmDCP 860 (996)
T KOG0196|consen 787 AAYTTLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-----QGYRLPPPMDCP 860 (996)
T ss_pred ccccccCCccceeecChhHhhhcccCch-hhccccceEEEEecccCCCcccccchHHHHHHHH-----hccCCCCCCCCc
Confidence 1112221 356999999999988755 899999999999876 999999887766554432 346677777899
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 155 LECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
..+..|+..||++|-..||.+.||+.+
T Consensus 861 ~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 861 AALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 999999999999999999999999874
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=226.01 Aligned_cols=171 Identities=18% Similarity=0.232 Sum_probs=123.9
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH---SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH---~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~ 77 (262)
||||+||+|.+++.. +++..+..++.|++.||+||| +.+|+||||||+||+++.+. ..++. ||.+....
T Consensus 762 ~Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~--~~~~~-~~~~~~~~-- 833 (968)
T PLN00113 762 HEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD--EPHLR-LSLPGLLC-- 833 (968)
T ss_pred EeCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCC--ceEEE-eccccccc--
Confidence 799999999999953 889999999999999999999 67999999999999998776 44543 55543221
Q ss_pred CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh----hHHHHHhc------ccccccc--
Q 024809 78 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP----KNFRKTIG------RILSVHY-- 145 (262)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~~~~------~~~~~~~-- 145 (262)
......||+.|+|||++.+..++.+ +||||+||++|||+||+.||...... ..+.+... .+.....
T Consensus 834 -~~~~~~~t~~y~aPE~~~~~~~~~~-sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 834 -TDTKCFISSAYVAPETRETKDITEK-SDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred -cCCCccccccccCcccccCCCCCcc-cchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence 1223478999999999988777655 89999999999999999998542211 11111000 0000000
Q ss_pred cCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 146 SFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 146 ~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
..+.......++.+++.+||+.+|++|||+.++++.
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 000001122357789999999999999999999874
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.1e-26 Score=197.78 Aligned_cols=101 Identities=28% Similarity=0.503 Sum_probs=73.3
Q ss_pred ccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCC------hhHHHHH---hcccc-----cc------
Q 024809 84 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPED------PKNFRKT---IGRIL-----SV------ 143 (262)
Q Consensus 84 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~~---~~~~~-----~~------ 143 (262)
+-|..|+|||++.+.+|... +||||++|++|||+||...|..... .+-+..+ +..+. .+
T Consensus 412 IQTRQYRapEVllGsgY~~~-ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdF 490 (590)
T KOG1290|consen 412 IQTRQYRAPEVLLGSGYSTS-ADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDF 490 (590)
T ss_pred hhhhhccCcceeecCCCCCc-hhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhh
Confidence 46888999999999999877 7999999999999999999975332 1112111 11110 00
Q ss_pred ------------------------cccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 144 ------------------------HYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 144 ------------------------~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
.|.|+. .-..++.+|+.-||+++|.+||||.++|+|||+...
T Consensus 491 Fnr~G~LrhI~~LK~WpL~~VL~eKY~~s~--e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~ 556 (590)
T KOG1290|consen 491 FNRRGELRHIRRLKPWPLYEVLIEKYEWSE--EDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPV 556 (590)
T ss_pred hccccceecccccCCCcHHHHHHHHhCCCH--HHHHHHHHHHHHHHhcCccccccHHHHhcCccccCC
Confidence 011111 123457899999999999999999999999999753
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.6e-27 Score=208.90 Aligned_cols=182 Identities=28% Similarity=0.400 Sum_probs=148.6
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-CC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (262)
||||-||+|.+.-.-.+.++|.++.+..+..++||+|||+.|=+|||||-.||+++..+ .+|++|||.+..+... .+
T Consensus 91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~g--DvklaDfgvsaqitati~K 168 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEG--DVKLADFGVSAQITATIAK 168 (829)
T ss_pred EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccC--ceeecccCchhhhhhhhhh
Confidence 89999999999988899999999999999999999999999999999999999998887 8999999998766543 45
Q ss_pred CCccccCCCCCCcccc---cCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHH
Q 024809 80 PKSTVGTPAYIAPEVL---TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 156 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~---~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (262)
...+.||+.|||||+- +..+|... +|||++|+...++---+.|-........ ..++.+-........+....++-
T Consensus 169 rksfiGtpywmapEvaaverkggynql-cdiwa~gitAiel~eLqpplfdlhpmr~-l~LmTkS~~qpp~lkDk~kws~~ 246 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQL-CDIWALGITAIELGELQPPLFDLHPMRA-LFLMTKSGFQPPTLKDKTKWSEF 246 (829)
T ss_pred hhcccCCccccchhHHHHHhccccccc-ccccccccchhhhhhcCCcccccchHHH-HHHhhccCCCCCcccCCccchHH
Confidence 6778999999999985 34556544 8999999999998777766443322222 22222322223334455578899
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
+-+|++.+|.++|++|||++.+|.|||+..
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 999999999999999999999999999865
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.3e-26 Score=201.34 Aligned_cols=177 Identities=23% Similarity=0.323 Sum_probs=139.1
Q ss_pred CCCCCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||+++|+|.+++.++. .+......+++.||+.|++||.+.++|||||.+.|+|++.+. ++||+|||+++......
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~--~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEF--TIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcc--cEEecCcccccccccCC
Confidence 69999999999998874 245567778999999999999999999999999999998777 99999999999654333
Q ss_pred CC---CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHH--hCCCCCCCCCChhHHHHHhccccc--ccccCCCcc
Q 024809 79 QP---KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML--VGAYPFEDPEDPKNFRKTIGRILS--VHYSFPDYV 151 (262)
Q Consensus 79 ~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll--~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 151 (262)
.. ...+-...|||+|.+..+++++. +|+|++|+++||++ |...||....+.+.....-..... ...-.+...
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFtta-SDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~ 770 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTA-SDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPP 770 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccch-hhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCC
Confidence 22 23455678999999999888766 89999999999975 588999887765544332221111 111112223
Q ss_pred cCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 152 RVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 152 ~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
-++..+.+++.+||..+-.+|||++++-.
T Consensus 771 ~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 771 ACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred cCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 57889999999999999999999999865
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=200.17 Aligned_cols=171 Identities=22% Similarity=0.345 Sum_probs=139.6
Q ss_pred CCCCCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
.|||..|+|.+||..+. .++.-.+.+++.||..|++||..+++|||||...|+|+..+. .||++|||+++.+...
T Consensus 342 TEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnh--iVKvADFGLsRlMtgD- 418 (1157)
T KOG4278|consen 342 TEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH--IVKVADFGLSRLMTGD- 418 (1157)
T ss_pred EecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccc--eEEeeccchhhhhcCC-
Confidence 38999999999998765 478888999999999999999999999999999999998776 8999999999976432
Q ss_pred CCCcccc---CCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCC
Q 024809 79 QPKSTVG---TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS 154 (262)
Q Consensus 79 ~~~~~~g---t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (262)
..+...| .+.|.|||-+..+.+..+ +|||+|||+|||+.| |-.||.+.+-.+.+..+ ...+.+...-.++
T Consensus 419 TYTAHAGAKFPIKWTAPEsLAyNtFSiK-SDVWAFGVLLWEIATYGMsPYPGidlSqVY~LL-----EkgyRM~~PeGCP 492 (1157)
T KOG4278|consen 419 TYTAHAGAKFPIKWTAPESLAYNTFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLL-----EKGYRMDGPEGCP 492 (1157)
T ss_pred ceecccCccCcccccCcccccccccccc-hhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHH-----hccccccCCCCCC
Confidence 1222233 457999999988888777 899999999999998 88999987655444332 2233433333799
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 155 LECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
+....|++.||++.|.+||++.++-+
T Consensus 493 pkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 493 PKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred HHHHHHHHHHhcCCcccCccHHHHHH
Confidence 99999999999999999999988743
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-24 Score=172.98 Aligned_cols=143 Identities=45% Similarity=0.688 Sum_probs=122.4
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-CCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG-STAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~-~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||+.|++|.+++... ..++...+..++.+++++|.+||+.|++|+||+|.||+++. ++ .++|+|||.+.......
T Consensus 70 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~--~~~l~d~~~~~~~~~~~ 147 (215)
T cd00180 70 MEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNG--KVKLADFGLSKLLTSDK 147 (215)
T ss_pred EecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCC--cEEEecCCceEEccCCc
Confidence 6899999999999876 46999999999999999999999999999999999999987 45 89999999987543321
Q ss_pred -CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHH
Q 024809 79 -QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 157 (262)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (262)
......+...|++||.+......+..+|+|++|+++++| ..+
T Consensus 148 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------~~~ 190 (215)
T cd00180 148 SLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------PEL 190 (215)
T ss_pred chhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------HHH
Confidence 133456788999999987762334558999999999999 567
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCc
Q 024809 158 KHLLSRIFVANSEKRITIPEIKNHP 182 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s~~e~l~hp 182 (262)
.+++.+|+..+|.+||++.+++.|+
T Consensus 191 ~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 191 KDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHHhhCCcccCcCHHHHhhCC
Confidence 8999999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=187.06 Aligned_cols=174 Identities=22% Similarity=0.281 Sum_probs=127.4
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH---------cCCeecCCCCCcEEecCCCCCcEEEeccCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS---------MQICHRDLKLENTLLDGSTAPRVKICDFGYS 71 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~---------~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a 71 (262)
+||-+.|+|.++|+.+ .++.....+++..+++||+|||+ ..|+|||||..|||+.++. +..|+|||+|
T Consensus 287 t~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl--TccIaDFGLA 363 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL--TCCIADFGLA 363 (534)
T ss_pred eeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC--cEEeecccee
Confidence 5788999999999988 49999999999999999999996 4599999999999999888 8999999999
Q ss_pred cCCCCCCC---CCccccCCCCCCcccccCCcC-----CCCchhHHHHHHHHHHHHhCCCCCC-CCC--------------
Q 024809 72 KSSVLHSQ---PKSTVGTPAYIAPEVLTKKEY-----DGKIADVWSCGVTLYVMLVGAYPFE-DPE-------------- 128 (262)
Q Consensus 72 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~~ll~g~~pf~-~~~-------------- 128 (262)
........ ....+||..|||||++.+... .-++.||||+|.+||||++...-+. +..
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 86654322 234789999999999976322 1234799999999999998643332 100
Q ss_pred -ChhHHHHHhcccccccccCCCc---ccCCHHHHHHHHHhcccCCCCCCCHhHH
Q 024809 129 -DPKNFRKTIGRILSVHYSFPDY---VRVSLECKHLLSRIFVANSEKRITIPEI 178 (262)
Q Consensus 129 -~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~L~~dp~~R~s~~e~ 178 (262)
..+..+..+.+ .+.+..+|+. .....-+++.+..||..||+.|.|+.=+
T Consensus 444 Pt~e~mq~~VV~-kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 444 PTLEEMQELVVR-KKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred CCHHHHHHHHHh-hccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 01111111111 1122233321 1233458899999999999999999543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.4e-24 Score=194.81 Aligned_cols=171 Identities=20% Similarity=0.382 Sum_probs=138.7
Q ss_pred CCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 2 EYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 2 E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
+|+++|.|.++++.+ ..+..+....|.+||++|+.|||.+++|||||-.+|+|++.-. .+|++|||+++........
T Consensus 777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~--hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPN--HVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCC--eEEEEecchhhccCccccc
Confidence 789999999999865 4799999999999999999999999999999999999998766 8999999999876554433
Q ss_pred Ccc---ccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCHH
Q 024809 81 KST---VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 156 (262)
Q Consensus 81 ~~~---~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (262)
... .-.+.|||=|.+....|... +||||+||++||++| |..|+.+....+. ...+.+ .-.++..+..+.+
T Consensus 855 y~~~~gK~pikwmale~i~~~~~thq-SDVWsfGVtiWElmTFGa~Py~gi~~~eI-~dlle~----geRLsqPpiCtiD 928 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKYTHQ-SDVWSFGVTIWELMTFGAKPYDGIPAEEI-PDLLEK----GERLSQPPICTID 928 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCCCch-hhhhhhhhhHHHHHhcCCCccCCCCHHHh-hHHHhc----cccCCCCCCccHH
Confidence 322 23456899999988888655 899999999999998 9999988654332 222222 1123333468899
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhc
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
+.-++.+||..|+..||+++++..
T Consensus 929 Vy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 929 VYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHHHhccCcccCccHHHHHH
Confidence 999999999999999999988764
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-24 Score=191.36 Aligned_cols=119 Identities=36% Similarity=0.605 Sum_probs=109.2
Q ss_pred CCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCCCccc
Q 024809 5 AGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTV 84 (262)
Q Consensus 5 ~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 84 (262)
+|-+|+++|.-+..++|.+++.|++|++.|+++||+.||||||||-+|+.++.++ -+||+|||.|... ..+....++
T Consensus 653 ~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g--~~klidfgsaa~~-ksgpfd~f~ 729 (772)
T KOG1152|consen 653 EGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNG--FVKLIDFGSAAYT-KSGPFDVFV 729 (772)
T ss_pred CCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCC--eEEEeeccchhhh-cCCCcceee
Confidence 5789999999999999999999999999999999999999999999999999888 8999999988633 345567889
Q ss_pred cCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 024809 85 GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFED 126 (262)
Q Consensus 85 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 126 (262)
||..|.|||++.+..|-++.-|||+||++||.++....||-+
T Consensus 730 gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 730 GTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred eeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999999999999999999989999999999999999999853
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.7e-23 Score=177.72 Aligned_cols=176 Identities=24% Similarity=0.373 Sum_probs=130.9
Q ss_pred CCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH--------cCCeecCCCCCcEEecCCCCCcEEEeccCCCcC
Q 024809 2 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS--------MQICHRDLKLENTLLDGSTAPRVKICDFGYSKS 73 (262)
Q Consensus 2 E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~--------~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (262)
+|-+.|||++||..+ .++.+...+++..++.||.|||- -.|.|||||..|||++.++ ++.|+|+|+|..
T Consensus 289 dYHe~GSL~DyL~r~-tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~--~C~IADLGLAv~ 365 (513)
T KOG2052|consen 289 DYHEHGSLYDYLNRN-TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGLAVR 365 (513)
T ss_pred ecccCCcHHHHHhhc-cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC--cEEEeeceeeEE
Confidence 789999999999985 69999999999999999999995 2499999999999999888 899999999964
Q ss_pred CCCC-----CCCCccccCCCCCCcccccCCcC-----CCCchhHHHHHHHHHHHHhC----------CCCCCCCCChhH-
Q 024809 74 SVLH-----SQPKSTVGTPAYIAPEVLTKKEY-----DGKIADVWSCGVTLYVMLVG----------AYPFEDPEDPKN- 132 (262)
Q Consensus 74 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~~ll~g----------~~pf~~~~~~~~- 132 (262)
.... ...+..+||..|||||++..... +.+.+||||+|.++||+... +.||.+....+.
T Consensus 366 h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs 445 (513)
T KOG2052|consen 366 HDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS 445 (513)
T ss_pred ecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC
Confidence 3322 23456799999999999865321 12448999999999999752 477765433222
Q ss_pred HHHHhc--ccccccccCCCcccCCH---HHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 133 FRKTIG--RILSVHYSFPDYVRVSL---ECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 133 ~~~~~~--~~~~~~~~~~~~~~~~~---~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
+..+.. -+.+.+...|+.-.-.+ .+..+++.||..||.-|.||-.+..
T Consensus 446 ~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 446 FEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred HHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 222222 22334444554323333 3557899999999999999965543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.9e-24 Score=191.59 Aligned_cols=169 Identities=35% Similarity=0.596 Sum_probs=145.0
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
++|..||+|+..+.+...+.+..++.+...++.|++++|+.+++|||+|++||+++.+| ++++.|||+++......
T Consensus 76 ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~G--hi~~tdfglske~v~~~-- 151 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEG--HIKLTDFGLSKEAVKEK-- 151 (612)
T ss_pred hhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccC--ccccCCchhhhHhHhhh--
Confidence 47889999999999998999999999999999999999999999999999999999888 99999999998654332
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 160 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 160 (262)
..+||..|||||++. +.. .++|.||+|+++++|+||..||.. .+...|.+....+|. .++..++++
T Consensus 152 -~~cgt~eymApEI~~--gh~-~a~D~ws~gvl~felltg~~pf~~--------~~~~~Il~~~~~~p~--~l~~~a~~~ 217 (612)
T KOG0603|consen 152 -IACGTYEYRAPEIIN--GHL-SAADWWSFGVLAFELLTGTLPFGG--------DTMKRILKAELEMPR--ELSAEARSL 217 (612)
T ss_pred -hcccchhhhhhHhhh--ccC-CcccchhhhhhHHHHhhCCCCCch--------HHHHHHhhhccCCch--hhhHHHHHH
Confidence 239999999999998 333 347999999999999999999987 233344444555665 688999999
Q ss_pred HHHhcccCCCCCCCH-----hHHhcCcccccc
Q 024809 161 LSRIFVANSEKRITI-----PEIKNHPWFLRN 187 (262)
Q Consensus 161 i~~~L~~dp~~R~s~-----~e~l~hp~~~~~ 187 (262)
+.+++..+|..|.-. .++++|+||...
T Consensus 218 ~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i 249 (612)
T KOG0603|consen 218 FRQLFKRNPENRLGAGPDGVDEIKQHEFFQSI 249 (612)
T ss_pred HHHHHhhCHHHHhccCcchhHHHhccchheee
Confidence 999999999999855 799999999754
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=171.85 Aligned_cols=169 Identities=17% Similarity=0.279 Sum_probs=132.8
Q ss_pred CCCCchHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCC
Q 024809 4 AAGGELFERICNA--------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV 75 (262)
Q Consensus 4 ~~gg~L~~~i~~~--------~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~ 75 (262)
+.-|+|..++.-. +.++..++..++.|++.|++|||+.||||.||..+|.+|++.- ++||+|=.++|..-
T Consensus 370 ~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~L--qVkltDsaLSRDLF 447 (563)
T KOG1024|consen 370 TGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQL--QVKLTDSALSRDLF 447 (563)
T ss_pred cCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhe--eEEeccchhccccC
Confidence 4458999988721 2478889999999999999999999999999999999998776 89999999988543
Q ss_pred CCCC---CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcc
Q 024809 76 LHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV 151 (262)
Q Consensus 76 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (262)
.... .........||+||.+.+..|+.. +|+|||||+||||+| |+.|+...+..+ ....+ +..+......
T Consensus 448 P~DYhcLGDnEnRPvkWMslEal~n~~yssa-sDvWsfGVllWELmtlg~~PyaeIDPfE-m~~yl----kdGyRlaQP~ 521 (563)
T KOG1024|consen 448 PGDYHCLGDNENRPVKWMSLEALQNSHYSSA-SDVWSFGVLLWELMTLGKLPYAEIDPFE-MEHYL----KDGYRLAQPF 521 (563)
T ss_pred cccccccCCCCCCcccccCHHHHhhhhhcch-hhhHHHHHHHHHHHhcCCCCccccCHHH-HHHHH----hccceecCCC
Confidence 2211 112233557999999999888766 899999999999998 999998765433 22222 2233333334
Q ss_pred cCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 152 RVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 152 ~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
++++++..++-.||+..|++||+.+|+..
T Consensus 522 NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 522 NCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred CCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 89999999999999999999999999865
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-22 Score=164.18 Aligned_cols=123 Identities=46% Similarity=0.775 Sum_probs=106.7
Q ss_pred CCCCCCCchHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-
Q 024809 1 MEYAAGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~-l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (262)
|||+.|++|.+++..... +++..+..++.|++.+|.+||+.+++|+||+|.||+++.+. .++|+|||.+.......
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~--~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 76 MEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG--LVKLADFGLARFIHRDLA 153 (225)
T ss_pred EeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEeeCceeeEecCccc
Confidence 689999999999988766 89999999999999999999999999999999999998775 89999999987654332
Q ss_pred -CCCccccCCCCCCcccc-cCCcCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 024809 79 -QPKSTVGTPAYIAPEVL-TKKEYDGKIADVWSCGVTLYVMLVGAYPFED 126 (262)
Q Consensus 79 -~~~~~~gt~~y~aPE~~-~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 126 (262)
......++..|++||.+ ....+.. ++|+|++|+++++|++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~-~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGE-AVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCc-hhhHHHHHHHHHHHHHCCCCccc
Confidence 33456788899999998 4444544 58999999999999999999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.8e-21 Score=161.73 Aligned_cols=185 Identities=35% Similarity=0.557 Sum_probs=140.3
Q ss_pred CCCCCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC
Q 024809 1 MEYAAGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~---~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~ 77 (262)
|||+.|+++.+++.... .+++..+..++.|++.++.|+|+.+++|||+||+||+++.... .++++|||.++.....
T Consensus 77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~-~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR-VVKLIDFGLAKLLPDP 155 (384)
T ss_pred EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC-eEEEeccCcceecCCC
Confidence 58999999998887765 7999999999999999999999999999999999999976542 4899999998744332
Q ss_pred C-------CCCccccCCCCCCcccccCC--cCCCCchhHHHHHHHHHHHHhCCCCCCCCCC---hhHHHHHhcccccccc
Q 024809 78 S-------QPKSTVGTPAYIAPEVLTKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPED---PKNFRKTIGRILSVHY 145 (262)
Q Consensus 78 ~-------~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~~~ 145 (262)
. ......||..|++||.+.+. .......|+||+|++++++++|..||..... .......+........
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccc
Confidence 2 23567899999999999873 3445558999999999999999999877654 2222222221111101
Q ss_pred cCCCccc----CCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 146 SFPDYVR----VSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 146 ~~~~~~~----~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
..+.... ....+.+++.+++..+|..|.+......+++...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 1111111 1257899999999999999999999988866654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.9e-22 Score=185.53 Aligned_cols=148 Identities=35% Similarity=0.613 Sum_probs=119.8
Q ss_pred HHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC----------------CCccccCCCCCCcccc
Q 024809 32 ISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ----------------PKSTVGTPAYIAPEVL 95 (262)
Q Consensus 32 ~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~----------------~~~~~gt~~y~aPE~~ 95 (262)
+.+++|||+.||+|||+||+|.+|+.-+ ++|++|||+++....... .+..+|||.|+|||++
T Consensus 153 vla~Eylh~ygivhrdlkpdnllIT~mG--hiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi 230 (1205)
T KOG0606|consen 153 VLAVEYLHSYGIVHRDLKPDNLLITSMG--HIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVI 230 (1205)
T ss_pred hHHhHhhccCCeecCCCCCCcceeeecc--cccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhh
Confidence 7899999999999999999999998877 999999999864321110 1234899999999999
Q ss_pred cCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCC-cccCCHHHHHHHHHhcccCCCCCC-
Q 024809 96 TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD-YVRVSLECKHLLSRIFVANSEKRI- 173 (262)
Q Consensus 96 ~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~- 173 (262)
...+| ++.+|+|++|+|+|+.+.|..||.+.+..+.+.+.+. ....+|+ .....+++++++.++|+.+|..|.
T Consensus 231 lrqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vis----d~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 231 LRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS----DDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred hhhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh----hhccccccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 98887 5669999999999999999999998766555554433 2333433 335789999999999999999995
Q ss_pred --CHhHHhcCccccc
Q 024809 174 --TIPEIKNHPWFLR 186 (262)
Q Consensus 174 --s~~e~l~hp~~~~ 186 (262)
.+-++.+|+||+.
T Consensus 306 t~ga~evk~h~ff~~ 320 (1205)
T KOG0606|consen 306 TGGALEVKQHGFFQL 320 (1205)
T ss_pred cchhhhhhhccceee
Confidence 5678899999964
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.1e-21 Score=168.70 Aligned_cols=170 Identities=25% Similarity=0.373 Sum_probs=129.7
Q ss_pred CCCCCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC
Q 024809 1 MEYAAGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~---~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~ 77 (262)
|++|.-++|.+.|.... .-+...++.++.|+..|++| +|.+|||+||.||+...+. .+||+|||+.......
T Consensus 335 Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~--q~kIgDFgl~ts~~~~ 409 (516)
T KOG1033|consen 335 MNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDD--QLKIGDFGLVTSQDKD 409 (516)
T ss_pred hhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccch--hhhhhhhhheeecccC
Confidence 78899999999997543 35677899999999999999 9999999999999998776 7999999998755443
Q ss_pred C-------CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCC
Q 024809 78 S-------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPD 149 (262)
Q Consensus 78 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (262)
. ......||.+||+||.+.+..|..+ +||||||+||+|++. =..+|.. ...+..+....++ |.
T Consensus 410 ~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~k-vdIyaLGlil~EL~~~f~T~~er-------~~t~~d~r~g~ip-~~ 480 (516)
T KOG1033|consen 410 ETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEK-VDIYALGLILAELLIQFSTQFER-------IATLTDIRDGIIP-PE 480 (516)
T ss_pred CcccchhhhhhhcccccccCCHHHHhhhhhhhh-cchhhHHHHHHHHHHHhccHHHH-------HHhhhhhhcCCCC-hH
Confidence 3 3345689999999999999988766 899999999999997 3333322 1222222222222 12
Q ss_pred cccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 150 YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 150 ~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
...-.++-..|+.+||...|.+||++.+.-.|+|.
T Consensus 481 ~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 481 FLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred HhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 22333456799999999999999988777777664
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.6e-19 Score=153.26 Aligned_cols=174 Identities=22% Similarity=0.153 Sum_probs=129.0
Q ss_pred CCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-C--CcEEEeccCCCc--CCCCCC
Q 024809 6 GGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-A--PRVKICDFGYSK--SSVLHS 78 (262)
Q Consensus 6 gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~-~--~~~kl~Dfg~a~--~~~~~~ 78 (262)
|-+|.++.... ++|+...+..++.|++.+|++||+.|++||||||.|+++.... . ..+.|.|||+++ ......
T Consensus 104 G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~ 183 (322)
T KOG1164|consen 104 GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDS 183 (322)
T ss_pred CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCC
Confidence 67898887543 5799999999999999999999999999999999999997553 1 368999999998 321111
Q ss_pred --------C-CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCC
Q 024809 79 --------Q-PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD 149 (262)
Q Consensus 79 --------~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (262)
. .....||..|+++.+..+.... +..|+||++.++.+++.|..||..........+........... ..
T Consensus 184 ~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~-r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~-~~ 261 (322)
T KOG1164|consen 184 GGNLRPPRPQKGLFRGTLRYASINVHLGIEQG-RRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTD-RF 261 (322)
T ss_pred CcccccCCCCccCCCCccccccHHHhCCCccC-CchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccc-cc
Confidence 1 1235699999999998887765 44899999999999999999998766433322222111111111 01
Q ss_pred cccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 150 YVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 150 ~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
....+.++..+...+-..+...+|....+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 262 GDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred cCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 12345678888888888899999998877653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.6e-20 Score=156.16 Aligned_cols=136 Identities=24% Similarity=0.316 Sum_probs=92.2
Q ss_pred HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCCCccccCCCCCCcccccCC----
Q 024809 23 EARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK---- 98 (262)
Q Consensus 23 ~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~---- 98 (262)
....+..|+++.+++||+.|++|+||||+|++++.++ .++|+||+........ ......+..|.+||.....
T Consensus 146 arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G--~v~Lg~F~~~~r~g~~--~~~~~~~~~~~PPe~~~~~~~~~ 221 (288)
T PF14531_consen 146 ARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDG--GVFLGDFSSLVRAGTR--YRCSEFPVAFTPPELESCAGQFG 221 (288)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS---EEE--GGGEEETTEE--EEGGGS-TTTS-HHHHHHHTSCH
T ss_pred HHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCC--CEEEcChHHHeecCce--eeccCCCcccCChhhhhhhcccC
Confidence 3455569999999999999999999999999999887 8999999877643221 1113456789999987442
Q ss_pred ---cCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHHHHHhcccCCCCC
Q 024809 99 ---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKR 172 (262)
Q Consensus 99 ---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 172 (262)
-..+.+.|.|+||+++|.|+||..||........ ....|....+++..++.||+++|+.+|.+|
T Consensus 222 ~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~----------~~~~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 222 QNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEAD----------PEWDFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGST----------SGGGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred cccceeeeccCHHHHHHHHHHHHHccCCCCCCCcccc----------ccccchhcCCcCHHHHHHHHHHccCCcccC
Confidence 1123447999999999999999999986533211 111333444788899999999999999988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.8e-19 Score=151.61 Aligned_cols=161 Identities=25% Similarity=0.404 Sum_probs=118.1
Q ss_pred CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe--cCCCCCcEEEeccCCCcCCCCCC--C---
Q 024809 7 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL--DGSTAPRVKICDFGYSKSSVLHS--Q--- 79 (262)
Q Consensus 7 g~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili--~~~~~~~~kl~Dfg~a~~~~~~~--~--- 79 (262)
.+|.+++..+. .+....+-++.|+++|+.|||++||.|||+|.+|||+ ++++.+.+.|+|||.+--....+ .
T Consensus 327 ~tLr~yl~~~~-~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~ 405 (598)
T KOG4158|consen 327 QTLREYLWTRH-RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYE 405 (598)
T ss_pred hhHHHHHhcCC-CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccc
Confidence 37888887663 6777888899999999999999999999999999999 55666789999999763221111 0
Q ss_pred --CCccccCCCCCCcccccCCc-----CCCCchhHHHHHHHHHHHHhCCCCCCCCCCh----hHHHHHhcccccccccCC
Q 024809 80 --PKSTVGTPAYIAPEVLTKKE-----YDGKIADVWSCGVTLYVMLVGAYPFEDPEDP----KNFRKTIGRILSVHYSFP 148 (262)
Q Consensus 80 --~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~ 148 (262)
.-..-|.-..||||+..... .+..++|.|+.|.+.||+++...||-..... .++++ ..-...|
T Consensus 406 S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe------~qLPalp 479 (598)
T KOG4158|consen 406 SDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQE------SQLPALP 479 (598)
T ss_pred cccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhh------hhCCCCc
Confidence 11123566789999975321 1223379999999999999999999763321 11111 1112334
Q ss_pred CcccCCHHHHHHHHHhcccCCCCCCCHh
Q 024809 149 DYVRVSLECKHLLSRIFVANSEKRITIP 176 (262)
Q Consensus 149 ~~~~~~~~~~~li~~~L~~dp~~R~s~~ 176 (262)
+ .+++.+++++..+|+.||++|+++.
T Consensus 480 ~--~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 480 S--RVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred c--cCChHHHHHHHHHhcCCccccCCcc
Confidence 4 6889999999999999999999874
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3e-19 Score=168.40 Aligned_cols=160 Identities=21% Similarity=0.382 Sum_probs=116.3
Q ss_pred chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCCC------
Q 024809 8 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK------ 81 (262)
Q Consensus 8 ~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~~------ 81 (262)
+|++.|.-+.-+..-+.+-|+.||+.||..+|..||+|+|||.+||||++=. -+.|+||...+.........
T Consensus 106 nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWN--W~~LtDFAsFKPtYLPeDNPadf~fF 183 (1431)
T KOG1240|consen 106 NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWN--WLYLTDFASFKPTYLPEDNPADFTFF 183 (1431)
T ss_pred hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeec--hhhhhcccccCCccCCCCCcccceEE
Confidence 7777777666678889999999999999999999999999999999997644 68999997665432222111
Q ss_pred --ccccCCCCCCcccccCCc----------CCCCchhHHHHHHHHHHHHh-CCCCCCCCC-------ChhHHHHHhcccc
Q 024809 82 --STVGTPAYIAPEVLTKKE----------YDGKIADVWSCGVTLYVMLV-GAYPFEDPE-------DPKNFRKTIGRIL 141 (262)
Q Consensus 82 --~~~gt~~y~aPE~~~~~~----------~~~~~~DiwslG~il~~ll~-g~~pf~~~~-------~~~~~~~~~~~~~ 141 (262)
+.....+|.|||.+.... .-.++.||||+||+++|+++ |++||.-+. +.......+.++
T Consensus 184 FDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~Le~I- 262 (1431)
T KOG1240|consen 184 FDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLLEKI- 262 (1431)
T ss_pred EecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHHHhC-
Confidence 112334799999875421 12345799999999999998 899986210 011111111111
Q ss_pred cccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 142 SVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
-+..++.||..|++.||.+|.||++.|+-
T Consensus 263 -----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 263 -----------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred -----------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 12358999999999999999999999975
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.1e-20 Score=166.00 Aligned_cols=177 Identities=24% Similarity=0.309 Sum_probs=132.1
Q ss_pred CCCCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCC-eecCCCCCcEEecCCCCCcEEEeccCCCcCCCC---
Q 024809 2 EYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQI-CHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL--- 76 (262)
Q Consensus 2 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~aL~~LH~~~i-vHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~--- 76 (262)
+||.-|+|++.+.. ..+++......+++.++.||.|||+..| +|+.++..|.+++..+ .+||+|||+......
T Consensus 27 ~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~~w--~lklt~~Gl~~~~~~~~~ 104 (484)
T KOG1023|consen 27 EYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVDSRW--VLKLTDFGLNSLLEETAE 104 (484)
T ss_pred eeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceeeeeE--EEEechhhhccccccccc
Confidence 68999999999987 4578999999999999999999998765 9999999999999988 899999999764421
Q ss_pred CCCCCccccCCCCCCcccccCCcC------CCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccc-----ccc
Q 024809 77 HSQPKSTVGTPAYIAPEVLTKKEY------DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS-----VHY 145 (262)
Q Consensus 77 ~~~~~~~~gt~~y~aPE~~~~~~~------~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-----~~~ 145 (262)
........-...|.|||+++.... -++++||||+|++++++++.+.||...........++..+.+ ...
T Consensus 105 ~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP 184 (484)
T KOG1023|consen 105 PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRP 184 (484)
T ss_pred ccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCc
Confidence 011122234556999999976422 234589999999999999999999874432221222222222 111
Q ss_pred cCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 146 SFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 146 ~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
.........+++..++.+||..+|.+||+++++-.
T Consensus 185 ~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 185 SIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred chhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 11211245667999999999999999999998865
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.7e-19 Score=167.57 Aligned_cols=184 Identities=33% Similarity=0.548 Sum_probs=149.6
Q ss_pred CCCCCCCchHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-HcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC-
Q 024809 1 MEYAAGGELFERI-CNAG-RFSEDEARFFFQQLISGVSYCH-SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL- 76 (262)
Q Consensus 1 mE~~~gg~L~~~i-~~~~-~l~e~~~~~~~~ql~~aL~~LH-~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~- 76 (262)
+||..||++++.+ .... ..+...+..++.|+..++.|+| ..++.||||||+|.+++.++. .++++|||+|.....
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~-~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS-ALKIADFGLATAYRNK 178 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC-cccCCCchhhcccccc
Confidence 4789999999999 5554 6889999999999999999999 999999999999999976654 689999999986654
Q ss_pred CCC---CCcccc-CCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCccc
Q 024809 77 HSQ---PKSTVG-TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR 152 (262)
Q Consensus 77 ~~~---~~~~~g-t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (262)
.+. ....+| ++.|+|||...+..+..+..|+||+|+++..+++|..||............+.... .......+..
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 257 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK-GRFTQLPWNS 257 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc-cccccCcccc
Confidence 222 234578 99999999998877777879999999999999999999987665443211111111 1222344557
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 153 VSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 153 ~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
++....+++.+++..+|..|.+.+++..+||+..
T Consensus 258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred CChhhhhcccccccCCchhccccccccccccccc
Confidence 8899999999999999999999999999999976
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.9e-16 Score=127.64 Aligned_cols=117 Identities=16% Similarity=0.175 Sum_probs=86.4
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCC-CCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDL-KLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDl-kp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||+.|.+|.+.+.. . ...++.|++.+|.++|++||+|||| ||+|||++.++ .++|+|||+|........
T Consensus 77 meyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g--~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 77 RSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDG--SPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred EeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCC--CEEEEECCCceecCCcch
Confidence 799999998754322 1 2457889999999999999999999 79999998666 899999999974432221
Q ss_pred C-----C---------ccccCCCCCCcccccCC-cCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 024809 80 P-----K---------STVGTPAYIAPEVLTKK-EYDGKIADVWSCGVTLYVMLVGAYPFED 126 (262)
Q Consensus 80 ~-----~---------~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~ 126 (262)
. . ....++.|+.|+-..-. ..+-...+.++.|+-+|.++|+..++-+
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 0 11357788888754322 2222336889999999999999988654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1e-15 Score=128.52 Aligned_cols=124 Identities=26% Similarity=0.388 Sum_probs=102.4
Q ss_pred CCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC---CCcEEEeccCCCcCCCCCC---
Q 024809 6 GGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST---APRVKICDFGYSKSSVLHS--- 78 (262)
Q Consensus 6 gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~---~~~~kl~Dfg~a~~~~~~~--- 78 (262)
|-||.+++.-++ +|+.+.+.-++.|++.-++|+|++.+|.|||||+|+||...+ ...|.++|||+|+.+....
T Consensus 107 GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~Tkq 186 (449)
T KOG1165|consen 107 GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQ 186 (449)
T ss_pred CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccc
Confidence 568888776554 599999999999999999999999999999999999995433 2367899999998654322
Q ss_pred -----CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh
Q 024809 79 -----QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP 130 (262)
Q Consensus 79 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 130 (262)
..++..||-.||+--...+...+.. .|+=|||-++.+.|-|..||++....
T Consensus 187 HIPYrE~KSLsGTARYMSINTHlGrEQSRR-DDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 187 HIPYREHKSLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred cCccccccccccceeeeEeeccccchhhhh-hhHHHhhhhhhhhccCCCccccccCc
Confidence 2345579999999888888777544 89999999999999999999986543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.9e-16 Score=138.80 Aligned_cols=88 Identities=19% Similarity=0.214 Sum_probs=68.8
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCC-CCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDL-KLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDl-kp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
||||+|++|.. +... . ...++.|+++||.|||++||+|||| ||+|||++.++ .+||+|||+|+.......
T Consensus 97 mE~~~G~~L~~-~~~~---~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~--~ikLiDFGlA~~~~~~~~ 167 (365)
T PRK09188 97 RGWTEGVPLHL-ARPH---G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDG--EAAVIDFQLASVFRRRGA 167 (365)
T ss_pred EEccCCCCHHH-hCcc---c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCC--CEEEEECccceecccCcc
Confidence 79999999963 2211 1 2568899999999999999999999 99999997665 899999999985543221
Q ss_pred C---------CccccCCCCCCcccccC
Q 024809 80 P---------KSTVGTPAYIAPEVLTK 97 (262)
Q Consensus 80 ~---------~~~~gt~~y~aPE~~~~ 97 (262)
. ....+++.|+|||.+.-
T Consensus 168 ~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 168 LYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred hhhhhhhhhhhhhhccCccCCcccCCh
Confidence 1 23468888999999854
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.1e-16 Score=126.24 Aligned_cols=70 Identities=23% Similarity=0.264 Sum_probs=62.4
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS 73 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~L-H~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (262)
|||++|+++...+...+.+++..+..++.|++.+|.++ |+.||+||||||+||+++. + .++|+|||+|..
T Consensus 96 mE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-~--~v~LiDFG~a~~ 166 (190)
T cd05147 96 MEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-G--KLYIIDVSQSVE 166 (190)
T ss_pred EEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-C--cEEEEEcccccc
Confidence 89999988876655567899999999999999999999 7999999999999999973 3 799999999863
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=9.4e-16 Score=123.70 Aligned_cols=173 Identities=21% Similarity=0.236 Sum_probs=121.7
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-APRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~-~~~~kl~Dfg~a~~~~~~~ 78 (262)
|+++ |-+|.+++.-+ ..|+.+.+.-++-|++.-++|+|.++++||||||+|+|+.-+. ...+.|+|||+|+.+....
T Consensus 90 MdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~ 168 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR 168 (341)
T ss_pred eecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence 3444 56787776533 2599999999999999999999999999999999999995332 2368899999998653221
Q ss_pred --------CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCC--
Q 024809 79 --------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP-- 148 (262)
Q Consensus 79 --------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-- 148 (262)
......||-.|.+--...+...+. ..|+=|+|.+|.++.-|..||++.......++. .+|.....+.|
T Consensus 169 t~~HIpyre~r~ltGTaRYASinAh~g~eqSR-RDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy-EkI~EkK~s~~ie 246 (341)
T KOG1163|consen 169 TRQHIPYREDRNLTGTARYASINAHLGIEQSR-RDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY-EKISEKKMSTPIE 246 (341)
T ss_pred ccccCccccCCccceeeeehhhhhhhhhhhhh-hhhhhhhcceeeeeecCCCcccccchhhHHHHH-HHHHHhhcCCCHH
Confidence 223456898898877766655543 479999999999999999999986543322221 11211111111
Q ss_pred -CcccCCHHHHHHHHHhcccCCCCCCCHh
Q 024809 149 -DYVRVSLECKHLLSRIFVANSEKRITIP 176 (262)
Q Consensus 149 -~~~~~~~~~~~li~~~L~~dp~~R~s~~ 176 (262)
-....+.++.-.+.-|-..--.+-|...
T Consensus 247 ~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ 275 (341)
T KOG1163|consen 247 VLCKGFPAEFAMYLNYCRGLGFEEKPDYM 275 (341)
T ss_pred HHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence 1235777888888888777667767653
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.4e-15 Score=122.51 Aligned_cols=168 Identities=21% Similarity=0.328 Sum_probs=125.9
Q ss_pred CCCCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC
Q 024809 2 EYAAGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQ--ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH 77 (262)
Q Consensus 2 E~~~gg~L~~~i~~~~~--l~e~~~~~~~~ql~~aL~~LH~~~--ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~ 77 (262)
.||+-|+|+..+..... .+..++.+++..+++|+.|||+.. |.---|....++|+.+-..++-.+|--++.+
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq---- 342 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---- 342 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee----
Confidence 48889999999987654 678899999999999999999974 3344688889999877744455555443321
Q ss_pred CCCCccccCCCCCCcccccCCcC--CCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 78 SQPKSTVGTPAYIAPEVLTKKEY--DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
.....-+|.||+||.+.+... +..++|+||+.+++||+.|...||......+--+++.- .......|. .++.
T Consensus 343 --e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial--eglrv~ipp--gis~ 416 (448)
T KOG0195|consen 343 --EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL--EGLRVHIPP--GISR 416 (448)
T ss_pred --ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh--ccccccCCC--CccH
Confidence 223345789999999987553 34458999999999999999999988665443333221 122334444 7899
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHh
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIK 179 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l 179 (262)
....|+.-|+..||.+||.+..++
T Consensus 417 hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 417 HMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHHHHHhcCCCCcCCCcceeh
Confidence 999999999999999999987654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.5e-15 Score=140.93 Aligned_cols=183 Identities=30% Similarity=0.469 Sum_probs=146.7
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC----
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL---- 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~---- 76 (262)
|+|+.||+|...+.+-+..+++..+.++..+++++++||+..+.|||++|.|+++..++ +.++++||.......
T Consensus 883 ~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~g--h~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDG--HRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred hHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccC--CcccCccccccccccccCc
Confidence 57889999999999988899999999999999999999999999999999999998777 889999984321100
Q ss_pred -----------------C-----------CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 024809 77 -----------------H-----------SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 128 (262)
Q Consensus 77 -----------------~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 128 (262)
. .......||+.|.+||...+...- ..+|+|++|+++++.++|..||....
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hg-s~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHG-SAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCC-CcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 0 001124689999999999877664 44899999999999999999999877
Q ss_pred ChhHHHHHhcccccccccCCCc-ccCCHHHHHHHHHhcccCCCCCCCHh---HHhcCccccccCCc
Q 024809 129 DPKNFRKTIGRILSVHYSFPDY-VRVSLECKHLLSRIFVANSEKRITIP---EIKNHPWFLRNLPI 190 (262)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~s~~---e~l~hp~~~~~~~~ 190 (262)
..+.+..+ .+....+|.. ...+.++++++.++|..+|.+|..+. ++..|+||+...+.
T Consensus 1040 pq~~f~ni----~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~ 1101 (1205)
T KOG0606|consen 1040 PQQIFENI----LNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWE 1101 (1205)
T ss_pred hhhhhhcc----ccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcc
Confidence 66555444 3334444432 25778899999999999999999887 89999999865443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.4e-15 Score=121.10 Aligned_cols=71 Identities=18% Similarity=0.187 Sum_probs=61.8
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCcEEEeccCCCcCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSS 74 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~-~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~ 74 (262)
|||++|+++........++++..+..++.|++.+|.++|+ .||+||||||+||+++ ++ .++|+|||+++..
T Consensus 96 mE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~--~~~liDFG~a~~~ 167 (190)
T cd05145 96 MEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG--KPYIIDVSQAVEL 167 (190)
T ss_pred EEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC--CEEEEEcccceec
Confidence 8999998765544445678999999999999999999999 9999999999999997 44 7999999999744
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1e-14 Score=139.32 Aligned_cols=121 Identities=29% Similarity=0.351 Sum_probs=103.7
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-----CCCCcEEEeccCCCcCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG-----STAPRVKICDFGYSKSSV 75 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~-----~~~~~~kl~Dfg~a~~~~ 75 (262)
+||.+-|+|.+++...+.+++..+..+..|++..+++||..+|||+||||+|+|+.. .....++|+|||.+.-+.
T Consensus 773 ~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~ 852 (974)
T KOG1166|consen 773 SEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK 852 (974)
T ss_pred eeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence 589999999999998888999999999999999999999999999999999999932 223368999999986543
Q ss_pred CCC---CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCC
Q 024809 76 LHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAY 122 (262)
Q Consensus 76 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 122 (262)
... .....++|-.+-.+|+..+..++.. +|.|.|..+++.||+|+.
T Consensus 853 lfp~~~~F~~~~~td~f~C~EM~~grpWtYq-~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 853 LFPDGTKFKAVWHTDLFDCIEMREGRPWTYQ-IDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EcCCCcEEeeeeccccchhHHHhcCCCCchh-hhhHHHHHHHHHHHHHHH
Confidence 322 3345678999999999999888766 899999999999999963
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.53 E-value=3e-15 Score=122.90 Aligned_cols=95 Identities=17% Similarity=0.244 Sum_probs=69.7
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||++|.+|.+.. .+++. .+.+++.+|..||..|++|||+||+||+++.++ ++|+|||.++........
T Consensus 122 mEyi~G~tL~~~~----~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g---i~liDfg~~~~~~e~~a~ 190 (232)
T PRK10359 122 IEYIEGVELNDMP----EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG---LRIIDLSGKRCTAQRKAK 190 (232)
T ss_pred EEEECCccHHHhh----hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC---EEEEECCCcccccchhhH
Confidence 7999999998773 23443 456999999999999999999999999997654 999999987643211110
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 118 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll 118 (262)
. .......+.. .+|+||||+.+....
T Consensus 191 d-----------~~vler~y~~-~~di~~lg~~~~~~~ 216 (232)
T PRK10359 191 D-----------RIDLERHYGI-KNEIKDLGYYLLIYK 216 (232)
T ss_pred H-----------HHHHHhHhcc-cccccceeEeehHHH
Confidence 0 0223334553 489999999987664
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.1e-13 Score=116.39 Aligned_cols=174 Identities=17% Similarity=0.279 Sum_probs=121.5
Q ss_pred CCCCCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecCCCCCcEEEeccCCCcCC
Q 024809 1 MEYAAGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQ--ICHRDLKLENTLLDGSTAPRVKICDFGYSKSS 74 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~----~~l~e~~~~~~~~ql~~aL~~LH~~~--ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~ 74 (262)
.||++.|+|.++|++. ..+.....++|+-||+.||.|||+.. |+|+++....|++..++ -+|++--... ..
T Consensus 151 teymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ng--LIkig~~ap~-s~ 227 (458)
T KOG1266|consen 151 TEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNG--LIKIGSVAPD-ST 227 (458)
T ss_pred EecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCc--eEEecccCcc-cc
Confidence 3899999999999754 35899999999999999999999874 99999999999998776 6666421111 00
Q ss_pred CC------CCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCC
Q 024809 75 VL------HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP 148 (262)
Q Consensus 75 ~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 148 (262)
.. ........+-++|.+||.=.-....+. +|||++|....+|..+..--...+........+.... ....
T Consensus 228 h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a-~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i---~~le 303 (458)
T KOG1266|consen 228 HPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGA-SDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVI---IGLE 303 (458)
T ss_pred chhhhhhhHhhhhccccCCccccCCcCcccccccc-hhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhe---eecc
Confidence 00 011122356788999987544444444 8999999999999988765444333222222222111 0111
Q ss_pred CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 149 DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 149 ~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
+ .--++++.+||+-.|..||++..++-||-...
T Consensus 304 n-----~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 304 N-----GLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred C-----ccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 1 11256899999999999999999999997654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.7e-13 Score=114.08 Aligned_cols=70 Identities=21% Similarity=0.234 Sum_probs=61.4
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC-CeecCCCCCcEEecCCCCCcEEEeccCCCcC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ-ICHRDLKLENTLLDGSTAPRVKICDFGYSKS 73 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~-ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (262)
|||+.|++|.........+.+..+..++.|++.+|.+||+.| ++||||||+||+++ ++ .++|+|||.+..
T Consensus 127 ~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~--~i~LiDFg~a~~ 197 (237)
T smart00090 127 MEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DG--KVVIIDVSQSVE 197 (237)
T ss_pred EEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CC--CEEEEEChhhhc
Confidence 799999888776655556778888999999999999999999 99999999999998 44 799999998863
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.39 E-value=7.1e-13 Score=108.09 Aligned_cols=68 Identities=22% Similarity=0.239 Sum_probs=55.0
Q ss_pred CCC--CCCCchHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHHcCCeecCCCCCcEEecCCC--CCcEEEeccCCC
Q 024809 1 MEY--AAGGELFERICNAGRFSEDEARFFFQQLISGV-SYCHSMQICHRDLKLENTLLDGST--APRVKICDFGYS 71 (262)
Q Consensus 1 mE~--~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL-~~LH~~~ivHrDlkp~Nili~~~~--~~~~kl~Dfg~a 71 (262)
||| +.+|+|.+++.+. .+++. ..++.|++.++ +|||+++|+||||||+|||++..+ ..+++|+||+-+
T Consensus 84 ~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred ecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 688 6689999999764 57766 46788888888 999999999999999999997432 337999995434
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.32 E-value=3e-12 Score=106.70 Aligned_cols=66 Identities=26% Similarity=0.386 Sum_probs=55.9
Q ss_pred CCCCCC-CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcC
Q 024809 1 MEYAAG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS 73 (262)
Q Consensus 1 mE~~~g-g~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (262)
|||++| ++|.+++... .+++.. +.|++.+|.+||++||+||||||.|||++.++ .++|+|||.++.
T Consensus 125 ~e~l~G~~~L~~~l~~~-~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~--~v~LIDfg~~~~ 191 (239)
T PRK01723 125 IERIEGARDLVALLQEA-PLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDG--KFWLIDFDRGEL 191 (239)
T ss_pred EEecCCCCCHHHHHhcC-CCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC--CEEEEECCCccc
Confidence 688997 6898887653 566653 57899999999999999999999999998765 799999998863
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.30 E-value=4e-12 Score=103.72 Aligned_cols=66 Identities=30% Similarity=0.395 Sum_probs=58.9
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS 73 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (262)
|||++|++|.+.+..... ....++.+++.+|.++|+.|++|||++|.||+++ ++ .++|+|||.++.
T Consensus 78 ~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~--~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GG--KIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CC--CEEEEECCcccC
Confidence 799999999999876432 8889999999999999999999999999999998 33 799999998864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.9e-12 Score=115.39 Aligned_cols=174 Identities=17% Similarity=0.151 Sum_probs=133.3
Q ss_pred CCCCCCchHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC
Q 024809 2 EYAAGGELFERICNAGR-FSEDEARFFFQQLIS----GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL 76 (262)
Q Consensus 2 E~~~gg~L~~~i~~~~~-l~e~~~~~~~~ql~~----aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (262)
|+|. .+|.++...... +++..++..+.+..+ ||.++|+.+++|-|+||.||++..++ ...+++|||+...+..
T Consensus 198 E~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~-~s~~~~df~~v~~i~~ 275 (524)
T KOG0601|consen 198 ELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDW-TSCKLTDFGLVSKISD 275 (524)
T ss_pred cccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccccc-ceeecCCcceeEEccC
Confidence 6664 588888776555 899999999999999 99999999999999999999998773 2789999999886654
Q ss_pred CCCCCc------cccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCC--CChhHHHHHhcccccccccCC
Q 024809 77 HSQPKS------TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP--EDPKNFRKTIGRILSVHYSFP 148 (262)
Q Consensus 77 ~~~~~~------~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~~ 148 (262)
...... ..|...|++||+..+.. +..+|++++|.++.+..+|..++... ..+.++.... ....
T Consensus 276 ~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~--~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-------ip~e 346 (524)
T KOG0601|consen 276 GNFSSVFKVSKRPEGDCIYAAKELLNGLA--TFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-------IPLE 346 (524)
T ss_pred CccccceeeeecCCCCceEeChhhhcccc--chHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-------Cchh
Confidence 432221 25777899999986543 45589999999999999988776654 3333322211 0101
Q ss_pred CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 149 DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 149 ~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
.....+..+...+..|+..+|..|++++.+++|+++..
T Consensus 347 ~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 347 FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred hhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 11246667777999999999999999999999999864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.7e-12 Score=103.13 Aligned_cols=66 Identities=24% Similarity=0.345 Sum_probs=56.3
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSS 74 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~ 74 (262)
|||++|++|.+.... .....++.+++.++.++|+.|++||||||+||+++.++ .++|+|||++...
T Consensus 110 ~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~--~~~liDfg~~~~~ 175 (198)
T cd05144 110 MEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE--KIYIIDWPQMVST 175 (198)
T ss_pred EEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC--cEEEEECCccccC
Confidence 799999998765421 35678899999999999999999999999999998765 8999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.28 E-value=4e-12 Score=102.82 Aligned_cols=63 Identities=27% Similarity=0.394 Sum_probs=55.7
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS 73 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (262)
|||++|++|.+.+..... .++.|++.+|.+||+.|++|||++|.||+++ ++ .++++|||+++.
T Consensus 76 ~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~--~~~liDfg~a~~ 138 (199)
T TIGR03724 76 MEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DD--KLYLIDFGLGKY 138 (199)
T ss_pred EEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CC--cEEEEECCCCcC
Confidence 799999999998765421 8899999999999999999999999999998 44 799999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.24 E-value=8.9e-12 Score=115.68 Aligned_cols=62 Identities=27% Similarity=0.386 Sum_probs=55.6
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS 73 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (262)
|||++|++|.+++. ....++.|++.+|.+||+.|++||||||+||+++ ++ .++|+|||+++.
T Consensus 415 ~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~--~~~liDFGla~~ 476 (535)
T PRK09605 415 MEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD--RLYLIDFGLGKY 476 (535)
T ss_pred EEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC--cEEEEeCccccc
Confidence 79999999999885 3577999999999999999999999999999994 33 799999999874
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.22 E-value=4.8e-12 Score=115.78 Aligned_cols=159 Identities=16% Similarity=0.282 Sum_probs=112.9
Q ss_pred HHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC----------CCccccCCCCCCc
Q 024809 24 ARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ----------PKSTVGTPAYIAP 92 (262)
Q Consensus 24 ~~~~~~ql~~aL~~LH~-~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~----------~~~~~gt~~y~aP 92 (262)
...=+.+++.|+.|+|. .++||++|.|++|.++.++ ..||+.|+.+........ .....-...|.||
T Consensus 101 ~f~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~--~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~ap 178 (700)
T KOG2137|consen 101 GFANLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANG--DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAP 178 (700)
T ss_pred hhhhhhcccchhhhhccCcceeecccchhheeeccCc--ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccc
Confidence 33345667799999996 5899999999999998877 899999998754322111 0012245579999
Q ss_pred ccccCCcCCCCchhHHHHHHHHHHHH-hCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHHHHHhcccCCCC
Q 024809 93 EVLTKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEK 171 (262)
Q Consensus 93 E~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~ 171 (262)
|++.... .+.++|++|+||++|.+. .|+.-+........+............... ..+++++++=+.++|..++..
T Consensus 179 E~~~~~~-~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s--~~~p~el~~~l~k~l~~~~~~ 255 (700)
T KOG2137|consen 179 EYLLGTT-NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYS--NNLPSELRESLKKLLNGDSAV 255 (700)
T ss_pred hhhcccc-ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccccccccc--ccCcHHHHHHHHHHhcCCccc
Confidence 9998744 455589999999999998 566555544333222222111111111222 478999999999999999999
Q ss_pred CCCHhHHhcCcccccc
Q 024809 172 RITIPEIKNHPWFLRN 187 (262)
Q Consensus 172 R~s~~e~l~hp~~~~~ 187 (262)
||++..++..|||...
T Consensus 256 rp~~~~l~~~~ff~D~ 271 (700)
T KOG2137|consen 256 RPTLDLLLSIPFFSDP 271 (700)
T ss_pred CcchhhhhcccccCCc
Confidence 9999999999999754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.1e-11 Score=111.67 Aligned_cols=172 Identities=21% Similarity=0.235 Sum_probs=123.5
Q ss_pred CCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCCC
Q 024809 2 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK 81 (262)
Q Consensus 2 E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~~ 81 (262)
|||+||++...+.-...+.+...+.+..|++.++.++|+..++|+|+||.||++..++ ...+++|||.++.... ...
T Consensus 346 e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~-~~~~~~~~~~~t~~~~--~~~ 422 (524)
T KOG0601|consen 346 EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG-FFSKLGDFGCWTRLAF--SSG 422 (524)
T ss_pred hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch-hhhhccccccccccce--ecc
Confidence 8999999887775555689999999999999999999999999999999999998754 3678999998864211 111
Q ss_pred ccccCCCCC-CcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHH
Q 024809 82 STVGTPAYI-APEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 160 (262)
Q Consensus 82 ~~~gt~~y~-aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 160 (262)
.....-.++ ..|++........++|++|||.-+.+..++...-....... .+... ..|.......++..+
T Consensus 423 ~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~-------~i~~~--~~p~~~~~~~~~q~~ 493 (524)
T KOG0601|consen 423 VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL-------TIRSG--DTPNLPGLKLQLQVL 493 (524)
T ss_pred cccccccccccchhhccccccccccccccccccccccccCcccCcccccce-------eeecc--cccCCCchHHhhhhh
Confidence 222333344 24444443333444899999999999999865433322211 12222 123333455788899
Q ss_pred HHHhcccCCCCCCCHhHHhcCcccc
Q 024809 161 LSRIFVANSEKRITIPEIKNHPWFL 185 (262)
Q Consensus 161 i~~~L~~dp~~R~s~~e~l~hp~~~ 185 (262)
.+.+...++..|+.+.++..|+-|.
T Consensus 494 ~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 494 LKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhcCCccccchhhhhhcccchhh
Confidence 9999999999999999998887654
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.9e-11 Score=96.76 Aligned_cols=69 Identities=20% Similarity=0.301 Sum_probs=53.9
Q ss_pred CCCCCCCchHHH-HHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCcEEEeccCCCcCC
Q 024809 1 MEYAAGGELFER-ICNAGRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSS 74 (262)
Q Consensus 1 mE~~~gg~L~~~-i~~~~~l~e~~~~~~~~ql~~aL~~LH~-~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~ 74 (262)
|||++||++... +... ... ..++.++.+++.++.++|+ .||+||||||+||+++ ++ .++|+|||.+...
T Consensus 94 ~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~--~~~liDfg~a~~~ 164 (187)
T cd05119 94 MEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG--KVYIIDVPQAVEI 164 (187)
T ss_pred EEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC--cEEEEECcccccc
Confidence 688888544321 2111 111 6788999999999999999 9999999999999998 44 7999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.7e-10 Score=91.63 Aligned_cols=70 Identities=17% Similarity=0.245 Sum_probs=56.0
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS 73 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~L-H~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (262)
|||+.|+.+..-..+...++++.+..++.|++.+|..| |+.|+||+||++.||+++.+ .++|+|||.+..
T Consensus 103 ME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~~~---~v~iIDF~qav~ 173 (197)
T cd05146 103 MSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWHDG---KVWFIDVSQSVE 173 (197)
T ss_pred EEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEECC---cEEEEECCCcee
Confidence 89997755533222333567778888999999999998 89999999999999999743 699999998864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.1e-08 Score=89.59 Aligned_cols=157 Identities=17% Similarity=0.174 Sum_probs=108.2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCCCccccCCCCCCcccccC
Q 024809 18 RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTK 97 (262)
Q Consensus 18 ~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~ 97 (262)
.+....+.+.++.|+.+..-||..|.+-+|+.++|+|+++.+ .|.|.|-..-............+|...|.+||...-
T Consensus 113 ~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~--~V~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~ 190 (637)
T COG4248 113 HCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDS--KVVLVDSDSFQINANGTLHLCPVGVSEFTPPELQTL 190 (637)
T ss_pred ccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCc--eEEEEcccceeeccCCceEecccCccccCCHHHhcc
Confidence 367889999999999999999999999999999999998777 788887432221122223345679999999998752
Q ss_pred -----CcCCCCchhHHHHHHHHHHHHhC-CCCCCCCCC----hhHHHHHhc--------c---cccccccCCCcccCCHH
Q 024809 98 -----KEYDGKIADVWSCGVTLYVMLVG-AYPFEDPED----PKNFRKTIG--------R---ILSVHYSFPDYVRVSLE 156 (262)
Q Consensus 98 -----~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~----~~~~~~~~~--------~---~~~~~~~~~~~~~~~~~ 156 (262)
-..+.. .|.|.||+++++++.| +.||.+... +..+..-+. + -.......+.+.-++++
T Consensus 191 ~sf~g~~r~~~-hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~ 269 (637)
T COG4248 191 PSFVGFERTAN-HDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPD 269 (637)
T ss_pred ccccccCCCcc-ccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHH
Confidence 223333 7999999999999886 999976321 111111100 0 00011111233457899
Q ss_pred HHHHHHHhcccC--CCCCCCHhH
Q 024809 157 CKHLLSRIFVAN--SEKRITIPE 177 (262)
Q Consensus 157 ~~~li~~~L~~d--p~~R~s~~e 177 (262)
+..|..+|++.- +.-|||++-
T Consensus 270 vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 270 VQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred HHHHHHHHhcccCCCCCCCCHHH
Confidence 999999999864 568999853
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.8e-09 Score=82.31 Aligned_cols=63 Identities=33% Similarity=0.481 Sum_probs=53.0
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc---CCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM---QICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~---~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
|||+.|+++..+ +......++.+++.+|.+||.. +++|+|++|.||+++..+ .++++|||.++
T Consensus 72 ~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~--~~~l~Df~~~~ 137 (155)
T cd05120 72 MEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK--ILGIIDWEYAG 137 (155)
T ss_pred EEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc--EEEEEeccccc
Confidence 577877776544 5567788899999999999984 799999999999998754 89999999876
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.83 E-value=5.6e-09 Score=82.05 Aligned_cols=63 Identities=30% Similarity=0.422 Sum_probs=51.8
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS 73 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (262)
|||++|-.|.+++... . ..++..+=.-+.-||.+||+|+||.++||++..+ .+.++|||++..
T Consensus 78 me~I~G~~lkd~l~~~---~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~---~i~~IDfGLg~~ 140 (204)
T COG3642 78 MEYIEGELLKDALEEA---R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG---RIYFIDFGLGEF 140 (204)
T ss_pred EEEeCChhHHHHHHhc---c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC---cEEEEECCcccc
Confidence 8999998888888766 2 4455666666777999999999999999999754 489999999873
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.4e-08 Score=85.82 Aligned_cols=72 Identities=18% Similarity=0.176 Sum_probs=60.2
Q ss_pred CCCCCCC-chHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-----CCCCcEEEeccCCCc
Q 024809 1 MEYAAGG-ELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG-----STAPRVKICDFGYSK 72 (262)
Q Consensus 1 mE~~~gg-~L~~~i~~--~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~-----~~~~~~kl~Dfg~a~ 72 (262)
||+++|- +|.+++.. ....++.....++.+++..+.-||.+||+|+|+++.|||++. ++...+.|+||+.+.
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 5788875 78888864 335677888899999999999999999999999999999974 234479999999775
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.81 E-value=6.3e-09 Score=94.12 Aligned_cols=69 Identities=17% Similarity=0.170 Sum_probs=54.0
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLIS-GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSS 74 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~-aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~ 74 (262)
|||++|++|.+..... ...+ ...++.+++. .+..+|..|++|+|+||.||+++.++ +++++|||++...
T Consensus 237 mE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g--~i~liDfG~~~~l 307 (437)
T TIGR01982 237 MEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDG--KIIALDFGIVGRL 307 (437)
T ss_pred EEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCC--cEEEEeCCCeeEC
Confidence 8999999998876532 1222 3445566655 47889999999999999999998776 8999999998754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.74 E-value=8.5e-09 Score=80.92 Aligned_cols=61 Identities=28% Similarity=0.438 Sum_probs=48.8
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCC-----eecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQI-----CHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~i-----vHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
|||++|.++... ......++.+++.+|..||+.++ +|+|++|.||+++ ++ .++++|||.+.
T Consensus 70 ~e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~--~~~liDf~~a~ 135 (170)
T cd05151 70 TEFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG--RLWLIDWEYAG 135 (170)
T ss_pred EEecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC--eEEEEeccccc
Confidence 688998887543 11124567899999999999885 9999999999998 33 69999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.69 E-value=3.9e-08 Score=80.16 Aligned_cols=73 Identities=21% Similarity=0.257 Sum_probs=62.0
Q ss_pred CCCCCCC-chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCcEEEeccCCCcC
Q 024809 1 MEYAAGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-APRVKICDFGYSKS 73 (262)
Q Consensus 1 mE~~~gg-~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~-~~~~kl~Dfg~a~~ 73 (262)
+|+++|- +|.+++......+......++.++...+.-||.+||+|+|+++.|||++.+. ...+.++||+.++.
T Consensus 96 te~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 96 TEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred EEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 4677774 7888888755578888999999999999999999999999999999997664 44789999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.65 E-value=5.6e-08 Score=76.36 Aligned_cols=73 Identities=22% Similarity=0.271 Sum_probs=57.6
Q ss_pred CCCCCC-CchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCC-cEEEeccCCCcC
Q 024809 1 MEYAAG-GELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAP-RVKICDFGYSKS 73 (262)
Q Consensus 1 mE~~~g-g~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~-~~kl~Dfg~a~~ 73 (262)
|||++| -++.+++.... .........++.++=+.+.-||.++|+|+||..+||++.+.+.. .+.++|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 899987 47788886543 23334447889999999999999999999999999999765543 348999999864
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.59 E-value=3.9e-08 Score=90.55 Aligned_cols=67 Identities=27% Similarity=0.349 Sum_probs=51.3
Q ss_pred CCCCCCCchHHH--HHhCC----CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC--CCcEEEeccCCCc
Q 024809 1 MEYAAGGELFER--ICNAG----RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST--APRVKICDFGYSK 72 (262)
Q Consensus 1 mE~~~gg~L~~~--i~~~~----~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~--~~~~kl~Dfg~a~ 72 (262)
||||+|+.|.++ +...+ .+.+..+..++.|++ ..|++|+|+||.||+++.++ .++++++|||++.
T Consensus 240 mE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg 312 (537)
T PRK04750 240 MERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVG 312 (537)
T ss_pred EeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEE
Confidence 899999999774 33433 355666666666665 48999999999999997654 3479999999987
Q ss_pred CC
Q 024809 73 SS 74 (262)
Q Consensus 73 ~~ 74 (262)
..
T Consensus 313 ~l 314 (537)
T PRK04750 313 SL 314 (537)
T ss_pred EC
Confidence 54
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=7.6e-07 Score=81.97 Aligned_cols=97 Identities=15% Similarity=0.292 Sum_probs=72.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHH-HcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC-CCccccCCCCCCccccc
Q 024809 19 FSEDEARFFFQQLISGVSYCH-SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLT 96 (262)
Q Consensus 19 l~e~~~~~~~~ql~~aL~~LH-~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~ 96 (262)
++...+..-++||+.||.||| +.+++|++|.-..|+++..+ ..||++|.++........ ......--.|..|+.+.
T Consensus 101 l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G--eWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~ 178 (690)
T KOG1243|consen 101 LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG--EWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEID 178 (690)
T ss_pred hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC--cEEEeeeEEEeccccCCcccccchhhhcccChhhcC
Confidence 347788889999999999998 57899999999999998877 899999988754332221 11122223466676654
Q ss_pred CCcCCCCchhHHHHHHHHHHHHhC
Q 024809 97 KKEYDGKIADVWSCGVTLYVMLVG 120 (262)
Q Consensus 97 ~~~~~~~~~DiwslG~il~~ll~g 120 (262)
.... ..|.|-|||++++++.|
T Consensus 179 ~s~~---s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 179 PSEW---SIDSWGLGCLIEELFNG 199 (690)
T ss_pred cccc---chhhhhHHHHHHHHhCc
Confidence 4332 26999999999999998
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.52 E-value=5.1e-08 Score=78.04 Aligned_cols=68 Identities=29% Similarity=0.405 Sum_probs=46.6
Q ss_pred CCCCC--CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcC
Q 024809 1 MEYAA--GGELFERICNAGRFSEDEARFFFQQLISGVSY-CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS 73 (262)
Q Consensus 1 mE~~~--gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~-LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (262)
|||++ |..+..+.... ++......++.+++..+.. +|+.||+|+||.+.||+++.+ .+.++|||.+..
T Consensus 85 ME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~---~~~iIDf~qav~ 155 (188)
T PF01163_consen 85 MEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG---KVYIIDFGQAVD 155 (188)
T ss_dssp EE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT---CEEE--GTTEEE
T ss_pred EEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc---eEEEEecCccee
Confidence 89998 65554433222 3355677788888885555 689999999999999999765 599999998763
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.43 E-value=2.3e-06 Score=83.25 Aligned_cols=169 Identities=24% Similarity=0.303 Sum_probs=119.6
Q ss_pred CCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCC---cEEecCCCCCcEEEe--ccCCCcCCCC
Q 024809 2 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLE---NTLLDGSTAPRVKIC--DFGYSKSSVL 76 (262)
Q Consensus 2 E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~---Nili~~~~~~~~kl~--Dfg~a~~~~~ 76 (262)
|||.+-++...+..-+.++.+.++.+..+++.||.|+|+....|.-+... +.-++ +.+.+..+ ||+.+.....
T Consensus 266 ~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~--~e~~~~~sl~~~~ss~~l~d 343 (1351)
T KOG1035|consen 266 EICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVD--GEGVVAISLSDFDSSKPLPD 343 (1351)
T ss_pred hhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccC--ccceeecchhhhcccccCCC
Confidence 68888999999999899999999999999999999999986655555444 22222 22355555 8888776655
Q ss_pred CCCCCccccCCCCCCcccccCCcCCCC-chhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 77 HSQPKSTVGTPAYIAPEVLTKKEYDGK-IADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 77 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
.........+..+.++|.......... ..|+|.+|..+..+..|..+-........ .. +. ....
T Consensus 344 ~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~~~-------~l------~~--~~~~ 408 (1351)
T KOG1035|consen 344 NEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVPVS-------LL------DV--LSTS 408 (1351)
T ss_pred cccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccchhh-------hh------cc--ccch
Confidence 444455556777888888766554322 25999999999999887544322111000 00 00 1111
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
...+++.+|+.-++++|+++.+++.|+|.+..
T Consensus 409 ~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 409 ELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred hhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 67889999999999999999999999998654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.28 E-value=7.9e-07 Score=72.35 Aligned_cols=61 Identities=23% Similarity=0.294 Sum_probs=48.3
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
|||++|-.|.+... +++ .+...+++++.-||+.|++|+|.+|.|++++.+ .++++||+..+
T Consensus 122 ~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~---~i~iID~~~k~ 182 (229)
T PF06176_consen 122 MEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN---GIRIIDTQGKR 182 (229)
T ss_pred EEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC---cEEEEECcccc
Confidence 79999988765532 333 244667788999999999999999999999855 49999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.07 E-value=3.4e-05 Score=69.58 Aligned_cols=133 Identities=17% Similarity=0.255 Sum_probs=94.0
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCCCccccCCCCCCcccccC
Q 024809 18 RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTK 97 (262)
Q Consensus 18 ~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~ 97 (262)
+++|..+|.++.||..||.++|+.|+.-+-|.|.+|++++.. +++|+..|......... + +.+..
T Consensus 389 ~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~--RIriS~C~i~Dvl~~d~------~-------~~le~ 453 (655)
T KOG3741|consen 389 KAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM--RIRISGCGIMDVLQEDP------T-------EPLES 453 (655)
T ss_pred CchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc--eEEEecccceeeecCCC------C-------cchhH
Confidence 588999999999999999999999999999999999998665 78888777654332211 1 12221
Q ss_pred CcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhH
Q 024809 98 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPE 177 (262)
Q Consensus 98 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e 177 (262)
. +.-|.-.||.++..|.||..--...+...... +..+ ...++.+++++|.-+...++.. -++.+
T Consensus 454 ~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~--~~~I---------~~~yS~D~rn~v~yl~s~~~~~-ksI~~ 517 (655)
T KOG3741|consen 454 Q----QQNDLRDLGLLLLALATGTENSNRTDSTQSSH--LTRI---------TTTYSTDLRNVVEYLESLNFRE-KSIQD 517 (655)
T ss_pred H----hhhhHHHHHHHHHHHhhcccccccccchHHHH--HHHh---------hhhhhHHHHHHHHHHHhcCccc-ccHHH
Confidence 1 22488899999999999853211111111110 1111 1257889999999999998887 67788
Q ss_pred HhcC
Q 024809 178 IKNH 181 (262)
Q Consensus 178 ~l~h 181 (262)
++.+
T Consensus 518 llp~ 521 (655)
T KOG3741|consen 518 LLPM 521 (655)
T ss_pred HHHH
Confidence 8765
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.06 E-value=1.4e-05 Score=64.89 Aligned_cols=66 Identities=9% Similarity=0.113 Sum_probs=55.1
Q ss_pred CchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 7 GELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 7 g~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
-||.+++... .+.++.....++.++...+.-||+.|+.|+|+-+.||+++.++...++++||.-++
T Consensus 111 ~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 111 ISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred ccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 3677777553 24678888999999999999999999999999999999986664459999998765
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=98.04 E-value=9.2e-07 Score=88.04 Aligned_cols=177 Identities=14% Similarity=0.105 Sum_probs=121.8
Q ss_pred CCCCCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHc-----CCeecCCCCCcEEecCCCCCcEEEeccCCC
Q 024809 1 MEYAAGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHSM-----QICHRDLKLENTLLDGSTAPRVKICDFGYS 71 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~----~l~e~~~~~~~~ql~~aL~~LH~~-----~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a 71 (262)
|+||.+|.++..|.+.- .+.+..+.....+.+.+..-+|+. -.+|+++|+.|.+|..+. +++++++|+.
T Consensus 1310 ~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny--~v~~gk~gLd 1387 (2724)
T KOG1826|consen 1310 SLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNY--NVKLGKGGLD 1387 (2724)
T ss_pred HHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCC--cccccccccc
Confidence 57899999999997642 355555665556658888888863 278999999999997666 8999999999
Q ss_pred c-CCCCCCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCc
Q 024809 72 K-SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDY 150 (262)
Q Consensus 72 ~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (262)
+ ............+++.|+.|+....-.++.+ +|+|..|+.+|..--|..+|.. ..+..++.+......+.-.
T Consensus 1388 KIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~r-sdilr~s~~ly~rs~~n~~fi~-----flq~~Lkgiidn~tf~sIe 1461 (2724)
T KOG1826|consen 1388 KIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKR-SDILRRSLSLYLRSDGNAYFIF-----FLQPALKGIIDNHTFFSIE 1461 (2724)
T ss_pred cccCchHhhhhhhhCCHHHHHHHHHHHHhhhhH-HHHHHHHHHHHHHhcccHHHHH-----HHHHHHcCccccccccccc
Confidence 8 3222233445678888999998877776655 8999999999999888777642 2223333332221111111
Q ss_pred ccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccc
Q 024809 151 VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFL 185 (262)
Q Consensus 151 ~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~ 185 (262)
.-.+.++......+|-++...||.-...+.-+.|.
T Consensus 1462 ~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1462 KLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred ccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 12344555666667777778889888888776663
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.01 E-value=5.8e-06 Score=67.42 Aligned_cols=71 Identities=25% Similarity=0.357 Sum_probs=53.8
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS---------------------------------------- 40 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~---------------------------------------- 40 (262)
|||++|+++.+.+.. ..+++.....++.+++++|..||+
T Consensus 79 ~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 79 MERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred EEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 678888887665432 347777888888888888888884
Q ss_pred ----------------cCCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 41 ----------------MQICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 41 ----------------~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
..++|+|++|.||+++.+..+.+.|+||+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 23589999999999987422267899998775
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.75 E-value=6.4e-05 Score=62.90 Aligned_cols=65 Identities=22% Similarity=0.310 Sum_probs=48.4
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
|||++|-.|...- ++.+....++..|+.-+.-+-..|+||+|+.+-||+++.++ .+.++||-.+.
T Consensus 186 Me~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg--~~~vIDwPQ~v 250 (304)
T COG0478 186 MEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDG--DIVVIDWPQAV 250 (304)
T ss_pred eehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCC--CEEEEeCcccc
Confidence 8999986664332 23445555566666655555589999999999999999877 79999997664
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.54 E-value=1.3e-05 Score=73.90 Aligned_cols=154 Identities=21% Similarity=0.187 Sum_probs=105.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCCCccccCCCCCCcccccCC
Q 024809 19 FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 98 (262)
Q Consensus 19 l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~ 98 (262)
+.+-+...+.+.-.++|+++|+.-=+||| ||+...+ ..++++|+...........++..+++.++|||+....
T Consensus 333 ~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~---~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~ 405 (829)
T KOG0576|consen 333 LEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEE---EVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQEN 405 (829)
T ss_pred hhhhhhhhhhhhhcccccccccccccCcc----ccccccc---ccccccccCCcccCcccccccCCCCCCCCCchhhccc
Confidence 44456666777778999999998778998 8887654 5799999998876655567788999999999999888
Q ss_pred cCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccc--ccCCCcccCCHHH-HHHHHHhcccCCCCCCCH
Q 024809 99 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH--YSFPDYVRVSLEC-KHLLSRIFVANSEKRITI 175 (262)
Q Consensus 99 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~-~~li~~~L~~dp~~R~s~ 175 (262)
.+... .|.|++|+--.+|--|..|-.... .. ...+.... ...-.....++.. +++...|+..-|..|+..
T Consensus 406 ~~~~~-p~~~~~~~~~~~~ap~~pPr~~P~--~~----~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~ 478 (829)
T KOG0576|consen 406 TIDGC-PDSGSLAVSAIQMAPGLPPRSSPP--AV----LPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVH 478 (829)
T ss_pred ccccC-CCccCCCcchhhcCCCCCCCCCCc--cc----cCCCCCCCCccccchhhhcCcccccCCcccccCCCCCCCcch
Confidence 88777 699999987677766666543211 00 00000000 0000000111112 247788999999999999
Q ss_pred hHHhcCccccc
Q 024809 176 PEIKNHPWFLR 186 (262)
Q Consensus 176 ~e~l~hp~~~~ 186 (262)
..++-|.+|..
T Consensus 479 mgacfsKvfng 489 (829)
T KOG0576|consen 479 MGACFSKVFNG 489 (829)
T ss_pred hhHHHHHHhcc
Confidence 99998888853
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.00061 Score=62.80 Aligned_cols=70 Identities=17% Similarity=0.189 Sum_probs=50.1
Q ss_pred CCCCCCCchHHHH--HhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCC
Q 024809 1 MEYAAGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV 75 (262)
Q Consensus 1 mE~~~gg~L~~~i--~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~ 75 (262)
|||++|-.+.+.. .. .+++.+.+.....++. +..+=..|+.|.|.+|.||+++.++ ++.+.|||+.....
T Consensus 245 mE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dgffHaDpHpGNi~v~~~g--~i~~lDfGi~g~l~ 316 (517)
T COG0661 245 MEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDGFFHADPHPGNILVRSDG--RIVLLDFGIVGRLD 316 (517)
T ss_pred EEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcCccccCCCccceEEecCC--cEEEEcCcceecCC
Confidence 8999999888874 44 3466444443333332 2233348999999999999998876 89999999987543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.00048 Score=57.07 Aligned_cols=52 Identities=17% Similarity=0.205 Sum_probs=43.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCcEEEeccCCCcC
Q 024809 19 FSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSTAPRVKICDFGYSKS 73 (262)
Q Consensus 19 l~e~~~~~~~~ql~~aL~~LH~-~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (262)
+...++..+..++++.+.-|-. .|+||+||+.-|||+.. + .+.++|||.|..
T Consensus 163 ~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~~-~--~p~iID~~QaV~ 215 (268)
T COG1718 163 LELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVHD-G--EPYIIDVSQAVT 215 (268)
T ss_pred cCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEEC-C--eEEEEECccccc
Confidence 4444788889999999988877 89999999999999973 3 689999998863
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0012 Score=60.98 Aligned_cols=71 Identities=17% Similarity=0.151 Sum_probs=51.9
Q ss_pred CCCCCCCchHH--HHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC--CCCcEEEeccCCCcCC
Q 024809 1 MEYAAGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS--TAPRVKICDFGYSKSS 74 (262)
Q Consensus 1 mE~~~gg~L~~--~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~--~~~~~kl~Dfg~a~~~ 74 (262)
||||+|..+.+ .|.+. +++...+...+.+... +.|=..|++|+|=+|.||++..+ +...+.+-|||+....
T Consensus 281 ME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~~~--~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 281 MEYVDGIKINDLDAIDKR-GISPHDILNKLVEAYL--EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred EEecCCccCCCHHHHHHc-CCCHHHHHHHHHHHHH--HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 89999988755 45555 4777765555555443 33446789999999999999853 3458999999998754
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.0071 Score=48.47 Aligned_cols=53 Identities=13% Similarity=0.029 Sum_probs=46.7
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHH---cCCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 18 RFSEDEARFFFQQLISGVSYCHS---MQICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 18 ~l~e~~~~~~~~ql~~aL~~LH~---~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
.-++....+++.+++..+++++. ..+.-.|++|+|+-++.++ ++|++|...+.
T Consensus 55 ~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~--~lk~iDld~v~ 110 (188)
T PF12260_consen 55 QSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDG--RLKLIDLDDVF 110 (188)
T ss_pred ccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCC--cEEEEechhcc
Confidence 35799999999999999999998 4588899999999998776 89999998664
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=95.97 E-value=0.023 Score=46.92 Aligned_cols=28 Identities=21% Similarity=0.291 Sum_probs=23.5
Q ss_pred CCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 42 QICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 42 ~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
.++|+|+.|.||+++.++ +.++||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~~~---~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG---TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcCCC---cEEEechhcC
Confidence 478999999999997543 7899998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=95.25 E-value=0.021 Score=47.29 Aligned_cols=30 Identities=27% Similarity=0.293 Sum_probs=24.1
Q ss_pred cCCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 41 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 41 ~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
.+++|+|+.|.||+++.+. ..-|+||+.+.
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~--i~giIDw~~a~ 193 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGR--LSAVIDFGCLG 193 (235)
T ss_pred ceEEeCCCCCCcEEEECCC--EEEEEeCcccC
Confidence 4589999999999997543 34699999764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.15 E-value=0.048 Score=46.92 Aligned_cols=29 Identities=34% Similarity=0.665 Sum_probs=24.4
Q ss_pred cCCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 41 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 41 ~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
.+++|+|+.+.||+++. + .+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~--~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-N--EVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-C--cEEEEECcccc
Confidence 57899999999999976 3 58899998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.14 E-value=0.023 Score=49.26 Aligned_cols=38 Identities=26% Similarity=0.235 Sum_probs=27.7
Q ss_pred HHHHHHHHHHHHHHHHHH----HcCCeecCCCCCcEEecCCC
Q 024809 22 DEARFFFQQLISGVSYCH----SMQICHRDLKLENTLLDGST 59 (262)
Q Consensus 22 ~~~~~~~~ql~~aL~~LH----~~~ivHrDlkp~Nili~~~~ 59 (262)
+-++.++.|++.-.-.+- ..+++|-||||.|||+-++.
T Consensus 279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~ 320 (444)
T PHA03111 279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSD 320 (444)
T ss_pred HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCC
Confidence 457778888876553342 35799999999999995544
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.12 E-value=0.04 Score=47.56 Aligned_cols=30 Identities=30% Similarity=0.467 Sum_probs=25.5
Q ss_pred cCCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 41 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 41 ~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
.+++|+|+++.||+++.++ .+.|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~--~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDS--VKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCc--eEEEeeccccc
Confidence 6899999999999998765 46899998764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.08 E-value=0.026 Score=46.48 Aligned_cols=30 Identities=30% Similarity=0.607 Sum_probs=25.2
Q ss_pred cCCeecCCCCCcEEecC-CCCCcEEEeccCCCc
Q 024809 41 MQICHRDLKLENTLLDG-STAPRVKICDFGYSK 72 (262)
Q Consensus 41 ~~ivHrDlkp~Nili~~-~~~~~~kl~Dfg~a~ 72 (262)
.+++|+|+.+.|||++. ++ .+.++||..|.
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~--~~~lIDwe~a~ 200 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKN--SVKFIDYEYAG 200 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCC--CEEEEEcccCC
Confidence 46999999999999986 23 69999998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=95.02 E-value=0.1 Score=42.19 Aligned_cols=56 Identities=21% Similarity=0.246 Sum_probs=39.2
Q ss_pred CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCC--cEEEec
Q 024809 7 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAP--RVKICD 67 (262)
Q Consensus 7 g~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~--~~kl~D 67 (262)
-+|.+++.+. .+++ .+...+. .-..||-.++|+.+|++|.||++.....+ .+.|+|
T Consensus 108 ~TL~~~l~~~-~~~~-~~~~~L~---~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 108 PTLEDYLKEG-GLTE-ELRQALD---EFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred ccHHHHHHcC-CccH-HHHHHHH---HHHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEe
Confidence 3677787554 4766 4444444 44467778999999999999999655543 467777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.99 E-value=0.054 Score=46.93 Aligned_cols=30 Identities=27% Similarity=0.409 Sum_probs=24.7
Q ss_pred cCCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 41 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 41 ~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
.+++|+|++|.||+++.+. ..-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~--~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDR--LSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCc--eEEEEeccccc
Confidence 4899999999999997543 34799998764
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=94.98 E-value=0.024 Score=49.37 Aligned_cols=52 Identities=29% Similarity=0.392 Sum_probs=33.4
Q ss_pred HHHHHHHHHHHHHHHHH----HHcCCeecCCCCCcEEecCCCCC----------------cEEEeccCCCcC
Q 024809 22 DEARFFFQQLISGVSYC----HSMQICHRDLKLENTLLDGSTAP----------------RVKICDFGYSKS 73 (262)
Q Consensus 22 ~~~~~~~~ql~~aL~~L----H~~~ivHrDlkp~Nili~~~~~~----------------~~kl~Dfg~a~~ 73 (262)
+-++.++.|++.-.--+ -..+++|-||||.|||+-++... .++|.||.+|+.
T Consensus 275 ~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv 346 (434)
T PF05445_consen 275 EYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQV 346 (434)
T ss_pred HHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHh
Confidence 35666677775433112 14579999999999999544321 346777777653
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.82 E-value=0.062 Score=46.15 Aligned_cols=29 Identities=34% Similarity=0.649 Sum_probs=24.8
Q ss_pred CCeecCCCCCcEEecCC----CCCcEEEeccCCCc
Q 024809 42 QICHRDLKLENTLLDGS----TAPRVKICDFGYSK 72 (262)
Q Consensus 42 ~ivHrDlkp~Nili~~~----~~~~~kl~Dfg~a~ 72 (262)
.++|+|+.|.||+++.+ + .++++||..|.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~--~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETK--KLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCC--cEEEEeeCCCC
Confidence 58999999999999863 4 79999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=94.53 E-value=0.1 Score=42.06 Aligned_cols=32 Identities=25% Similarity=0.299 Sum_probs=25.7
Q ss_pred cCCeecCCCCCcEEecCCCCC---cEEEeccCCCc
Q 024809 41 MQICHRDLKLENTLLDGSTAP---RVKICDFGYSK 72 (262)
Q Consensus 41 ~~ivHrDlkp~Nili~~~~~~---~~kl~Dfg~a~ 72 (262)
..++|||+.+.||++..++.+ .+.+.||..++
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 468999999999999754432 58899998775
|
subfamily of choline kinases |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=94.41 E-value=0.071 Score=45.57 Aligned_cols=30 Identities=30% Similarity=0.455 Sum_probs=24.9
Q ss_pred cCCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 41 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 41 ~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
.+++|+|+.|.||+++.++ .+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~--~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDE--LSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCc--eEEEeehhhhc
Confidence 4799999999999998654 45799998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=94.29 E-value=0.046 Score=47.47 Aligned_cols=44 Identities=14% Similarity=0.269 Sum_probs=34.7
Q ss_pred HHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCC
Q 024809 26 FFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYS 71 (262)
Q Consensus 26 ~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a 71 (262)
.+...+..-+--|..+|+||+|..-=||+++.++ .++++||-..
T Consensus 206 ~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~--~i~vIDFPQm 249 (465)
T KOG2268|consen 206 TLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDD--KIVVIDFPQM 249 (465)
T ss_pred HHHHHHHHHHHHHHHcCceecccchheeEEecCC--CEEEeechHh
Confidence 3444455555667889999999999999998766 8999999654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=94.23 E-value=0.028 Score=45.72 Aligned_cols=30 Identities=33% Similarity=0.448 Sum_probs=19.8
Q ss_pred cCCeecCCCCCcEEec-CCCCCcEEEeccCCCc
Q 024809 41 MQICHRDLKLENTLLD-GSTAPRVKICDFGYSK 72 (262)
Q Consensus 41 ~~ivHrDlkp~Nili~-~~~~~~~kl~Dfg~a~ 72 (262)
..++|+|+.|.||+++ .++ .+.|+||+.+.
T Consensus 166 ~~~~HgD~~~~Nil~~~~~~--~i~iID~e~a~ 196 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVDPSDG--RIGIIDFEDAG 196 (239)
T ss_dssp EEEE-SS-SGGGEEEESSTT--EEEE--GTT-E
T ss_pred cEEEEeccccccceeeeccc--eeEEEecccce
Confidence 5699999999999998 333 56799998664
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=93.78 E-value=0.11 Score=44.09 Aligned_cols=51 Identities=22% Similarity=0.279 Sum_probs=38.6
Q ss_pred CHHHHHHHHHHHHHHHHHHHHc--CCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 20 SEDEARFFFQQLISGVSYCHSM--QICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 20 ~e~~~~~~~~ql~~aL~~LH~~--~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
+...+...+..+-.++.-.+.. -++|+|+.|.|++.++.+ .++|+||..|.
T Consensus 130 ~~~~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~--~l~LIDWEyAg 182 (269)
T COG0510 130 DNHLLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKG--GLFLIDWEYAG 182 (269)
T ss_pred hhHHHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCC--cEEEEecccCC
Confidence 3445555666666666666655 589999999999998745 79999998764
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=93.69 E-value=0.1 Score=42.21 Aligned_cols=40 Identities=28% Similarity=0.329 Sum_probs=33.3
Q ss_pred HHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCC
Q 024809 25 RFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYS 71 (262)
Q Consensus 25 ~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a 71 (262)
..-+.+|++-+..+|..||+-+|+++.|.. ++ +|+|||.+
T Consensus 167 ~~~~~~~~~dl~~~~k~gI~~~Dv~~~ny~---~G----~lvDfs~~ 206 (207)
T PF13095_consen 167 IRDIPQMLRDLKILHKLGIVPRDVKPRNYR---GG----KLVDFSSS 206 (207)
T ss_pred hhHHHHHHHHHHHHHHCCeeeccCcccccc---CC----EEEecccC
Confidence 344667888888999999999999999987 34 89999864
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.42 E-value=0.073 Score=42.56 Aligned_cols=28 Identities=21% Similarity=0.373 Sum_probs=23.7
Q ss_pred CCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 42 QICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 42 ~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
-.+|+|+.|.||+++.+ .++|+||+.|.
T Consensus 78 ~p~H~D~~~~N~~~~~~---~~~lIDwe~a~ 105 (188)
T PRK10271 78 APLHMDVHAGNLVHSAS---GLRLIDWEYAG 105 (188)
T ss_pred eeecCCCCCccEEEECC---CEEEEeCCccc
Confidence 36899999999999755 38999999875
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=93.15 E-value=0.074 Score=44.12 Aligned_cols=30 Identities=23% Similarity=0.306 Sum_probs=24.8
Q ss_pred cCCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 41 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 41 ~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
..++|+|+.|.||+++.+. .+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~--~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGK--FSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCc--EEEEEEccccc
Confidence 3489999999999998754 56899998664
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=93.07 E-value=0.12 Score=45.44 Aligned_cols=31 Identities=32% Similarity=0.728 Sum_probs=25.1
Q ss_pred cCCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 41 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 41 ~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
..++|+|+++.||+++... +.+.++||..+.
T Consensus 200 ~~~cH~Dl~~~Nil~~~~~-~~~~lID~Eya~ 230 (344)
T PLN02236 200 IGFCHNDLQYGNIMIDEET-RAITIIDYEYAS 230 (344)
T ss_pred ceEEeCCCCcCcEEEeCCC-CcEEEEeehhcc
Confidence 3689999999999997532 269999998765
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=92.96 E-value=0.18 Score=44.54 Aligned_cols=50 Identities=32% Similarity=0.458 Sum_probs=42.7
Q ss_pred CHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 20 SEDEARFFFQQLISGVSYCHSM-QICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 20 ~e~~~~~~~~ql~~aL~~LH~~-~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
..+++..++.+.+..+.-+.++ .+-||++.-.||||+ .| +|.|+||-++|
T Consensus 319 ~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G--nvtLIDfklsR 369 (488)
T COG5072 319 RSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG--NVTLIDFKLSR 369 (488)
T ss_pred cHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC--ceEEEEeeeee
Confidence 4678888899988888777765 688999999999998 55 89999999998
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.60 E-value=0.35 Score=43.49 Aligned_cols=57 Identities=14% Similarity=0.078 Sum_probs=42.2
Q ss_pred CCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HcCCeecCCCCCcEEecCCC
Q 024809 2 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-SMQICHRDLKLENTLLDGST 59 (262)
Q Consensus 2 E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH-~~~ivHrDlkp~Nili~~~~ 59 (262)
+|..|-++..+++..+ .+|...+.++.-.++||--+- --+++|.|++|.||++..+.
T Consensus 325 ~~~~Gl~v~~~v~~~~-~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~ 382 (565)
T KOG1236|consen 325 TYERGLSVLRFVKWKS-QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNK 382 (565)
T ss_pred eccccccHHhhhhccc-ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecC
Confidence 4778888888886553 567777777777777765543 46899999999999995443
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=92.57 E-value=0.098 Score=43.81 Aligned_cols=28 Identities=21% Similarity=0.358 Sum_probs=24.1
Q ss_pred CCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 42 QICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 42 ~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
.++|+|+.|.||+++.++ +.|+||..|.
T Consensus 147 ~l~H~Dl~~~Nil~~~~~---~~lIDwE~a~ 174 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG---LKLIDWEYAS 174 (256)
T ss_pred eeecCCCCcCcEEEeCCC---CEEEeccccC
Confidence 589999999999997654 7899998775
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=92.47 E-value=0.22 Score=42.97 Aligned_cols=30 Identities=20% Similarity=0.265 Sum_probs=25.6
Q ss_pred cCCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 41 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 41 ~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
.+++|+|+.+.|++++.++ .+.++||..+.
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~--~~~iIDfd~~~ 225 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETR--GGYFINFEKAS 225 (309)
T ss_pred eeeeCCCCcHHhEEEcCCC--CEEEEEhhhcc
Confidence 3799999999999997766 68899998765
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=92.32 E-value=0.2 Score=40.61 Aligned_cols=30 Identities=37% Similarity=0.716 Sum_probs=19.2
Q ss_pred cCCeecCCCCCcEEe-cCCCCCcEEEeccCCCc
Q 024809 41 MQICHRDLKLENTLL-DGSTAPRVKICDFGYSK 72 (262)
Q Consensus 41 ~~ivHrDlkp~Nili-~~~~~~~~kl~Dfg~a~ 72 (262)
..+.|+|+.|.||++ +.++ .++++||..|.
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~--~~~lIDfEya~ 173 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDG--EVKLIDFEYAG 173 (211)
T ss_dssp EEEE-S--SGGGEEETSSSS--CEEE--GTT-E
T ss_pred ceEeeccCccccEEeccCCC--eEEEecHHHHh
Confidence 358899999999999 4444 79999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.14 E-value=0.23 Score=43.49 Aligned_cols=29 Identities=34% Similarity=0.457 Sum_probs=24.3
Q ss_pred CeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 43 ICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 43 ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
+||+|+.|.||+++.+.. .+.+.||+-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~-~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTD-VSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCC-eeeEEEccccc
Confidence 999999999999987652 36899998664
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.81 E-value=0.08 Score=48.67 Aligned_cols=83 Identities=13% Similarity=0.112 Sum_probs=55.6
Q ss_pred CchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccC-------CCcccCCHHHHHHHHHhcccCCCCCCCH
Q 024809 103 KIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF-------PDYVRVSLECKHLLSRIFVANSEKRITI 175 (262)
Q Consensus 103 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~~L~~dp~~R~s~ 175 (262)
+++||||+|.++.++.-|...|..-...+....+.+ ........ -....++.....+..+|+...|..||..
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k-~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~ 188 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLK-YYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLP 188 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHH-hccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccch
Confidence 468999999999999999877765444333222211 11000000 0011355567889999999999999999
Q ss_pred hHHhcCccccc
Q 024809 176 PEIKNHPWFLR 186 (262)
Q Consensus 176 ~e~l~hp~~~~ 186 (262)
.++..++-|..
T Consensus 189 ~~~~k~~i~~e 199 (725)
T KOG1093|consen 189 MELSKRCSFTE 199 (725)
T ss_pred hHHhcCccHHH
Confidence 99999988854
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=91.66 E-value=0.23 Score=49.88 Aligned_cols=33 Identities=24% Similarity=0.300 Sum_probs=25.6
Q ss_pred HcCCeecCCCCCcEEecCCCCCc---EEEeccCCCc
Q 024809 40 SMQICHRDLKLENTLLDGSTAPR---VKICDFGYSK 72 (262)
Q Consensus 40 ~~~ivHrDlkp~Nili~~~~~~~---~kl~Dfg~a~ 72 (262)
..++||+|+.+.||+++.+..+. .-|+|||-+.
T Consensus 207 ~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~ 242 (972)
T PRK06149 207 PLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLV 242 (972)
T ss_pred cccccCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence 36899999999999998653222 3699999764
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=91.56 E-value=0.29 Score=49.40 Aligned_cols=33 Identities=30% Similarity=0.475 Sum_probs=26.3
Q ss_pred cCCeecCCCCCcEEecCCCCCcEE-EeccCCCcC
Q 024809 41 MQICHRDLKLENTLLDGSTAPRVK-ICDFGYSKS 73 (262)
Q Consensus 41 ~~ivHrDlkp~Nili~~~~~~~~k-l~Dfg~a~~ 73 (262)
.++||+|+.+.|||++.+...++. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 579999999999999866433455 999998753
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=91.24 E-value=0.17 Score=43.10 Aligned_cols=30 Identities=23% Similarity=0.350 Sum_probs=23.7
Q ss_pred CCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 42 QICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 42 ~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
.++|+|++|.||+++.++ ...-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~-~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDA-RVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCC-CEEEEECcHhcc
Confidence 489999999999998643 124699999775
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=91.17 E-value=0.36 Score=41.19 Aligned_cols=49 Identities=16% Similarity=0.287 Sum_probs=33.3
Q ss_pred HHHHHHHHHHHHHHHHH------cCCeecCCCCCcEEecCCCCC---cEEEeccCCCc
Q 024809 24 ARFFFQQLISGVSYCHS------MQICHRDLKLENTLLDGSTAP---RVKICDFGYSK 72 (262)
Q Consensus 24 ~~~~~~ql~~aL~~LH~------~~ivHrDlkp~Nili~~~~~~---~~kl~Dfg~a~ 72 (262)
+..+...+...+..+.. +-++|+|++..|||+..++.+ .+++.||..++
T Consensus 192 l~~~~~~~~~~~~~~~~~~~~~~~vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~ 249 (294)
T PF02958_consen 192 LEALLDKFFERMQELVDPSKEPFNVLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR 249 (294)
T ss_pred HHHHHHHHHHHHHHHhccccCCceEEEcCccCHHhEeEccccccccccceeecccccc
Confidence 34444445544444441 238999999999999766543 68999998765
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.19 E-value=0.92 Score=39.55 Aligned_cols=28 Identities=18% Similarity=0.196 Sum_probs=23.0
Q ss_pred cCCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 41 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 41 ~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
.+++|+|+.+.|||++ + .+.++||+-+.
T Consensus 196 ~~liHgD~h~~NvL~~-d---~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D---GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C---CcEEEeCCCCC
Confidence 4689999999999994 2 36789998664
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=88.62 E-value=0.93 Score=39.64 Aligned_cols=29 Identities=28% Similarity=0.489 Sum_probs=24.0
Q ss_pred CeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 43 ICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 43 ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
++|+|+.+.||+++.++ +.++++||..|.
T Consensus 184 ~CHnDl~~~NiL~~~~~-~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDE-GKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEeCCC-CcEEEEcccccC
Confidence 78999999999996432 279999998774
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=88.33 E-value=0.36 Score=41.94 Aligned_cols=31 Identities=16% Similarity=0.279 Sum_probs=26.6
Q ss_pred cCCeecCCCCCcEEecCCCCCcEEEeccCCCcC
Q 024809 41 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKS 73 (262)
Q Consensus 41 ~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (262)
-.++|+|+.+.|++++.+. .+=+.||+++..
T Consensus 198 ~~lvHGD~~~gNlii~~~~--~~gVlDwe~~~l 228 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGR--PTGVLDWELATL 228 (321)
T ss_pred ceeeeCCcccCCEEEeCCC--eeEEEecccccc
Confidence 3589999999999998776 488999998864
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=88.11 E-value=0.5 Score=39.04 Aligned_cols=37 Identities=24% Similarity=0.214 Sum_probs=30.8
Q ss_pred HHHHHHHHH--cCCeecCCCCCcEEecCCCCCcEEEeccCC
Q 024809 32 ISGVSYCHS--MQICHRDLKLENTLLDGSTAPRVKICDFGY 70 (262)
Q Consensus 32 ~~aL~~LH~--~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~ 70 (262)
+++|.-.|+ .+.+|+|..|+||+-+..+ .+||.|=+.
T Consensus 151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G--~lKlVDP~~ 189 (308)
T PF07387_consen 151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFG--YLKLVDPVC 189 (308)
T ss_pred HHHHHHhhccCCCeecCCCChhheeecCCC--CEEecChhh
Confidence 567888894 4699999999999998777 899998653
|
The function of this family is unknown. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=87.24 E-value=0.48 Score=42.60 Aligned_cols=29 Identities=17% Similarity=0.271 Sum_probs=24.4
Q ss_pred cCCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 41 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 41 ~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
..++|||+.+.||++..+ .++++||.++.
T Consensus 223 ~~l~HgDl~~gni~~~~~---~~~viD~E~a~ 251 (401)
T PRK09550 223 EALLHGDLHTGSIFVTEE---ETKVIDPEFAF 251 (401)
T ss_pred CceeeccCCcccEEeeCC---CcEEEeccccc
Confidence 469999999999999765 48999997664
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=84.33 E-value=1.7 Score=39.13 Aligned_cols=29 Identities=17% Similarity=0.310 Sum_probs=24.2
Q ss_pred cCCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 41 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 41 ~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
..++|+||+|.|||++.+ ..|++|..+|.
T Consensus 227 ~aLlHGDlHtGSI~v~~~---~~kvIDpEFAf 255 (409)
T PRK12396 227 QALIHGDLHTGSVFVKND---STKVIDPEFAF 255 (409)
T ss_pred hhhccCcCCCCCEEecCC---ceEEEcccccc
Confidence 459999999999999865 48999977664
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=84.24 E-value=0.67 Score=41.03 Aligned_cols=29 Identities=17% Similarity=0.265 Sum_probs=24.0
Q ss_pred cCCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 41 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 41 ~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
..++|+|+.+.||+++.+ .++++|+..+.
T Consensus 192 ~~llHGDl~~gNi~~~~~---~~~~iD~e~~~ 220 (370)
T TIGR01767 192 ETLLHGDLHSGSIFVSEH---ETKVIDPEFAF 220 (370)
T ss_pred ceeeeccCCcccEEEcCC---CCEEEcCcccc
Confidence 469999999999999754 47899997664
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=84.07 E-value=2.7 Score=33.50 Aligned_cols=62 Identities=23% Similarity=0.308 Sum_probs=41.5
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCC--CcEEecCCCCCcEEEeccCCCc
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKL--ENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp--~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
|||++|-+|.+.-... +-+. +..++.+---|-..||-|..|.- .||++..+ .+.|+||..|+
T Consensus 91 me~i~G~~L~~~~~~~---~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~---~~~iIDFd~At 154 (201)
T COG2112 91 MEYIDGRPLGKLEIGG---DRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDR---DVYIIDFDSAT 154 (201)
T ss_pred hhhhcCcchhhhhhcc---cHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecCC---cEEEEEccchh
Confidence 8999987876654322 2223 33455554456678999999975 46666533 68999998776
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 262 | ||||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-106 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-106 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-105 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-105 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-102 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-101 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-41 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-38 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-38 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-37 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-37 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-37 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-36 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-36 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-36 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-36 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-36 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-35 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-35 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-35 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-35 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-35 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-35 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-33 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 9e-33 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-32 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-31 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-30 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-30 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-30 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-30 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-30 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-30 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-30 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-30 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-30 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-30 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-30 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-30 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-30 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-30 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-30 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-29 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-29 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-28 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-28 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-28 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-28 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-28 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-28 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-28 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-28 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-28 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-28 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-28 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-28 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-28 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-27 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-27 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-27 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-27 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-27 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-27 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-27 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-27 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-27 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-27 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-27 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-27 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-27 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-27 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-27 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-27 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-27 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-27 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-27 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-27 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-27 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-27 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-27 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-27 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-27 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-27 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-27 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-27 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-27 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-27 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-27 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-27 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-27 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-27 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-27 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-27 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-27 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-27 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-27 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-27 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-27 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-27 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-27 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-27 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-27 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 9e-27 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-27 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-26 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-26 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-26 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-26 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-26 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-26 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-26 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-26 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-26 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-26 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-26 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-26 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-26 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-26 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-26 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-26 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-26 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-26 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-26 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-26 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-26 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-26 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-26 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-26 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 9e-26 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 9e-26 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-26 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-25 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-25 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-25 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-25 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-25 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-25 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-25 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-25 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-25 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-25 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-25 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-25 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-25 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-25 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-25 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-25 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-25 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-25 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-25 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-25 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-25 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-25 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-25 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-25 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-25 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-25 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-25 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-25 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-25 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-25 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-25 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-25 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-25 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-25 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-25 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-25 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-25 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-25 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-25 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-25 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-25 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-25 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-25 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-24 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-24 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-24 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-24 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-24 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-24 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-24 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-24 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-24 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-24 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-24 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-24 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-24 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-24 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-24 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-24 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-24 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-24 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-24 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-24 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-24 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-24 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-24 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-24 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-24 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-24 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-24 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-24 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-24 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-24 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-24 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-24 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-24 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-24 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-24 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-24 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-24 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-24 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-24 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-24 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-24 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-24 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-24 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-24 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-24 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-24 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-23 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-23 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-23 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-23 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-23 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-23 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-23 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-23 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-23 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-23 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-23 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-23 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-23 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-23 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-23 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-22 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-22 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-22 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-22 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-22 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-22 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-22 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-22 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-22 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-22 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-22 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-22 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-22 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-22 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-22 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-22 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-22 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-22 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-22 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-22 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-22 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-22 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-22 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-22 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-22 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-22 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-22 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-22 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-22 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-22 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 7e-22 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 7e-22 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-22 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 7e-22 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-21 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-21 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-21 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-21 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-21 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-21 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-21 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-21 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-21 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-21 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-21 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-21 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 7e-21 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-21 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-21 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-21 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-21 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-21 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-21 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-21 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-21 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-21 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-21 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-21 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-21 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-20 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-20 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-20 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-20 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-20 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-20 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-20 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-20 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-20 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-20 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-20 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-20 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-20 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-20 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-20 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-20 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-19 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-19 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-19 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-19 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-19 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-19 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-19 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-19 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-19 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-19 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-18 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-18 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-18 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-18 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-18 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-18 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-18 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-17 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-17 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-17 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-17 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-17 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-17 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-17 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-17 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-17 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-17 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 8e-17 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-16 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 9e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-15 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-14 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-14 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-14 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-14 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-13 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 8e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 8e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 9e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 9e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 9e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-11 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-11 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-11 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 9e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-11 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-11 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-10 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-10 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 7e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-09 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-09 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-09 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-09 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-09 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-09 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-09 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-09 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-09 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-09 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-09 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-09 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-09 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-09 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-09 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-09 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-09 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-09 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-09 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-09 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-09 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-09 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 8e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 9e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 9e-09 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 9e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-08 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-08 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-08 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 6e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 6e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-08 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-08 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 9e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 9e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-07 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-07 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-07 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-07 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-07 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-07 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-07 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-07 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-07 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-07 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-07 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-07 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-07 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-07 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-07 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-07 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-07 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-07 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-07 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-07 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-07 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-07 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-07 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-07 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-07 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-07 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-07 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-07 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-07 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-07 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-07 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-07 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-07 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 9e-07 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-06 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-06 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-06 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-06 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-06 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-06 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-06 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-06 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-06 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-06 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-06 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-06 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-06 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-06 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-06 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-06 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-06 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-06 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-06 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-06 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-06 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 7e-06 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-06 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-06 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-06 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-06 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-06 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-06 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-06 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-06 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-06 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 8e-06 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-06 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 9e-06 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-06 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-05 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-05 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-05 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-05 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-05 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-05 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-05 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-05 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-05 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-05 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-05 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-05 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-05 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-05 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-05 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-05 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-05 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-05 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-05 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-05 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-05 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-05 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-05 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-05 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-05 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-05 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-05 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-05 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-05 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 6e-05 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-05 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-05 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-05 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-04 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-04 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-04 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-04 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-04 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-04 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-04 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-04 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-04 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-04 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-04 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-04 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 2e-04 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-04 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-04 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-04 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-04 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-04 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-04 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-04 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-04 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-04 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 3e-04 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-04 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-04 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 3e-04 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-04 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 3e-04 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 3e-04 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-04 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-04 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-04 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-04 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-04 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-04 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-04 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-04 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-04 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-04 |
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 405 bits (1042), Expect = e-143
Identities = 183/267 (68%), Positives = 213/267 (79%), Gaps = 5/267 (1%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEYA+GGEL+ERICNAGRFSEDEARFFFQQL+SGVSYCHSMQICHRDLKLENTLLDGS A
Sbjct: 95 MEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPA 154
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
PR+KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL ++EYDGKIADVWSCGVTLYVMLVG
Sbjct: 155 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
AYPFEDPE+P+++RKTI RILSV YS PD +R+S EC HL+SRIFVA+ RI+IPEIK
Sbjct: 215 AYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274
Query: 181 HPWFLRNLPIELTEGGSW--QSHDVNNPSQSLEEVLSLIHEATKPLEAPRVGGHLLGSSM 238
H WFL+NLP +L + Q + P QSL+ ++ +I EAT P R + ++
Sbjct: 275 HSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIPAVRNRCLDDFMTDNL 334
Query: 239 ELDDLDADADLE---DTETSGDFVCPL 262
+LDD D D E D ++SG+ V L
Sbjct: 335 DLDDDMDDFDSESEIDIDSSGEIVYAL 361
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 313 bits (805), Expect = e-108
Identities = 73/234 (31%), Positives = 111/234 (47%), Gaps = 10/234 (4%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+EY +GGELF+RI E +A+ FF QL++GV Y H + I HRD+K EN LLD
Sbjct: 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-- 141
Query: 61 PRVKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVM 117
+KI DFG + +++ GT Y+APE+L ++E+ + DVWSCG+ L M
Sbjct: 142 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 201
Query: 118 LVGAYPFEDPEDP-KNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIP 176
L G P++ P D + + + ++ LL +I V N RITIP
Sbjct: 202 LAGELPWDQPSDSCQEYSD----WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIP 257
Query: 177 EIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHEATKPLEAPRVG 230
+IK W+ + L +PS + + S + + + G
Sbjct: 258 DIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASRTPG 311
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 304 bits (782), Expect = e-105
Identities = 69/196 (35%), Positives = 101/196 (51%), Gaps = 10/196 (5%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+EY +GGELF+RI E +A+ FF QL++GV Y H + I HRD+K EN LLD
Sbjct: 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-- 141
Query: 61 PRVKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVM 117
+KI DFG + +++ GT Y+APE+L ++E+ + DVWSCG+ L M
Sbjct: 142 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 201
Query: 118 LVGAYPFEDPEDP-KNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIP 176
L G P++ P D + + + ++ LL +I V N RITIP
Sbjct: 202 LAGELPWDQPSDSCQEYSD----WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIP 257
Query: 177 EIKNHPWFLRNLPIEL 192
+IK W+ + L
Sbjct: 258 DIKKDRWYNKPLKKGA 273
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 257 bits (660), Expect = 1e-86
Identities = 80/189 (42%), Positives = 106/189 (56%), Gaps = 8/189 (4%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY +GGELF+ IC GR E EAR FQQ++S V YCH + HRDLK EN LLD
Sbjct: 90 MEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHM- 148
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
KI DFG S +++ G+P Y APEV++ + Y G D+WSCGV LY +L G
Sbjct: 149 -NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCG 207
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
PF+D P F+K I + P+Y ++ LL + + KR TI +I+
Sbjct: 208 TLPFDDEHVPTLFKK----IRGGVFYIPEY--LNRSVATLLMHMLQVDPLKRATIKDIRE 261
Query: 181 HPWFLRNLP 189
H WF ++LP
Sbjct: 262 HEWFKQDLP 270
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 2e-84
Identities = 75/189 (39%), Positives = 103/189 (54%), Gaps = 8/189 (4%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEYA+GGE+F+ + GR E EAR F+Q++S V YCH +I HRDLK EN LLD
Sbjct: 93 MEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADM- 151
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
+KI DFG+S + + + G P Y APE+ K+YDG DVWS GV LY ++ G
Sbjct: 152 -NIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
+ PF+ + + +L Y P Y +S +C++LL R V N KR T+ +I
Sbjct: 211 SLPFDGQNLKELRER----VLRGKYRIPFY--MSTDCENLLKRFLVLNPIKRGTLEQIMK 264
Query: 181 HPWFLRNLP 189
W
Sbjct: 265 DRWINAGHE 273
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 252 bits (647), Expect = 3e-84
Identities = 77/193 (39%), Positives = 102/193 (52%), Gaps = 18/193 (9%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
E G + E + SED+ARF+FQ LI G+ Y H +I HRD+K N L+
Sbjct: 117 FELVNQGPVME-VPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDG- 174
Query: 61 PRVKICDFGYS-----KSSVLHSQPKSTVGTPAYIAPEVL--TKKEYDGKIADVWSCGVT 113
+KI DFG S ++L +TVGTPA++APE L T+K + GK DVW+ GVT
Sbjct: 175 -HIKIADFGVSNEFKGSDALLS----NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVT 229
Query: 114 LYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI 173
LY + G PF D K I S FPD ++ + K L++R+ N E RI
Sbjct: 230 LYCFVFGQCPFMDERIMCLHSK----IKSQALEFPDQPDIAEDLKDLITRMLDKNPESRI 285
Query: 174 TIPEIKNHPWFLR 186
+PEIK HPW R
Sbjct: 286 VVPEIKLHPWVTR 298
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 7e-84
Identities = 93/218 (42%), Positives = 124/218 (56%), Gaps = 11/218 (5%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+EYA GGELF+ I R +EDE R FFQQ+I + YCH +I HRDLK EN LLD +
Sbjct: 88 IEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNL- 145
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
VKI DFG S + K++ G+P Y APEV+ K Y G DVWSCG+ LYVMLVG
Sbjct: 146 -NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVG 204
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
PF+D P F+K + S Y PD+ +S + L+ R+ VA+ +RITI EI+
Sbjct: 205 RLPFDDEFIPNLFKK----VNSCVYVMPDF--LSPGAQSLIRRMIVADPMQRITIQEIRR 258
Query: 181 HPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIH 218
PWF NLP L Q ++ + + ++ +
Sbjct: 259 DPWFNVNLPDYLRPMEEVQGSYADS--RIVSKLGEAMG 294
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 256 bits (656), Expect = 2e-83
Identities = 84/218 (38%), Positives = 113/218 (51%), Gaps = 9/218 (4%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY +GGELF+ IC GR E E+R FQQ++SGV YCH + HRDLK EN LLD
Sbjct: 95 MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHM- 153
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
KI DFG S +++ G+P Y APEV++ + Y G D+WS GV LY +L G
Sbjct: 154 -NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCG 212
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
PF+D P F+K I + P Y ++ LL + + KR TI +I+
Sbjct: 213 TLPFDDDHVPTLFKK----ICDGIFYTPQY--LNPSVISLLKHMLQVDPMKRATIKDIRE 266
Query: 181 HPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIH 218
H WF ++LP L S + + L+EV
Sbjct: 267 HEWFKQDLPKYLFPEDPSYSSTMIDDEA-LKEVCEKFE 303
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 1e-82
Identities = 60/189 (31%), Positives = 99/189 (52%), Gaps = 10/189 (5%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+E+A GEL++ + GRF E + F ++L + YCH ++ HRD+K EN L+
Sbjct: 93 LEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKG- 151
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
+KI DFG+S + + ++ GT Y+ PE++ K +D K D+W GV Y LVG
Sbjct: 152 -ELKIADFGWSVHAP-SLRRRTMCGTLDYLPPEMIEGKTHDEK-VDLWCAGVLCYEFLVG 208
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
PF+ P + R+ I++V FP + +S K L+S++ + +R+ + +
Sbjct: 209 MPPFDSPSHTETHRR----IVNVDLKFPPF--LSDGSKDLISKLLRYHPPQRLPLKGVME 262
Query: 181 HPWFLRNLP 189
HPW N
Sbjct: 263 HPWVKANSR 271
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 2e-82
Identities = 65/194 (33%), Positives = 95/194 (48%), Gaps = 11/194 (5%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+E L E +E EAR++ +Q++ G Y H ++ HRDLKL N L+
Sbjct: 94 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL- 152
Query: 61 PRVKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
VKI DFG + + K + GTP YIAPEVL+KK + + DVWS G +Y +LV
Sbjct: 153 -EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLV 210
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIK 179
G PFE ++T RI YS P + ++ L+ ++ + R TI E+
Sbjct: 211 GKPPFET----SCLKETYLRIKKNEYSIPKH--INPVAASLIQKMLQTDPTARPTINELL 264
Query: 180 NHPWFLRN-LPIEL 192
N +F +P L
Sbjct: 265 NDEFFTSGYIPARL 278
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 3e-82
Identities = 64/198 (32%), Positives = 105/198 (53%), Gaps = 11/198 (5%)
Query: 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
+E GE+ + N FSE+EAR F Q+I+G+ Y HS I HRDL L N LL +
Sbjct: 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNM 149
Query: 60 APRVKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 118
+KI DFG + + + T+ GTP YI+PE+ T+ + + +DVWS G Y +L
Sbjct: 150 --NIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLE-SDVWSLGCMFYTLL 206
Query: 119 VGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEI 178
+G PF+ + T+ +++ Y P + +S+E K L+ ++ N R+++ +
Sbjct: 207 IGRPPFDT----DTVKNTLNKVVLADYEMPSF--LSIEAKDLIHQLLRRNPADRLSLSSV 260
Query: 179 KNHPWFLRNLPIELTEGG 196
+HP+ RN + + G
Sbjct: 261 LDHPFMSRNSSTKSKDEG 278
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 4e-82
Identities = 67/228 (29%), Positives = 99/228 (43%), Gaps = 17/228 (7%)
Query: 1 MEYAAGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
MEY G E+ + + RF +A +F QLI G+ Y HS I H+D+K N LL
Sbjct: 87 MEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTG 145
Query: 59 TAPRVKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLT-KKEYDGKIADVWSCGVTL 114
+KI G +++ + +++ G+PA+ PE+ + G D+WS GVTL
Sbjct: 146 G--TLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 203
Query: 115 YVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRIT 174
Y + G YPFE K F I Y+ P LL + KR +
Sbjct: 204 YNITTGLYPFEGDNIYKLFEN----IGKGSYAIPGD--CGPPLSDLLKGMLEYEPAKRFS 257
Query: 175 IPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSL--IHEA 220
I +I+ H WF + P S D + +S+ V L +H A
Sbjct: 258 IRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWRSMTVVPYLEDLHGA 305
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 7e-82
Identities = 64/189 (33%), Positives = 99/189 (52%), Gaps = 10/189 (5%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+EYA G ++ + +F E + +L + +SYCHS ++ HRD+K EN LL +
Sbjct: 88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG- 146
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
+KI DFG+S S+ GT Y+ PE++ + +D K D+WS GV Y LVG
Sbjct: 147 -ELKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVG 203
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
PFE +++T RI V ++FPD+ V+ + L+SR+ N +R + E+
Sbjct: 204 KPPFEA----NTYQETYKRISRVEFTFPDF--VTEGARDLISRLLKHNPSQRPMLREVLE 257
Query: 181 HPWFLRNLP 189
HPW N
Sbjct: 258 HPWITANSS 266
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 1e-81
Identities = 65/194 (33%), Positives = 95/194 (48%), Gaps = 11/194 (5%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+E L E +E EAR++ +Q++ G Y H ++ HRDLKL N L+
Sbjct: 120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL- 178
Query: 61 PRVKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
VKI DFG + + K + GTP YIAPEVL+KK + + DVWS G +Y +LV
Sbjct: 179 -EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLV 236
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIK 179
G PFE ++T RI YS P + ++ L+ ++ + R TI E+
Sbjct: 237 GKPPFET----SCLKETYLRIKKNEYSIPKH--INPVAASLIQKMLQTDPTARPTINELL 290
Query: 180 NHPWFLRN-LPIEL 192
N +F +P L
Sbjct: 291 NDEFFTSGYIPARL 304
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 5e-79
Identities = 68/199 (34%), Positives = 91/199 (45%), Gaps = 22/199 (11%)
Query: 1 MEYAAG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
+E +LF+ I G E+ AR FF Q++ V +CH+ + HRD+K EN L+D +
Sbjct: 127 LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR 186
Query: 60 APRVKICDFGYS---KSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYV 116
+K+ DFG K +V GT Y PE + Y G+ A VWS G+ LY
Sbjct: 187 G-ELKLIDFGSGALLKDTVYT----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYD 241
Query: 117 MLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIP 176
M+ G PFE E I+ F VS EC+HL+ R T
Sbjct: 242 MVCGDIPFEHDE----------EIIRGQVFFRQR--VSSECQHLIRWCLALRPSDRPTFE 289
Query: 177 EIKNHPWFLR-NLPIELTE 194
EI+NHPW LP E E
Sbjct: 290 EIQNHPWMQDVLLPQETAE 308
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 2e-78
Identities = 57/193 (29%), Positives = 82/193 (42%), Gaps = 21/193 (10%)
Query: 1 MEYAA-GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
+E +LF+ I G E +R FF Q+++ + +CHS + HRD+K EN L+D
Sbjct: 117 LERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRR 176
Query: 60 APRVKICDFGYS---KSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYV 116
K+ DFG GT Y PE +++ +Y A VWS G+ LY
Sbjct: 177 G-CAKLIDFGSGALLHDEPYT----DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYD 231
Query: 117 MLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIP 176
M+ G PFE + IL FP + VS +C L+ R R ++
Sbjct: 232 MVCGDIPFERDQ----------EILEAELHFPAH--VSPDCCALIRRCLAPKPSSRPSLE 279
Query: 177 EIKNHPWFLRNLP 189
EI PW
Sbjct: 280 EILLDPWMQTPAE 292
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 7e-77
Identities = 64/227 (28%), Positives = 92/227 (40%), Gaps = 17/227 (7%)
Query: 1 MEYAA-GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
ME G +LF I R E A + F+QL+S V Y I HRD+K EN ++
Sbjct: 108 MEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF 167
Query: 60 APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+K+ DFG + + GT Y APEVL Y G ++WS GVTLY ++
Sbjct: 168 --TIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVF 225
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIK 179
PF + E + P VS E L+S + E+R T+ ++
Sbjct: 226 EENPFCELE----------ETVEAAIHPPYL--VSKELMSLVSGLLQPVPERRTTLEKLV 273
Query: 180 NHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHEATKPLEA 226
PW P+ L + + VN P + SL +
Sbjct: 274 TDPWV--TQPVNLADYTWEEVFRVNKPESGVLSAASLEMGNRSLSDV 318
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 3e-76
Identities = 50/224 (22%), Positives = 81/224 (36%), Gaps = 39/224 (17%)
Query: 1 MEYAAGGELFERICNAG--------RFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLE 51
EY + + + + +++ SY H+ ICHRD+K
Sbjct: 122 YEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPS 181
Query: 52 NTLLDGSTAPRVKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLT-KKEYDGKIADV 107
N L+D + RVK+ DFG S+ + + GT ++ PE + + Y+G D+
Sbjct: 182 NILMDKNG--RVKLSDFGESEYMVDKKIKG----SRGTYEFMPPEFFSNESSYNGAKVDI 235
Query: 108 WSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR--------------- 152
WS G+ LYVM PF + + I + + +P
Sbjct: 236 WSLGICLYVMFYNVVPFSLKI---SLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSN 292
Query: 153 --VSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTE 194
+S E L N +RIT + H W +L E
Sbjct: 293 NFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLRE 336
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 3e-70
Identities = 65/190 (34%), Positives = 91/190 (47%), Gaps = 10/190 (5%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+E GGELF+++ R E + +F Q++ V Y H I HRDLK EN LL
Sbjct: 93 LELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEE 152
Query: 61 P-RVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYD--GKIADVWSCGVTLYVM 117
+KI DFG+SK S ++ GTP Y+APEVL + D WS GV L++
Sbjct: 153 DCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 212
Query: 118 LVGAYPFEDPEDPKN-FRKTIGRILSVHYSFPDYV--RVSLECKHLLSRIFVANSEKRIT 174
L G PF + + + I S Y+F V VS + L+ ++ V + + R T
Sbjct: 213 LSGYPPFSEHRTQVSLKDQ----ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFT 268
Query: 175 IPEIKNHPWF 184
E HPW
Sbjct: 269 TEEALRHPWL 278
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 2e-69
Identities = 68/192 (35%), Positives = 102/192 (53%), Gaps = 9/192 (4%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG-ST 59
ME GGELFER+ + F E +A + ++S V+YCH + + HRDLK EN L S
Sbjct: 85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSP 144
Query: 60 APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+K+ DFG + ++ VGTP Y++P+VL + Y G D WS GV +YV+L
Sbjct: 145 DSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL-EGLY-GPECDEWSAGVMMYVLLC 202
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECKHLLSRIFVANSEKRITIPE 177
G PF P D + K I ++F D++ VS + + L+ R+ + ++RIT +
Sbjct: 203 GYPPFSAPTDSEVMLK----IREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQ 258
Query: 178 IKNHPWFLRNLP 189
H WF + L
Sbjct: 259 ALEHEWFEKQLS 270
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 6e-69
Identities = 64/189 (33%), Positives = 92/189 (48%), Gaps = 8/189 (4%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+E GGELF+++ R E + +F Q++ V Y H I HRDLK EN LL
Sbjct: 218 LELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEE 277
Query: 61 P-RVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYD--GKIADVWSCGVTLYVM 117
+KI DFG+SK S ++ GTP Y+APEVL + D WS GV L++
Sbjct: 278 DCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 337
Query: 118 LVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECKHLLSRIFVANSEKRITI 175
L G PF + + + +I S Y+F + VS + L+ ++ V + + R T
Sbjct: 338 LSGYPPFSEHRTQVSLKD---QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTT 394
Query: 176 PEIKNHPWF 184
E HPW
Sbjct: 395 EEALRHPWL 403
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 3e-67
Identities = 55/190 (28%), Positives = 90/190 (47%), Gaps = 12/190 (6%)
Query: 1 MEYAAGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD 56
ME GGEL ERI SE +Q+++ ++Y HS + H+DLK EN L
Sbjct: 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQ 158
Query: 57 GSTA-PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY 115
++ +KI DFG ++ + GT Y+APEV K++ K D+WS GV +Y
Sbjct: 159 DTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF-KRDVTFK-CDIWSAGVVMY 216
Query: 116 VMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR-VSLECKHLLSRIFVANSEKRIT 174
+L G PF + +K ++ R ++ + LL ++ + E+R +
Sbjct: 217 FLLTGCLPFTGTSLEEVQQK----ATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPS 272
Query: 175 IPEIKNHPWF 184
++ +H WF
Sbjct: 273 AAQVLHHEWF 282
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 5e-67
Identities = 66/199 (33%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+ GELF+ + SE E R + L+ + H + I HRDLK EN LLD
Sbjct: 103 FDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM- 161
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYD-----GKIADVWSCGVTLY 115
+K+ DFG+S + + GTP+Y+APE++ D GK D+WS GV +Y
Sbjct: 162 -NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMY 220
Query: 116 VMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECKHLLSRIFVANSEKRI 173
+L G+ PF + R I+S +Y F P++ S K L+SR V +KR
Sbjct: 221 TLLAGSPPFWHRKQMLMLRM----IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY 276
Query: 174 TIPEIKNHPWFLRNLPIEL 192
T E HP+F + + E+
Sbjct: 277 TAEEALAHPFFQQYVVEEV 295
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 8e-67
Identities = 68/187 (36%), Positives = 98/187 (52%), Gaps = 8/187 (4%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL-DGST 59
+ GGELFE I +SE +A QQ++ ++YCHS I HR+LK EN LL +
Sbjct: 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAK 143
Query: 60 APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
VK+ DFG + GTP Y++PEVL K Y K D+W+CGV LY++LV
Sbjct: 144 GAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLV 202
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECKHLLSRIFVANSEKRITIPE 177
G PF D + + + + I + Y + P++ V+ E K L+ + N +KRIT +
Sbjct: 203 GYPPFWDEDQHRLYAQ----IKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQ 258
Query: 178 IKNHPWF 184
PW
Sbjct: 259 ALKVPWI 265
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 3e-66
Identities = 44/197 (22%), Positives = 74/197 (37%), Gaps = 20/197 (10%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
ME +L + E + +++ ++ V H I H DLK N L+
Sbjct: 107 MECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-- 163
Query: 61 PRVKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLTKKEYD----------GKIADV 107
+K+ DFG + S VGT Y+ PE + +DV
Sbjct: 164 -MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDV 222
Query: 108 WSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVA 167
WS G LY M G PF+ + + I+ ++ + + +L
Sbjct: 223 WSLGCILYYMTYGKTPFQQIINQI---SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKR 279
Query: 168 NSEKRITIPEIKNHPWF 184
+ ++RI+IPE+ HP+
Sbjct: 280 DPKQRISIPELLAHPYV 296
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 3e-66
Identities = 45/226 (19%), Positives = 83/226 (36%), Gaps = 37/226 (16%)
Query: 1 MEYAAGGELFERIC---NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG 57
ME+ G L+ + NA E E + ++ G+++ I HR++K N +
Sbjct: 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVI 147
Query: 58 STAPR--VKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTK--------KEYDGKIADV 107
+ K+ DFG ++ Q S GT Y+ P++ + K+Y D+
Sbjct: 148 GEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGAT-VDL 206
Query: 108 WSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR--------------- 152
WS GVT Y G+ PF E P+ ++ + +I++ S
Sbjct: 207 WSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMP 266
Query: 153 --------VSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPI 190
+ + +L+ I A+ EK + + +
Sbjct: 267 VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRGN 312
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 1e-65
Identities = 62/191 (32%), Positives = 91/191 (47%), Gaps = 13/191 (6%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+ GELF+ + SE E R + L+ VS+ H+ I HRDLK EN LLD +
Sbjct: 179 FDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQ 238
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYD-----GKIADVWSCGVTLY 115
+++ DFG+S + + GTP Y+APE+L + GK D+W+CGV L+
Sbjct: 239 --IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILF 296
Query: 116 VMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV--RVSLECKHLLSRIFVANSEKRI 173
+L G+ PF R I+ Y F S K L+SR+ + E R+
Sbjct: 297 TLLAGSPPFWHRRQILMLRM----IMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARL 352
Query: 174 TIPEIKNHPWF 184
T + HP+F
Sbjct: 353 TAEQALQHPFF 363
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 2e-65
Identities = 44/197 (22%), Positives = 75/197 (38%), Gaps = 20/197 (10%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
ME +L + E + +++ ++ V H I H DLK N L+
Sbjct: 88 MECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-- 144
Query: 61 PRVKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLTKKEYD----------GKIADV 107
+K+ DFG + S VGT Y+ PE + +DV
Sbjct: 145 -MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDV 203
Query: 108 WSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVA 167
WS G LY M G PF+ + + + I+ ++ + + +L
Sbjct: 204 WSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKR 260
Query: 168 NSEKRITIPEIKNHPWF 184
+ ++RI+IPE+ HP+
Sbjct: 261 DPKQRISIPELLAHPYV 277
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 203 bits (520), Expect = 2e-65
Identities = 64/188 (34%), Positives = 100/188 (53%), Gaps = 9/188 (4%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+E +GGELF+ + +EDEA F +Q++ GV Y HS +I H DLK EN +L
Sbjct: 87 LELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNV 146
Query: 61 P--RVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 118
P R+K+ DFG + ++ K+ GTP ++APE++ + G AD+WS GV Y++L
Sbjct: 147 PNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILL 205
Query: 119 VGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHLLSRIFVANSEKRITIP 176
GA PF + I +V+Y F + + S K + R+ V + ++R+TI
Sbjct: 206 SGASPFLGETKQETLTN----ISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIA 261
Query: 177 EIKNHPWF 184
+ H W
Sbjct: 262 QSLEHSWI 269
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 5e-65
Identities = 68/188 (36%), Positives = 103/188 (54%), Gaps = 9/188 (4%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+E AGGELF+ + +E+EA F +Q+++GV Y HS+QI H DLK EN +L
Sbjct: 93 LELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNV 152
Query: 61 --PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 118
PR+KI DFG + ++ K+ GTP ++APE++ + G AD+WS GV Y++L
Sbjct: 153 PKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILL 211
Query: 119 VGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHLLSRIFVANSEKRITIP 176
GA PF + + +V+Y F D + S K + R+ V + +KR+TI
Sbjct: 212 SGASPFLGDTKQETLAN----VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQ 267
Query: 177 EIKNHPWF 184
+ HPW
Sbjct: 268 DSLQHPWI 275
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 5e-65
Identities = 65/188 (34%), Positives = 98/188 (52%), Gaps = 9/188 (4%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST- 59
+E +GGELF+ + SE+EA F +Q++ GV+Y H+ +I H DLK EN +L
Sbjct: 94 LELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNI 153
Query: 60 -APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 118
P +K+ DFG + + K+ GTP ++APE++ + G AD+WS GV Y++L
Sbjct: 154 PIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILL 212
Query: 119 VGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHLLSRIFVANSEKRITIP 176
GA PF + I SV Y F + + S K + ++ V + KR+TI
Sbjct: 213 SGASPFLGDTKQETLAN----ITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQ 268
Query: 177 EIKNHPWF 184
E HPW
Sbjct: 269 EALRHPWI 276
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 1e-64
Identities = 70/191 (36%), Positives = 100/191 (52%), Gaps = 11/191 (5%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD--GS 58
E GGELF+ I RFSE +A +Q+ SG++Y H I HRDLK EN LL+
Sbjct: 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEK 159
Query: 59 TAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 118
+KI DFG S +++ K +GT YIAPEVL + YD K DVWS GV LY++L
Sbjct: 160 DCD-IKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYDEK-CDVWSAGVILYILL 216
Query: 119 VGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECKHLLSRIFVANSEKRITIP 176
G PF + ++ + + Y+F P + +S + K L+ ++ + RIT
Sbjct: 217 SGTPPFYGKNEYDILKR----VETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITAT 272
Query: 177 EIKNHPWFLRN 187
+ HPW +
Sbjct: 273 QCLEHPWIQKY 283
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 1e-64
Identities = 68/191 (35%), Positives = 99/191 (51%), Gaps = 8/191 (4%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL-DGST 59
ME GGELFERI FSE EA + ++L+S VS+ H + + HRDLK EN L D +
Sbjct: 85 MELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDEND 144
Query: 60 APRVKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 118
+KI DFG+++ +QP K+ T Y APE+L + YD + D+WS GV LY ML
Sbjct: 145 NLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYD-ESCDLWSLGVILYTML 203
Query: 119 VGAYPFEDPEDPKNFRKTIG---RILSVHYSFPDYV--RVSLECKHLLSRIFVANSEKRI 173
G PF+ + + +I +SF VS E K L+ + + KR+
Sbjct: 204 SGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRL 263
Query: 174 TIPEIKNHPWF 184
+ ++ + W
Sbjct: 264 KMSGLRYNEWL 274
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 2e-64
Identities = 63/189 (33%), Positives = 90/189 (47%), Gaps = 7/189 (3%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL--DGS 58
E GGEL ++I FSE EA + V Y H+ + HRDLK N L +
Sbjct: 95 TELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESG 154
Query: 59 TAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVM 117
++ICDFG++K + T T ++APEVL ++ YD D+WS GV LY M
Sbjct: 155 NPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYD-AACDIWSLGVLLYTM 213
Query: 118 LVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV--RVSLECKHLLSRIFVANSEKRITI 175
L G PF + D + + RI S +S VS K L+S++ + +R+T
Sbjct: 214 LTGYTPFANGPD-DTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTA 272
Query: 176 PEIKNHPWF 184
+ HPW
Sbjct: 273 ALVLRHPWI 281
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 2e-64
Identities = 68/187 (36%), Positives = 98/187 (52%), Gaps = 8/187 (4%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG-ST 59
+ GGELFE I +SE +A QQ++ ++YCHS I HR+LK EN LL +
Sbjct: 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAK 166
Query: 60 APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
VK+ DFG + GTP Y++PEVL K Y K D+W+CGV LY++LV
Sbjct: 167 GAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLV 225
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECKHLLSRIFVANSEKRITIPE 177
G PF D + + + + I + Y + P++ V+ E K L+ + N +KRIT +
Sbjct: 226 GYPPFWDEDQHRLYAQ----IKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQ 281
Query: 178 IKNHPWF 184
PW
Sbjct: 282 ALKVPWI 288
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 2e-64
Identities = 64/188 (34%), Positives = 99/188 (52%), Gaps = 9/188 (4%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST- 59
+E +GGELF+ + SE+EA F +Q++ GV+Y H+ +I H DLK EN +L
Sbjct: 94 LELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNI 153
Query: 60 -APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 118
P +K+ DFG + + K+ GTP ++APE++ + G AD+WS GV Y++L
Sbjct: 154 PIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILL 212
Query: 119 VGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHLLSRIFVANSEKRITIP 176
GA PF + I +V Y F + + + S K + ++ V + KR+TI
Sbjct: 213 SGASPFLGDTKQETLAN----ITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQ 268
Query: 177 EIKNHPWF 184
E HPW
Sbjct: 269 EALRHPWI 276
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 3e-64
Identities = 56/202 (27%), Positives = 83/202 (41%), Gaps = 26/202 (12%)
Query: 1 MEYAAGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
MEY G L++ I + DE F+Q++ +SY HS I HRDLK N +D S
Sbjct: 94 MEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR 153
Query: 60 APRVKICDFGYSKS---------------SVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 104
VKI DFG +K+ S +GT Y+A EVL + +
Sbjct: 154 --NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEK 211
Query: 105 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV--RVSLECKHLLS 162
D++S G+ + M+ YPF + N K ++ SV FP K ++
Sbjct: 212 IDMYSLGIIFFEMI---YPFSTGMERVNILK---KLRSVSIEFPPDFDDNKMKVEKKIIR 265
Query: 163 RIFVANSEKRITIPEIKNHPWF 184
+ + KR + N W
Sbjct: 266 LLIDHDPNKRPGARTLLNSGWL 287
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 4e-64
Identities = 68/188 (36%), Positives = 96/188 (51%), Gaps = 11/188 (5%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL-DGST 59
M+ +GGELF+RI G ++E +A QQ++S V Y H I HRDLK EN L
Sbjct: 85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEE 144
Query: 60 APRVKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 118
++ I DFG SK + + + GTP Y+APEVL +K Y K D WS GV Y++L
Sbjct: 145 NSKIMITDFGLSK--MEQNGIMSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVITYILL 201
Query: 119 VGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECKHLLSRIFVANSEKRITIP 176
G PF + + K F K I +Y F P + +S K + + + +R T
Sbjct: 202 CGYPPFYEETESKLFEK----IKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCE 257
Query: 177 EIKNHPWF 184
+ +HPW
Sbjct: 258 KALSHPWI 265
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 4e-64
Identities = 46/202 (22%), Positives = 75/202 (37%), Gaps = 20/202 (9%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
ME +L + E + +++ ++ V H I H DLK N L+
Sbjct: 135 MECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-- 191
Query: 61 PRVKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLTKKEYD----------GKIADV 107
+K+ DFG + + S VG Y+ PE + +DV
Sbjct: 192 -MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDV 250
Query: 108 WSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVA 167
WS G LY M G PF+ + + I + FPD + + +L
Sbjct: 251 WSLGCILYYMTYGKTPFQQIINQISKLHAIID-PNHEIEFPDI--PEKDLQDVLKCCLKR 307
Query: 168 NSEKRITIPEIKNHPWFLRNLP 189
+ ++RI+IPE+ HP+
Sbjct: 308 DPKQRISIPELLAHPYVQIQTH 329
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 6e-64
Identities = 61/236 (25%), Positives = 92/236 (38%), Gaps = 54/236 (22%)
Query: 1 MEYAAGGELFERICNAGR----------------------------------------FS 20
ME GG L +++
Sbjct: 107 MELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQR 166
Query: 21 EDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80
E +Q+ S + Y H+ ICHRD+K EN L + + +K+ DFG SK +
Sbjct: 167 EKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG 226
Query: 81 -----KSTVGTPAYIAPEVL--TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNF 133
+ GTP ++APEVL T + Y G D WS GV L+++L+GA PF D
Sbjct: 227 EYYGMTTKAGTPYFVAPEVLNTTNESY-GPKCDAWSAGVLLHLLLMGAVPFPGVNDADTI 285
Query: 134 RKTIGRILSVHYSF--PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187
+ +L+ F P+Y +S + LLS + N ++R HPW +
Sbjct: 286 SQ----VLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF 337
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 8e-64
Identities = 57/189 (30%), Positives = 88/189 (46%), Gaps = 10/189 (5%)
Query: 1 MEYAAGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
+EYAAGGE+F A SE++ +Q++ GV Y H I H DLK +N LL
Sbjct: 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSI 167
Query: 59 TA-PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVM 117
+KI DFG S+ + + +GTP Y+APE+L D+W+ G+ Y++
Sbjct: 168 YPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPI-TTATDMWNIGIIAYML 226
Query: 118 LVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHLLSRIFVANSEKRITI 175
L PF ++ + + I V+ + + + VS + + V N EKR T
Sbjct: 227 LTHTSPFVGEDNQETYLN----ISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTA 282
Query: 176 PEIKNHPWF 184
+H W
Sbjct: 283 EICLSHSWL 291
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 2e-63
Identities = 70/191 (36%), Positives = 99/191 (51%), Gaps = 11/191 (5%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
E GGELF+ I RFSE +A +Q+ SG++Y H I HRDLK EN LL+ S
Sbjct: 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLE-SKE 158
Query: 61 P--RVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 118
+KI DFG S +++ K +GT YIAPEVL + YD K DVWS GV LY++L
Sbjct: 159 KDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYDEK-CDVWSAGVILYILL 216
Query: 119 VGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV--RVSLECKHLLSRIFVANSEKRITIP 176
G PF + ++ + + Y+F +S + K L+ ++ + RIT
Sbjct: 217 SGTPPFYGKNEYDILKR----VETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITAT 272
Query: 177 EIKNHPWFLRN 187
+ HPW +
Sbjct: 273 QCLEHPWIQKY 283
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 2e-63
Identities = 71/188 (37%), Positives = 99/188 (52%), Gaps = 11/188 (5%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
E+ GGELFE+I N +F E +A +Q++SG+ Y H I HRD+K EN LL+ +
Sbjct: 125 TEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLE-NKN 183
Query: 61 P--RVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 118
+KI DFG S + + +GT YIAPEVL KK+Y+ K DVWSCGV +Y++L
Sbjct: 184 SLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVL-KKKYNEK-CDVWSCGVIMYILL 241
Query: 119 VGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV--RVSLECKHLLSRIFVANSEKRITIP 176
G PF +N + I ++ Y F +S E K L+ + + KR T
Sbjct: 242 CGYPPFGG----QNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAE 297
Query: 177 EIKNHPWF 184
E N W
Sbjct: 298 EALNSRWI 305
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 3e-63
Identities = 82/251 (32%), Positives = 118/251 (47%), Gaps = 25/251 (9%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
ME GGELF+ I + +F+E +A +Q++SGV+Y H I HRDLK EN LL+ S
Sbjct: 115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLE-SKE 173
Query: 61 P--RVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 118
+KI DFG S + K +GT YIAPEVL +K+YD K DVWS GV L+++L
Sbjct: 174 KDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-RKKYDEK-CDVWSIGVILFILL 231
Query: 119 VGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV--RVSLECKHLLSRIFVANSEKRITIP 176
G PF D + RK + Y+F VS K L+ ++ +S++RI+
Sbjct: 232 AGYPPFGGQTDQEILRK----VEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQ 287
Query: 177 EIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHE--ATKPL--EAPRVGGH 232
+ HPW + SL + + + ++ L A
Sbjct: 288 QALEHPWIKEMC----------SKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMAS 337
Query: 233 LLGSSMELDDL 243
L S E +L
Sbjct: 338 KLTSQEETKEL 348
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 3e-63
Identities = 69/188 (36%), Positives = 97/188 (51%), Gaps = 11/188 (5%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
E GGELF+ I + RFSE +A +Q++SG++Y H +I HRDLK EN LL+ S +
Sbjct: 105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLE-SKS 163
Query: 61 P--RVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 118
++I DFG S + K +GT YIAPEVL YD K DVWS GV LY++L
Sbjct: 164 KDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTYDEK-CDVWSTGVILYILL 221
Query: 119 VGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV--RVSLECKHLLSRIFVANSEKRITIP 176
G PF + +K + Y+F +VS K L+ ++ RI+
Sbjct: 222 SGCPPFNGANEYDILKK----VEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISAR 277
Query: 177 EIKNHPWF 184
+ +H W
Sbjct: 278 DALDHEWI 285
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 2e-62
Identities = 49/187 (26%), Positives = 84/187 (44%), Gaps = 8/187 (4%)
Query: 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
E+ +G ++FERI + +E E + Q+ + + HS I H D++ EN +
Sbjct: 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRR 139
Query: 60 APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+ +KI +FG ++ + P Y APEV D+WS G +YV+L
Sbjct: 140 SSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLS 198
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHLLSRIFVANSEKRITIPE 177
G PF + + I++ Y+F + + +S+E + R+ V + R+T E
Sbjct: 199 GINPFLAETNQQIIEN----IMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASE 254
Query: 178 IKNHPWF 184
HPW
Sbjct: 255 ALQHPWL 261
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 2e-62
Identities = 62/187 (33%), Positives = 93/187 (49%), Gaps = 8/187 (4%)
Query: 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
MEY GGELF+RI + +E + F +Q+ G+ + H M I H DLK EN L
Sbjct: 165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRD 224
Query: 60 APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
A ++KI DFG ++ + K GTP ++APEV+ ++ D+WS GV Y++L
Sbjct: 225 AKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVV-NYDFVSFPTDMWSVGVIAYMLLS 283
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHLLSRIFVANSEKRITIPE 177
G PF D + IL+ + D + +S E K +S++ + RI+ E
Sbjct: 284 GLSPFLGDNDAETLNN----ILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASE 339
Query: 178 IKNHPWF 184
HPW
Sbjct: 340 ALKHPWL 346
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 5e-62
Identities = 73/189 (38%), Positives = 102/189 (53%), Gaps = 11/189 (5%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD--GS 58
+ GGELFE I +SE +A QQ++ V +CH M + HR+LK EN LL
Sbjct: 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLK 148
Query: 59 TAPRVKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVM 117
A VK+ DFG + Q GTP Y++PEVL K Y GK D+W+CGV LY++
Sbjct: 149 GAA-VKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY-GKPVDLWACGVILYIL 206
Query: 118 LVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECKHLLSRIFVANSEKRITI 175
LVG PF D + + +++ I + Y F P++ V+ E K L++++ N KRIT
Sbjct: 207 LVGYPPFWDEDQHRLYQQ----IKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITA 262
Query: 176 PEIKNHPWF 184
E HPW
Sbjct: 263 AEALKHPWI 271
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 5e-62
Identities = 56/187 (29%), Positives = 89/187 (47%), Gaps = 8/187 (4%)
Query: 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
+E+ +GGELF+RI + SE E + +Q G+ + H I H D+K EN + +
Sbjct: 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKK 186
Query: 60 APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
A VKI DFG + K T T + APE++ ++ G D+W+ GV YV+L
Sbjct: 187 ASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLS 245
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHLLSRIFVANSEKRITIPE 177
G PF +D + + + + F + + VS E K + + KR+T+ +
Sbjct: 246 GLSPFAGEDDLETLQN----VKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHD 301
Query: 178 IKNHPWF 184
HPW
Sbjct: 302 ALEHPWL 308
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 5e-62
Identities = 72/188 (38%), Positives = 99/188 (52%), Gaps = 9/188 (4%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL-DGST 59
+E GGELF+RI G +SE +A +Q++ V+Y H I HRDLK EN L +
Sbjct: 127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAP 186
Query: 60 APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+KI DFG SK K+ GTP Y APE+L Y G D+WS G+ Y++L
Sbjct: 187 DAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY-GPEVDMWSVGIITYILLC 245
Query: 120 GAYPFEDPEDPKN-FRKTIGRILSVHYSF--PDYVRVSLECKHLLSRIFVANSEKRITIP 176
G PF D + FR+ IL+ Y F P + VSL K L+ ++ V + +KR+T
Sbjct: 246 GFEPFYDERGDQFMFRR----ILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTF 301
Query: 177 EIKNHPWF 184
+ HPW
Sbjct: 302 QALQHPWV 309
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 7e-62
Identities = 45/226 (19%), Positives = 84/226 (37%), Gaps = 37/226 (16%)
Query: 1 MEYAAGGELFERIC---NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG 57
ME+ G L+ + NA E E + ++ G+++ I HR++K N +
Sbjct: 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVI 147
Query: 58 STAPR--VKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTK--------KEYDGKIADV 107
+ K+ DFG ++ Q S GT Y+ P++ + K+Y D+
Sbjct: 148 GEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGAT-VDL 206
Query: 108 WSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR--------------- 152
WS GVT Y G+ PF E P+ ++ + +I++ S
Sbjct: 207 WSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMP 266
Query: 153 --------VSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPI 190
+ + +L+ I A+ EK + + + +
Sbjct: 267 VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMV 312
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 1e-61
Identities = 66/190 (34%), Positives = 94/190 (49%), Gaps = 9/190 (4%)
Query: 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL-DG 57
ME GGELF RI G F+E EA + + + + + HS I HRD+K EN L
Sbjct: 105 MECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSK 164
Query: 58 STAPRVKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYV 116
+K+ DFG++K ++ TP Y+APEVL ++YD K D+WS GV +Y+
Sbjct: 165 EKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYI 221
Query: 117 MLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV--RVSLECKHLLSRIFVANSEKRIT 174
+L G PF RI Y FP+ VS + K L+ + + +R+T
Sbjct: 222 LLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLT 281
Query: 175 IPEIKNHPWF 184
I + NHPW
Sbjct: 282 ITQFMNHPWI 291
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 1e-61
Identities = 53/206 (25%), Positives = 79/206 (38%), Gaps = 23/206 (11%)
Query: 1 MEYAAGGELFERIC---NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG 57
MEY GG+L + + N E R + S + Y H +I HRDLK EN +L
Sbjct: 97 MEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQP 156
Query: 58 ST-APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYV 116
KI D GY+K VGT Y+APE+L +K+Y D WS G +
Sbjct: 157 GPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVT-VDYWSFGTLAFE 215
Query: 117 MLVGAYPFEDPEDPKNFRKTI----------GRILSVHYSFPDYVRV--------SLECK 158
+ G PF P + + L+ F + + + +
Sbjct: 216 CITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLE 275
Query: 159 HLLSRIFVANSEKRITIPEIKNHPWF 184
L + + + +R T P+ N F
Sbjct: 276 RWLQCMLMWHQRQRGTDPQNPNVGCF 301
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-60
Identities = 71/190 (37%), Positives = 97/190 (51%), Gaps = 8/190 (4%)
Query: 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL--D 56
ME GGELF RI + G F+E EA + + + Y HS+ I HRD+K EN L
Sbjct: 138 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSK 197
Query: 57 GSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYV 116
A +K+ DFG++K + H+ + TP Y+APEVL ++YD K D+WS GV +Y+
Sbjct: 198 RPNAI-LKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYI 255
Query: 117 MLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV--RVSLECKHLLSRIFVANSEKRIT 174
+L G PF RI Y FP+ VS E K L+ + +R+T
Sbjct: 256 LLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT 315
Query: 175 IPEIKNHPWF 184
I E NHPW
Sbjct: 316 ITEFMNHPWI 325
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 3e-60
Identities = 61/193 (31%), Positives = 92/193 (47%), Gaps = 16/193 (8%)
Query: 1 MEYAAGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD 56
E+ G +L I +SE A + +Q++ + YCH I HRD+K LL
Sbjct: 105 FEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLA 164
Query: 57 G--STAPRVKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVT 113
++AP VK+ FG + VGTP ++APEV+ ++ Y GK DVW CGV
Sbjct: 165 SKENSAP-VKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPY-GKPVDVWGCGVI 222
Query: 114 LYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECKHLLSRIFVANSEK 171
L+++L G PF + F I+ Y + +S K L+ R+ + + +
Sbjct: 223 LFILLSGCLPFYG-TKERLFEG----IIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAE 277
Query: 172 RITIPEIKNHPWF 184
RIT+ E NHPW
Sbjct: 278 RITVYEALNHPWL 290
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 6e-60
Identities = 58/187 (31%), Positives = 92/187 (49%), Gaps = 8/187 (4%)
Query: 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
E+ +GGELFE++ + + SEDEA + +Q+ G+ + H H DLK EN +
Sbjct: 233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKR 292
Query: 60 APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+ +K+ DFG + K T GT + APEV K G D+WS GV Y++L
Sbjct: 293 SNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLS 351
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHLLSRIFVANSEKRITIPE 177
G PF D + R + S ++ D + +S + K + ++ +A+ R+TI +
Sbjct: 352 GLSPFGGENDDETLRN----VKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQ 407
Query: 178 IKNHPWF 184
HPW
Sbjct: 408 ALEHPWL 414
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 2e-58
Identities = 61/216 (28%), Positives = 91/216 (42%), Gaps = 28/216 (12%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD--GS 58
E GG + I F+E EA Q + S + + H+ I HRDLK EN L +
Sbjct: 90 FEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQ 149
Query: 59 TAPRVKICDFGYSK--------SSVLHSQPKSTVGTPAYIAPEVLTKKEYD----GKIAD 106
+P VKICDF S + + + G+ Y+APEV+ + K D
Sbjct: 150 VSP-VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCD 208
Query: 107 VWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG-----------RILSVHYSFPDYV--RV 153
+WS GV LY++L G PF I Y FPD +
Sbjct: 209 LWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHI 268
Query: 154 SLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLP 189
S K L+S++ V ++++R++ ++ HPW P
Sbjct: 269 SCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP 304
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 9e-58
Identities = 61/193 (31%), Positives = 98/193 (50%), Gaps = 18/193 (9%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+ YA GEL + I G F E RF+ +++S + Y H I HRDLK EN LL+
Sbjct: 109 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM- 167
Query: 61 PRVKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVM 117
++I DFG +K S+ VGT Y++PE+LT+K K +D+W+ G +Y +
Sbjct: 168 -HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQL 225
Query: 118 LVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIP- 176
+ G PF + F+K I+ + Y FP+ + + L+ ++ V ++ KR+
Sbjct: 226 VAGLPPFRAGNEYLIFQK----IIKLEYDFPEK--FFPKARDLVEKLLVLDATKRLGCEE 279
Query: 177 -----EIKNHPWF 184
+K HP+F
Sbjct: 280 MEGYGPLKAHPFF 292
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 5e-57
Identities = 43/203 (21%), Positives = 75/203 (36%), Gaps = 21/203 (10%)
Query: 1 MEYAAGGELFERI----CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD 56
+ + G L+ I +ED+ + + G+ H+ HRDLK N LL
Sbjct: 109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG 168
Query: 57 GSTAPRVKICDFGYSKSSVLHSQPKST----------VGTPAYIAPEVLTKKEYD--GKI 104
+ + D G + +H + T +Y APE+ + + + +
Sbjct: 169 DEG--QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDER 226
Query: 105 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 164
DVWS G LY M+ G P++ + + S P R S LL+ +
Sbjct: 227 TDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA---LAVQNQLSIPQSPRHSSALWQLLNSM 283
Query: 165 FVANSEKRITIPEIKNHPWFLRN 187
+ +R IP + + L+
Sbjct: 284 MTVDPHQRPHIPLLLSQLEALQP 306
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 4e-55
Identities = 26/192 (13%), Positives = 49/192 (25%), Gaps = 25/192 (13%)
Query: 3 YAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPR 62
G L Q+I ++ H + H L+ + +LD
Sbjct: 187 QTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG--G 244
Query: 63 VKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT----------KKEYDGKIADVWSCGV 112
V + F V + + + PE+ ++ D W+ G+
Sbjct: 245 VFLTGFE---HLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301
Query: 113 TLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKR 172
+Y + P I + P + LL E R
Sbjct: 302 VIYWIWCADLPITKDAALGGSEW----IFRSCKNIPQ------PVRALLEGFLRYPKEDR 351
Query: 173 ITIPEIKNHPWF 184
+ + P +
Sbjct: 352 LLPLQAMETPEY 363
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 1e-54
Identities = 52/209 (24%), Positives = 82/209 (39%), Gaps = 30/209 (14%)
Query: 1 MEYAAGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHSMQ--ICHRDLKLENTLL 55
+ G+L E + G S D F Q V + H + I HRDLK+EN LL
Sbjct: 112 LTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL 171
Query: 56 DGSTAPRVKICDFGYSKSSVLHSQPKST-------------VGTPAYIAPEV--LTKKEY 100
+K+CDFG + + + + TP Y PE+ L
Sbjct: 172 SNQG--TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFP 229
Query: 101 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 160
G+ D+W+ G LY++ +PFED RI++ YS P + L
Sbjct: 230 IGEKQDIWALGCILYLLCFRQHPFEDG--------AKLRIVNGKYSIPPHDTQYTVFHSL 281
Query: 161 LSRIFVANSEKRITIPEIKNHPWFLRNLP 189
+ + N E+R++I E+ + +
Sbjct: 282 IRAMLQVNPEERLSIAEVVHQLQEIAAAR 310
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 2e-54
Identities = 49/191 (25%), Positives = 80/191 (41%), Gaps = 15/191 (7%)
Query: 1 MEYAAGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
ME+ G L + I + + A F+Q+ GV Y HS ++ +RDLK N L +
Sbjct: 99 MEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT 158
Query: 59 TAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 118
+VKI DFG S + + GT Y++PE ++ ++Y + D+++ G+ L +L
Sbjct: 159 K--QVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKE-VDLYALGLILAELL 215
Query: 119 VGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEI 178
E K F I+S + + K LL ++ E R EI
Sbjct: 216 HVCDTA--FETSKFFTDLRDGIISDIFDK--------KEKTLLQKLLSKKPEDRPNTSEI 265
Query: 179 KNHPWFLRNLP 189
+ P
Sbjct: 266 LRTLTVWKKSP 276
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 6e-54
Identities = 49/189 (25%), Positives = 88/189 (46%), Gaps = 12/189 (6%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD--GS 58
++ GG+L + F E+ + F +L+ + Y + +I HRD+K +N LLD G
Sbjct: 94 VDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHG- 152
Query: 59 TAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDG--KIADVWSCGVTLYV 116
V I DF + +Q + GT Y+APE+ + ++ G D WS GVT Y
Sbjct: 153 ---HVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYE 209
Query: 117 MLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI-TI 175
+L G P+ + ++ + + ++P S E LL ++ N ++R +
Sbjct: 210 LLRGRRPYHI-RSSTSSKEIVHTFETTVVTYPSA--WSQEMVSLLKKLLEPNPDQRFSQL 266
Query: 176 PEIKNHPWF 184
+++N P+
Sbjct: 267 SDVQNFPYM 275
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-53
Identities = 65/192 (33%), Positives = 105/192 (54%), Gaps = 19/192 (9%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD--GS 58
+++ GG+LF R+ F+E++ +F+ +L + + HS+ I +RDLK EN LLD G
Sbjct: 105 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG- 163
Query: 59 TAPRVKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVM 117
+K+ DFG SK S+ H + + GT Y+APEV+ ++ + + AD WS GV ++ M
Sbjct: 164 ---HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEM 219
Query: 118 LVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI---- 173
L G PF+ K+ ++T+ IL P + +S E + LL +F N R+
Sbjct: 220 LTGTLPFQG----KDRKETMTMILKAKLGMPQF--LSPEAQSLLRMLFKRNPANRLGAGP 273
Query: 174 -TIPEIKNHPWF 184
+ EIK H +F
Sbjct: 274 DGVEEIKRHSFF 285
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 3e-53
Identities = 56/198 (28%), Positives = 87/198 (43%), Gaps = 18/198 (9%)
Query: 1 MEYAAGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHSM-----QICHRDLKLE 51
MEY GG+L I + E+ QL + CH + HRDLK
Sbjct: 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPA 145
Query: 52 NTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSC 110
N LDG VK+ DFG ++ + S K+ VGTP Y++PE + + Y+ K +D+WS
Sbjct: 146 NVFLDGK--QNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEK-SDIWSL 202
Query: 111 GVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSE 170
G LY + PF + ++ G+I + R S E +++R+
Sbjct: 203 GCLLYELCALMPPFTA----FSQKELAGKIREGKFR-RIPYRYSDELNEIITRMLNLKDY 257
Query: 171 KRITIPEIKNHPWFLRNL 188
R ++ EI +P L +
Sbjct: 258 HRPSVEEILENPLILEHH 275
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-52
Identities = 66/192 (34%), Positives = 100/192 (52%), Gaps = 19/192 (9%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD--GS 58
+EY +GGELF ++ G F ED A F+ ++ + + H I +RDLK EN +L+ G
Sbjct: 100 LEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG- 158
Query: 59 TAPRVKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVM 117
VK+ DFG K S+ T GT Y+APE+L + + + D WS G +Y M
Sbjct: 159 ---HVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDM 214
Query: 118 LVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI---- 173
L GA PF +N +KTI +IL + P Y ++ E + LL ++ N+ R+
Sbjct: 215 LTGAPPFTG----ENRKKTIDKILKCKLNLPPY--LTQEARDLLKKLLKRNAASRLGAGP 268
Query: 174 -TIPEIKNHPWF 184
E++ HP+F
Sbjct: 269 GDAGEVQAHPFF 280
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 1e-51
Identities = 64/193 (33%), Positives = 86/193 (44%), Gaps = 29/193 (15%)
Query: 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD-- 56
ME GGELF RI + G F+E EA + + + Y HS+ I HRD+K EN L
Sbjct: 94 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSK 153
Query: 57 GSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYV 116
A +K+ DFG A E +K YD K D+WS GV +Y+
Sbjct: 154 RPNAI-LKLTDFG--------------------FAKETTGEK-YD-KSCDMWSLGVIMYI 190
Query: 117 MLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV--RVSLECKHLLSRIFVANSEKRIT 174
+L G PF RI Y FP+ VS E K L+ + +R+T
Sbjct: 191 LLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT 250
Query: 175 IPEIKNHPWFLRN 187
I E NHPW +++
Sbjct: 251 ITEFMNHPWIMQS 263
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 1e-51
Identities = 72/191 (37%), Positives = 102/191 (53%), Gaps = 20/191 (10%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD--GS 58
M+Y GGELF + + RF A+F+ ++ + Y HS I +RDLK EN LLD G
Sbjct: 85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG- 143
Query: 59 TAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 118
+KI DFG++K + + GTP YIAPEV++ K Y K D WS G+ +Y ML
Sbjct: 144 ---HIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEML 197
Query: 119 VGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI----- 173
G PF D + KT +IL+ FP + + + K LLSR+ + +R+
Sbjct: 198 AGYTPFYD-SNTM---KTYEKILNAELRFPPF--FNEDVKDLLSRLITRDLSQRLGNLQN 251
Query: 174 TIPEIKNHPWF 184
++KNHPWF
Sbjct: 252 GTEDVKNHPWF 262
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-51
Identities = 52/197 (26%), Positives = 98/197 (49%), Gaps = 11/197 (5%)
Query: 1 MEYAAGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
M+Y GG+LF+RI F ED+ +F Q+ + + H +I HRD+K +N L
Sbjct: 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD 161
Query: 59 TAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVM 117
V++ DFG ++ + ++ +GTP Y++PE+ K Y+ K +D+W+ G LY +
Sbjct: 162 --GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNK-SDIWALGCVLYEL 218
Query: 118 LVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPE 177
+ FE + + + +I+S + P + S + + L+S++F N R ++
Sbjct: 219 CTLKHAFEA----GSMKNLVLKIISGSFP-PVSLHYSYDLRSLVSQLFKRNPRDRPSVNS 273
Query: 178 IKNHPWFLRNLPIELTE 194
I + + + L+
Sbjct: 274 ILEKGFIAKRIEKFLSP 290
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-51
Identities = 61/194 (31%), Positives = 97/194 (50%), Gaps = 16/194 (8%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD--GS 58
++Y GGELF + RF+E E + + +++ + + H + I +RD+KLEN LLD G
Sbjct: 138 LDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG- 196
Query: 59 TAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLTKKEY-DGKIADVWSCGVTLY 115
V + DFG SK V ++ GT Y+AP+++ + K D WS GV +Y
Sbjct: 197 ---HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMY 253
Query: 116 VMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI-- 173
+L GA PF + + + RIL +P +S K L+ R+ + + +KR+
Sbjct: 254 ELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE--MSALAKDLIQRLLMKDPKKRLGC 311
Query: 174 ---TIPEIKNHPWF 184
EIK H +F
Sbjct: 312 GPRDADEIKEHLFF 325
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 3e-51
Identities = 71/188 (37%), Positives = 101/188 (53%), Gaps = 15/188 (7%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD--GS 58
MEY GG+L I + +F A F+ ++I G+ + HS I +RDLKL+N LLD G
Sbjct: 97 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG- 155
Query: 59 TAPRVKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVM 117
+KI DFG K ++L +T GTP YIAPE+L ++Y D WS GV LY M
Sbjct: 156 ---HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEM 211
Query: 118 LVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI-TIP 176
L+G PF ++ + F I + +P + + E K LL ++FV EKR+
Sbjct: 212 LIGQSPFHGQDEEELFHS----IRMDNPFYPRW--LEKEAKDLLVKLFVREPEKRLGVRG 265
Query: 177 EIKNHPWF 184
+I+ HP F
Sbjct: 266 DIRQHPLF 273
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 3e-51
Identities = 67/191 (35%), Positives = 95/191 (49%), Gaps = 18/191 (9%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD--GS 58
++Y GGELF + F E ARF+ ++ S + Y HS+ I +RDLK EN LLD G
Sbjct: 118 LDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG- 176
Query: 59 TAPRVKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVM 117
+ + DFG K ++ H+ ST GTP Y+APEVL K+ Y + D W G LY M
Sbjct: 177 ---HIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEM 232
Query: 118 LVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIP- 176
L G PF +N + IL+ ++ +HLL + + KR+
Sbjct: 233 LYGLPPFYS----RNTAEMYDNILNKPLQLKPN--ITNSARHLLEGLLQKDRTKRLGAKD 286
Query: 177 ---EIKNHPWF 184
EIK+H +F
Sbjct: 287 DFMEIKSHVFF 297
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 5e-51
Identities = 50/219 (22%), Positives = 84/219 (38%), Gaps = 42/219 (19%)
Query: 1 MEYAAGGELFERICNAGRFSED-------EARFFFQQLISGVSYCHSMQICHRDLKLENT 53
+E L + + + E+ +Q+ SGV++ HS++I HRDLK +N
Sbjct: 88 LELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNI 146
Query: 54 LLDGSTAP-----------RVKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLTK 97
L+ S+ R+ I DFG K S + + GT + APE+L +
Sbjct: 147 LVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEE 206
Query: 98 KEYD------GKIADVWSCGVTLYVMLVGAY-PFEDPEDPKNFRKTIGRILSVHYSFPDY 150
+ D++S G Y +L PF D I+ +S +
Sbjct: 207 SNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS------RESNIIRGIFSLDEM 260
Query: 151 VR-----VSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184
+ E L+S++ + KR T ++ HP F
Sbjct: 261 KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 8e-51
Identities = 67/190 (35%), Positives = 98/190 (51%), Gaps = 15/190 (7%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEYA GGELF + F+E+ ARF+ +++S + Y HS + +RD+KLEN +LD
Sbjct: 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG- 142
Query: 61 PRVKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+KI DFG K + T GTP Y+APEVL +Y G+ D W GV +Y M+
Sbjct: 143 -HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMC 200
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI-----T 174
G PF + + + F IL FP +S E K LL+ + + ++R+
Sbjct: 201 GRLPFYNQDHERLFEL----ILMEEIRFPRT--LSPEAKSLLAGLLKKDPKQRLGGGPSD 254
Query: 175 IPEIKNHPWF 184
E+ H +F
Sbjct: 255 AKEVMEHRFF 264
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-50
Identities = 68/191 (35%), Positives = 100/191 (52%), Gaps = 20/191 (10%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD--GS 58
MEY AGGE+F + GRFSE ARF+ Q++ Y HS+ + +RDLK EN L+D G
Sbjct: 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG- 178
Query: 59 TAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 118
+++ DFG++K + + + GTP +APE++ K Y K D W+ GV +Y M
Sbjct: 179 ---YIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMA 232
Query: 119 VGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI----- 173
G PF + + + K I+S FP + S + K LL + + KR
Sbjct: 233 AGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDLLRNLLQVDLTKRFGNLKN 286
Query: 174 TIPEIKNHPWF 184
+ +IKNH WF
Sbjct: 287 GVNDIKNHKWF 297
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 4e-50
Identities = 65/191 (34%), Positives = 91/191 (47%), Gaps = 16/191 (8%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
ME+ GG+L I + RF E ARF+ ++IS + + H I +RDLKL+N LLD
Sbjct: 103 MEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG- 161
Query: 61 PRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
K+ DFG K + + +T GTP YIAPE+L + Y G D W+ GV LY ML
Sbjct: 162 -HCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLC 219
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI------ 173
G PFE + F IL+ +P + + + +L N R+
Sbjct: 220 GHAPFEAENEDDLFEA----ILNDEVVYPTW--LHEDATGILKSFMTKNPTMRLGSLTQG 273
Query: 174 TIPEIKNHPWF 184
I HP+F
Sbjct: 274 GEHAILRHPFF 284
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 6e-50
Identities = 64/190 (33%), Positives = 94/190 (49%), Gaps = 15/190 (7%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY GG+L I GRF E A F+ ++ G+ + S I +RDLKL+N +LD
Sbjct: 100 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG- 158
Query: 61 PRVKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+KI DFG K ++ T GTP YIAPE++ + Y GK D W+ GV LY ML
Sbjct: 159 -HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLA 216
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI-----T 174
G PFE ++ + I+ + ++P +S E + + + KR+
Sbjct: 217 GQAPFEG----EDEDELFQSIMEHNVAYPKS--MSKEAVAICKGLMTKHPGKRLGCGPEG 270
Query: 175 IPEIKNHPWF 184
+IK H +F
Sbjct: 271 ERDIKEHAFF 280
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-49
Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 17/196 (8%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+EY GG+L + + E+ ARF+ ++ ++Y H I +RDLKL+N LLD
Sbjct: 89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG- 147
Query: 61 PRVKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+K+ D+G K + ST GTP YIAPE+L ++Y G D W+ GV ++ M+
Sbjct: 148 -HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMA 205
Query: 120 GAYPF-----EDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI- 173
G PF D D IL P +S++ +L + ++R+
Sbjct: 206 GRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS--LSVKAASVLKSFLNKDPKERLG 263
Query: 174 -----TIPEIKNHPWF 184
+I+ HP+F
Sbjct: 264 CHPQTGFADIQGHPFF 279
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 2e-49
Identities = 43/196 (21%), Positives = 73/196 (37%), Gaps = 17/196 (8%)
Query: 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL---D 56
+E L E + E QQ SG+++ HS+ I HRDLK N L+ +
Sbjct: 97 IELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPN 155
Query: 57 GSTAPRVKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVL---TKKEYDGKIADVWS 109
+ I DFG K S+ GT +IAPE+L K+ D++S
Sbjct: 156 AHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYT-VDIFS 214
Query: 110 CGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR-VSLECKHLLSRIFVAN 168
G Y ++ + +G + + + L+ ++ +
Sbjct: 215 AGCVFYYVISEGSHPFGKSLQRQANILLGA---CSLDCLHPEKHEDVIARELIEKMIAMD 271
Query: 169 SEKRITIPEIKNHPWF 184
+KR + + HP+F
Sbjct: 272 PQKRPSAKHVLKHPFF 287
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-49
Identities = 68/194 (35%), Positives = 97/194 (50%), Gaps = 18/194 (9%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY GG+L + + E ARF+ +++ + HSM HRD+K +N LLD S
Sbjct: 148 MEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG- 205
Query: 61 PRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLTKKEYD---GKIADVWSCGVTLY 115
+K+ DFG + VGTP YI+PEVL + D G+ D WS GV LY
Sbjct: 206 -HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 264
Query: 116 VMLVGAYPFEDPEDPKNFRKTIGRILS--VHYSFPDYVRVSLECKHLLSRIFVANSEKRI 173
MLVG PF + T +I++ +FPD +S E K+L+ F+ + E R+
Sbjct: 265 EMLVGDTPFYA----DSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICA-FLTDREVRL 319
Query: 174 T---IPEIKNHPWF 184
+ EIK H +F
Sbjct: 320 GRNGVEEIKRHLFF 333
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 2e-49
Identities = 30/196 (15%), Positives = 57/196 (29%), Gaps = 14/196 (7%)
Query: 1 MEYAAG------GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTL 54
M A+ L G QLI + S + H +N
Sbjct: 167 MPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLF 226
Query: 55 LDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYD-GKIADVWSCGVT 113
+ R+ + D + ++ ++ Y E L + W G++
Sbjct: 227 IMPDG--RLMLGDVSALWK--VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLS 282
Query: 114 LYVMLVGAYPFEDPEDPKNF---RKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSE 170
+Y + PF R ++ + +F + K L+ R +
Sbjct: 283 IYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRR 342
Query: 171 KRITIPEIKNHPWFLR 186
+R+ E P FL+
Sbjct: 343 RRLLPLEAMETPEFLQ 358
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 4e-49
Identities = 57/189 (30%), Positives = 90/189 (47%), Gaps = 11/189 (5%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
++ GG+L + G FSE + RF+ ++I G+ + H+ + +RDLK N LLD
Sbjct: 271 LDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG- 329
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
V+I D G + +P ++VGT Y+APEVL K AD +S G L+ +L G
Sbjct: 330 -HVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI-----TI 175
PF K+ + L++ PD S E + LL + + +R+
Sbjct: 388 HSPFRQ-HKTKDKHEIDRMTLTMAVELPDS--FSPELRSLLEGLLQRDVNRRLGCLGRGA 444
Query: 176 PEIKNHPWF 184
E+K P+F
Sbjct: 445 QEVKESPFF 453
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-48
Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 17/196 (8%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+EY GG+L + + E+ ARF+ ++ ++Y H I +RDLKL+N LLD
Sbjct: 132 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG- 190
Query: 61 PRVKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+K+ D+G K + ST GTP YIAPE+L ++Y G D W+ GV ++ M+
Sbjct: 191 -HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMA 248
Query: 120 GAYPF-----EDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI- 173
G PF D D IL P +S++ +L + ++R+
Sbjct: 249 GRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS--LSVKAASVLKSFLNKDPKERLG 306
Query: 174 -----TIPEIKNHPWF 184
+I+ HP+F
Sbjct: 307 CHPQTGFADIQGHPFF 322
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-48
Identities = 62/197 (31%), Positives = 98/197 (49%), Gaps = 20/197 (10%)
Query: 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
M+Y GG+L + R E+ ARF+ +++ + H + HRD+K +N L+D +
Sbjct: 153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG 212
Query: 60 APRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLTKKEYD----GKIADVWSCGVT 113
+++ DFG + +S+ VGTP YI+PE+L E G D WS GV
Sbjct: 213 --HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVC 270
Query: 114 LYVMLVGAYPFEDPEDPKNFRKTIGRILS--VHYSFPDYV-RVSLECKHLLSRIFVANSE 170
+Y ML G PF ++ +T G+I++ + FP V VS K L+ R+ + E
Sbjct: 271 MYEMLYGETPFYA----ESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSR-E 325
Query: 171 KRIT---IPEIKNHPWF 184
R+ I + K HP+F
Sbjct: 326 HRLGQNGIEDFKKHPFF 342
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 3e-48
Identities = 72/191 (37%), Positives = 98/191 (51%), Gaps = 16/191 (8%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ-ICHRDLKLENTLLDGST 59
MEYA GGELF + FSED ARF+ +++S + Y HS + + +RDLKLEN +LD
Sbjct: 227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG 286
Query: 60 APRVKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 118
+KI DFG K + T GTP Y+APEVL +Y G+ D W GV +Y M+
Sbjct: 287 --HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMM 343
Query: 119 VGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI----- 173
G PF + + K F IL FP + E K LLS + + ++R+
Sbjct: 344 CGRLPFYNQDHEKLFEL----ILMEEIRFPRT--LGPEAKSLLSGLLKKDPKQRLGGGSE 397
Query: 174 TIPEIKNHPWF 184
EI H +F
Sbjct: 398 DAKEIMQHRFF 408
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 9e-48
Identities = 56/199 (28%), Positives = 86/199 (43%), Gaps = 22/199 (11%)
Query: 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
MEY GG+L + G R + ARF+ +++ + H + HRD+K +N LLD
Sbjct: 140 MEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG 199
Query: 60 APRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLTKKEYD------GKIADVWSCG 111
+++ DFG +S VGTP Y++PE+L G D W+ G
Sbjct: 200 --HIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALG 257
Query: 112 VTLYVMLVGAYPFEDPEDPKNFRKTIGRILS--VHYSFPDY-VRVSLECKHLLSRIFVAN 168
V Y M G PF + +T G+I+ H S P V E + + R +
Sbjct: 258 VFAYEMFYGQTPFYA----DSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQR-LLCP 312
Query: 169 SEKRIT---IPEIKNHPWF 184
E R+ + + HP+F
Sbjct: 313 PETRLGRGGAGDFRTHPFF 331
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-47
Identities = 40/185 (21%), Positives = 68/185 (36%), Gaps = 13/185 (7%)
Query: 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
E G L + G E + + + + +++ HS + H D+K N L
Sbjct: 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRG 194
Query: 60 APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
R K+ DFG + G P Y+APE+L Y ADV+S G+T+ +
Sbjct: 195 --RCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGS-YGTA-ADVFSLGLTILEVAC 250
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIK 179
E + R+ + F +S E + +L + + + R T +
Sbjct: 251 NMELPHGGEGWQQLRQGY-----LPPEFTAG--LSSELRSVLVMMLEPDPKLRATAEALL 303
Query: 180 NHPWF 184
P
Sbjct: 304 ALPVL 308
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 7e-47
Identities = 64/190 (33%), Positives = 95/190 (50%), Gaps = 15/190 (7%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY GG+L I GRF E A F+ ++ G+ + S I +RDLKL+N +LD +
Sbjct: 421 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD--SE 478
Query: 61 PRVKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+KI DFG K ++ T GTP YIAPE++ + Y GK D W+ GV LY ML
Sbjct: 479 GHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLA 537
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI-----T 174
G PFE ++ + I+ + ++P +S E + + + KR+
Sbjct: 538 GQAPFEG----EDEDELFQSIMEHNVAYPKS--MSKEAVAICKGLMTKHPGKRLGCGPEG 591
Query: 175 IPEIKNHPWF 184
+IK H +F
Sbjct: 592 ERDIKEHAFF 601
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-45
Identities = 57/194 (29%), Positives = 86/194 (44%), Gaps = 15/194 (7%)
Query: 1 MEYAAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD 56
M GG++ I N F E A F+ Q++SG+ + H I +RDLK EN LLD
Sbjct: 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLD 323
Query: 57 GSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY 115
V+I D G + GTP ++APE+L +EY D ++ GVTLY
Sbjct: 324 DDG--NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY-DFSVDYFALGVTLY 380
Query: 116 VMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI-- 173
M+ PF + ++ R+L ++PD S K + + EKR+
Sbjct: 381 EMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK--FSPASKDFCEALLQKDPEKRLGF 438
Query: 174 ---TIPEIKNHPWF 184
+ ++ HP F
Sbjct: 439 RDGSCDGLRTHPLF 452
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-45
Identities = 53/191 (27%), Positives = 86/191 (45%), Gaps = 12/191 (6%)
Query: 1 MEYAAGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
+ GG+L I + G+ F E A F+ ++ G+ H +I +RDLK EN LLD
Sbjct: 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDH 322
Query: 59 TAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 118
++I D G + K VGT Y+APEV+ + Y D W+ G LY M+
Sbjct: 323 G--HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMI 379
Query: 119 VGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI----- 173
G PF+ + + + V + + S + + L S++ + +R+
Sbjct: 380 AGQSPFQQRKKKIKREEVERLVKEVPEEYSER--FSPQARSLCSQLLCKDPAERLGCRGG 437
Query: 174 TIPEIKNHPWF 184
+ E+K HP F
Sbjct: 438 SAREVKEHPLF 448
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 5e-45
Identities = 51/194 (26%), Positives = 82/194 (42%), Gaps = 10/194 (5%)
Query: 1 MEYAAGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD 56
+E A G+L I + + E +F QL S + + HS ++ HRD+K N +
Sbjct: 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT 170
Query: 57 GSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY 115
+ VK+ D G + S + S VGTP Y++PE + + Y+ K +D+WS G LY
Sbjct: 171 ATG--VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLY 227
Query: 116 VMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITI 175
M PF D N +I Y S E + L++ + EKR +
Sbjct: 228 EMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDV 285
Query: 176 PEIKNHPWFLRNLP 189
+ + +
Sbjct: 286 TYVYDVAKRMHACT 299
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-44
Identities = 27/187 (14%), Positives = 51/187 (27%), Gaps = 18/187 (9%)
Query: 6 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKI 65
G L Q+I ++ H + H L+ + +LD V +
Sbjct: 195 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR--GGVFL 252
Query: 66 CDFGYSKS--SVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI----ADVWSCGVTLYVMLV 119
F + + S P A +L ++ + D W+ G+ +Y +
Sbjct: 253 TGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIK 179
P D F + + LL E R+ +
Sbjct: 313 ADLPNTDDAALGGSEWI----------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAM 362
Query: 180 NHPWFLR 186
P + +
Sbjct: 363 ETPEYEQ 369
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 4e-44
Identities = 40/200 (20%), Positives = 73/200 (36%), Gaps = 26/200 (13%)
Query: 1 MEYAAGGELFERI---CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG 57
M+ L + + C F Q+ V + HS + HRDLK N
Sbjct: 94 MQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTM 153
Query: 58 STAPRVKICDFGYSK-------------SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 104
VK+ DFG +++ VGT Y++PE + Y K
Sbjct: 154 DD--VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHK- 210
Query: 105 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 164
D++S G+ L+ +L YPF + +T+ + ++ + P + + ++ +
Sbjct: 211 VDIFSLGLILFELL---YPFSTQMERV---RTLTDVRNLKFP-PLFTQKYPCEYVMVQDM 263
Query: 165 FVANSEKRITIPEIKNHPWF 184
+ +R I + F
Sbjct: 264 LSPSPMERPEAINIIENAVF 283
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-42
Identities = 39/219 (17%), Positives = 74/219 (33%), Gaps = 37/219 (16%)
Query: 1 MEYAAGGELFERIC-----NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL 55
E + G L I + F +++ + H +I H D+K +N +L
Sbjct: 146 GELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFIL 205
Query: 56 DGSTAPR---------VKICDFGYSKSSVLHSQPKSTV-----GTPAYIAPEVLTKKEYD 101
+ + + D G S + PK T+ T + E+L+ K ++
Sbjct: 206 GNGFLEQDDEDDLSAGLALIDLGQSID--MKLFPKGTIFTAKCETSGFQCVEMLSNKPWN 263
Query: 102 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGR----------ILSVHYSFPDYV 151
+I D + T+Y ML G Y E + + + R V + PD
Sbjct: 264 YQI-DYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCH 322
Query: 152 RVSL--ECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL 188
+ + L ++F + +I + + L
Sbjct: 323 HLPSLDLLRQKLKKVFQQHYTNKI---RALRNRLIVLLL 358
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-41
Identities = 40/204 (19%), Positives = 75/204 (36%), Gaps = 27/204 (13%)
Query: 1 MEYAAGGELFERI---CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG 57
M+ L + + C+ F Q+ V + HS + HRDLK N
Sbjct: 140 MQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTM 199
Query: 58 STAPRVKICDFGYSKSSVLHSQPKST-------------VGTPAYIAPEVLTKKEYDGKI 104
VK+ DFG + + ++ VGT Y++PE + Y K
Sbjct: 200 DD--VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK- 256
Query: 105 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 164
D++S G+ L+ +L Y F + I + ++ + + + + ++ +
Sbjct: 257 VDIFSLGLILFELL---YSFSTQM---ERVRIITDVRNLKFP-LLFTQKYPQEHMMVQDM 309
Query: 165 FVANSEKRITIPEIKNHPWFLRNL 188
+ +R +I + F NL
Sbjct: 310 LSPSPTERPEATDIIENAIF-ENL 332
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-37
Identities = 45/208 (21%), Positives = 71/208 (34%), Gaps = 34/208 (16%)
Query: 1 MEYAAGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD 56
EY GG L + I R F E E + Q+ G+ Y HSM + H D+K N +
Sbjct: 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFIS 149
Query: 57 -----------------GSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT-KK 98
S KI D G+ S P+ G ++A EVL
Sbjct: 150 RTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR---ISSPQVEEGDSRFLANEVLQENY 206
Query: 99 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 158
+ K AD+++ +T+ + + R+ + S E
Sbjct: 207 THLPK-ADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLPRIPQVL--------SQEFT 257
Query: 159 HLLSRIFVANSEKRITIPEIKNHPWFLR 186
LL + + E+R + + H L
Sbjct: 258 ELLKVMIHPDPERRPSAMALVKHSVLLS 285
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 7e-37
Identities = 49/198 (24%), Positives = 73/198 (36%), Gaps = 11/198 (5%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
ME GG L + I G ED A ++ Q + G+ Y H+ +I H D+K +N LL S
Sbjct: 129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS-SDG 187
Query: 61 PRVKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTL 114
R +CDFG++ GT ++APEV+ K D K D+WS +
Sbjct: 188 SRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK-VDIWSSCCMM 246
Query: 115 YVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRIT 174
ML G +P+ K I P + + R +
Sbjct: 247 LHMLNGCHPWTQYFRGPLCLK-IASEPPPIREIPP--SCAPLTAQAIQEGLRKEPVHRAS 303
Query: 175 IPEIKNHPWFLRNLPIEL 192
E++ L
Sbjct: 304 AMELRRKVGKALQEVGGL 321
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-33
Identities = 56/191 (29%), Positives = 93/191 (48%), Gaps = 15/191 (7%)
Query: 1 MEYAAGG---ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG 57
ME GG L + +E F+ +Q++ G+ Y H QI HRD+K +N L++
Sbjct: 98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT 157
Query: 58 STAPRVKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLTKKE--YDGKIADVWSCGVTL 114
+ +KI DFG SK + ++ ++ GT Y+APE++ K Y AD+WS G T+
Sbjct: 158 YSG-VLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA-ADIWSLGCTI 215
Query: 115 YVMLVGAYPFEDPEDPKN--FRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKR 172
M G PF + +P+ F+ +G VH P+ +S E K + + F + +KR
Sbjct: 216 IEMATGKPPFYELGEPQAAMFK--VGM-FKVHPEIPE--SMSAEAKAFILKCFEPDPDKR 270
Query: 173 ITIPEIKNHPW 183
++ +
Sbjct: 271 ACANDLLVDEF 281
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-31
Identities = 48/187 (25%), Positives = 86/187 (45%), Gaps = 11/187 (5%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--ICHRDLKLENTLLDGS 58
E G L + R + +Q++ G+ + H+ I HRDLK +N + G
Sbjct: 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP 167
Query: 59 TAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 118
T VKI D G + S K+ +GTP ++APE+ +++YD DV++ G+ + M
Sbjct: 168 TG-SVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMY-EEKYDES-VDVYAFGMCMLEMA 223
Query: 119 VGAYPFEDPEDPKN-FRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPE 177
YP+ + ++ +R+ + SF E K ++ N ++R +I +
Sbjct: 224 TSEYPYSECQNAAQIYRRVTSGVKPA--SFDK--VAIPEVKEIIEGCIRQNKDERYSIKD 279
Query: 178 IKNHPWF 184
+ NH +F
Sbjct: 280 LLNHAFF 286
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-29
Identities = 57/225 (25%), Positives = 89/225 (39%), Gaps = 43/225 (19%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGST 59
ME+ GG L + + AGR E +I G++Y +I HRD+K N L+ ++
Sbjct: 110 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV--NS 167
Query: 60 APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+K+CDFG S + S S VGT +Y++PE L Y + +D+WS G++L M V
Sbjct: 168 RGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAV 225
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH--------------LLSRI- 164
G YP P+ + ++ P R + LL I
Sbjct: 226 GRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIV 285
Query: 165 ------------------FVA-----NSEKRITIPEIKNHPWFLR 186
FV N +R + ++ H + R
Sbjct: 286 NEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-28
Identities = 46/136 (33%), Positives = 67/136 (49%), Gaps = 10/136 (7%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLI---SGVSYCHSMQ---ICHRDLKLENTL 54
MEYA GG L+ + A A + GV+Y HSMQ + HRDLK N L
Sbjct: 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLL 137
Query: 55 LDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTL 114
L + +KICDFG + + + + G+ A++APEV Y K DV+S G+ L
Sbjct: 138 LV-AGGTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVFEGSNYSEK-CDVFSWGIIL 193
Query: 115 YVMLVGAYPFEDPEDP 130
+ ++ PF++ P
Sbjct: 194 WEVITRRKPFDEIGGP 209
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-28
Identities = 54/196 (27%), Positives = 96/196 (48%), Gaps = 25/196 (12%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
ME+ GG L + I + R +E++ + ++ ++Y H+ + HRD+K ++ LL +
Sbjct: 121 MEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL--TLD 177
Query: 61 PRVKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
RVK+ DFG+ + S + KS VGTP ++APEV+++ Y + D+WS G+ + M+
Sbjct: 178 GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATE-VDIWSLGIMVIEMVD 236
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF--------VANSEK 171
G P+ + P + D L+ H +S + V + ++
Sbjct: 237 GEPPYFS-DSP----------VQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQE 285
Query: 172 RITIPEIKNHPWFLRN 187
R T E+ +HP FL
Sbjct: 286 RATAQELLDHP-FLLQ 300
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-28
Identities = 59/196 (30%), Positives = 91/196 (46%), Gaps = 25/196 (12%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY AGG L + + E + ++ + + + HS Q+ HRD+K +N LL
Sbjct: 96 MEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL--GMD 152
Query: 61 PRVKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
VK+ DFG+ + + S+ + VGTP ++APEV+T+K Y K D+WS G+ M+
Sbjct: 153 GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIE 211
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF--------VANSEK 171
G P+ + E+P L Y L+ LS IF + EK
Sbjct: 212 GEPPYLN-ENP----------LRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEK 260
Query: 172 RITIPEIKNHPWFLRN 187
R + E+ H FL+
Sbjct: 261 RGSAKELLQHQ-FLKI 275
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-27
Identities = 59/197 (29%), Positives = 87/197 (44%), Gaps = 28/197 (14%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY GG + + G E + ++++ G+ Y HS + HRD+K N LL S
Sbjct: 99 MEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL--SEH 155
Query: 61 PRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
VK+ DFG + ++T VGTP ++APEV+ + YD K AD+WS G+T +
Sbjct: 156 GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAR 214
Query: 120 GAYPFEDPEDPKNFRKTIGRI-------LSVHYS--FPDYVRVSLECKHLLSRIFVANSE 170
G P + P K + I L +YS ++V L
Sbjct: 215 GEPPHSE-LHP---MKVLFLIPKNNPPTLEGNYSKPLKEFVEACL----------NKEPS 260
Query: 171 KRITIPEIKNHPWFLRN 187
R T E+ H + LRN
Sbjct: 261 FRPTAKELLKHKFILRN 277
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-27
Identities = 49/198 (24%), Positives = 82/198 (41%), Gaps = 23/198 (11%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGST 59
ME + G E ++ + Y + HRD+K N LLD
Sbjct: 103 MELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD--E 160
Query: 60 APRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL-----TKKEYDGKIADVWSCGVT 113
++K+CDFG S V + K G AY+APE + TK +YD + ADVWS G++
Sbjct: 161 RGQIKLCDFGISGRLV-DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIR-ADVWSLGIS 218
Query: 114 LYVMLVGAYPFEDPEDPKNFRKTIGRILS--VHY---SFPDYVRVSLECKHLLSRIFVAN 168
L + G +P+++ KT +L+ + P ++ S + + + +
Sbjct: 219 LVELATGQFPYKNC-------KTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKD 271
Query: 169 SEKRITIPEIKNHPWFLR 186
KR ++ H + R
Sbjct: 272 HRKRPKYNKLLEHSFIKR 289
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-26
Identities = 56/197 (28%), Positives = 89/197 (45%), Gaps = 25/197 (12%)
Query: 1 MEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
MEY G + + I +EDE Q + G+ Y H M+ HRD+K N LL +T
Sbjct: 103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL--NT 160
Query: 60 APRVKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 118
K+ DFG + + + ++ + +GTP ++APEV+ + Y+ AD+WS G+T M
Sbjct: 161 EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCV-ADIWSLGITAIEMA 219
Query: 119 VGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF--------VANSE 170
G P+ D P + + P + L S F V + E
Sbjct: 220 EGKPPYAD-IHP----------MRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPE 268
Query: 171 KRITIPEIKNHPWFLRN 187
+R T ++ HP F+R+
Sbjct: 269 QRATATQLLQHP-FVRS 284
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-26
Identities = 52/197 (26%), Positives = 87/197 (44%), Gaps = 20/197 (10%)
Query: 1 MEYAAGG--ELFERICN-AGRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLD 56
ME + ++++ + ED ++ + + HS + + HRD+K N L++
Sbjct: 85 MELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLIN 144
Query: 57 GSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEV----LTKKEYDGKIADVWSCG 111
+VK+CDFG S V K G Y+APE L +K Y K +D+WS G
Sbjct: 145 --ALGQVKMCDFGISGYLV-DDVAKDIDAGCKPYMAPERINPELNQKGYSVK-SDIWSLG 200
Query: 112 VTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP--DYVRVSLECKHLLSRIFVANS 169
+T+ + + +P++ P K + V P + S E S+ NS
Sbjct: 201 ITMIELAILRFPYDSWGTPFQQLKQV-----VEEPSPQLPADKFSAEFVDFTSQCLKKNS 255
Query: 170 EKRITIPEIKNHPWFLR 186
++R T PE+ HP+F
Sbjct: 256 KERPTYPELMQHPFFTL 272
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 58/208 (27%), Positives = 85/208 (40%), Gaps = 36/208 (17%)
Query: 18 RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH 77
+ + QL ++Y HS ICHRD+K +N LLD TA +K+CDFG +K L
Sbjct: 152 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK--QLV 208
Query: 78 SQPKST--VGTPAYIAPEV-LTKKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPED--- 129
+ + + Y APE+ +Y I DVWS G L +L+G +P + D
Sbjct: 209 RGEPNVSYICSRYYRAPELIFGATDYTSSI-DVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 130 --------PKNFRKTIGRILS--VHYSFPDYVRVSL----------ECKHLLSRIFVANS 169
P R+ I + + FP E L SR+
Sbjct: 268 EIIKVLGTPT--REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 325
Query: 170 EKRITIPEIKNHPWF--LRNLPIELTEG 195
R+T E H +F LR+ ++L G
Sbjct: 326 TARLTPLEACAHSFFDELRDPNVKLPNG 353
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-25
Identities = 48/129 (37%), Positives = 67/129 (51%), Gaps = 9/129 (6%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL--DGS 58
MEY G L E I + G S D A F Q++ G+ + H M+I HRD+K +N L+ +
Sbjct: 90 MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNK- 148
Query: 59 TAPRVKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYV 116
+KI DFG +K S +Q +GT Y +PE + D D++S G+ LY
Sbjct: 149 ---TLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC-TDIYSIGIVLYE 204
Query: 117 MLVGAYPFE 125
MLVG PF
Sbjct: 205 MLVGEPPFN 213
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-25
Identities = 52/208 (25%), Positives = 85/208 (40%), Gaps = 36/208 (17%)
Query: 18 RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH 77
+ + QL+ ++Y HS+ ICHRD+K +N LLD + +K+ DFG +K +L
Sbjct: 137 TMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG-VLKLIDFGSAK--ILI 193
Query: 78 SQPKST--VGTPAYIAPEV-LTKKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPED--- 129
+ + + + Y APE+ Y I D+WS G + ++ G +P E D
Sbjct: 194 AGEPNVSYICSRYYRAPELIFGATNYTTNI-DIWSTGCVMAELMQGQPLFPGESGIDQLV 252
Query: 130 --------PKNFRKTIGRILS--VHYSFPDYVRVSL----------ECKHLLSRIFVANS 169
P R+ I + + + FP + L+SR+
Sbjct: 253 EIIKVLGTPS--REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTP 310
Query: 170 EKRITIPEIKNHPWF--LRNLPIELTEG 195
R+T E HP+F LR + G
Sbjct: 311 SARLTAIEALCHPFFDELRTGEARMPNG 338
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-25
Identities = 34/134 (25%), Positives = 56/134 (41%), Gaps = 11/134 (8%)
Query: 1 MEYAAGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSM--QICHRDLKLENTLLDG 57
ME+ G+L+ R+ + + G+ Y + I HRDL+ N L
Sbjct: 100 MEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQS 159
Query: 58 STAPR---VKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT--KKEYDGKIADVWSCGV 112
K+ DFG S+ +G ++APE + ++ Y K AD +S +
Sbjct: 160 LDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQWMAPETIGAEEESYTEK-ADTYSFAM 216
Query: 113 TLYVMLVGAYPFED 126
LY +L G PF++
Sbjct: 217 ILYTILTGEGPFDE 230
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-25
Identities = 55/221 (24%), Positives = 85/221 (38%), Gaps = 32/221 (14%)
Query: 18 RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH 77
+ + QL V + HS+ ICHRD+K +N L++ +K+CDFG +K +
Sbjct: 137 SIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN-TLKLCDFGSAKKLIPS 195
Query: 78 SQPKSTVGTPAYIAPEV-LTKKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPED----- 129
+ + + Y APE+ L EY I D+WS G +++G + E D
Sbjct: 196 EPSVAYICSRFYRAPELMLGATEYTPSI-DLWSIGCVFGELILGKPLFSGETSIDQLVRI 254
Query: 130 ------PKNFRKTIGRILSVH--YSFPDYVRVSL----------ECKHLLSRIFVANSEK 171
P ++ + R+ + FP LL +I +
Sbjct: 255 IQIMGTPT--KEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312
Query: 172 RITIPEIKNHPWF--LRNLPIELTEGGSWQSHDVNNPSQSL 210
RI E HP+F LRN + S H VN L
Sbjct: 313 RINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQL 353
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-25
Identities = 42/134 (31%), Positives = 69/134 (51%), Gaps = 11/134 (8%)
Query: 1 MEYAAGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
ME+ G + + + E+ + ++++ G+S+ H ++ HRD+K +N LL +
Sbjct: 106 MEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL--T 163
Query: 59 TAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKE-----YDGKIADVWSCGV 112
VK+ DFG S ++T +GTP ++APEV+ E YD K +D+WS G+
Sbjct: 164 ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFK-SDLWSLGI 222
Query: 113 TLYVMLVGAYPFED 126
T M GA P D
Sbjct: 223 TAIEMAEGAPPLCD 236
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-25
Identities = 43/135 (31%), Positives = 61/135 (45%), Gaps = 12/135 (8%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM---QICHRDLKLENTLLDG 57
ME+A GG L + R D + Q+ G++Y H I HRDLK N L+
Sbjct: 85 MEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQ 143
Query: 58 STAPR------VKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCG 111
+KI DFG ++ + S G A++APEV+ + +DVWS G
Sbjct: 144 KVENGDLSNKILKITDFGLARE-WHRTTKMSAAGAYAWMAPEVIRASMFSKG-SDVWSYG 201
Query: 112 VTLYVMLVGAYPFED 126
V L+ +L G PF
Sbjct: 202 VLLWELLTGEVPFRG 216
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 6e-25
Identities = 43/134 (32%), Positives = 66/134 (49%), Gaps = 13/134 (9%)
Query: 1 MEYAAGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHSM--QICHRDLKLENTLL 55
EY + G L+ + +G E + G++Y H+ I HR+LK N L+
Sbjct: 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV 172
Query: 56 DGSTAPRVKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGV 112
D VK+CDFG S+ + S KS GTP ++APEVL + + K +DV+S GV
Sbjct: 173 DKK--YTVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEK-SDVYSFGV 227
Query: 113 TLYVMLVGAYPFED 126
L+ + P+ +
Sbjct: 228 ILWELATLQQPWGN 241
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 8e-25
Identities = 46/202 (22%), Positives = 84/202 (41%), Gaps = 26/202 (12%)
Query: 1 MEYAAGG--ELFERICNA--GRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLL 55
ME + + ++ + + E+ + +++ ++I HRD+K N LL
Sbjct: 100 MELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILL 159
Query: 56 DGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL----TKKEYDGKIADVWSCG 111
D + +K+CDFG S V G Y+APE + +++ YD + +DVWS G
Sbjct: 160 D--RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVR-SDVWSLG 216
Query: 112 VTLYVMLVGAYPFEDPEDPKNFRKTIGRILS--VHYSFP-----DYVRVSLECKHLLSRI 164
+TLY + G +P+ ++ L+ V P + S + ++
Sbjct: 217 ITLYELATGRFPYPKWN-------SVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLC 269
Query: 165 FVANSEKRITIPEIKNHPWFLR 186
+ KR E+ HP+ L
Sbjct: 270 LTKDESKRPKYKELLKHPFILM 291
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 9e-25
Identities = 31/132 (23%), Positives = 55/132 (41%), Gaps = 12/132 (9%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSMQ--ICHRDLKLENTLLD 56
+ G L+ + F D+++ F + G+++ H+++ I L + ++D
Sbjct: 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID 147
Query: 57 GSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI--ADVWSCGVTL 114
+I S Q + PA++APE L KK D AD+WS V L
Sbjct: 148 EDM--TARISMADVKFSF----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLL 201
Query: 115 YVMLVGAYPFED 126
+ ++ PF D
Sbjct: 202 WELVTREVPFAD 213
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-24
Identities = 41/157 (26%), Positives = 63/157 (40%), Gaps = 25/157 (15%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL--DGS 58
MEY G L + + G + A +++ H I HRD+K N ++
Sbjct: 95 MEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN- 153
Query: 59 TAPRVKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTL 114
VK+ DFG + S +Q + +GT Y++PE D + +DV+S G L
Sbjct: 154 ---AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVL 209
Query: 115 YVMLVGAYPF--------------EDPEDPKNFRKTI 137
Y +L G PF EDP P + +
Sbjct: 210 YEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 246
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-24
Identities = 30/125 (24%), Positives = 52/125 (41%), Gaps = 10/125 (8%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY G L + EA + +++ +SY HS+ + + DLK EN +L
Sbjct: 163 MEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-- 218
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
++K+ D G + GTP + APE++ D+++ G TL + +
Sbjct: 219 -QLKLIDLGAVSR---INSFGYLYGTPGFQAPEIVRTGPTVA--TDIYTVGRTLAALTLD 272
Query: 121 AYPFE 125
Sbjct: 273 LPTRN 277
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-24
Identities = 34/127 (26%), Positives = 58/127 (45%), Gaps = 5/127 (3%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
M G +L + G + A +Q+ S + H+ HRD+K EN L+
Sbjct: 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSAD-- 170
Query: 61 PRVKICDFG--YSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 118
+ DFG + + +Q +TVGT Y+APE ++ + AD+++ LY L
Sbjct: 171 DFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYR-ADIYALTCVLYECL 229
Query: 119 VGAYPFE 125
G+ P++
Sbjct: 230 TGSPPYQ 236
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 7e-24
Identities = 47/200 (23%), Positives = 84/200 (42%), Gaps = 21/200 (10%)
Query: 1 MEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
++ G L+ + + +F + +Q G+ Y H+ I HRDLK N L
Sbjct: 98 TQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHED- 156
Query: 60 APRVKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLTKKE---YDGKIADVWSCGVT 113
VKI DFG + Q + G+ ++APEV+ ++ Y + +DV++ G+
Sbjct: 157 -NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ-SDVYAFGIV 214
Query: 114 LYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC----KHLLSRIFVANS 169
LY ++ G P+ + + + +GR PD +V C K L++
Sbjct: 215 LYELMTGQLPYSNINNRDQIIEMVGR----GSLSPDLSKVRSNCPKRMKRLMAECLKKKR 270
Query: 170 EKRITIPEIKNHPWFLRNLP 189
++R + P I + L
Sbjct: 271 DERPSFPRILAE---IEELA 287
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-23
Identities = 45/202 (22%), Positives = 81/202 (40%), Gaps = 39/202 (19%)
Query: 18 RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH 77
++ + RF+ +++ + YCHSM I HRD+K N ++D ++++ D+G ++ H
Sbjct: 126 TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFY--H 182
Query: 78 SQPKST--VGTPAYIAPEVL-TKKEYDGKIADVWSCGVTLYVMLVGAYPF---EDPED-- 129
+ V + + PE+L + YD + D+WS G L M+ PF D D
Sbjct: 183 PGQEYNVRVASRYFKGPELLVDYQMYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQL 241
Query: 130 -----------PKNFRKTIGRILSVHY--SFPDYVR--------------VSLECKHLLS 162
++ L + + R VS E L
Sbjct: 242 VRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLD 301
Query: 163 RIFVANSEKRITIPEIKNHPWF 184
++ + + R+T E HP+F
Sbjct: 302 KLLRYDHQSRLTAREAMEHPYF 323
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 1e-23
Identities = 31/142 (21%), Positives = 57/142 (40%), Gaps = 20/142 (14%)
Query: 1 MEYAAGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
G L+ + +A ++ R Q+++ G+ Y H+ I H+DLK +N D
Sbjct: 108 TSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGK 167
Query: 60 APRVKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVL---------TKKEYDGKI 104
V I DFG + + + G ++APE++ K +
Sbjct: 168 ---VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKH- 223
Query: 105 ADVWSCGVTLYVMLVGAYPFED 126
+DV++ G Y + +PF+
Sbjct: 224 SDVFALGTIWYELHAREWPFKT 245
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 2e-23
Identities = 34/138 (24%), Positives = 59/138 (42%), Gaps = 15/138 (10%)
Query: 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
+ A G + IC +E + Q ++ + Y H M HR +K + L+
Sbjct: 105 TSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD 164
Query: 59 TAPRVKICDFGYS--------KSSVLHSQPKSTVGTPAYIAPEVLT--KKEYDGKIADVW 108
V + + + V+H PK +V +++PEVL + YD K +D++
Sbjct: 165 GK--VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK-SDIY 221
Query: 109 SCGVTLYVMLVGAYPFED 126
S G+T + G PF+D
Sbjct: 222 SVGITACELANGHVPFKD 239
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-23
Identities = 54/215 (25%), Positives = 89/215 (41%), Gaps = 25/215 (11%)
Query: 1 MEYAAGGELF--------ERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLEN 52
M+ +GG + + +G E ++++ G+ Y H HRD+K N
Sbjct: 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGN 151
Query: 53 TLLDGSTAPRVKICDFGYS------KSSVLHSQPKSTVGTPAYIAPEVLTK-KEYDGKIA 105
LL + V+I DFG S + K+ VGTP ++APEV+ + + YD K A
Sbjct: 152 ILLGEDGS--VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFK-A 208
Query: 106 DVWSCGVTLYVMLVGAYPFEDPEDP-----KNFRKTIGRILSVHYSFPDYVRVSLECKHL 160
D+WS G+T + GA P+ P + + + + + +
Sbjct: 209 DIWSFGITAIELATGAAPYHK-YPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKM 267
Query: 161 LSRIFVANSEKRITIPEIKNHPWFLRNLPIE-LTE 194
+S + EKR T E+ H +F + E L E
Sbjct: 268 ISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQE 302
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 7e-23
Identities = 50/206 (24%), Positives = 86/206 (41%), Gaps = 29/206 (14%)
Query: 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
+E+ GG + + +E + + +Q++ +++ HS +I HRDLK N L+ +
Sbjct: 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM--TL 152
Query: 60 APRVKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLT-----KKEYDGKIADVWSCGVT 113
+++ DFG S K+ + S +GTP ++APEV+ YD K AD+WS G+T
Sbjct: 153 EGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYK-ADIWSLGIT 211
Query: 114 LYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF-------- 165
L M P + +P + V +L S F
Sbjct: 212 LIEMAQIEPPHHE-LNP----------MRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIAL 260
Query: 166 VANSEKRITIPEIKNHPWFLRNLPIE 191
N E R + ++ HP+ +
Sbjct: 261 DKNPETRPSAAQLLEHPFVSSITSNK 286
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-22
Identities = 43/129 (33%), Positives = 60/129 (46%), Gaps = 9/129 (6%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY G + E E + G++Y HS + HRD+K N LL S
Sbjct: 133 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL--SEP 190
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV---LTKKEYDGKIADVWSCGVTLYVM 117
VK+ DFG + + S VGTP ++APEV + + +YDGK DVWS G+T +
Sbjct: 191 GLVKLGDFGSASI---MAPANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIEL 246
Query: 118 LVGAYPFED 126
P +
Sbjct: 247 AERKPPLFN 255
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 5e-22
Identities = 46/221 (20%), Positives = 73/221 (33%), Gaps = 53/221 (23%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--------ICHRDLKLEN 52
Y G L++ + + SG+++ H I HRDLK +N
Sbjct: 85 THYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKN 143
Query: 53 TLLDGSTAPRVKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVL------TKKEYD 101
L+ + + I D G + ++ L VGT Y+APEVL +
Sbjct: 144 ILVKKNG--QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSY 201
Query: 102 GKIADVWSCGVTLYVMLVGAY----------PFED--PEDP-----------KNFRKTIG 138
+ D+W+ G+ L+ + PF D P DP R I
Sbjct: 202 KR-VDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIP 260
Query: 139 RILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIK 179
+ ++ EC + N R+T IK
Sbjct: 261 NRWFSDPTLTSLAKLMKECWY-------QNPSARLTALRIK 294
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 9e-22
Identities = 48/205 (23%), Positives = 73/205 (35%), Gaps = 37/205 (18%)
Query: 12 RICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYS 71
+ G E+ AR F QL+ G+ Y HS + HRDLK N ++ + +KI DFG +
Sbjct: 110 NVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN-TEDLVLKIGDFGLA 168
Query: 72 KSSVLHSQPKST----VGTPAYIAPEV-LTKKEYDGKIADVWSCGVTLYVMLVGAYPFE- 125
+ H K + T Y +P + L+ Y I D+W+ G ML G F
Sbjct: 169 RIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAI-DMWAAGCIFAEMLTGKTLFAG 227
Query: 126 -----------------DPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK---------H 159
ED + I + + L
Sbjct: 228 AHELEQMQLILESIPVVHEEDRQELLSVIPVYIR---NDMTEPHKPLTQLLPGISREAVD 284
Query: 160 LLSRIFVANSEKRITIPEIKNHPWF 184
L +I + R+T E +HP+
Sbjct: 285 FLEQILTFSPMDRLTAEEALSHPYM 309
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 9e-22
Identities = 44/206 (21%), Positives = 71/206 (34%), Gaps = 42/206 (20%)
Query: 14 CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS 73
+ + +Q + G+ + H+ I HRDLK EN L+ VK+ DFG ++
Sbjct: 112 APPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG--TVKLADFGLARI 169
Query: 74 SVLHSQPK---STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPE 128
+S V T Y APEVL + Y + D+WS G M +
Sbjct: 170 ---YSYQMALTPVVVTLWYRAPEVLLQSTYATPV-DMWSVGCIFAEMFRRKPLFCGNSEA 225
Query: 129 DPKNFRKTIGRILSV----------------HYSFPDYVRVSLECK---------HLLSR 163
D +G+I + +FP ++ LL
Sbjct: 226 D------QLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLE 279
Query: 164 IFVANSEKRITIPEIKNHPWFLRNLP 189
+ N KRI+ H + ++
Sbjct: 280 MLTFNPHKRISAFRALQHSYLHKDEG 305
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-21
Identities = 46/209 (22%), Positives = 82/209 (39%), Gaps = 33/209 (15%)
Query: 18 RFSEDEARFFFQQLISGVSYCH--SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV 75
+ F QLI + H S+ +CHRD+K N L++ + +K+CDFG +K
Sbjct: 125 APPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG-TLKLCDFGSAKKLS 183
Query: 76 LHSQPKSTVGTPAYIAPEV-LTKKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPED--- 129
+ + + Y APE+ + Y + D+WS G M++G + ++
Sbjct: 184 PSEPNVAYICSRYYRAPELIFGNQHYTTAV-DIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242
Query: 130 ------------------PKNFRKTIGRILSVHYS--FPDYV-RVSLECKHLLSRIFVAN 168
P + + + +S F D+ + + E LLS +
Sbjct: 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYL 302
Query: 169 SEKRITIPEIKNHPWF--LRNLPIELTEG 195
E+R+ E HP+F L + +L
Sbjct: 303 PEERMKPYEALCHPYFDELHDPATKLPNN 331
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 3e-21
Identities = 53/212 (25%), Positives = 85/212 (40%), Gaps = 43/212 (20%)
Query: 15 NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPR---VKICDFGYS 71
S + F QLI+GV++CHS + HRDLK +N LL S A +KI DFG +
Sbjct: 125 KNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184
Query: 72 KSSVLHSQPKST-VGTPAYIAPEVLT-KKEYDGKIADVWSCGVTLYVMLVGA--YPFEDP 127
++ + + + + T Y PE+L + Y + D+WS ML+ +P +
Sbjct: 185 RAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSV-DIWSIACIWAEMLMKTPLFPGDSE 243
Query: 128 EDPKNFRKTIGRILSV------------------HYSFPDYVRVSL----------ECKH 159
D + +I V SFP + +L E
Sbjct: 244 ID------QLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLD 297
Query: 160 LLSRIFVANSEKRITIPEIKNHPWFLRNLPIE 191
LL+ + + KRI+ HP+F + +
Sbjct: 298 LLTAMLEMDPVKRISAKNALEHPYF-SHNDFD 328
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 4e-21
Identities = 49/203 (24%), Positives = 82/203 (40%), Gaps = 34/203 (16%)
Query: 17 GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL 76
+ ++F QL+ G+++CH +I HRDLK +N L++ ++K+ DFG +++ +
Sbjct: 103 RGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRG--QLKLGDFGLARAFGI 160
Query: 77 HSQPKST-VGTPAYIAPEVLT-KKEYDGKIADVWSCGVTLYVMLVGA------------- 121
S+ V T Y AP+VL + Y I D+WSCG L M+ G
Sbjct: 161 PVNTFSSEVVTLWYRAPDVLMGSRTYSTSI-DIWSCGCILAEMITGKPLFPGTNDEEQLK 219
Query: 122 -------YPFED--------PEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFV 166
P E P+ N ++ R L + L +
Sbjct: 220 LIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQ 279
Query: 167 ANSEKRITIPEIKNHPWFLRNLP 189
N + R++ + +HPWF
Sbjct: 280 LNPDMRLSAKQALHHPWF-AEYY 301
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 4e-21
Identities = 50/199 (25%), Positives = 83/199 (41%), Gaps = 40/199 (20%)
Query: 17 GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL 76
G A+ F QL++G++YCH ++ HRDLK +N L++ +KI DFG +++ +
Sbjct: 95 GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG--ELKIADFGLARAFGI 152
Query: 77 HSQPKST-VGTPAYIAPEVLT-KKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPEDPKN 132
+ + + T Y AP+VL K+Y I D+WS G M+ G +P D
Sbjct: 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTI-DIWSVGCIFAEMVNGTPLFPGVSEAD--- 208
Query: 133 FRKTIGRILSV------------------HYSFPDYVRVSL---------ECKHLLSRIF 165
+ RI + +F Y + LLS++
Sbjct: 209 ---QLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKML 265
Query: 166 VANSEKRITIPEIKNHPWF 184
+ +RIT + H +F
Sbjct: 266 KLDPNQRITAKQALEHAYF 284
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 4e-21
Identities = 50/205 (24%), Positives = 78/205 (38%), Gaps = 41/205 (20%)
Query: 14 CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS 73
+ + QL+ G+ + HS ++ HRDLK +N L+ S ++K+ DFG ++
Sbjct: 112 VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADFGLARI 169
Query: 74 SVLHSQPKST--VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPED 129
Q T V T Y APEVL + Y + D+WS G M + D
Sbjct: 170 --YSFQMALTSVVVTLWYRAPEVLLQSSYATPV-DLWSVGCIFAEMFRRKPLFRGSSDVD 226
Query: 130 PKNFRKTIGRILSV----------------HYSFPDYVRVSLECK---------HLLSRI 164
+G+IL V +F +E LL +
Sbjct: 227 ------QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKC 280
Query: 165 FVANSEKRITIPEIKNHPWFLRNLP 189
N KRI+ +HP+F ++L
Sbjct: 281 LTFNPAKRISAYSALSHPYF-QDLE 304
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 88.3 bits (220), Expect = 7e-21
Identities = 49/205 (23%), Positives = 82/205 (40%), Gaps = 42/205 (20%)
Query: 17 GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL 76
G + + F QL+ G+ +CHS + HRDLK +N L++ + +K+ +FG +++ +
Sbjct: 96 GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG--ELKLANFGLARAFGI 153
Query: 77 HSQPKST-VGTPAYIAPEVLT-KKEYDGKIADVWSCGVTLYVMLVGAYPF---EDPEDPK 131
+ S V T Y P+VL K Y I D+WS G + P D +D
Sbjct: 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSI-DMWSAGCIFAELANAGRPLFPGNDVDD-- 210
Query: 132 NFRKTIGRILSV-----------HYSFPDYV----------------RVSLECKHLLSRI 164
+ RI + PDY +++ + LL +
Sbjct: 211 ----QLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNL 266
Query: 165 FVANSEKRITIPEIKNHPWFLRNLP 189
N +RI+ E HP+F +
Sbjct: 267 LKCNPVQRISAEEALQHPYF-SDFC 290
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 9e-21
Identities = 51/195 (26%), Positives = 85/195 (43%), Gaps = 35/195 (17%)
Query: 18 RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH 77
+FSE++ ++ Q++ G+ Y HS + HRDLK N ++ +KI DFG ++
Sbjct: 122 KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC--ELKILDFGLARH---- 175
Query: 78 SQPKST--VGTPAYIAPEV-LTKKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPED--- 129
+ + T V T Y APEV L+ Y+ + D+WS G + ML G + +D D
Sbjct: 176 ADAEMTGYVVTRWYRAPEVILSWMHYNQTV-DIWSVGCIMAEMLTGKTLFKGKDYLDQLT 234
Query: 130 ---------PKNFRKTIGRILSVHY--SFPDYVRVSL---------ECKHLLSRIFVANS 169
F + + + Y S P R + LL ++ +
Sbjct: 235 QILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDV 294
Query: 170 EKRITIPEIKNHPWF 184
+KR+T + HP+F
Sbjct: 295 DKRLTAAQALTHPFF 309
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-20
Identities = 52/201 (25%), Positives = 84/201 (41%), Gaps = 35/201 (17%)
Query: 12 RICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYS 71
I + ++D +F Q++ G+ Y HS I HRDLK N ++ +KI DFG +
Sbjct: 122 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC--ELKILDFGLA 179
Query: 72 KSSVLHSQPKST--VGTPAYIAPEV-LTKKEYDGKIADVWSCGVTLYVMLVGA--YPFED 126
+ + + T V T Y APE+ L Y+ + D+WS G + +L G +P D
Sbjct: 180 RH----TADEMTGYVATRWYRAPEIMLNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTD 234
Query: 127 PED------------PKNFRKTIGRILSVHY--SFPDYVRVSL---------ECKHLLSR 163
D K I + +Y S +++ LL +
Sbjct: 235 HIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK 294
Query: 164 IFVANSEKRITIPEIKNHPWF 184
+ V +S+KRIT + H +F
Sbjct: 295 MLVLDSDKRITAAQALAHAYF 315
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 1e-20
Identities = 49/208 (23%), Positives = 90/208 (43%), Gaps = 42/208 (20%)
Query: 17 GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL 76
+ + + + QL+ GV++CH +I HRDLK +N L++ +K+ DFG +++ +
Sbjct: 114 TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG--ALKLADFGLARAFGI 171
Query: 77 HSQPKST-VGTPAYIAPEVLT-KKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPEDPKN 132
+ + V T Y AP+VL K+Y + D+WS G M+ G +P +D
Sbjct: 172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSV-DIWSIGCIFAEMITGKPLFPGVTDDD--- 227
Query: 133 FRKTIGRILSV-------------------HYSFPDYVRVSLECK---------HLLSRI 164
+ +I S+ +F + + LLS +
Sbjct: 228 ---QLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNM 284
Query: 165 FVANSEKRITIPEIKNHPWFLRNLPIEL 192
+ KRI+ + NHP+F ++L ++
Sbjct: 285 LCFDPNKRISARDAMNHPYF-KDLDPQI 311
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-20
Identities = 37/200 (18%), Positives = 70/200 (35%), Gaps = 34/200 (17%)
Query: 14 CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS 73
S ++F ++ G+ H + HRDL N LL + + ICDF ++
Sbjct: 126 DQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN--DITICDFNLARE 183
Query: 74 SVLHSQPKSTVGTPAYIAPEV-LTKKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPED- 129
+ V Y APE+ + K + + D+WS G + M + +
Sbjct: 184 DTADANKTHYVTHRWYRAPELVMQFKGFTKLV-DMWSAGCVMAEMFNRKALFRGSTFYNQ 242
Query: 130 ----------PKNFRKTIGRILS------VHYSFPDYVRVSL---------ECKHLLSRI 164
PK + + S + S + + L++++
Sbjct: 243 LNKIVEVVGTPK--IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKM 300
Query: 165 FVANSEKRITIPEIKNHPWF 184
N ++RI+ + HP+F
Sbjct: 301 LEFNPQRRISTEQALRHPYF 320
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-20
Identities = 51/201 (25%), Positives = 85/201 (42%), Gaps = 35/201 (17%)
Query: 12 RICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYS 71
++ + ED +F Q++ G+ Y H+ I HRDLK N ++ +KI DFG +
Sbjct: 118 KLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC--ELKILDFGLA 175
Query: 72 KSSVLHSQPKST--VGTPAYIAPEV-LTKKEYDGKIADVWSCGVTLYVMLVGA--YPFED 126
+ + + T V T Y APEV L Y + D+WS G + M+ G + D
Sbjct: 176 RQ----ADSEMTGYVVTRWYRAPEVILNWMRYTQTV-DIWSVGCIMAEMITGKTLFKGSD 230
Query: 127 PED------------PKNFRKTIGRILSVHY--SFPDYVRVSL---------ECKHLLSR 163
D P F + + + +Y P+ + +LL +
Sbjct: 231 HLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEK 290
Query: 164 IFVANSEKRITIPEIKNHPWF 184
+ V ++E+R+T E HP+F
Sbjct: 291 MLVLDAEQRVTAGEALAHPYF 311
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-20
Identities = 46/205 (22%), Positives = 83/205 (40%), Gaps = 42/205 (20%)
Query: 17 GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL 76
+ + F QL+ G++YCH ++ HRDLK +N L++ +K+ DFG +++ +
Sbjct: 95 NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE--LKLADFGLARAKSI 152
Query: 77 HSQPKST-VGTPAYIAPEVLT-KKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPEDPKN 132
++ V T Y P++L +Y +I D+W G Y M G +P E+
Sbjct: 153 PTKTYDNEVVTLWYRPPDILLGSTDYSTQI-DMWGVGCIFYEMATGRPLFPGSTVEE--- 208
Query: 133 FRKTIGRILSV-------------------HYSFPDYVRVSLECK---------HLLSRI 164
+ I + Y++P Y +L LL+++
Sbjct: 209 ---QLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKL 265
Query: 165 FVANSEKRITIPEIKNHPWFLRNLP 189
RI+ + HP+F +L
Sbjct: 266 LQFEGRNRISAEDAMKHPFF-LSLG 289
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-20
Identities = 39/143 (27%), Positives = 62/143 (43%), Gaps = 19/143 (13%)
Query: 1 MEYAAGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
EY GG L I + + + F + + SG++Y HSM I HRDL N L+ +
Sbjct: 86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENK 145
Query: 60 APRVKICDFGYSK---------------SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 104
V + DFG ++ + + VG P ++APE++ + YD K
Sbjct: 146 --NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEK- 202
Query: 105 ADVWSCGVTLYVMLVGAYPFEDP 127
DV+S G+ L ++ D
Sbjct: 203 VDVFSFGIVLCEIIGRVNADPDY 225
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-20
Identities = 51/225 (22%), Positives = 69/225 (30%), Gaps = 58/225 (25%)
Query: 19 FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78
FS R F ++ + H +I H DLK EN LL +K+ DFG SS
Sbjct: 197 FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG---SSCYEH 253
Query: 79 QPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY---------------------V 116
Q T + + Y APEV+ Y I D+WS G L +
Sbjct: 254 QRVYTYIQSRFYRAPEVILGARYGMPI-DMWSLGCILAELLTGYPLLPGEDEGDQLACMI 312
Query: 117 MLVGAYP-------------FEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC------ 157
L+G P+ T SV + R L
Sbjct: 313 ELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESRE 372
Query: 158 -------------KHLLSRIFVANSEKRITIPEIKNHPWFLRNLP 189
L + + R+T + HPW R LP
Sbjct: 373 WGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLP 417
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 8e-20
Identities = 48/222 (21%), Positives = 77/222 (34%), Gaps = 53/222 (23%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS--------MQICHRDLKLEN 52
+Y G LF+ + N + + SG+++ H I HRDLK +N
Sbjct: 119 SDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKN 177
Query: 53 TLLDGSTAPRVKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVL------TKKEYD 101
L+ + I D G + + + P VGT Y+APEVL E
Sbjct: 178 ILVKKN--GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF 235
Query: 102 GKIADVWSCGVTLYVMLVG----------AYPFED--PEDP-----------KNFRKTIG 138
+ AD+++ G+ + + P+ D P DP + R I
Sbjct: 236 KR-ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIP 294
Query: 139 RILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
+ ++ EC + AN R+T IK
Sbjct: 295 NRWQSCEALRVMAKIMRECWY-------ANGAARLTALRIKK 329
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-19
Identities = 52/243 (21%), Positives = 90/243 (37%), Gaps = 47/243 (19%)
Query: 18 RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH 77
+ + Q++ G+ + HS I HRDLK N ++ +KI DFG ++++
Sbjct: 123 ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAGTS 180
Query: 78 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFE------------ 125
V T Y APEV+ Y + D+WS G + M+ G F
Sbjct: 181 FMMTPYVVTRYYRAPEVILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 239
Query: 126 ------DPEDPKNFRKTIGRILSVHYSFPDYVRVSL---------------------ECK 158
PE K + T+ + + P Y S + +
Sbjct: 240 EQLGTPCPEFMKKLQPTVRTYVE---NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQAR 296
Query: 159 HLLSRIFVANSEKRITIPEIKNHPWF--LRNLPIELTEGGSWQSHDVNNPSQSLEEVLSL 216
LLS++ V ++ KRI++ E HP+ + ++ ++EE L
Sbjct: 297 DLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKEL 356
Query: 217 IHE 219
I++
Sbjct: 357 IYK 359
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-19
Identities = 48/196 (24%), Positives = 79/196 (40%), Gaps = 32/196 (16%)
Query: 17 GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL 76
+ + Q+I+G+ +CHS I HRD+K EN L+ S VK+CDFG++++
Sbjct: 119 NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG--VVKLCDFGFARTLAA 176
Query: 77 HSQPKST-VGTPAYIAPEVLT-KKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPED--P 130
+ V T Y APE+L +Y + DVW+ G + M +G +P + D
Sbjct: 177 PGEVYDDEVATRWYRAPELLVGDVKYGKAV-DVWAIGCLVTEMFMGEPLFPGDSDIDQLY 235
Query: 131 KNFRKTIG----RILSVHYSFPDYVRVSL------------------ECKHLLSRIFVAN 168
+G R + P + V L L + +
Sbjct: 236 HIMM-CLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHID 294
Query: 169 SEKRITIPEIKNHPWF 184
+KR E+ +H +F
Sbjct: 295 PDKRPFCAELLHHDFF 310
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 1e-19
Identities = 46/201 (22%), Positives = 79/201 (39%), Gaps = 37/201 (18%)
Query: 19 FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78
E + Q + V++CH HRD+K EN L+ + +K+CDFG+++ L
Sbjct: 99 VPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHS--VIKLCDFGFARL--LTG 154
Query: 79 QPKS-T--VGTPAYIAPEVLTK-KEYDGKIADVWSCGVTLYVMLVGA--YPFEDPED--P 130
V T Y +PE+L +Y + DVW+ G +L G +P + D
Sbjct: 155 PSDYYDDEVATRWYRSPELLVGDTQYGPPV-DVWAIGCVFAELLSGVPLWPGKSDVDQLY 213
Query: 131 KNFRKTIG----RILSVHYSFPDYVRVSL------------------ECKHLLSRIFVAN 168
+ T+G R V + + V + LL +
Sbjct: 214 LIRK-TLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMD 272
Query: 169 SEKRITIPEIKNHPWFLRNLP 189
+R+T ++ +HP+F N+
Sbjct: 273 PTERLTCEQLLHHPYF-ENIR 292
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-19
Identities = 45/226 (19%), Positives = 74/226 (32%), Gaps = 54/226 (23%)
Query: 15 NAGRFSEDEARFFFQQLISGVSYCHSM-QICHRDLKLENTLLDGSTAPR----VKICDFG 69
+ +QL+ G+ Y H I H D+K EN L++ +P +KI D G
Sbjct: 124 EHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG 183
Query: 70 YSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPED 129
+ +++ T Y +PEVL + D+WS ++ ++ G + FE E
Sbjct: 184 --NACWYDEHYTNSIQTREYRSPEVLLGAPWGCGA-DIWSTACLIFELITGDFLFEPDEG 240
Query: 130 --------------------PKNF------------------------RKTIGRILSVHY 145
P + +L+ Y
Sbjct: 241 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKY 300
Query: 146 SFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIE 191
F + E LS + + KR + NHPW L +E
Sbjct: 301 KFSK--DEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGME 344
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-19
Identities = 54/203 (26%), Positives = 81/203 (39%), Gaps = 33/203 (16%)
Query: 12 RICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYS 71
++ S D +F Q++ G+ Y HS + HRDLK N LL+ + +KICDFG +
Sbjct: 118 KLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC--DLKICDFGLA 175
Query: 72 KSSVLHSQPKST----VGTPAYIAPEV-LTKKEYDGKIADVWSCGVTLYVMLVGA--YPF 124
+ + V T Y APE+ L K Y I D+WS G L ML +P
Sbjct: 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPG 234
Query: 125 EDPED------------PKNFRKTIGRILSVHY--SFPDYVRVSLECK---------HLL 161
+ D + I + + +Y S P +V LL
Sbjct: 235 KHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLL 294
Query: 162 SRIFVANSEKRITIPEIKNHPWF 184
++ N KRI + + HP+
Sbjct: 295 DKMLTFNPHKRIEVEQALAHPYL 317
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 4e-19
Identities = 45/221 (20%), Positives = 75/221 (33%), Gaps = 53/221 (23%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--------ICHRDLKLEN 52
+Y G L++ + + +SG+ + H+ I HRDLK +N
Sbjct: 114 TDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKN 172
Query: 53 TLLDGSTAPRVKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVL------TKKEYD 101
L+ + I D G + ++ + P + VGT Y+ PEVL +
Sbjct: 173 ILVKKN--GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSY 230
Query: 102 GKIADVWSCGVTLYVMLVG----------AYPFED--PEDP-----------KNFRKTIG 138
AD++S G+ L+ + P+ D P DP K R +
Sbjct: 231 IM-ADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFP 289
Query: 139 RILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIK 179
S ++ EC N R+T +K
Sbjct: 290 NRWSSDECLRQMGKLMTECWA-------HNPASRLTALRVK 323
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 4e-19
Identities = 46/219 (21%), Positives = 70/219 (31%), Gaps = 50/219 (22%)
Query: 19 FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPR--VKICDFG----YSK 72
+ Q++ G+ Y H+ + HRDLK N L+ G R VKI D G ++
Sbjct: 125 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184
Query: 73 SSVLHSQPKSTVGTPAYIAPEVLT-KKEYDGKIADVWSCGVTLYVML------------- 118
+ V T Y APE+L + Y I D+W+ G +L
Sbjct: 185 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAI-DIWAIGCIFAELLTSEPIFHCRQEDI 243
Query: 119 ----------------------------VGAYPFEDPEDPKNFRKTIGRILSVHYSFPDY 150
+ P R T + Y
Sbjct: 244 KTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHK 303
Query: 151 VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLP 189
V+ + HLL ++ + KRIT + P+F P
Sbjct: 304 VKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF-LEDP 341
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 6e-19
Identities = 50/206 (24%), Positives = 80/206 (38%), Gaps = 42/206 (20%)
Query: 15 NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSS 74
N+ + + + + G+ Y H I HRDLK N LLD + +K+ DFG +KS
Sbjct: 105 NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG--VLKLADFGLAKSF 162
Query: 75 VLHSQPKST-VGTPAYIAPEVLT-KKEYDGKIADVWSCGVTLYVMLVGAYPF---EDPED 129
++ + V T Y APE+L + Y + D+W+ G L +L+ PF + D
Sbjct: 163 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGV-DMWAVGCILAELLLRV-PFLPGDSDLD 220
Query: 130 PKNFRKTIGRILSV----------------HY-SFPDYVRVSLECK---------HLLSR 163
+ RI Y +F + + L L+
Sbjct: 221 ------QLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQG 274
Query: 164 IFVANSEKRITIPEIKNHPWFLRNLP 189
+F+ N RIT + +F N P
Sbjct: 275 LFLFNPCARITATQALKMKYF-SNRP 299
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 9e-19
Identities = 50/232 (21%), Positives = 73/232 (31%), Gaps = 65/232 (28%)
Query: 19 FSEDEARFFFQQLISGVSYCHS--MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL 76
S + R F QQ+ + + + + + I H DLK EN LL +KI DFG SS
Sbjct: 154 VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQ 210
Query: 77 HSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG--------------- 120
Q + + Y +PEVL YD I D+WS G L M G
Sbjct: 211 LGQRIYQYIQSRFYRSPEVLLGMPYDLAI-DMWSLGCILVEMHTGEPLFSGANEVDQMNK 269
Query: 121 -----------------------------AYPFEDPEDPKN-----FRKTIGRILSVHYS 146
+ + +D K + + IL V
Sbjct: 270 IVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETG 329
Query: 147 FPDYVRVSLECK---------HLLSRIFVANSEKRITIPEIKNHPWFLRNLP 189
P R L+ R+ + + RI H +F +
Sbjct: 330 GPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 9e-19
Identities = 59/211 (27%), Positives = 86/211 (40%), Gaps = 41/211 (19%)
Query: 12 RICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFG-- 69
R+ + S+D ++F Q + V H + HRDLK N L++ + +K+CDFG
Sbjct: 102 RVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC--DLKVCDFGLA 159
Query: 70 --YSKSSVLHSQPKST-------VGTPAYIAPEV-LTKKEYDGKIADVWSCGVTLYVMLV 119
+S+ +S+P V T Y APEV LT +Y + DVWSCG L + +
Sbjct: 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM-DVWSCGCILAELFL 218
Query: 120 GA--YPFEDPED-------------PKNFRKTIGRILSVHY--SFPDYVRVSL------- 155
+P D N + I + Y S P Y L
Sbjct: 219 RRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRV 278
Query: 156 --ECKHLLSRIFVANSEKRITIPEIKNHPWF 184
+ LL R+ V + KRIT E HP+
Sbjct: 279 NPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-18
Identities = 47/221 (21%), Positives = 81/221 (36%), Gaps = 42/221 (19%)
Query: 18 RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFG----YSKS 73
+F+ E + Q L++G+ Y H +I HRD+K N L+ +K+ DFG +S +
Sbjct: 120 KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG--VLKLADFGLARAFSLA 177
Query: 74 SVLHSQP-KSTVGTPAYIAPEVLT-KKEYDGKIADVWSCGVTLYVMLVGA---------- 121
+ V T Y PE+L +++Y I D+W G + M +
Sbjct: 178 KNSQPNRYTNRVVTLWYRPPELLLGERDYGPPI-DLWGAGCIMAEMWTRSPIMQGNTEQH 236
Query: 122 ----------YPFED--PE-------DPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLS 162
+ P + K R + YVR L+
Sbjct: 237 QLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDR--LKAYVR-DPYALDLID 293
Query: 163 RIFVANSEKRITIPEIKNHPWFLRN-LPIELTEGGSWQSHD 202
++ V + +RI + NH +F + +P +L S
Sbjct: 294 KLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTS 334
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 5e-18
Identities = 46/206 (22%), Positives = 79/206 (38%), Gaps = 49/206 (23%)
Query: 20 SEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79
+ + Q++ G+ + HS I HRDLK N ++ +KI DFG +++ +
Sbjct: 162 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLART--AGTS 217
Query: 80 PKST--VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFE------------ 125
T V T Y APEV+ Y + D+WS G + M+ F
Sbjct: 218 FMMTPYVVTRYYRAPEVILGMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 276
Query: 126 ------DPEDPKNFRKTIGRILSVHYSFPDYVRVSL---------------------ECK 158
PE K + T+ + + P Y ++ + +
Sbjct: 277 EQLGTPCPEFMKKLQPTVRNYVE---NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQAR 333
Query: 159 HLLSRIFVANSEKRITIPEIKNHPWF 184
LLS++ V + KRI++ + HP+
Sbjct: 334 DLLSKMLVIDPAKRISVDDALQHPYI 359
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-17
Identities = 50/258 (19%), Positives = 79/258 (30%), Gaps = 68/258 (26%)
Query: 9 LFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA------ 60
FE + + R QL + + H Q+ H DLK EN L S
Sbjct: 108 TFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNE 167
Query: 61 -----------PRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVW 108
+++ DFG S+ + +T V T Y PEV+ + + DVW
Sbjct: 168 HKSCEEKSVKNTSIRVADFG---SATFDHEHHTTIVATRHYRPPEVILELGWAQPC-DVW 223
Query: 109 SCGVTLYVMLVGA--YPFED------------------------------------PEDP 130
S G L+ G + + E+
Sbjct: 224 SIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENS 283
Query: 131 KNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPI 190
+ R + ++ L+ R+ + +RIT+ E HP+F P
Sbjct: 284 SDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPE 343
Query: 191 ELTEGGSWQSHDVNNPSQ 208
E H NPS+
Sbjct: 344 ER------SFHTSRNPSR 355
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 1e-16
Identities = 46/221 (20%), Positives = 75/221 (33%), Gaps = 53/221 (23%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ----------ICHRDLKL 50
+ G L + + A S +E + + G++Y H I HRD+K
Sbjct: 101 TAFHEKGSLSDFL-KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKS 159
Query: 51 ENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVL-----TKKEYDG 102
+N LL + I DFG + T VGT Y+APEVL +++
Sbjct: 160 KNVLLKNNL--TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFL 217
Query: 103 KIADVWSCGVTL---------YVMLVGAY--PFED--PEDP-----------KNFRKTIG 138
+ D+++ G+ L V Y PFE+ + P K R +
Sbjct: 218 R-IDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLR 276
Query: 139 RILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIK 179
H EC ++E R++ +
Sbjct: 277 DYWQKHAGMAMLCETIEECWD-------HDAEARLSAGCVG 310
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 2e-16
Identities = 45/216 (20%), Positives = 72/216 (33%), Gaps = 46/216 (21%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM---------QICHRDLKLE 51
MEY G L + + + + + G++Y H+ I HRDL
Sbjct: 91 MEYYPNGSLXKYL-SLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSR 149
Query: 52 NTLLDGSTAPRVKICDFGYSK---------SSVLHSQPKSTVGTPAYIAPEVL------T 96
N L+ I DFG S + S VGT Y+APEVL
Sbjct: 150 NVLVKNDG--TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLR 207
Query: 97 KKEYDGKIADVWSCGVTLYVML---VGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRV 153
E K D+++ G+ + + +P E + Y V
Sbjct: 208 DXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE---------------YQMAFQTEV 252
Query: 154 SLECKHLLSRIFVANSEKRITIPE-IKNHPWFLRNL 188
++ V+ ++R PE K + +R+L
Sbjct: 253 GNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSL 288
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 4e-16
Identities = 52/234 (22%), Positives = 79/234 (33%), Gaps = 62/234 (26%)
Query: 9 LFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA------ 60
++ I G F D R Q+ V++ HS ++ H DLK EN L S
Sbjct: 103 TYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP 162
Query: 61 -----------PRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVW 108
P +K+ DFG S+ + ST V T Y APEV+ + DVW
Sbjct: 163 KIKRDERTLINPDIKVVDFG---SATYDDEHHSTLVSTRHYRAPEVILALGWSQPC-DVW 218
Query: 109 SCGVTLY---------------------VMLVGAYP------------FEDPEDPKNFRK 135
S G L ++G P F +
Sbjct: 219 SIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHS 278
Query: 136 TIGR-ILSVHYSFPDYVRVS----LECKHLLSRIFVANSEKRITIPEIKNHPWF 184
+ GR + +++ L+ ++ + KRIT+ E HP+F
Sbjct: 279 SAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-15
Identities = 41/247 (16%), Positives = 71/247 (28%), Gaps = 80/247 (32%)
Query: 9 LFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA------ 60
L+E I F ++ + + +++ ++Y M + H DLK EN LLD
Sbjct: 122 LYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLIT 181
Query: 61 -----------------PRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDG 102
+K+ DFG + S + + T Y APEV+ +D
Sbjct: 182 VRRVTDGKKIQIYRTKSTGIKLIDFG---CATFKSDYHGSIINTRQYRAPEVILNLGWDV 238
Query: 103 KIADVWSCGVTLYVMLVG------------------------------------------ 120
D+WS G L + G
Sbjct: 239 SS-DMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNK 297
Query: 121 ---AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPE 177
+ + N K + + L ++ L I + R + E
Sbjct: 298 DELKLAWPENASSINSIKHVKKCLPLYKIIKH-----ELFCDFLYSILQIDPTLRPSPAE 352
Query: 178 IKNHPWF 184
+ H +
Sbjct: 353 LLKHKFL 359
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 3e-15
Identities = 49/237 (20%), Positives = 75/237 (31%), Gaps = 67/237 (28%)
Query: 12 RICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYS 71
+ A ++ QLI + Y HS + HRD+K N LL+ VK+ DFG S
Sbjct: 99 AVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAEC--HVKVADFGLS 156
Query: 72 KSSVLHSQPKST----------------------VGTPAYIAPEV-LTKKEYDGKIADVW 108
+S V + + V T Y APE+ L +Y I D+W
Sbjct: 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI-DMW 215
Query: 109 SCGVTLYVMLVG-----------------------------------------AYPFEDP 127
S G L +L G + +
Sbjct: 216 SLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVE 275
Query: 128 EDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184
N R + ++ + E LL ++ N KRI+ + HP+
Sbjct: 276 IRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFV 332
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 6e-15
Identities = 51/242 (21%), Positives = 79/242 (32%), Gaps = 80/242 (33%)
Query: 20 SEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFG---------- 69
+E+ + L+ G ++ H I HRDLK N LL+ VK+CDFG
Sbjct: 127 TEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDC--SVKVCDFGLARTINSEKD 184
Query: 70 -----------YSKSSVLHSQPKST--VGTPAYIAPEV-LTKKEYDGKIADVWSCGVTLY 115
+ + + T V T Y APE+ L ++ Y I D+WS G
Sbjct: 185 TNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI-DIWSTGCIFA 243
Query: 116 VMLVG------------------------AYPFEDPEDPKNFRKTIGRILSV-------- 143
+L K+ R + I ++
Sbjct: 244 ELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDD 303
Query: 144 ----------HY--SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHP 182
Y FP ++L + +LL + N KRITI + +HP
Sbjct: 304 LKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHP 363
Query: 183 WF 184
+
Sbjct: 364 YL 365
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 5e-14
Identities = 55/250 (22%), Positives = 77/250 (30%), Gaps = 88/250 (35%)
Query: 20 SEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79
+E + L+ GV Y HS I HRDLK N L++ VK+CDFG +++
Sbjct: 154 TELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC--SVKVCDFGLARTVDYPEN 211
Query: 80 PKSTVGTPA----------------------------YIAPEV-LTKKEYDGKIADVWSC 110
S + Y APE+ L ++ Y I DVWS
Sbjct: 212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI-DVWSI 270
Query: 111 G---------------------------VTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV 143
G + + + R + I ++
Sbjct: 271 GCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNI 330
Query: 144 ------------------HY--SFPDYVRVSL---------ECKHLLSRIFVANSEKRIT 174
Y FP L + HLL R+ V N KRIT
Sbjct: 331 LGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRIT 390
Query: 175 IPEIKNHPWF 184
I E HP+F
Sbjct: 391 INECLAHPFF 400
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-12
Identities = 43/146 (29%), Positives = 63/146 (43%), Gaps = 12/146 (8%)
Query: 1 MEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
MEY G L + + + R + + Q+ G+ Y + + HRDL N L+
Sbjct: 92 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV--EN 149
Query: 60 APRVKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLTKKEYDGKIADVWSCGVTL 114
RVKI DFG +K + + V P APE LT+ ++ +DVWS GV L
Sbjct: 150 ENRVKIGDFGLTK-VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVA-SDVWSFGVVL 207
Query: 115 YVMLVGAYPFEDPEDPKNFRKTIGRI 140
Y + Y + P F + IG
Sbjct: 208 YELF--TYIEKSKSPPAEFMRMIGND 231
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-12
Identities = 43/146 (29%), Positives = 63/146 (43%), Gaps = 12/146 (8%)
Query: 1 MEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
MEY G L + + + R + + Q+ G+ Y + + HRDL N L+
Sbjct: 123 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV--EN 180
Query: 60 APRVKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLTKKEYDGKIADVWSCGVTL 114
RVKI DFG +K + + V P APE LT+ ++ +DVWS GV L
Sbjct: 181 ENRVKIGDFGLTK-VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVA-SDVWSFGVVL 238
Query: 115 YVMLVGAYPFEDPEDPKNFRKTIGRI 140
Y + Y + P F + IG
Sbjct: 239 YELF--TYIEKSKSPPAEFMRMIGND 262
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 4e-12
Identities = 22/132 (16%), Positives = 33/132 (25%), Gaps = 35/132 (26%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL--DGS 58
E+ GG L E S A Q L + H + + DG
Sbjct: 110 AEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDG- 166
Query: 59 TAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 118
V + PA + D+ G +LY +L
Sbjct: 167 ---DVV-------------------LAYPATMPDA--------NPQDDIRGIGASLYALL 196
Query: 119 VGAYPFEDPEDP 130
V +P +
Sbjct: 197 VNRWPLPEAGVR 208
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 9e-12
Identities = 35/133 (26%), Positives = 51/133 (38%), Gaps = 12/133 (9%)
Query: 1 MEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
ME GG+ + R +G+ Y S HRDL N L+
Sbjct: 191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN 250
Query: 60 APRVKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLTKKEYDGKIADVWSCGVTL 114
+KI DFG S+ + G + APE L Y + +DVWS G+ L
Sbjct: 251 V--LKISDFGMSR--EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSE-SDVWSFGILL 305
Query: 115 Y-VMLVGAYPFED 126
+ +GA P+ +
Sbjct: 306 WETFSLGASPYPN 318
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-11
Identities = 38/134 (28%), Positives = 53/134 (39%), Gaps = 13/134 (9%)
Query: 1 MEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
E A G L +R+ + G F + Q+ G+ Y S + HRDL N LL +T
Sbjct: 99 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL--AT 156
Query: 60 APRVKICDFGYSKSSVLHSQP---KSTVGTPAYI---APEVLTKKEYDGKIADVWSCGVT 113
VKI DFG + L APE L + + +D W GVT
Sbjct: 157 RDLVKIGDFGLMR--ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHA-SDTWMFGVT 213
Query: 114 LY-VMLVGAYPFED 126
L+ + G P+
Sbjct: 214 LWEMFTYGQEPWIG 227
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 1e-11
Identities = 34/131 (25%), Positives = 52/131 (39%), Gaps = 8/131 (6%)
Query: 1 MEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
E+ G L + R CN S + Q+ S + Y HR+L N L+ +
Sbjct: 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGEN 354
Query: 59 TAPRVKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLTKKEYDGKIADVWSCGVTLY- 115
VK+ DFG S+ + APE L ++ K +DVW+ GV L+
Sbjct: 355 HL--VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWE 411
Query: 116 VMLVGAYPFED 126
+ G P+
Sbjct: 412 IATYGMSPYPG 422
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-11
Identities = 48/267 (17%), Positives = 72/267 (26%), Gaps = 97/267 (36%)
Query: 10 FERICNAGRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLD------------ 56
+ N + QQ++ G+ Y H+ +I H D+K EN LL
Sbjct: 134 WIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAE 193
Query: 57 -----------------------------------GSTAPRVKICDFGYSKSSVLHSQPK 81
+ +VKI D G + +H
Sbjct: 194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLG--NACWVHKHFT 251
Query: 82 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFE--------DPED---- 129
+ T Y + EVL Y+ AD+WS + + G Y FE ED
Sbjct: 252 EDIQTRQYRSLEVLIGSGYNTP-ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIAL 310
Query: 130 --------PKNFRK------------------------TIGRILSVHYSFPDYVRVSLEC 157
P+ + +L Y + +
Sbjct: 311 IIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQ--EEAAGF 368
Query: 158 KHLLSRIFVANSEKRITIPEIKNHPWF 184
L + EKR T E HPW
Sbjct: 369 TDFLLPMLELIPEKRATAAECLRHPWL 395
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-11
Identities = 34/131 (25%), Positives = 59/131 (45%), Gaps = 8/131 (6%)
Query: 1 MEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
+ G L + + + + Q+ G++Y ++ HRDL N L+ T
Sbjct: 95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV--KT 152
Query: 60 APRVKICDFGYSKSSVLHSQPKSTVGT--P-AYIAPEVLTKKEYDGKIADVWSCGVTLY- 115
VKI DFG +K + G P ++A E + + Y + +DVWS GVT++
Sbjct: 153 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWE 211
Query: 116 VMLVGAYPFED 126
+M G+ P++
Sbjct: 212 LMTFGSKPYDG 222
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-11
Identities = 38/152 (25%), Positives = 58/152 (38%), Gaps = 13/152 (8%)
Query: 1 MEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
MEY G L + + + R + Q+ G+ Y S + HRDL N L+ +
Sbjct: 105 MEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV--ES 162
Query: 60 APRVKICDFGYSKSSVLHSQPKS-TVGTPAYI-----APEVLTKKEYDGKIADVWSCGVT 113
VKI DFG +K +L V P APE L+ + + +DVWS GV
Sbjct: 163 EAHVKIADFGLAK--LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQ-SDVWSFGVV 219
Query: 114 LY-VMLVGAYPFEDPEDPKNFRKTIGRILSVH 144
LY + + + ++
Sbjct: 220 LYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-11
Identities = 38/122 (31%), Positives = 58/122 (47%), Gaps = 12/122 (9%)
Query: 1 MEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
ME+ G L E + N + + + + Q+ G+ Y S Q HRDL N L++
Sbjct: 104 MEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH 163
Query: 60 APRVKICDFGYSKSSVLHSQPKS-TVGTPAYI-----APEVLTKKEYDGKIADVWSCGVT 113
+VKI DFG +K + + + TV APE L + ++ +DVWS GVT
Sbjct: 164 --QVKIGDFGLTK--AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIA-SDVWSFGVT 218
Query: 114 LY 115
L+
Sbjct: 219 LH 220
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 4e-11
Identities = 38/133 (28%), Positives = 53/133 (39%), Gaps = 12/133 (9%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
ME A G L + + + Q+ G+ Y HRDL N LL T
Sbjct: 96 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL--VTQ 153
Query: 61 PRVKICDFGYSKSSVLHSQP---KSTVGT--P-AYIAPEVLTKKEYDGKIADVWSCGVTL 114
KI DFG SK L + K+ P + APE + ++ K +DVWS GV +
Sbjct: 154 HYAKISDFGLSK--ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLM 210
Query: 115 Y-VMLVGAYPFED 126
+ G P+
Sbjct: 211 WEAFSYGQKPYRG 223
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 7e-11
Identities = 37/132 (28%), Positives = 56/132 (42%), Gaps = 10/132 (7%)
Query: 1 MEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
E+ G L + R CN S + Q+ S + Y HRDL N L+ +
Sbjct: 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN 147
Query: 59 TAPRVKICDFGYSKSSVLHSQPKSTVGT--PA-YIAPEVLTKKEYDGKIADVWSCGVTLY 115
VK+ DFG S+ + + G P + APE L ++ K +DVW+ GV L+
Sbjct: 148 HL--VKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLW 203
Query: 116 -VMLVGAYPFED 126
+ G P+
Sbjct: 204 EIATYGMSPYPG 215
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 8e-11
Identities = 34/105 (32%), Positives = 54/105 (51%), Gaps = 13/105 (12%)
Query: 34 GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK-SSVLHSQPKST--VGTPAYI 90
G+++ H HRD+K N LLD + KI DFG ++ S ++ VGT AY+
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTA--KISDFGLARASEKFAQTVMTSRIVGTTAYM 202
Query: 91 APEVLTKKEYDGKI---ADVWSCGVTLYVMLVGAYPFEDPEDPKN 132
APE L G+I +D++S GV L ++ G ++ +P+
Sbjct: 203 APEALR-----GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 9e-11
Identities = 40/120 (33%), Positives = 53/120 (44%), Gaps = 10/120 (8%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY G L + + + F QQ+ G++Y H+ HRDL N LL
Sbjct: 114 MEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL--DND 170
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLTKKEYDGKIADVWSCGVTLY 115
VKI DFG +K+ V V APE L + ++ +DVWS GVTLY
Sbjct: 171 RLVKIGDFGLAKA-VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYA-SDVWSFGVTLY 228
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-10
Identities = 37/134 (27%), Positives = 55/134 (41%), Gaps = 13/134 (9%)
Query: 1 MEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
ME A GG L + + Q+ G+ Y HRDL N LL
Sbjct: 88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL--VN 145
Query: 60 APRVKICDFGYSKSSVLHSQP---KSTVGT--P-AYIAPEVLTKKEYDGKIADVWSCGVT 113
KI DFG SK L + + P + APE + +++ + +DVWS GVT
Sbjct: 146 RHYAKISDFGLSK--ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVT 202
Query: 114 LY-VMLVGAYPFED 126
++ + G P++
Sbjct: 203 MWEALSYGQKPYKK 216
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-10
Identities = 34/132 (25%), Positives = 51/132 (38%), Gaps = 14/132 (10%)
Query: 1 MEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
EY A G L + R D F + + Y HRDL N L+
Sbjct: 266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED 325
Query: 59 TAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLTKKEYDGKIADVWSCGVTLY 115
K+ DFG +K + + + APE L +K++ K +DVWS G+ L+
Sbjct: 326 NV--AKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLW 377
Query: 116 -VMLVGAYPFED 126
+ G P+
Sbjct: 378 EIYSFGRVPYPR 389
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-10
Identities = 34/133 (25%), Positives = 59/133 (44%), Gaps = 12/133 (9%)
Query: 1 MEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
+Y G L + + + G + Q+ G+ Y + HR+L N LL +
Sbjct: 93 TQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL--KS 150
Query: 60 APRVKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLTKKEYDGKIADVWSCGVTL 114
+V++ DFG + +L K + + A A E + +Y + +DVWS GVT+
Sbjct: 151 PSQVQVADFGVAD--LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQ-SDVWSYGVTV 207
Query: 115 Y-VMLVGAYPFED 126
+ +M GA P+
Sbjct: 208 WELMTFGAEPYAG 220
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-10
Identities = 34/131 (25%), Positives = 59/131 (45%), Gaps = 8/131 (6%)
Query: 1 MEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
+ G L + + + + Q+ G++Y ++ HRDL N L+ T
Sbjct: 95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV--KT 152
Query: 60 APRVKICDFGYSKSSVLHSQPKSTVGT--P-AYIAPEVLTKKEYDGKIADVWSCGVTLY- 115
VKI DFG +K + G P ++A E + + Y + +DVWS GVT++
Sbjct: 153 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWE 211
Query: 116 VMLVGAYPFED 126
+M G+ P++
Sbjct: 212 LMTFGSKPYDG 222
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-10
Identities = 32/131 (24%), Positives = 50/131 (38%), Gaps = 8/131 (6%)
Query: 1 MEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
EY + G L F + + Q+ SG++Y M HRDL+ N L+ +
Sbjct: 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN 316
Query: 59 TAPRVKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLTKKEYDGKIADVWSCGVTLY- 115
K+ DFG ++ + APE + K +DVWS G+ L
Sbjct: 317 LV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTE 373
Query: 116 VMLVGAYPFED 126
+ G P+
Sbjct: 374 LTTKGRVPYPG 384
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 2e-10
Identities = 32/131 (24%), Positives = 50/131 (38%), Gaps = 8/131 (6%)
Query: 1 MEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
EY + G L F + + Q+ SG++Y M HRDL+ N L+ +
Sbjct: 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN 399
Query: 59 TAPRVKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLTKKEYDGKIADVWSCGVTLY- 115
K+ DFG ++ + APE + K +DVWS G+ L
Sbjct: 400 LV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTE 456
Query: 116 VMLVGAYPFED 126
+ G P+
Sbjct: 457 LTTKGRVPYPG 467
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-10
Identities = 37/133 (27%), Positives = 60/133 (45%), Gaps = 11/133 (8%)
Query: 1 MEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
EY G L F R + G+F+ + + + +G+ Y + HRDL N L+D +
Sbjct: 129 TEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSN 187
Query: 59 TAPRVKICDFGYSKSSVLHSQP-KSTVGTPAYI---APEVLTKKEYDGKIADVWSCGVTL 114
K+ DFG S+ +T G I APE + + + +DVWS GV +
Sbjct: 188 LV--CKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSA-SDVWSFGVVM 244
Query: 115 Y-VMLVGAYPFED 126
+ V+ G P+ +
Sbjct: 245 WEVLAYGERPYWN 257
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 3e-10
Identities = 34/132 (25%), Positives = 51/132 (38%), Gaps = 14/132 (10%)
Query: 1 MEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
EY A G L + R D F + + Y HRDL N L+
Sbjct: 94 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED 153
Query: 59 TAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLTKKEYDGKIADVWSCGVTLY 115
K+ DFG +K + + + APE L +K++ K +DVWS G+ L+
Sbjct: 154 NV--AKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLW 205
Query: 116 -VMLVGAYPFED 126
+ G P+
Sbjct: 206 EIYSFGRVPYPR 217
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 4e-10
Identities = 35/134 (26%), Positives = 54/134 (40%), Gaps = 13/134 (9%)
Query: 1 MEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
ME A GG L + + Q+ G+ Y HR+L N LL
Sbjct: 414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL--VN 471
Query: 60 APRVKICDFGYSKSSVLHSQP---KSTVGTPAYI---APEVLTKKEYDGKIADVWSCGVT 113
KI DFG SK L + + + APE + +++ + +DVWS GVT
Sbjct: 472 RHYAKISDFGLSK--ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVT 528
Query: 114 LY-VMLVGAYPFED 126
++ + G P++
Sbjct: 529 MWEALSYGQKPYKK 542
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 6e-10
Identities = 39/135 (28%), Positives = 62/135 (45%), Gaps = 15/135 (11%)
Query: 1 MEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
EY G L F R + +F+ + + + SG+ Y M HRDL N L++ +
Sbjct: 125 TEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN 183
Query: 59 TAPRVKICDFGYSKSSVLHSQP---KSTVGTPAYI---APEVLTKKEYDGKIADVWSCGV 112
K+ DFG + VL P +T G I +PE + +++ +DVWS G+
Sbjct: 184 LV--CKVSDFGLGR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA-SDVWSYGI 238
Query: 113 TLY-VMLVGAYPFED 126
L+ VM G P+ +
Sbjct: 239 VLWEVMSYGERPYWE 253
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 7e-10
Identities = 39/132 (29%), Positives = 62/132 (46%), Gaps = 11/132 (8%)
Query: 1 MEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
E+ G L + R G F+ + + G++Y + HRDL N L+ +
Sbjct: 82 TEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN 140
Query: 59 TAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLTKKEYDGKIADVWSCGVTLY 115
+K+ DFG ++ VL Q S+ GT + +PEV + Y K +DVWS GV ++
Sbjct: 141 QV--IKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMW 196
Query: 116 -VMLVGAYPFED 126
V G P+E+
Sbjct: 197 EVFSEGKIPYEN 208
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 8e-10
Identities = 38/133 (28%), Positives = 62/133 (46%), Gaps = 11/133 (8%)
Query: 1 MEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
EY G L F R G FS + + + +G+ Y +M HRDL N L++ +
Sbjct: 125 TEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN 183
Query: 59 TAPRVKICDFGYSKSSVLHSQP-KSTVGTPAYI---APEVLTKKEYDGKIADVWSCGVTL 114
K+ DFG S+ + +T G I APE ++ +++ +DVWS G+ +
Sbjct: 184 LV--CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSA-SDVWSFGIVM 240
Query: 115 Y-VMLVGAYPFED 126
+ VM G P+ +
Sbjct: 241 WEVMTYGERPYWE 253
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 9e-10
Identities = 32/132 (24%), Positives = 59/132 (44%), Gaps = 10/132 (7%)
Query: 1 MEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
EY G L F + + + + ++ Q+ G+++ HRDL+ N L+ +
Sbjct: 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT 145
Query: 59 TAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLTKKEYDGKIADVWSCGVTLY 115
+ KI DFG ++ + ++ + G I APE + + K +DVWS G+ L
Sbjct: 146 LS--CKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLT 201
Query: 116 -VMLVGAYPFED 126
++ G P+
Sbjct: 202 EIVTHGRIPYPG 213
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 1e-09
Identities = 40/132 (30%), Positives = 63/132 (47%), Gaps = 11/132 (8%)
Query: 1 MEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
EY + G L + R + + + G+++ S Q HRDL N L+D
Sbjct: 82 TEYISNGCLLNYLR-SHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRD 140
Query: 59 TAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLTKKEYDGKIADVWSCGVTLY 115
VK+ DFG ++ VL Q S+VGT + APEV +Y K +DVW+ G+ ++
Sbjct: 141 LC--VKVSDFGMTRY-VLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSK-SDVWAFGILMW 196
Query: 116 -VMLVGAYPFED 126
V +G P++
Sbjct: 197 EVFSLGKMPYDL 208
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 2e-09
Identities = 40/95 (42%), Positives = 49/95 (51%), Gaps = 16/95 (16%)
Query: 34 GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK-STV--GTPAYI 90
G+ Y H+ I HRD+K N LLD + P KI DFG SK Q STV GT YI
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVP--KITDFGISKKGTELDQTHLSTVVKGTLGYI 208
Query: 91 APE-----VLTKKEYDGKIADVWSCGVTLYVMLVG 120
PE LT+K +DV+S GV L+ +L
Sbjct: 209 DPEYFIKGRLTEK------SDVYSFGVVLFEVLCA 237
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-09
Identities = 33/138 (23%), Positives = 50/138 (36%), Gaps = 17/138 (12%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHSMQICHRDLKLENT 53
+E AGG+L + + L+ G Y HRD+ N
Sbjct: 153 LELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNC 212
Query: 54 LLDGSTAPR-VKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLTKKEYDGKIADV 107
LL R KI DFG ++ ++ G A + PE + + K D
Sbjct: 213 LLTCPGPGRVAKIGDFGMAR--DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSK-TDT 269
Query: 108 WSCGVTLY-VMLVGAYPF 124
WS GV L+ + +G P+
Sbjct: 270 WSFGVLLWEIFSLGYMPY 287
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-09
Identities = 34/138 (24%), Positives = 50/138 (36%), Gaps = 17/138 (12%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHSMQICHRDLKLENT 53
ME AGG+L + + L+ G Y HRD+ N
Sbjct: 112 MELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNC 171
Query: 54 LLDGSTAPR-VKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLTKKEYDGKIADV 107
LL R KI DFG ++ ++ G A + PE + + K D
Sbjct: 172 LLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSK-TDT 228
Query: 108 WSCGVTLY-VMLVGAYPF 124
WS GV L+ + +G P+
Sbjct: 229 WSFGVLLWEIFSLGYMPY 246
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-09
Identities = 37/139 (26%), Positives = 56/139 (40%), Gaps = 23/139 (16%)
Query: 1 MEYAAGGEL--FERICNAGRFSEDEARFFFQQLI-------SGVSYCHSMQICHRDLKLE 51
+ + G+L F A R E+ Q L+ G+ Y S HRDL
Sbjct: 110 LPFMKHGDLHAFLL---ASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAAR 166
Query: 52 NTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLTKKEYDGKIAD 106
N +L V + DFG S+ ++S G + + A E L Y +D
Sbjct: 167 NCMLAEDMT--VCVADFGLSR--KIYSGDYYRQGCASKLPVKWLALESLADNLYTVH-SD 221
Query: 107 VWSCGVTLY-VMLVGAYPF 124
VW+ GVT++ +M G P+
Sbjct: 222 VWAFGVTMWEIMTRGQTPY 240
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-09
Identities = 34/132 (25%), Positives = 57/132 (43%), Gaps = 10/132 (7%)
Query: 1 MEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
E+ A G L F + + + F Q+ G+++ HRDL+ N L+ S
Sbjct: 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS 320
Query: 59 TAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLTKKEYDGKIADVWSCGVTLY 115
KI DFG ++ + ++ + G I APE + + K +DVWS G+ L
Sbjct: 321 LV--CKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLM 376
Query: 116 -VMLVGAYPFED 126
++ G P+
Sbjct: 377 EIVTYGRIPYPG 388
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 4e-09
Identities = 35/132 (26%), Positives = 61/132 (46%), Gaps = 11/132 (8%)
Query: 1 MEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
ME GEL + + QL + ++Y S + HRD+ N L+ S+
Sbjct: 469 MELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV--SS 526
Query: 60 APRVKICDFGYSKSSVLHSQP--KSTVG-TPA-YIAPEVLTKKEYDGKIADVWSCGVTLY 115
VK+ DFG S+ + K++ G P ++APE + + + +DVW GV ++
Sbjct: 527 NDCVKLGDFGLSR--YMEDSTYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMW 583
Query: 116 -VMLVGAYPFED 126
+++ G PF+
Sbjct: 584 EILMHGVKPFQG 595
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 6e-09
Identities = 40/132 (30%), Positives = 63/132 (47%), Gaps = 11/132 (8%)
Query: 1 MEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
EY A G L + R RF + + + + Y S Q HRDL N L++
Sbjct: 98 TEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ 156
Query: 59 TAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLTKKEYDGKIADVWSCGVTLY 115
VK+ DFG S+ VL + S+VG+ + PEVL ++ K +D+W+ GV ++
Sbjct: 157 GV--VKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK-SDIWAFGVLMW 212
Query: 116 -VMLVGAYPFED 126
+ +G P+E
Sbjct: 213 EIYSLGKMPYER 224
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 6e-09
Identities = 35/139 (25%), Positives = 54/139 (38%), Gaps = 23/139 (16%)
Query: 1 MEYAAGGEL--FERICNAGRFSEDEARFFFQQLI-------SGVSYCHSMQICHRDLKLE 51
+ + G+L + R Q L+ G+ Y + HRDL
Sbjct: 120 LPFMKYGDLHTYLLYS---RLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAAR 176
Query: 52 NTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLTKKEYDGKIAD 106
N +L V + DFG SK ++S G A + A E L + Y K +D
Sbjct: 177 NCMLRDDMT--VCVADFGLSK--KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SD 231
Query: 107 VWSCGVTLY-VMLVGAYPF 124
VW+ GVT++ + G P+
Sbjct: 232 VWAFGVTMWEIATRGMTPY 250
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 8e-09
Identities = 35/132 (26%), Positives = 59/132 (44%), Gaps = 11/132 (8%)
Query: 1 MEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
ME GEL F + + QL + ++Y S + HRD+ N L+ S
Sbjct: 94 MELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV--S 150
Query: 59 TAPRVKICDFGYSKSSVLHSQPKSTVGT--PA-YIAPEVLTKKEYDGKIADVWSCGVTLY 115
+ VK+ DFG S+ + S P ++APE + + + +DVW GV ++
Sbjct: 151 SNDCVKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMW 208
Query: 116 -VMLVGAYPFED 126
+++ G PF+
Sbjct: 209 EILMHGVKPFQG 220
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 9e-09
Identities = 32/133 (24%), Positives = 55/133 (41%), Gaps = 13/133 (9%)
Query: 1 MEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
ME GEL + N + Q+ ++Y S+ HRD+ + N L+ ++
Sbjct: 91 MELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILV--AS 148
Query: 60 APRVKICDFGYSKSSVLHSQPKSTVGT--PAYI---APEVLTKKEYDGKIADVWSCGVTL 114
VK+ DFG S+ + T P I +PE + + + +DVW V +
Sbjct: 149 PECVKLGDFGLSR-YIEDEDYYKASVTRLP--IKWMSPESINFRRFTTA-SDVWMFAVCM 204
Query: 115 Y-VMLVGAYPFED 126
+ ++ G PF
Sbjct: 205 WEILSFGKQPFFW 217
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 1e-08
Identities = 34/117 (29%), Positives = 56/117 (47%), Gaps = 11/117 (9%)
Query: 27 FFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGT 86
+ Q+ G+ + S + HRDL N LL VKICDFG ++ ++ P
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARD--IYKDPDYVRKG 253
Query: 87 PAYI-----APEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEDPKNFRKTI 137
A + APE + + Y + +DVWS GV L+ + +GA P+ + + F + +
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 309
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 2e-08
Identities = 37/147 (25%), Positives = 58/147 (39%), Gaps = 29/147 (19%)
Query: 1 MEYAAGGEL-----------FERICNAGRFSEDEARFFFQQLIS-------GVSYCHSMQ 42
EY G+L + +DE + L+S G+++ S
Sbjct: 106 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN 165
Query: 43 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLTK 97
HRDL N LL KICDFG ++ + + V A + APE +
Sbjct: 166 CIHRDLAARNILLTHGRI--TKICDFGLAR--DIKNDSNYVVKGNARLPVKWMAPESIFN 221
Query: 98 KEYDGKIADVWSCGVTLY-VMLVGAYP 123
Y + +DVWS G+ L+ + +G+ P
Sbjct: 222 CVYTFE-SDVWSYGIFLWELFSLGSSP 247
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 4e-08
Identities = 30/94 (31%), Positives = 41/94 (43%), Gaps = 24/94 (25%)
Query: 34 GVSYCH---SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTV-----G 85
G++Y H +I HRD+K N LLD + DFG +K L + V G
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEA--VVGDFGLAK---LMDYKDTHVTTAVRG 197
Query: 86 TPAYIAPE-----VLTKKEYDGKIADVWSCGVTL 114
T +IAPE ++K DV+ GV L
Sbjct: 198 TIGHIAPEYLSTGKSSEK------TDVFGYGVML 225
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 6e-08
Identities = 38/132 (28%), Positives = 58/132 (43%), Gaps = 12/132 (9%)
Query: 1 MEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
+ Y G+L F R + + F Q+ G+ + S + HRDL N +LD
Sbjct: 170 LPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK 228
Query: 59 TAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLTKKEYDGKIADVWSCGVT 113
VK+ DFG ++ T A + A E L +++ K +DVWS GV
Sbjct: 229 FT--VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVL 285
Query: 114 LY-VMLVGAYPF 124
L+ +M GA P+
Sbjct: 286 LWELMTRGAPPY 297
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 8e-08
Identities = 40/132 (30%), Positives = 61/132 (46%), Gaps = 12/132 (9%)
Query: 1 MEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
+ Y G+L F R + + F Q+ G+ Y S + HRDL N +LD
Sbjct: 106 LPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK 164
Query: 59 TAPRVKICDFGYSK---SSVLHSQPKSTVGT-PA-YIAPEVLTKKEYDGKIADVWSCGVT 113
VK+ DFG ++ +S T P ++A E L +++ K +DVWS GV
Sbjct: 165 FT--VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVL 221
Query: 114 LY-VMLVGAYPF 124
L+ +M GA P+
Sbjct: 222 LWELMTRGAPPY 233
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 1e-07
Identities = 34/144 (23%), Positives = 57/144 (39%), Gaps = 27/144 (18%)
Query: 1 MEYAAGGELFE-------RICNAGRFSEDEARFFFQQLIS-------GVSYCHSMQICHR 46
EY G+L + F+ + + L+ G+++ S HR
Sbjct: 129 TEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHR 188
Query: 47 DLKLENTLL-DGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLTKKEY 100
D+ N LL +G KI DFG ++ + + V A + APE + Y
Sbjct: 189 DVAARNVLLTNGHV---AKIGDFGLARD--IMNDSNYIVKGNARLPVKWMAPESIFDCVY 243
Query: 101 DGKIADVWSCGVTLY-VMLVGAYP 123
+ +DVWS G+ L+ + +G P
Sbjct: 244 TVQ-SDVWSYGILLWEIFSLGLNP 266
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 1e-07
Identities = 36/137 (26%), Positives = 56/137 (40%), Gaps = 28/137 (20%)
Query: 1 MEYAAGGELFE---------RICNAGRFSEDEARFFFQQLI-------SGVSYCHSMQIC 44
EY G+L + I G+ + + Q++ SG+ Y S
Sbjct: 96 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFV 155
Query: 45 HRDLKLENTLL-DGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLTKK 98
HRDL N L+ VKI DFG S+ ++S VG + PE + +
Sbjct: 156 HRDLATRNCLVGANLL---VKIGDFGMSR--DVYSTDYYRVGGHTMLPIRWMPPESIMYR 210
Query: 99 EYDGKIADVWSCGVTLY 115
++ + +DVWS GV L+
Sbjct: 211 KFTTE-SDVWSFGVILW 226
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-07
Identities = 37/147 (25%), Positives = 63/147 (42%), Gaps = 29/147 (19%)
Query: 1 MEYAAGGEL---------FERICNAGRFSEDEARFFFQQLIS-------GVSYCHSMQIC 44
+EYA+ G L + E + F+ L+S G+ Y S +
Sbjct: 166 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI 225
Query: 45 HRDLKLENTLL-DGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLTKK 98
HRDL N L+ + + +KI DFG ++ +++ T + APE L +
Sbjct: 226 HRDLAARNVLVTENNV---MKIADFGLAR--DINNIDYYKKTTNGRLPVKWMAPEALFDR 280
Query: 99 EYDGKIADVWSCGVTLY-VMLVGAYPF 124
Y + +DVWS GV ++ + +G P+
Sbjct: 281 VYTHQ-SDVWSFGVLMWEIFTLGGSPY 306
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-07
Identities = 25/139 (17%), Positives = 50/139 (35%), Gaps = 21/139 (15%)
Query: 1 MEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
E+ G L + + N + +QL + + + + H ++ +N LL
Sbjct: 91 QEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIRE 149
Query: 59 TAPR------VKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI----ADVW 108
+ +K+ D G S + + + + ++ PE + + K D W
Sbjct: 150 EDRKTGNPPFIKLSDPGISITVLPKDILQERI---PWVPPECIE----NPKNLNLATDKW 202
Query: 109 SCGVTLY-VMLVGAYPFED 126
S G TL+ + G P
Sbjct: 203 SFGTTLWEICSGGDKPLSA 221
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-07
Identities = 37/145 (25%), Positives = 61/145 (42%), Gaps = 27/145 (18%)
Query: 1 MEYAAGGEL---------FERICNAGRFSEDEARFFFQQLIS-------GVSYCHSMQIC 44
+EYA+ G L + E + F+ L+S G+ Y S +
Sbjct: 120 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI 179
Query: 45 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLTKKE 99
HRDL N L+ + +KI DFG ++ +++ T + APE L +
Sbjct: 180 HRDLAARNVLVTENNV--MKIADFGLAR--DINNIDYYKKTTNGRLPVKWMAPEALFDRV 235
Query: 100 YDGKIADVWSCGVTLY-VMLVGAYP 123
Y + +DVWS GV ++ + +G P
Sbjct: 236 YTHQ-SDVWSFGVLMWEIFTLGGSP 259
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 3e-07
Identities = 37/146 (25%), Positives = 57/146 (39%), Gaps = 27/146 (18%)
Query: 1 MEYAAGGEL---------FERICNAGRFSEDEARFFFQQLIS-------GVSYCHSMQIC 44
+E+ G L + + LI G+ + S +
Sbjct: 111 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI 170
Query: 45 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLTKKE 99
HRDL N LL VKICDFG ++ ++ P A + APE + +
Sbjct: 171 HRDLAARNILLSEKNV--VKICDFGLAR--DIYKDPDYVRKGDARLPLKWMAPETIFDRV 226
Query: 100 YDGKIADVWSCGVTLY-VMLVGAYPF 124
Y + +DVWS GV L+ + +GA P+
Sbjct: 227 YTIQ-SDVWSFGVLLWEIFSLGASPY 251
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 3e-07
Identities = 38/145 (26%), Positives = 54/145 (37%), Gaps = 30/145 (20%)
Query: 1 MEYAAGGEL---------FERICNAGRFSEDEARFFFQQLI-------SGVSYCHSMQIC 44
+EYA G L E + + QQL+ G+ Y Q
Sbjct: 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFI 164
Query: 45 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLTKKE 99
HRDL N L+ + KI DFG S+ ++ T + A E L
Sbjct: 165 HRDLAARNILVGENYV--AKIADFGLSRGQEVY-----VKKTMGRLPVRWMAIESLNYSV 217
Query: 100 YDGKIADVWSCGVTLY-VMLVGAYP 123
Y +DVWS GV L+ ++ +G P
Sbjct: 218 YTTN-SDVWSYGVLLWEIVSLGGTP 241
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-07
Identities = 36/136 (26%), Positives = 54/136 (39%), Gaps = 26/136 (19%)
Query: 1 MEYAAGGEL---------FERICNAGRFSEDEARFFFQQLIS-------GVSYCHSMQIC 44
+EYA+ G L + E + + L+S G+ Y S +
Sbjct: 154 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI 213
Query: 45 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLTKKE 99
HRDL N L+ +KI DFG ++ +H T + APE L +
Sbjct: 214 HRDLAARNVLVTEDNV--MKIADFGLAR--DIHHIDYYKKTTNGRLPVKWMAPEALFDRI 269
Query: 100 YDGKIADVWSCGVTLY 115
Y + +DVWS GV L+
Sbjct: 270 YTHQ-SDVWSFGVLLW 284
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 4e-07
Identities = 30/140 (21%), Positives = 54/140 (38%), Gaps = 21/140 (15%)
Query: 1 MEYAAGGEL--FERICNAGRFSEDEAR--------FFFQQLISGVSYCHSMQICHRDLKL 50
ME G+L + R + ++ G++Y ++ + HRDL
Sbjct: 107 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAA 166
Query: 51 ENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLTKKEYDGKIA 105
N ++ VKI DFG ++ ++ G + +PE L + +
Sbjct: 167 RNCMVAEDFT--VKIGDFGMTR--DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-S 221
Query: 106 DVWSCGVTLY-VMLVGAYPF 124
DVWS GV L+ + + P+
Sbjct: 222 DVWSFGVVLWEIATLAEQPY 241
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 4e-07
Identities = 37/145 (25%), Positives = 56/145 (38%), Gaps = 26/145 (17%)
Query: 1 MEYAAGGELFE--------RICNAGRFSEDEARFFFQQLI-------SGVSYCHSMQICH 45
EY G+L AG QL+ +G+ Y + H
Sbjct: 122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVH 181
Query: 46 RDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLTKKEY 100
RDL N L+ VKI DFG S+ ++S VG + PE + +++
Sbjct: 182 RDLATRNCLVGQGLV--VKIGDFGMSR--DIYSTDYYRVGGRTMLPIRWMPPESILYRKF 237
Query: 101 DGKIADVWSCGVTLY-VMLVGAYPF 124
+ +DVWS GV L+ + G P+
Sbjct: 238 TTE-SDVWSFGVVLWEIFTYGKQPW 261
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 6e-07
Identities = 38/132 (28%), Positives = 58/132 (43%), Gaps = 12/132 (9%)
Query: 1 MEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
+ Y G+L F R + + F Q+ G+ Y + HRDL N +LD S
Sbjct: 102 LPYMCHGDLLQFIR-SPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDES 160
Query: 59 TAPRVKICDFGYSK---SSVLHSQPKSTVGT-PA-YIAPEVLTKKEYDGKIADVWSCGVT 113
VK+ DFG ++ +S + P + A E L + K +DVWS GV
Sbjct: 161 FT--VKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTK-SDVWSFGVL 217
Query: 114 LY-VMLVGAYPF 124
L+ ++ GA P+
Sbjct: 218 LWELLTRGAPPY 229
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 1e-06
Identities = 29/147 (19%), Positives = 55/147 (37%), Gaps = 29/147 (19%)
Query: 1 MEYAAGGEL---------FERICNAGRFSEDEARFFFQQLI-------SGVSYCHSMQIC 44
Y + G+L + + ++ + +G+ Y S +
Sbjct: 91 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVV 150
Query: 45 HRDLKLENTLL-DGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLTKK 98
H+DL N L+ D VKI D G + +++ + + + APE +
Sbjct: 151 HKDLATRNVLVYDKLN---VKISDLGLFR--EVYAADYYKLLGNSLLPIRWMAPEAIMYG 205
Query: 99 EYDGKIADVWSCGVTLY-VMLVGAYPF 124
++ +D+WS GV L+ V G P+
Sbjct: 206 KFSID-SDIWSYGVVLWEVFSYGLQPY 231
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-06
Identities = 18/71 (25%), Positives = 32/71 (45%), Gaps = 11/71 (15%)
Query: 30 QLISGVSYCHSMQICHRDLKLENTLL---DGSTAPRVKICDFGYSK-----SSVLH---S 78
Q+++ V H + +RD+K +N L+ + A + + DFG K + H
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYR 173
Query: 79 QPKSTVGTPAY 89
+ K+ GT Y
Sbjct: 174 EKKNLSGTARY 184
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 47.3 bits (112), Expect = 2e-06
Identities = 29/91 (31%), Positives = 43/91 (47%), Gaps = 11/91 (12%)
Query: 8 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD-GSTAPRVKIC 66
+LF C+ + S Q+I+ V + HS HRD+K +N L+ G A +V I
Sbjct: 91 DLF-NFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 148
Query: 67 DFGYSK-----SSVLH---SQPKSTVGTPAY 89
DFG +K S+ H + K+ GT Y
Sbjct: 149 DFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-06
Identities = 39/154 (25%), Positives = 59/154 (38%), Gaps = 35/154 (22%)
Query: 1 MEYAAGGEL-----------------FERICNAGRFSEDEARFFFQQLIS-------GVS 36
+EYA G L ++ DE LIS G+
Sbjct: 105 VEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQ 164
Query: 37 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI-----A 91
Y M++ HRDL N L+ +KI DFG S+ ++ + + I A
Sbjct: 165 YLAEMKLVHRDLAARNILVAEGRK--MKISDFGLSRD--VYEEDSYVKRSQGRIPVKWMA 220
Query: 92 PEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 124
E L Y + +DVWS GV L+ ++ +G P+
Sbjct: 221 IESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPY 253
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-06
Identities = 39/152 (25%), Positives = 55/152 (36%), Gaps = 34/152 (22%)
Query: 1 MEYAAGGEL----------------FERICNAGRFSEDEARFFFQQLIS-------GVSY 37
EY G+L ED F+ L+ G+ +
Sbjct: 128 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 187
Query: 38 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI-----AP 92
HRDL N L+ VKICDFG ++ + S V A + AP
Sbjct: 188 LEFKSCVHRDLAARNVLVTHGKV--VKICDFGLARD--IMSDSNYVVRGNARLPVKWMAP 243
Query: 93 EVLTKKEYDGKIADVWSCGVTLY-VMLVGAYP 123
E L + Y K +DVWS G+ L+ + +G P
Sbjct: 244 ESLFEGIYTIK-SDVWSYGILLWEIFSLGVNP 274
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 4e-06
Identities = 35/155 (22%), Positives = 56/155 (36%), Gaps = 37/155 (23%)
Query: 1 MEYAAGGEL-----------------FERICNAGRFSEDEARFFFQQLI-------SGVS 36
EY A G+L + A S + + +G++
Sbjct: 129 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMA 188
Query: 37 YCHSMQICHRDLKLENTLL-DGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI----- 90
Y + HRDL N L+ + VKI DFG S++ ++S I
Sbjct: 189 YLSERKFVHRDLATRNCLVGENMV---VKIADFGLSRN--IYSADYYKADGNDAIPIRWM 243
Query: 91 APEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 124
PE + Y + +DVW+ GV L+ + G P+
Sbjct: 244 PPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPY 277
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 6e-06
Identities = 24/71 (33%), Positives = 33/71 (46%), Gaps = 11/71 (15%)
Query: 30 QLISGVSYCHSMQICHRDLKLENTLL---DGSTAPRVKICDFGYSK-----SSVLH---S 78
QLIS + Y HS + +RD+K EN L+ T + I DF +K + H
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYR 172
Query: 79 QPKSTVGTPAY 89
+ KS GT Y
Sbjct: 173 EHKSLTGTARY 183
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 8e-06
Identities = 20/75 (26%), Positives = 32/75 (42%), Gaps = 4/75 (5%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-SMQICHRDLKLENTLLDGST 59
+E+ GG E++ S A+ QL + ++ S++ HRDL N LL +
Sbjct: 141 LEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKT- 198
Query: 60 APRVKICDFGYSKSS 74
K+ KSS
Sbjct: 199 -SLKKLHYTLNGKSS 212
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 9e-06
Identities = 14/91 (15%), Positives = 29/91 (31%), Gaps = 9/91 (9%)
Query: 8 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICD 67
+ SE +L+ + + H + H ++ EN +D +V +
Sbjct: 146 SALDV-SPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAG 204
Query: 68 FGYSK---SSVLH-----SQPKSTVGTPAYI 90
+G++ S H G +I
Sbjct: 205 YGFAFRYCPSGKHVAYVEGSRSPHEGDLEFI 235
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 12/43 (27%), Positives = 21/43 (48%)
Query: 30 QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK 72
+++ + Y H + H D+K N LL +V + D+G S
Sbjct: 159 RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-05
Identities = 29/91 (31%), Positives = 41/91 (45%), Gaps = 11/91 (12%)
Query: 8 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL-DGSTAPRVKIC 66
+LF C+ +FS Q+IS + Y HS HRD+K +N L+ G V I
Sbjct: 93 DLF-NFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYII 150
Query: 67 DFGYSK-----SSVLH---SQPKSTVGTPAY 89
DFG +K + H + K+ GT Y
Sbjct: 151 DFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 2e-05
Identities = 11/43 (25%), Positives = 22/43 (51%)
Query: 30 QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK 72
+++ + Y H + H D+K N LL+ +V + D+G +
Sbjct: 160 RILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 262 | |||
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.8 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.64 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.4 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.18 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.49 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.29 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.26 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.11 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.01 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.75 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.38 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 96.69 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 96.55 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 96.15 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 96.04 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 95.29 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 94.11 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 93.83 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 93.51 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 92.97 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 91.8 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 91.65 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 91.4 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 89.31 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 88.34 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 86.55 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 85.87 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 84.56 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 83.63 |
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=353.87 Aligned_cols=180 Identities=47% Similarity=0.778 Sum_probs=147.5
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||| ||+|.++|.+++++++..++.++.||+.||+|||++||+||||||+|||++.++ ++||+|||+|+........
T Consensus 92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~--~vkl~DFGla~~~~~~~~~ 168 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHL--NVKIADFGLSNIMTDGNFL 168 (275)
T ss_dssp EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTC--CEEECCSSCC---------
T ss_pred EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCC--CEEEeecCCCeecCCCCcc
Confidence 8999 689999999999999999999999999999999999999999999999998777 8999999999866555555
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 160 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 160 (262)
.+.+||+.|||||++.+..|++.++||||+||++|+|+||+.||.+.+....+ ..+....+.+|. .+|+++++|
T Consensus 169 ~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~----~~i~~~~~~~p~--~~s~~~~~l 242 (275)
T 3hyh_A 169 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLF----KNISNGVYTLPK--FLSPGAAGL 242 (275)
T ss_dssp ------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHTCCCCCT--TSCHHHHHH
T ss_pred CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHH----HHHHcCCCCCCC--CCCHHHHHH
Confidence 67899999999999998888777799999999999999999999875443333 334444455665 689999999
Q ss_pred HHHhcccCCCCCCCHhHHhcCccccccCC
Q 024809 161 LSRIFVANSEKRITIPEIKNHPWFLRNLP 189 (262)
Q Consensus 161 i~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 189 (262)
|.+||+.||++|||++|+++||||+...|
T Consensus 243 i~~~L~~dP~~R~s~~eil~hpw~k~~~p 271 (275)
T 3hyh_A 243 IKRMLIVNPLNRISIHEIMQDDWFKVDLP 271 (275)
T ss_dssp HHHHSCSSGGGSCCHHHHHHCHHHHTTCC
T ss_pred HHHHccCChhHCcCHHHHHcCcccccCCC
Confidence 99999999999999999999999987654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=354.01 Aligned_cols=177 Identities=34% Similarity=0.662 Sum_probs=154.0
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC---
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH--- 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~--- 77 (262)
||||+||+|+++|.+.+.++|..++.|+.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus 111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g--~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS--CEEECCCTTCEECCTTTTC
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCC--CEEEEEcCCceecCCCCCc
Confidence 89999999999999999999999999999999999999999999999999999998777 8999999999865322
Q ss_pred CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHH
Q 024809 78 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 157 (262)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (262)
....+.+||+.|||||++.+..|+ .++|||||||++|+|+||+.||.+.+..+.+. ++....+.+|. .+|+++
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~----~i~~~~~~~p~--~~s~~~ 261 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEGLIFA----KIIKLEYDFPE--KFFPKA 261 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHTCCCCCT--TCCHHH
T ss_pred ccccCcccCcccCCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHcCCCCCCc--ccCHHH
Confidence 234567899999999999888775 45899999999999999999998765444333 34445566666 689999
Q ss_pred HHHHHHhcccCCCCCCCHhH------HhcCccccc
Q 024809 158 KHLLSRIFVANSEKRITIPE------IKNHPWFLR 186 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s~~e------~l~hp~~~~ 186 (262)
++||.+||++||.+|||++| +++||||+.
T Consensus 262 ~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 262 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296 (311)
T ss_dssp HHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred HHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence 99999999999999999988 588999974
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-51 Score=354.57 Aligned_cols=182 Identities=28% Similarity=0.514 Sum_probs=155.2
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-CC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (262)
||||+||+|.+++.+. ++++..++.|+.||+.||.|||++|||||||||+|||++.++ .+||+|||+|+..... ..
T Consensus 150 mEy~~gg~L~~~l~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g--~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 150 MEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG--RVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp ECCCTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCCTTCEECCSSSCC
T ss_pred EeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCC--CEEEecCcCceecCCCCCc
Confidence 8999999999998764 699999999999999999999999999999999999998777 8999999999865433 33
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
..+.+||+.|||||++.+..|+. ++|||||||++|+|++|+.||.+.+..+.+..+... ....++.+..+|+++++
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~-~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~---~~~~~~~~~~~s~~~~d 302 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGP-EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN---LPPRLKNLHKVSPSLKG 302 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---SCCCCSCGGGSCHHHHH
T ss_pred ccccccCcCcCCHHHHCCCCCCc-HHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC---CCCCCCccccCCHHHHH
Confidence 45679999999999998888854 589999999999999999999886655444433222 12233445579999999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCccccccCC
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWFLRNLP 189 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 189 (262)
||.+||++||++|||++|+|+||||++..+
T Consensus 303 li~~~L~~dP~~R~ta~e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 303 FLDRLLVRDPAQRATAAELLKHPFLAKAGP 332 (346)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HHHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence 999999999999999999999999987544
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-51 Score=348.83 Aligned_cols=177 Identities=36% Similarity=0.638 Sum_probs=152.9
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-CC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (262)
||||+||+|+++|.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+..... ..
T Consensus 105 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g--~vKl~DFGla~~~~~~~~~ 182 (304)
T 3ubd_A 105 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG--HIKLTDFGLSKESIDHEKK 182 (304)
T ss_dssp ECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTS--CEEEESSEEEEC-----CC
T ss_pred EEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCC--CEEecccccceeccCCCcc
Confidence 89999999999999999999999999999999999999999999999999999998777 8999999999854332 34
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
..+.+||+.|||||++.+..|+.+ +|||||||++|+|+||+.||.+.+..+.+.. +....+.+|. .+|+++++
T Consensus 183 ~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyemltG~~PF~~~~~~~~~~~----i~~~~~~~p~--~~s~~~~~ 255 (304)
T 3ubd_A 183 AYSFCGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGTLPFQGKDRKETMTM----ILKAKLGMPQ--FLSPEAQS 255 (304)
T ss_dssp CCSCCCCGGGCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHCCCCCCT--TSCHHHHH
T ss_pred ccccccCcccCCHHHhccCCCCCC-CcccchHHHHHHHHhCCCCCCCcCHHHHHHH----HHcCCCCCCC--cCCHHHHH
Confidence 456789999999999998888654 8999999999999999999988665444433 3334455555 68999999
Q ss_pred HHHHhcccCCCCCCCH-----hHHhcCccccc
Q 024809 160 LLSRIFVANSEKRITI-----PEIKNHPWFLR 186 (262)
Q Consensus 160 li~~~L~~dp~~R~s~-----~e~l~hp~~~~ 186 (262)
||.+||++||++|||+ +|+++||||+.
T Consensus 256 li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 256 LLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp HHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 9999999999999984 79999999974
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=343.10 Aligned_cols=178 Identities=25% Similarity=0.435 Sum_probs=148.4
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecC-CCCCcEEEeccCCCcCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--ICHRDLKLENTLLDG-STAPRVKICDFGYSKSSVLH 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~--ivHrDlkp~Nili~~-~~~~~~kl~Dfg~a~~~~~~ 77 (262)
||||+||+|.++|.+.+.+++..++.|+.||+.||.|||++| ||||||||+|||++. ++ .+||+|||+|+... .
T Consensus 108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g--~vKl~DFGla~~~~-~ 184 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG--SVKIGDLGLATLKR-A 184 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTS--CEEECCTTGGGGCC-T
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCC--CEEEEeCcCCEeCC-C
Confidence 799999999999999889999999999999999999999999 999999999999974 45 89999999997432 3
Q ss_pred CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHH
Q 024809 78 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 157 (262)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (262)
....+.+||+.|||||++.+ .|+ .++|||||||++|+|+||+.||.+......+...+.. ...........++++
T Consensus 185 ~~~~~~~GTp~YmAPE~~~~-~y~-~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~---~~~~~~~~~~~~~~~ 259 (290)
T 3fpq_A 185 SFAKAVIGTPEFMAPEMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS---GVKPASFDKVAIPEV 259 (290)
T ss_dssp TSBEESCSSCCCCCGGGGGT-CCC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT---TCCCGGGGGCCCHHH
T ss_pred CccCCcccCccccCHHHcCC-CCC-cHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc---CCCCCCCCccCCHHH
Confidence 34456789999999999865 465 5599999999999999999999876665544333322 111111123578899
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 158 KHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
++||.+||+.||++|||++|+|+||||++
T Consensus 260 ~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 260 KEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 99999999999999999999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=354.68 Aligned_cols=182 Identities=28% Similarity=0.514 Sum_probs=154.8
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-CC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (262)
||||+||+|.+++... ++++..++.|+.||+.||.|||++|||||||||+|||++.++ .+||+|||+|+..... ..
T Consensus 227 mEy~~gG~L~~~i~~~-~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g--~vKl~DFGla~~~~~~~~~ 303 (423)
T 4fie_A 227 MEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG--RVKLSDFGFCAQVSKEVPR 303 (423)
T ss_dssp EECCTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTC--CEEECCCTTCEECCSSCCC
T ss_pred EeCCCCCcHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC--CEEEecCccceECCCCCcc
Confidence 8999999999998764 699999999999999999999999999999999999998777 8999999999865433 34
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
..+.+||+.|||||++.+..|+. ++|||||||++|+|++|+.||.+.+..+.+..+... ....++....+|+++++
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~-~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~---~~~~~~~~~~~s~~~~d 379 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGP-EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN---LPPRLKNLHKVSPSLKG 379 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---CCCCCSCTTSSCHHHHH
T ss_pred ccccccCcCcCCHHHHCCCCCCc-HHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC---CCCCCcccccCCHHHHH
Confidence 45679999999999998888864 589999999999999999999876654444433222 12233444579999999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCccccccCC
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWFLRNLP 189 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 189 (262)
||.+||+.||.+|||+.|+|+||||++..+
T Consensus 380 li~~~L~~dP~~R~ta~ell~Hp~~~~~~~ 409 (423)
T 4fie_A 380 FLDRLLVRDPAQRATAAELLKHPFLAKAGP 409 (423)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HHHHHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence 999999999999999999999999987543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-50 Score=351.38 Aligned_cols=262 Identities=69% Similarity=1.141 Sum_probs=169.9
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
||||+||+|.+++...+++++..++.++.||+.||.|||++||+||||||+|||++.++.+++||+|||+++........
T Consensus 95 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~ 174 (361)
T 3uc3_A 95 MEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 174 (361)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCC
Confidence 79999999999999888999999999999999999999999999999999999998777556999999999855444455
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 160 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 160 (262)
....||+.|+|||++.+..++++++|||||||++|+|++|+.||.+......+...+..+....+.+|....+++++++|
T Consensus 175 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 254 (361)
T 3uc3_A 175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHL 254 (361)
T ss_dssp ------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHH
T ss_pred CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHH
Confidence 56789999999999988887777689999999999999999999987766666666666666667777777899999999
Q ss_pred HHHhcccCCCCCCCHhHHhcCccccccCCccccCCCC--ccccCCCCCCCCHHHHHHHhHHhcCCCCCCccCCccccCCC
Q 024809 161 LSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGS--WQSHDVNNPSQSLEEVLSLIHEATKPLEAPRVGGHLLGSSM 238 (262)
Q Consensus 161 i~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (262)
|.+||+.||.+|||+.++++||||.+..+........ .......++.++++++.+.+.+...+....+...+....+.
T Consensus 255 i~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (361)
T 3uc3_A 255 ISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIPAVRNRCLDDFMTDNL 334 (361)
T ss_dssp HHHHSCSCTTTSCCHHHHHTSHHHHTTCCCC------------------CCHHHHHHHHHHHTCC---------------
T ss_pred HHHHccCChhHCcCHHHHHhCcchhcCCchhhhccccccccccCCcccccCHHHHHHHHhhccCcccccccchhcccccc
Confidence 9999999999999999999999998776654432211 11122345567888998888888766544433333334444
Q ss_pred CCCcccc---ccccccccCCCcccccC
Q 024809 239 ELDDLDA---DADLEDTETSGDFVCPL 262 (262)
Q Consensus 239 ~~~~~~~---~~~~~~~~~~~~~~~~~ 262 (262)
+.|++++ ++++.|+|.+|+++|++
T Consensus 335 d~d~~~~~~d~~~~~d~d~~g~~~~~~ 361 (361)
T 3uc3_A 335 DLDDDMDDFDSESEIDIDSSGEIVYAL 361 (361)
T ss_dssp ---------------------------
T ss_pred ccccccccccchhhhccCCCCcEEecC
Confidence 4443332 23456899999999986
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=350.10 Aligned_cols=179 Identities=28% Similarity=0.506 Sum_probs=151.1
Q ss_pred CCCCCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
||||+||+|+++|...+ .++|..++.|+.||+.||.|||++|||||||||+|||++.++ .+||+|||+|+......
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g--~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG--TVQLGDFGIARVLNSTV 179 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTC--CEEECSTTEESCCCHHH
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC--CEEEcccccceeecCCc
Confidence 89999999999997543 579999999999999999999999999999999999998777 89999999998653221
Q ss_pred -CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHH
Q 024809 79 -QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 157 (262)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (262)
.....+||+.|||||++.+..|+. ++|||||||++|+|+||+.||.+.+..+.+.++... .+. +....+|+++
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~-~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~----~~~-~~~~~~s~~~ 253 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNN-KSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG----SFP-PVSLHYSYDL 253 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT----CCC-CCCTTSCHHH
T ss_pred ccccccCCCccccCHHHHCCCCCCc-HHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC----CCC-CCCccCCHHH
Confidence 223468999999999999888764 599999999999999999999886655544443322 221 2234689999
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 158 KHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
++||.+||++||.+|||+.|+|+||||++.
T Consensus 254 ~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 254 RSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 999999999999999999999999999764
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=342.28 Aligned_cols=182 Identities=26% Similarity=0.384 Sum_probs=149.7
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC-
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ- 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~- 79 (262)
||||+||+|.++|.+.+.|++..++.|+.||+.||.|||++|||||||||+|||++.++. ++||+|||+|+.......
T Consensus 129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~-~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS-RAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSC-CEEECCCTTCEEC------
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCC-EEEEeeCCCCeEccCCCcc
Confidence 899999999999999889999999999999999999999999999999999999986652 599999999986543221
Q ss_pred -----CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCC
Q 024809 80 -----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS 154 (262)
Q Consensus 80 -----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (262)
....+||+.|||||++.+..|+.+ +|||||||++|+|+||+.||.+......+.++...... ...+| ..++
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~-~~~~~--~~~s 283 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPP-IREIP--PSCA 283 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCG-GGGSC--TTSC
T ss_pred cceecCCccccCccccCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCC-chhcC--ccCC
Confidence 233579999999999998887655 89999999999999999999886655544444332211 11223 3689
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHH-------------hcCcccccc
Q 024809 155 LECKHLLSRIFVANSEKRITIPEI-------------KNHPWFLRN 187 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~~e~-------------l~hp~~~~~ 187 (262)
+++++||.+||++||.+|||+.|+ |+|||+.+.
T Consensus 284 ~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 284 PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 999999999999999999999997 578998654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=343.88 Aligned_cols=186 Identities=25% Similarity=0.382 Sum_probs=155.0
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC---
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH--- 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~--- 77 (262)
||||+ |+|+++|.+.+++++..++.+++||+.||.|||++|||||||||+|||++.++ .+||+|||+|+.....
T Consensus 138 mE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~--~~Ki~DFGla~~~~~~~~~ 214 (398)
T 4b99_A 138 LDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENC--ELKIGDFGMARGLCTSPAE 214 (398)
T ss_dssp EECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC--CEEECCCTTCBCC------
T ss_pred EeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCC--CEEEeecceeeecccCccc
Confidence 79996 68999999999999999999999999999999999999999999999998777 8999999999864322
Q ss_pred --CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccc----------
Q 024809 78 --SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY---------- 145 (262)
Q Consensus 78 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~---------- 145 (262)
....+.+||+.|||||++.+..+++.++||||+||++|+|++|+.||.+.+..+.+..+.........
T Consensus 215 ~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~ 294 (398)
T 4b99_A 215 HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAER 294 (398)
T ss_dssp -CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----C
T ss_pred cccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhh
Confidence 23446789999999999988777677799999999999999999999988776666655433221110
Q ss_pred ------cCCC---------cccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCC
Q 024809 146 ------SFPD---------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLP 189 (262)
Q Consensus 146 ------~~~~---------~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 189 (262)
.+|. +..+++++++||.+||++||.+|||+.|+|+||||++...
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 295 VRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 353 (398)
T ss_dssp HHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred hhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence 0111 1347899999999999999999999999999999987654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=339.64 Aligned_cols=182 Identities=28% Similarity=0.447 Sum_probs=142.2
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
||||+||+|.+++. ++++.+++.+++||+.||+|||++||+||||||+|||++.+. +.+||+|||+|+......
T Consensus 99 mE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~-~~~kl~DFGla~~~~~~~~~ 174 (361)
T 4f9c_A 99 MPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRL-KKYALVDFGLAQGTHDTKIE 174 (361)
T ss_dssp EECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT-TEEEECCCTTCEECTTCSCG
T ss_pred EeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCC-CeEEECcCCCCcccCCcccc
Confidence 79999999999983 599999999999999999999999999999999999997652 389999999997432211
Q ss_pred ---------------------------CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh-
Q 024809 79 ---------------------------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP- 130 (262)
Q Consensus 79 ---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~- 130 (262)
.....+||+.|||||++.+..+++.++||||+||++|+|+||+.||....+.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~ 254 (361)
T 4f9c_A 175 LLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDL 254 (361)
T ss_dssp GGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHH
Confidence 1234579999999999988765567699999999999999999999665543
Q ss_pred hHHHHHhccc----------------------------------ccc--------------cccCCCcccCCHHHHHHHH
Q 024809 131 KNFRKTIGRI----------------------------------LSV--------------HYSFPDYVRVSLECKHLLS 162 (262)
Q Consensus 131 ~~~~~~~~~~----------------------------------~~~--------------~~~~~~~~~~~~~~~~li~ 162 (262)
+.+..+.... ... ....+.+..+|+++++||+
T Consensus 255 ~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~ 334 (361)
T 4f9c_A 255 TALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLD 334 (361)
T ss_dssp HHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHH
T ss_pred HHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHH
Confidence 2222221100 000 0011234468999999999
Q ss_pred HhcccCCCCCCCHhHHhcCccccc
Q 024809 163 RIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 163 ~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
+||++||.+|+|++|+|+||||+.
T Consensus 335 ~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 335 KLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp HHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHCcCChhHCcCHHHHhcCcccCC
Confidence 999999999999999999999974
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=354.31 Aligned_cols=180 Identities=31% Similarity=0.520 Sum_probs=153.9
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
||||+||+|+++|.+.+.|++..++.|+.||+.||.|||++|||||||||+|||++.++ ++||+|||+|+.... ...
T Consensus 271 mEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G--~vKL~DFGlA~~~~~-~~~ 347 (689)
T 3v5w_A 271 LDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSK-KKP 347 (689)
T ss_dssp ECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTS--CEEECCCTTCEECSS-CCC
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCC--CEEecccceeeecCC-CCC
Confidence 89999999999999999999999999999999999999999999999999999998877 899999999986543 345
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 160 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 160 (262)
.+.+||+.|||||++.++..++.++|||||||++|+|++|+.||.+...... ..+...+......+|. .+|+++++|
T Consensus 348 ~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~-~~i~~~i~~~~~~~p~--~~S~~a~dL 424 (689)
T 3v5w_A 348 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVELPD--SFSPELRSL 424 (689)
T ss_dssp CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH-HHHHHHHHHCCCCCCT--TSCHHHHHH
T ss_pred CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhhcCCCCCCCc--cCCHHHHHH
Confidence 6789999999999997554345669999999999999999999976443222 2333344444555665 689999999
Q ss_pred HHHhcccCCCCCCC-----HhHHhcCccccc
Q 024809 161 LSRIFVANSEKRIT-----IPEIKNHPWFLR 186 (262)
Q Consensus 161 i~~~L~~dp~~R~s-----~~e~l~hp~~~~ 186 (262)
|.+||+.||.+|++ +++|++||||+.
T Consensus 425 I~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 425 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp HHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred HHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 99999999999998 799999999975
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=316.07 Aligned_cols=179 Identities=24% Similarity=0.372 Sum_probs=140.7
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC--
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-- 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-- 77 (262)
||||+||+|.++|... +++++..+..|+.||+.||.|||+++||||||||+|||++.++ .+||+|||+|+.....
T Consensus 110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~--~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGL--TVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTE--EEEECCCSSCBC------
T ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCC--cEEEeeccCceecccCCc
Confidence 7999999999999764 5799999999999999999999999999999999999998877 8999999999854322
Q ss_pred -CCCCccccCCCCCCcccccCCc--CCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCC
Q 024809 78 -SQPKSTVGTPAYIAPEVLTKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS 154 (262)
Q Consensus 78 -~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (262)
......+||+.|||||++.+.. .++.++|||||||++|||+||+.||.+.+........+...............++
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 267 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCP 267 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSC
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccch
Confidence 2234568999999999996432 2345599999999999999999999987765554444332111110111223688
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 155 LECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
+++.+||.+||+.||++|||+.+++++
T Consensus 268 ~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 268 KAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp HHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999988654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=345.75 Aligned_cols=183 Identities=30% Similarity=0.563 Sum_probs=156.4
Q ss_pred CCCCCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
||||+||+|+++|.. .+.|++..++.+++||+.||.|||++||+||||||+|||++.+..+.+||+|||+|+.......
T Consensus 233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~ 312 (573)
T 3uto_A 233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312 (573)
T ss_dssp EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence 799999999999974 4579999999999999999999999999999999999999866445899999999987655545
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccC--CCcccCCHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLEC 157 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 157 (262)
....+||+.|||||++.+..|. .++|||||||++|+|++|+.||.+.+..+.+..+.. ..+.+ +.+..+|+++
T Consensus 313 ~~~~~GT~~y~APEv~~~~~y~-~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~----~~~~~~~~~~~~~s~~~ 387 (573)
T 3uto_A 313 VKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS----CDWNMDDSAFSGISEDG 387 (573)
T ss_dssp EEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT----TCCCCCSGGGTTSCHHH
T ss_pred eeeeEECccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHh----CCCCCCcccccCCCHHH
Confidence 5567899999999999988875 458999999999999999999998766555544332 22332 2345789999
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 024809 158 KHLLSRIFVANSEKRITIPEIKNHPWFLRNL 188 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 188 (262)
++||.+||+.||.+|||+.|+|+||||+...
T Consensus 388 ~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~ 418 (573)
T 3uto_A 388 KDFIRKLLLADPNTRMTIHQALEHPWLTPGN 418 (573)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSTTTSCCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcCcCCCC
Confidence 9999999999999999999999999998643
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=319.79 Aligned_cols=175 Identities=22% Similarity=0.348 Sum_probs=134.5
Q ss_pred CCCCCCCchHHHHHhCCCC---CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC
Q 024809 1 MEYAAGGELFERICNAGRF---SEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l---~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~ 77 (262)
||||+||+|.+++...+.+ ++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus 94 mE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~--~vKl~DFGla~~~~~~ 171 (299)
T 4g31_A 94 MQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD--VVKVGDFGLVTAMDQD 171 (299)
T ss_dssp EECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECCCCCC------
T ss_pred EecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCC--cEEEccCccceecCCC
Confidence 7999999999999877654 4567899999999999999999999999999999998777 8999999999865332
Q ss_pred C-------------CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccc
Q 024809 78 S-------------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH 144 (262)
Q Consensus 78 ~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 144 (262)
. .....+||+.|||||++.+..|+. ++|||||||++|+|++ ||....+ ....+..+...
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~-~~DiwSlGvilyell~---Pf~~~~~---~~~~~~~~~~~- 243 (299)
T 4g31_A 172 EEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSH-KVDIFSLGLILFELLY---PFSTQME---RVRTLTDVRNL- 243 (299)
T ss_dssp --------------------CCCTTSCHHHHTTCCCCT-HHHHHHHHHHHHHHHS---CCSSHHH---HHHHHHHHHTT-
T ss_pred ccccccccccccccccCCcccCccccCHHHHcCCCCCC-HHHHHHHHHHHHHHcc---CCCCccH---HHHHHHHHhcC-
Confidence 1 123457999999999999888765 4899999999999996 7764221 11222222221
Q ss_pred ccCC-CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 145 YSFP-DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 145 ~~~~-~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
.+| .....++.+++||.+||+.||.+|||+.|+|+||||+.
T Consensus 244 -~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 244 -KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285 (299)
T ss_dssp -CCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred -CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence 222 23356788899999999999999999999999999974
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=306.29 Aligned_cols=180 Identities=41% Similarity=0.738 Sum_probs=157.2
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
||||+||+|.+++...+++++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++........
T Consensus 93 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~~~~~ 170 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADM--NIKIADFGFSNEFTVGGKL 170 (328)
T ss_dssp ECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECSTTCCGGGSSSCGG
T ss_pred EECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCC--CEEEeeccCceecCCCCcc
Confidence 79999999999999888999999999999999999999999999999999999998777 8999999999866555555
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 160 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 160 (262)
...+||+.|+|||++.+..+++.++||||+||++|+|++|+.||.+.+....... +....+..|. .+++++.+|
T Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~----i~~~~~~~p~--~~s~~~~~l 244 (328)
T 3fe3_A 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER----VLRGKYRIPF--YMSTDCENL 244 (328)
T ss_dssp GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHCCCCCCT--TSCHHHHHH
T ss_pred ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCCCCCC--CCCHHHHHH
Confidence 6678999999999999888877779999999999999999999987654433332 3333444554 589999999
Q ss_pred HHHhcccCCCCCCCHhHHhcCccccccC
Q 024809 161 LSRIFVANSEKRITIPEIKNHPWFLRNL 188 (262)
Q Consensus 161 i~~~L~~dp~~R~s~~e~l~hp~~~~~~ 188 (262)
|++||+.||.+|||++++++||||....
T Consensus 245 i~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 245 LKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 9999999999999999999999998654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=314.73 Aligned_cols=174 Identities=24% Similarity=0.394 Sum_probs=145.6
Q ss_pred CCCCCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEE
Q 024809 1 MEYAAGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVK 64 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~k 64 (262)
||||+||+|.++|.+. ..+++..+..++.||+.||.|||+++||||||||+|||++.++ .+|
T Consensus 148 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~--~vK 225 (353)
T 4ase_A 148 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN--VVK 225 (353)
T ss_dssp EECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEE
T ss_pred EEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCC--CEE
Confidence 7999999999999753 2489999999999999999999999999999999999998877 899
Q ss_pred EeccCCCcCCCCCCC---CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhccc
Q 024809 65 ICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRI 140 (262)
Q Consensus 65 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~ 140 (262)
|+|||+|+....... .....||+.|||||++.+..|+.+ +|||||||++|||+| |+.||.+......+.+.+..-
T Consensus 226 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~k-sDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g 304 (353)
T 4ase_A 226 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 304 (353)
T ss_dssp ECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHT
T ss_pred ECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCc-ccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcC
Confidence 999999986543322 234579999999999988887644 899999999999998 999998876555444443321
Q ss_pred ccccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 141 LSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
.....|. .+++++.+||.+||+.||.+|||+.++++|
T Consensus 305 --~~~~~p~--~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 305 --TRMRAPD--YTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp --CCCCCCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --CCCCCCc--cCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 1233444 689999999999999999999999999987
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=307.30 Aligned_cols=173 Identities=21% Similarity=0.365 Sum_probs=138.2
Q ss_pred CCCCCCCchHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEE
Q 024809 1 MEYAAGGELFERICNA---------------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKI 65 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~---------------~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl 65 (262)
||||+||+|.++|.+. +++++.++..|+.||+.||.|||+++||||||||+|||++.++ .+||
T Consensus 122 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~--~~Ki 199 (329)
T 4aoj_A 122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL--VVKI 199 (329)
T ss_dssp EECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT--EEEE
T ss_pred EEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC--cEEE
Confidence 7999999999999754 3599999999999999999999999999999999999998877 8999
Q ss_pred eccCCCcCCCCCC---CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccc
Q 024809 66 CDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRIL 141 (262)
Q Consensus 66 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 141 (262)
+|||+|+...... ......||+.|||||++.+..|+.+ +|||||||++|||+| |+.||.+....+.+..+...
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~-sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g-- 276 (329)
T 4aoj_A 200 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG-- 276 (329)
T ss_dssp CCCC----------------CCCCGGGCCHHHHTTCCCCHH-HHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT--
T ss_pred cccccceeccCCCcceecCcccccccccChhhhcCCCCCcc-ccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC--
Confidence 9999998553322 2234679999999999998887654 899999999999999 99999887655444333221
Q ss_pred cccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 142 SVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
.....|. .+++++.+|+.+||+.||++|||+.|++++
T Consensus 277 -~~~~~p~--~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 277 -RELERPR--ACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp -CCCCCCT--TCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred -CCCCCcc--cccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 1233343 689999999999999999999999999874
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=307.06 Aligned_cols=175 Identities=23% Similarity=0.350 Sum_probs=144.0
Q ss_pred CCCCCCCchHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEec
Q 024809 1 MEYAAGGELFERICNA-------------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICD 67 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-------------~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~D 67 (262)
||||+||+|.++|.+. ..|++..+..++.||+.||.|||+++||||||||+|||++.++ .+||+|
T Consensus 94 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~--~~Ki~D 171 (299)
T 4asz_A 94 FEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL--LVKIGD 171 (299)
T ss_dssp EECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECC
T ss_pred EEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC--cEEECC
Confidence 7999999999999764 3699999999999999999999999999999999999998877 899999
Q ss_pred cCCCcCCCCCC---CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccc
Q 024809 68 FGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSV 143 (262)
Q Consensus 68 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 143 (262)
||+|+...... ......||+.|||||++.+..|+.+ +||||+||++|||+| |+.||.+.+..+.+..+... .
T Consensus 172 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k-~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~---~ 247 (299)
T 4asz_A 172 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG---R 247 (299)
T ss_dssp CSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHT---C
T ss_pred cccceecCCCCceeecCceecChhhcCHHHHcCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC---C
Confidence 99997543222 1233569999999999988887654 899999999999998 89999987654444333221 1
Q ss_pred cccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccc
Q 024809 144 HYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFL 185 (262)
Q Consensus 144 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~ 185 (262)
....|. .+++++.+|+.+||+.||++|||+.+++ +|+.
T Consensus 248 ~~~~p~--~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~ 285 (299)
T 4asz_A 248 VLQRPR--TCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQ 285 (299)
T ss_dssp CCCCCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHH
T ss_pred CCCCCc--cchHHHHHHHHHHcCCChhHCcCHHHHH--HHHH
Confidence 123333 6899999999999999999999999994 4553
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=303.32 Aligned_cols=173 Identities=20% Similarity=0.331 Sum_probs=143.9
Q ss_pred CCCCCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEE
Q 024809 1 MEYAAGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVK 64 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~k 64 (262)
||||+||||.++|... ..+++..+..++.||+.||.|||+++||||||||+|||++.++ ++|
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~--~~K 185 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL--NVK 185 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEE
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCC--CEE
Confidence 7999999999999653 3589999999999999999999999999999999999998877 899
Q ss_pred EeccCCCcCCCCC---CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhccc
Q 024809 65 ICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRI 140 (262)
Q Consensus 65 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~ 140 (262)
|+|||+|+..... .......||+.|||||++.+..|+.+ +||||+||++|||+| |+.||.+.+..+....+...
T Consensus 186 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~k-sDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~- 263 (308)
T 4gt4_A 186 ISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNR- 263 (308)
T ss_dssp ECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTT-
T ss_pred ECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCcc-chhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-
Confidence 9999999854322 22345689999999999988887654 899999999999998 89999987654444333221
Q ss_pred ccccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 141 LSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
.....| ..+++++.+|+.+||+.||.+|||+.+|+++
T Consensus 264 --~~~~~p--~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 264 --QVLPCP--DDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp --CCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --CCCCCc--ccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 112233 3689999999999999999999999999875
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=297.87 Aligned_cols=177 Identities=37% Similarity=0.686 Sum_probs=152.2
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC-CCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (262)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.... ...
T Consensus 84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~vkL~DFG~a~~~~~~~~~ 161 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCSCCTTCC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCC--CEEEeeccchhhcccCCCc
Confidence 79999999999999888999999999999999999999999999999999999998777 899999999985332 233
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
....+||+.|+|||++.+..++. ++|||||||++|+|++|+.||.+.+....+..+ ......+|. .+++++++
T Consensus 162 ~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i----~~~~~~~p~--~~s~~~~~ 234 (337)
T 1o6l_A 162 MKTFCGTPEYLAPEVLEDNDYGR-AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI----LMEEIRFPR--TLSPEAKS 234 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCT-THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----HHCCCCCCT--TSCHHHHH
T ss_pred ccccccChhhCChhhhcCCCCCc-hhhcccchhHHHHHhcCCCCCCCCCHHHHHHHH----HcCCCCCCC--CCCHHHHH
Confidence 45678999999999998877754 489999999999999999999876544433332 233344554 68999999
Q ss_pred HHHHhcccCCCCCC-----CHhHHhcCccccc
Q 024809 160 LLSRIFVANSEKRI-----TIPEIKNHPWFLR 186 (262)
Q Consensus 160 li~~~L~~dp~~R~-----s~~e~l~hp~~~~ 186 (262)
||.+||+.||.+|| +++++++||||..
T Consensus 235 li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence 99999999999999 9999999999975
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=305.41 Aligned_cols=181 Identities=29% Similarity=0.570 Sum_probs=151.7
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCC-CCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV-LHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~-~~~~ 79 (262)
||||+||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++... ....
T Consensus 132 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g--~ikL~DFGla~~~~~~~~~ 209 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG--HIKLTDYGMCKEGLRPGDT 209 (396)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCCCCTTCC
T ss_pred EEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCC--CEEEeecceeeecccCCCc
Confidence 79999999999999888999999999999999999999999999999999999998777 89999999998532 2334
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChh-----HHHHHhcccccccccCCCcccCC
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPK-----NFRKTIGRILSVHYSFPDYVRVS 154 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 154 (262)
....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||....... ........+......+|. .++
T Consensus 210 ~~~~~gt~~Y~aPE~l~~~~~~-~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~s 286 (396)
T 4dc2_A 210 TSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLS 286 (396)
T ss_dssp BCCCCBCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT--TSC
T ss_pred cccccCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC--cCC
Confidence 4567899999999999888775 45899999999999999999997533211 111222333444455565 689
Q ss_pred HHHHHHHHHhcccCCCCCCCH------hHHhcCccccc
Q 024809 155 LECKHLLSRIFVANSEKRITI------PEIKNHPWFLR 186 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~------~e~l~hp~~~~ 186 (262)
+++++||++||+.||.+||++ +++++||||+.
T Consensus 287 ~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 287 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp HHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred HHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 999999999999999999995 79999999975
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=298.02 Aligned_cols=180 Identities=49% Similarity=0.848 Sum_probs=155.2
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||+ +|+|.+++...+++++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.........
T Consensus 88 ~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~--~~kl~DFG~s~~~~~~~~~ 164 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNL--NVKIADFGLSNIMTDGNFL 164 (336)
T ss_dssp ECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTC--CEEECCSSCTBTTTTSBTT
T ss_pred EECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCC--CEEEEEeccceeccCCccc
Confidence 7999 789999999888999999999999999999999999999999999999998776 8999999999866555555
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 160 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 160 (262)
...+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+..... ....+....+.+|. .+++++++|
T Consensus 165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~----~~~~i~~~~~~~p~--~~s~~~~~l 238 (336)
T 3h4j_B 165 KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN----LFKKVNSCVYVMPD--FLSPGAQSL 238 (336)
T ss_dssp CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT----CBCCCCSSCCCCCT--TSCHHHHHH
T ss_pred ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH----HHHHHHcCCCCCcc--cCCHHHHHH
Confidence 667899999999999888776677999999999999999999998754332 22333333444454 589999999
Q ss_pred HHHhcccCCCCCCCHhHHhcCccccccCC
Q 024809 161 LSRIFVANSEKRITIPEIKNHPWFLRNLP 189 (262)
Q Consensus 161 i~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 189 (262)
|.+||+.||.+|||++|+++||||+...+
T Consensus 239 i~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 267 (336)
T 3h4j_B 239 IRRMIVADPMQRITIQEIRRDPWFNVNLP 267 (336)
T ss_dssp HHTTSCSSGGGSCCHHHHTTCHHHHTTCC
T ss_pred HHHHcCCChhHCcCHHHHHhChhhccCCc
Confidence 99999999999999999999999987654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=303.82 Aligned_cols=178 Identities=35% Similarity=0.611 Sum_probs=149.3
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-CC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (262)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..... ..
T Consensus 103 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g--~ikL~DFG~a~~~~~~~~~ 180 (353)
T 3txo_A 103 MEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG--HCKLADFGMCKEGICNGVT 180 (353)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCSCC----
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCC--CEEEccccceeecccCCcc
Confidence 79999999999999888999999999999999999999999999999999999998777 8999999999853322 23
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..+.+..+ ......+|. .+++++++
T Consensus 181 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i----~~~~~~~p~--~~~~~~~~ 253 (353)
T 3txo_A 181 TATFCGTPDYIAPEILQEMLYG-PAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI----LNDEVVYPT--WLHEDATG 253 (353)
T ss_dssp -----CCGGGCCHHHHHHHHCT-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----HHCCCCCCT--TSCHHHHH
T ss_pred ccccCCCcCeEChhhcCCCCcC-CccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHH----HcCCCCCCC--CCCHHHHH
Confidence 4457899999999999877775 4589999999999999999999886654444433 334445555 58999999
Q ss_pred HHHHhcccCCCCCCCH------hHHhcCcccccc
Q 024809 160 LLSRIFVANSEKRITI------PEIKNHPWFLRN 187 (262)
Q Consensus 160 li~~~L~~dp~~R~s~------~e~l~hp~~~~~ 187 (262)
||++||+.||.+||++ .++++||||+..
T Consensus 254 li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 254 ILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp HHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred HHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 9999999999999999 899999999753
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=302.07 Aligned_cols=181 Identities=34% Similarity=0.625 Sum_probs=153.7
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC--CcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA--PRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~--~~~kl~Dfg~a~~~~~~~ 78 (262)
||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. ..+||+|||+++......
T Consensus 94 ~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~ 173 (361)
T 2yab_A 94 LELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV 173 (361)
T ss_dssp EECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTC
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCC
Confidence 799999999999998889999999999999999999999999999999999999976542 269999999998665544
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCC--CcccCCHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP--DYVRVSLE 156 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 156 (262)
.....+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+......+..+. ...+.++ .+..++++
T Consensus 174 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~----~~~~~~~~~~~~~~s~~ 248 (361)
T 2yab_A 174 EFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANIT----AVSYDFDEEFFSQTSEL 248 (361)
T ss_dssp CCCCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH----TTCCCCCHHHHTTSCHH
T ss_pred ccccCCCCccEECchHHcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----hcCCCCCchhccCCCHH
Confidence 55667899999999999877765 45899999999999999999998866544444332 2333333 23468999
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
+++||.+||..||.+|||+.++++||||..
T Consensus 249 ~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 249 AKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred HHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 999999999999999999999999999974
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=296.79 Aligned_cols=177 Identities=36% Similarity=0.646 Sum_probs=152.1
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC-CCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (262)
||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.... ...
T Consensus 100 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g--~vkL~DFG~a~~~~~~~~~ 177 (353)
T 2i0e_A 100 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENIWDGVT 177 (353)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCCCCTTCC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCC--cEEEEeCCcccccccCCcc
Confidence 79999999999999888899999999999999999999999999999999999998777 899999999985332 223
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+....+..+ ......+|. .+++++++
T Consensus 178 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i----~~~~~~~p~--~~s~~~~~ 250 (353)
T 2i0e_A 178 TKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI----MEHNVAYPK--SMSKEAVA 250 (353)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----HHCCCCCCT--TSCHHHHH
T ss_pred cccccCCccccChhhhcCCCcC-CcccccchHHHHHHHHcCCCCCCCCCHHHHHHHH----HhCCCCCCC--CCCHHHHH
Confidence 4567899999999999887775 4589999999999999999999876554444333 333445554 68999999
Q ss_pred HHHHhcccCCCCCCC-----HhHHhcCccccc
Q 024809 160 LLSRIFVANSEKRIT-----IPEIKNHPWFLR 186 (262)
Q Consensus 160 li~~~L~~dp~~R~s-----~~e~l~hp~~~~ 186 (262)
||.+||..||.+||+ ++++++||||+.
T Consensus 251 li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 251 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp HHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred HHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 999999999999994 699999999975
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=298.39 Aligned_cols=178 Identities=38% Similarity=0.687 Sum_probs=152.6
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-CC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (262)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..... ..
T Consensus 97 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~vkL~DFG~a~~~~~~~~~ 174 (345)
T 1xjd_A 97 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG--HIKIADFGMCKENMLGDAK 174 (345)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCCCCTTCC
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCC--CEEEeEChhhhhcccCCCc
Confidence 79999999999999888899999999999999999999999999999999999998777 8999999999854322 23
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+....+..+ ......+|. .+++++++
T Consensus 175 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i----~~~~~~~p~--~~s~~~~~ 247 (345)
T 1xjd_A 175 TNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI----RMDNPFYPR--WLEKEAKD 247 (345)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----HHCCCCCCT--TSCHHHHH
T ss_pred ccCCCCCcccCChhhhcCCCCC-ChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH----HhCCCCCCc--ccCHHHHH
Confidence 4567899999999999887775 4589999999999999999999876554443333 233344554 58999999
Q ss_pred HHHHhcccCCCCCCCHh-HHhcCcccccc
Q 024809 160 LLSRIFVANSEKRITIP-EIKNHPWFLRN 187 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~-e~l~hp~~~~~ 187 (262)
||.+||+.||.+||++. ++++||||+..
T Consensus 248 li~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 248 LLVKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp HHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence 99999999999999998 99999999753
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=295.91 Aligned_cols=181 Identities=29% Similarity=0.570 Sum_probs=150.4
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC-CCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (262)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+++.... ...
T Consensus 89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~~kL~DFG~a~~~~~~~~~ 166 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG--HIKLTDYGMCKEGLRPGDT 166 (345)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCGGGCBCSCCTTCC
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC--CEEEEeccccccccCCCCc
Confidence 79999999999999888899999999999999999999999999999999999998777 899999999985332 233
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh-----hHHHHHhcccccccccCCCcccCC
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP-----KNFRKTIGRILSVHYSFPDYVRVS 154 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 154 (262)
....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||...... .........+......+|. .++
T Consensus 167 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~s 243 (345)
T 3a8x_A 167 TSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLS 243 (345)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT--TSC
T ss_pred ccccCCCccccCccccCCCCCC-hHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC--CCC
Confidence 4557899999999999887775 4589999999999999999999753221 1111222233334445555 689
Q ss_pred HHHHHHHHHhcccCCCCCCCH------hHHhcCccccc
Q 024809 155 LECKHLLSRIFVANSEKRITI------PEIKNHPWFLR 186 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~------~e~l~hp~~~~ 186 (262)
.++++||.+||+.||.+||++ .++++||||+.
T Consensus 244 ~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp HHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred HHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 999999999999999999996 79999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=296.06 Aligned_cols=222 Identities=24% Similarity=0.371 Sum_probs=164.7
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||+ |++|.+++.. +.+++..++.+++||+.||.|||++||+||||||+|||++.++ .+||+|||+++... ...
T Consensus 109 ~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~--~~~ 182 (367)
T 1cm8_A 109 MPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC--ELKILDFGLARQAD--SEM 182 (367)
T ss_dssp EECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEECC--SSC
T ss_pred EecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCC--CEEEEeeecccccc--ccc
Confidence 6899 7899999877 4799999999999999999999999999999999999998777 89999999998543 234
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccc----------------
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH---------------- 144 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---------------- 144 (262)
....||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+....+..+........
T Consensus 183 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~ 262 (367)
T 1cm8_A 183 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 262 (367)
T ss_dssp CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHH
T ss_pred CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHH
Confidence 5578999999999998744445569999999999999999999998776555544432211100
Q ss_pred --------ccCC-CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCCccccCCCCccccCCCCCCCCHHHHHH
Q 024809 145 --------YSFP-DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLS 215 (262)
Q Consensus 145 --------~~~~-~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (262)
..+. .....++++++||.+||+.||.+|||+.++|+||||..........................+++.+
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (367)
T 1cm8_A 263 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKR 342 (367)
T ss_dssp HHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCCCCCCC-----CCHHHHHH
T ss_pred HhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCCCCCCCCChhhhcCCHHHHHH
Confidence 0000 1235789999999999999999999999999999998755433221111111222333457788888
Q ss_pred HhHHhcCCCCCCc
Q 024809 216 LIHEATKPLEAPR 228 (262)
Q Consensus 216 ~~~~~~~~~~~~~ 228 (262)
.+.+....+.++.
T Consensus 343 ~~~~~~~~~~~~~ 355 (367)
T 1cm8_A 343 VTYKEVLSFKPPR 355 (367)
T ss_dssp HHHHHHHTCCC--
T ss_pred HHHHHHHHhcccc
Confidence 8888776666553
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=290.99 Aligned_cols=176 Identities=39% Similarity=0.696 Sum_probs=152.4
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++... ...
T Consensus 85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~~kL~Dfg~a~~~~--~~~ 160 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG--HIKITDFGFAKYVP--DVT 160 (318)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS--CEEECCCSSCEECS--SCB
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCC--CEEEeecCcceecC--Ccc
Confidence 79999999999999988999999999999999999999999999999999999998777 89999999997543 233
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 160 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 160 (262)
...+||+.|+|||++.+..++.. +|||||||++|+|++|+.||...+....+..+. .....+|. .+++++++|
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~----~~~~~~p~--~~~~~~~~l 233 (318)
T 1fot_A 161 YTLCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL----NAELRFPP--FFNEDVKDL 233 (318)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH----HCCCCCCT--TSCHHHHHH
T ss_pred ccccCCccccCHhHhcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH----hCCCCCCC--CCCHHHHHH
Confidence 45689999999999988777654 899999999999999999998766544444433 33344554 688999999
Q ss_pred HHHhcccCCCCCC-----CHhHHhcCcccccc
Q 024809 161 LSRIFVANSEKRI-----TIPEIKNHPWFLRN 187 (262)
Q Consensus 161 i~~~L~~dp~~R~-----s~~e~l~hp~~~~~ 187 (262)
|.+||..||.+|| +++++++||||+..
T Consensus 234 i~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 234 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp HHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 9999999999999 99999999999753
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=299.01 Aligned_cols=216 Identities=25% Similarity=0.303 Sum_probs=158.2
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC---
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH--- 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~--- 77 (262)
||||+ |+|.+++... .+++..++.+++||+.||.|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus 90 ~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~~~~~ 165 (388)
T 3oz6_A 90 FDYME-TDLHAVIRAN-ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAEC--HVKVADFGLSRSFVNIRRV 165 (388)
T ss_dssp EECCS-EEHHHHHHHT-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEESSSCCCC
T ss_pred ecccC-cCHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCC--CEEecCCcccccccccccc
Confidence 78998 5999999774 799999999999999999999999999999999999998777 8999999999754221
Q ss_pred -------------------CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhc
Q 024809 78 -------------------SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG 138 (262)
Q Consensus 78 -------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~ 138 (262)
......+||++|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..++.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 245 (388)
T 3oz6_A 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245 (388)
T ss_dssp CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 1123457999999999998755445669999999999999999999998776666555543
Q ss_pred ccccccc-----------------------------------------cCCCcccCCHHHHHHHHHhcccCCCCCCCHhH
Q 024809 139 RILSVHY-----------------------------------------SFPDYVRVSLECKHLLSRIFVANSEKRITIPE 177 (262)
Q Consensus 139 ~~~~~~~-----------------------------------------~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e 177 (262)
.+..... .......+++++++||.+||+.||.+|||++|
T Consensus 246 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e 325 (388)
T 3oz6_A 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAND 325 (388)
T ss_dssp HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHH
Confidence 2211100 00011257899999999999999999999999
Q ss_pred HhcCccccccCCccccCCC--CccccCCCCCCCCHHHHHHHhHHh
Q 024809 178 IKNHPWFLRNLPIELTEGG--SWQSHDVNNPSQSLEEVLSLIHEA 220 (262)
Q Consensus 178 ~l~hp~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 220 (262)
+|+||||............ .+......+...+++++...+.+.
T Consensus 326 ~l~Hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (388)
T 3oz6_A 326 ALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDYRNLVYSE 370 (388)
T ss_dssp HTTSTTTTTTCCGGGCCCCSSCCCCC------CCHHHHHHHHHHH
T ss_pred HhCCHHHHHhcCCccCCCCCCCCCCCccccccCCHHHHHHHHHHH
Confidence 9999999865543322111 111111112335666666665554
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=297.16 Aligned_cols=182 Identities=26% Similarity=0.532 Sum_probs=152.5
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
||||+||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++....+.+||+|||+++.......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~ 159 (321)
T 1tki_A 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence 79999999999997654 79999999999999999999999999999999999999874445899999999986654444
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCC--CcccCCHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP--DYVRVSLEC 157 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 157 (262)
.....||+.|+|||++.+..++ .++|||||||++|+|++|..||.+......+..+.. ..+.++ .+..++.++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~----~~~~~~~~~~~~~s~~~ 234 (321)
T 1tki_A 160 FRLLFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN----AEYTFDEEAFKEISIEA 234 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH----TCCCCCHHHHTTSCHHH
T ss_pred cccccCChhhcCcHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHc----CCCCCChhhhccCCHHH
Confidence 4556799999999999877664 458999999999999999999988665444443332 222222 234689999
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 158 KHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
++||.+||..||.+|||+.|+|+||||++.
T Consensus 235 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 235 MDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 999999999999999999999999999754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=295.98 Aligned_cols=183 Identities=36% Similarity=0.662 Sum_probs=153.5
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-APRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~-~~~~kl~Dfg~a~~~~~~~~ 79 (262)
||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+||+|||+++.......
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~ 186 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 186 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence 79999999999999888899999999999999999999999999999999999997654 23699999999986654444
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....||+.|+|||++.+..++. ++|||||||++|+|++|+.||.+.+....+..+... ...+..+.+..+++++++
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~ 263 (362)
T 2bdw_A 187 WHGFAGTPGYLSPEVLKKDPYSK-PVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG--AYDYPSPEWDTVTPEAKS 263 (362)
T ss_dssp CCCSCSCTTTCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCTTGGGGSCHHHHH
T ss_pred cccCCCCccccCHHHHccCCCCc-hhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC--CCCCCcccccCCCHHHHH
Confidence 55678999999999998877754 589999999999999999999876544433332221 112223345578999999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
||.+||+.||.+|||+.++|+||||..
T Consensus 264 li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 264 LIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 999999999999999999999999964
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=301.62 Aligned_cols=183 Identities=36% Similarity=0.655 Sum_probs=153.2
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-CCCcEEEeccCCCcCCCCCC-
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS-TAPRVKICDFGYSKSSVLHS- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~-~~~~~kl~Dfg~a~~~~~~~- 78 (262)
||||+||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.. ..+.+||+|||+++......
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~ 168 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence 7999999999999999899999999999999999999999999999999999999753 23479999999997654332
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 158 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (262)
......||+.|+|||++.+..++. ++||||+||++|+|++|..||.+......+..+.... ..+..+.+..++++++
T Consensus 169 ~~~~~~gt~~Y~APE~l~~~~~~~-~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~s~~~~ 245 (444)
T 3soa_A 169 AWFGFAGTPGYLSPEVLRKDPYGK-PVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA--YDFPSPEWDTVTPEAK 245 (444)
T ss_dssp BCCCSCSCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC--CCCCTTTTTTSCHHHH
T ss_pred eeecccCCcccCCHHHhcCCCCCC-ccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC--CCCCccccccCCHHHH
Confidence 234568999999999998877754 4899999999999999999998766544444332221 1223344567899999
Q ss_pred HHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 159 HLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 159 ~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
+||.+||+.||.+|||+.|+|+||||..
T Consensus 246 ~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 246 DLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred HHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 9999999999999999999999999964
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=303.65 Aligned_cols=186 Identities=37% Similarity=0.632 Sum_probs=143.7
Q ss_pred CCCCCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCcEEEeccCCCcCCCCC
Q 024809 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-APRVKICDFGYSKSSVLH 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~-~~~~kl~Dfg~a~~~~~~ 77 (262)
||||+||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++... .+.+||+|||+++.....
T Consensus 138 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~ 217 (400)
T 1nxk_A 138 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217 (400)
T ss_dssp EECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--
T ss_pred EEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCC
Confidence 79999999999998754 599999999999999999999999999999999999998632 348999999999865544
Q ss_pred CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccccc--CCCcccCCH
Q 024809 78 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYS--FPDYVRVSL 155 (262)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 155 (262)
......+||+.|+|||++.+..++. ++|||||||++|+|++|+.||.+.............+....+. .+.+..++.
T Consensus 218 ~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 296 (400)
T 1nxk_A 218 NSLTTPCYTPYYVAPEVLGPEKYDK-SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 296 (400)
T ss_dssp ---------CTTCCGGGSCCCCSSS-HHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCH
T ss_pred CccccCCCCCCccCHhhcCCCCCCC-cccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCH
Confidence 4455678999999999998777754 4899999999999999999998654322111111112222222 334457899
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
++++||.+||+.||.+|||+.++++||||...
T Consensus 297 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 297 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 99999999999999999999999999999754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=292.47 Aligned_cols=182 Identities=36% Similarity=0.658 Sum_probs=152.3
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC--CCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST--APRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~--~~~~kl~Dfg~a~~~~~~~ 78 (262)
||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+||+|||+++......
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~ 172 (326)
T 2y0a_A 93 LELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172 (326)
T ss_dssp EECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTS
T ss_pred EEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCC
Confidence 79999999999999888899999999999999999999999999999999999997654 2369999999998665444
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCC--CcccCCHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP--DYVRVSLE 156 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 156 (262)
......||+.|+|||++.+..++ .++|||||||++|+|++|..||.+......+..... ....++ .+..++..
T Consensus 173 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 247 (326)
T 2y0a_A 173 EFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSA----VNYEFEDEYFSNTSAL 247 (326)
T ss_dssp CCCCCCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH----TCCCCCHHHHTTSCHH
T ss_pred ccccccCCcCcCCceeecCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHh----cCCCcCccccccCCHH
Confidence 45567899999999999877765 448999999999999999999987655444333222 222222 12468899
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
+++||.+||+.||.+|||+.++|+||||+..
T Consensus 248 ~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred HHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 9999999999999999999999999999753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=285.77 Aligned_cols=181 Identities=27% Similarity=0.451 Sum_probs=150.8
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-C
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-Q 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (262)
||||+||+|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++....... .
T Consensus 96 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~ 172 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSK 172 (297)
T ss_dssp EECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCCTTCEECCSTTCC
T ss_pred EECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCC--CEEEeeCCCceecCCcccc
Confidence 7999999999999876 699999999999999999999999999999999999998777 89999999987554332 2
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....||+.|+|||++.+..++. ++|||||||++|+|++|+.||.+............. ..........++..+++
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 248 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGP-KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN---GTPELQNPEKLSAIFRD 248 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH---CSCCCSCGGGSCHHHHH
T ss_pred cCCccCCcCccChhhhcCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---CCCCCCCccccCHHHHH
Confidence 34568999999999998887754 489999999999999999999876654443332221 11222233468999999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCccccccC
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWFLRNL 188 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 188 (262)
||.+||+.||.+|||+.++++||||+...
T Consensus 249 li~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 249 FLNRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHccCChhHCcCHHHHhhChhhcccC
Confidence 99999999999999999999999997543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=295.32 Aligned_cols=221 Identities=22% Similarity=0.369 Sum_probs=153.7
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||+ |++|.+++.. +++++..++.+++||+.||.|||++||+||||||+|||++.++ .+||+|||+++... ...
T Consensus 113 ~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~--~~kL~DFG~a~~~~--~~~ 186 (367)
T 2fst_X 113 THLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARHTA--DEM 186 (367)
T ss_dssp EECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECC-------------
T ss_pred eccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCC--CEEEeecccccccc--ccC
Confidence 5777 7899998876 5799999999999999999999999999999999999998777 89999999997543 234
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccc----------------
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH---------------- 144 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---------------- 144 (262)
....||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+..+...+....
T Consensus 187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~ 266 (367)
T 2fst_X 187 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 266 (367)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHH
T ss_pred CCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHH
Confidence 4568999999999998744445669999999999999999999998776555544433211100
Q ss_pred ---ccCC------CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCCccccCCCCccccCCCCCCCCHHHHHH
Q 024809 145 ---YSFP------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLS 215 (262)
Q Consensus 145 ---~~~~------~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (262)
...+ .....++++++||.+||+.||.+|||+.++|+||||.............-............+++.+
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (367)
T 2fst_X 267 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSLESRDLLIDEWKS 346 (367)
T ss_dssp HTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCCCCCCCGGGSSCCCCHHHHHH
T ss_pred hccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCCCCCCCCcchhhccCCHHHHHH
Confidence 0000 0124688999999999999999999999999999998765443221111111222334567788888
Q ss_pred HhHHhcCCCCCC
Q 024809 216 LIHEATKPLEAP 227 (262)
Q Consensus 216 ~~~~~~~~~~~~ 227 (262)
.+.+....+.++
T Consensus 347 ~~~~e~~~~~~~ 358 (367)
T 2fst_X 347 LTYDEVISFVPP 358 (367)
T ss_dssp HHHHHHHHCCCC
T ss_pred HHHHHHHHhccC
Confidence 887776655544
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=305.05 Aligned_cols=181 Identities=43% Similarity=0.791 Sum_probs=157.4
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++........
T Consensus 95 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~--~vkL~DFG~a~~~~~~~~~ 172 (476)
T 2y94_A 95 MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHM--NAKIADFGLSNMMSDGEFL 172 (476)
T ss_dssp EECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTC--CEEECCCSSCEECCTTCCB
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCC--CeEEEeccchhhccccccc
Confidence 79999999999999888999999999999999999999999999999999999998777 8999999999866544445
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 160 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 160 (262)
...+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+......+.++.. ..+..|. .+++++++|
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~----~~~~~p~--~~s~~~~~L 246 (476)
T 2y94_A 173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICD----GIFYTPQ--YLNPSVISL 246 (476)
T ss_dssp CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHT----TCCCCCT--TCCHHHHHH
T ss_pred cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc----CCcCCCc--cCCHHHHHH
Confidence 5678999999999998887767779999999999999999999988766554444332 2333443 588999999
Q ss_pred HHHhcccCCCCCCCHhHHhcCccccccCC
Q 024809 161 LSRIFVANSEKRITIPEIKNHPWFLRNLP 189 (262)
Q Consensus 161 i~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 189 (262)
|.+||+.||.+|||+.++++||||++..+
T Consensus 247 i~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 275 (476)
T 2y94_A 247 LKHMLQVDPMKRATIKDIREHEWFKQDLP 275 (476)
T ss_dssp HHHHTCSSTTTSCCHHHHHTCHHHHTTCC
T ss_pred HHHHcCCCchhCcCHHHHHhCHHhhhcCc
Confidence 99999999999999999999999987543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=291.58 Aligned_cols=184 Identities=38% Similarity=0.667 Sum_probs=153.0
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC---
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH--- 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~--- 77 (262)
||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCTTCEECEETTEE
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCC--CEEEEEeeccceeccCCcc
Confidence 79999999999998888899999999999999999999999999999999999998777 8999999999754322
Q ss_pred CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHH
Q 024809 78 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 157 (262)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (262)
.......||+.|+|||++.+..+.+.++|||||||++|+|++|+.||............. .......+.+..+++++
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 238 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW---KEKKTYLNPWKKIDSAP 238 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHH---HTTCTTSTTGGGSCHHH
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH---hcccccCCccccCCHHH
Confidence 223456899999999999887776666999999999999999999998765542222211 11122233445789999
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCccccccCC
Q 024809 158 KHLLSRIFVANSEKRITIPEIKNHPWFLRNLP 189 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 189 (262)
.+||.+||+.||.+|||+.|+++||||++...
T Consensus 239 ~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 270 (323)
T 3tki_A 239 LALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (323)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence 99999999999999999999999999986543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=304.47 Aligned_cols=214 Identities=25% Similarity=0.381 Sum_probs=153.0
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
||||+| +|.+.+.. .+++..++.+++||+.||.|||++||+||||||+|||++.++ .+||+|||+++........
T Consensus 146 ~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~~~~~ 220 (464)
T 3ttj_A 146 MELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAGTSFMM 220 (464)
T ss_dssp EECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCCCCC-----CCCC
T ss_pred EeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCC--CEEEEEEEeeeecCCCccc
Confidence 799986 57777754 499999999999999999999999999999999999998777 8999999999876554455
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccc----------------
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH---------------- 144 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---------------- 144 (262)
...+||+.|+|||++.+..|+.+ +|||||||++|+|++|+.||.+.+..+++.+++.......
T Consensus 221 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~ 299 (464)
T 3ttj_A 221 TPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 299 (464)
T ss_dssp ----CCCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHT
T ss_pred CCCcccccccCHHHHcCCCCCHH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhh
Confidence 66789999999999998877654 8999999999999999999998776666555543322110
Q ss_pred -------cc----CCCc---------ccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCCccccCCC--CccccC
Q 024809 145 -------YS----FPDY---------VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGG--SWQSHD 202 (262)
Q Consensus 145 -------~~----~~~~---------~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~--~~~~~~ 202 (262)
.. ++.. ...++++++||.+||+.||.+|||++|+|+||||............ ......
T Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~~~~~~~~~~~~~~ 379 (464)
T 3ttj_A 300 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQ 379 (464)
T ss_dssp TSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHSCCC-------
T ss_pred cccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCcccccCCCCccCCcc
Confidence 00 0000 0015679999999999999999999999999999876543322111 111122
Q ss_pred CCCCCCCHHHHHHHhHHh
Q 024809 203 VNNPSQSLEEVLSLIHEA 220 (262)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~ 220 (262)
........+++.+.+.+.
T Consensus 380 ~~~~~~~~~~~~~~~~~e 397 (464)
T 3ttj_A 380 LDEREHTIEEWKELIYKE 397 (464)
T ss_dssp ----CCCHHHHHHHHHHH
T ss_pred hhhccCCHHHHHHHHHHH
Confidence 223345666766666554
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=284.36 Aligned_cols=183 Identities=25% Similarity=0.348 Sum_probs=150.2
Q ss_pred CCCCCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~--l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||+. |+|.+++..... +++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++......
T Consensus 98 ~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~--~~kl~Dfg~a~~~~~~~ 174 (308)
T 3g33_A 98 FEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG--TVKLADFGLARIYSYQM 174 (308)
T ss_dssp EECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTS--CEEECSCSCTTTSTTCC
T ss_pred ehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC--CEEEeeCccccccCCCc
Confidence 68997 499999987654 99999999999999999999999999999999999998777 89999999998665555
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccc-ccCC---------
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH-YSFP--------- 148 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~--------- 148 (262)
......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.........+........ ..++
T Consensus 175 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 253 (308)
T 3g33_A 175 ALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGA 253 (308)
T ss_dssp CSGGGGCCCSSCCHHHHHTSCCCST-HHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGG
T ss_pred ccCCccccccccCchHHcCCCCCch-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence 5566789999999999988777554 8999999999999999999998776665555443221110 0010
Q ss_pred -----------CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 149 -----------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 149 -----------~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
....+++++.+||.+||+.||.+|||+.|+|+||||++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 254 FPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp SCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred cCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 012578899999999999999999999999999999754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=294.15 Aligned_cols=177 Identities=35% Similarity=0.622 Sum_probs=152.1
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC-CCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (262)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+++.... ...
T Consensus 118 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g--~ikL~DFG~a~~~~~~~~~ 195 (373)
T 2r5t_A 118 LDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG--HIVLTDFGLCKENIEHNST 195 (373)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCCCBCGGGBCCCCC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC--CEEEeeCccccccccCCCc
Confidence 79999999999999888899999999999999999999999999999999999998777 899999999985332 234
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+....+..+.. ....++. .++.++++
T Consensus 196 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~----~~~~~~~--~~~~~~~~ 268 (373)
T 2r5t_A 196 TSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN----KPLQLKP--NITNSARH 268 (373)
T ss_dssp CCSBSCCCCCCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHH----SCCCCCS--SSCHHHHH
T ss_pred cccccCCccccCHHHhCCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh----cccCCCC--CCCHHHHH
Confidence 4567899999999999887775 458999999999999999999987655444444332 2334443 68999999
Q ss_pred HHHHhcccCCCCCCCH----hHHhcCccccc
Q 024809 160 LLSRIFVANSEKRITI----PEIKNHPWFLR 186 (262)
Q Consensus 160 li~~~L~~dp~~R~s~----~e~l~hp~~~~ 186 (262)
||.+||+.||.+||++ .++++||||+.
T Consensus 269 li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 269 LLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp HHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred HHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 9999999999999987 69999999975
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=294.71 Aligned_cols=180 Identities=27% Similarity=0.507 Sum_probs=151.4
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
||||.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++........
T Consensus 94 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g--~vkL~DFG~a~~~~~~~~~ 171 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHG--HVHITDFNIAAMLPRETQI 171 (384)
T ss_dssp ECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECCTTCCB
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCC--CEEEeccceeeeccCCCce
Confidence 79999999999999988999999999999999999999999999999999999998777 8999999999866555555
Q ss_pred CccccCCCCCCcccccCC---cCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHH
Q 024809 81 KSTVGTPAYIAPEVLTKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 157 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (262)
...+||+.|+|||++... .++ .++|||||||++|+|++|+.||....... .......+......+|. .+++++
T Consensus 172 ~~~~gt~~Y~aPE~~~~~~~~~~~-~~~DiwSlG~il~elltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~p~--~~s~~~ 247 (384)
T 4fr4_A 172 TTMAGTKPYMAPEMFSSRKGAGYS-FAVDWWSLGVTAYELLRGRRPYHIRSSTS-SKEIVHTFETTVVTYPS--AWSQEM 247 (384)
T ss_dssp CCCCSCGGGCCGGGTCCCSSCCBC-TTHHHHHHHHHHHHHHHSSCSSCCCTTSC-HHHHHHHHHHCCCCCCT--TSCHHH
T ss_pred eccCCCccccCCeeeccCCCCCCC-ccceeechHHHHHHHHhCCCCCCCCCCcc-HHHHHHHHhhcccCCCC--cCCHHH
Confidence 677899999999998642 344 45899999999999999999998644322 12222223333344444 689999
Q ss_pred HHHHHHhcccCCCCCCC-HhHHhcCccccc
Q 024809 158 KHLLSRIFVANSEKRIT-IPEIKNHPWFLR 186 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s-~~e~l~hp~~~~ 186 (262)
.+||.+||+.||.+||+ ++++++||||..
T Consensus 248 ~~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 248 VSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp HHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred HHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 99999999999999998 899999999975
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=293.04 Aligned_cols=175 Identities=38% Similarity=0.672 Sum_probs=151.6
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++... ...
T Consensus 120 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~~kL~DFg~a~~~~--~~~ 195 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG--YIQVTDFGFAKRVK--GRT 195 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECS--SCB
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCC--CEEEcccccceecc--CCc
Confidence 79999999999999888999999999999999999999999999999999999998777 89999999998543 233
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 160 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 160 (262)
...+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+......+..+ ......+|. .+++++++|
T Consensus 196 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i----~~~~~~~p~--~~~~~~~~l 268 (350)
T 1rdq_E 196 WTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----VSGKVRFPS--HFSSDLKDL 268 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----HHCCCCCCT--TCCHHHHHH
T ss_pred ccccCCccccCHHHhcCCCCC-CcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHH----HcCCCCCCC--CCCHHHHHH
Confidence 457899999999999887775 4589999999999999999999876544443333 333444554 689999999
Q ss_pred HHHhcccCCCCCCC-----HhHHhcCccccc
Q 024809 161 LSRIFVANSEKRIT-----IPEIKNHPWFLR 186 (262)
Q Consensus 161 i~~~L~~dp~~R~s-----~~e~l~hp~~~~ 186 (262)
|.+||+.||.+||+ ++++++||||..
T Consensus 269 i~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 99999999999998 999999999974
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=297.23 Aligned_cols=184 Identities=29% Similarity=0.522 Sum_probs=152.2
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
||||+||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+..+.+||+|||+++.......
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 79999999999997654 79999999999999999999999999999999999999865555899999999986544444
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....||+.|+|||++.+..+. .++|||||||++|+|++|..||.+......+..+..... ....+.+..+++++++
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~s~~~~~ 283 (387)
T 1kob_A 207 VKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW--EFDEDAFSSVSPEAKD 283 (387)
T ss_dssp EEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC--CCCSSTTTTSCHHHHH
T ss_pred eeeeccCCCccCchhccCCCCC-CcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCccccccCCHHHHH
Confidence 4456799999999999877765 458999999999999999999988665444433322111 1122233468999999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
||.+||+.||.+|||+.++|+||||+..
T Consensus 284 li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 284 FIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp HHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 9999999999999999999999999754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=295.74 Aligned_cols=222 Identities=25% Similarity=0.315 Sum_probs=154.9
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
|||+. |+|.+++...+.+++..++.+++||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 136 ~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~--~~kl~DFGla~~~~~~~~~ 212 (458)
T 3rp9_A 136 LEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC--SVKVCDFGLARTVDYPENG 212 (458)
T ss_dssp ECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC--CEEECCCTTCBCTTSCTTC
T ss_pred Eeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCC--CEeecccccchhccCcccc
Confidence 68885 69999999888899999999999999999999999999999999999998877 89999999998643211
Q ss_pred --------------------------CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-----------CC
Q 024809 79 --------------------------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-----------GA 121 (262)
Q Consensus 79 --------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-----------g~ 121 (262)
.....+||++|+|||++.....++.++|||||||++|+|++ |+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~ 292 (458)
T 3rp9_A 213 NSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRG 292 (458)
T ss_dssp CCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCC
T ss_pred ccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccccccc
Confidence 12345789999999987554444566999999999999998 67
Q ss_pred CCCCCCCC--------------------hhHHHHHhcccccc------------------------ccc-CCCcccCCHH
Q 024809 122 YPFEDPED--------------------PKNFRKTIGRILSV------------------------HYS-FPDYVRVSLE 156 (262)
Q Consensus 122 ~pf~~~~~--------------------~~~~~~~~~~~~~~------------------------~~~-~~~~~~~~~~ 156 (262)
.+|.+... ..++..++..+... ... ...+...+++
T Consensus 293 p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 372 (458)
T 3rp9_A 293 PLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSAD 372 (458)
T ss_dssp CSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHH
T ss_pred ccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHH
Confidence 77765431 11111111110000 000 0112357899
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcCccccccCCccccCCCCc-cccCC-CCCCCCHHHHHHHhHHhcCCCC
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSW-QSHDV-NNPSQSLEEVLSLIHEATKPLE 225 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 225 (262)
+++||.+||++||.+|||++|+|+||||+............. ....+ .....+..++...+.++...+.
T Consensus 373 ~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~ 443 (458)
T 3rp9_A 373 AIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFNDWMNMDEPQLRYAFVKEIQRYH 443 (458)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCCCCSSCTTSCCCHHHHHHHHHHHHTTTC
T ss_pred HHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCCCCCccccccCCHHHHHHHHHHHHHHhC
Confidence 999999999999999999999999999987654433211110 00111 1233566777777766655443
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=297.62 Aligned_cols=181 Identities=36% Similarity=0.589 Sum_probs=152.6
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
||||+||+|.+++... ++++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 148 ~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g--~ikL~DFG~a~~~~~~~~~ 224 (410)
T 3v8s_A 148 MEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMNKEGMV 224 (410)
T ss_dssp ECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECCTTSEE
T ss_pred EeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCC--CEEEeccceeEeeccCCcc
Confidence 7999999999999764 699999999999999999999999999999999999998777 89999999997554322
Q ss_pred CCCccccCCCCCCcccccCCc---CCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
.....+||+.|+|||++.+.. +.+.++|||||||++|+|++|+.||.+.+....+.++.... ....+|....+++
T Consensus 225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~~~s~ 302 (410)
T 3v8s_A 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK--NSLTFPDDNDISK 302 (410)
T ss_dssp ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH--HHCCCCTTCCCCH
T ss_pred cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc--ccccCCCcccccH
Confidence 234678999999999997654 13455899999999999999999998866555555544322 2345666667999
Q ss_pred HHHHHHHHhcccCCCC--CCCHhHHhcCccccc
Q 024809 156 ECKHLLSRIFVANSEK--RITIPEIKNHPWFLR 186 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~--R~s~~e~l~hp~~~~ 186 (262)
++++||.+||+.+|.+ |++++++++||||+.
T Consensus 303 ~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~ 335 (410)
T 3v8s_A 303 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 335 (410)
T ss_dssp HHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred HHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence 9999999999999988 999999999999975
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=297.57 Aligned_cols=182 Identities=31% Similarity=0.622 Sum_probs=151.8
Q ss_pred CCCCCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
||||+||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus 153 ~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g--~vkL~DFGla~~~~~~~~ 230 (437)
T 4aw2_A 153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG--HIRLADFGSCLKLMEDGT 230 (437)
T ss_dssp ECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECCTTSC
T ss_pred EecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCC--CEEEcchhhhhhcccCCC
Confidence 799999999999987 56899999999999999999999999999999999999998777 899999999975433222
Q ss_pred --CCccccCCCCCCccccc-----CCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCc-c
Q 024809 80 --PKSTVGTPAYIAPEVLT-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDY-V 151 (262)
Q Consensus 80 --~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 151 (262)
....+||+.|+|||++. ...+ +.++|||||||++|+|++|+.||.+.+..+.+.+++... ....+|.. .
T Consensus 231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~~ 307 (437)
T 4aw2_A 231 VQSSVAVGTPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK--ERFQFPTQVT 307 (437)
T ss_dssp EECCSCCSCGGGCCHHHHHHHHTSCCEE-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH--HHCCCCSSCC
T ss_pred cccccccCCcCeeChHHHhhcccCCCCC-CCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc--ccccCCcccc
Confidence 23468999999999986 3344 455999999999999999999999876655555554322 12344443 4
Q ss_pred cCCHHHHHHHHHhcccCCCC--CCCHhHHhcCcccccc
Q 024809 152 RVSLECKHLLSRIFVANSEK--RITIPEIKNHPWFLRN 187 (262)
Q Consensus 152 ~~~~~~~~li~~~L~~dp~~--R~s~~e~l~hp~~~~~ 187 (262)
.+++++++||++||..+|++ |++++++++||||+..
T Consensus 308 ~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 308 DVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred cCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 58999999999999998888 9999999999999753
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=298.84 Aligned_cols=177 Identities=40% Similarity=0.684 Sum_probs=150.5
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC-CC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~-~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~ 78 (262)
||||+||+|.+++...+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.... ..
T Consensus 227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~~~~ 304 (446)
T 4ejn_A 227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG--HIKITDFGLCKEGIKDGA 304 (446)
T ss_dssp ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS--CEEECCCCCCCTTCC---
T ss_pred EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC--CEEEccCCCceeccCCCc
Confidence 7999999999999988899999999999999999999998 9999999999999998777 899999999975332 22
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 158 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (262)
.....+||+.|+|||++.+..++. ++|||||||++|+|++|+.||.+......+..+ ......+|. .++++++
T Consensus 305 ~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i----~~~~~~~p~--~~~~~~~ 377 (446)
T 4ejn_A 305 TMKTFCGTPEYLAPEVLEDNDYGR-AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI----LMEEIRFPR--TLGPEAK 377 (446)
T ss_dssp --CCSSSCGGGCCHHHHHTSCCCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----HHCCCCCCT--TSCHHHH
T ss_pred ccccccCCccccCHhhcCCCCCCC-ccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH----HhCCCCCCc--cCCHHHH
Confidence 345578999999999998877754 589999999999999999999876554443333 223334454 6889999
Q ss_pred HHHHHhcccCCCCCC-----CHhHHhcCccccc
Q 024809 159 HLLSRIFVANSEKRI-----TIPEIKNHPWFLR 186 (262)
Q Consensus 159 ~li~~~L~~dp~~R~-----s~~e~l~hp~~~~ 186 (262)
+||.+||+.||.+|| |++++++||||..
T Consensus 378 ~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp HHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 999999999999999 9999999999974
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=312.23 Aligned_cols=178 Identities=35% Similarity=0.640 Sum_probs=154.6
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC-CCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (262)
|||++||+|.+++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.++ ++||+|||+++.... ...
T Consensus 421 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g--~ikL~DFGla~~~~~~~~~ 498 (674)
T 3pfq_A 421 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENIWDGVT 498 (674)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSS--CEEECCCTTCEECCCTTCC
T ss_pred EeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCC--cEEEeecceeeccccCCcc
Confidence 79999999999999888999999999999999999999999999999999999998877 899999999985332 233
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..+.+..+ ......+|. .+++++++
T Consensus 499 ~~~~~GT~~Y~APE~l~~~~~~-~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i----~~~~~~~p~--~~s~~~~~ 571 (674)
T 3pfq_A 499 TKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI----MEHNVAYPK--SMSKEAVA 571 (674)
T ss_dssp BCCCCSCSSSCCHHHHTCCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----HSSCCCCCT--TSCHHHHH
T ss_pred cccccCCCcccCHhhhcCCCCC-ccceEechHHHHHHHHcCCCCCCCCCHHHHHHHH----HhCCCCCCc--cCCHHHHH
Confidence 4567899999999999888775 4589999999999999999999986655444443 334455665 68999999
Q ss_pred HHHHhcccCCCCCCCH-----hHHhcCcccccc
Q 024809 160 LLSRIFVANSEKRITI-----PEIKNHPWFLRN 187 (262)
Q Consensus 160 li~~~L~~dp~~R~s~-----~e~l~hp~~~~~ 187 (262)
||++||+.||.+|+++ ++|++||||+..
T Consensus 572 li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 572 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp HHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred HHHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 9999999999999998 999999999753
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=307.92 Aligned_cols=181 Identities=30% Similarity=0.515 Sum_probs=152.4
Q ss_pred CCCCCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
||||+||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g--~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG--HIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS--CEEECCCTTCEECCTTC
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCC--CeEEEecccceecccCc
Confidence 79999999999998765 399999999999999999999999999999999999998777 89999999998654444
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 158 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (262)
.....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...........+...+......++. .++++++
T Consensus 341 ~~~~~~GT~~Y~APEvl~~~~~~-~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~--~~s~~~~ 417 (576)
T 2acx_A 341 TIKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSE--RFSPQAR 417 (576)
T ss_dssp CEECCCSCGGGCCHHHHTTCEES-SHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCT--TSCHHHH
T ss_pred cccccCCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCc--cCCHHHH
Confidence 44556899999999999887775 44899999999999999999998765432222333333333344443 6899999
Q ss_pred HHHHHhcccCCCCCC-----CHhHHhcCccccc
Q 024809 159 HLLSRIFVANSEKRI-----TIPEIKNHPWFLR 186 (262)
Q Consensus 159 ~li~~~L~~dp~~R~-----s~~e~l~hp~~~~ 186 (262)
+||.+||+.||.+|| ++.++++||||+.
T Consensus 418 dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 418 SLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp HHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred HHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 999999999999999 8899999999975
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=282.81 Aligned_cols=184 Identities=26% Similarity=0.423 Sum_probs=147.3
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-C
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-S 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~ 78 (262)
||||+| +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..... .
T Consensus 98 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 98 FEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG--ALKLADFGLARAFGIPVR 174 (311)
T ss_dssp EECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEETTSCCC
T ss_pred EcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCC--CEEEccCcCceecCCCcc
Confidence 799985 8888887654 599999999999999999999999999999999999998777 8999999999765322 2
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccccc-CC---------
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYS-FP--------- 148 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~--------- 148 (262)
......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+......+..+.......... ++
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 254 (311)
T 3niz_A 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK 254 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHH
T ss_pred cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhh
Confidence 23446789999999999775544566999999999999999999999877766555544322211000 00
Q ss_pred --------------CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 149 --------------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 149 --------------~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
....+++++++||.+||+.||.+|||++|+|+||||+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 012467899999999999999999999999999999753
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=286.04 Aligned_cols=177 Identities=33% Similarity=0.607 Sum_probs=147.4
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-CC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (262)
||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..... ..
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~ 177 (327)
T 3a62_A 100 LEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG--HVKLTDFGLCKESIHDGTV 177 (327)
T ss_dssp EECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTS--CEEECCCSCC---------
T ss_pred EeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCC--cEEEEeCCcccccccCCcc
Confidence 79999999999999888899999999999999999999999999999999999998776 8999999998754322 23
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+......+..+. .....+|. .++.++++
T Consensus 178 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~----~~~~~~p~--~~~~~~~~ 250 (327)
T 3a62_A 178 THTFCGTIEYMAPEILMRSGHN-RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL----KCKLNLPP--YLTQEARD 250 (327)
T ss_dssp -CTTSSCCTTSCHHHHTTSCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH----HTCCCCCT--TSCHHHHH
T ss_pred ccccCCCcCccCHhhCcCCCCC-CcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHH----hCCCCCCC--CCCHHHHH
Confidence 3456899999999999877765 45899999999999999999998766544443332 23334444 68899999
Q ss_pred HHHHhcccCCCCCC-----CHhHHhcCccccc
Q 024809 160 LLSRIFVANSEKRI-----TIPEIKNHPWFLR 186 (262)
Q Consensus 160 li~~~L~~dp~~R~-----s~~e~l~hp~~~~ 186 (262)
||.+||..||.+|| ++.++++||||+.
T Consensus 251 li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 251 LLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp HHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred HHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence 99999999999999 8899999999975
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=287.54 Aligned_cols=184 Identities=36% Similarity=0.598 Sum_probs=141.9
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-CCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG-STAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~-~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++. +..+.+||+|||+++.......
T Consensus 127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 206 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL 206 (349)
T ss_dssp ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc
Confidence 799999999999998888999999999999999999999999999999999999975 2234899999999986544434
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHH-HHHhcccccccccCCCcccCCHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNF-RKTIGRILSVHYSFPDYVRVSLECK 158 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (262)
.....||+.|+|||++.+..++ .++|||||||++|+|++|+.||......... ..+.... .....+.+..++.+++
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~ 283 (349)
T 2w4o_A 207 MKTVCGTPGYCAPEILRGCAYG-PEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE--YYFISPWWDEVSLNAK 283 (349)
T ss_dssp ------CGGGSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTC--CCCCTTTTTTSCHHHH
T ss_pred cccccCCCCccCHHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCC--CccCCchhhhCCHHHH
Confidence 4567899999999999877765 4589999999999999999999876654422 2222111 1112233457899999
Q ss_pred HHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 159 HLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 159 ~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
+||.+||..||.+|||+.++++||||...
T Consensus 284 ~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 312 (349)
T 2w4o_A 284 DLVRKLIVLDPKKRLTTFQALQHPWVTGK 312 (349)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred HHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 99999999999999999999999999753
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=289.60 Aligned_cols=185 Identities=34% Similarity=0.574 Sum_probs=150.2
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC--CCcEEEeccCCCcCCCCC-
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST--APRVKICDFGYSKSSVLH- 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~--~~~~kl~Dfg~a~~~~~~- 77 (262)
||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+.... .+.+||+|||+++.....
T Consensus 95 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 95 TELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp ECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 79999999999999988999999999999999999999999999999999999985432 135999999999855332
Q ss_pred CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCC--CcccCCH
Q 024809 78 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP--DYVRVSL 155 (262)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 155 (262)
......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.... ....+...+....+.++ .+..+++
T Consensus 175 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~ 252 (342)
T 2qr7_A 175 GLLMTPCYTANFVAPEVLERQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDD-TPEEILARIGSGKFSLSGGYWNSVSD 252 (342)
T ss_dssp CCBCCSSCCSSCCCHHHHHHHHHH-HHHHHHHHHHHHHHHHHSSCSSCSSTTS-CHHHHHHHHHHCCCCCCSTTTTTSCH
T ss_pred CceeccCCCccccCHHHhcCCCCC-CccCeeeHhHHHHHHhcCCCCCCCCCcC-CHHHHHHHHccCCcccCccccccCCH
Confidence 233456899999999999876665 4489999999999999999999864321 12222333333333332 2356899
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
++++||.+||..||.+|||+.++++||||..+
T Consensus 253 ~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 253 TAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 99999999999999999999999999999653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=282.11 Aligned_cols=186 Identities=25% Similarity=0.442 Sum_probs=148.7
Q ss_pred CCCCCCCchHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCC
Q 024809 1 MEYAAGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSS 74 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~------~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~ 74 (262)
||||+| +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 82 ~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~--~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 82 FEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRG--QLKLGDFGLARAF 158 (317)
T ss_dssp EECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCSSCEET
T ss_pred EEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCC--CEEECcCccceec
Confidence 799985 999998754 3599999999999999999999999999999999999998777 8999999999755
Q ss_pred CCC-CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccc-------c
Q 024809 75 VLH-SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY-------S 146 (262)
Q Consensus 75 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-------~ 146 (262)
... .......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+......+..+......... .
T Consensus 159 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp TSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred CCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 322 23345679999999999977544456699999999999999999999987665554444322111000 0
Q ss_pred CC---------------------CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCC
Q 024809 147 FP---------------------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLP 189 (262)
Q Consensus 147 ~~---------------------~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 189 (262)
.+ ....++.++++||.+||+.||.+|||+.++|+||||.+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 00 01247889999999999999999999999999999987654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=299.86 Aligned_cols=184 Identities=36% Similarity=0.627 Sum_probs=152.5
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-APRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~-~~~~kl~Dfg~a~~~~~~~~ 79 (262)
||||.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++..+ .+.+||+|||+++.......
T Consensus 100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 179 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (486)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc
Confidence 79999999999999888999999999999999999999999999999999999996432 34799999999986655545
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
....+||+.|+|||++.+. + +.++||||+||++|+|++|+.||.+......+..+... ......+.+..+++++++
T Consensus 180 ~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~ 255 (486)
T 3mwu_A 180 MKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG--KYAFDLPQWRTISDDAKD 255 (486)
T ss_dssp --CCTTGGGGCCGGGGGSC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCSCSGGGGGSCHHHHH
T ss_pred cCCCcCCCCCCCHHHhCCC-C-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCcccCCCCHHHHH
Confidence 5567899999999998753 4 45589999999999999999999886655444433222 122334556679999999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCccccccC
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWFLRNL 188 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 188 (262)
||.+||+.||.+|||+.++|+||||++..
T Consensus 256 li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 256 LIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred HHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 99999999999999999999999998643
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=277.62 Aligned_cols=185 Identities=36% Similarity=0.645 Sum_probs=154.5
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC-CcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA-PRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~-~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||++||+|.+.+...+.+++..++.++.|++.||.|||++||+||||||+||+++.++. ..+||+|||++........
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence 799999999999998888999999999999999999999999999999999999976542 3599999999976554444
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....||+.|+|||++.+..++. ++||||||+++|+|++|+.||.+.............. .....+.+..+++++.+
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 240 (284)
T 3kk8_A 164 WHGFAGTPGYLSPEVLKKDPYSK-PVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA--YDYPSPEWDTVTPEAKS 240 (284)
T ss_dssp CCCSCSCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--CCCCTTTTTTSCHHHHH
T ss_pred ccCCCCCcCCcCchhhcCCCCCc-ccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcc--ccCCchhhcccCHHHHH
Confidence 45678999999999998877754 4899999999999999999998766544433332221 12233444578999999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCccccccC
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWFLRNL 188 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 188 (262)
||.+||+.||.+|||+.++++||||....
T Consensus 241 li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 241 LIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred HHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 99999999999999999999999997643
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=293.41 Aligned_cols=183 Identities=32% Similarity=0.563 Sum_probs=151.9
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+..+..+.+||+|||+++.......
T Consensus 165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~ 244 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK 244 (373)
T ss_dssp EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB
T ss_pred EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc
Confidence 7999999999998754 469999999999999999999999999999999999999543444899999999986655444
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+......+..+...... .....+..+++++++
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~~~~ 321 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVS-FPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD--LEDEEFQDISEEAKE 321 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC--SCSGGGTTSCHHHHH
T ss_pred cccccCCCcEeChhhccCCCCC-cHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC--CChhhhccCCHHHHH
Confidence 5566899999999999776664 4589999999999999999999987665555544332111 111223468999999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
||.+||+.||.+|||+.++|+||||..
T Consensus 322 li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 322 FISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred HHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 999999999999999999999999974
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=279.83 Aligned_cols=185 Identities=22% Similarity=0.373 Sum_probs=143.1
Q ss_pred CCCCCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-C
Q 024809 1 MEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-S 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~-~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~ 78 (262)
||||+| +|.+.+. ..+.+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++..... .
T Consensus 80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG--ELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECCSCCS
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEeecccceecCCccc
Confidence 799986 5555554 466899999999999999999999999999999999999998777 8999999999755322 2
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh-hHHHHHhcccccccc------------
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP-KNFRKTIGRILSVHY------------ 145 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~------------ 145 (262)
......||+.|+|||++.+....+.++||||+||++|+|++|..||...... ..+..+.........
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence 3345678999999999987765556699999999999999988885444433 333333221111000
Q ss_pred -----------cCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 024809 146 -----------SFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL 188 (262)
Q Consensus 146 -----------~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 188 (262)
.......+++++++||.+||+.||.+|||++|+++||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 0011124788999999999999999999999999999998643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=301.43 Aligned_cols=181 Identities=33% Similarity=0.524 Sum_probs=151.0
Q ss_pred CCCCCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC
Q 024809 1 MEYAAGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~----~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (262)
||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g--~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG--NVRISDLGLAVELKA 341 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS--CEEECCCTTCEECCT
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCC--CEEEeecceeeeccC
Confidence 7999999999999764 3699999999999999999999999999999999999998777 899999999986543
Q ss_pred CCC-CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 77 HSQ-PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 77 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
... ....+||+.|+|||++.+..++. ++|||||||++|+|++|+.||.+.........+...+......+|. .+++
T Consensus 342 ~~~~~~~~~GT~~Y~APE~l~~~~~~~-~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~--~~s~ 418 (543)
T 3c4z_A 342 GQTKTKGYAGTPGFMAPELLLGEEYDF-SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD--KFSP 418 (543)
T ss_dssp TCCCBCCCCSCTTTSCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCT--TSCH
T ss_pred CCcccccccCCccccChhhhcCCCCCh-HHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCc--ccCH
Confidence 332 23458999999999998877764 4899999999999999999998764432223333334444445554 6899
Q ss_pred HHHHHHHHhcccCCCCCCC-----HhHHhcCccccc
Q 024809 156 ECKHLLSRIFVANSEKRIT-----IPEIKNHPWFLR 186 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s-----~~e~l~hp~~~~ 186 (262)
++++||.+||+.||.+||+ +.++++||||+.
T Consensus 419 ~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 419 ASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp HHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred HHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 9999999999999999996 589999999975
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=292.32 Aligned_cols=222 Identities=24% Similarity=0.287 Sum_probs=154.9
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
|||+. |+|.+++...+.+++..++.+++||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 109 ~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~--~~kL~DFGla~~~~~~~~~ 185 (432)
T 3n9x_A 109 LEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDC--SVKVCDFGLARTINSEKDT 185 (432)
T ss_dssp EECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEEC------
T ss_pred EecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCC--CEEEccCCCcccccccccc
Confidence 68887 59999999888899999999999999999999999999999999999998777 89999999998543221
Q ss_pred ---------------------CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCC-----------CCCCC
Q 024809 79 ---------------------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGA-----------YPFED 126 (262)
Q Consensus 79 ---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-----------~pf~~ 126 (262)
.....+||++|+|||++.....++.++|||||||++|+|++|. ++|.+
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g 265 (432)
T 3n9x_A 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPG 265 (432)
T ss_dssp -------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCC
T ss_pred cccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCC
Confidence 1255789999999999755554456699999999999999844 44433
Q ss_pred CCC-----------------hhHHHHHhccccc--------------------ccccCC-----CcccCCHHHHHHHHHh
Q 024809 127 PED-----------------PKNFRKTIGRILS--------------------VHYSFP-----DYVRVSLECKHLLSRI 164 (262)
Q Consensus 127 ~~~-----------------~~~~~~~~~~~~~--------------------~~~~~~-----~~~~~~~~~~~li~~~ 164 (262)
... ..++..++..+.. .....+ .+..+++++++||.+|
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~m 345 (432)
T 3n9x_A 266 SSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESM 345 (432)
T ss_dssp SCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHH
T ss_pred ccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHH
Confidence 221 1111111111100 000000 1235899999999999
Q ss_pred cccCCCCCCCHhHHhcCccccccCCccccCC--CCccccCCCCCCCCHHHHHHHhHHhcCCCC
Q 024809 165 FVANSEKRITIPEIKNHPWFLRNLPIELTEG--GSWQSHDVNNPSQSLEEVLSLIHEATKPLE 225 (262)
Q Consensus 165 L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (262)
|+.||.+|||++|+|+||||+.......... .............+.+++...+.++...+.
T Consensus 346 L~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~ 408 (432)
T 3n9x_A 346 LKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFDDWMVLSETQLRYIFLKEVQSFH 408 (432)
T ss_dssp SCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCCCCSSCTTCCCCHHHHHHHHHHHHHHHC
T ss_pred hcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCCCCChhhcccCCHHHHHHHHHHHHHHhC
Confidence 9999999999999999999987544332211 111111111234566777777776655443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=285.37 Aligned_cols=186 Identities=35% Similarity=0.616 Sum_probs=132.5
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCcEEEeccCCCcCCCCC-C
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-APRVKICDFGYSKSSVLH-S 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~-~~~~kl~Dfg~a~~~~~~-~ 78 (262)
||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+||+|||+++..... .
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 85 MELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp ECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred EEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 79999999999999998999999999999999999999999999999999999996543 226999999999754332 2
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh---hHHHHHhcccccccccCC--CcccC
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP---KNFRKTIGRILSVHYSFP--DYVRV 153 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~--~~~~~ 153 (262)
......||+.|+|||++.+..++ .++|||||||++|+|++|+.||...... .........+....+.++ .+..+
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNV 243 (325)
T ss_dssp -------------------CCCC-HHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTS
T ss_pred cccccCCCcCccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCC
Confidence 23456789999999999887775 4589999999999999999999865432 111223333333333333 23468
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 154 SLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 154 ~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
++++++||.+||..||.+|||+.++++||||+..
T Consensus 244 s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 244 SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp CHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred CHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 9999999999999999999999999999999754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=288.26 Aligned_cols=182 Identities=33% Similarity=0.595 Sum_probs=149.3
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 138 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kl~DfG~a~~~~~~~~~ 215 (355)
T 1vzo_A 138 LDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG--HVVLTDFGLSKEFVADETE 215 (355)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEESCSSEEEECCGGGGG
T ss_pred eecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--cEEEeeCCCCeecccCCCC
Confidence 79999999999999888899999999999999999999999999999999999998777 89999999997543221
Q ss_pred CCCccccCCCCCCcccccCCc-CCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 157 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (262)
......||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||...........+...+......++. .++..+
T Consensus 216 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 293 (355)
T 1vzo_A 216 RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EMSALA 293 (355)
T ss_dssp GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT--TSCHHH
T ss_pred cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCc--ccCHHH
Confidence 223467999999999997532 23455899999999999999999998654433333333333333333443 688999
Q ss_pred HHHHHHhcccCCCCCC-----CHhHHhcCccccc
Q 024809 158 KHLLSRIFVANSEKRI-----TIPEIKNHPWFLR 186 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~-----s~~e~l~hp~~~~ 186 (262)
++||.+||..||.+|| |+.++++||||..
T Consensus 294 ~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 294 KDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp HHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 9999999999999999 9999999999975
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=278.71 Aligned_cols=183 Identities=25% Similarity=0.399 Sum_probs=144.0
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-C
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-S 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~ 78 (262)
|||++| +|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++..... .
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG--ELKIADFGLARAFGIPVR 155 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECCTTHHHHHCC---
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC--CEEEeECccccccCcccc
Confidence 689986 999998864 5799999999999999999999999999999999999998777 8999999998754322 2
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccc--------------
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH-------------- 144 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-------------- 144 (262)
......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+......+..+........
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 234457899999999997655445669999999999999999999988766555544433211100
Q ss_pred ccCC---------CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 145 YSFP---------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 145 ~~~~---------~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
..++ ....+++++++||.+||+.||.+|||+.++++||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 0000 01247899999999999999999999999999999974
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=283.31 Aligned_cols=181 Identities=34% Similarity=0.636 Sum_probs=151.6
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC--CcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA--PRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~--~~~kl~Dfg~a~~~~~~~ 78 (262)
|||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++. ..+||+|||+++......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~ 173 (321)
T 2a2a_A 94 LELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV 173 (321)
T ss_dssp ECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTC
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCccc
Confidence 799999999999998888999999999999999999999999999999999999976552 269999999998655444
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCC--cccCCHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLE 156 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 156 (262)
......||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.........+.. ....++. ...++..
T Consensus 174 ~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~----~~~~~~~~~~~~~~~~ 248 (321)
T 2a2a_A 174 EFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANITS----VSYDFDEEFFSHTSEL 248 (321)
T ss_dssp CCCCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT----TCCCCCHHHHTTCCHH
T ss_pred cccccCCCCCccCcccccCCCCC-CccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh----cccccChhhhcccCHH
Confidence 44566799999999999877765 458999999999999999999987655444333322 2222221 2368899
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
+++||.+||..||.+|||+.++++||||..
T Consensus 249 ~~~li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 249 AKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp HHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence 999999999999999999999999999974
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=292.53 Aligned_cols=181 Identities=30% Similarity=0.574 Sum_probs=148.2
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
||||+||+|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+++.......
T Consensus 140 mE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g--~vkL~DFGla~~~~~~~~ 217 (412)
T 2vd5_A 140 MEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG--HIRLADFGSCLKLRADGT 217 (412)
T ss_dssp ECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECCTTSC
T ss_pred EcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCC--CEEEeechhheeccCCCc
Confidence 79999999999998754 799999999999999999999999999999999999998777 899999999976543322
Q ss_pred --CCccccCCCCCCcccccC-------CcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCC-
Q 024809 80 --PKSTVGTPAYIAPEVLTK-------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD- 149 (262)
Q Consensus 80 --~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~- 149 (262)
....+||+.|+|||++.. ..+ +.++|||||||++|+|++|+.||.+.+..+.+.++.... ....+|.
T Consensus 218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~ 294 (412)
T 2vd5_A 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSY-GPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK--EHLSLPLV 294 (412)
T ss_dssp EECSSCCSCGGGCCHHHHHHHHTCTTCSEE-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH--HHCCCC--
T ss_pred cccceeccccCcCCHHHHhhcccCcCCCCC-ChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--cCcCCCcc
Confidence 234689999999999873 344 455999999999999999999998876655555544321 1123332
Q ss_pred cccCCHHHHHHHHHhcccCCCCC---CCHhHHhcCcccccc
Q 024809 150 YVRVSLECKHLLSRIFVANSEKR---ITIPEIKNHPWFLRN 187 (262)
Q Consensus 150 ~~~~~~~~~~li~~~L~~dp~~R---~s~~e~l~hp~~~~~ 187 (262)
...+++++++||++||. +|.+| ++++++++||||+..
T Consensus 295 ~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 295 DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp --CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 23689999999999999 99998 599999999999754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=282.44 Aligned_cols=179 Identities=41% Similarity=0.667 Sum_probs=147.1
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-C
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-Q 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (262)
|||++||+|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...... .
T Consensus 117 ~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~ 193 (298)
T 2zv2_A 117 FELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDG--HIKIADFGVSNEFKGSDAL 193 (298)
T ss_dssp EECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS--CEEECCCTTCEECSSSSCE
T ss_pred EecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC--CEEEecCCCcccccccccc
Confidence 79999999988654 45799999999999999999999999999999999999998776 89999999997543322 2
Q ss_pred CCccccCCCCCCcccccCCcC--CCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEY--DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 157 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (262)
.....||+.|+|||++.+... .+.++|||||||++|+|++|+.||.......... .+......++....+++++
T Consensus 194 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l 269 (298)
T 2zv2_A 194 LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHS----KIKSQALEFPDQPDIAEDL 269 (298)
T ss_dssp ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHCCCCCCSSSCCCHHH
T ss_pred ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHH----HHhcccCCCCCccccCHHH
Confidence 234679999999999976542 3556899999999999999999998754332222 2223334455556789999
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 158 KHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
++||.+||+.||.+|||+.++++||||.+
T Consensus 270 ~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 270 KDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 99999999999999999999999999963
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=286.14 Aligned_cols=178 Identities=23% Similarity=0.294 Sum_probs=131.5
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc--------CCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM--------QICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~--------~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
||||+||+|.++|... +++++.+..++.|++.||.|||++ +||||||||+|||++.++ ++||+|||+|+
T Consensus 80 ~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~--~~Ki~DFGla~ 156 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGLAV 156 (303)
T ss_dssp EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS--CEEECCCTTCE
T ss_pred ecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC--CEEEEeCCCCc
Confidence 7999999999999765 599999999999999999999987 999999999999998877 89999999997
Q ss_pred CCCCCC-----CCCccccCCCCCCcccccCCc-----CCCCchhHHHHHHHHHHHHhCCCCCCCCCChh-----------
Q 024809 73 SSVLHS-----QPKSTVGTPAYIAPEVLTKKE-----YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPK----------- 131 (262)
Q Consensus 73 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----------- 131 (262)
...... .....+||+.|||||++.+.. .++.++|||||||+||||+||..||......+
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 543222 123457999999999987542 12345899999999999999987764322110
Q ss_pred HHHHHhccccc--ccccCCCcc---cCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 132 NFRKTIGRILS--VHYSFPDYV---RVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 132 ~~~~~~~~~~~--~~~~~~~~~---~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
........+.. ....+|... ..+..+.+|+.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 01111111111 112233211 233568899999999999999999999863
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=299.51 Aligned_cols=182 Identities=39% Similarity=0.655 Sum_probs=153.0
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-APRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~-~~~~kl~Dfg~a~~~~~~~~ 79 (262)
||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++..+ ...+||+|||+++.......
T Consensus 115 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~ 194 (494)
T 3lij_A 115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK 194 (494)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc
Confidence 79999999999999888999999999999999999999999999999999999997643 34699999999986655445
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
....+||+.|+|||++.+ .++ .++||||+||++|+|++|..||.+......+..+.... ..+..+.+..+++++++
T Consensus 195 ~~~~~gt~~y~aPE~l~~-~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~s~~~~~ 270 (494)
T 3lij_A 195 MKERLGTAYYIAPEVLRK-KYD-EKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGK--YTFDSPEWKNVSEGAKD 270 (494)
T ss_dssp BCCCCSCTTTCCHHHHTT-CBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--CCCCSGGGTTSCHHHHH
T ss_pred ccccCCCcCeeCHHHHcc-cCC-CchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCchhcccCCHHHHH
Confidence 556789999999999864 454 45899999999999999999999876554444332221 12233445679999999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
||.+||+.||.+|||+.++|+||||+.
T Consensus 271 li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 271 LIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred HHHHHCCCChhhCccHHHHhcCccccc
Confidence 999999999999999999999999975
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=287.85 Aligned_cols=181 Identities=35% Similarity=0.626 Sum_probs=150.4
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||++||+|.+++.....+++..++.++.||+.||.|||+.||+||||||+||+++.++ .+||+|||++.........
T Consensus 179 ~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~--~ikl~DfG~~~~~~~~~~~ 256 (365)
T 2y7j_A 179 FDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNM--QIRLSDFGFSCHLEPGEKL 256 (365)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCTTCEECCTTCCB
T ss_pred EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--CEEEEecCcccccCCCccc
Confidence 79999999999999888899999999999999999999999999999999999998777 8999999999866544445
Q ss_pred CccccCCCCCCcccccCC------cCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCC
Q 024809 81 KSTVGTPAYIAPEVLTKK------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS 154 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (262)
....||+.|+|||++.+. .+ +.++|||||||++|+|++|+.||........+..+.... .....+.+...+
T Consensus 257 ~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~ 333 (365)
T 2y7j_A 257 RELCGTPGYLAPEILKCSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQ--YQFSSPEWDDRS 333 (365)
T ss_dssp CCCCSCGGGCCHHHHHHTTCTTSCCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--CCCCHHHHSSSC
T ss_pred ccCCCCCCccChhhccccccccCcCC-CchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC--CCCCCcccccCC
Confidence 567899999999998632 34 445899999999999999999998765443333322211 111223345688
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 155 LECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
.++.+||.+||..||.+|||+.++++||||++
T Consensus 334 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 334 STVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 99999999999999999999999999999963
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=284.69 Aligned_cols=184 Identities=31% Similarity=0.517 Sum_probs=147.8
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCcEEEeccCCCcCCCCC
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-APRVKICDFGYSKSSVLH 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~-~~~~kl~Dfg~a~~~~~~ 77 (262)
||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++... .+.+||+|||+++.....
T Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence 7999999999998653 5799999999999999999999999999999999999997621 238999999999866544
Q ss_pred CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHH
Q 024809 78 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 157 (262)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (262)
.......||+.|+|||++.+..++. ++|||||||++|+|++|+.||.+.........+.... ..+..+....+++.+
T Consensus 188 ~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~ 264 (327)
T 3lm5_A 188 CELREIMGTPEYLAPEILNYDPITT-ATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVN--VDYSEETFSSVSQLA 264 (327)
T ss_dssp ------CCCGGGCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--CCCCTTTTTTSCHHH
T ss_pred cccccccCCcCccCCeeecCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcc--cccCchhhcccCHHH
Confidence 4445568999999999998777654 4899999999999999999998876555444333221 122233345789999
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 158 KHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
++||.+||+.||.+|||++++|+||||+..
T Consensus 265 ~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~ 294 (327)
T 3lm5_A 265 TDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294 (327)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred HHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence 999999999999999999999999999764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=301.53 Aligned_cols=184 Identities=36% Similarity=0.620 Sum_probs=154.1
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-CCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS-TAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~-~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
||||.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.. ..+.+||+|||+++.......
T Consensus 105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 184 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184 (484)
T ss_dssp ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc
Confidence 7999999999999998899999999999999999999999999999999999999532 234899999999976554444
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....||+.|+|||++.+ .++ .++|||||||++|+|++|+.||.+......+..+... ...+..+.+..+++++++
T Consensus 185 ~~~~~gt~~y~aPE~~~~-~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~ 260 (484)
T 3nyv_A 185 MKDKIGTAYYIAPEVLHG-TYD-EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKG--KYTFELPQWKKVSESAKD 260 (484)
T ss_dssp HHHHTTGGGTCCHHHHHT-CCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCSGGGGGSCHHHHH
T ss_pred cccCCCCccccCceeecC-CCC-CcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCCCCCcccccCCHHHHH
Confidence 455689999999999876 454 5589999999999999999999987655444443322 122334556679999999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCccccccC
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWFLRNL 188 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 188 (262)
||.+||+.||.+|||+.++|+||||+...
T Consensus 261 li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 261 LIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred HHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 99999999999999999999999998653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=276.74 Aligned_cols=179 Identities=36% Similarity=0.699 Sum_probs=150.7
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe---cCCCCCcEEEeccCCCcCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL---DGSTAPRVKICDFGYSKSSVLH 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili---~~~~~~~~kl~Dfg~a~~~~~~ 77 (262)
|||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+||++ +.++ .+||+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~--~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDS--PLKLIDFGLAARFKPG 162 (277)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTC--CEEECCCTTCEECCTT
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCC--cEEEEecccceeccCc
Confidence 7999999999999988889999999999999999999999999999999999999 4444 8999999999866555
Q ss_pred CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCC--cccCCH
Q 024809 78 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSL 155 (262)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 155 (262)
.......||+.|+|||++.+. + +.++||||||+++|+|++|+.||.............. ....++. +..+++
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~ 236 (277)
T 3f3z_A 163 KMMRTKVGTPYYVSPQVLEGL-Y-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIRE----GTFTFPEKDWLNVSP 236 (277)
T ss_dssp SCBCCCCSCTTTCCHHHHTTC-B-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----CCCCCCHHHHTTSCH
T ss_pred cchhccCCCCCccChHHhccc-C-CchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh----CCCCCCchhhhcCCH
Confidence 555567899999999998654 4 4558999999999999999999988665444433322 2222322 236899
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
++.+||.+||+.||.+|||+.++++||||++.
T Consensus 237 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 237 QAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 99999999999999999999999999999764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=282.83 Aligned_cols=174 Identities=33% Similarity=0.506 Sum_probs=148.8
Q ss_pred CCCCCCC-chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg-~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||+.+| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus 108 ~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~Dfg~a~~~~~~~~ 185 (335)
T 3dls_A 108 MEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF--TIKLIDFGSAAYLERGKL 185 (335)
T ss_dssp EECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS--CEEECCCTTCEECCTTCC
T ss_pred EEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCC--cEEEeecccceECCCCCc
Confidence 6888776 9999999988999999999999999999999999999999999999998776 899999999986655444
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....||+.|+|||++.+..+.+.++|||||||++|+|++|+.||..... ........| ..+++++++
T Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------~~~~~~~~~--~~~~~~l~~ 253 (335)
T 3dls_A 186 FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------TVEAAIHPP--YLVSKELMS 253 (335)
T ss_dssp BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----------GTTTCCCCS--SCCCHHHHH
T ss_pred eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH----------HHhhccCCC--cccCHHHHH
Confidence 55678999999999998887766778999999999999999999975221 111111222 258899999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCccccccC
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWFLRNL 188 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 188 (262)
||.+||..||.+|||+.++++||||++..
T Consensus 254 li~~~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 254 LVSGLLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred HHHHHccCChhhCcCHHHHhcCccccCCc
Confidence 99999999999999999999999997643
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=291.05 Aligned_cols=185 Identities=25% Similarity=0.384 Sum_probs=148.2
Q ss_pred CCCCCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec-CCCCCcEEEeccCCCcCCC
Q 024809 1 MEYAAGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD-GSTAPRVKICDFGYSKSSV 75 (262)
Q Consensus 1 mE~~~gg~L~~~i~----~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~-~~~~~~~kl~Dfg~a~~~~ 75 (262)
||||+|+ +.+.+. ..+.+++..++.+++||+.||.|||++||+||||||+|||++ .++ .+||+|||+++...
T Consensus 117 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 117 LEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG--VLKLIDFGSAKILI 193 (394)
T ss_dssp EECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT--EEEECCCTTCEECC
T ss_pred eeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCC--cEEEeeCCCccccc
Confidence 7899875 444332 356799999999999999999999999999999999999998 455 89999999998665
Q ss_pred CCCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc------------
Q 024809 76 LHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV------------ 143 (262)
Q Consensus 76 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------------ 143 (262)
.........||+.|+|||++.+...++.++||||+||++|+|++|+.||.+....+.+..++......
T Consensus 194 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 273 (394)
T 4e7w_A 194 AGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNY 273 (394)
T ss_dssp TTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGG
T ss_pred CCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence 55555667899999999999776544566999999999999999999999877666555544321110
Q ss_pred -cccCCC----------cccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 024809 144 -HYSFPD----------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL 188 (262)
Q Consensus 144 -~~~~~~----------~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 188 (262)
...++. ...+++++++||.+||+.||.+|||+.++++||||....
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 274 MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp SSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred hhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 011111 124788999999999999999999999999999998643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=287.37 Aligned_cols=184 Identities=23% Similarity=0.398 Sum_probs=144.3
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH- 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~- 77 (262)
||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||.+......
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~--~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 105 TSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG--KVYLSGLRSNLSMISHG 182 (389)
T ss_dssp EECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCGGGCEECEETT
T ss_pred EEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEcccccceeecccc
Confidence 7999999999999876 6799999999999999999999999999999999999998777 8999999987533211
Q ss_pred -------CCCCccccCCCCCCcccccC--CcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc-----
Q 024809 78 -------SQPKSTVGTPAYIAPEVLTK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV----- 143 (262)
Q Consensus 78 -------~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----- 143 (262)
.......||+.|+|||++.+ ..++ .++|||||||++|+|++|+.||.+......+..........
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 261 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS 261 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBC-THHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------
T ss_pred ccccccccccccccccccccCHHHHhccCCCCC-cHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccc
Confidence 12233578999999999987 3454 55899999999999999999998866554443332211100
Q ss_pred -----------------------------------cccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 144 -----------------------------------HYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 144 -----------------------------------~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
....+....+++++++||.+||+.||.+|||+.++|+||||+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~ 340 (389)
T 3gni_B 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340 (389)
T ss_dssp --------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred ccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence 00011223578899999999999999999999999999999754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=283.10 Aligned_cols=186 Identities=29% Similarity=0.410 Sum_probs=143.5
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC---CCcEEEeccCCCcCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST---APRVKICDFGYSKSSVLH 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~---~~~~kl~Dfg~a~~~~~~ 77 (262)
||||+| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+.+||+|||+++.....
T Consensus 112 ~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~ 190 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190 (329)
T ss_dssp EECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred EecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence 799985 9999999988999999999999999999999999999999999999995332 236999999999754322
Q ss_pred -CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccc-cc---------
Q 024809 78 -SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH-YS--------- 146 (262)
Q Consensus 78 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-~~--------- 146 (262)
.......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+......+..+........ ..
T Consensus 191 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (329)
T 3gbz_A 191 IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPD 270 (329)
T ss_dssp ---------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhh
Confidence 2334567899999999998765445669999999999999999999988776555555443221110 00
Q ss_pred ----CCCc----------ccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 147 ----FPDY----------VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 147 ----~~~~----------~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
++.. ..+++++++||.+||+.||.+|||+.|+|+||||+..
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 271 WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp CCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 0110 1167899999999999999999999999999999753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=279.03 Aligned_cols=180 Identities=28% Similarity=0.526 Sum_probs=148.7
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-CC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (262)
|||++||+|.+++.. .++++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++..... ..
T Consensus 121 ~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~~~~~~~~~~~ 197 (321)
T 2c30_A 121 MEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG--RVKLSDFGFCAQISKDVPK 197 (321)
T ss_dssp ECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCCTTCEECCSSSCC
T ss_pred EecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--cEEEeeeeeeeecccCccc
Confidence 799999999998865 4699999999999999999999999999999999999998776 8999999998755332 22
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....||+.|+|||++.+..++. ++|||||||++|+|++|+.||............... ..........+++++++
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~ 273 (321)
T 2c30_A 198 RKSLVGTPYWMAPEVISRSLYAT-EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PPPKLKNSHKVSPVLRD 273 (321)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---SCCCCTTGGGSCHHHHH
T ss_pred cccccCCccccCHhhhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---CCCCcCccccCCHHHHH
Confidence 34568999999999998777654 489999999999999999999876544433322211 11122333468899999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
||.+||+.||.+|||+.++++||||.+.
T Consensus 274 li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 274 FLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred HHHHHccCChhhCcCHHHHhcChhhccC
Confidence 9999999999999999999999999764
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=294.31 Aligned_cols=183 Identities=34% Similarity=0.599 Sum_probs=141.8
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-APRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~-~~~~kl~Dfg~a~~~~~~~~ 79 (262)
||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+||+|||+++.......
T Consensus 218 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~ 297 (419)
T 3i6u_A 218 LELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 297 (419)
T ss_dssp EECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC----
T ss_pred EEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCCCcc
Confidence 79999999999999888999999999999999999999999999999999999997543 23699999999987654444
Q ss_pred CCccccCCCCCCcccccC--CcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccC--CCcccCCH
Q 024809 80 PKSTVGTPAYIAPEVLTK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSL 155 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 155 (262)
....+||+.|+|||++.+ ....+.++|||||||++|+|++|+.||........+...+.. ..+.+ ..+..+++
T Consensus 298 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~---~~~~~~~~~~~~~~~ 374 (419)
T 3i6u_A 298 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS---GKYNFIPEVWAEVSE 374 (419)
T ss_dssp -------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHT---TCCCCCHHHHTTSCH
T ss_pred ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhc---CCCCCCchhhcccCH
Confidence 556789999999999864 222345589999999999999999999875544333332221 11121 12246899
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
++++||.+||+.||.+|||+.++|+||||+.
T Consensus 375 ~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 375 KALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 9999999999999999999999999999964
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=281.53 Aligned_cols=186 Identities=33% Similarity=0.593 Sum_probs=143.4
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC-CcEEEeccCCCcCCCCCC-
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA-PRVKICDFGYSKSSVLHS- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~-~~~kl~Dfg~a~~~~~~~- 78 (262)
||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. ..+||+|||+++......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 169 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169 (316)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred EEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence 799999999999998888999999999999999999999999999999999999976552 249999999987543211
Q ss_pred -------CCCccccCCCCCCcccccC-----CcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChh-----------HHHH
Q 024809 79 -------QPKSTVGTPAYIAPEVLTK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPK-----------NFRK 135 (262)
Q Consensus 79 -------~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----------~~~~ 135 (262)
......||+.|+|||++.+ ..++ .++|||||||++|+|++|+.||.+..... ....
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 248 (316)
T 2ac3_A 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYD-KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248 (316)
T ss_dssp ------------CCSGGGCCHHHHHHTSHHHHHHT-TTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHH
T ss_pred cccccccccccccCCcCccChHHhhcccccccCCC-cccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHH
Confidence 1223469999999999864 3344 45899999999999999999998754311 0111
Q ss_pred HhcccccccccCCC--cccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 136 TIGRILSVHYSFPD--YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 136 ~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
....+......+|. +..+++++++||.+||..||.+|||+.++++||||+..
T Consensus 249 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp HHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred HHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 22223333333432 24688999999999999999999999999999999754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=288.03 Aligned_cols=183 Identities=25% Similarity=0.407 Sum_probs=149.0
Q ss_pred CCCCCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-CCCCcEEEeccCCCcCCC
Q 024809 1 MEYAAGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG-STAPRVKICDFGYSKSSV 75 (262)
Q Consensus 1 mE~~~gg~L~~~i~----~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~-~~~~~~kl~Dfg~a~~~~ 75 (262)
||||+| +|.+.+. ..+.+++..++.++.||+.||.|||++||+||||||+|||++. ++ .+||+|||+++...
T Consensus 117 ~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~--~~kl~Dfg~a~~~~ 193 (383)
T 3eb0_A 117 MEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN--TLKLCDFGSAKKLI 193 (383)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTT--EEEECCCTTCEECC
T ss_pred EecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCC--cEEEEECCCCcccC
Confidence 799985 7776664 4567999999999999999999999999999999999999973 44 89999999998665
Q ss_pred CCCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc------------
Q 024809 76 LHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV------------ 143 (262)
Q Consensus 76 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------------ 143 (262)
.........||+.|+|||++.+....+.++||||+||++|+|++|+.||.+....+.+..++......
T Consensus 194 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~ 273 (383)
T 3eb0_A 194 PSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHY 273 (383)
T ss_dssp TTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC
T ss_pred CCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCccc
Confidence 55555667899999999998876644566999999999999999999999877666655554322110
Q ss_pred -cccCCC----------cccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 144 -HYSFPD----------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 144 -~~~~~~----------~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
...+|. ....++++++||.+||+.||.+|||+.|+|+||||..
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 274 TEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp --CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred ccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHH
Confidence 011111 1147889999999999999999999999999999974
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=275.60 Aligned_cols=181 Identities=43% Similarity=0.799 Sum_probs=144.3
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||++||+|.+++...+.+++..++.++.||+.||.|||++|++||||||+||+++.++ .+||+|||++.........
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~~l~dfg~~~~~~~~~~~ 167 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHM--NAKIADFGLSNMMSDGEFL 167 (276)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTS--CEEECCCCGGGCCCC----
T ss_pred EeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCC--CEEEeecccccccCCCcce
Confidence 69999999999999888899999999999999999999999999999999999998776 8999999999865444444
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 160 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 160 (262)
....||+.|+|||.+.+..+.+.++||||||+++|+|++|+.||...........+ .......|. .++.++.++
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~--~~~~~l~~l 241 (276)
T 2h6d_A 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI----RGGVFYIPE--YLNRSVATL 241 (276)
T ss_dssp ---------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----HHCCCCCCT--TSCHHHHHH
T ss_pred ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh----hcCcccCch--hcCHHHHHH
Confidence 55679999999999987766556699999999999999999999875543333322 222233343 578999999
Q ss_pred HHHhcccCCCCCCCHhHHhcCccccccCC
Q 024809 161 LSRIFVANSEKRITIPEIKNHPWFLRNLP 189 (262)
Q Consensus 161 i~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 189 (262)
|.+||..||.+|||+.++++||||++..+
T Consensus 242 i~~~l~~~p~~Rps~~~~l~h~~~~~~~~ 270 (276)
T 2h6d_A 242 LMHMLQVDPLKRATIKDIREHEWFKQDLP 270 (276)
T ss_dssp HHHHTCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred HHHHccCChhhCCCHHHHHhChhhccCch
Confidence 99999999999999999999999987654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=286.50 Aligned_cols=215 Identities=25% Similarity=0.388 Sum_probs=152.5
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
||||+| +|.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++........
T Consensus 109 ~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~--~~kl~Dfg~a~~~~~~~~~ 183 (371)
T 2xrw_A 109 MELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAGTSFMM 183 (371)
T ss_dssp EECCSE-EHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECCCCC----------
T ss_pred EEcCCC-CHHHHHhh--ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC--CEEEEEeeccccccccccc
Confidence 689985 88888863 599999999999999999999999999999999999998776 8999999999865443344
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccc----------------
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH---------------- 144 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---------------- 144 (262)
....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+..++.......
T Consensus 184 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 262 (371)
T 2xrw_A 184 TPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 262 (371)
T ss_dssp ------CTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHH
T ss_pred CCceecCCccCHHHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHh
Confidence 55789999999999988777654 8999999999999999999998776655555443321110
Q ss_pred --cc--------------CCCc----ccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCCccccC--CCCccccC
Q 024809 145 --YS--------------FPDY----VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTE--GGSWQSHD 202 (262)
Q Consensus 145 --~~--------------~~~~----~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~--~~~~~~~~ 202 (262)
.. +|.. ...++++++||.+||+.||.+|||++++|+||||.......... ........
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~ 342 (371)
T 2xrw_A 263 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQ 342 (371)
T ss_dssp SSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHHHTCCCCCCCTTT
T ss_pred hCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccccCCCCCCCCChh
Confidence 00 0000 01256799999999999999999999999999998655432211 11222223
Q ss_pred CCCCCCCHHHHHHHhHHhc
Q 024809 203 VNNPSQSLEEVLSLIHEAT 221 (262)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~ 221 (262)
........+++.+++....
T Consensus 343 ~~~~~~~~~~~~~~~~~~~ 361 (371)
T 2xrw_A 343 LDEREHTIEEWKELIYKEV 361 (371)
T ss_dssp TCCCCCCHHHHHHHHHHHH
T ss_pred hccccCcHHHHHHHHHHHH
Confidence 3344567788877776653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=287.16 Aligned_cols=180 Identities=32% Similarity=0.629 Sum_probs=145.8
Q ss_pred CCCCCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCcEEEeccCCCcCCC
Q 024809 1 MEYAAGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-APRVKICDFGYSKSSV 75 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~----~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~-~~~~kl~Dfg~a~~~~ 75 (262)
||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+||+|||+++...
T Consensus 105 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 184 (351)
T 3c0i_A 105 FEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG 184 (351)
T ss_dssp EECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECC
T ss_pred EeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEec
Confidence 7999999999888643 2589999999999999999999999999999999999997654 2359999999997654
Q ss_pred CCCC-CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCC--Cccc
Q 024809 76 LHSQ-PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP--DYVR 152 (262)
Q Consensus 76 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 152 (262)
.... ....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.. ...+.. +....+.++ .+..
T Consensus 185 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~----i~~~~~~~~~~~~~~ 258 (351)
T 3c0i_A 185 ESGLVAGGRVGTPHFMAPEVVKREPYG-KPVDVWGCGVILFILLSGCLPFYGTK-ERLFEG----IIKGKYKMNPRQWSH 258 (351)
T ss_dssp TTSCBCCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHH----HHHTCCCCCHHHHTT
T ss_pred CCCeeecCCcCCcCccCHHHHcCCCCC-chHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHH----HHcCCCCCCcccccc
Confidence 3322 3456799999999999887775 45899999999999999999998742 222222 222222222 2346
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 153 VSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 153 ~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
++.++++||.+||+.||.+|||+.++++||||+.
T Consensus 259 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 8999999999999999999999999999999974
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=274.88 Aligned_cols=181 Identities=29% Similarity=0.549 Sum_probs=140.1
Q ss_pred CCCCCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-CCCcEEEeccCCCcCCC
Q 024809 1 MEYAAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS-TAPRVKICDFGYSKSSV 75 (262)
Q Consensus 1 mE~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~-~~~~~kl~Dfg~a~~~~ 75 (262)
||||+||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.+ ..+.+||+|||+++...
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 799999999999854 3679999999999999999999999999999999999999542 23479999999998655
Q ss_pred CCCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 76 LHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 76 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
.........||+.|+|||++.+ .+ +.++|||||||++|+|++|+.||.+............... .. ......+++
T Consensus 179 ~~~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~ 253 (285)
T 3is5_A 179 SDEHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP--NY-AVECRPLTP 253 (285)
T ss_dssp --------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CC-CC--CCCCH
T ss_pred CcccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCc--cc-ccccCcCCH
Confidence 4444556789999999999864 44 4558999999999999999999987654333322211111 11 112235789
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 254 ~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 254 QAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 9999999999999999999999999999974
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=278.70 Aligned_cols=184 Identities=24% Similarity=0.477 Sum_probs=143.0
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-C
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-S 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~ 78 (262)
||||+| +|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++..... .
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERG--ELKLADFGLARAKSIPTK 155 (324)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTC--CEEECSSSEEECC-----
T ss_pred eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCC--CEEEccCcccccccCCcc
Confidence 799985 9999988754 599999999999999999999999999999999999998777 8999999998754322 2
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccc--------------
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH-------------- 144 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-------------- 144 (262)
......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+....+....+........
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 233457899999999987755445669999999999999999999998766555444433221110
Q ss_pred -ccCC---------CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 145 -YSFP---------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 145 -~~~~---------~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
+.++ ....+++++++||.+||+.||.+|||++|+|+||||...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 0011 112478899999999999999999999999999999754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=297.90 Aligned_cols=184 Identities=38% Similarity=0.639 Sum_probs=153.6
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC-CcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA-PRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~-~~~kl~Dfg~a~~~~~~~~ 79 (262)
||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. ..+||+|||+++.......
T Consensus 125 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 204 (504)
T 3q5i_A 125 TEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204 (504)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSC
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCc
Confidence 799999999999998889999999999999999999999999999999999999976543 2699999999986654444
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....||+.|+|||++.+ .++ .++||||+||++|+|++|..||.+......+..+.... ..+..+.+..+++++++
T Consensus 205 ~~~~~gt~~y~aPE~~~~-~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~s~~~~~ 280 (504)
T 3q5i_A 205 LRDRLGTAYYIAPEVLKK-KYN-EKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGK--YYFDFNDWKNISDEAKE 280 (504)
T ss_dssp BCCCCSCTTTCCHHHHTT-CBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCHHHHTTSCHHHHH
T ss_pred cccccCCcCCCCHHHhcc-CCC-chHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCCccccCCCCHHHHH
Confidence 556789999999999864 454 45899999999999999999999866554444332221 11222334578999999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCccccccC
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWFLRNL 188 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 188 (262)
||.+||+.||.+|||+.++|+||||++..
T Consensus 281 li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 281 LIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred HHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 99999999999999999999999998654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=289.43 Aligned_cols=185 Identities=28% Similarity=0.425 Sum_probs=148.6
Q ss_pred CCCCCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC
Q 024809 1 MEYAAGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~----~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (262)
|||++| +|.+.+. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ..+||+|||+++....
T Consensus 132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~-~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT-AVLKLCDFGSAKQLVR 209 (420)
T ss_dssp EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTT-TEEEECCCTTCEECCT
T ss_pred hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCC-CeEEeccchhhhhccc
Confidence 689986 6766654 356799999999999999999999999999999999999998543 2689999999986654
Q ss_pred CCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccc-------------c
Q 024809 77 HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS-------------V 143 (262)
Q Consensus 77 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-------------~ 143 (262)
........||+.|+|||++.+...++.++|||||||++|+|++|+.||.+....+.+.+++..... .
T Consensus 210 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~ 289 (420)
T 1j1b_A 210 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 289 (420)
T ss_dssp TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCC
T ss_pred CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence 445556789999999999977544456699999999999999999999987766665555432211 0
Q ss_pred cccCCC----------cccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 144 HYSFPD----------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 144 ~~~~~~----------~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
.+.+|. ...+++++++||.+||++||.+|||+.|+++||||...
T Consensus 290 ~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 290 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp CCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 112221 12468899999999999999999999999999999754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=279.93 Aligned_cols=185 Identities=24% Similarity=0.375 Sum_probs=144.8
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-CC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (262)
||||+||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++..... ..
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHS--VIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECC-----
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCC--CEEEeeCCCchhccCcccc
Confidence 79999999999998888899999999999999999999999999999999999998776 8999999999754422 22
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc---------------c
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV---------------H 144 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---------------~ 144 (262)
.....||+.|+|||++.+....+.++||||+||++|+|++|+.||.+....+............ .
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 3456799999999999775544566999999999999999999998876655443322211100 0
Q ss_pred ccCC----------CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 145 YSFP----------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 145 ~~~~----------~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
...+ ....++.++.+||.+||..||.+|||++++++||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 291 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence 0001 113578899999999999999999999999999999754
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=290.98 Aligned_cols=185 Identities=25% Similarity=0.332 Sum_probs=145.8
Q ss_pred CCCCCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||+. |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++...+||+|||+++... .
T Consensus 178 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~--~ 254 (429)
T 3kvw_A 178 FELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH--Q 254 (429)
T ss_dssp ECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETT--C
T ss_pred EeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecC--C
Confidence 68996 59999998764 4999999999999999999999999999999999999988774449999999997432 3
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccc-------------
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY------------- 145 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~------------- 145 (262)
.....+||+.|+|||++.+..++. ++|||||||++|+|++|+.||.+.+..+.+..++........
T Consensus 255 ~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~ 333 (429)
T 3kvw_A 255 RVYTYIQSRFYRAPEVILGARYGM-PIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFV 333 (429)
T ss_dssp CCCSSCSCGGGCCHHHHHTBCCCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHB
T ss_pred cccccCCCCCccChHHHhCCCCCc-hHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhcc
Confidence 345678999999999998877754 489999999999999999999987765554443321110000
Q ss_pred ---cC-----------------------------CC--------cccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccc
Q 024809 146 ---SF-----------------------------PD--------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFL 185 (262)
Q Consensus 146 ---~~-----------------------------~~--------~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~ 185 (262)
.+ +. ....++++++||.+||+.||.+|||+.|+|+||||+
T Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~ 413 (429)
T 3kvw_A 334 SSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLR 413 (429)
T ss_dssp CTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC
T ss_pred CCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhc
Confidence 00 00 002378899999999999999999999999999998
Q ss_pred ccCC
Q 024809 186 RNLP 189 (262)
Q Consensus 186 ~~~~ 189 (262)
+..+
T Consensus 414 ~~~~ 417 (429)
T 3kvw_A 414 RRLP 417 (429)
T ss_dssp ----
T ss_pred cCCC
Confidence 7544
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=273.81 Aligned_cols=177 Identities=34% Similarity=0.661 Sum_probs=147.0
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++ .++|+|||++..... ...
T Consensus 88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~--~~~l~Dfg~~~~~~~-~~~ 164 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG--ELKIADFGWSVHAPS-SRR 164 (279)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTS--CEEECSCCEESCC------
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCC--CEEEEeccccccCCc-ccc
Confidence 79999999999999888899999999999999999999999999999999999998777 899999999864332 233
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 160 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 160 (262)
....||+.|+|||.+.+..++. ++||||||+++|+|++|+.||........... +......+|. .++.++++|
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~--~~~~~~~~l 237 (279)
T 3fdn_A 165 TDLCGTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEFLVGKPPFEANTYQETYKR----ISRVEFTFPD--FVTEGARDL 237 (279)
T ss_dssp ---CCCCTTCCHHHHTTCCCCT-THHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HHHTCCCCCT--TSCHHHHHH
T ss_pred cccCCCCCccCHhHhccCCCCc-cchhHhHHHHHHHHHHCCCCCCCCcHHHHHHH----HHhCCCCCCC--cCCHHHHHH
Confidence 4567999999999998776654 48999999999999999999987654433332 2223334444 588999999
Q ss_pred HHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 161 LSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 161 i~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
|.+||..||.+|||+.++++||||+..
T Consensus 238 i~~~l~~~p~~Rps~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 238 ISRLLKHNPSQRPMLREVLEHPWITAN 264 (279)
T ss_dssp HHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred HHHHhccChhhCCCHHHHhhCccccCC
Confidence 999999999999999999999999764
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=281.39 Aligned_cols=222 Identities=25% Similarity=0.384 Sum_probs=162.7
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
|||+.| +|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 109 ~e~~~~-~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~a~~~~~~~~~ 184 (364)
T 3qyz_A 109 QDLMET-DLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC--DLKICDFGLARVADPDHDH 184 (364)
T ss_dssp EECCSE-EHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEECCGGGCB
T ss_pred EcccCc-CHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCC--CEEEEeCcceEecCCCCCc
Confidence 688874 999998765 699999999999999999999999999999999999998777 89999999997543221
Q ss_pred --CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccc------------
Q 024809 79 --QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH------------ 144 (262)
Q Consensus 79 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------------ 144 (262)
......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+....+.+..+........
T Consensus 185 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 264 (364)
T 3qyz_A 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264 (364)
T ss_dssp CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHH
T ss_pred cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhH
Confidence 124458999999999976655445669999999999999999999998776655554432211100
Q ss_pred ----ccCC---------CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCCccccCCCCcc-ccCCCCCCCCH
Q 024809 145 ----YSFP---------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQ-SHDVNNPSQSL 210 (262)
Q Consensus 145 ----~~~~---------~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 210 (262)
...+ ....+++++++||.+||+.||.+|||+.++|+||||.+............. ........-..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (364)
T 3qyz_A 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPK 344 (364)
T ss_dssp HHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSSCCCCC-----CCH
T ss_pred HHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcccccCCCCcCCcccccccCCH
Confidence 0000 013578999999999999999999999999999999876543222111110 11111222345
Q ss_pred HHHHHHhHHhcCCCCC
Q 024809 211 EEVLSLIHEATKPLEA 226 (262)
Q Consensus 211 ~~~~~~~~~~~~~~~~ 226 (262)
+.+.+.+.+....+.+
T Consensus 345 ~~~~~~~~~e~~~~~~ 360 (364)
T 3qyz_A 345 EKLKELIFEETARFQP 360 (364)
T ss_dssp HHHHHHHHHHTGGGCC
T ss_pred HHHHHHHHHHHHHhhh
Confidence 6777777776655543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=281.16 Aligned_cols=184 Identities=22% Similarity=0.361 Sum_probs=145.3
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC---
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL--- 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~--- 76 (262)
||||+| +|.+.+... +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 103 ~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~--~~kl~Dfg~a~~~~~~~~ 179 (351)
T 3mi9_A 103 FDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG--VLKLADFGLARAFSLAKN 179 (351)
T ss_dssp EECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECCCCSS
T ss_pred EeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC--CEEEccchhccccccccc
Confidence 689986 787777654 5799999999999999999999999999999999999998777 899999999975432
Q ss_pred --CCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccccc-CCCcc--
Q 024809 77 --HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYS-FPDYV-- 151 (262)
Q Consensus 77 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~-- 151 (262)
........||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+.......... ++...
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 259 (351)
T 3mi9_A 180 SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 259 (351)
T ss_dssp SSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred ccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccc
Confidence 1223446789999999999775544566999999999999999999999876555444433222111111 11100
Q ss_pred -----------------------cCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 152 -----------------------RVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 152 -----------------------~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
..++++++||.+||+.||.+|||+.|+|+||||...
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 260 ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318 (351)
T ss_dssp GGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred hhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence 026789999999999999999999999999999754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=283.41 Aligned_cols=181 Identities=24% Similarity=0.414 Sum_probs=143.4
Q ss_pred CCCCCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC--------------------
Q 024809 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS-------------------- 58 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~-------------------- 58 (262)
|||| ||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++..
T Consensus 115 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~ 193 (360)
T 3llt_A 115 FEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI 193 (360)
T ss_dssp ECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEE
T ss_pred EcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccc
Confidence 7999 899999998764 59999999999999999999999999999999999999751
Q ss_pred ---CCCcEEEeccCCCcCCCCCCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHH
Q 024809 59 ---TAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRK 135 (262)
Q Consensus 59 ---~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 135 (262)
..+.+||+|||+++... .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||......+.+..
T Consensus 194 ~~~~~~~~kl~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 270 (360)
T 3llt_A 194 YRTKSTGIKLIDFGCATFKS--DYHGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLFRTHEHMEHLAM 270 (360)
T ss_dssp EEESCCCEEECCCTTCEETT--SCCCSCCSCGGGCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred cccCCCCEEEEeccCceecC--CCCcCccCcccccCcHHHcCCCCCCc-cchHHHHHHHHHHHHCCCCCCCCcHHHHHHH
Confidence 13489999999997533 23445689999999999988877655 8999999999999999999987665444333
Q ss_pred Hhcccccc----------------------cccCCCc------------------ccCCHHHHHHHHHhcccCCCCCCCH
Q 024809 136 TIGRILSV----------------------HYSFPDY------------------VRVSLECKHLLSRIFVANSEKRITI 175 (262)
Q Consensus 136 ~~~~~~~~----------------------~~~~~~~------------------~~~~~~~~~li~~~L~~dp~~R~s~ 175 (262)
+....... ...+|.. ...++.+.+||.+||+.||.+|||+
T Consensus 271 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta 350 (360)
T 3llt_A 271 MESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSP 350 (360)
T ss_dssp HHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCH
Confidence 22211100 0011110 0124678899999999999999999
Q ss_pred hHHhcCcccc
Q 024809 176 PEIKNHPWFL 185 (262)
Q Consensus 176 ~e~l~hp~~~ 185 (262)
.|+|+||||+
T Consensus 351 ~elL~hp~f~ 360 (360)
T 3llt_A 351 AELLKHKFLE 360 (360)
T ss_dssp HHHTTSGGGC
T ss_pred HHHhcCcccC
Confidence 9999999995
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=273.85 Aligned_cols=183 Identities=33% Similarity=0.580 Sum_probs=151.9
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||++||+|.+++...+.+++..++.++.||+.||.|||++|++||||||+||+++.++ .+||+|||++.........
T Consensus 103 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~dfg~~~~~~~~~~~ 180 (298)
T 1phk_A 103 FDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM--NIKLTDFGFSCQLDPGEKL 180 (298)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCTTCEECCTTCCB
T ss_pred EeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCC--cEEEecccchhhcCCCccc
Confidence 79999999999999888899999999999999999999999999999999999998777 8999999999765544445
Q ss_pred CccccCCCCCCccccc------CCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCC
Q 024809 81 KSTVGTPAYIAPEVLT------KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS 154 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~------~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (262)
....||+.|+|||++. ...+ +.++||||||+++|+|++|+.||...........+.... .....+.+..++
T Consensus 181 ~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 257 (298)
T 1phk_A 181 REVCGTPSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN--YQFGSPEWDDYS 257 (298)
T ss_dssp CCCCSCGGGCCHHHHHHHHCTTSCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--CCCCTTTGGGSC
T ss_pred ccccCCccccCHHHhccccccccccC-CcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCC--cccCcccccccC
Confidence 5667999999999985 2334 455899999999999999999998765444333322221 122233445789
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 024809 155 LECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL 188 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 188 (262)
.++++||.+||+.||.+|||+.++++||||++..
T Consensus 258 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 258 DTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred HHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 9999999999999999999999999999997643
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=281.12 Aligned_cols=217 Identities=18% Similarity=0.301 Sum_probs=152.6
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||+. |+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++.......
T Consensus 113 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~~~~ 189 (362)
T 3pg1_A 113 TELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN--DITICDFNLAREDTADAN 189 (362)
T ss_dssp EECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECCTTC---------
T ss_pred EccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCC--CEEEEecCcccccccccc
Confidence 68998 58888887554 699999999999999999999999999999999999998777 899999999985544444
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccc---------------
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH--------------- 144 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--------------- 144 (262)
.....||+.|+|||++.+....+.++|||||||++|+|++|+.||.+......+..+........
T Consensus 190 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 269 (362)
T 3pg1_A 190 KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDY 269 (362)
T ss_dssp ------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHH
T ss_pred cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHH
Confidence 55678999999999988744445669999999999999999999998765554444332111100
Q ss_pred -----ccCC------CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCCccccCCCCccccCCCCCCCCHHHH
Q 024809 145 -----YSFP------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEV 213 (262)
Q Consensus 145 -----~~~~------~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (262)
...+ .....++.+.+||.+||+.||.+|||+.++++||||+..........................++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (362)
T 3pg1_A 270 LRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGLSERFHFDESVTDVYDM 349 (362)
T ss_dssp TTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGTTTCCCCCCCCTTCCCHHHH
T ss_pred HHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccccccccccccChhhhhhhHHHH
Confidence 0000 11246888999999999999999999999999999987654433222222222233344455555
Q ss_pred HHHhHHh
Q 024809 214 LSLIHEA 220 (262)
Q Consensus 214 ~~~~~~~ 220 (262)
.+.+.+.
T Consensus 350 ~~~~~~e 356 (362)
T 3pg1_A 350 HKIFTAE 356 (362)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 5555443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=278.48 Aligned_cols=174 Identities=22% Similarity=0.288 Sum_probs=138.7
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||| +|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~--~~kl~DFG~a~~~~~~~~ 212 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRG--RCKLGDFGLLVELGTAGA 212 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGG--CEEECCCTTCEECC----
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC--CEEEccceeeeecccCCC
Confidence 6899 669999887644 699999999999999999999999999999999999998777 899999999976654444
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....||+.|+|||++.+ .++ .++|||||||++|+|++|..||.... ............ . ....+++++.+
T Consensus 213 ~~~~~gt~~y~aPE~~~~-~~~-~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~~~--~--~~~~~~~~l~~ 283 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQG-SYG-TAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYLPP--E--FTAGLSSELRS 283 (311)
T ss_dssp --CCCCCGGGCCGGGGGT-CCS-THHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCCCH--H--HHTTSCHHHHH
T ss_pred CcccCCCccccCHhHhcC-CCC-chhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCCCc--c--cccCCCHHHHH
Confidence 556679999999999876 454 55899999999999999977765432 222222211111 1 12358899999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
||.+||+.||.+|||+.++++||||++
T Consensus 284 li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 284 VLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHcCCChhhCcCHHHHHhCccccC
Confidence 999999999999999999999999974
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=271.45 Aligned_cols=178 Identities=24% Similarity=0.416 Sum_probs=145.9
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEec-CCCCCcEEEeccCCCcCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--ICHRDLKLENTLLD-GSTAPRVKICDFGYSKSSVLH 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~--ivHrDlkp~Nili~-~~~~~~~kl~Dfg~a~~~~~~ 77 (262)
|||++||+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+||+++ .++ .+||+|||++.... .
T Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~--~~kl~Dfg~~~~~~-~ 184 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG--SVKIGDLGLATLKR-A 184 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTS--CEEECCTTGGGGCC-T
T ss_pred EEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCC--CEEEeeCCCccccc-c
Confidence 699999999999998888999999999999999999999999 99999999999997 455 89999999996432 2
Q ss_pred CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHH
Q 024809 78 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 157 (262)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (262)
.......||+.|+|||++.+ .+ +.++|||||||++|+|++|+.||................. .........++++
T Consensus 185 ~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l 259 (290)
T 1t4h_A 185 SFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV---KPASFDKVAIPEV 259 (290)
T ss_dssp TSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC---CCGGGGGCCCHHH
T ss_pred cccccccCCcCcCCHHHHhc-cC-CCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccC---CccccCCCCCHHH
Confidence 23345679999999998864 34 4558999999999999999999988666544433322211 1111123567899
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 158 KHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
.+||.+||..||.+|||+.++++||||+.
T Consensus 260 ~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 260 KEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 99999999999999999999999999975
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=279.10 Aligned_cols=185 Identities=24% Similarity=0.337 Sum_probs=149.8
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-C
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-S 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~ 78 (262)
|||++| +|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++..... .
T Consensus 91 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~--~~kl~Dfg~a~~~~~~~~ 167 (346)
T 1ua2_A 91 FDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG--VLKLADFGLAKSFGSPNR 167 (346)
T ss_dssp EECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECCCGGGSTTTSCCC
T ss_pred EEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCC--CEEEEecccceeccCCcc
Confidence 689986 8998887654 699999999999999999999999999999999999998777 8999999999865332 2
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccc-ccCCC--------
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH-YSFPD-------- 149 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~-------- 149 (262)
......||+.|+|||++.+....+.++|||||||++|+|++|..||.+......+..+........ ..++.
T Consensus 168 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T 1ua2_A 168 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 247 (346)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccc
Confidence 334568999999999997655455669999999999999999999998776665555443321110 00110
Q ss_pred -------------cccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 024809 150 -------------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL 188 (262)
Q Consensus 150 -------------~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 188 (262)
...++.++++||.+||+.||.+|||+.|+|+||||....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 248 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred cccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 134678999999999999999999999999999998643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=271.61 Aligned_cols=182 Identities=37% Similarity=0.670 Sum_probs=150.5
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC---
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH--- 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~--- 77 (262)
|||++||+|.+++.....+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||++......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCTTCEECEETTEE
T ss_pred EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCC--CEEEeeCCCccccCCCcch
Confidence 69999999999998887899999999999999999999999999999999999998776 8999999998754322
Q ss_pred CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHH
Q 024809 78 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 157 (262)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (262)
.......||+.|+|||++.+..+.+.++||||||+++|+|++|+.||............+. ......+....+++.+
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 238 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK---EKKTYLNPWKKIDSAP 238 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHH---TTCTTSTTGGGSCHHH
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhh---hcccccCchhhcCHHH
Confidence 1234567999999999998777656669999999999999999999987654322221111 1112233345689999
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 158 KHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
++||.+||..||.+|||+.++++||||++.
T Consensus 239 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 239 LALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 999999999999999999999999999754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=274.80 Aligned_cols=181 Identities=36% Similarity=0.652 Sum_probs=149.3
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe---cCCCCCcEEEeccCCCcCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL---DGSTAPRVKICDFGYSKSSVLH 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili---~~~~~~~~kl~Dfg~a~~~~~~ 77 (262)
|||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+||++ +.++ .+||+|||+++... .
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~--~~kl~Dfg~~~~~~-~ 161 (304)
T 2jam_A 85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENS--KIMITDFGLSKMEQ-N 161 (304)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTC--CEEBCSCSTTCCCC-C
T ss_pred EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCC--CEEEccCCcceecC-C
Confidence 7999999999999988889999999999999999999999999999999999999 4444 89999999987432 2
Q ss_pred CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHH
Q 024809 78 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 157 (262)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (262)
.......||+.|+|||++.+..++ .++|||||||++|+|++|+.||...........+..... ....+....+++++
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~ 238 (304)
T 2jam_A 162 GIMSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYY--EFESPFWDDISESA 238 (304)
T ss_dssp BTTHHHHSCCCBCCTTTBSSCSCC-HHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCC--CCCTTTTTTSCHHH
T ss_pred CccccccCCCCccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC--CCCccccccCCHHH
Confidence 223445799999999999877665 458999999999999999999987655444333322211 11222334689999
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 158 KHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
++||.+||..||.+|||+.++++||||...
T Consensus 239 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 239 KDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 999999999999999999999999999754
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=289.73 Aligned_cols=180 Identities=16% Similarity=0.189 Sum_probs=141.9
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHH------HHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcC
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEA------RFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS 73 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~------~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (262)
||||+ |+|.+++...+ .+++... ..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 167 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~--~~kL~DFG~a~~ 243 (371)
T 3q60_A 167 MPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDG--RLMLGDVSALWK 243 (371)
T ss_dssp ECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTS--CEEECCGGGEEE
T ss_pred ecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCC--CEEEEecceeee
Confidence 79999 79999998643 3555555 67779999999999999999999999999998777 899999999985
Q ss_pred CCCCCCCCccccCCCCCCcccccC--CcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhH--HHH-HhcccccccccCC
Q 024809 74 SVLHSQPKSTVGTPAYIAPEVLTK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKN--FRK-TIGRILSVHYSFP 148 (262)
Q Consensus 74 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~-~~~~~~~~~~~~~ 148 (262)
.. .......+|+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||........ +.. ...........++
T Consensus 244 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (371)
T 3q60_A 244 VG--TRGPASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFG 320 (371)
T ss_dssp TT--CEEEGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCT
T ss_pred cC--CCccCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchh
Confidence 42 22225667899999999976 445 4559999999999999999999987543211 000 0011122334455
Q ss_pred CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 149 DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 149 ~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
....+++++++||.+||+.||.+|||+.++++||||++
T Consensus 321 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 321 SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp TSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 55678999999999999999999999999999999974
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=275.83 Aligned_cols=183 Identities=22% Similarity=0.391 Sum_probs=144.5
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||++||+|.+++.. +++..++.++.||+.||.|||++||+||||||+|||++.++. .+||+|||+++........
T Consensus 112 ~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~-~~kl~Dfg~a~~~~~~~~~ 187 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEY 187 (330)
T ss_dssp EECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCCTTCEECCTTCCC
T ss_pred EeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCC-EEEEEeCCCceEcCCCCcc
Confidence 799999999988743 899999999999999999999999999999999999975442 6999999999866555555
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh-hHHHHHhccccc---------cc------
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP-KNFRKTIGRILS---------VH------ 144 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~---------~~------ 144 (262)
....||+.|+|||++.+....+.++|||||||++|+|++|+.||...... ..+..+...... ..
T Consensus 188 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (330)
T 3nsz_A 188 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 267 (330)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTH
T ss_pred ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccc
Confidence 66789999999999987454456699999999999999999999654432 222111110000 00
Q ss_pred ----------------ccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 145 ----------------YSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 145 ----------------~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
........+++++++||.+||+.||.+|||++++|+||||+..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 268 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp HHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred hhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 0011112378999999999999999999999999999999753
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=284.19 Aligned_cols=187 Identities=25% Similarity=0.373 Sum_probs=135.6
Q ss_pred CCCCCCCchHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC--CCCCcEEEeccC
Q 024809 1 MEYAAGGELFERICNA---------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG--STAPRVKICDFG 69 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~---------~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~--~~~~~~kl~Dfg 69 (262)
|||+.| +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+.. ...+.+||+|||
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 177 (405)
T 3rgf_A 99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 177 (405)
T ss_dssp EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTT
T ss_pred EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECC
Confidence 689975 888888632 24999999999999999999999999999999999999932 122389999999
Q ss_pred CCcCCCCC----CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh---------hHHHHH
Q 024809 70 YSKSSVLH----SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP---------KNFRKT 136 (262)
Q Consensus 70 ~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------~~~~~~ 136 (262)
+++..... ......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.... +.+..+
T Consensus 178 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i 257 (405)
T 3rgf_A 178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 257 (405)
T ss_dssp CCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHH
T ss_pred CceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHH
Confidence 99855322 22344689999999999987665566799999999999999999999765431 222222
Q ss_pred hcccccccc-cC-------------------------------CCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 137 IGRILSVHY-SF-------------------------------PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 137 ~~~~~~~~~-~~-------------------------------~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
+..+..... .+ ......++++.+||.+||+.||.+|||++|+|+||||
T Consensus 258 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f 337 (405)
T 3rgf_A 258 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 337 (405)
T ss_dssp HHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhh
Confidence 221110000 00 0011237789999999999999999999999999999
Q ss_pred cccC
Q 024809 185 LRNL 188 (262)
Q Consensus 185 ~~~~ 188 (262)
....
T Consensus 338 ~~~~ 341 (405)
T 3rgf_A 338 LEDP 341 (405)
T ss_dssp TSSS
T ss_pred ccCC
Confidence 8654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=270.93 Aligned_cols=177 Identities=33% Similarity=0.675 Sum_probs=150.5
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++..... ...
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~Dfg~~~~~~~-~~~ 169 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKG--ELKIADFGWSVHAPS-LRR 169 (284)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTC--CEEECCCTTCEECSS-SCB
T ss_pred EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCC--CEEEecccccccCcc-ccc
Confidence 79999999999999888899999999999999999999999999999999999998776 899999999865432 223
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 160 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 160 (262)
....|++.|+|||++.+..++.. +||||||+++|+|++|..||...........+. .....+|. .++.++++|
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~----~~~~~~~~--~~~~~~~~l 242 (284)
T 2vgo_A 170 RTMCGTLDYLPPEMIEGKTHDEK-VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV----NVDLKFPP--FLSDGSKDL 242 (284)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH----TTCCCCCT--TSCHHHHHH
T ss_pred ccccCCCCcCCHHHhccCCCCcc-cchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh----ccccCCCC--cCCHHHHHH
Confidence 45679999999999988777544 899999999999999999998765544333322 22333443 588999999
Q ss_pred HHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 161 LSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 161 i~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
|.+||..||.+|||+.++++||||+..
T Consensus 243 i~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 243 ISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp HHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred HHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 999999999999999999999999753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=269.18 Aligned_cols=178 Identities=35% Similarity=0.643 Sum_probs=127.0
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-C
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-S 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~ 78 (262)
|||++||+|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||++...... .
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~--~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNM--NIKIADFGLATQLKMPHE 167 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTC--CEEECCCTTCEECC----
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC--CEEEEeecceeeccCCCC
Confidence 6999999999999875 5799999999999999999999999999999999999998776 8999999999754322 2
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 158 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (262)
......||+.|+|||.+.+..+.. ++||||||+++|+|++|+.||........... +....+..|. .++.+++
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~--~~~~~~~ 240 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATRSAHGL-ESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK----VVLADYEMPS--FLSIEAK 240 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------CCSSCCCCCT--TSCHHHH
T ss_pred cceeccCCCCcCCcchhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH----HhhcccCCcc--ccCHHHH
Confidence 233467999999999998766654 48999999999999999999987654333222 2222233333 5789999
Q ss_pred HHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 159 HLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 159 ~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
+||.+||..||.+|||+.++++||||.+.
T Consensus 241 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 241 DLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp HHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred HHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 99999999999999999999999999753
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=272.77 Aligned_cols=181 Identities=34% Similarity=0.619 Sum_probs=146.6
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC--CCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST--APRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~--~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||++||+|.+++...+.+++..++.++.||+.||.|||++|++||||||+||+++.++ ...+||+|||++.......
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~ 166 (283)
T 3bhy_A 87 LELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 166 (283)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC---
T ss_pred EeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCCC
Confidence 69999999999998888899999999999999999999999999999999999997654 2369999999998654444
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCC--CcccCCHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP--DYVRVSLE 156 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 156 (262)
......||+.|+|||++.+..++. ++||||||+++|+|++|..||........+...... ...++ ....++..
T Consensus 167 ~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~ 241 (283)
T 3bhy_A 167 EFKNIFGTPEFVAPEIVNYEPLGL-EADMWSIGVITYILLSGASPFLGETKQETLTNISAV----NYDFDEEYFSNTSEL 241 (283)
T ss_dssp -----CCCGGGCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT----CCCCCHHHHTTCCHH
T ss_pred cccccCCCcCccCcceecCCCCCc-chhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhc----ccCCcchhcccCCHH
Confidence 445567999999999998777654 489999999999999999999886554443332221 12221 12367899
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
+++||.+||..||.+|||+.++++||||+.
T Consensus 242 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred HHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 999999999999999999999999999974
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=290.09 Aligned_cols=169 Identities=15% Similarity=0.152 Sum_probs=137.1
Q ss_pred CCCCCCCchHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcC
Q 024809 1 MEYAAGGELFERICNAGRFSE-------DEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS 73 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e-------~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (262)
|||| +|+|.+++...+.+++ ..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 179 ~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~--~~kL~DFG~a~~ 255 (377)
T 3byv_A 179 YPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG--GVFLTGFEHLVR 255 (377)
T ss_dssp EECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEEECCGGGCEE
T ss_pred Eecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEEechhhee
Confidence 6899 6799999987666666 88889999999999999999999999999999998776 899999999984
Q ss_pred CCCCCCCCccccCCCCCCcccccCC-----------cCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccc
Q 024809 74 SVLHSQPKSTVGTPAYIAPEVLTKK-----------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS 142 (262)
Q Consensus 74 ~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 142 (262)
.. .......| +.|+|||++.+. .++ .++|||||||++|+|++|+.||.+..........
T Consensus 256 ~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~-~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~------ 325 (377)
T 3byv_A 256 DG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMT-FSFDAWALGLVIYWIWCADLPITKDAALGGSEWI------ 325 (377)
T ss_dssp TT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECC-HHHHHHHHHHHHHHHHHSSCCC------CCSGGG------
T ss_pred cC--CcccCCCC-cCccChhhhcccccccccccccccCC-hhhhHHHHHHHHHHHHHCCCCCcccccccchhhh------
Confidence 32 23345567 999999999876 554 5599999999999999999999765432221111
Q ss_pred ccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 143 VHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 143 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
......+++++++||.+||+.||.+|||+.++++||||+.
T Consensus 326 ----~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 326 ----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp ----GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred ----hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 1122468899999999999999999999999999999964
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=281.25 Aligned_cols=185 Identities=32% Similarity=0.545 Sum_probs=146.5
Q ss_pred CCCCCCCchHHHHHh----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHH
Q 024809 1 MEYAAGGELFERICN----------------------------------------AGRFSEDEARFFFQQLISGVSYCHS 40 (262)
Q Consensus 1 mE~~~gg~L~~~i~~----------------------------------------~~~l~e~~~~~~~~ql~~aL~~LH~ 40 (262)
||||+||+|.+++.. ...+++..++.++.||+.||.|||+
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~ 186 (345)
T 3hko_A 107 MELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN 186 (345)
T ss_dssp EECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence 799999999999852 1124788999999999999999999
Q ss_pred cCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-----CCCccccCCCCCCcccccCC-cCCCCchhHHHHHHHH
Q 024809 41 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLTKK-EYDGKIADVWSCGVTL 114 (262)
Q Consensus 41 ~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il 114 (262)
+||+||||||+||+++.++...+||+|||+++...... ......||+.|+|||++.+. ...+.++|||||||++
T Consensus 187 ~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il 266 (345)
T 3hko_A 187 QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266 (345)
T ss_dssp TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHH
T ss_pred CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHH
Confidence 99999999999999986665579999999997543211 12456799999999998752 3334569999999999
Q ss_pred HHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 115 YVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 115 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
|+|++|+.||.+............... ....+....+++++++||.+||+.||.+|||+.++++||||+..
T Consensus 267 ~el~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~ 337 (345)
T 3hko_A 267 HLLLMGAVPFPGVNDADTISQVLNKKL--CFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF 337 (345)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHCCC--CTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred HHHHHCCCCCCCCChHHHHHHHHhccc--ccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence 999999999988776655554443321 22233444689999999999999999999999999999999754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=277.32 Aligned_cols=214 Identities=23% Similarity=0.333 Sum_probs=154.6
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||+. |+|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++... ...
T Consensus 126 ~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~--~~kL~Dfg~a~~~~--~~~ 198 (371)
T 4exu_A 126 MPFMQ-TDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC--ELKILDFGLARHAD--AEM 198 (371)
T ss_dssp EECCC-EEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECSTTCC---------
T ss_pred Ecccc-ccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCC--CEEEEecCcccccc--cCc
Confidence 68887 589888743 499999999999999999999999999999999999998777 89999999997543 234
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccc---------------
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY--------------- 145 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------- 145 (262)
....||+.|+|||++.+....+.++|||||||++|+|++|+.||.+....+.+..+.........
T Consensus 199 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 278 (371)
T 4exu_A 199 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYI 278 (371)
T ss_dssp -CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHH
T ss_pred CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhh
Confidence 45689999999999987444455699999999999999999999887655554444321111000
Q ss_pred ------cC----CCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCCccccCCCCc-cccCCCCCCCCHHHHH
Q 024809 146 ------SF----PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSW-QSHDVNNPSQSLEEVL 214 (262)
Q Consensus 146 ------~~----~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 214 (262)
.. .....+++++++||.+||+.||.+|||+.++|+||||.............. ............+++.
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (371)
T 4exu_A 279 QSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEWK 358 (371)
T ss_dssp HHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSCCCCTTSSCCCCHHHHH
T ss_pred hccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcccccccccCcCcchhhcccchHHHH
Confidence 00 001257899999999999999999999999999999986543332211111 1111222334567777
Q ss_pred HHhHHhc
Q 024809 215 SLIHEAT 221 (262)
Q Consensus 215 ~~~~~~~ 221 (262)
+.+.+..
T Consensus 359 ~~~~~~~ 365 (371)
T 4exu_A 359 QHIYKEI 365 (371)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 7666543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=277.98 Aligned_cols=184 Identities=27% Similarity=0.417 Sum_probs=145.5
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-CC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (262)
|||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++..... ..
T Consensus 103 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~ 180 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG--VVKLCDFGFARTLAAPGEV 180 (331)
T ss_dssp EECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCCTTC---------
T ss_pred EecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCC--cEEEEeCCCceeecCCccc
Confidence 79999999999888888899999999999999999999999999999999999998777 8999999999754332 22
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccc---------------cc
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS---------------VH 144 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------------~~ 144 (262)
.....||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+...... ..
T Consensus 181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG 260 (331)
T ss_dssp ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence 345679999999999987644456699999999999999999999887665544433221110 00
Q ss_pred ccCC----------CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 145 YSFP----------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 145 ~~~~----------~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
...+ ....+++++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 0111 11257899999999999999999999999999999974
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=281.35 Aligned_cols=185 Identities=35% Similarity=0.612 Sum_probs=126.8
Q ss_pred CCCCCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCcEEEeccCCCcCCCCC
Q 024809 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-APRVKICDFGYSKSSVLH 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~-~~~~kl~Dfg~a~~~~~~ 77 (262)
||||+||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||+++.++ .+.+||+|||+++... .
T Consensus 105 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~-~ 183 (336)
T 3fhr_A 105 MECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT-Q 183 (336)
T ss_dssp EECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---
T ss_pred EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecc-c
Confidence 79999999999998764 699999999999999999999999999999999999997643 3469999999997543 2
Q ss_pred CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc--cccCCCcccCCH
Q 024809 78 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV--HYSFPDYVRVSL 155 (262)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 155 (262)
.......||+.|+|||++.+..++ .++|||||||++|+|++|+.||...............+... ....+.+..+++
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (336)
T 3fhr_A 184 NALQTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSE 262 (336)
T ss_dssp --------------------CHHH-HHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCH
T ss_pred cccccCCCCcCccChhhhCCCCCC-chhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCH
Confidence 233456789999999999777665 44899999999999999999997755433222222222222 223344457899
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
++++||.+||..||.+|||+.++++||||++.
T Consensus 263 ~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 263 DAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 99999999999999999999999999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=274.56 Aligned_cols=182 Identities=26% Similarity=0.374 Sum_probs=144.0
Q ss_pred CCCCCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-----------------CC
Q 024809 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-----------------AP 61 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~-----------------~~ 61 (262)
|||+ ||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++... .+
T Consensus 96 ~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~ 174 (339)
T 1z57_A 96 FELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP 174 (339)
T ss_dssp EECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCC
T ss_pred EcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCC
Confidence 7899 889999998765 689999999999999999999999999999999999997633 34
Q ss_pred cEEEeccCCCcCCCCCCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccc
Q 024809 62 RVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIL 141 (262)
Q Consensus 62 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 141 (262)
.+||+|||+++... .......||+.|+|||++.+..++. ++|||||||++|+|++|..||...+..+....+.....
T Consensus 175 ~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 251 (339)
T 1z57_A 175 DIKVVDFGSATYDD--EHHSTLVSTRHYRAPEVILALGWSQ-PCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILG 251 (339)
T ss_dssp CEEECCCSSCEETT--SCCCSSCSCGGGCCHHHHTTSCCCT-HHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHC
T ss_pred CceEeeCcccccCc--cccccccCCccccChHHhhCCCCCc-chhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 79999999997533 2344568999999999998877754 48999999999999999999987665443322211110
Q ss_pred cc-----------------cccC---------------------CCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcc
Q 024809 142 SV-----------------HYSF---------------------PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPW 183 (262)
Q Consensus 142 ~~-----------------~~~~---------------------~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~ 183 (262)
.. ...+ ......++++.+||.+||+.||.+|||+.|+++|||
T Consensus 252 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 331 (339)
T 1z57_A 252 PLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPF 331 (339)
T ss_dssp SCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGG
T ss_pred CCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHH
Confidence 00 0000 001123567899999999999999999999999999
Q ss_pred ccc
Q 024809 184 FLR 186 (262)
Q Consensus 184 ~~~ 186 (262)
|+.
T Consensus 332 f~~ 334 (339)
T 1z57_A 332 FDL 334 (339)
T ss_dssp GGG
T ss_pred HHH
Confidence 974
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=281.95 Aligned_cols=183 Identities=26% Similarity=0.341 Sum_probs=143.9
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH--HcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCH--SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH--~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (262)
|||+.| +|.+++... +.+++..++.++.||+.||.||| +.||+||||||+|||++.+..+.+||+|||+++...
T Consensus 135 ~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~- 212 (382)
T 2vx3_A 135 FEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG- 212 (382)
T ss_dssp EECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETT-
T ss_pred EecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceecc-
Confidence 789965 999999865 46999999999999999999999 579999999999999965444589999999997543
Q ss_pred CCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc-------------
Q 024809 77 HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV------------- 143 (262)
Q Consensus 77 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------------- 143 (262)
.......||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+....+.+..+.......
T Consensus 213 -~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 290 (382)
T 2vx3_A 213 -QRIYQYIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARK 290 (382)
T ss_dssp -CCCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHH
T ss_pred -cccccccCCccccChHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHH
Confidence 234567899999999999887775 45899999999999999999999876655544433221100
Q ss_pred --------cc------------cCCCcc-------------------------cCCHHHHHHHHHhcccCCCCCCCHhHH
Q 024809 144 --------HY------------SFPDYV-------------------------RVSLECKHLLSRIFVANSEKRITIPEI 178 (262)
Q Consensus 144 --------~~------------~~~~~~-------------------------~~~~~~~~li~~~L~~dp~~R~s~~e~ 178 (262)
.+ ..+... ..++++++||.+||+.||.+|||++|+
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~ 370 (382)
T 2vx3_A 291 FFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYA 370 (382)
T ss_dssp HEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred HHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHH
Confidence 00 000000 001378999999999999999999999
Q ss_pred hcCcccccc
Q 024809 179 KNHPWFLRN 187 (262)
Q Consensus 179 l~hp~~~~~ 187 (262)
|+||||++.
T Consensus 371 L~hp~f~~~ 379 (382)
T 2vx3_A 371 LQHSFFKKT 379 (382)
T ss_dssp TTSGGGCC-
T ss_pred hcCcccccC
Confidence 999999754
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=278.57 Aligned_cols=185 Identities=24% Similarity=0.373 Sum_probs=146.7
Q ss_pred CCCCCCCchHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHH--HcCCeecCCCCCcEEecC-CCCCcEEEeccCCCcC
Q 024809 1 MEYAAGGELFERI----CNAGRFSEDEARFFFQQLISGVSYCH--SMQICHRDLKLENTLLDG-STAPRVKICDFGYSKS 73 (262)
Q Consensus 1 mE~~~gg~L~~~i----~~~~~l~e~~~~~~~~ql~~aL~~LH--~~~ivHrDlkp~Nili~~-~~~~~~kl~Dfg~a~~ 73 (262)
||||+| +|...+ .....+++..++.++.|++.||.||| ++||+||||||+|||++. ++ .+||+|||+++.
T Consensus 105 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~--~~kl~Dfg~a~~ 181 (360)
T 3e3p_A 105 MEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG--TLKLCDFGSAKK 181 (360)
T ss_dssp EECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTT--EEEECCCTTCBC
T ss_pred eecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCC--cEEEeeCCCcee
Confidence 789987 444433 35567999999999999999999999 999999999999999985 55 899999999987
Q ss_pred CCCCCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccc---------
Q 024809 74 SVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH--------- 144 (262)
Q Consensus 74 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--------- 144 (262)
...........||+.|+|||++.+....+.++|||||||++|+|++|+.||.+......+..+........
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3e3p_A 182 LSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNP 261 (360)
T ss_dssp CCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCT
T ss_pred cCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhccc
Confidence 65555555678999999999997766445669999999999999999999998766555544433211100
Q ss_pred ----cc------------CC-CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 024809 145 ----YS------------FP-DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL 188 (262)
Q Consensus 145 ----~~------------~~-~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 188 (262)
.. ++ .....++++++||.+||+.||.+|||+.|+|+||||+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 262 SHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp TCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred chhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 00 00 1112567899999999999999999999999999998643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=275.14 Aligned_cols=179 Identities=34% Similarity=0.562 Sum_probs=151.3
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-CC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (262)
||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++..... ..
T Consensus 120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~~~~~ 197 (335)
T 2owb_A 120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL--EVKIGDFGLATKVEYDGER 197 (335)
T ss_dssp ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEEECCCTTCEECCSTTCC
T ss_pred EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCC--CEEEeeccCceecccCccc
Confidence 79999999999999888899999999999999999999999999999999999998776 8999999999765422 22
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....||+.|+|||++.+..+. .++|||||||++|+|++|+.||........+... ......++. .+++++.+
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~----~~~~~~~~~--~~~~~~~~ 270 (335)
T 2owb_A 198 KKVLCGTPNYIAPEVLSKKGHS-FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI----KKNEYSIPK--HINPVAAS 270 (335)
T ss_dssp BCCCCSCCSSCCHHHHHTSCBC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----HHTCCCCCT--TSCHHHHH
T ss_pred ccccCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH----hcCCCCCCc--cCCHHHHH
Confidence 3446799999999999877765 4489999999999999999999876544433322 222333444 68899999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCccccccC
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWFLRNL 188 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 188 (262)
||.+||+.||.+|||+.++++||||....
T Consensus 271 li~~~l~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 271 LIQKMLQTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp HHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred HHHHHccCChhHCcCHHHHhcCccccCCC
Confidence 99999999999999999999999997653
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=270.18 Aligned_cols=179 Identities=26% Similarity=0.408 Sum_probs=133.3
Q ss_pred CCCCCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCCcEEEeccCCCcCCC
Q 024809 1 MEYAAGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSM-QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV 75 (262)
Q Consensus 1 mE~~~gg~L~~~i~----~~~~l~e~~~~~~~~ql~~aL~~LH~~-~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~ 75 (262)
|||++| +|.+++. ..+.+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+++...
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG--QVKMCDFGISGYLV 161 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC--CEEBCCC-------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC--CEEEeecCCccccc
Confidence 689985 8877765 356799999999999999999999998 999999999999998776 89999999998655
Q ss_pred CCCCCCccccCCCCCCccccc---CCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhH-HHHHhcccccccccCCCcc
Q 024809 76 LHSQPKSTVGTPAYIAPEVLT---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKN-FRKTIGRILSVHYSFPDYV 151 (262)
Q Consensus 76 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 151 (262)
.........||+.|+|||++. .....+.++||||+||++|+|++|+.||........ ....... .....+ ..
T Consensus 162 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~-~~ 237 (290)
T 3fme_A 162 DDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE---PSPQLP-AD 237 (290)
T ss_dssp --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHS---CCCCCC-TT
T ss_pred ccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhcc---CCCCcc-cc
Confidence 444445568999999999973 233334568999999999999999999987544322 2222211 111122 23
Q ss_pred cCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 152 RVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 152 ~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
.+++++.+||.+||+.||.+|||+.++++||||+.
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred cCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 58899999999999999999999999999999974
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=276.27 Aligned_cols=179 Identities=27% Similarity=0.430 Sum_probs=139.1
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
|| +.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++. + .+||+|||+++......
T Consensus 88 ~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~-~--~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G--MLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp EC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T--EEEECCCSSSCCC------
T ss_pred Ee-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC-C--cEEEeecccccccCccccc
Confidence 67 567899999999989999999999999999999999999999999999999963 3 79999999998654322
Q ss_pred -CCCccccCCCCCCcccccC----------CcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChh-HHHHHhccccccccc
Q 024809 79 -QPKSTVGTPAYIAPEVLTK----------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPK-NFRKTIGRILSVHYS 146 (262)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~----------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~~~~~~~ 146 (262)
......||+.|+|||++.+ ....+.++|||||||++|+|++|+.||....... .+...... .....
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~~~~~ 241 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP--NHEIE 241 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT--TSCCC
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcC--CcccC
Confidence 1235679999999999854 1233455899999999999999999998754432 12222111 11222
Q ss_pred CCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 147 FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 147 ~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
+|. ..+.++.+||.+||+.||.+|||+.++++||||+..
T Consensus 242 ~~~--~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 242 FPD--IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp CCC--CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred Ccc--cCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 333 467889999999999999999999999999999754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=276.79 Aligned_cols=182 Identities=35% Similarity=0.623 Sum_probs=146.0
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-APRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~-~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++ ...+||+|||+++.......
T Consensus 93 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 172 (322)
T 2ycf_A 93 LELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172 (322)
T ss_dssp EECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHH
T ss_pred EecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecccccc
Confidence 79999999999999888999999999999999999999999999999999999997654 23599999999975533222
Q ss_pred CCccccCCCCCCccccc---CCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCC--CcccCC
Q 024809 80 PKSTVGTPAYIAPEVLT---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP--DYVRVS 154 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 154 (262)
.....||+.|+|||++. ...+ +.++|||||||++|+|++|..||........+...+.. ....+. .+..++
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 248 (322)
T 2ycf_A 173 MRTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS---GKYNFIPEVWAEVS 248 (322)
T ss_dssp HHHHHSCCTTCCHHHHHHTTTTTC-TTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH---TCCCCCHHHHTTSC
T ss_pred cccccCCcCccCchhhccCCCCCC-CchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh---CccccCchhhhhcC
Confidence 23457999999999974 2334 45589999999999999999999875543332222211 111111 123578
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 155 LECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
.++.+||.+||..||.+|||+.++++||||..
T Consensus 249 ~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 249 EKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred HHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 99999999999999999999999999999964
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=280.39 Aligned_cols=183 Identities=30% Similarity=0.471 Sum_probs=144.6
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~-~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
||||+||+|.+++...+.+++..++.++.|++.||.|||+. ||+||||||+||+++.++ .+||+|||++..... ..
T Consensus 110 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~-~~ 186 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLID-SM 186 (360)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC--CEEECCCCCCHHHHH-HC
T ss_pred EECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCC--CEEEEECCCCccccc-cc
Confidence 79999999999999888899999999999999999999996 999999999999998777 899999999864322 22
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHH-----------------------
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKT----------------------- 136 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~----------------------- 136 (262)
.....||+.|+|||++.+..++ .++|||||||++|+|++|+.||............
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (360)
T 3eqc_A 187 ANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265 (360)
T ss_dssp ----CCCCTTCCHHHHTTCCCS-HHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred ccCCCCCCCeECHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence 3456899999999999887765 4589999999999999999999875432211110
Q ss_pred ---------------hcccccccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 137 ---------------IGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 137 ---------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
...+............++.++++||.+||+.||.+|||+.++|+||||+..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp --------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 000000111111112478899999999999999999999999999999754
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=268.62 Aligned_cols=179 Identities=34% Similarity=0.558 Sum_probs=151.2
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-CC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (262)
|||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++..... ..
T Consensus 94 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~dfg~~~~~~~~~~~ 171 (294)
T 2rku_A 94 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL--EVKIGDFGLATKVEYDGER 171 (294)
T ss_dssp EECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEECCSTTCC
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCC--CEEEEeccCceecccCccc
Confidence 79999999999999888899999999999999999999999999999999999998776 8999999999755422 22
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....||+.|+|||++.+..++. ++||||||+++|+|++|+.||......+.+... .......|. .+++.+.+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~--~~~~~~~~ 244 (294)
T 2rku_A 172 KKVLCGTPNYIAPEVLSKKGHSF-EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI----KKNEYSIPK--HINPVAAS 244 (294)
T ss_dssp BCCCCSCCSSCCHHHHTTSCBCT-HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----HTTCCCCCT--TSCHHHHH
T ss_pred cccccCCCCcCCcchhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----hhccCCCcc--ccCHHHHH
Confidence 34467999999999998776654 489999999999999999999876554433332 222333443 68899999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCccccccC
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWFLRNL 188 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 188 (262)
+|.+||..||.+|||+.++++||||....
T Consensus 245 li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 273 (294)
T 2rku_A 245 LIQKMLQTDPTARPTINELLNDEFFTSGY 273 (294)
T ss_dssp HHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred HHHHHcccChhhCcCHHHHhhChheecCC
Confidence 99999999999999999999999997643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=281.13 Aligned_cols=179 Identities=26% Similarity=0.422 Sum_probs=141.2
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
|| +.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++. + .+||+|||+++......
T Consensus 135 ~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~-~--~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G--MLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp EE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS-S--CEEECCCSSSCCC------
T ss_pred Ee-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC-C--eEEEEecCccccccCCCcc
Confidence 67 567899999999889999999999999999999999999999999999999963 3 79999999998654322
Q ss_pred -CCCccccCCCCCCcccccCC----------cCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh-hHHHHHhccccccccc
Q 024809 79 -QPKSTVGTPAYIAPEVLTKK----------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP-KNFRKTIGRILSVHYS 146 (262)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~ 146 (262)
.....+||+.|+|||++.+. ...+.++|||||||++|+|++|+.||...... ..+...... .....
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~--~~~~~ 288 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP--NHEIE 288 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCT--TSCCC
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCc--cccCC
Confidence 22456799999999998652 23345689999999999999999999875443 222222211 11222
Q ss_pred CCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 147 FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 147 ~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
+|. ..+.++++||.+||+.||.+|||+.++|+||||+..
T Consensus 289 ~~~--~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 289 FPD--IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp CCC--CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred CCc--cchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 333 457899999999999999999999999999999754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=270.52 Aligned_cols=183 Identities=27% Similarity=0.375 Sum_probs=149.1
Q ss_pred CCCCCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||+. |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++......
T Consensus 98 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~--~~kl~Dfg~~~~~~~~~ 174 (326)
T 1blx_A 98 FEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADFGLARIYSFQM 174 (326)
T ss_dssp EECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECSCCSCCCCCGGG
T ss_pred EecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCC--CEEEecCcccccccCCC
Confidence 68998 59999998754 499999999999999999999999999999999999998777 89999999997654333
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc-cccCC---------
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-HYSFP--------- 148 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~--------- 148 (262)
......||+.|+|||++.+..++. ++|||||||++|+|++|+.||.+......+..+....... ...++
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 253 (326)
T 1blx_A 175 ALTSVVVTLWYRAPEVLLQSSYAT-PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 253 (326)
T ss_dssp GGCCCCCCCTTCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGG
T ss_pred CccccccccceeCHHHHhcCCCCc-chhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhh
Confidence 344567999999999998777654 4899999999999999999999877655554443321100 00000
Q ss_pred -----------CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 149 -----------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 149 -----------~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
....++..+++||.+||..||.+|||+.++++||||...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 254 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp SCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred hcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 113578899999999999999999999999999999754
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=269.50 Aligned_cols=183 Identities=36% Similarity=0.634 Sum_probs=151.0
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-APRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~-~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||++||+|.+++...+.+++..++.++.||+.||.|||++|++||||||+||+++.++ ...+||+|||++........
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~ 179 (287)
T 2wei_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (287)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS
T ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc
Confidence 69999999999998888899999999999999999999999999999999999997643 34799999999986554444
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....||+.|+|||++.+. + +.++||||||+++|+|++|..||.+............. ......+.+..+++++++
T Consensus 180 ~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 255 (287)
T 2wei_A 180 MKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG--KYAFDLPQWRTISDDAKD 255 (287)
T ss_dssp CSCHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCSGGGTTSCHHHHH
T ss_pred cccccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCchhhhhcCHHHHH
Confidence 4556789999999998754 4 45589999999999999999999876544333332221 112233444578999999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
||.+||..||.+|||+.++++||||++.
T Consensus 256 li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 256 LIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 9999999999999999999999999754
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=271.29 Aligned_cols=185 Identities=29% Similarity=0.441 Sum_probs=145.1
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
|||+. |+|.+++... .+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++......
T Consensus 93 ~e~~~-~~L~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~--~~kl~Dfg~a~~~~~~~~~ 168 (353)
T 2b9h_A 93 QELMQ-TDLHRVISTQ-MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC--DLKVCDFGLARIIDESAAD 168 (353)
T ss_dssp ECCCS-EEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEEECCCTTCEECC-----
T ss_pred EeccC-ccHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCC--cEEEEeccccccccccccc
Confidence 68997 5999998764 699999999999999999999999999999999999998776 89999999997543211
Q ss_pred ---------CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccc-----
Q 024809 79 ---------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH----- 144 (262)
Q Consensus 79 ---------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~----- 144 (262)
......||+.|+|||++......+.++|||||||++|+|++|+.||.+......+..+........
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T 2b9h_A 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDL 248 (353)
T ss_dssp -----------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTT
T ss_pred ccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccc
Confidence 112357899999999987644455669999999999999999999988765444333322111000
Q ss_pred ---------------ccCC------CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCC
Q 024809 145 ---------------YSFP------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLP 189 (262)
Q Consensus 145 ---------------~~~~------~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 189 (262)
...+ ....+++++++||.+||..||.+|||+.++++||||+....
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 249 RCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred cccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 0000 01358899999999999999999999999999999986543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=267.82 Aligned_cols=175 Identities=23% Similarity=0.323 Sum_probs=139.9
Q ss_pred CCCCCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-----------------
Q 024809 1 MEYAAGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST----------------- 59 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~----~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~----------------- 59 (262)
||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 7999999999999764 6799999999999999999999999999999999999997432
Q ss_pred CCcEEEeccCCCcCCCCCCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcc
Q 024809 60 APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGR 139 (262)
Q Consensus 60 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~ 139 (262)
...+||+|||++..... .....||+.|+|||++.+....+.++|||||||++|+|++|..|+.... ........
T Consensus 170 ~~~~kl~Dfg~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~~ 243 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISS---PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEIRQG 243 (289)
T ss_dssp CCCEEECCCTTCEETTC---SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHHHTT
T ss_pred ceEEEEcccccccccCC---ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHHHcC
Confidence 23789999999875432 2345699999999999876444456999999999999999988775432 22222211
Q ss_pred cccccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 140 ILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 140 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
. ....+ ..+++++.+||.+||..||.+|||+.++++||||..
T Consensus 244 ~---~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 244 R---LPRIP--QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285 (289)
T ss_dssp C---CCCCS--SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred C---CCCCC--cccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence 1 11222 268899999999999999999999999999999975
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=274.79 Aligned_cols=181 Identities=22% Similarity=0.326 Sum_probs=142.8
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++......
T Consensus 95 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~a~~~~~~~~~ 172 (311)
T 3ork_A 95 MEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN--AVKVMDFGIARAIADSGNS 172 (311)
T ss_dssp EECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTS--CEEECCCSCC---------
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCC--CEEEeeccCcccccccccc
Confidence 79999999999999888999999999999999999999999999999999999998777 89999999997543321
Q ss_pred --CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHH
Q 024809 79 --QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 156 (262)
Q Consensus 79 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (262)
......||+.|+|||++.+..++. ++|||||||++|+|++|+.||.+................. .......++.+
T Consensus 173 ~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 249 (311)
T 3ork_A 173 VTQTAAVIGTAQYLSPEQARGDSVDA-RSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP--PSARHEGLSAD 249 (311)
T ss_dssp ---------CCTTCCHHHHHTCCCCH-HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC--HHHHSTTCCHH
T ss_pred cccccccCcCcccCCHHHhcCCCCCc-hHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC--cccccCCCCHH
Confidence 223356999999999998877654 4899999999999999999998766544333332221111 11112358899
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
+.+||.+||+.||.+||++.+++.|+|++.
T Consensus 250 l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 250 LDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 999999999999999999999999999864
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=271.47 Aligned_cols=216 Identities=23% Similarity=0.344 Sum_probs=157.5
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||+. |+|.+++.. ++++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++... ...
T Consensus 108 ~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~--~~kl~Dfg~~~~~~--~~~ 180 (353)
T 3coi_A 108 MPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC--ELKILDFGLARHAD--AEM 180 (353)
T ss_dssp EECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTC--CEEECSTTCTTC-------
T ss_pred ecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCC--cEEEeecccccCCC--CCc
Confidence 68887 599888743 599999999999999999999999999999999999998776 89999999997543 223
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccc------------------
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS------------------ 142 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~------------------ 142 (262)
....||+.|+|||++.+....+.++|||||||++|+|++|+.||.+......+..+......
T Consensus 181 ~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 260 (353)
T 3coi_A 181 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYI 260 (353)
T ss_dssp ---CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHH
T ss_pred cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHH
Confidence 45678999999999877444455699999999999999999999886654444333221100
Q ss_pred ------ccccCC-CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCCccccCCC-CccccCCCCCCCCHHHHH
Q 024809 143 ------VHYSFP-DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGG-SWQSHDVNNPSQSLEEVL 214 (262)
Q Consensus 143 ------~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 214 (262)
....+. ....+++++++||.+||..||.+|||+.++++||||......+..... ............+.+++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (353)
T 3coi_A 261 QSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEWK 340 (353)
T ss_dssp HTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSCCCCTTTTCCCCHHHHH
T ss_pred HhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccCCCCCccchhhccCCHHHHH
Confidence 000111 123578999999999999999999999999999999865443322111 111222233456778888
Q ss_pred HHhHHhcCC
Q 024809 215 SLIHEATKP 223 (262)
Q Consensus 215 ~~~~~~~~~ 223 (262)
..+.+....
T Consensus 341 ~~~~~~~~~ 349 (353)
T 3coi_A 341 QHIYKEIVN 349 (353)
T ss_dssp HHHHHHHHT
T ss_pred HHHHHHHHh
Confidence 777765433
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=269.79 Aligned_cols=185 Identities=27% Similarity=0.400 Sum_probs=142.2
Q ss_pred CCCCCCCchHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 1 MEYAAGGELFERICN--------AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 1 mE~~~gg~L~~~i~~--------~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
|||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++.
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~dfg~~~ 169 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG--SVQIADFGVSA 169 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC--CEEECCCHHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCC--CEEEEeccchh
Confidence 799999999999974 45699999999999999999999999999999999999998776 89999999986
Q ss_pred CCCCCC------CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccc--
Q 024809 73 SSVLHS------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH-- 144 (262)
Q Consensus 73 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-- 144 (262)
...... ......||+.|+|||++.+....+.++|||||||++|+|++|+.||....................
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 249 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccc
Confidence 443221 123457999999999987633334568999999999999999999988766554443332211110
Q ss_pred --ccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 145 --YSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 145 --~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
........++.++++||.+||..||.+|||+.++++||||.+.
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp -----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 0011123578899999999999999999999999999999754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=274.75 Aligned_cols=183 Identities=24% Similarity=0.360 Sum_probs=141.7
Q ss_pred CCCCCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-----------------CCC
Q 024809 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS-----------------TAP 61 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~-----------------~~~ 61 (262)
|||+ +|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+... ..+
T Consensus 101 ~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~ 179 (355)
T 2eu9_A 101 FELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT 179 (355)
T ss_dssp EECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCC
T ss_pred Eecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCC
Confidence 6899 567888877653 69999999999999999999999999999999999999432 233
Q ss_pred cEEEeccCCCcCCCCCCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccc
Q 024809 62 RVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIL 141 (262)
Q Consensus 62 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 141 (262)
.+||+|||+++... .......||+.|+|||++.+..++. ++|||||||++|+|++|+.||...........+.....
T Consensus 180 ~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 256 (355)
T 2eu9_A 180 SIRVADFGSATFDH--EHHTTIVATRHYRPPEVILELGWAQ-PCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILG 256 (355)
T ss_dssp CEEECCCTTCEETT--SCCCSSCSCGGGCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cEEEeecCcccccc--ccccCCcCCCcccCCeeeecCCCCC-ccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence 89999999997532 2344568999999999998877754 48999999999999999999987665443332211110
Q ss_pred cc-----------------ccc---------------------CCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcc
Q 024809 142 SV-----------------HYS---------------------FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPW 183 (262)
Q Consensus 142 ~~-----------------~~~---------------------~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~ 183 (262)
.. ... .......+.++.+||.+||+.||.+|||+.++++|||
T Consensus 257 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~ 336 (355)
T 2eu9_A 257 PIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPF 336 (355)
T ss_dssp CCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGG
T ss_pred CCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 00 000 0011123457899999999999999999999999999
Q ss_pred cccc
Q 024809 184 FLRN 187 (262)
Q Consensus 184 ~~~~ 187 (262)
|...
T Consensus 337 f~~~ 340 (355)
T 2eu9_A 337 FAGL 340 (355)
T ss_dssp GGGC
T ss_pred hcCC
Confidence 9854
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=274.16 Aligned_cols=179 Identities=26% Similarity=0.448 Sum_probs=140.4
Q ss_pred CCCCCCCchHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe----cCCCCCcEEEeccCCCcC
Q 024809 1 MEYAAGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL----DGSTAPRVKICDFGYSKS 73 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~---l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili----~~~~~~~~kl~Dfg~a~~ 73 (262)
||||+||+|.+++..... +++..++.++.||+.||.|||++||+||||||+|||+ +.++ .+||+|||+++.
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~--~~kL~Dfg~a~~ 165 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS--VYKLTDFGAARE 165 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCE--EEEECCCTTCEE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCc--eEEEccCCCcee
Confidence 799999999999986543 9999999999999999999999999999999999998 4444 799999999986
Q ss_pred CCCCCCCCccccCCCCCCccccc--------CCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccc
Q 024809 74 SVLHSQPKSTVGTPAYIAPEVLT--------KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY 145 (262)
Q Consensus 74 ~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 145 (262)
...........||+.|+|||++. +..+ +.++|||||||++|+|++|+.||............+..+.....
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p 244 (319)
T 4euu_A 166 LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (319)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCB-CTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred cCCCCceeecccCCCccCHHHhhhccccccccCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence 65554455678999999999986 3444 44589999999999999999999765543332222222211110
Q ss_pred -------------------cCCCc----ccCCHHHHHHHHHhcccCCCCCCCHhHHhcCc
Q 024809 146 -------------------SFPDY----VRVSLECKHLLSRIFVANSEKRITIPEIKNHP 182 (262)
Q Consensus 146 -------------------~~~~~----~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp 182 (262)
.++.. ..++..+.+||.+||+.||.+|||+.|+|+||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 11111 13456789999999999999999999999986
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=274.05 Aligned_cols=175 Identities=21% Similarity=0.328 Sum_probs=138.7
Q ss_pred CCCCCCCchHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC
Q 024809 1 MEYAAGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~---l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~ 77 (262)
||||+||+|.+++..... .++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 140 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~DfG~a~~~~~~ 217 (332)
T 3qd2_B 140 MQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD--VVKVGDFGLVTAMDQD 217 (332)
T ss_dssp EECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEECSCC
T ss_pred EEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCC--CEEEeecCcccccccc
Confidence 799999999999987653 56677999999999999999999999999999999998777 8999999999765432
Q ss_pred C-------------CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccc
Q 024809 78 S-------------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH 144 (262)
Q Consensus 78 ~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 144 (262)
. ......||+.|+|||++.+..++ .++|||||||++|+|++|..|+.. ...........
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~~~~~~~------~~~~~~~~~~~- 289 (332)
T 3qd2_B 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYS-HKVDIFSLGLILFELLYSFSTQME------RVRIITDVRNL- 289 (332)
T ss_dssp --------------CCCSCC-CGGGSCHHHHHCCCCC-THHHHHHHHHHHHHHHSCCCCHHH------HHHHHHHHHTT-
T ss_pred hhhccccccccccccccccCCCcCccChHHhcCCCCc-chhhHHHHHHHHHHHHHcCCChhH------HHHHHHHhhcc-
Confidence 1 22345799999999999887775 448999999999999998766532 11111111111
Q ss_pred ccCC-CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 145 YSFP-DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 145 ~~~~-~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
.++ .....++++++||.+||+.||.+|||+.++++||||++
T Consensus 290 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 290 -KFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp -CCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred -CCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 111 12346788999999999999999999999999999964
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=276.92 Aligned_cols=181 Identities=27% Similarity=0.386 Sum_probs=138.5
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCC------------------
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSM-QICHRDLKLENTLLDGST------------------ 59 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~-~ivHrDlkp~Nili~~~~------------------ 59 (262)
|||+ +|+|.+.+... +.+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 124 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~ 202 (397)
T 1wak_A 124 FEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGA 202 (397)
T ss_dssp ECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC-------
T ss_pred Eecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCC
Confidence 7999 56777777654 4699999999999999999999998 999999999999997553
Q ss_pred -----------------------------CCcEEEeccCCCcCCCCCCCCCccccCCCCCCcccccCCcCCCCchhHHHH
Q 024809 60 -----------------------------APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSC 110 (262)
Q Consensus 60 -----------------------------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 110 (262)
...+||+|||+++.... ......||+.|+|||++.+..++. ++|||||
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~-~~Diwsl 279 (397)
T 1wak_A 203 PPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLIGSGYNT-PADIWST 279 (397)
T ss_dssp --------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHHHHHTSCCCT-HHHHHHH
T ss_pred CCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCChhhcCCCCCc-HHHHHHH
Confidence 12699999999975432 244568999999999998877754 5899999
Q ss_pred HHHHHHHHhCCCCCCCCCCh------hHHHHHhcccccc--------ccc----------------------------CC
Q 024809 111 GVTLYVMLVGAYPFEDPEDP------KNFRKTIGRILSV--------HYS----------------------------FP 148 (262)
Q Consensus 111 G~il~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~--------~~~----------------------------~~ 148 (262)
||++|+|++|+.||...... ..+..+....... .+. +.
T Consensus 280 G~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (397)
T 1wak_A 280 ACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYE 359 (397)
T ss_dssp HHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSC
T ss_pred HHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcc
Confidence 99999999999999865432 1111111110000 000 00
Q ss_pred CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccc
Q 024809 149 DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFL 185 (262)
Q Consensus 149 ~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~ 185 (262)
.....+.++++||.+||+.||.+|||+.|+|+||||+
T Consensus 360 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 360 WSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp CCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred cchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 0112456789999999999999999999999999996
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=265.20 Aligned_cols=181 Identities=28% Similarity=0.443 Sum_probs=148.4
Q ss_pred CCCCCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-C
Q 024809 1 MEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-S 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~-~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~ 78 (262)
|||++||+|.+++. ..+.+++..++.++.||+.||.|||++|++||||||+||+++.++ .+||+|||++...... .
T Consensus 103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEG--HAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCCTTCEECBTTBS
T ss_pred eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCC--CEEEeecccchhhhhhcc
Confidence 79999999999997 456799999999999999999999999999999999999998776 8999999999754332 2
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 158 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (262)
......||+.|+|||++.+..++.+ +||||||+++|+|++|+.||............... ....+.....++.++.
T Consensus 181 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~ 256 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQEIGYNCV-ADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN---PPPTFRKPELWSDNFT 256 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTT-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---CCCCCSSGGGSCHHHH
T ss_pred ccCccCCCCCccChhhcCCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC---CCcccCCcccCCHHHH
Confidence 2344679999999999988777655 89999999999999999999876544332222111 1112222335789999
Q ss_pred HHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 159 HLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 159 ~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
+||.+||..||.+|||+.++++||||...
T Consensus 257 ~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 257 DFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp HHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred HHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 99999999999999999999999999754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=268.51 Aligned_cols=180 Identities=26% Similarity=0.419 Sum_probs=140.1
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH- 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~- 77 (262)
|||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++......
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~~~ 183 (326)
T 2x7f_A 106 MEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA--EVKLVDFGVSAQLDRTV 183 (326)
T ss_dssp EECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC--CEEECCCTTTC------
T ss_pred EEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCC--CEEEeeCcCceecCcCc
Confidence 7999999999999864 4699999999999999999999999999999999999998776 8999999998754322
Q ss_pred CCCCccccCCCCCCccccc-----CCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCccc
Q 024809 78 SQPKSTVGTPAYIAPEVLT-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR 152 (262)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (262)
.......||+.|+|||++. ...+ +.++|||||||++|+|++|+.||............... .........
T Consensus 184 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~ 258 (326)
T 2x7f_A 184 GRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN----PAPRLKSKK 258 (326)
T ss_dssp -------CCGGGCCHHHHC--------C-CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS----CCCCCSCSC
T ss_pred cccccccCCccccChhhhccccccCcCC-CccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC----ccccCCccc
Confidence 2234567999999999986 3334 45589999999999999999999876544333222111 111112246
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 153 VSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 153 ~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
++..+++||.+||..||.+|||+.++++||||+..
T Consensus 259 ~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 259 WSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp SCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred cCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 78999999999999999999999999999999753
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=273.23 Aligned_cols=179 Identities=28% Similarity=0.479 Sum_probs=147.4
Q ss_pred CCCCCCCchHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCcEEEeccCCC
Q 024809 1 MEYAAGGELFER------ICN--AGRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSTAPRVKICDFGYS 71 (262)
Q Consensus 1 mE~~~gg~L~~~------i~~--~~~l~e~~~~~~~~ql~~aL~~LH~-~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a 71 (262)
|||++||+|.++ +.. .+.+++..++.++.||+.||.|||+ +||+||||||+||+++.++ .+||+|||++
T Consensus 122 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~--~~kl~dfg~~ 199 (348)
T 2pml_X 122 YEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNG--RVKLSDFGES 199 (348)
T ss_dssp EECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTS--CEEECCCTTC
T ss_pred EeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCC--cEEEeccccc
Confidence 799999999998 665 5679999999999999999999999 9999999999999998777 8999999999
Q ss_pred cCCCCCCCCCccccCCCCCCcccccCC-cCCCCchhHHHHHHHHHHHHhCCCCCCCCCC-hhHHHHHhcccccccccCCC
Q 024809 72 KSSVLHSQPKSTVGTPAYIAPEVLTKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPED-PKNFRKTIGRILSVHYSFPD 149 (262)
Q Consensus 72 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~ 149 (262)
...... ......||+.|+|||++.+. .+...++|||||||++|+|++|+.||..... ......+.. ....+|.
T Consensus 200 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~----~~~~~~~ 274 (348)
T 2pml_X 200 EYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRT----KNIEYPL 274 (348)
T ss_dssp EECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTS----CCCCCCC
T ss_pred cccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc----cCcCCcc
Confidence 754322 33456799999999999876 4544368999999999999999999988766 333333222 2222221
Q ss_pred c-----------------ccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 150 Y-----------------VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 150 ~-----------------~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
. ..+++++.+||.+||+.||.+|||+.++++||||..
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 328 (348)
T 2pml_X 275 DRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328 (348)
T ss_dssp SSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred chhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence 1 468899999999999999999999999999999974
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=274.74 Aligned_cols=183 Identities=26% Similarity=0.388 Sum_probs=139.6
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCC----CCcEEEeccCCCcC
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSM-QICHRDLKLENTLLDGST----APRVKICDFGYSKS 73 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~-~ivHrDlkp~Nili~~~~----~~~~kl~Dfg~a~~ 73 (262)
|||+ ||+|.+++... +.+++..++.++.||+.||.|||++ ||+||||||+|||++..+ ...+||+|||+++.
T Consensus 109 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~ 187 (373)
T 1q8y_A 109 FEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187 (373)
T ss_dssp ECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEE
T ss_pred EecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccc
Confidence 6899 89999999863 4599999999999999999999998 999999999999995322 22799999999975
Q ss_pred CCCCCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh------hHHHHHhccccc-----
Q 024809 74 SVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP------KNFRKTIGRILS----- 142 (262)
Q Consensus 74 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~~~~~~~~----- 142 (262)
... ......||+.|+|||++.+..++ .++|||||||++|+|++|+.||...... ..+..+......
T Consensus 188 ~~~--~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 264 (373)
T 1q8y_A 188 YDE--HYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYL 264 (373)
T ss_dssp TTB--CCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHH
T ss_pred cCC--CCCCCCCCccccCcHHHhCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHH
Confidence 432 33456899999999999887765 4589999999999999999999865421 111121111000
Q ss_pred ---------------------------------ccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCC
Q 024809 143 ---------------------------------VHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLP 189 (262)
Q Consensus 143 ---------------------------------~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 189 (262)
....++ ...+.++.+||.+||+.||.+|||+.++|+||||+....
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 342 (373)
T 1q8y_A 265 LRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFS--KDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLG 342 (373)
T ss_dssp HHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCC--HHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTT
T ss_pred HhccchhhhhcCCcchhcccccccccchhhhhhhcccCC--cchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcccC
Confidence 000111 135678999999999999999999999999999986543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=269.24 Aligned_cols=172 Identities=37% Similarity=0.599 Sum_probs=144.6
Q ss_pred CCCCCC-CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec-CCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD-GSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~g-g~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~-~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||+.+ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++ .+||+|||+++.... .
T Consensus 127 ~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~~kL~Dfg~~~~~~~-~ 203 (320)
T 3a99_A 127 LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG--ELKLIDFGSGALLKD-T 203 (320)
T ss_dssp EECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT--EEEECCCTTCEECCS-S
T ss_pred EEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCC--CEEEeeCcccccccc-c
Confidence 578876 89999999888999999999999999999999999999999999999997 445 899999999975432 2
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 158 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (262)
......||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.... . .. .....++ ..+++++.
T Consensus 204 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---~---~~----~~~~~~~--~~~~~~~~ 271 (320)
T 3a99_A 204 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---E---II----RGQVFFR--QRVSSECQ 271 (320)
T ss_dssp CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---H---HH----HCCCCCS--SCCCHHHH
T ss_pred cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh---h---hh----ccccccc--ccCCHHHH
Confidence 23446799999999999877766666899999999999999999997521 1 11 1111222 36889999
Q ss_pred HHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 159 HLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 159 ~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
+||.+||..||.+|||+.++++||||...
T Consensus 272 ~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 272 HLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 99999999999999999999999999754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=270.21 Aligned_cols=176 Identities=26% Similarity=0.356 Sum_probs=144.0
Q ss_pred CCCCCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~-~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
||||. |+|.+++. ..+.+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++... .
T Consensus 133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~DfG~a~~~~---~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG--LVKLGDFGSASIMA---P 206 (348)
T ss_dssp EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT--EEEECCCTTCBSSS---S
T ss_pred EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC--CEEEeeccCceecC---C
Confidence 79998 58888875 456799999999999999999999999999999999999998777 89999999997543 2
Q ss_pred CCccccCCCCCCccccc---CCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHH
Q 024809 80 PKSTVGTPAYIAPEVLT---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 156 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (262)
.....||+.|+|||++. ...++ .++|||||||++|+|++|+.||.+............. .........++..
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~-~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~ 281 (348)
T 1u5q_A 207 ANSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----ESPALQSGHWSEY 281 (348)
T ss_dssp BCCCCSCGGGCCHHHHHTTSSCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS----CCCCCCCTTSCHH
T ss_pred CCcccCCcceeCHhhhccccCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc----CCCCCCCCCCCHH
Confidence 34568999999999985 34444 4589999999999999999999876654444333222 1111122367899
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
+++||.+||+.||.+|||+.++++||||.+.
T Consensus 282 l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 282 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 9999999999999999999999999999754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=263.53 Aligned_cols=180 Identities=33% Similarity=0.582 Sum_probs=145.7
Q ss_pred CCCCCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
||||+|| |.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++.......
T Consensus 87 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~--~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 87 MEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGG--TLKISALGVAEALHPFA 163 (305)
T ss_dssp EECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCTTCEECCTTC
T ss_pred ehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCC--cEEeeccccccccCccc
Confidence 6999986 7777765 45699999999999999999999999999999999999998776 89999999997543221
Q ss_pred ---CCCccccCCCCCCcccccCCc-CCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCC
Q 024809 79 ---QPKSTVGTPAYIAPEVLTKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS 154 (262)
Q Consensus 79 ---~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (262)
......||+.|+|||++.+.. +.+.++||||||+++|+|++|+.||.+......... +......++. .++
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----i~~~~~~~~~--~~~ 237 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFEN----IGKGSYAIPG--DCG 237 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH----HHHCCCCCCS--SSC
T ss_pred cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH----HhcCCCCCCC--ccC
Confidence 123456999999999987643 234568999999999999999999987554333322 2223333443 688
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhcCccccccCC
Q 024809 155 LECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLP 189 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 189 (262)
+.+.+||.+||..||.+|||+.++++||||++..+
T Consensus 238 ~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 238 PPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 99999999999999999999999999999986544
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=263.68 Aligned_cols=178 Identities=29% Similarity=0.450 Sum_probs=146.7
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-C
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-Q 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (262)
|||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++....... .
T Consensus 99 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~ 175 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG--EVKLADFGVAGQLTDTQIK 175 (303)
T ss_dssp EECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECBTTBCC
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCC--CEEEeecccceecCccccc
Confidence 799999999999865 4799999999999999999999999999999999999998776 89999999997543322 2
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....||+.|+|||++.+..++. ++||||||+++|+|++|+.||............... .....+ ..++..+.+
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~--~~~~~~l~~ 249 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDS-KADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN---NPPTLE--GNYSKPLKE 249 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---CCCCCC--SSCCHHHHH
T ss_pred cCccCCCcCccCHHHHhcCCCCc-hhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC---CCCCCc--cccCHHHHH
Confidence 34567999999999998877764 489999999999999999999876543332222111 111122 368899999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
||.+||..||.+|||+.++++||||...
T Consensus 250 li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 250 FVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp HHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 9999999999999999999999999754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=265.73 Aligned_cols=184 Identities=27% Similarity=0.407 Sum_probs=143.4
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC---
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH--- 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~--- 77 (262)
|||++ |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++..+ +.+||+|||+++.....
T Consensus 101 ~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~kl~Dfg~~~~~~~~~~~ 177 (320)
T 2i6l_A 101 QEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED-LVLKIGDFGLARIMDPHYSH 177 (320)
T ss_dssp EECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-TEEEECCCTTCBCC------
T ss_pred eeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CeEEEccCccccccCCCccc
Confidence 68998 599999865 5799999999999999999999999999999999999996332 27999999999754321
Q ss_pred -CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccc--------------
Q 024809 78 -SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS-------------- 142 (262)
Q Consensus 78 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-------------- 142 (262)
.......+|+.|+|||.+.+....+.++|||||||++|+|++|+.||.+.........+......
T Consensus 178 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (320)
T 2i6l_A 178 KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIP 257 (320)
T ss_dssp --CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSC
T ss_pred ccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCc
Confidence 12334568999999999876444456699999999999999999999987655444433322100
Q ss_pred ----ccccCC------CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 143 ----VHYSFP------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 143 ----~~~~~~------~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
.....+ ....++.++++||.+||+.||.+|||+.++++||||+..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 258 VYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp HHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred ccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 000000 012578999999999999999999999999999999753
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=265.47 Aligned_cols=181 Identities=25% Similarity=0.411 Sum_probs=142.7
Q ss_pred CCCCCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC-CC
Q 024809 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~ 78 (262)
||||+||+|.+++.. .+.+++..++.++.||+.||.|||++|++||||||+||+++.++ .+||+|||++..... ..
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~ 172 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG--DIRLADFGVSAKNLKTLQ 172 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTS--CEEECCCHHHHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCC--CEEEEECCCCcccccccc
Confidence 699999999999875 45799999999999999999999999999999999999998776 899999998753211 11
Q ss_pred CCCccccCCCCCCccccc-----CCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccC
Q 024809 79 QPKSTVGTPAYIAPEVLT-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRV 153 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (262)
......||+.|+|||++. ...+ +.++||||||+++|+|++|+.||................ .........+
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 248 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD---PPTLLTPSKW 248 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTT-TTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC---CCCCSSGGGS
T ss_pred ccccccCChhhcCCeeeccccCCCCCC-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccC---CcccCCcccc
Confidence 223457999999999984 3344 455899999999999999999998766544433322211 1112223467
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 154 SLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 154 ~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
+.++.+||.+||..||.+|||+.++++||||...
T Consensus 249 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 249 SVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp CHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 8999999999999999999999999999999753
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=261.97 Aligned_cols=178 Identities=30% Similarity=0.466 Sum_probs=135.4
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC--
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-- 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-- 77 (262)
||||+||+|.+++...+ .+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++.....
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~--~~kl~dfg~~~~~~~~~~ 171 (303)
T 1zy4_A 94 MEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR--NVKIGDFGLAKNVHRSLD 171 (303)
T ss_dssp EECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECCCCCCSCTTC---
T ss_pred EecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCC--CEEEeeCcchhhcccccc
Confidence 69999999999998654 589999999999999999999999999999999999998776 8999999999754321
Q ss_pred -------------CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccc
Q 024809 78 -------------SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH 144 (262)
Q Consensus 78 -------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 144 (262)
.......||+.|+|||++.+....+.++|||||||++|+|++ ||......... ...+....
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~---~~~~~~~~ 245 (303)
T 1zy4_A 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI---LKKLRSVS 245 (303)
T ss_dssp ----------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH---HHHHHSTT
T ss_pred hhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH---HHhccccc
Confidence 122345799999999999866444566999999999999998 56532222222 22222222
Q ss_pred ccCCC--cccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 145 YSFPD--YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 145 ~~~~~--~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
..+|. ....+..++++|.+||..||.+|||+.++++||||..
T Consensus 246 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 246 IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 22222 2356778999999999999999999999999999964
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=266.79 Aligned_cols=179 Identities=25% Similarity=0.382 Sum_probs=123.6
Q ss_pred CCCCCCCchHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCCcEEEeccCCCcCC
Q 024809 1 MEYAAGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHSM-QICHRDLKLENTLLDGSTAPRVKICDFGYSKSS 74 (262)
Q Consensus 1 mE~~~gg~L~~~i~~-----~~~l~e~~~~~~~~ql~~aL~~LH~~-~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~ 74 (262)
|||++| +|.+++.. .+.+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .+||+|||+++..
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~--~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG--NIKLCDFGISGQL 176 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTT--EEEECCCSSSCC-
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCC--CEEEccCCCceec
Confidence 799986 88888763 56799999999999999999999999 999999999999998777 8999999999865
Q ss_pred CCCCCCCccccCCCCCCccccc----CCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc-c--ccC
Q 024809 75 VLHSQPKSTVGTPAYIAPEVLT----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-H--YSF 147 (262)
Q Consensus 75 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-~--~~~ 147 (262)
..........||+.|+|||++. +..+ +.++|||||||++|+|++|+.||........ ....+... . ...
T Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~ 252 (327)
T 3aln_A 177 VDSIAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVFD---QLTQVVKGDPPQLSN 252 (327)
T ss_dssp -----------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC----------CCCCCSCCCCCCC
T ss_pred ccccccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHHH---HHHHHhcCCCCCCCC
Confidence 4443344457999999999984 3444 4558999999999999999999986543211 11111111 1 111
Q ss_pred CCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 148 PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 148 ~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
.....+++++.+||.+||..||.+|||+.++++||||..
T Consensus 253 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 253 SEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred cccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 122458899999999999999999999999999999974
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=262.33 Aligned_cols=180 Identities=29% Similarity=0.406 Sum_probs=139.9
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
||||+||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++......
T Consensus 90 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNK--TLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCCSSSTTC------
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEEeCCCcccccccccc
Confidence 79999999999999888999999999999999999999999999999999999998777 89999999997653322
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 158 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (262)
......||+.|+|||.+.+..++. ++|||||||++|+|++|+.||.+........+.+...... ........+++.+.
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~ 245 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKGEATDE-CTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPN-VTTDVRKDIPQSLS 245 (294)
T ss_dssp -------CCSSCCHHHHHTCCCCT-THHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCC-HHHHSCTTSCHHHH
T ss_pred ccCccccCccccCHhHhcCCCCCc-hHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCC-cchhcccCCCHHHH
Confidence 223457999999999998877654 4899999999999999999998866544433333221111 00111236889999
Q ss_pred HHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 159 HLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 159 ~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
++|.+||+.||.+||+..+.+.+.|.
T Consensus 246 ~li~~~l~~dp~~R~~~~~~l~~~l~ 271 (294)
T 4eqm_A 246 NVILRATEKDKANRYKTIQEMKDDLS 271 (294)
T ss_dssp HHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred HHHHHHhcCCHhHccccHHHHHHHHH
Confidence 99999999999999966666655553
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=265.25 Aligned_cols=179 Identities=22% Similarity=0.353 Sum_probs=136.1
Q ss_pred CCCCCCCchHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCC
Q 024809 1 MEYAAGGELFERICNAG------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSS 74 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~------~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~ 74 (262)
|||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 110 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~--~~kl~Dfg~a~~~ 187 (323)
T 3qup_A 110 LPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM--TVCVADFGLSRKI 187 (323)
T ss_dssp EECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS--CEEECCCCC----
T ss_pred EEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC--CEEEeeccccccc
Confidence 68999999999996543 599999999999999999999999999999999999998776 8999999999754
Q ss_pred CCCCC---CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCc
Q 024809 75 VLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDY 150 (262)
Q Consensus 75 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (262)
..... .....+++.|+|||.+.+..++ .++|||||||++|+|++ |+.||.+.............. ..+..
T Consensus 188 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~ 261 (323)
T 3qup_A 188 YSGDYYRQGCASKLPVKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN-----RLKQP 261 (323)
T ss_dssp -------------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-----CCCCC
T ss_pred cccccccccccccCcccccCchhhcCCCCC-CccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC-----CCCCC
Confidence 33221 2234567889999999877665 45899999999999999 999999877655544433221 12222
Q ss_pred ccCCHHHHHHHHHhcccCCCCCCC-------HhHHhcCcccccc
Q 024809 151 VRVSLECKHLLSRIFVANSEKRIT-------IPEIKNHPWFLRN 187 (262)
Q Consensus 151 ~~~~~~~~~li~~~L~~dp~~R~s-------~~e~l~hp~~~~~ 187 (262)
..+++++.+||.+||..||.+||| +++++.|||+...
T Consensus 262 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 262 PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 368899999999999999999999 7788899999754
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=264.87 Aligned_cols=172 Identities=33% Similarity=0.579 Sum_probs=144.7
Q ss_pred CCC-CCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec-CCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEY-AAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD-GSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~-~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~-~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
||| +.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++ .++ .+||+|||+++.... .
T Consensus 117 ~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~kl~dfg~~~~~~~-~ 193 (312)
T 2iwi_A 117 LERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG--CAKLIDFGSGALLHD-E 193 (312)
T ss_dssp EECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTT--EEEECCCSSCEECCS-S
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCC--eEEEEEcchhhhccc-C
Confidence 467 78999999999888899999999999999999999999999999999999998 555 899999999875533 2
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 158 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (262)
......||+.|+|||++.+..+...++|||||||++|+|++|+.||.... . . ......++. .++.+++
T Consensus 194 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~---~----~~~~~~~~~--~~~~~~~ 261 (312)
T 2iwi_A 194 PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---E---I----LEAELHFPA--HVSPDCC 261 (312)
T ss_dssp CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---H---H----HHTCCCCCT--TSCHHHH
T ss_pred cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH---H---H----hhhccCCcc--cCCHHHH
Confidence 33456799999999999877766656899999999999999999997521 1 1 111223333 6889999
Q ss_pred HHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 159 HLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 159 ~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
+||.+||+.||.+|||+.++++||||+..
T Consensus 262 ~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 262 ALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred HHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 99999999999999999999999999753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=261.96 Aligned_cols=173 Identities=27% Similarity=0.447 Sum_probs=134.9
Q ss_pred CCCCCCCchHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecCCCCCcEEEeccCCCcCCC
Q 024809 1 MEYAAGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHSMQ--ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV 75 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~---l~e~~~~~~~~ql~~aL~~LH~~~--ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~ 75 (262)
||||+||+|.+++...+. +++..++.++.||+.||.|||++| |+||||||+||+++.++ .+||+|||+++...
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~--~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKY--TVKVCDFGLSRLKA 190 (309)
T ss_dssp EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTC--CEEECCCC------
T ss_pred EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCC--cEEECCCCCCcccc
Confidence 799999999999987654 999999999999999999999999 99999999999998776 89999999997543
Q ss_pred CCC-CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCC
Q 024809 76 LHS-QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS 154 (262)
Q Consensus 76 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (262)
... ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||............... ......|. .++
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~--~~~~~~~~--~~~ 265 (309)
T 3p86_A 191 STFLSSKSAAGTPEWMAPEVLRDEPSNEK-SDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK--CKRLEIPR--NLN 265 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTT-HHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHS--CCCCCCCT--TSC
T ss_pred ccccccccCCCCccccChhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--CCCCCCCc--cCC
Confidence 221 2345679999999999988777544 89999999999999999999876654433332111 11223333 689
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 155 LECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
+++.+||.+||..+|.+|||+.++++
T Consensus 266 ~~l~~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 266 PQVAAIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999999999999987
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=260.11 Aligned_cols=180 Identities=24% Similarity=0.382 Sum_probs=134.3
Q ss_pred CCCCCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSM-QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~aL~~LH~~-~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||+ |+.+..+... .+.+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++.......
T Consensus 103 ~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~--~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG--QIKLCDFGISGRLVDDK 179 (318)
T ss_dssp ECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTS--CEEECCCTTC-------
T ss_pred Eecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCC--CEEEEECCCchhccCCc
Confidence 6899 5566555543 46799999999999999999999995 999999999999998776 89999999997654444
Q ss_pred CCCccccCCCCCCcccccC----CcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhH-HHHHhcccccccccCCCcccC
Q 024809 79 QPKSTVGTPAYIAPEVLTK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKN-FRKTIGRILSVHYSFPDYVRV 153 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 153 (262)
......||+.|+|||++.. ....+.++|||||||++|+|++|+.||........ +..... ......+....+
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 256 (318)
T 2dyl_A 180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ---EEPPLLPGHMGF 256 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHH---SCCCCCCSSSCC
T ss_pred cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhc---cCCCCCCccCCC
Confidence 4445679999999999852 22234558999999999999999999987544332 222221 122234444568
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 154 SLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 154 ~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
++++.+||.+||..||.+|||+.++++||||++
T Consensus 257 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 257 SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 999999999999999999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=260.34 Aligned_cols=179 Identities=26% Similarity=0.422 Sum_probs=138.2
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
|| +.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++. + .+||+|||+++......
T Consensus 107 ~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~--~~kL~Dfg~~~~~~~~~~~ 182 (313)
T 3cek_A 107 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G--MLKLIDFGIANQMQPDTTS 182 (313)
T ss_dssp EC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T--EEEECCCSSSCC-------
T ss_pred Ee-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-C--eEEEeeccccccccCcccc
Confidence 57 567899999999889999999999999999999999999999999999999964 3 79999999997653322
Q ss_pred -CCCccccCCCCCCcccccCC----------cCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhH-HHHHhccccccccc
Q 024809 79 -QPKSTVGTPAYIAPEVLTKK----------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKN-FRKTIGRILSVHYS 146 (262)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~ 146 (262)
......||+.|+|||++.+. ...+.++|||||||++|+|++|+.||........ +...... .....
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~--~~~~~ 260 (313)
T 3cek_A 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP--NHEIE 260 (313)
T ss_dssp -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT--TSCCC
T ss_pred ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhc--ccccC
Confidence 12345799999999998652 2334558999999999999999999987554322 2221111 11122
Q ss_pred CCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 147 FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 147 ~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
++. ..+.++.+||.+||..||.+|||+.++++||||+..
T Consensus 261 ~~~--~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 261 FPD--IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp CCC--CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred Ccc--cchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 333 467899999999999999999999999999999754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=267.03 Aligned_cols=173 Identities=24% Similarity=0.352 Sum_probs=141.2
Q ss_pred CCCCCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEE
Q 024809 1 MEYAAGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVK 64 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~k 64 (262)
||||+||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~--~~k 243 (370)
T 2psq_A 166 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN--VMK 243 (370)
T ss_dssp EECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEE
T ss_pred EEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCC--CEE
Confidence 79999999999998653 489999999999999999999999999999999999998777 899
Q ss_pred EeccCCCcCCCCCC---CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhccc
Q 024809 65 ICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRI 140 (262)
Q Consensus 65 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~ 140 (262)
|+|||+++...... ......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+....+.+.......
T Consensus 244 l~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 322 (370)
T 2psq_A 244 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH 322 (370)
T ss_dssp ECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC
T ss_pred EccccCCcccCcccceecccCCCcccceECHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 99999997543322 22334678899999999877765 45899999999999999 999998866544333322211
Q ss_pred ccccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 141 LSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
....| ..++.++.++|.+||..+|.+|||+.+++++
T Consensus 323 ---~~~~~--~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 323 ---RMDKP--ANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp ---CCCCC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CCCCC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11222 3688999999999999999999999999874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=259.09 Aligned_cols=182 Identities=31% Similarity=0.483 Sum_probs=142.8
Q ss_pred CCCCCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-CCCCcEEEeccCCCcCCCC
Q 024809 1 MEYAAGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG-STAPRVKICDFGYSKSSVL 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~---~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~-~~~~~~kl~Dfg~a~~~~~ 76 (262)
|||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++. ++ .+||+|||+++....
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSG--VLKISDFGTSKRLAG 175 (295)
T ss_dssp EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTC--CEEECCTTTCEESCC
T ss_pred EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCC--CEEEeecccccccCC
Confidence 69999999999998652 4679999999999999999999999999999999999976 44 899999999975432
Q ss_pred C-CCCCccccCCCCCCcccccCCc-CCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCC
Q 024809 77 H-SQPKSTVGTPAYIAPEVLTKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS 154 (262)
Q Consensus 77 ~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (262)
. .......||+.|+|||++.+.. ..+.++||||||+++|+|++|+.||............. .........+ ..++
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~--~~~~ 252 (295)
T 2clq_A 176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV-GMFKVHPEIP--ESMS 252 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH-HHHCCCCCCC--TTSC
T ss_pred CCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh-cccccccccc--ccCC
Confidence 2 2234567999999999987543 23455899999999999999999997654433211111 0111112223 3688
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 155 LECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
+++.+||.+||+.||.+|||+.++++||||+..
T Consensus 253 ~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 253 AEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp HHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 999999999999999999999999999999743
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=261.16 Aligned_cols=179 Identities=30% Similarity=0.497 Sum_probs=143.6
Q ss_pred CCCCCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHcC-----CeecCCCCCcEEecCCCCCcEEEeccCCC
Q 024809 1 MEYAAGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQ-----ICHRDLKLENTLLDGSTAPRVKICDFGYS 71 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~----~~l~e~~~~~~~~ql~~aL~~LH~~~-----ivHrDlkp~Nili~~~~~~~~kl~Dfg~a 71 (262)
|||++||+|.+++... ..+++..++.++.|++.||.|||++| |+||||||+||+++.++ .+||+|||++
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~--~~kl~dfg~~ 163 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLA 163 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSS--CEEECCCCHH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCC--CEEEecCchh
Confidence 7999999999999753 34999999999999999999999999 99999999999998776 8999999998
Q ss_pred cCCCCCCC-CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccc-cCCC
Q 024809 72 KSSVLHSQ-PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY-SFPD 149 (262)
Q Consensus 72 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~ 149 (262)
+....... .....||+.|+|||++.+..++ .++||||||+++|+|++|+.||...........+. .... ..+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~----~~~~~~~~~ 238 (279)
T 2w5a_A 164 RILNHDTSFAKTFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR----EGKFRRIPY 238 (279)
T ss_dssp HHC---CHHHHHHHSCCTTCCHHHHHCC-CC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----HTCCCCCCT
T ss_pred eeeccccccccccCCCccccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHh----hcccccCCc
Confidence 75432211 1235799999999999877665 45899999999999999999998765433322221 1111 2222
Q ss_pred cccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 024809 150 YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL 188 (262)
Q Consensus 150 ~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 188 (262)
.++.++.++|.+||..||.+|||+.++++|+|+....
T Consensus 239 --~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 239 --RYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp --TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred --ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 6889999999999999999999999999999997643
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=267.56 Aligned_cols=156 Identities=24% Similarity=0.398 Sum_probs=127.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC---CCCccccCCCCCCcccc
Q 024809 19 FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVL 95 (262)
Q Consensus 19 l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~ 95 (262)
+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...... ......||+.|+|||++
T Consensus 190 l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~ 267 (359)
T 3vhe_A 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN--VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 267 (359)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC--cEEEEeccceeeecccccchhccccCCCceeEChhhh
Confidence 89999999999999999999999999999999999998776 89999999997543322 12345688999999999
Q ss_pred cCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHHHHHhcccCCCCCCC
Q 024809 96 TKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRIT 174 (262)
Q Consensus 96 ~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s 174 (262)
.+..++ .++|||||||++|+|++ |+.||.+..........+.... ....+ ..+++++.++|.+||+.||.+|||
T Consensus 268 ~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--~~~~~--~~~~~~l~~li~~~l~~dP~~Rps 342 (359)
T 3vhe_A 268 FDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT--RMRAP--DYTTPEMYQTMLDCWHGEPSQRPT 342 (359)
T ss_dssp HHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTC--CCCCC--TTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred cCCCCC-chhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCC--CCCCC--CCCCHHHHHHHHHHccCChhhCCC
Confidence 877765 45899999999999998 9999988765554443332211 12223 358899999999999999999999
Q ss_pred HhHHhcC
Q 024809 175 IPEIKNH 181 (262)
Q Consensus 175 ~~e~l~h 181 (262)
+.++++|
T Consensus 343 ~~ell~~ 349 (359)
T 3vhe_A 343 FSELVEH 349 (359)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=272.40 Aligned_cols=182 Identities=26% Similarity=0.418 Sum_probs=134.7
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC---CCCCcEEEeccCCCcCCCC
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG---STAPRVKICDFGYSKSSVL 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~---~~~~~~kl~Dfg~a~~~~~ 76 (262)
||||. |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++...+||+|||+++....
T Consensus 97 ~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp EECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred EECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 78997 59999998664 4667778899999999999999999999999999999953 2333688999999976543
Q ss_pred C----CCCCccccCCCCCCcccccCC--cCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCC
Q 024809 77 H----SQPKSTVGTPAYIAPEVLTKK--EYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPD 149 (262)
Q Consensus 77 ~----~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (262)
. .......||+.|+|||++.+. ...+.++|||||||++|+|++ |..||....... ........ ... ....
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-~~~~~~~~-~~~-~~~~ 252 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-ANILLGAC-SLD-CLHP 252 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-HHHHTTCC-CCT-TSCT
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-HHHHhccC-Ccc-ccCc
Confidence 2 123346799999999999742 223445899999999999999 999997644322 22221111 111 1111
Q ss_pred cccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 150 YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 150 ~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
....+..+++||.+||+.||.+|||+.++++||||..
T Consensus 253 ~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 253 EKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred cccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 1235567899999999999999999999999999963
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=257.21 Aligned_cols=177 Identities=19% Similarity=0.228 Sum_probs=138.5
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC---CcEEEeccCCCcCCCC
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA---PRVKICDFGYSKSSVL 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~---~~~kl~Dfg~a~~~~~ 76 (262)
|||+ ||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||+++.++. ..+||+|||+++....
T Consensus 85 ~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~ 163 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163 (298)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred EEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence 6899 999999998754 5999999999999999999999999999999999999976541 2499999999975443
Q ss_pred CC--------CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCC
Q 024809 77 HS--------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP 148 (262)
Q Consensus 77 ~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 148 (262)
.. ......||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+......... ...+.......+
T Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~ 241 (298)
T 1csn_A 164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK-YERIGEKKQSTP 241 (298)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH-HHHHHHHHHHSC
T ss_pred ccccccccccCccCCCCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHHcCCCCcchhhccccHHH-HHHHHhhccCcc
Confidence 21 12446799999999999877764 558999999999999999999987543222111 111111111111
Q ss_pred ---CcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 149 ---DYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 149 ---~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
....+++++.+++.+||..||.+|||+.++++
T Consensus 242 ~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 242 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 11258899999999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=257.12 Aligned_cols=177 Identities=24% Similarity=0.406 Sum_probs=133.0
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC--
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-- 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-- 77 (262)
||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++.....
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 98 TQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN--TVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp EECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT--EEEECCCC----------
T ss_pred EEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC--CEEEccceeccccccccc
Confidence 6999999999999643 4699999999999999999999999999999999999998777 8999999999754321
Q ss_pred -CCCCccccCCCCCCccccc---CCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccC
Q 024809 78 -SQPKSTVGTPAYIAPEVLT---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRV 153 (262)
Q Consensus 78 -~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (262)
.......||+.|+|||++. ...+ +.++||||||+++|+|++|+.||............................+
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNC 254 (289)
T ss_dssp --------CCCTTCCHHHHC----CCS-CHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTS
T ss_pred cccccccCCCccccCchhhcccCCCCC-CcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccC
Confidence 1223457999999999986 3333 4458999999999999999999988776655544433221111111112367
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 154 SLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 154 ~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
++++++||.+||..+|.+|||+.++++
T Consensus 255 ~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 255 PKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 899999999999999999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=267.21 Aligned_cols=177 Identities=16% Similarity=0.234 Sum_probs=138.5
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||| ||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+..+.+||+|||+++.......
T Consensus 131 ~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~ 209 (364)
T 3op5_A 131 MDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGV 209 (364)
T ss_dssp EECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGC
T ss_pred EeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCc
Confidence 7999 99999999876 579999999999999999999999999999999999999833344899999999975432211
Q ss_pred --------CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc------cc
Q 024809 80 --------PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV------HY 145 (262)
Q Consensus 80 --------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------~~ 145 (262)
.....||+.|+|||++.+..++ .++|||||||++|+|+||+.||.+................. ..
T Consensus 210 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (364)
T 3op5_A 210 HKAYAADPKRCHDGTIEFTSIDAHNGVAPS-RRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDK 288 (364)
T ss_dssp CCCSSCCSSCCCCCCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHH
T ss_pred ccccccCcccccCCCCCccCHHHhCCCCCC-chhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHH
Confidence 1334599999999999887765 55899999999999999999998643332222111110000 00
Q ss_pred cCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 146 SFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 146 ~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
.++ ...++.++.+++.+||..+|.+||++.++++
T Consensus 289 ~~~-~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 289 CFP-AANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HSC-TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred hcc-cccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 111 1357899999999999999999999999886
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=265.53 Aligned_cols=173 Identities=24% Similarity=0.359 Sum_probs=142.0
Q ss_pred CCCCCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEE
Q 024809 1 MEYAAGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVK 64 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~k 64 (262)
||||+||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~k 231 (382)
T 3tt0_A 154 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN--VMK 231 (382)
T ss_dssp EECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEE
T ss_pred EEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCC--cEE
Confidence 79999999999998754 499999999999999999999999999999999999998776 899
Q ss_pred EeccCCCcCCCCCC---CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhccc
Q 024809 65 ICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRI 140 (262)
Q Consensus 65 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~ 140 (262)
|+|||+++...... ......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+....+.........
T Consensus 232 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 310 (382)
T 3tt0_A 232 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 310 (382)
T ss_dssp ECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred EcccCcccccccccccccccCCCCCcceeCHHHhcCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999998654322 22345678899999999877765 45899999999999999 999998765443333222211
Q ss_pred ccccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 141 LSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
....+ ..+++++.+||.+||+.||.+|||+.+++++
T Consensus 311 ---~~~~~--~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 311 ---RMDKP--SNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp ---CCCCC--SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CCCCC--ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11222 3688999999999999999999999999985
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=265.07 Aligned_cols=178 Identities=15% Similarity=0.226 Sum_probs=141.8
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||| ||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++...+||+|||+++......
T Consensus 137 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 215 (352)
T 2jii_A 137 LPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215 (352)
T ss_dssp EECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGG
T ss_pred ecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCC
Confidence 7999 99999999876 68999999999999999999999999999999999999986653479999999997543221
Q ss_pred --------CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCC-ChhHHHHHhccccccccc---
Q 024809 79 --------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE-DPKNFRKTIGRILSVHYS--- 146 (262)
Q Consensus 79 --------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~~~~~~~~~~~~--- 146 (262)
......||+.|+|||++.+..++ .++|||||||++|+|++|+.||.... ..................
T Consensus 216 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (352)
T 2jii_A 216 KHVAYVEGSRSPHEGDLEFISMDLHKGCGPS-RRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVG 294 (352)
T ss_dssp CCCCCCTTSSCTTCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEEC
T ss_pred ccccccccccccccCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhh
Confidence 11335799999999999877664 45899999999999999999998764 333333322222111111
Q ss_pred -CCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 147 -FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 147 -~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
...+..+++++.+||.+||..||.+|||+.++++
T Consensus 295 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 295 PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 1222357899999999999999999999999987
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=261.76 Aligned_cols=173 Identities=24% Similarity=0.362 Sum_probs=140.8
Q ss_pred CCCCCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEE
Q 024809 1 MEYAAGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVK 64 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~k 64 (262)
|||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||+++.++ .+|
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~--~~k 182 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY--VAK 182 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG--CEE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC--eEE
Confidence 79999999999998654 699999999999999999999999999999999999998776 899
Q ss_pred EeccCCCcCCCCCCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccc
Q 024809 65 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSV 143 (262)
Q Consensus 65 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 143 (262)
|+|||+++............+++.|+|||++.+..++ .++|||||||++|+|++ |+.||.+.............
T Consensus 183 L~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~---- 257 (327)
T 1fvr_A 183 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---- 257 (327)
T ss_dssp ECCTTCEESSCEECCC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT----
T ss_pred EcccCcCccccccccccCCCCCccccChhhhccccCC-chhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC----
Confidence 9999999754433334455678899999999776665 45899999999999998 99999876554433332211
Q ss_pred cccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 144 HYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 144 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
...+....+++++.+||.+||..+|.+|||+.+++++
T Consensus 258 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 258 -YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp -CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1122223688999999999999999999999999985
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=261.95 Aligned_cols=173 Identities=20% Similarity=0.340 Sum_probs=139.9
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||+.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~--~~kl~Dfg~a~~~~~~~~ 170 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPS--QVQVADFGVADLLPPDDK 170 (325)
T ss_dssp EECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSS--CEEECSCSGGGGSCCCTT
T ss_pred EEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCC--eEEECCCCcccccCcccc
Confidence 6899999999999875 5799999999999999999999999999999999999998776 899999999986543222
Q ss_pred ---CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 80 ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 80 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
.....||+.|+|||++.+..++ .++|||||||++|+|++ |+.||.+............. .....+. .++.
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~--~~~~ 244 (325)
T 3kex_A 171 QLLYSEAKTPIKWMALESIHFGKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG---ERLAQPQ--ICTI 244 (325)
T ss_dssp CCC-----CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT---CBCCCCT--TBCT
T ss_pred cccccCCCCcccccChHHhccCCCC-hhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC---CCCCCCC--cCcH
Confidence 2345678899999999877765 45899999999999999 99999886654433322211 1122222 5788
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
++.++|.+||..||.+|||+.++++|
T Consensus 245 ~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 245 DVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp TTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 89999999999999999999999986
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=269.13 Aligned_cols=180 Identities=17% Similarity=0.272 Sum_probs=145.1
Q ss_pred CCCCCCCchHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCcEEEeccCCCc
Q 024809 1 MEYAAGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-APRVKICDFGYSK 72 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-------~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~-~~~~kl~Dfg~a~ 72 (262)
||||+||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+||+|||+++
T Consensus 153 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~ 232 (367)
T 3l9p_A 153 LELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232 (367)
T ss_dssp EECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHH
T ss_pred EEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCcccc
Confidence 79999999999998643 599999999999999999999999999999999999998544 2259999999987
Q ss_pred CCC---CCCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCC
Q 024809 73 SSV---LHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFP 148 (262)
Q Consensus 73 ~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 148 (262)
... .........||+.|+|||++.+..++ .++|||||||++|+|++ |..||................ ....
T Consensus 233 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~---~~~~- 307 (367)
T 3l9p_A 233 DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG---RMDP- 307 (367)
T ss_dssp HHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC---CCCC-
T ss_pred ccccccccccCCCcCCcccEECHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---CCCC-
Confidence 432 12233456789999999999877765 45899999999999998 999998866544433322211 1122
Q ss_pred CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 149 DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 149 ~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
...++..+.+||.+||+.||.+|||+.++++|.++..
T Consensus 308 -~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 308 -PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 2368899999999999999999999999999987653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=267.68 Aligned_cols=178 Identities=19% Similarity=0.238 Sum_probs=140.0
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC-
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ- 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~- 79 (262)
|||| ||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+.+||+|||+++.......
T Consensus 131 ~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~ 209 (345)
T 2v62_A 131 MERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209 (345)
T ss_dssp EECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCC
T ss_pred Eecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceeccccccc
Confidence 7999 99999999888789999999999999999999999999999999999999876655899999999975432111
Q ss_pred -------CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCC-ChhHHHHHhcccccccc----cC
Q 024809 80 -------PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE-DPKNFRKTIGRILSVHY----SF 147 (262)
Q Consensus 80 -------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~~~~~~~~~~~----~~ 147 (262)
.....||+.|+|||++.+..++ .++|||||||++|+|++|+.||.... ................. ..
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (345)
T 2v62_A 210 KQYQENPRKGHNGTIEFTSLDAHKGVALS-RRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKW 288 (345)
T ss_dssp CCCCCCGGGCSCSCTTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHH
T ss_pred ccchhccccccCCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhh
Confidence 1345799999999999877665 55899999999999999999996532 22222221111111000 00
Q ss_pred CCcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 148 PDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 148 ~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
.....++.+++++|.+||..||.+|||+.++++
T Consensus 289 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 289 APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 011268899999999999999999999999987
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=252.51 Aligned_cols=176 Identities=23% Similarity=0.369 Sum_probs=137.7
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecCCCC---CcEEEeccCCCcCC
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQ--ICHRDLKLENTLLDGSTA---PRVKICDFGYSKSS 74 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~--ivHrDlkp~Nili~~~~~---~~~kl~Dfg~a~~~ 74 (262)
|||++||+|.+++.... .+++..++.++.|++.||.|||++| |+||||||+||+++.++. ..+||+|||+++..
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~ 179 (287)
T 4f0f_A 100 MEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS 179 (287)
T ss_dssp EECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCC
T ss_pred EEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccccc
Confidence 79999999999887554 6999999999999999999999999 999999999999976551 13999999999743
Q ss_pred CCCCCCCccccCCCCCCcccccCC-cCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccC
Q 024809 75 VLHSQPKSTVGTPAYIAPEVLTKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRV 153 (262)
Q Consensus 75 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (262)
. .......||+.|+|||++... ...+.++|||||||++|+|++|+.||.......................+ ..+
T Consensus 180 ~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 255 (287)
T 4f0f_A 180 V--HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP--EDC 255 (287)
T ss_dssp S--SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCC--TTS
T ss_pred c--ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCC--ccc
Confidence 3 233456799999999998432 22345589999999999999999999876543321111111111112223 368
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 154 SLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 154 ~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
++++.++|.+||+.||.+|||+.++++
T Consensus 256 ~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 256 PPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 899999999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=271.16 Aligned_cols=183 Identities=28% Similarity=0.387 Sum_probs=131.5
Q ss_pred CCCCCCCchHHHHHhCCCC-------CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-----------CCCc
Q 024809 1 MEYAAGGELFERICNAGRF-------SEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS-----------TAPR 62 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l-------~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~-----------~~~~ 62 (262)
||||. |+|.+++...+.. ++..++.++.||+.||.|||++||+||||||+|||++.. ....
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 79996 5999999876533 233467899999999999999999999999999999653 2347
Q ss_pred EEEeccCCCcCCCCCC-----CCCccccCCCCCCcccccC------CcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCh
Q 024809 63 VKICDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLTK------KEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDP 130 (262)
Q Consensus 63 ~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~ 130 (262)
+||+|||+++...... ......||+.|+|||++.+ ....+.++|||||||++|+|++ |+.||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 9999999998654322 1234579999999999865 1233556999999999999999 99999765433
Q ss_pred hHHHHHhcccccc-cccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 131 KNFRKTIGRILSV-HYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 131 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
. ..+....... .........+++++++||.+||+.||.+|||+.++++||||..
T Consensus 247 ~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 247 E--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp H--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred H--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 2 1111111110 1111112245688999999999999999999999999999953
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=277.75 Aligned_cols=224 Identities=25% Similarity=0.322 Sum_probs=162.2
Q ss_pred CCCCCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC-CcEEEeccCCCcCCCC
Q 024809 1 MEYAAGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA-PRVKICDFGYSKSSVL 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~---~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~-~~~kl~Dfg~a~~~~~ 76 (262)
||||+||+|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++. ..+||+|||++.....
T Consensus 97 mEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~ 176 (676)
T 3qa8_A 97 MEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 176 (676)
T ss_dssp EECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTS
T ss_pred EEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccccccc
Confidence 79999999999998754 5999999999999999999999999999999999999986552 2489999999987655
Q ss_pred CCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHh----------ccccccccc
Q 024809 77 HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTI----------GRILSVHYS 146 (262)
Q Consensus 77 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~----------~~~~~~~~~ 146 (262)
........||+.|+|||++.+..++.. +|||||||++|+|++|..||.+......+.... .........
T Consensus 177 ~~~~~~~~gt~~Y~APE~l~~~~~s~k-sDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~ 255 (676)
T 3qa8_A 177 GELCTEFVGTLQYLAPELLEQKKYTVT-VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVK 255 (676)
T ss_dssp CCCCCCCCSCCTTCSSCSSCCSCCSTT-HHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCC
T ss_pred ccccccccCCcccCChHHhccCCCCch-hHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccc
Confidence 555566789999999999987777654 899999999999999999997643322211100 000111111
Q ss_pred CCC--------cccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCCc---c---ccCCC-CccccCCCCCCCCHH
Q 024809 147 FPD--------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPI---E---LTEGG-SWQSHDVNNPSQSLE 211 (262)
Q Consensus 147 ~~~--------~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~---~---~~~~~-~~~~~~~~~~~~~~~ 211 (262)
++. ...+++.+.+||.+||..||.+|||+.++++||||...... . ..... .........+..++.
T Consensus 256 ~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~kil~~f~~~~~~~~~~~i~~~~tl~ 335 (676)
T 3qa8_A 256 FSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLKLLSVMNMVSGRVHTYPVTENENLQ 335 (676)
T ss_dssp CCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCCEEECCCSSSSCCCEEECCTTCCHH
T ss_pred cccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhccccccccccccccceeecCCCccHH
Confidence 111 12366789999999999999999999999999999642110 0 00000 111111234667889
Q ss_pred HHHHHhHHhcCCCC
Q 024809 212 EVLSLIHEATKPLE 225 (262)
Q Consensus 212 ~~~~~~~~~~~~~~ 225 (262)
++..++.+.+.-.+
T Consensus 336 ~l~~~i~~~T~i~~ 349 (676)
T 3qa8_A 336 NLKSWLQQDTGIPE 349 (676)
T ss_dssp HHHHHHHTTSCCCS
T ss_pred HHHHHHHHHhCCCH
Confidence 99999988875433
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=258.76 Aligned_cols=173 Identities=25% Similarity=0.372 Sum_probs=137.2
Q ss_pred CCCCCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
||||+||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++.......
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENK--NVVVADFGLARLMVDEKT 163 (310)
T ss_dssp EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTS--CEEECCCTTCEECC----
T ss_pred EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCC--CEEEeecccceecccccc
Confidence 799999999999987 56799999999999999999999999999999999999998776 899999999975432211
Q ss_pred C---------------CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHH-HHHhcccccc
Q 024809 80 P---------------KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNF-RKTIGRILSV 143 (262)
Q Consensus 80 ~---------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~ 143 (262)
. ....||+.|+|||++.+..++. ++|||||||++|+|++|..||......... ....... .
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~--~ 240 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDE-KVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF--L 240 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH--H
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCc-HHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc--c
Confidence 1 1457999999999998877754 489999999999999999998764321110 0000000 0
Q ss_pred cccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 144 HYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 144 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
....+ ..+++.+.++|.+||..||.+|||+.++++
T Consensus 241 ~~~~~--~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 241 DRYCP--PNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHTCC--TTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccCC--CCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 01112 257889999999999999999999999987
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=255.13 Aligned_cols=172 Identities=23% Similarity=0.283 Sum_probs=137.7
Q ss_pred CCCCCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec---CCCCCcEEEeccCCCcCCCC
Q 024809 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD---GSTAPRVKICDFGYSKSSVL 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~---~~~~~~~kl~Dfg~a~~~~~ 76 (262)
|||+ ||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++ .++ .+||+|||+++....
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~--~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN--LVYIIDFGLAKKYRD 160 (296)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTT--CEEECCCTTCEECBC
T ss_pred EEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCC--eEEEeeCCCcccccc
Confidence 6999 8999999974 45799999999999999999999999999999999999994 444 899999999975443
Q ss_pred CCC--------CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh---hHHHHHhcccccccc
Q 024809 77 HSQ--------PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP---KNFRKTIGRILSVHY 145 (262)
Q Consensus 77 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~~~~~~~~~~~ 145 (262)
... .....||+.|+|||++.+..++ .++|||||||++|+|++|+.||...... ..+...... ..
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----~~ 235 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK----KM 235 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH----HH
T ss_pred cccccccccccccccccccccCChhhhcCCCCC-cchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc----cc
Confidence 221 2456799999999999887765 5589999999999999999999874332 222222111 11
Q ss_pred cCC---CcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 146 SFP---DYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 146 ~~~---~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
..+ ....+++++.+||.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred CCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 111 11357899999999999999999999999886
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=260.25 Aligned_cols=176 Identities=24% Similarity=0.345 Sum_probs=135.0
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------HcCCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH--------SMQICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH--------~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
|||++||+|.+++.. +.+++..++.++.|++.||.||| ++||+||||||+|||++.++ .+||+|||+++
T Consensus 85 ~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~--~~kl~Dfg~a~ 161 (301)
T 3q4u_A 85 THYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG--QCCIADLGLAV 161 (301)
T ss_dssp ECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS--CEEECCCTTCE
T ss_pred hhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC--CEEEeeCCCee
Confidence 799999999999955 47999999999999999999999 99999999999999998777 89999999986
Q ss_pred CCCCCCC-----CCccccCCCCCCcccccCCcCC-----CCchhHHHHHHHHHHHHhC----------CCCCCCCCCh--
Q 024809 73 SSVLHSQ-----PKSTVGTPAYIAPEVLTKKEYD-----GKIADVWSCGVTLYVMLVG----------AYPFEDPEDP-- 130 (262)
Q Consensus 73 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~-----~~~~DiwslG~il~~ll~g----------~~pf~~~~~~-- 130 (262)
....... .....||+.|+|||++.+.... +.++|||||||++|+|++| +.||......
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~ 241 (301)
T 3q4u_A 162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 241 (301)
T ss_dssp EEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred ecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCc
Confidence 4432221 2335799999999999776322 1458999999999999999 8888653321
Q ss_pred --hHHHHHhcccccccccCCC---cccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 131 --KNFRKTIGRILSVHYSFPD---YVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 131 --~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
......... .......+. ....++++.+||.+||+.||.+|||+.++++
T Consensus 242 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 242 SFEDMRKVVCV-DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp CHHHHHHHHTT-SCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred chhhhhHHHhc-cCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 122221111 111111221 1135578999999999999999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=255.52 Aligned_cols=173 Identities=21% Similarity=0.347 Sum_probs=132.6
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||++||+|.+++...+ .+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++.......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~ 171 (281)
T 1mp8_A 94 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND--CVKLGDFGLSRYMEDSTY 171 (281)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECC------------
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCC--CEEECccccccccCcccc
Confidence 79999999999998654 699999999999999999999999999999999999998776 899999999976533221
Q ss_pred --CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCHH
Q 024809 80 --PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 156 (262)
Q Consensus 80 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (262)
.....+|+.|+|||++....++ .++|||||||++|+|++ |..||.+....+....+... . ..+....++++
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~---~--~~~~~~~~~~~ 245 (281)
T 1mp8_A 172 YKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG---E--RLPMPPNCPPT 245 (281)
T ss_dssp -------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT---C--CCCCCTTCCHH
T ss_pred cccccCCCcccccChhhcccCCCC-CccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC---C--CCCCCCCCCHH
Confidence 2234567889999999876665 45899999999999996 99999887655444333221 1 11222368999
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
+.++|.+||..||.+|||+.+++++
T Consensus 246 l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 246 LYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=252.82 Aligned_cols=173 Identities=23% Similarity=0.349 Sum_probs=141.1
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (262)
|||++||+|.+++...+ .+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDL--CVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTC--CEEECCTTCEEECCTTCE
T ss_pred EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCC--CEEEccCccceecchhhh
Confidence 79999999999998754 599999999999999999999999999999999999998777 89999999997543221
Q ss_pred -CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCHH
Q 024809 79 -QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 156 (262)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (262)
......+|+.|+|||++.+..++.+ +||||||+++|+|++ |+.||................ ....+ ...+++
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~--~~~~~~ 233 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSK-SDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH---RLYRP--HLASDT 233 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETT-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC---CCCCC--TTSCHH
T ss_pred hcccCCCcCcccCCHHHHhccCCchh-hhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC---CCCCC--CcChHH
Confidence 1123446678999999987776555 899999999999999 999998766554443332211 11122 257889
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
+.++|.+||..+|.+|||+.+++++
T Consensus 234 l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 234 IYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=259.69 Aligned_cols=172 Identities=22% Similarity=0.366 Sum_probs=139.5
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~ 206 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL--VCKVSDFGLSRVLEDDPD 206 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCSSCEECC----
T ss_pred eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCC--CEEECCCCcccccccCcc
Confidence 7999999999999755 5799999999999999999999999999999999999998776 899999999975533221
Q ss_pred ----CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCC
Q 024809 80 ----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS 154 (262)
Q Consensus 80 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (262)
.....+|+.|+|||++.+..++. ++|||||||++|+|++ |..||............... ...+....++
T Consensus 207 ~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~ 280 (325)
T 3kul_A 207 AAYTTTGGKIPIRWTAPEAIAFRTFSS-ASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-----YRLPAPMGCP 280 (325)
T ss_dssp CCEECC---CCGGGSCHHHHHHCEECH-HHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-----CCCCCCTTCC
T ss_pred ceeeccCCCCcccccCHhHhcCCCCCc-HHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-----CCCCCCCCcC
Confidence 12234677899999998777654 4899999999999999 99999886655444333222 2223334789
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 155 LECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
+++.+||.+||..||.+|||+.++++
T Consensus 281 ~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 281 HALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999999999999987
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=260.65 Aligned_cols=177 Identities=24% Similarity=0.428 Sum_probs=135.8
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc--------CCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM--------QICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~--------~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
||||+||+|.+++... .+++..++.++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||+++
T Consensus 114 ~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~--~~kl~Dfg~a~ 190 (337)
T 3mdy_A 114 TDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGLAV 190 (337)
T ss_dssp ECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS--CEEECCCTTCE
T ss_pred EeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC--CEEEEeCCCce
Confidence 7999999999999765 699999999999999999999998 999999999999998777 89999999997
Q ss_pred CCCCCCC-----CCccccCCCCCCcccccCCcCCCC-----chhHHHHHHHHHHHHhC----------CCCCCCCCCh--
Q 024809 73 SSVLHSQ-----PKSTVGTPAYIAPEVLTKKEYDGK-----IADVWSCGVTLYVMLVG----------AYPFEDPEDP-- 130 (262)
Q Consensus 73 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~-----~~DiwslG~il~~ll~g----------~~pf~~~~~~-- 130 (262)
....... .....||+.|+|||++.+..+... ++|||||||++|+|++| +.||......
T Consensus 191 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~ 270 (337)
T 3mdy_A 191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP 270 (337)
T ss_dssp ECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred eeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCC
Confidence 5433221 124579999999999977655433 37999999999999999 6777553221
Q ss_pred --hHHHHHhcccccccccCCC---cccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 131 --KNFRKTIGRILSVHYSFPD---YVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 131 --~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
....... ........++. ...+++++.+||.+||+.||.+|||+.++++|
T Consensus 271 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 271 SYEDMREIV-CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CHHHHHHHH-TTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred chhhhHHHH-hhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 1111111 11111122222 12456779999999999999999999999985
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=261.12 Aligned_cols=175 Identities=25% Similarity=0.405 Sum_probs=143.2
Q ss_pred CCCCCCCchHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC
Q 024809 1 MEYAAGGELFERICNAG-----------------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG 57 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-----------------------~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~ 57 (262)
||||+||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.
T Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~ 207 (344)
T 1rjb_A 128 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH 207 (344)
T ss_dssp EECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEET
T ss_pred EecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcC
Confidence 79999999999998653 2799999999999999999999999999999999999987
Q ss_pred CCCCcEEEeccCCCcCCCCCCC---CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHH
Q 024809 58 STAPRVKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNF 133 (262)
Q Consensus 58 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 133 (262)
++ .+||+|||+++....... .....||+.|+|||++.+..++ .++|||||||++|+|+| |..||.+......+
T Consensus 208 ~~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 284 (344)
T 1rjb_A 208 GK--VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPVDANF 284 (344)
T ss_dssp TT--EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred CC--cEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCC-hhHhHHHHHHHHHHHHcCCCCCcccCCcHHHH
Confidence 77 899999999975543322 1234678899999999876665 55899999999999998 99999887655554
Q ss_pred HHHhcccccccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCc
Q 024809 134 RKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHP 182 (262)
Q Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp 182 (262)
...+... ...+....+++++.+||.+||..||.+|||+.++++|.
T Consensus 285 ~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 285 YKLIQNG----FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp HHHHHTT----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhcC----CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 4433321 12222236789999999999999999999999999863
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=256.03 Aligned_cols=172 Identities=23% Similarity=0.284 Sum_probs=137.9
Q ss_pred CCCCCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe---cCCCCCcEEEeccCCCcCCCC
Q 024809 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL---DGSTAPRVKICDFGYSKSSVL 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili---~~~~~~~~kl~Dfg~a~~~~~ 76 (262)
|||+ ||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++ .+||+|||+++....
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~--~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN--LVYIIDFGLAKKYRD 160 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTT--CEEECCCTTCEECBC
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCC--eEEEecCccceeccC
Confidence 7899 8999999985 4579999999999999999999999999999999999999 5555 899999999975443
Q ss_pred CC--------CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChh---HHHHHhcccccccc
Q 024809 77 HS--------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPK---NFRKTIGRILSVHY 145 (262)
Q Consensus 77 ~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~~~~~~~~~~~ 145 (262)
.. ......||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+..... .+...... ..
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----~~ 235 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK----KM 235 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH----HH
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCC-chhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc----cc
Confidence 22 12346799999999999887764 55899999999999999999998754321 12221111 11
Q ss_pred cCC---CcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 146 SFP---DYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 146 ~~~---~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
..+ ....+++++.+||.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred cchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 111 11357899999999999999999999999987
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=256.92 Aligned_cols=173 Identities=24% Similarity=0.358 Sum_probs=140.9
Q ss_pred CCCCCCCchHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec
Q 024809 1 MEYAAGGELFERICNAGR------------------------FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD 56 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~------------------------l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~ 56 (262)
||||+||+|.+++...+. +++..++.++.||+.||.|||++||+||||||+||+++
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~ 184 (314)
T 2ivs_A 105 VEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA 184 (314)
T ss_dssp EECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE
T ss_pred EeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEc
Confidence 799999999999987543 89999999999999999999999999999999999998
Q ss_pred CCCCCcEEEeccCCCcCCCCCC---CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhH
Q 024809 57 GSTAPRVKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKN 132 (262)
Q Consensus 57 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 132 (262)
.++ .+||+|||+++...... ......+|+.|+|||.+.+..++ .++|||||||++|+|++ |..||.+......
T Consensus 185 ~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 261 (314)
T 2ivs_A 185 EGR--KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261 (314)
T ss_dssp TTT--EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred CCC--CEEEccccccccccccccceeccCCCCcccccChhhhcCCCcC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 776 89999999997543222 12334678889999999876665 45899999999999999 9999987665443
Q ss_pred HHHHhcccccccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 133 FRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
....... ...+....+++++.++|.+||+.||.+|||+.+++++
T Consensus 262 ~~~~~~~-----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 262 FNLLKTG-----HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp HHHHHTT-----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhhcC-----CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 3322211 1112223688999999999999999999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=254.04 Aligned_cols=173 Identities=21% Similarity=0.362 Sum_probs=141.8
Q ss_pred CCCCCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC--
Q 024809 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-- 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-- 77 (262)
|||++||+|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++.....
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~--~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 98 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG--VVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp ECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTS--CEEECSTTGGGGBCCHHH
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCC--CEEEcccccccccccccc
Confidence 799999999999986 45799999999999999999999999999999999999998776 8999999999754321
Q ss_pred CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCHH
Q 024809 78 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 156 (262)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (262)
.......+|+.|+|||++.+..++ .++||||||+++|+|++ |+.||...........+.... ....+ ...++.
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~--~~~~~~ 249 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL---RLYRP--HLASEK 249 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC---CCCCC--TTCCHH
T ss_pred ccccCCccCcccCCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhccc---CCCCC--CcCCHH
Confidence 112234567889999999877664 45899999999999998 999998876554444332221 11222 357889
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
+.++|.+||+.+|.+|||+.++++|
T Consensus 250 l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 250 VYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCChhHCcCHHHHHHH
Confidence 9999999999999999999999986
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=252.87 Aligned_cols=173 Identities=20% Similarity=0.369 Sum_probs=141.0
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (262)
|||++||+|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ--VIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG--CEEECCTTGGGGBCCHHH
T ss_pred EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCC--CEEecccccccccccccc
Confidence 7999999999999754 4699999999999999999999999999999999999998776 89999999997543211
Q ss_pred -CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCHH
Q 024809 79 -QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 156 (262)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (262)
......+|+.|+|||++.+..++ .++||||+|+++|+|++ |+.||............... .....+ ...+++
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~---~~~~~~--~~~~~~ 235 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG---FRLYKP--RLASTH 235 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT---CCCCCC--TTSCHH
T ss_pred ccccCcccccccCCHHHhcCCCCC-chhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC---ccCCCC--CcCCHH
Confidence 22344577889999999877765 45899999999999999 99999886654443333222 111222 357899
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
+.+++.+||+.||.+|||+.++++|
T Consensus 236 ~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 236 VYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCCcccCcCHHHHHHH
Confidence 9999999999999999999999985
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=259.07 Aligned_cols=177 Identities=21% Similarity=0.235 Sum_probs=137.7
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC---CcEEEeccCCCcCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA---PRVKICDFGYSKSSVL 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~---~~~kl~Dfg~a~~~~~ 76 (262)
|||+ ||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++. ..+||+|||+++....
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 84 LELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred EEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 7999 99999999864 57999999999999999999999999999999999999986651 1299999999975433
Q ss_pred CCC--------CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCC
Q 024809 77 HSQ--------PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP 148 (262)
Q Consensus 77 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 148 (262)
... .....||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+...... ......+.......+
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~Pf~~~~~~~~-~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQS-RRDDLEALGHMFMYFLRGSLPWQGLKADTL-KERYQKIGDTKRATP 240 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTTTCCCSSH-HHHHHHHHHHHHHSC
T ss_pred CCCCccccccccCCcCCCccccChHHHcCCCCC-chhHHHHHHHHHHHHhcCCCCccccccccH-HHHHHHHHhhhccCC
Confidence 221 2456899999999999887765 558999999999999999999987543222 222222221111111
Q ss_pred C--cccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 149 D--YVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 149 ~--~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
. .....+++.+++.+||..+|.+||++.++++
T Consensus 241 ~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 241 IEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 1 1122349999999999999999999998876
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-36 Score=255.39 Aligned_cols=174 Identities=25% Similarity=0.365 Sum_probs=142.9
Q ss_pred CCCCCCCchHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCc
Q 024809 1 MEYAAGGELFERICNAG------------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPR 62 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~------------------~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~ 62 (262)
||||+||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||+++.++ .
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~ 183 (313)
T 1t46_A 106 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR--I 183 (313)
T ss_dssp EECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT--E
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCC--C
Confidence 79999999999998654 389999999999999999999999999999999999998776 8
Q ss_pred EEEeccCCCcCCCCCCC---CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhc
Q 024809 63 VKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIG 138 (262)
Q Consensus 63 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~ 138 (262)
+||+|||+++....... .....||+.|+|||++.+..++ .++|||||||++|+|++ |+.||.+............
T Consensus 184 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 262 (313)
T 1t46_A 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 262 (313)
T ss_dssp EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHH
T ss_pred EEEccccccccccccccceeccCCCCcceeeChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhc
Confidence 99999999976543322 2234578899999998776665 55899999999999999 9999988765544444332
Q ss_pred ccccccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 139 RILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
.. ...+....++.++.++|.+||..||.+|||+.+++++
T Consensus 263 ~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 263 EG----FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HT----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cC----CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 21 1222223688999999999999999999999999874
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=255.01 Aligned_cols=165 Identities=36% Similarity=0.652 Sum_probs=129.3
Q ss_pred CCCCCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCcEEEeccCCCcCCCCC
Q 024809 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-APRVKICDFGYSKSSVLH 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~-~~~~kl~Dfg~a~~~~~~ 77 (262)
||||+||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||+++... .+.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-- 171 (299)
T 3m2w_A 94 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-- 171 (299)
T ss_dssp ECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT--
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc--
Confidence 79999999999998764 699999999999999999999999999999999999998632 2389999999986331
Q ss_pred CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCC--CcccCCH
Q 024809 78 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP--DYVRVSL 155 (262)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 155 (262)
+..+ +.++|||||||++|+|++|+.||...............+......++ .+..+++
T Consensus 172 -------------------~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (299)
T 3m2w_A 172 -------------------GEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 231 (299)
T ss_dssp -------------------TCGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCH
T ss_pred -------------------cccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCH
Confidence 1223 34589999999999999999999875543322222222222233333 1246899
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
++++||.+||..||.+|||+.++++||||.+.
T Consensus 232 ~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 232 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 99999999999999999999999999999754
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=254.33 Aligned_cols=172 Identities=17% Similarity=0.182 Sum_probs=135.9
Q ss_pred CCCCCCCchHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC------CcEEEeccCCCcC
Q 024809 1 MEYAAGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA------PRVKICDFGYSKS 73 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~-l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~------~~~kl~Dfg~a~~ 73 (262)
||||+||+|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||++.++. +.+||+|||++..
T Consensus 91 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~ 170 (289)
T 4fvq_A 91 QEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT 170 (289)
T ss_dssp EECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTT
T ss_pred EECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCccccc
Confidence 799999999999987654 999999999999999999999999999999999999987662 1199999999864
Q ss_pred CCCCCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccC
Q 024809 74 SVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRV 153 (262)
Q Consensus 74 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (262)
.. ......||+.|+|||++.+....+.++|||||||++|+|++|..|+.............. .....+. ..
T Consensus 171 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~----~~~~~~~--~~ 241 (289)
T 4fvq_A 171 VL---PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE----DRHQLPA--PK 241 (289)
T ss_dssp TS---CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH----TTCCCCC--CS
T ss_pred cc---CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh----ccCCCCC--CC
Confidence 32 223456899999999998744445669999999999999996544444333332222221 1122222 46
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 154 SLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 154 ~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
+.++.+||.+||+.||.+|||+.++++|
T Consensus 242 ~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 242 AAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp SCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 7889999999999999999999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=259.67 Aligned_cols=173 Identities=19% Similarity=0.343 Sum_probs=140.1
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||+.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~--~~kl~Dfg~a~~~~~~~~ 172 (327)
T 3poz_A 95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ--HVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp EECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT--EEEECCTTHHHHHTTTCC
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCC--CEEEccCcceeEccCCcc
Confidence 5899999999999874 5799999999999999999999999999999999999998777 899999999975433222
Q ss_pred ---CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 80 ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 80 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
.....||+.|+|||.+.+..++ .++|||||||++|+|++ |+.||.+......... +.. ....+.....+.
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-~~~----~~~~~~~~~~~~ 246 (327)
T 3poz_A 173 EYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-LEK----GERLPQPPICTI 246 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-HHT----TCCCCCCTTBCH
T ss_pred cccccCCCccccccChHHhccCCCC-chhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHH-HHc----CCCCCCCccCCH
Confidence 1234568899999999877765 45899999999999999 9999987655433222 211 112223346889
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
++.+++.+||+.+|.+|||+.+++++
T Consensus 247 ~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 247 DVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 99999999999999999999999975
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=272.93 Aligned_cols=166 Identities=16% Similarity=0.159 Sum_probs=134.8
Q ss_pred CCCchHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC
Q 024809 5 AGGELFERICN-------AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH 77 (262)
Q Consensus 5 ~gg~L~~~i~~-------~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~ 77 (262)
.+|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 187 ~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~--~~kL~DFG~a~~~~~~ 264 (413)
T 3dzo_A 187 MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG--GVFLTGFEHLVRDGAS 264 (413)
T ss_dssp CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEEECCGGGCEETTEE
T ss_pred hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCC--eEEEEeccceeecCCc
Confidence 45799988841 23488889999999999999999999999999999999998877 7999999998754322
Q ss_pred CCCCccccCCCCCCcccc----------cCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccC
Q 024809 78 SQPKSTVGTPAYIAPEVL----------TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF 147 (262)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~----------~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 147 (262)
....+| +.|+|||++ ....+ +.++|||||||++|+|++|+.||........... .+
T Consensus 265 --~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~----------~~ 330 (413)
T 3dzo_A 265 --AVSPIG-RGFAPPETTAERMLPFGQHHPTLM-TFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEW----------IF 330 (413)
T ss_dssp --ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGG----------GG
T ss_pred --cccCCC-CceeCchhhhccccccccccCcCC-CchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHH----------HH
Confidence 345577 999999998 33334 3458999999999999999999986543222111 12
Q ss_pred CCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 148 PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 148 ~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
.....+++++++||.+||+.||.+|||+.++++||||+.
T Consensus 331 ~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 331 RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 233468899999999999999999999999999999964
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=251.02 Aligned_cols=173 Identities=26% Similarity=0.364 Sum_probs=143.2
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++.......
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~ 176 (284)
T 2a19_B 99 MEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK--QVKIGDFGLVTSLKNDG 176 (284)
T ss_dssp ECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--EEEECCCTTCEESSCCS
T ss_pred EeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCC--CEEECcchhheeccccc
Confidence 7999999999999754 5799999999999999999999999999999999999998777 89999999998665544
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 158 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (262)
......||+.|+|||++.+..++ .++||||||+++|+|++|..||... ... ...+... ..+ ..++.+++
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~---~~~---~~~~~~~--~~~--~~~~~~~~ 245 (284)
T 2a19_B 177 KRTRSKGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFET---SKF---FTDLRDG--IIS--DIFDKKEK 245 (284)
T ss_dssp CCCCCCSCCTTSCHHHHHCSCCC-THHHHHHHHHHHHHHHSCCSSHHHH---HHH---HHHHHTT--CCC--TTSCHHHH
T ss_pred cccccCCcccccChhhhccCCCc-chhhhHHHHHHHHHHHhcCCcchhH---HHH---HHHhhcc--ccc--ccCCHHHH
Confidence 45566899999999999877765 4589999999999999999887531 111 1111111 122 25788999
Q ss_pred HHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 159 HLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 159 ~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
++|.+||..||.+|||+.++++|.+...
T Consensus 246 ~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 246 TLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 9999999999999999999999987654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=253.21 Aligned_cols=176 Identities=24% Similarity=0.328 Sum_probs=135.3
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (262)
||||+||+|.+++...+ ++++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++......
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~ 169 (295)
T 3ugc_A 92 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN--RVKIGDFGLTKVLPQDKE 169 (295)
T ss_dssp EECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECCCCSCC-------
T ss_pred EEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCC--eEEEccCcccccccCCcc
Confidence 79999999999998754 599999999999999999999999999999999999998777 89999999998653322
Q ss_pred ---CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh------------hHHHHHhcccccc
Q 024809 79 ---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP------------KNFRKTIGRILSV 143 (262)
Q Consensus 79 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------------~~~~~~~~~~~~~ 143 (262)
......+++.|+|||.+.+..++ .++||||||+++|+|++|..||...... .........+ ..
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 247 (295)
T 3ugc_A 170 FFKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL-KN 247 (295)
T ss_dssp ------CTTCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH-HT
T ss_pred eeeeccCCCCccceeCcHHhcCCCCC-hHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH-hc
Confidence 12234567789999999877765 4589999999999999999998643210 0000111111 11
Q ss_pred cccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 144 HYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 144 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
....+....+++++.+||.+||..||.+|||+.++++
T Consensus 248 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 248 NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1223333468999999999999999999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=250.08 Aligned_cols=174 Identities=28% Similarity=0.412 Sum_probs=134.3
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC---CeecCCCCCcEEecCC------CCCcEEEeccCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ---ICHRDLKLENTLLDGS------TAPRVKICDFGYS 71 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~---ivHrDlkp~Nili~~~------~~~~~kl~Dfg~a 71 (262)
|||++||+|.+++.. +++++..++.++.|++.||.|||++| |+||||||+||+++.. ..+.+||+|||++
T Consensus 85 ~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~ 163 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163 (271)
T ss_dssp EECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred EEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence 799999999998854 47999999999999999999999999 8999999999999752 1337999999999
Q ss_pred cCCCCCCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcc
Q 024809 72 KSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV 151 (262)
Q Consensus 72 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (262)
+..... ......||+.|+|||.+.+..++ .++||||||+++|+|++|+.||.+............. ....+...
T Consensus 164 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~ 237 (271)
T 3dtc_A 164 REWHRT-TKMSAAGAYAWMAPEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN----KLALPIPS 237 (271)
T ss_dssp -------------CCGGGSCHHHHHHCCCS-HHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS----CCCCCCCT
T ss_pred cccccc-cccCCCCccceeCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC----CCCCCCCc
Confidence 754322 23356799999999999876664 4589999999999999999999876654433332221 12222223
Q ss_pred cCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 152 RVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 152 ~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
.+++++.++|.+||..||.+|||+.++++|
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 688999999999999999999999999874
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=254.17 Aligned_cols=173 Identities=20% Similarity=0.301 Sum_probs=136.1
Q ss_pred CCCCCCCchHHHHH------hCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCC
Q 024809 1 MEYAAGGELFERIC------NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSS 74 (262)
Q Consensus 1 mE~~~gg~L~~~i~------~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~ 74 (262)
|||++||+|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++..
T Consensus 120 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~--~~kl~Dfg~~~~~ 197 (313)
T 3brb_A 120 LPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM--TVCVADFGLSKKI 197 (313)
T ss_dssp EECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS--CEEECSCSCC---
T ss_pred EecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC--cEEEeecCcceec
Confidence 68999999999994 335699999999999999999999999999999999999998776 8999999999754
Q ss_pred CCCC---CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCc
Q 024809 75 VLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDY 150 (262)
Q Consensus 75 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (262)
.... ......+++.|+|||.+.+..++ .++||||||+++|+|++ |..||................ .... .
T Consensus 198 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~---~~~~--~ 271 (313)
T 3brb_A 198 YSGDYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH---RLKQ--P 271 (313)
T ss_dssp -------------CCGGGSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC---CCCC--B
T ss_pred ccccccCcccccCCCccccCchhhcCCCcc-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC---CCCC--C
Confidence 3321 12334578899999999877765 45899999999999999 999998876554444332221 1122 2
Q ss_pred ccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 151 VRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 151 ~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
..+++++.++|.+||..||.+|||+.+++++
T Consensus 272 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 272 EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3688999999999999999999999999874
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-36 Score=256.52 Aligned_cols=174 Identities=24% Similarity=0.379 Sum_probs=142.4
Q ss_pred CCCCCCCchHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEE
Q 024809 1 MEYAAGGELFERICNAGR----------------FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVK 64 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~----------------l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~k 64 (262)
||||+||+|.+++..... +++..++.++.||+.||.|||++||+||||||+||+++.++ .+|
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~--~~k 188 (316)
T 2xir_A 111 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN--VVK 188 (316)
T ss_dssp EECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEE
T ss_pred EEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC--CEE
Confidence 699999999999987654 89999999999999999999999999999999999998766 899
Q ss_pred EeccCCCcCCCCCCC---CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhccc
Q 024809 65 ICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRI 140 (262)
Q Consensus 65 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~ 140 (262)
|+|||+++....... .....||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+......+...+...
T Consensus 189 l~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~ 267 (316)
T 2xir_A 189 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 267 (316)
T ss_dssp ECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHT
T ss_pred ECCCccccccccCccceeccCCCcceeecCchhhcccccc-chhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccC
Confidence 999999975533221 1235678899999999877665 45899999999999998 999998866544443332221
Q ss_pred ccccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 141 LSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
. ....+ ..+++++.++|.+||..||.+|||+.++++|
T Consensus 268 ~--~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 268 T--RMRAP--DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp C--CCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred c--cCCCC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1 12222 3578999999999999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=251.13 Aligned_cols=173 Identities=21% Similarity=0.272 Sum_probs=138.9
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (262)
|||++||+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++.......
T Consensus 91 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~ 168 (281)
T 3cc6_A 91 MELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE--CVKLGDFGLSRYIEDEDY 168 (281)
T ss_dssp EECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETT--EEEECCCCGGGCC-----
T ss_pred EecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCC--cEEeCccCCCcccccccc
Confidence 69999999999997654 599999999999999999999999999999999999998776 89999999997543322
Q ss_pred -CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCHH
Q 024809 79 -QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 156 (262)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (262)
......+|+.|+|||++.+..++ .++||||||+++|+|++ |+.||............... ...+....+++.
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 242 (281)
T 3cc6_A 169 YKASVTRLPIKWMSPESINFRRFT-TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG-----DRLPKPDLCPPV 242 (281)
T ss_dssp ----CCCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHT-----CCCCCCTTCCHH
T ss_pred cccccCCCCcceeCchhhccCCCC-chhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcC-----CCCCCCCCCCHH
Confidence 12334578889999999776665 45899999999999998 99999876554433322211 112222368899
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
+.++|.+||..||.+|||+.+++++
T Consensus 243 l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 243 LYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCCchhCcCHHHHHHH
Confidence 9999999999999999999999874
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=259.22 Aligned_cols=173 Identities=24% Similarity=0.344 Sum_probs=139.7
Q ss_pred CCCCCCCchHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec
Q 024809 1 MEYAAGGELFERICNA------------------------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD 56 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~------------------------~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~ 56 (262)
||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~ 208 (343)
T 1luf_A 129 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG 208 (343)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred EecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEC
Confidence 7999999999999864 5699999999999999999999999999999999999998
Q ss_pred CCCCCcEEEeccCCCcCCCCC---CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhH
Q 024809 57 GSTAPRVKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKN 132 (262)
Q Consensus 57 ~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 132 (262)
.++ .+||+|||+++..... .......||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+......
T Consensus 209 ~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 285 (343)
T 1luf_A 209 ENM--VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 285 (343)
T ss_dssp GGG--CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred CCC--eEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcC-cccccHHHHHHHHHHHhcCCCcCCCCChHHH
Confidence 776 8999999998643221 122345688999999999877665 45899999999999999 9999987654443
Q ss_pred HHHHhcccccccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 133 FRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
...+... .....+. .+++++.++|.+||..||.+|||+.+++++
T Consensus 286 ~~~~~~~---~~~~~~~--~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 286 IYYVRDG---NILACPE--NCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp HHHHHTT---CCCCCCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhCC---CcCCCCC--CCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 3332221 1112233 688999999999999999999999999874
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=258.70 Aligned_cols=179 Identities=23% Similarity=0.274 Sum_probs=137.7
Q ss_pred CCCCCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC
Q 024809 1 MEYAAGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~----~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (262)
||||+||+|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++....
T Consensus 114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENF--VPKITDFGISKKGTE 191 (321)
T ss_dssp EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTC--CEEECCCTTCEECSS
T ss_pred EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCC--CEEEeeccccccccc
Confidence 79999999999987543 599999999999999999999999999999999999998776 899999999975332
Q ss_pred CC---CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHH--HHH---------hccccc
Q 024809 77 HS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNF--RKT---------IGRILS 142 (262)
Q Consensus 77 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~~---------~~~~~~ 142 (262)
.. ......||+.|+|||++.+..++ .++|||||||++|+|++|+.||......... ... +.....
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
T 2qkw_B 192 LDQTHLSTVVKGTLGYIDPEYFIKGRLT-EKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270 (321)
T ss_dssp SSCCCCBCCCEEETTTCCHHHHHHCBCC-THHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred ccccccccccCCCccccCHHHhcCCCCC-cccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence 21 22345689999999999877765 4489999999999999999999765432110 000 000001
Q ss_pred ccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCc
Q 024809 143 VHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHP 182 (262)
Q Consensus 143 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp 182 (262)
...........+..+.+++.+||+.||.+|||+.++++|.
T Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 1111111123556789999999999999999999999864
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=246.25 Aligned_cols=170 Identities=22% Similarity=0.313 Sum_probs=139.9
Q ss_pred CCCCCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC
Q 024809 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQ--ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~--ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (262)
|||++||+|.+++...+ .+++..++.++.||+.||.|||++| ++||||||+||+++.++ .++|+|||++...
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~--~~~l~~~~~~~~~-- 163 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM--TARISMADVKFSF-- 163 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTS--CEEEEGGGSCCTT--
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCc--ceeEEeccceeee--
Confidence 79999999999998765 4899999999999999999999999 99999999999998776 7899988876532
Q ss_pred CCCCCccccCCCCCCcccccCCcCCCC--chhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCC
Q 024809 77 HSQPKSTVGTPAYIAPEVLTKKEYDGK--IADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS 154 (262)
Q Consensus 77 ~~~~~~~~gt~~y~aPE~~~~~~~~~~--~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (262)
......||+.|+|||++.+..+... ++|||||||++|+|++|+.||................ .....+ ..++
T Consensus 164 --~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~--~~~~ 237 (271)
T 3kmu_A 164 --QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEG--LRPTIP--PGIS 237 (271)
T ss_dssp --SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSC--CCCCCC--TTCC
T ss_pred --cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcC--CCCCCC--CCCC
Confidence 2344678999999999987655432 5899999999999999999998766544433332221 112223 3689
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 155 LECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
+++.++|.+||+.||.+|||+.++++
T Consensus 238 ~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 238 PHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999999986
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=265.29 Aligned_cols=170 Identities=22% Similarity=0.360 Sum_probs=139.5
Q ss_pred CCCCCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~--l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
||||+||+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 266 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~--~~kl~DfG~a~~~~~-- 341 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN--VAKVSDFGLTKEASS-- 341 (450)
T ss_dssp EECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTS--CEEECCCTTCEECC---
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCC--CEEEeeCCCcccccc--
Confidence 799999999999987654 79999999999999999999999999999999999998776 899999999974432
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 157 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (262)
......+++.|+|||++.+..++. ++|||||||++|+|++ |+.||.+....+....+... .....| ..+++++
T Consensus 342 ~~~~~~~~~~y~aPE~~~~~~~~~-~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~---~~~~~p--~~~~~~l 415 (450)
T 1k9a_A 342 TQDTGKLPVKWTAPEALREKKFST-KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---YKMDAP--DGCPPAV 415 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCH-HHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTT---CCCCCC--TTCCHHH
T ss_pred cccCCCCCcceeCHHHhcCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---CCCCCC--CcCCHHH
Confidence 223346788999999998877754 4899999999999998 99999887655444333221 112223 3689999
Q ss_pred HHHHHHhcccCCCCCCCHhHHhc
Q 024809 158 KHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
.+||.+||..||.+|||+.+++.
T Consensus 416 ~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 416 YDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999876
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=258.28 Aligned_cols=177 Identities=20% Similarity=0.257 Sum_probs=134.4
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc----------CCeecCCCCCcEEecCCCCCcEEEeccCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM----------QICHRDLKLENTLLDGSTAPRVKICDFGY 70 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~----------~ivHrDlkp~Nili~~~~~~~~kl~Dfg~ 70 (262)
||||+||+|.+++... .+++..++.++.|++.||.|||+. ||+||||||+|||++.++ .+||+|||+
T Consensus 101 ~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~--~~kL~DFg~ 177 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL--TACIADFGL 177 (322)
T ss_dssp EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC--CEEECCCTT
T ss_pred EecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC--eEEEccCCc
Confidence 7999999999999775 599999999999999999999999 999999999999998776 899999999
Q ss_pred CcCCCCCC---CCCccccCCCCCCcccccCCcC----CCCchhHHHHHHHHHHHHhCCCCCCCCCChhH-----------
Q 024809 71 SKSSVLHS---QPKSTVGTPAYIAPEVLTKKEY----DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKN----------- 132 (262)
Q Consensus 71 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~----~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----------- 132 (262)
++...... ......||+.|+|||++.+... .+.++|||||||++|+|++|+.||.+......
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 257 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence 97543322 2334679999999999976322 22347999999999999999999976433110
Q ss_pred -HHHHhccccc--ccccCCC---cccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 133 -FRKTIGRILS--VHYSFPD---YVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 133 -~~~~~~~~~~--~~~~~~~---~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
.......... .....+. ....+.++.+||.+||+.||.+|||+.++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 258 SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0001000100 0111111 1123456999999999999999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=254.25 Aligned_cols=173 Identities=19% Similarity=0.327 Sum_probs=135.9
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||+.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus 95 ~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~--~~kL~DfG~a~~~~~~~~ 172 (327)
T 3lzb_A 95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ--HVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp ECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT--EEEECCTTC---------
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCC--CEEEccCcceeEccCccc
Confidence 6899999999999864 5699999999999999999999999999999999999998777 899999999976533222
Q ss_pred ---CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 80 ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 80 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
.....+|+.|+|||.+.+..++ .++|||||||++|+|++ |+.||.+............. ...+....++.
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 246 (327)
T 3lzb_A 173 EYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-----ERLPQPPICTI 246 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-----CCCCCCTTBCH
T ss_pred cccccCCCccccccCHHHHcCCCCC-hHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-----CCCCCCccCCH
Confidence 2234567789999999877765 45899999999999999 99999876654433222211 12233346889
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
++.++|.+||..||.+|||+.++++.
T Consensus 247 ~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 247 DVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999999999999999873
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=251.01 Aligned_cols=172 Identities=22% Similarity=0.306 Sum_probs=139.8
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC-
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ- 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~- 79 (262)
|||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++.......
T Consensus 96 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~ 173 (291)
T 1xbb_A 96 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH--YAKISDFGLSKALRADENY 173 (291)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--EEEECCCTTCEECCTTCSE
T ss_pred EEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCC--cEEEccCCcceeeccCCCc
Confidence 69999999999999988899999999999999999999999999999999999998776 899999999975433221
Q ss_pred ---CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 80 ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 80 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
.....+++.|+|||.+.+..++ .++||||||+++|+|++ |+.||............... .....+ ..+++
T Consensus 174 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~--~~~~~ 247 (291)
T 1xbb_A 174 YKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG---ERMGCP--AGCPR 247 (291)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT---CCCCCC--TTCCH
T ss_pred ccccccCCCCceeeChHHhccCCCC-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---CCCCCC--CCCCH
Confidence 1223467889999999776665 45899999999999999 99999876554332222111 111222 36889
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
++.++|.+||..||.+|||+.++++
T Consensus 248 ~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 248 EMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=250.84 Aligned_cols=174 Identities=25% Similarity=0.372 Sum_probs=142.2
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++.......
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~kl~Dfg~~~~~~~~~~ 165 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH--YAKISDFGLSKALGADDS 165 (287)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT--EEEECCCTTCEECTTCSC
T ss_pred EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCC--CEEECcccceeeeccCcc
Confidence 6999999999999754 4699999999999999999999999999999999999998776 899999999975432221
Q ss_pred ----CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCC
Q 024809 80 ----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS 154 (262)
Q Consensus 80 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (262)
.....||+.|+|||++.+..++ .++|||||||++|+|++ |+.||......+....+... ....++ ..++
T Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~---~~~~~~--~~~~ 239 (287)
T 1u59_A 166 YYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG---KRMECP--PECP 239 (287)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT---CCCCCC--TTCC
T ss_pred eeeccccccccccccCHHHhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC---CcCCCC--CCcC
Confidence 2234568899999999776665 45899999999999998 99999887665443332221 112223 3689
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhcCc
Q 024809 155 LECKHLLSRIFVANSEKRITIPEIKNHP 182 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~~e~l~hp 182 (262)
+++.++|.+||..+|.+|||+.++++|.
T Consensus 240 ~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 240 PELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 9999999999999999999999999874
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=251.35 Aligned_cols=174 Identities=23% Similarity=0.338 Sum_probs=131.6
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
|||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++.......
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~~~~~ 190 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADD--FAYLVDFGIASATTDEKLT 190 (309)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECSCCC----------
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCC--CEEEecCccCccccccccc
Confidence 69999999999999888899999999999999999999999999999999999998776 89999999987543321
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 158 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (262)
......||+.|+|||++.+..++.+ +||||||+++|+|++|+.||...... .....+......... ....+++++.
T Consensus 191 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~--~~~~~~~~l~ 266 (309)
T 2h34_A 191 QLGNTVGTLYYMAPERFSESHATYR-ADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAIPRPST--VRPGIPVAFD 266 (309)
T ss_dssp ------CCGGGCCGGGTCC----CC-CHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSCCCCGGG--TSTTCCTHHH
T ss_pred cccccCCCcCccCHHHHcCCCCCch-HhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccCCCCccc--cCCCCCHHHH
Confidence 2234579999999999987766544 89999999999999999999875432 222222211111111 1236889999
Q ss_pred HHHHHhcccCCCCCC-CHhHHhc
Q 024809 159 HLLSRIFVANSEKRI-TIPEIKN 180 (262)
Q Consensus 159 ~li~~~L~~dp~~R~-s~~e~l~ 180 (262)
++|.+||..||.+|| |++++++
T Consensus 267 ~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 267 AVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHhccCCHHHHHHhHHHHHH
Confidence 999999999999999 8888775
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=257.32 Aligned_cols=176 Identities=24% Similarity=0.327 Sum_probs=131.6
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc---------CCeecCCCCCcEEecCCCCCcEEEeccCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM---------QICHRDLKLENTLLDGSTAPRVKICDFGYS 71 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~---------~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a 71 (262)
||||+||+|.+++... .+++..++.++.||+.||.|||+. ||+||||||+|||++.++ .+||+|||++
T Consensus 91 ~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~--~~kL~DFG~a 167 (336)
T 3g2f_A 91 MEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG--TCVISDFGLS 167 (336)
T ss_dssp ECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS--CEEECCCTTC
T ss_pred EecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC--cEEEeeccce
Confidence 7999999999999766 469999999999999999999999 999999999999998776 8999999999
Q ss_pred cCCCCCC---------CCCccccCCCCCCcccccCC------cCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhH----
Q 024809 72 KSSVLHS---------QPKSTVGTPAYIAPEVLTKK------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKN---- 132 (262)
Q Consensus 72 ~~~~~~~---------~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---- 132 (262)
+...... ......||+.|+|||++.+. ...+.++|||||||++|+|++|..||........
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~ 247 (336)
T 3g2f_A 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA 247 (336)
T ss_dssp EECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCT
T ss_pred eecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHh
Confidence 7543211 12245799999999998762 1223458999999999999999777643322110
Q ss_pred -------------HHHHhcccccccccCC----CcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 133 -------------FRKTIGRILSVHYSFP----DYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 133 -------------~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
....... ......+| .....++++.+||.+||+.||.+|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 248 FQTEVGNHPTFEDMQVLVSR-EKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp THHHHCSSCCHHHHHHHHTT-SCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhcccCCCchHHHHHhhhcc-cccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 0010000 01111222 12234567999999999999999999999954
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=253.97 Aligned_cols=173 Identities=20% Similarity=0.282 Sum_probs=140.2
Q ss_pred CCCCCCCchHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCC
Q 024809 1 MEYAAGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGY 70 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~----------~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~ 70 (262)
||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+
T Consensus 107 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~--~~kl~Dfg~ 184 (322)
T 1p4o_A 107 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF--TVKIGDFGM 184 (322)
T ss_dssp EECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC--CEEECCTTC
T ss_pred EEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC--eEEECcCcc
Confidence 7999999999999753 3579999999999999999999999999999999999998776 899999999
Q ss_pred CcCCCCCC---CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhccccccccc
Q 024809 71 SKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYS 146 (262)
Q Consensus 71 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 146 (262)
++...... ......||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.............. ..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~---~~- 259 (322)
T 1p4o_A 185 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG---LL- 259 (322)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC---CC-
T ss_pred ccccccccccccccCCCCCCCccChhhhccCCCC-chhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC---cC-
Confidence 97543221 12234678899999999876665 45899999999999999 899998765544333322211 11
Q ss_pred CCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 147 FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 147 ~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
+....++..+.+||.+||..||.+|||+.++++|
T Consensus 260 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 260 -DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1223688999999999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=246.37 Aligned_cols=173 Identities=23% Similarity=0.325 Sum_probs=138.0
Q ss_pred CCCCCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC--
Q 024809 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-- 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-- 77 (262)
|||+.||+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++.....
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~--~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESF--TVKVADFGLARDILDREY 179 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC--CEEECCTTSSCTTTTGGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC--cEEeCcCCCcccccCCcc
Confidence 689999999999987 44699999999999999999999999999999999999998776 8999999999754221
Q ss_pred ---CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCC
Q 024809 78 ---SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS 154 (262)
Q Consensus 78 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (262)
.......+|+.|+|||.+.+..++ .++|||||||++|+|++|..||............+.... ..+....++
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 254 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR----RLPQPEYCP 254 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC----CCCCCTTCC
T ss_pred cccccCcCCCCCccccChhhhccCCCC-hhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC----CCCCCccch
Confidence 222345678899999999877765 458999999999999996555544444333333222211 122233688
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 155 LECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
+++.+++.+||..||.+|||+.++++
T Consensus 255 ~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 255 DSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999999999999987
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=247.99 Aligned_cols=170 Identities=21% Similarity=0.358 Sum_probs=134.3
Q ss_pred CCCCCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~--l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||++||+|.+++...+. +++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~~l~Dfg~~~~~~~-- 169 (278)
T 1byg_A 94 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN--VAKVSDFGLTKEASS-- 169 (278)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS--CEEECCCCC--------
T ss_pred EecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCC--cEEEeeccccccccc--
Confidence 799999999999986643 89999999999999999999999999999999999998776 899999999875432
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 157 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (262)
......+++.|+|||++.+..++ .++||||||+++|+|++ |+.||............... ...+....+++.+
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l 243 (278)
T 1byg_A 170 TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-----YKMDAPDGCPPAV 243 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-----CCCCCCTTCCHHH
T ss_pred cccCCCccccccCHHHhCCCCCC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-----CCCCCcccCCHHH
Confidence 23345678999999999776665 45899999999999998 99999876554433332211 1122223688999
Q ss_pred HHHHHHhcccCCCCCCCHhHHhc
Q 024809 158 KHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
.++|.+||..||.+|||+.++++
T Consensus 244 ~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 244 YEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCChhhCCCHHHHHH
Confidence 99999999999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-35 Score=249.51 Aligned_cols=174 Identities=29% Similarity=0.448 Sum_probs=132.8
Q ss_pred CCCCCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHH---cCCeecCCCCCcEEecCCCCCcEEEeccCCCcCC
Q 024809 1 MEYAAGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHS---MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSS 74 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~---~l~e~~~~~~~~ql~~aL~~LH~---~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~ 74 (262)
|||++||+|.+++...+ .+++..+..++.|+++||.|||+ +||+||||||+||+++.++. .+||+|||++...
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT-VLKICDFGTACDI 156 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT-EEEECCCCC----
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC-EEEEccccccccc
Confidence 79999999999998765 37899999999999999999999 89999999999999986652 3799999999754
Q ss_pred CCCCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCC
Q 024809 75 VLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS 154 (262)
Q Consensus 75 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (262)
.. ......||+.|+|||++.+..++ .++|||||||++|+|++|+.||......... ......... ..+....++
T Consensus 157 ~~--~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~ 230 (307)
T 2eva_A 157 QT--HMTNNKGSAAWMAPEVFEGSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAFR-IMWAVHNGT--RPPLIKNLP 230 (307)
T ss_dssp ----------CCTTSSCHHHHTCCCCC-THHHHHHHHHHHHHHHHTCCTTTTTCSSHHH-HHHHHHTTC--CCCCBTTCC
T ss_pred cc--ccccCCCCCceEChhhhCCCCCC-cHHHHHHHHHHHHHHHHCCCCchhhCccHHH-HHHHHhcCC--CCCcccccC
Confidence 32 23345799999999999877765 4489999999999999999999865433211 111111111 112234688
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 155 LECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
..+.++|.+||+.||.+|||+.+++++
T Consensus 231 ~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 231 KPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 999999999999999999999999874
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=259.02 Aligned_cols=173 Identities=23% Similarity=0.318 Sum_probs=132.0
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (262)
||||+||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~--~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF--TVKVADFGLARDMYDKEF 247 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCC-----------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCC--CEEEeecccccccccccc
Confidence 79999999999998654 589999999999999999999999999999999999998776 89999999997543221
Q ss_pred ----CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccC
Q 024809 79 ----QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRV 153 (262)
Q Consensus 79 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (262)
......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||......+........ .....| ..+
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~---~~~~~p--~~~ 321 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG---RRLLQP--EYC 321 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT---CCCCCC--TTC
T ss_pred ccccccCCCCCcccccChHHhcCCCCC-cHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC---CCCCCC--CCC
Confidence 11234577889999999877665 45899999999999999 77888776554433332221 111222 358
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 154 SLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 154 ~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
+..+.++|.+||..||.+|||+.+++++
T Consensus 322 ~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 322 PDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8999999999999999999999999874
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=248.22 Aligned_cols=172 Identities=23% Similarity=0.322 Sum_probs=137.1
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (262)
|||++||+|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++......
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 106 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF--TVKVADFGLARDMYDKEY 183 (298)
T ss_dssp EECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC--CEEECSCGGGCCCSCGGG
T ss_pred EeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCC--CEEECcccccccccccch
Confidence 7999999999999864 4699999999999999999999999999999999999998776 89999999997543221
Q ss_pred ----CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccC
Q 024809 79 ----QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRV 153 (262)
Q Consensus 79 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (262)
......||+.|+|||.+.+..++ .++||||||+++|+|++ |..||................ ....+ ..+
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~--~~~ 257 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR---RLLQP--EYC 257 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC---CCCCC--TTC
T ss_pred hccccccCCCCCccccChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC---CCCCC--ccC
Confidence 12334678899999999877665 45899999999999999 666776655444333322221 11122 257
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 154 SLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 154 ~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
+..+.+++.+||..||.+|||+.++++
T Consensus 258 ~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 258 PDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 889999999999999999999999987
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=245.98 Aligned_cols=173 Identities=20% Similarity=0.369 Sum_probs=140.3
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC--
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-- 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-- 77 (262)
|||++||+|.+++... +.+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++......
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~--~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ--VIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGG--CEEECCTTGGGGBCCHHH
T ss_pred EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCC--CEEEcccccccccccccc
Confidence 7999999999999865 4699999999999999999999999999999999999998776 8999999998754321
Q ss_pred CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCHH
Q 024809 78 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 156 (262)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (262)
.......+++.|+|||++.+..++ .++||||||+++|+|++ |+.||...........+.... ....+ ...+..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~---~~~~~--~~~~~~ 233 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF---RLYKP--RLASTH 233 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC---CCCCC--TTSCHH
T ss_pred cccccccccccccChhhhcCCCcc-chhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC---cCCCC--ccCcHH
Confidence 112334577889999999876664 55899999999999999 899998765544333322211 11122 357899
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
+.+++.+||..||.+|||+.+++++
T Consensus 234 l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 234 VYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999999874
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=254.31 Aligned_cols=173 Identities=23% Similarity=0.339 Sum_probs=140.2
Q ss_pred CCCCCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEE
Q 024809 1 MEYAAGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVK 64 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~k 64 (262)
|||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++ .+|
T Consensus 120 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~k 197 (334)
T 2pvf_A 120 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN--VMK 197 (334)
T ss_dssp EECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEE
T ss_pred EECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCC--CEE
Confidence 79999999999998654 389999999999999999999999999999999999998776 899
Q ss_pred EeccCCCcCCCCCC---CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhccc
Q 024809 65 ICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRI 140 (262)
Q Consensus 65 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~ 140 (262)
|+|||+++...... ......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+....+.........
T Consensus 198 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 276 (334)
T 2pvf_A 198 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH 276 (334)
T ss_dssp ECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC
T ss_pred EccccccccccccccccccCCCCcccceeChHHhcCCCcC-hHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCC
Confidence 99999997543321 12334578889999999776665 45899999999999999 999998765443332221111
Q ss_pred ccccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 141 LSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
..+....++.++.++|.+||..+|.+|||+.+++++
T Consensus 277 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 277 -----RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 112223688999999999999999999999999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=265.47 Aligned_cols=172 Identities=23% Similarity=0.370 Sum_probs=141.0
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
||||+||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~--~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL--VCKIADFGLARVIEDNE 338 (454)
T ss_dssp ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTC--CEEECSTTGGGGBCCHH
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCC--cEEEeeCCCceEcCCCc
Confidence 7999999999999754 3699999999999999999999999999999999999998776 89999999998543211
Q ss_pred --CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 79 --QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 79 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
......+++.|+|||++....++ .++|||||||++|+|++ |+.||.+....+....+... ...+....+++
T Consensus 339 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-----~~~~~~~~~~~ 412 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-----YRMPRPENCPE 412 (454)
T ss_dssp HHTTCSSSSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT-----CCCCCCTTSCH
T ss_pred eeccCCCcccccccCHHHhccCCCC-cHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----CCCCCCCCCCH
Confidence 12234567789999999877665 45899999999999999 99999887655444333221 22333346899
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
++.+||.+||..||.+|||+.+++.
T Consensus 413 ~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 413 ELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHHH
Confidence 9999999999999999999999976
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=257.90 Aligned_cols=172 Identities=20% Similarity=0.370 Sum_probs=130.6
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
||||+||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus 125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~ 202 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL--VCKVSDFGLGRVLEDDPE 202 (373)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCC-----------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCC--CEEECcCccccccccCCc
Confidence 79999999999998754 699999999999999999999999999999999999998776 899999999975533211
Q ss_pred ----CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCC
Q 024809 80 ----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS 154 (262)
Q Consensus 80 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (262)
.....+++.|+|||++.+..++. ++|||||||++|+|++ |+.||............... ...+....++
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~-----~~~~~~~~~~ 276 (373)
T 2qol_A 203 AAYTTRGGKIPIRWTSPEAIAYRKFTS-ASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-----YRLPPPMDCP 276 (373)
T ss_dssp -----------CTTSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTT-----EECCCCTTCB
T ss_pred cceeccCCCcCCCccChhhhccCCcCc-hhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----CCCCCCcccc
Confidence 11234577899999998777654 5899999999999998 99999876554433332221 1223334688
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 155 LECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
.++.++|.+||+.||.+|||+.++++
T Consensus 277 ~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 277 AALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 99999999999999999999999886
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=250.95 Aligned_cols=176 Identities=23% Similarity=0.335 Sum_probs=138.2
Q ss_pred CCCCCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-
Q 024809 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (262)
|||++||+|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++......
T Consensus 104 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~ 181 (302)
T 4e5w_A 104 MEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH--QVKIGDFGLTKAIETDKE 181 (302)
T ss_dssp EECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--EEEECCCTTCEECCTTCC
T ss_pred EEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCC--CEEECcccccccccCCCc
Confidence 799999999999954 45799999999999999999999999999999999999998777 89999999997554332
Q ss_pred ---CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCC-----------ChhHHHHHhccccccc
Q 024809 79 ---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE-----------DPKNFRKTIGRILSVH 144 (262)
Q Consensus 79 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----------~~~~~~~~~~~~~~~~ 144 (262)
......||..|+|||++.+..++ .++|||||||++|+|++|..|+.... ...........+. ..
T Consensus 182 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 259 (302)
T 4e5w_A 182 YYTVKDDRDSPVFWYAPECLMQSKFY-IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK-EG 259 (302)
T ss_dssp EEECCCCTTCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH-TT
T ss_pred ceeccCCCCCCccccCCeeecCCCCC-cchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh-cc
Confidence 22345688889999999877765 44899999999999999998864321 1111111111111 11
Q ss_pred ccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 145 YSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 145 ~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
...+....+++++.+||.+||+.||.+|||+.++++
T Consensus 260 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 260 KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 222333468899999999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=258.25 Aligned_cols=168 Identities=18% Similarity=0.208 Sum_probs=133.1
Q ss_pred CCCCCCCchHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-----------CCCCcEE
Q 024809 1 MEYAAGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG-----------STAPRVK 64 (262)
Q Consensus 1 mE~~~gg~L~~~i~~-----~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~-----------~~~~~~k 64 (262)
||||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++. ++ .+|
T Consensus 146 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~--~~k 223 (365)
T 3e7e_A 146 GELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSA--GLA 223 (365)
T ss_dssp ECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CT--TEE
T ss_pred EeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccC--CEE
Confidence 799999999999973 457999999999999999999999999999999999999976 44 899
Q ss_pred EeccCCCcCCCC---CCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccc
Q 024809 65 ICDFGYSKSSVL---HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIL 141 (262)
Q Consensus 65 l~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 141 (262)
|+|||+|+.... .......+||+.|+|||++.+..++. ++|||||||++|+|+||+.||....... .
T Consensus 224 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~elltg~~pf~~~~~~~---------~ 293 (365)
T 3e7e_A 224 LIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNY-QIDYFGVAATVYCMLFGTYMKVKNEGGE---------C 293 (365)
T ss_dssp ECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBST-HHHHHHHHHHHHHHHHSSCCCEEEETTE---------E
T ss_pred EeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCc-cccHHHHHHHHHHHHhCCCccccCCCCc---------e
Confidence 999999964321 22234567999999999998887754 5899999999999999999996533211 0
Q ss_pred cccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 142 SVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
.....++.. ..++.+.+++.+||+.+|.+|++..+.+.+
T Consensus 294 ~~~~~~~~~-~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 294 KPEGLFRRL-PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp EECSCCTTC-SSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred eechhcccc-CcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 011111221 346778999999999999999765554443
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=247.14 Aligned_cols=172 Identities=20% Similarity=0.341 Sum_probs=140.2
Q ss_pred CCCCCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||++||+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++.......
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL--SCKIADFGLARLIEDNE 163 (279)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS--CEEECCCTTCEECSSSC
T ss_pred EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCC--CEEECCCcccccccCcc
Confidence 69999999999997543 699999999999999999999999999999999999998776 89999999997543322
Q ss_pred --CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 79 --QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 79 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
......+++.|+|||++.+..++ .++||||||+++|+|++ |+.||.+....+........ ........++.
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 237 (279)
T 1qpc_A 164 YTAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-----YRMVRPDNCPE 237 (279)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----CCCCCCTTCCH
T ss_pred cccccCCCCccCccChhhhccCCCC-chhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc-----cCCCCcccccH
Confidence 12234578899999999776665 45899999999999999 99999876654443333221 11122236889
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
++.+++.+||..||.+|||+.++++
T Consensus 238 ~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 238 ELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhccChhhCCCHHHHHH
Confidence 9999999999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=255.44 Aligned_cols=174 Identities=22% Similarity=0.344 Sum_probs=141.5
Q ss_pred CCCCCCCchHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEe
Q 024809 1 MEYAAGGELFERICNA--------------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKIC 66 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--------------~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~ 66 (262)
||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+
T Consensus 129 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~--~~kl~ 206 (333)
T 2i1m_A 129 TEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH--VAKIG 206 (333)
T ss_dssp EECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG--EEEBC
T ss_pred EecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC--eEEEC
Confidence 7999999999999753 3589999999999999999999999999999999999998776 89999
Q ss_pred ccCCCcCCCCCCC---CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhccccc
Q 024809 67 DFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILS 142 (262)
Q Consensus 67 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 142 (262)
|||+++....... .....||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+......+.......
T Consensus 207 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-- 283 (333)
T 2i1m_A 207 DFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG-- 283 (333)
T ss_dssp CCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHT--
T ss_pred ccccccccccccceeecCCCCCCccccCHHHhccCCCC-hHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcC--
Confidence 9999975433221 2334678899999999876665 55899999999999998 999998866554444333221
Q ss_pred ccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 143 VHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 143 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
...+.....+.++.++|.+||+.||.+|||+.+++++
T Consensus 284 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 284 --YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 1222223578899999999999999999999999873
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=248.26 Aligned_cols=172 Identities=22% Similarity=0.327 Sum_probs=140.7
Q ss_pred CCCCCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
|||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++.......
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSRLMTGDT 165 (288)
T ss_dssp EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGG--CEEECCCCGGGTSCSSS
T ss_pred EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCC--CEEEccCccceeccCCc
Confidence 69999999999998643 599999999999999999999999999999999999998776 89999999997553222
Q ss_pred C--CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 79 Q--PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 79 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
. .....+|+.|+|||.+.+..++ .++||||||+++|+|++ |..||............... ...+....+++
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 239 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-----YRMERPEGCPE 239 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-----CCCCCCTTCCH
T ss_pred cccccCCccccCcCChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc-----CCCCCCCCCCH
Confidence 1 1234578889999999877665 45899999999999999 99999876654433332221 11222236889
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
++.+||.+||..||.+|||+.++++
T Consensus 240 ~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 240 KVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhCCChhhCcCHHHHHH
Confidence 9999999999999999999999987
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=259.62 Aligned_cols=172 Identities=23% Similarity=0.335 Sum_probs=138.4
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (262)
||||+||+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 191 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~--~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN--VLKISDFGMSREEADGVY 268 (377)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCGGGCEECTTSEE
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCC--cEEECcCCCceecCCCce
Confidence 79999999999998654 699999999999999999999999999999999999998776 89999999997532211
Q ss_pred --CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 79 --QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 79 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
......+++.|+|||++....++ .++|||||||++|+|++ |..||.+............. .....| ..+++
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~---~~~~~~--~~~~~ 342 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYS-SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG---GRLPCP--ELCPD 342 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTT---CCCCCC--TTCCH
T ss_pred eecCCCCCCCcCcCCHhHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---CCCCCC--CCCCH
Confidence 11123456789999999877665 44899999999999998 99999876654333222111 112223 35889
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
++.+||.+||+.||.+|||+.++++
T Consensus 343 ~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 343 AVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHH
Confidence 9999999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-35 Score=252.22 Aligned_cols=173 Identities=20% Similarity=0.384 Sum_probs=135.9
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++.......
T Consensus 125 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~~~~~~~~~~ 202 (333)
T 1mqb_A 125 TEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL--VCKVSDFGLSRVLEDDPE 202 (333)
T ss_dssp EECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCCCC---------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCC--cEEECCCCcchhhccccc
Confidence 7999999999999865 5799999999999999999999999999999999999998776 899999999975433211
Q ss_pred ----CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCC
Q 024809 80 ----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS 154 (262)
Q Consensus 80 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (262)
.....+|+.|+|||++.+..++ .++|||||||++|+|++ |+.||...........+... ...+....++
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~-----~~~~~~~~~~ 276 (333)
T 1mqb_A 203 ATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-----FRLPTPMDCP 276 (333)
T ss_dssp --------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-----CCCCCCTTCB
T ss_pred cccccCCCCccccccCchhcccCCCC-chhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCC-----CcCCCcccCC
Confidence 1123467789999999877765 45899999999999998 99999876544333322211 1223334688
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 155 LECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
.++.++|.+||..+|.+|||+.+++++
T Consensus 277 ~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 277 SAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999999874
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=249.36 Aligned_cols=174 Identities=25% Similarity=0.379 Sum_probs=140.5
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||++||+|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++.......
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~--~~kl~Dfg~~~~~~~~~~ 176 (291)
T 1u46_A 99 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD--LVKIGDFGLMRALPQNDD 176 (291)
T ss_dssp EECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT--EEEECCCTTCEECCC-CC
T ss_pred EecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCC--CEEEcccccccccccccc
Confidence 6899999999999764 5699999999999999999999999999999999999998776 899999999875533221
Q ss_pred ----CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCC
Q 024809 80 ----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS 154 (262)
Q Consensus 80 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (262)
.....+|+.|+|||++.+..++ .++||||||+++|+|++ |+.||.+............ .....+....++
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 251 (291)
T 1u46_A 177 HYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK----EGERLPRPEDCP 251 (291)
T ss_dssp EEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT----SCCCCCCCTTCC
T ss_pred chhhhccCCCCceeeCchhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHc----cCCCCCCCcCcC
Confidence 2234578889999999876664 45899999999999999 9999987665444333322 222333344789
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 155 LECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
.++.++|.+||..||.+|||+.+++++
T Consensus 252 ~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 252 QDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 999999999999999999999999973
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=254.21 Aligned_cols=180 Identities=18% Similarity=0.276 Sum_probs=143.3
Q ss_pred CCCCCCCchHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCcEEEeccCCCc
Q 024809 1 MEYAAGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-APRVKICDFGYSK 72 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-------~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~-~~~~kl~Dfg~a~ 72 (262)
||||+||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+||+|||+++
T Consensus 112 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~ 191 (327)
T 2yfx_A 112 MELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191 (327)
T ss_dssp EECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHH
T ss_pred EecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcccccc
Confidence 79999999999998753 489999999999999999999999999999999999998433 2369999999986
Q ss_pred CCCCC---CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCC
Q 024809 73 SSVLH---SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFP 148 (262)
Q Consensus 73 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 148 (262)
..... .......||+.|+|||++.+..++ .++|||||||++|+|++ |..||............... .....
T Consensus 192 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~---~~~~~- 266 (327)
T 2yfx_A 192 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG---GRMDP- 266 (327)
T ss_dssp HHHC------CCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT---CCCCC-
T ss_pred ccccccccccCCCcCCCcceeCHhHhcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcC---CCCCC-
Confidence 43221 223345789999999999776665 45899999999999998 99999876544333322211 11122
Q ss_pred CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 149 DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 149 ~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
...++..+.++|.+||..||.+|||+.++++|.|+..
T Consensus 267 -~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 267 -PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 2368899999999999999999999999999988754
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-35 Score=264.22 Aligned_cols=175 Identities=21% Similarity=0.254 Sum_probs=137.5
Q ss_pred CCCCCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec---CCCCCcEEEeccCCCcCCCC
Q 024809 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD---GSTAPRVKICDFGYSKSSVL 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~---~~~~~~~kl~Dfg~a~~~~~ 76 (262)
|||| ||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++ .+||+|||+++....
T Consensus 82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~--~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN--QVYIIDFGLAKKYRD 158 (483)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTT--CEEECCCTTCEECBC
T ss_pred EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCC--eEEEEeCCcceeccC
Confidence 7899 8999999985 45799999999999999999999999999999999999993 444 899999999975543
Q ss_pred CCC--------CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhH---HHHHhcccccccc
Q 024809 77 HSQ--------PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKN---FRKTIGRILSVHY 145 (262)
Q Consensus 77 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~~~~~~~~~~~ 145 (262)
... .....||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+...... +.++.........
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 221 2256799999999999887765 458999999999999999999987554222 2221111110000
Q ss_pred cCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 146 SFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 146 ~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
......++.++.+||.+||..+|.+||++.++++
T Consensus 238 -~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 238 -EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp -HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred -HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0011257899999999999999999999988764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-35 Score=250.96 Aligned_cols=179 Identities=21% Similarity=0.247 Sum_probs=136.7
Q ss_pred CCCCCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHc---CCeecCCCCCcEEecCCCCCcEEEeccCCCcC
Q 024809 1 MEYAAGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHSM---QICHRDLKLENTLLDGSTAPRVKICDFGYSKS 73 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~----~l~e~~~~~~~~ql~~aL~~LH~~---~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (262)
||||+||+|.+++.... .+++..++.++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||+++.
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~--~~kl~Dfg~~~~ 183 (326)
T 3uim_A 106 YPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF--EAVVGDFGLAKL 183 (326)
T ss_dssp EECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC--CEEECCCSSCEE
T ss_pred EEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC--CEEeccCccccc
Confidence 79999999999998654 399999999999999999999999 999999999999998776 899999999975
Q ss_pred CCCCCC--CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCC----CChhHHHHHhccccc-----
Q 024809 74 SVLHSQ--PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP----EDPKNFRKTIGRILS----- 142 (262)
Q Consensus 74 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~~~~~~~~~~~----- 142 (262)
...... .....||+.|+|||++.+..++ .++|||||||++|+|++|+.||... ...............
T Consensus 184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (326)
T 3uim_A 184 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSS-EKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 262 (326)
T ss_dssp CCSSSSCEECCCCSCGGGCCHHHHHHSEEC-HHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCST
T ss_pred cCcccccccccccCCcCccCHHHhccCCCC-ccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhh
Confidence 432222 2335699999999999777765 4589999999999999999999621 111111111111100
Q ss_pred ----ccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCc
Q 024809 143 ----VHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHP 182 (262)
Q Consensus 143 ----~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp 182 (262)
...........+.++.+++.+||+.||.+|||+.++++|-
T Consensus 263 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 306 (326)
T 3uim_A 263 ALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306 (326)
T ss_dssp TSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred hhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence 0000011113446799999999999999999999999974
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=248.64 Aligned_cols=173 Identities=21% Similarity=0.309 Sum_probs=135.7
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC--
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-- 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-- 77 (262)
|||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||+++ ++ .+||+|||+++.....
T Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~--~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NG--KVVITDFGLFSISGVLQA 184 (319)
T ss_dssp CBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC-----CCEECCCSCCC-------
T ss_pred eecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CC--CEEEeecCCccccccccc
Confidence 79999999999998765 699999999999999999999999999999999999997 33 7999999998643211
Q ss_pred ----CCCCccccCCCCCCcccccCC--------cCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccc
Q 024809 78 ----SQPKSTVGTPAYIAPEVLTKK--------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY 145 (262)
Q Consensus 78 ----~~~~~~~gt~~y~aPE~~~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 145 (262)
.......||+.|+|||++... ...+.++|||||||++|+|++|+.||............... ..
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----~~ 260 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG----MK 260 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT----CC
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC----CC
Confidence 122334689999999998752 22345689999999999999999999876544433332221 11
Q ss_pred cCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 146 SFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 146 ~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
.......++.++.++|.+||..||.+|||+.++++
T Consensus 261 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 261 PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp CCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred CCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 11122357889999999999999999999999987
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=255.94 Aligned_cols=177 Identities=23% Similarity=0.373 Sum_probs=139.5
Q ss_pred CCCCCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-
Q 024809 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (262)
||||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++......
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~~~~~~~~~~ 182 (327)
T 3lxl_A 105 MEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA--HVKIADFGLAKLLPLDKD 182 (327)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--EEEECCGGGCEECCTTCS
T ss_pred EeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCC--CEEEcccccceecccCCc
Confidence 799999999999986 44699999999999999999999999999999999999998777 89999999997543322
Q ss_pred ---CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChh-----------HHHHHhccccccc
Q 024809 79 ---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPK-----------NFRKTIGRILSVH 144 (262)
Q Consensus 79 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----------~~~~~~~~~~~~~ 144 (262)
......||+.|+|||++.+..++ .++|||||||++|+|++|+.||....... ........+ ...
T Consensus 183 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 260 (327)
T 3lxl_A 183 YYVVREPGQSPIFWYAPESLSDNIFS-RQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL-EEG 260 (327)
T ss_dssp EEECSSCCCSCGGGSCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH-HTT
T ss_pred cceeeccCCccccccCHHHhccCCCC-hHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh-hcc
Confidence 12334688889999999877664 45899999999999999999986532210 001111111 111
Q ss_pred ccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 145 YSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 145 ~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
...+....+++++.+||.+||+.||.+|||+.+++++
T Consensus 261 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 261 QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2223334789999999999999999999999999765
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=263.23 Aligned_cols=219 Identities=23% Similarity=0.364 Sum_probs=151.4
Q ss_pred CCCCCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe----cCCCCCcEEEeccCCCcC
Q 024809 1 MEYAAGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL----DGSTAPRVKICDFGYSKS 73 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~---~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili----~~~~~~~~kl~Dfg~a~~ 73 (262)
||||+||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++ .+||+|||+++.
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~--~~kL~DFG~a~~ 165 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS--VYKLTDFGAARE 165 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCE--EEEECCGGGCEE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCce--eEEEecCCCceE
Confidence 79999999999997643 39999999999999999999999999999999999998 4443 799999999986
Q ss_pred CCCCCCCCccccCCCCCCcccccC--------CcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccc
Q 024809 74 SVLHSQPKSTVGTPAYIAPEVLTK--------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY 145 (262)
Q Consensus 74 ~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 145 (262)
...........||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||............+..+.....
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p 244 (396)
T 4eut_A 166 LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (396)
T ss_dssp CCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHH-HHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred ccCCCccccccCCccccCHHHhhccccccccccCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence 554444456789999999999864 233 34589999999999999999999754432221111111111100
Q ss_pred -------------------cCCCc----ccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcc--ccccCCccccCCCCccc
Q 024809 146 -------------------SFPDY----VRVSLECKHLLSRIFVANSEKRITIPEIKNHPW--FLRNLPIELTEGGSWQS 200 (262)
Q Consensus 146 -------------------~~~~~----~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~--~~~~~~~~~~~~~~~~~ 200 (262)
.++.. ..++..+.++|.+||+.||.+|||+.+++++-. +.+.. ...........
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~~-~~~~~~~~~~~ 323 (396)
T 4eut_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMV-IHVFSLQQMTA 323 (396)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCEE-EEEEETTTTEE
T ss_pred cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhceE-EEEEEeccceE
Confidence 11111 124467889999999999999999999865311 11000 00000111111
Q ss_pred -cCCCCCCCCHHHHHHHhHHhcCC
Q 024809 201 -HDVNNPSQSLEEVLSLIHEATKP 223 (262)
Q Consensus 201 -~~~~~~~~~~~~~~~~~~~~~~~ 223 (262)
.....+..+..++.+.+.+.+..
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~t~i 347 (396)
T 4eut_A 324 HKIYIHSYNTATIFHELVYKQTKI 347 (396)
T ss_dssp EEEEECTTCBHHHHHHHHHHHHCC
T ss_pred EEEEcCchhHHHHHHHHHHHhcCC
Confidence 11223456778888888777653
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=253.64 Aligned_cols=175 Identities=24% Similarity=0.397 Sum_probs=136.8
Q ss_pred CCCCCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC
Q 024809 1 MEYAAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (262)
|||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++....
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~--~~kl~dfg~~~~~~~ 186 (317)
T 2buj_A 109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEG--QPVLMDLGSMNQACI 186 (317)
T ss_dssp EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS--CEEECCCSSCEESCE
T ss_pred EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC--CEEEEecCcchhccc
Confidence 699999999999975 45799999999999999999999999999999999999998776 899999999874321
Q ss_pred CCCC----------CccccCCCCCCcccccCCcC--CCCchhHHHHHHHHHHHHhCCCCCCCCCCh-hHHHHHhcccccc
Q 024809 77 HSQP----------KSTVGTPAYIAPEVLTKKEY--DGKIADVWSCGVTLYVMLVGAYPFEDPEDP-KNFRKTIGRILSV 143 (262)
Q Consensus 77 ~~~~----------~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~ 143 (262)
.... ....||+.|+|||++..... .+.++|||||||++|+|++|+.||...... ........ .
T Consensus 187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----~ 262 (317)
T 2buj_A 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ----N 262 (317)
T ss_dssp EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH----C
T ss_pred ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh----c
Confidence 1111 12357999999999875431 245589999999999999999999541100 01111111 1
Q ss_pred cccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 144 HYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 144 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
....+....+++++.++|.+||+.||.+|||+.+++++
T Consensus 263 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 263 QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 22344445789999999999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=273.86 Aligned_cols=172 Identities=22% Similarity=0.303 Sum_probs=139.7
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 448 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~--~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 448 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH--YAKISDFGLSKALRADENY 525 (635)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECCTTHHHHTTC----
T ss_pred EEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCC--CEEEEEcCCccccccCccc
Confidence 79999999999999888999999999999999999999999999999999999998777 89999999997543222
Q ss_pred --CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 79 --QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 79 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
......+|+.|+|||++.+..++ .++|||||||++|+|++ |+.||.+....+....+... .....|. .++.
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~---~~~~~p~--~~~~ 599 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG---ERMGCPA--GCPR 599 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT---CCCCCCT--TCCH
T ss_pred cccccCCCCceeeeChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---CCCCCCC--CCCH
Confidence 12234567889999999877765 45899999999999998 99999887654443333221 1122233 6889
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
++.+||.+||..||.+|||+.++++
T Consensus 600 ~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 600 EMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 9999999999999999999999976
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=250.39 Aligned_cols=170 Identities=29% Similarity=0.475 Sum_probs=119.8
Q ss_pred CCCCCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecCCCCCcEEEeccCCCcCCC
Q 024809 1 MEYAAGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHSMQ--ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV 75 (262)
Q Consensus 1 mE~~~gg~L~~~i~~---~~~l~e~~~~~~~~ql~~aL~~LH~~~--ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~ 75 (262)
|||+. |+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||+++...
T Consensus 113 ~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~~~~~~ 189 (337)
T 3ll6_A 113 TELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG--TIKLCDFGSATTIS 189 (337)
T ss_dssp EECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTS--CEEBCCCTTCBCCS
T ss_pred EEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCC--CEEEecCccceecc
Confidence 68996 699998864 457999999999999999999999999 99999999999998777 89999999997654
Q ss_pred CCCC-------------CCccccCCCCCCccccc---CCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcc
Q 024809 76 LHSQ-------------PKSTVGTPAYIAPEVLT---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGR 139 (262)
Q Consensus 76 ~~~~-------------~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~ 139 (262)
.... .....||+.|+|||++. +..+ +.++|||||||++|+|++|+.||........
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------- 261 (337)
T 3ll6_A 190 HYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFEDGAKLRI------- 261 (337)
T ss_dssp SCC-------------------------------CCTTSCS-SHHHHHHHHHHHHHHHHHSSCCC---------------
T ss_pred ccCcccccccccccchhhccccCCCCcCChhhhhccccCCC-ChHHhHHHHHHHHHHHHhCCCCCcchhHHHh-------
Confidence 3221 11446999999999983 3333 4558999999999999999999976443221
Q ss_pred cccccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCc
Q 024809 140 ILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHP 182 (262)
Q Consensus 140 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp 182 (262)
.......+.....+..+.+||.+||+.||.+|||+.++++|-
T Consensus 262 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 262 -VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp -----CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred -hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 112223333446778899999999999999999999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=263.49 Aligned_cols=172 Identities=21% Similarity=0.324 Sum_probs=140.6
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
||||+||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENH--LVKVADFGLSRLMTGDT 372 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG--CEEECCTTCEECCTTCC
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCC--cEEEeecccceeccCCc
Confidence 7999999999999864 3599999999999999999999999999999999999998776 89999999998543221
Q ss_pred --CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 79 --QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 79 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
......+++.|+|||++....++ .++|||||||++|+|++ |..||.+.........+.. ....+....+++
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 446 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-----DYRMERPEGCPE 446 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT-----TCCCCCCTTCCH
T ss_pred eeecCCCcCCcceeCHhHHhcCCCC-cHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----CCCCCCCCCCCH
Confidence 12234467789999999877765 44899999999999999 9999988765444333222 122222336889
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
++.+||.+||+.||.+|||+.++++
T Consensus 447 ~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 447 KVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCcChhHCcCHHHHHH
Confidence 9999999999999999999999987
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=248.99 Aligned_cols=177 Identities=25% Similarity=0.354 Sum_probs=136.5
Q ss_pred CCCCCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC
Q 024809 1 MEYAAGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~---~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~ 77 (262)
|||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++.....
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAF--TAKISDFGLARASEKF 186 (307)
T ss_dssp EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEEECCCTTCEECCSC
T ss_pred EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC--cEEEeecccccccccc
Confidence 689999999999974 34699999999999999999999999999999999999998776 8999999998754322
Q ss_pred CC---CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccc--------cc
Q 024809 78 SQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH--------YS 146 (262)
Q Consensus 78 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--------~~ 146 (262)
.. .....||+.|+|||++.+. ++ .++||||||+++|+|++|..||...............+.... ..
T Consensus 187 ~~~~~~~~~~g~~~y~aPE~~~~~-~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (307)
T 2nru_A 187 AQTVMTSRIVGTTAYMAPEALRGE-IT-PKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKK 264 (307)
T ss_dssp SSCEECSSCCSCGGGCCHHHHTTE-EC-THHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSS
T ss_pred cccccccccCCCcCcCChHHhcCC-CC-ccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccc
Confidence 11 2345799999999998653 44 458999999999999999999987554332222111111000 00
Q ss_pred CC-CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 147 FP-DYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 147 ~~-~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
.+ .....+..+.+++.+||..+|.+|||+.+++++
T Consensus 265 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 265 MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 11 112345678999999999999999999999874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=246.52 Aligned_cols=175 Identities=27% Similarity=0.387 Sum_probs=129.3
Q ss_pred CCCCCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC
Q 024809 1 MEYAAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (262)
|||++||+|.+++.. ...+++..++.++.||+.||.|||++|++||||||+||+++.++ .+||+|||+++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~--~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG--VVKLGDLGLGRFFSS 188 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCC--------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCC--CEEEEeccceeeecC
Confidence 799999999999864 45699999999999999999999999999999999999998776 899999999875433
Q ss_pred CC-CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh-hHHHHHhcccccccccCCCcccCC
Q 024809 77 HS-QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP-KNFRKTIGRILSVHYSFPDYVRVS 154 (262)
Q Consensus 77 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 154 (262)
.. ......|++.|+|||++.+..++ .++||||||+++|+|++|+.||.+.... ...... +....+.......++
T Consensus 189 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 264 (310)
T 2wqm_A 189 KTTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK---IEQCDYPPLPSDHYS 264 (310)
T ss_dssp ----------CCSSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHH---HHTTCSCCCCTTTSC
T ss_pred CCccccccCCCeeEeChHHhCCCCCC-chhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHH---hhcccCCCCcccccC
Confidence 22 22345799999999999877665 4589999999999999999999764322 122221 111122111223688
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 155 LECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
.++++||.+||..||.+|||+.+++++
T Consensus 265 ~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 265 EELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999999999873
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=261.07 Aligned_cols=172 Identities=21% Similarity=0.322 Sum_probs=136.7
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
||||+||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~--~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL--VCKVADFGLARLIEDNE 334 (452)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECCCCTTC------
T ss_pred ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCC--CEEECCCccceecCCCc
Confidence 7999999999999743 4699999999999999999999999999999999999998776 89999999998543221
Q ss_pred --CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 79 --QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 79 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
......+++.|+|||++....++ .++|||||||++|+|++ |+.||.+....+........ ...+....+++
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-----~~~~~~~~~~~ 408 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-----YRMPCPPECPE 408 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----CCCCCCTTSCH
T ss_pred eecccCCcccccccCHhHHhcCCCC-ccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----CCCCCCCCCCH
Confidence 12234567889999999877665 45899999999999999 99999886654443333221 12222336889
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
.+.+||.+||..||.+|||+.++++
T Consensus 409 ~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 409 SLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHH
Confidence 9999999999999999999999987
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=249.96 Aligned_cols=175 Identities=27% Similarity=0.384 Sum_probs=137.8
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
||||+||+|.+++... .+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++......
T Consensus 114 ~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~--~~kl~Dfg~a~~~~~~~~~ 190 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDR--LVKIGDFGLAKAVPEGHEY 190 (318)
T ss_dssp ECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCGGGCEECCTTCSE
T ss_pred EecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCC--CEEECCccccccccccccc
Confidence 7999999999999776 499999999999999999999999999999999999998776 89999999997654322
Q ss_pred --CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChh-----------HHHHHhcccccccc
Q 024809 79 --QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPK-----------NFRKTIGRILSVHY 145 (262)
Q Consensus 79 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----------~~~~~~~~~~~~~~ 145 (262)
......||+.|+|||++.+..++ .++|||||||++|+|++|..||....... ...... .......
T Consensus 191 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 268 (318)
T 3lxp_A 191 YRVREDGDSPVFWYAPECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT-ELLERGE 268 (318)
T ss_dssp EEC---CCCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHH-HHHHTTC
T ss_pred cccccCCCCCceeeChHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHH-HHHhccc
Confidence 12334678889999999877765 45899999999999999999997532110 000111 1111122
Q ss_pred cCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 146 SFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 146 ~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
..+....++.++.+||.+||+.||.+|||+.++++
T Consensus 269 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 269 RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 23333468899999999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=251.32 Aligned_cols=177 Identities=24% Similarity=0.365 Sum_probs=136.5
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------HcCCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH--------SMQICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH--------~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
|||++||+|.+++.+. ++++..++.++.|++.||.||| ++||+||||||+||+++.++ .+||+|||+++
T Consensus 119 ~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~--~~kL~Dfg~~~ 195 (342)
T 1b6c_B 119 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGLAV 195 (342)
T ss_dssp ECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS--CEEECCCTTCE
T ss_pred EeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC--CEEEEECCCce
Confidence 7999999999999765 6999999999999999999999 89999999999999998777 89999999997
Q ss_pred CCCCCC-----CCCccccCCCCCCcccccCCcCCC-----CchhHHHHHHHHHHHHhC----------CCCCCCCCCh--
Q 024809 73 SSVLHS-----QPKSTVGTPAYIAPEVLTKKEYDG-----KIADVWSCGVTLYVMLVG----------AYPFEDPEDP-- 130 (262)
Q Consensus 73 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~-----~~~DiwslG~il~~ll~g----------~~pf~~~~~~-- 130 (262)
...... ......||+.|+|||++.+..... .++|||||||++|+|++| +.||......
T Consensus 196 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~ 275 (342)
T 1b6c_B 196 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 275 (342)
T ss_dssp EEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred eccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcc
Confidence 543322 234457999999999987653221 458999999999999999 7888764321
Q ss_pred --hHHHHHhcccccccccCCC---cccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 131 --KNFRKTIGRILSVHYSFPD---YVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 131 --~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
......+.. ......++. ....+..+.+||.+||..||.+|||+.++++|
T Consensus 276 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 276 SVEEMRKVVCE-QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CHHHHHHHHTT-SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cHHHHHHHHHH-HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 122221111 011112222 11344678999999999999999999999985
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=267.50 Aligned_cols=172 Identities=24% Similarity=0.376 Sum_probs=138.0
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus 414 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~--~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH--YAKISDFGLSKALGADDS 491 (613)
T ss_dssp EECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECCCSTTTTCC----
T ss_pred EEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCC--cEEEeeccCcccccCCCc
Confidence 7999999999999754 4599999999999999999999999999999999999998777 899999999986532221
Q ss_pred ----CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCC
Q 024809 80 ----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS 154 (262)
Q Consensus 80 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (262)
.....+++.|+|||++....++. ++|||||||++|+|++ |+.||.+....+....+... .....| ..++
T Consensus 492 ~~~~~~~~~~~~~y~APE~~~~~~~~~-~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~---~~~~~p--~~~~ 565 (613)
T 2ozo_A 492 YYTARSAGKWPLKWYAPECINFRKFSS-RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG---KRMECP--PECP 565 (613)
T ss_dssp ----------CCTTSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTT---CCCCCC--TTCC
T ss_pred eeeeccCCCCccceeCHhhhcCCCCCc-HHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC---CCCCCC--CcCC
Confidence 12234568999999998777654 5899999999999998 99999987765544433221 112233 3688
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 155 LECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
+++.+||.+||..+|.+|||+.++++
T Consensus 566 ~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 566 PELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp HHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999999864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=247.07 Aligned_cols=177 Identities=24% Similarity=0.341 Sum_probs=137.6
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++.......
T Consensus 123 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~--~~kL~Dfg~~~~~~~~~~ 200 (326)
T 2w1i_A 123 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN--RVKIGDFGLTKVLPQDKE 200 (326)
T ss_dssp ECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT--EEEECCCTTCEECCSSCS
T ss_pred EECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCC--cEEEecCcchhhcccccc
Confidence 7999999999999876 4699999999999999999999999999999999999998777 899999999975533221
Q ss_pred ----CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh-----------hHHHHHhccccccc
Q 024809 80 ----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP-----------KNFRKTIGRILSVH 144 (262)
Q Consensus 80 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----------~~~~~~~~~~~~~~ 144 (262)
.....++..|+|||.+.+..++ .++|||||||++|+|++|..||...... ......+.......
T Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (326)
T 2w1i_A 201 YYKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 279 (326)
T ss_dssp EEECSSCCSCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred ccccccCCCCceeEECchhhcCCCCC-chhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcC
Confidence 2234577789999999876664 4589999999999999999998642100 00000011111111
Q ss_pred ccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 145 YSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 145 ~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
...+....++.++.++|.+||..||.+|||+.++++
T Consensus 280 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 280 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 122333468899999999999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=262.46 Aligned_cols=172 Identities=21% Similarity=0.322 Sum_probs=140.4
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
||||+||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL--VCKVADFGLARLIEDNE 417 (535)
T ss_dssp ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECCTTSTTTCCCHH
T ss_pred eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCC--cEEEcccccceecCCCc
Confidence 7999999999999743 4699999999999999999999999999999999999998776 89999999997543211
Q ss_pred --CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 79 --QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 79 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
......++..|+|||++....++ .++|||||||++|+|++ |+.||.+....+....+... +..+....++.
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~-----~~~~~~~~~~~ 491 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-----YRMPCPPECPE 491 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTT-----CCCCCCTTCCH
T ss_pred eecccCCcCcccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----CCCCCCCCCCH
Confidence 12234567889999999877665 45899999999999999 99999886654443333221 12222336889
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
++.+||.+||..||.+|||+.+++.
T Consensus 492 ~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 492 SLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999999987
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=265.18 Aligned_cols=172 Identities=22% Similarity=0.360 Sum_probs=138.5
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
||||+||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus 469 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~--~vkL~DFG~a~~~~~~~~ 546 (656)
T 2j0j_A 469 MELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND--CVKLGDFGLSRYMEDSTY 546 (656)
T ss_dssp EECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECCCCCCCSCCC---
T ss_pred EEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCC--CEEEEecCCCeecCCCcc
Confidence 79999999999998654 699999999999999999999999999999999999998777 899999999986533221
Q ss_pred --CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCHH
Q 024809 80 --PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 156 (262)
Q Consensus 80 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (262)
.....+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+....+....+... .....+ ..+++.
T Consensus 547 ~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~---~~~~~~--~~~~~~ 620 (656)
T 2j0j_A 547 YKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG---ERLPMP--PNCPPT 620 (656)
T ss_dssp -------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHT---CCCCCC--TTCCHH
T ss_pred eeccCCCCCcceeCHHHhcCCCCC-chhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC---CCCCCC--ccccHH
Confidence 2234567899999999877665 45899999999999997 99999886654443333221 112223 368899
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhc
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
+.+||.+||..||.+|||+.++++
T Consensus 621 l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 621 LYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=250.04 Aligned_cols=173 Identities=16% Similarity=0.180 Sum_probs=131.3
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HcCCeecCCCCCcEEecCCCC------------------C
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-SMQICHRDLKLENTLLDGSTA------------------P 61 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH-~~~ivHrDlkp~Nili~~~~~------------------~ 61 (262)
||||+||++.+.+.+ +.+++..++.++.||+.||.||| ++||+||||||+|||++.++. .
T Consensus 141 ~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~ 219 (336)
T 2vuw_A 141 LEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGL 219 (336)
T ss_dssp EEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTE
T ss_pred EEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCc
Confidence 799999988777754 56999999999999999999999 999999999999999986641 2
Q ss_pred cEEEeccCCCcCCCCCCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHH-HHHHHhCCCCCCCCCChh-HHHHHhcc
Q 024809 62 RVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVT-LYVMLVGAYPFEDPEDPK-NFRKTIGR 139 (262)
Q Consensus 62 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~i-l~~ll~g~~pf~~~~~~~-~~~~~~~~ 139 (262)
.+||+|||+|+... ....+||+.|+|||++.+.. +.++||||+|++ .+++++|..||....... ........
T Consensus 220 ~vkL~DFG~a~~~~----~~~~~gt~~y~aPE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~ 293 (336)
T 2vuw_A 220 QVSIIDYTLSRLER----DGIVVFCDVSMDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQ 293 (336)
T ss_dssp EEEECCCTTCBEEE----TTEEECCCCTTCSGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHT
T ss_pred eEEEeeccccEecC----CCcEEEeecccChhhhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhh
Confidence 79999999998543 23568999999999998665 456999998777 777888999985311001 11111111
Q ss_pred cccc-cccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHh-cCcccc
Q 024809 140 ILSV-HYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIK-NHPWFL 185 (262)
Q Consensus 140 ~~~~-~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l-~hp~~~ 185 (262)
.... ....+....+++++++||++||++| |+.|+| +||||+
T Consensus 294 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 294 MTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp CCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred hccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 1111 1111112357889999999999977 999999 999984
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-32 Score=258.28 Aligned_cols=163 Identities=22% Similarity=0.278 Sum_probs=131.2
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
||||+||+|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++.... .
T Consensus 163 ~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~---~~kl~DFG~a~~~~~---~ 234 (681)
T 2pzi_A 163 MEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSRINS---F 234 (681)
T ss_dssp EECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS---CEEECCCTTCEETTC---C
T ss_pred EEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC---cEEEEecccchhccc---C
Confidence 799999999998765 69999999999999999999999999999999999999864 699999999975432 2
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 160 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 160 (262)
....||+.|+|||++.+.. +.++|||||||++|+|++|..||.+.... .+. ........++.+.+|
T Consensus 235 ~~~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------~~~----~~~~~~~~~~~l~~l 300 (681)
T 2pzi_A 235 GYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVD--------GLP----EDDPVLKTYDSYGRL 300 (681)
T ss_dssp SCCCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETTEECS--------SCC----TTCHHHHHCHHHHHH
T ss_pred CccCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCcccccc--------ccc----ccccccccCHHHHHH
Confidence 5567999999999986543 45699999999999999999888752110 000 011112356789999
Q ss_pred HHHhcccCCCCCCCHhHHhcCcccc
Q 024809 161 LSRIFVANSEKRITIPEIKNHPWFL 185 (262)
Q Consensus 161 i~~~L~~dp~~R~s~~e~l~hp~~~ 185 (262)
|.+||+.||.+||+..+.+.|+|+.
T Consensus 301 i~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 301 LRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HhhhccCChhhCCCHHHHHHHHHHH
Confidence 9999999999999999999998874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.96 E-value=7.9e-30 Score=217.00 Aligned_cols=147 Identities=14% Similarity=0.107 Sum_probs=113.8
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
||||+||+|.+++... .....+..++.||+.||.|||++||+||||||+|||++.++ .+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g--~~kl~~~~----------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDG--DVVLAYPA----------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTS--CEEECSCC-----------
T ss_pred EEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCC--CEEEEecc-----------
Confidence 7999999999999543 46678899999999999999999999999999999998777 88987443
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccC--CCcccCCHHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECK 158 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 158 (262)
|++| .+.++|||||||++|+|++|+.||.+......+......+. ..... .....+++++.
T Consensus 175 --------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~ 237 (286)
T 3uqc_A 175 --------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTA-GQPIEPADIDRDIPFQIS 237 (286)
T ss_dssp --------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTT-SCBCCHHHHCTTSCHHHH
T ss_pred --------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhc-cCCCChhhcccCCCHHHH
Confidence 2332 24558999999999999999999987654322111111111 11111 11236889999
Q ss_pred HHHHHhcccCCCCCCCHhHHhc
Q 024809 159 HLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 159 ~li~~~L~~dp~~R~s~~e~l~ 180 (262)
+||.+||+.||.+| |+.++++
T Consensus 238 ~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 238 AVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp HHHHHHHCTTSSCC-CHHHHHH
T ss_pred HHHHHHcccCCccC-CHHHHHH
Confidence 99999999999999 9999987
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.5e-30 Score=236.21 Aligned_cols=116 Identities=16% Similarity=0.167 Sum_probs=84.8
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-CC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (262)
||||+||+|.++|...+.+++. .|+.||+.||.|||++|||||||||+|||++.++ ++||+|||+|+..... ..
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg--~vKL~DFGlAr~~~~~~~~ 395 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQ--HARLIDFGSIVTTPQDCSW 395 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTS--CEEECCCTTEESCC---CC
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCC--CEEEeecccCeeCCCCCcc
Confidence 8999999999999999999875 4789999999999999999999999999998777 8999999999865432 23
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCC
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYP 123 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p 123 (262)
..+.+||+.|||||++.+.. . ..+|+||+|++++.+.++..+
T Consensus 396 ~~t~vGTp~YmAPE~l~g~~-~-~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAENK-S-WNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp SHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred ccCceechhhccHHHhCCCC-C-Ccccccccccchhhhccccch
Confidence 44578999999999997643 2 347999999998887665433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.4e-21 Score=179.80 Aligned_cols=111 Identities=23% Similarity=0.250 Sum_probs=92.6
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC-
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ- 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~- 79 (262)
||||+||+|.+++.. +..++.|++.||.|||++||+||||||+|||++. .+||+|||+++.......
T Consensus 418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~----~~kL~DFGla~~~~~~~~~ 485 (540)
T 3en9_A 418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK----DLYIIDFGLGKISNLDEDK 485 (540)
T ss_dssp EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS----SEEECCCTTCEECCCHHHH
T ss_pred EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC----eEEEEECccCEECCCcccc
Confidence 799999999999876 6789999999999999999999999999999976 699999999986533211
Q ss_pred -------CCccccCCCCCCcccccC--CcCCCCchhHHHHHHHHHHHHhCCCCC
Q 024809 80 -------PKSTVGTPAYIAPEVLTK--KEYDGKIADVWSCGVTLYVMLVGAYPF 124 (262)
Q Consensus 80 -------~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf 124 (262)
.....||+.|||||++.. ..|... +|+||.++-..+.+.++.+|
T Consensus 486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~-~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSV-YDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHH-CTTHHHHHHHHHHHHTCSCC
T ss_pred ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHH-HhHHHHHHHHHHHHHhcccc
Confidence 125679999999999976 455434 79999998888887776665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=2.1e-17 Score=140.02 Aligned_cols=74 Identities=23% Similarity=0.241 Sum_probs=62.8
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
||||+||+|.+ +. ......++.|++.||.|||++||+||||||+|||++ ++ .+||+|||+|+.
T Consensus 179 mE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~--~vkl~DFG~a~~------- 241 (282)
T 1zar_A 179 MELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EE--GIWIIDFPQSVE------- 241 (282)
T ss_dssp EECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TT--EEEECCCTTCEE-------
T ss_pred EEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CC--cEEEEECCCCeE-------
Confidence 79999999987 42 134567999999999999999999999999999998 55 899999999863
Q ss_pred CccccCCCCCCccccc
Q 024809 81 KSTVGTPAYIAPEVLT 96 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~ 96 (262)
+..++|||.+.
T Consensus 242 -----~~~~~a~e~l~ 252 (282)
T 1zar_A 242 -----VGEEGWREILE 252 (282)
T ss_dssp -----TTSTTHHHHHH
T ss_pred -----CCCCCHHHHHH
Confidence 34568898874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=9.4e-14 Score=115.89 Aligned_cols=66 Identities=21% Similarity=0.277 Sum_probs=55.1
Q ss_pred CCCCCC-C----chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HcCCeecCCCCCcEEecCCCCCcEEEeccCCCcC
Q 024809 1 MEYAAG-G----ELFERICNAGRFSEDEARFFFQQLISGVSYCH-SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS 73 (262)
Q Consensus 1 mE~~~g-g----~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH-~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (262)
|||+.+ | +|.+.... +++..+..++.|++.||.||| +.||+||||||+|||++. .++|+|||+|..
T Consensus 147 mE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~----~~~liDFG~a~~ 218 (258)
T 1zth_A 147 MEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID----KVYFIDMGQAVT 218 (258)
T ss_dssp EECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS----SEEECCCTTCEE
T ss_pred EEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC----cEEEEECccccc
Confidence 799932 4 67666433 346678899999999999999 999999999999999975 699999999964
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.18 E-value=4.5e-12 Score=111.19 Aligned_cols=66 Identities=15% Similarity=0.105 Sum_probs=54.1
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCC--------cEEEeccCCCc
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAP--------RVKICDFGYSK 72 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~--------~~kl~Dfg~a~ 72 (262)
|||++|++|.++. .......++.||+.+|.+||++|||||||||.|||++.++++ .+.|+||+.+.
T Consensus 190 ME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 190 MSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp EECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCE
T ss_pred EEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcc
Confidence 8999999986542 223456789999999999999999999999999999766532 27899998765
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.49 E-value=5.4e-08 Score=82.57 Aligned_cols=119 Identities=20% Similarity=0.218 Sum_probs=77.8
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS---------------------------------------- 40 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~---------------------------------------- 40 (262)
||+++|.+|...... .++..+...++.|+...|..||+
T Consensus 95 m~~i~G~~l~~~~~~--~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLLN--NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHHH--TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCccccc--cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 567999888765443 47888889999999999999996
Q ss_pred ------------------cCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCCCccccCCCC---CCcccccC--
Q 024809 41 ------------------MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAY---IAPEVLTK-- 97 (262)
Q Consensus 41 ------------------~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y---~aPE~~~~-- 97 (262)
..++|+|++|.||+++.+....+.|+||+.+...... .-......+ ..|+....
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~---~Dl~~~~~~~~~~~~~~~~~~l 249 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD---NDFISLMEDDEEYGMEFVSKIL 249 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT---HHHHTTCCTTTSCCHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH---HHHHHHHhhccccCHHHHHHHH
Confidence 1369999999999998742225789999987532110 000000111 22222110
Q ss_pred CcCCCC-----------chhHHHHHHHHHHHHhCCCCC
Q 024809 98 KEYDGK-----------IADVWSCGVTLYVMLVGAYPF 124 (262)
Q Consensus 98 ~~~~~~-----------~~DiwslG~il~~ll~g~~pf 124 (262)
..|... ..+.|++|.++|.+.+|..+|
T Consensus 250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 001011 158999999999999998766
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=4e-07 Score=75.24 Aligned_cols=65 Identities=22% Similarity=0.210 Sum_probs=50.9
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS---------------------------------------- 40 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~---------------------------------------- 40 (262)
|||++|.+|.+.+. +......++.++..+|..||+
T Consensus 89 ~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 89 MSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 79999999876531 223345788999999999998
Q ss_pred -------------------cCCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 41 -------------------MQICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 41 -------------------~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
..++|+|++|.||+++.+. .+.|+||+.+.
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~--~~~lIDwe~a~ 212 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK--VSGFIDLGRSG 212 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE--EEEECCCTTCE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc--EEEEEEchhcc
Confidence 4589999999999997543 45699998664
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.26 E-value=4.4e-07 Score=78.70 Aligned_cols=71 Identities=20% Similarity=0.375 Sum_probs=57.1
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS---------------------------------------- 40 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~---------------------------------------- 40 (262)
|||++|..+.+.. ...+++.....++.+++.+|..||+
T Consensus 120 me~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 120 MEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp EECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred EEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 7899998775422 2247888999999999999999997
Q ss_pred ------------------cCCeecCCCCCcEEecCCCCCcEEEeccCCCcC
Q 024809 41 ------------------MQICHRDLKLENTLLDGSTAPRVKICDFGYSKS 73 (262)
Q Consensus 41 ------------------~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (262)
..++|+|++|.||+++.++...+.|+||+.+..
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 358999999999999866532468999998863
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.11 E-value=6.9e-07 Score=73.31 Aligned_cols=28 Identities=21% Similarity=0.275 Sum_probs=23.5
Q ss_pred CeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 43 ICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 43 ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
++|+|++|.||+++.+. .+.|+|||.+.
T Consensus 186 l~HgDl~~~Nil~~~~~--~~~liD~~~a~ 213 (264)
T 1nd4_A 186 VTHGDACLPNIMVENGR--FSGFIDCGRLG 213 (264)
T ss_dssp EECSSCCGGGEEEETTE--EEEECCCTTCE
T ss_pred EECCCCCCCcEEEECCc--EEEEEcchhcc
Confidence 99999999999997543 45699999764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.01 E-value=0.00013 Score=58.38 Aligned_cols=122 Identities=15% Similarity=0.041 Sum_probs=74.7
Q ss_pred CchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCCCccc
Q 024809 7 GELFERICN-AGRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTV 84 (262)
Q Consensus 7 g~L~~~i~~-~~~l~e~~~~~~~~ql~~aL~~LH~-~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 84 (262)
-+|.++|.. +++|+|+++|.+++|.+.+|.-+-. +.-..+=+.|..|++..+| .|...+ +.+. .
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG--~V~f~~-~~s~-----------~ 98 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDG--AVTLAP-AADD-----------A 98 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTS--CEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCC--ceeccc-cccc-----------c
Confidence 368888874 5589999999999999999877622 1111233446888887777 665442 1110 1
Q ss_pred cCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHHHHHh
Q 024809 85 GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 164 (262)
Q Consensus 85 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 164 (262)
....+.|||.... ....+.=|||||+++|.-+-=..|- .....+|+++..||..|
T Consensus 99 ~~~~~~~pe~~~~--~~te~~~IysLG~tLY~ALDygL~e-----------------------~eE~eLS~~LE~LL~~M 153 (229)
T 2yle_A 99 GEPPPVAGKLGYS--QCMETEVIESLGIIIYKALDYGLKE-----------------------NEERELSPPLEQLIDHM 153 (229)
T ss_dssp --------CCSSS--SSCHHHHHHHHHHHHHHHHTTTCCT-----------------------TEEECCCHHHHHHHHHH
T ss_pred cccCCCChhhccc--cchHHHHHHHHHHHHHHHhhcCCCc-----------------------ccchhhCHHHHHHHHHH
Confidence 1224567877631 2223368999999999887421111 11236899999999999
Q ss_pred ccc
Q 024809 165 FVA 167 (262)
Q Consensus 165 L~~ 167 (262)
..-
T Consensus 154 t~~ 156 (229)
T 2yle_A 154 ANT 156 (229)
T ss_dssp TTC
T ss_pred Hhc
Confidence 766
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00025 Score=59.97 Aligned_cols=70 Identities=20% Similarity=0.171 Sum_probs=48.5
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc---------------------------------------
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM--------------------------------------- 41 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~--------------------------------------- 41 (262)
|||++|.+|...... .++......++.++...|..||+.
T Consensus 92 ~e~i~G~~l~~~~~~--~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 92 YRKVQGQILGEDGMA--VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp EECCCSEECHHHHHT--TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred EeccCCeECchhhhh--hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 678888877664322 256666666677777776666642
Q ss_pred ---------------------CCeecCCCCCcEEecCC-CCCc-EEEeccCCCc
Q 024809 42 ---------------------QICHRDLKLENTLLDGS-TAPR-VKICDFGYSK 72 (262)
Q Consensus 42 ---------------------~ivHrDlkp~Nili~~~-~~~~-~kl~Dfg~a~ 72 (262)
.++|+|++|.||+++.+ ..+. +.|+||+.+.
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 34899999999999861 1124 4799999775
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0014 Score=53.93 Aligned_cols=28 Identities=25% Similarity=0.452 Sum_probs=23.2
Q ss_pred CeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 43 ICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 43 ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
++|+|+.+.||+++.++ .+-|+||+.+.
T Consensus 195 l~HGDl~~~Nil~~~~~--~~~viDwe~a~ 222 (272)
T 4gkh_A 195 VTHGDFSLDNLIFDEGK--LIGCIDVGRVG 222 (272)
T ss_dssp EECSCCCTTSEEEETTE--EEEECCCTTCE
T ss_pred EEcCCCCCCeEEEECCe--EEEEEECcccc
Confidence 78999999999998654 45699998764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=96.55 E-value=0.0031 Score=53.44 Aligned_cols=30 Identities=27% Similarity=0.480 Sum_probs=25.5
Q ss_pred cCCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 41 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 41 ~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
..++|+|+++.||+++.++ .+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~--~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENE--QIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGG--CEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCC--cEEEEehhhcc
Confidence 5799999999999997554 68999998664
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=96.04 E-value=0.0017 Score=55.65 Aligned_cols=30 Identities=17% Similarity=0.193 Sum_probs=24.3
Q ss_pred cCCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 41 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 41 ~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
..++|+|++|.||+++.+. .+.|+||+.+.
T Consensus 222 ~~l~HgDl~~~Nil~~~~~--~~~vIDwe~a~ 251 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQ--PVAVLDWEMVA 251 (357)
T ss_dssp CEEECSSCSGGGEEEETTE--EEEECCGGGCE
T ss_pred ceEEeCCCCCCeEEEeCCc--EEEEEcccccc
Confidence 4689999999999998422 46899998775
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=95.29 E-value=0.012 Score=51.78 Aligned_cols=32 Identities=16% Similarity=0.279 Sum_probs=26.7
Q ss_pred HHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcC
Q 024809 39 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS 73 (262)
Q Consensus 39 H~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (262)
+...++|+|++|.||+++.++ ++++||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~---~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS---TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC---EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC---CEEEeCccccc
Confidence 456799999999999997553 89999998763
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=94.11 E-value=0.062 Score=44.74 Aligned_cols=28 Identities=39% Similarity=0.499 Sum_probs=23.0
Q ss_pred CCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 42 QICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 42 ~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
.++|+|+.+.||+.+ ++ .+.++||..+.
T Consensus 174 ~l~HgDl~~~Nil~~-~~--~~~lID~e~a~ 201 (301)
T 3dxq_A 174 AACHCDPLCENFLDT-GE--RMWIVDWEYSG 201 (301)
T ss_dssp EEECSCCCGGGEEEC-SS--CEEECCCTTCE
T ss_pred eeeccCCCcCCEEEC-CC--CEEEEeccccc
Confidence 389999999999953 33 68999998775
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=93.83 E-value=0.027 Score=47.32 Aligned_cols=30 Identities=23% Similarity=0.351 Sum_probs=24.3
Q ss_pred cCCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 41 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 41 ~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
.+++|+|+++.||+++.+. .+.|+||+.+.
T Consensus 187 ~~liHgDl~~~Nil~~~~~--~~~lIDf~~a~ 216 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDE--LSGLIDFYFAC 216 (322)
T ss_dssp EEEECSCCCGGGEEEETTE--EEEECCCTTCE
T ss_pred cccCCCCCCccCEEEeCCc--eEEEecchhcc
Confidence 4699999999999997653 44799998664
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=93.51 E-value=0.031 Score=47.25 Aligned_cols=32 Identities=34% Similarity=0.447 Sum_probs=25.8
Q ss_pred cCCeecCCCCCcEEecCCC--CCcEEEeccCCCc
Q 024809 41 MQICHRDLKLENTLLDGST--APRVKICDFGYSK 72 (262)
Q Consensus 41 ~~ivHrDlkp~Nili~~~~--~~~~kl~Dfg~a~ 72 (262)
..++|+|+.+.||+++.+. .+.+.|+||+.+.
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence 4699999999999997641 1268999999875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=92.97 E-value=0.074 Score=44.67 Aligned_cols=28 Identities=18% Similarity=0.171 Sum_probs=23.7
Q ss_pred cCCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 41 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 41 ~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
..++|+|+++.||+++ + .+.|+||+.+.
T Consensus 195 ~~l~HgD~~~~Nil~~-~---~~~lIDfe~a~ 222 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D---GPMFVDLDDAR 222 (328)
T ss_dssp CEECCSSCSGGGEEES-S---SEEECCCTTCC
T ss_pred eeeeeCCCCcccEeEc-C---CCEEEECCCCC
Confidence 4588999999999997 3 58999998765
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=91.80 E-value=0.17 Score=43.36 Aligned_cols=29 Identities=31% Similarity=0.637 Sum_probs=23.8
Q ss_pred cCCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 41 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 41 ~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
..++|+|+++.|||++.+ .+.|+||..+.
T Consensus 212 ~~l~HgDl~~~Nil~~~~---~~~lID~e~a~ 240 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNK---CLRLIDFEYSG 240 (369)
T ss_dssp EEEECSCCCGGGEEECC----CEEECCCTTCE
T ss_pred eEEEeCCCCcccEEecCC---cEEEEEecCCC
Confidence 358999999999999743 48999998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=91.65 E-value=0.13 Score=44.52 Aligned_cols=30 Identities=17% Similarity=0.248 Sum_probs=24.9
Q ss_pred HcCCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 40 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 40 ~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
...++|+|+.|.||+++.+ .++++||..+.
T Consensus 226 ~~~L~HGDl~~~Nil~~~~---~~~lID~e~a~ 255 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH---ETKVIDPEFAF 255 (397)
T ss_dssp CCEEECSCCSGGGEEECSS---CEEECCCTTCE
T ss_pred CCceeeCCCCcCcEEEeCC---CeEEEeCcccc
Confidence 3579999999999999754 48999997664
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=91.40 E-value=0.1 Score=44.36 Aligned_cols=30 Identities=23% Similarity=0.480 Sum_probs=25.5
Q ss_pred cCCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 41 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 41 ~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
..++|+|+.+.||+++.++ .+.|+||+.+.
T Consensus 206 ~~~~HgD~~~~N~l~~~~~--~~~~iD~e~~~ 235 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEE--SIYIIDWDEPM 235 (339)
T ss_dssp CEEECSCCCGGGEEECGGG--CEEECCCSSCE
T ss_pred ceeEeCCCCcCCEEEeCCC--eEEEEECCCCe
Confidence 4699999999999997654 68999998765
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=89.31 E-value=0.23 Score=44.28 Aligned_cols=15 Identities=33% Similarity=0.541 Sum_probs=14.1
Q ss_pred CCeecCCCCCcEEec
Q 024809 42 QICHRDLKLENTLLD 56 (262)
Q Consensus 42 ~ivHrDlkp~Nili~ 56 (262)
.++|+|+.+.|||++
T Consensus 291 v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 291 VLCHCDLLSSNIINT 305 (458)
T ss_dssp EEECSCCCGGGEEEC
T ss_pred eEEecCCCCCcEEee
Confidence 589999999999997
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=88.34 E-value=0.16 Score=44.85 Aligned_cols=17 Identities=41% Similarity=0.704 Sum_probs=14.7
Q ss_pred CCeecCCCCCcEEecCC
Q 024809 42 QICHRDLKLENTLLDGS 58 (262)
Q Consensus 42 ~ivHrDlkp~Nili~~~ 58 (262)
.++|+|+.+.|||++.+
T Consensus 250 v~~H~Dl~~gNiL~~~~ 266 (429)
T 1nw1_A 250 TFCHNDLQEGNILLPKA 266 (429)
T ss_dssp EEECSCCCGGGEEEEC-
T ss_pred EEEeCCCCCCeEEeeCC
Confidence 58999999999999764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=86.55 E-value=0.31 Score=42.30 Aligned_cols=31 Identities=35% Similarity=0.610 Sum_probs=24.8
Q ss_pred CCeecCCCCCcEEecCC--CCCcEEEeccCCCc
Q 024809 42 QICHRDLKLENTLLDGS--TAPRVKICDFGYSK 72 (262)
Q Consensus 42 ~ivHrDlkp~Nili~~~--~~~~~kl~Dfg~a~ 72 (262)
.++|+|+.+.||+++.+ ..+.+.++||..+.
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 58999999999999765 12378999998764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=83.63 E-value=0.52 Score=40.98 Aligned_cols=30 Identities=37% Similarity=0.596 Sum_probs=23.6
Q ss_pred CeecCCCCCcEEecC----CCCCcEEEeccCCCc
Q 024809 43 ICHRDLKLENTLLDG----STAPRVKICDFGYSK 72 (262)
Q Consensus 43 ivHrDlkp~Nili~~----~~~~~~kl~Dfg~a~ 72 (262)
++|+|+.+.||++.. +....++++||..|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 679999999999943 122379999998775
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 262 | ||||
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-56 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-54 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-53 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-53 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-52 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-52 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-50 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-50 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-50 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-49 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-49 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-48 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-48 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-47 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-46 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-46 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-46 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-43 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-41 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-39 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-38 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-37 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-37 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-37 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-35 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-35 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-35 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-34 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-34 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-34 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-33 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-33 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-33 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-32 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-32 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-32 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-32 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-31 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-31 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-30 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-30 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-30 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-30 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-29 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 9e-29 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-28 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-27 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-26 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-26 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-26 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-25 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-09 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 2e-56
Identities = 69/192 (35%), Positives = 100/192 (52%), Gaps = 8/192 (4%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+EY +GGELF+RI E +A+ FF QL++GV Y H + I HRD+K EN LLD
Sbjct: 82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD- 140
Query: 61 PRVKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVM 117
+KI DFG + +++ + GT Y+APE+L ++E+ + DVWSCG+ L M
Sbjct: 141 -NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 199
Query: 118 LVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPE 177
L G P++ P D + ++ LL +I V N RITIP+
Sbjct: 200 LAGELPWDQPSDSCQEYS---DWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPD 256
Query: 178 IKNHPWFLRNLP 189
IK W+ + L
Sbjct: 257 IKKDRWYNKPLK 268
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 2e-56
Identities = 64/187 (34%), Positives = 101/187 (54%), Gaps = 10/187 (5%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+EYA G ++ + +F E + +L + +SYCHS ++ HRD+K EN LL +
Sbjct: 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA-- 142
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
+KI DFG+S + S+ + GT Y+ PE++ + +D K D+WS GV Y LVG
Sbjct: 143 GELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVG 200
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180
PFE +++T RI V ++FPD+ V+ + L+SR+ N +R + E+
Sbjct: 201 KPPFEA----NTYQETYKRISRVEFTFPDF--VTEGARDLISRLLKHNPSQRPMLREVLE 254
Query: 181 HPWFLRN 187
HPW N
Sbjct: 255 HPWITAN 261
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 177 bits (450), Expect = 1e-54
Identities = 62/231 (26%), Positives = 99/231 (42%), Gaps = 18/231 (7%)
Query: 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
+E+ +GGELF+RI + SE E + +Q G+ + H I H D+K EN + +
Sbjct: 105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKK 164
Query: 60 APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
A VKI DFG + K T T + APE++ ++ D+W+ GV YV+L
Sbjct: 165 ASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLS 223
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHLLSRIFVANSEKRITIPE 177
G PF +D + + + + F + + VS E K + + KR+T+ +
Sbjct: 224 GLSPFAGEDDLETLQN----VKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHD 279
Query: 178 IKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHEATKPLEAPR 228
HPW G + PS ++ I E AP+
Sbjct: 280 ALEHPWLK----------GDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQ 320
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 172 bits (438), Expect = 1e-53
Identities = 64/191 (33%), Positives = 93/191 (48%), Gaps = 13/191 (6%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+ GELF+ + SE E R + L+ + H + I HRDLK EN LLD
Sbjct: 89 FDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM- 147
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYD-----GKIADVWSCGVTLY 115
+K+ DFG+S + + GTP+Y+APE++ D GK D+WS GV +Y
Sbjct: 148 -NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMY 206
Query: 116 VMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECKHLLSRIFVANSEKRI 173
+L G+ PF + + I+S +Y F P++ S K L+SR V +KR
Sbjct: 207 TLLAGSPPFWH----RKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY 262
Query: 174 TIPEIKNHPWF 184
T E HP+F
Sbjct: 263 TAEEALAHPFF 273
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 6e-53
Identities = 70/198 (35%), Positives = 101/198 (51%), Gaps = 6/198 (3%)
Query: 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
ME GGELF RI + G F+E EA + + + Y HS+ I HRD+K EN L
Sbjct: 88 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSK 147
Query: 59 TAP-RVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVM 117
+K+ DFG++K + H+ + TP Y+APEVL ++YD D+WS GV +Y++
Sbjct: 148 RPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYIL 206
Query: 118 LVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHLLSRIFVANSEKRITI 175
L G PF RI Y FP+ + VS E K L+ + +R+TI
Sbjct: 207 LCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI 266
Query: 176 PEIKNHPWFLRNLPIELT 193
E NHPW +++ + T
Sbjct: 267 TEFMNHPWIMQSTKVPQT 284
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 171 bits (435), Expect = 3e-52
Identities = 57/187 (30%), Positives = 91/187 (48%), Gaps = 8/187 (4%)
Query: 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
E+ +GGELFE++ + + SEDEA + +Q+ G+ + H H DLK EN +
Sbjct: 102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKR 161
Query: 60 APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+ +K+ DFG + K T GT + APEV K D+WS GV Y++L
Sbjct: 162 SNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY-TDMWSVGVLSYILLS 220
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHLLSRIFVANSEKRITIPE 177
G PF D + R + S ++ D + +S + K + ++ +A+ R+TI +
Sbjct: 221 GLSPFGGENDDETLRN----VKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQ 276
Query: 178 IKNHPWF 184
HPW
Sbjct: 277 ALEHPWL 283
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 6e-52
Identities = 51/192 (26%), Positives = 89/192 (46%), Gaps = 8/192 (4%)
Query: 1 MEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
E+ +G ++FERI +A +E E + Q+ + + HS I H D++ EN +
Sbjct: 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRR 139
Query: 60 APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+ +KI +FG ++ + P Y APEV D+WS G +YV+L
Sbjct: 140 SSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA-TDMWSLGTLVYVLLS 198
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHLLSRIFVANSEKRITIPE 177
G PF + ++ I I++ Y+F + + +S+E + R+ V + R+T E
Sbjct: 199 GINPFLA----ETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASE 254
Query: 178 IKNHPWFLRNLP 189
HPW + +
Sbjct: 255 ALQHPWLKQKIE 266
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 2e-50
Identities = 59/193 (30%), Positives = 96/193 (49%), Gaps = 18/193 (9%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+ YA GEL + I G F E RF+ +++S + Y H I HRDLK EN LL+
Sbjct: 87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED-- 144
Query: 61 PRVKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVM 117
++I DFG +K S+ VGT Y++PE+LT+K +D+W+ G +Y +
Sbjct: 145 MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKS-SDLWALGCIIYQL 203
Query: 118 LVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITI-- 175
+ G PF N +I+ + Y FP+ + + + L+ ++ V ++ KR+
Sbjct: 204 VAGLPPFRA----GNEYLIFQKIIKLEYDFPE--KFFPKARDLVEKLLVLDATKRLGCEE 257
Query: 176 ----PEIKNHPWF 184
+K HP+F
Sbjct: 258 MEGYGPLKAHPFF 270
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 5e-50
Identities = 48/186 (25%), Positives = 83/186 (44%), Gaps = 9/186 (4%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM--QICHRDLKLENTLLDGS 58
E G L + R + +Q++ G+ + H+ I HRDLK +N + G
Sbjct: 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP 150
Query: 59 TAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 118
T VKI D G + S K+ +GTP ++APE+ +K YD DV++ G+ + M
Sbjct: 151 T-GSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMYEEK-YDES-VDVYAFGMCMLEMA 206
Query: 119 VGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEI 178
YP+ + ++ + R+ S E K ++ N ++R +I ++
Sbjct: 207 TSEYPYSECQNAAQIYR---RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263
Query: 179 KNHPWF 184
NH +F
Sbjct: 264 LNHAFF 269
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 164 bits (416), Expect = 5e-50
Identities = 69/194 (35%), Positives = 96/194 (49%), Gaps = 8/194 (4%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
M+ +GGELF+RI G ++E +A Q++ V Y H + I HRDLK EN L
Sbjct: 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDE 145
Query: 61 P-RVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
++ I DFG SK S + GTP Y+APEVL +K Y D WS GV Y++L
Sbjct: 146 DSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKA-VDCWSIGVIAYILLC 204
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECKHLLSRIFVANSEKRITIPE 177
G PF D +N K +IL Y F P + +S K + + + EKR T +
Sbjct: 205 GYPPFYD----ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQ 260
Query: 178 IKNHPWFLRNLPIE 191
HPW + ++
Sbjct: 261 ALQHPWIAGDTALD 274
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (408), Expect = 8e-49
Identities = 51/192 (26%), Positives = 76/192 (39%), Gaps = 13/192 (6%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY G + E E + G++Y HS + HRD+K N LL
Sbjct: 94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG- 152
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL---TKKEYDGKIADVWSCGVTLYVM 117
VK+ DFG + + + S VGTP ++APEV+ + +YDGK DVWS G+T +
Sbjct: 153 -LVKLGDFGSAS---IMAPANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIEL 207
Query: 118 LVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPE 177
P + N + I S ++ + + R T
Sbjct: 208 AERKPPLFN----MNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEV 263
Query: 178 IKNHPWFLRNLP 189
+ H + LR P
Sbjct: 264 LLKHRFVLRERP 275
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 9e-49
Identities = 55/226 (24%), Positives = 92/226 (40%), Gaps = 43/226 (19%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ-ICHRDLKLENTLLDGST 59
ME+ GG L + + AGR E +I G++Y I HRD+K N L++
Sbjct: 83 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR- 141
Query: 60 APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+K+CDFG S ++ S S VGT +Y++PE L Y + +D+WS G++L M V
Sbjct: 142 -GEIKLCDFGVSG-QLIDSMANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAV 198
Query: 120 GAYPFEDPED--------------------------------------PKNFRKTIGRIL 141
G YP P+ P + + I+
Sbjct: 199 GRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIV 258
Query: 142 SVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187
+ SLE + +++ + N +R + ++ H + R+
Sbjct: 259 NEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 1e-48
Identities = 53/191 (27%), Positives = 88/191 (46%), Gaps = 8/191 (4%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY AGG L + + E + ++ + + + HS Q+ HRD+K +N LL
Sbjct: 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-- 152
Query: 61 PRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
VK+ DFG+ +ST VGTP ++APEV+T+K Y K D+WS G+ M+
Sbjct: 153 GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIE 211
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIK 179
G P+ + + + + ++S + L+R + EKR + E+
Sbjct: 212 GEPPYLNENPLRALYL---IATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELL 268
Query: 180 NHPWFLRNLPI 190
H + P+
Sbjct: 269 QHQFLKIAKPL 279
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 1e-48
Identities = 51/190 (26%), Positives = 83/190 (43%), Gaps = 11/190 (5%)
Query: 1 MEYAAGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
+E+ AGG + + R +E + + +Q + ++Y H +I HRDLK N L
Sbjct: 88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLD- 146
Query: 60 APRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKI----ADVWSCGVTL 114
+K+ DFG S + Q + + +GTP ++APEV+ + + ADVWS G+TL
Sbjct: 147 -GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITL 205
Query: 115 YVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRIT 174
M P + + K S + R S K L + N + R T
Sbjct: 206 IEMAEIEPPHHELNPMRVLLKIAK---SEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWT 262
Query: 175 IPEIKNHPWF 184
++ HP+
Sbjct: 263 TSQLLQHPFV 272
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 6e-47
Identities = 52/193 (26%), Positives = 81/193 (41%), Gaps = 18/193 (9%)
Query: 1 MEYAAGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH-----SMQICHRDLKLE 51
MEY GG+L I + E+ QL + CH + HRDLK
Sbjct: 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPA 143
Query: 52 NTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVG-TPAYIAPEVLTKKEYDGKIADVWSC 110
N LDG VK+ DFG ++ + TP Y++PE + + Y+ K +D+WS
Sbjct: 144 NVFLDGK--QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEK-SDIWSL 200
Query: 111 GVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSE 170
G LY + PF + ++ G+I + Y R S E +++R+
Sbjct: 201 GCLLYELCALMPPFTA----FSQKELAGKIREGKFRRIPY-RYSDELNEIITRMLNLKDY 255
Query: 171 KRITIPEIKNHPW 183
R ++ EI +P
Sbjct: 256 HRPSVEEILENPL 268
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 2e-46
Identities = 68/188 (36%), Positives = 105/188 (55%), Gaps = 9/188 (4%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD--GS 58
+E AGGELF+ + +E+EA F +Q+++GV Y HS+QI H DLK EN +L
Sbjct: 92 LELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNV 151
Query: 59 TAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 118
PR+KI DFG + ++ K+ GTP ++APE++ + AD+WS GV Y++L
Sbjct: 152 PKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILL 210
Query: 119 VGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHLLSRIFVANSEKRITIP 176
GA PF ++T+ + +V+Y F D + S K + R+ V + +KR+TI
Sbjct: 211 SGASPFLG----DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQ 266
Query: 177 EIKNHPWF 184
+ HPW
Sbjct: 267 DSLQHPWI 274
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 3e-46
Identities = 67/197 (34%), Positives = 94/197 (47%), Gaps = 18/197 (9%)
Query: 1 MEYAAGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
+E +LF+ I G E+ AR FF Q++ V +CH+ + HRD+K EN L+D +
Sbjct: 88 LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR 147
Query: 60 APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+K+ DFG + + GT Y PE + Y G+ A VWS G+ LY M+
Sbjct: 148 -GELKLIDFGSGAL-LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 205
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIK 179
G PFE E+ I+ F RVS EC+HL+ R T EI+
Sbjct: 206 GDIPFEHDEE----------IIRGQVFFRQ--RVSSECQHLIRWCLALRPSDRPTFEEIQ 253
Query: 180 NHPWFLRN--LPIELTE 194
NHPW ++ LP E E
Sbjct: 254 NHPWM-QDVLLPQETAE 269
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 7e-46
Identities = 69/186 (37%), Positives = 101/186 (54%), Gaps = 11/186 (5%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY GG+L I + +F A F+ ++I G+ + HS I +RDLKL+N LLD
Sbjct: 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG- 140
Query: 61 PRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+KI DFG K ++L +T GTP YIAPE+L ++Y+ D WS GV LY ML+
Sbjct: 141 -HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLI 198
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIP-EI 178
G PF ++ + I + +P + + E K LL ++FV EKR+ + +I
Sbjct: 199 GQSPFHG----QDEEELFHSIRMDNPFYPRW--LEKEAKDLLVKLFVREPEKRLGVRGDI 252
Query: 179 KNHPWF 184
+ HP F
Sbjct: 253 RQHPLF 258
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 148 bits (375), Expect = 3e-43
Identities = 57/189 (30%), Positives = 90/189 (47%), Gaps = 11/189 (5%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
++ GG+L + G FSE + RF+ ++I G+ + H+ + +RDLK N LLD
Sbjct: 86 LDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH-- 143
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
V+I D G + +P ++VGT Y+APEVL K AD +S G L+ +L G
Sbjct: 144 GHVRISDLGLACDFS-KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 202
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIP---- 176
PF K+ + L++ PD S E + LL + + +R+
Sbjct: 203 HSPF-RQHKTKDKHEIDRMTLTMAVELPDS--FSPELRSLLEGLLQRDVNRRLGCLGRGA 259
Query: 177 -EIKNHPWF 184
E+K P+F
Sbjct: 260 QEVKESPFF 268
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 5e-43
Identities = 45/196 (22%), Positives = 79/196 (40%), Gaps = 9/196 (4%)
Query: 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
++ G L+ + +F + +Q G+ Y H+ I HRDLK N L
Sbjct: 82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL 141
Query: 60 APRVKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLTKKEYD--GKIADVWSCGVTL 114
VKI DFG + Q + G+ ++APEV+ ++ + +DV++ G+ L
Sbjct: 142 --TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVL 199
Query: 115 YVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRIT 174
Y ++ G P+ + + +GR K L++ ++R
Sbjct: 200 YELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPL 259
Query: 175 IPEIKNHPWFL-RNLP 189
P+I L R+LP
Sbjct: 260 FPQILASIELLARSLP 275
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 142 bits (358), Expect = 3e-41
Identities = 71/189 (37%), Positives = 102/189 (53%), Gaps = 16/189 (8%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
M+Y GGELF + + RF A+F+ ++ + Y HS I +RDLK EN LLD +
Sbjct: 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN-- 140
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
+KI DFG++K + + GTP YIAPEV++ K Y+ D WS G+ +Y ML G
Sbjct: 141 GHIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAG 197
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI-----TI 175
PF D N KT +IL+ FP + + + K LLSR+ + +R+
Sbjct: 198 YTPFYD----SNTMKTYEKILNAELRFPPF--FNEDVKDLLSRLITRDLSQRLGNLQNGT 251
Query: 176 PEIKNHPWF 184
++KNHPWF
Sbjct: 252 EDVKNHPWF 260
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 9e-40
Identities = 65/190 (34%), Positives = 97/190 (51%), Gaps = 15/190 (7%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEYA GGELF + F+E+ ARF+ +++S + Y HS + +RD+KLEN +LD
Sbjct: 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-- 141
Query: 61 PRVKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+KI DFG K + K+ GTP Y+APEVL +Y D W GV +Y M+
Sbjct: 142 GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMC 200
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI-----T 174
G PF + ++ + IL FP +S E K LL+ + + ++R+
Sbjct: 201 GRLPFYN----QDHERLFELILMEEIRFPRT--LSPEAKSLLAGLLKKDPKQRLGGGPSD 254
Query: 175 IPEIKNHPWF 184
E+ H +F
Sbjct: 255 AKEVMEHRFF 264
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 3e-39
Identities = 56/223 (25%), Positives = 82/223 (36%), Gaps = 29/223 (13%)
Query: 1 MEYAAGG---ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG 57
++Y + + QL ++Y HS ICHRD+K +N LLD
Sbjct: 98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP 157
Query: 58 STAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVM 117
TA K+CDFG +K V S + + Y APE++ DVWS G L +
Sbjct: 158 DTAVL-KLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 216
Query: 118 LVGAYPFEDPEDPKNFRKTIGRILS-------------VHYSFPDY----------VRVS 154
L+G F + I + + + FP R
Sbjct: 217 LLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTP 276
Query: 155 LECKHLLSRIFVANSEKRITIPEIKNHPWF--LRNLPIELTEG 195
E L SR+ R+T E H +F LR+ ++L G
Sbjct: 277 PEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNG 319
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 2e-38
Identities = 48/212 (22%), Positives = 75/212 (35%), Gaps = 26/212 (12%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
++ N+ + + + + G+ Y H I HRDLK N LLD +
Sbjct: 79 FDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN-- 136
Query: 61 PRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+K+ DFG +KS + V T Y APE+L G D+W+ G L +L+
Sbjct: 137 GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLL 196
Query: 120 GAYPFEDPEDPKNFRKTIGRILSV-------HYSFPDYV---------------RVSLEC 157
D + + + S PDYV +
Sbjct: 197 RVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDL 256
Query: 158 KHLLSRIFVANSEKRITIPEIKNHPWFLRNLP 189
L+ +F+ N RIT + +F N P
Sbjct: 257 LDLIQGLFLFNPCARITATQALKMKYF-SNRP 287
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 134 bits (339), Expect = 2e-38
Identities = 42/216 (19%), Positives = 81/216 (37%), Gaps = 36/216 (16%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
E+ + + ++ + RF+ +++ + YCHSM I HRD+K N ++D
Sbjct: 111 FEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH- 166
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
++++ D+G ++ + V + + PE+L + D+WS G L M+
Sbjct: 167 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFR 226
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSF--------------------------------P 148
PF D + I ++L +
Sbjct: 227 KEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSE 286
Query: 149 DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184
+ VS E L ++ + + R+T E HP+F
Sbjct: 287 NQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 133 bits (335), Expect = 1e-37
Identities = 60/183 (32%), Positives = 91/183 (49%), Gaps = 16/183 (8%)
Query: 7 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKIC 66
GE+F + GRFSE ARF+ Q++ Y HS+ + +RDLK EN L+D +++
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG--YIQVT 183
Query: 67 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFED 126
DFG++K + + GTP +APE++ K Y+ D W+ GV +Y M G PF
Sbjct: 184 DFGFAKRV--KGRTWTLCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFA 240
Query: 127 PEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI-----TIPEIKNH 181
+ +I+S FP + S + K LL + + KR + +IKNH
Sbjct: 241 ----DQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294
Query: 182 PWF 184
WF
Sbjct: 295 KWF 297
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 3e-37
Identities = 49/206 (23%), Positives = 74/206 (35%), Gaps = 25/206 (12%)
Query: 1 MEYAAGGEL-FERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
E+ + + + QL+ G+ + HS ++ HRDLK +N L+ S
Sbjct: 94 FEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS- 152
Query: 60 APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
++K+ DFG ++ S V T Y APEVL + Y D+WS G M
Sbjct: 153 -GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFR 210
Query: 120 GAYPFEDPEDPKNFRKTIGRILS-VHYSFPDYVR--------------------VSLECK 158
F D K + I +P V + K
Sbjct: 211 RKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGK 270
Query: 159 HLLSRIFVANSEKRITIPEIKNHPWF 184
LL + N KRI+ +HP+F
Sbjct: 271 DLLLKCLTFNPAKRISAYSALSHPYF 296
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 130 bits (328), Expect = 3e-37
Identities = 39/178 (21%), Positives = 67/178 (37%), Gaps = 9/178 (5%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
MEY G L + + G + A +++ H I HRD+K N ++ + A
Sbjct: 90 MEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA 149
Query: 61 PRVKICDFG--YSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 118
+V + S +Q + +GT Y++PE D + +DV+S G LY +L
Sbjct: 150 VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVL 208
Query: 119 VGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR--VSLECKHLLSRIFVANSEKRIT 174
G PF + + P +S + ++ + N E R
Sbjct: 209 TGEPPFTGDSPVSVAYQ----HVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ 262
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 5e-37
Identities = 56/249 (22%), Positives = 92/249 (36%), Gaps = 33/249 (13%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+ + G +L++ + S D +F Q++ G+ Y HS + HRDLK N LL+ +
Sbjct: 89 VTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT-- 145
Query: 61 PRVKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYV 116
+KICDFG ++ V T Y APE++ + K D+WS G L
Sbjct: 146 CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAE 205
Query: 117 MLVGAYPFEDPEDPKNFRKTIG----------------RILSVHYSFPDYVR-------- 152
ML F +G + + S P +
Sbjct: 206 MLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFP 265
Query: 153 -VSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL-PIELTEGGSWQSHDVNNPSQSL 210
+ LL ++ N KRI + + HP+ + P + + D+
Sbjct: 266 NADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPK 325
Query: 211 EEVLSLIHE 219
E++ LI E
Sbjct: 326 EKLKELIFE 334
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 7e-37
Identities = 41/228 (17%), Positives = 79/228 (34%), Gaps = 42/228 (18%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
++ +F+ E + Q L++G+ Y H +I HRD+K N L+
Sbjct: 96 FDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG- 154
Query: 61 PRVKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY 115
+K+ DFG ++ + ++ + V T Y PE+L + G D+W G +
Sbjct: 155 -VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMA 213
Query: 116 VMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR----------------------- 152
M + + + + I + S V
Sbjct: 214 EMWTRSPIMQG----NTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVK 269
Query: 153 -------VSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN-LPIEL 192
L+ ++ V + +RI + NH +F + +P +L
Sbjct: 270 DRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDL 317
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 1e-36
Identities = 38/183 (20%), Positives = 67/183 (36%), Gaps = 11/183 (6%)
Query: 1 MEYAAGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
EY A G L + + + GR D F + + Y HRDL N L+
Sbjct: 80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED 139
Query: 59 TAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 118
K+ DFG +K S + + APE L +K++ K +DVWS G+ L+ +
Sbjct: 140 N--VAKVSDFGLTKE--ASSTQDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIY 194
Query: 119 VGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEI 178
K+ + + PD ++ + ++ R + ++
Sbjct: 195 SFGRVPYPRIPLKDVVPRVEK--GYKMDAPDG--CPPAVYEVMKNCWHLDAAMRPSFLQL 250
Query: 179 KNH 181
+
Sbjct: 251 REQ 253
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 1e-36
Identities = 59/192 (30%), Positives = 95/192 (49%), Gaps = 12/192 (6%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
++Y GGELF + RF+E E + + +++ + + H + I +RD+KLEN LLD +
Sbjct: 108 LDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN-- 165
Query: 61 PRVKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVL-TKKEYDGKIADVWSCGVTLYVM 117
V + DFG SK + + GT Y+AP+++ K D WS GV +Y +
Sbjct: 166 GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYEL 225
Query: 118 LVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI---- 173
L GA PF + + + RIL +P +S K L+ R+ + + +KR+
Sbjct: 226 LTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EMSALAKDLIQRLLMKDPKKRLGCGP 283
Query: 174 -TIPEIKNHPWF 184
EIK H +F
Sbjct: 284 RDADEIKEHLFF 295
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 1e-35
Identities = 57/246 (23%), Positives = 101/246 (41%), Gaps = 35/246 (14%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
M + G ++ + ED +F Q++ G+ Y H+ I HRDLK N ++
Sbjct: 102 MPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED-- 157
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
+KI DFG ++ S+ V T Y APEV+ + D+WS G + M+ G
Sbjct: 158 CELKILDFGLARQ--ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 215
Query: 121 AYPFEDPED--------------PKNFRKTIGRILSVHY--SFPDYVR---------VSL 155
F+ + P F + + + +Y P+ + S
Sbjct: 216 KTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASP 275
Query: 156 ECKHLLSRIFVANSEKRITIPEIKNHPWF--LRNLPIELTEGGSWQSHDVNNPSQSLEEV 213
+LL ++ V ++E+R+T E HP+F L + E S D + ++L+E
Sbjct: 276 LAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFD--DVDRTLDEW 333
Query: 214 LSLIHE 219
+ ++
Sbjct: 334 KRVTYK 339
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 124 bits (313), Expect = 5e-35
Identities = 45/208 (21%), Positives = 80/208 (38%), Gaps = 26/208 (12%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
E+ G A+ F QL++G++YCH ++ HRDLK +N L++
Sbjct: 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE-- 136
Query: 61 PRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+KI DFG +++ + + + + T Y AP+VL + D+WS G M+
Sbjct: 137 GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN 196
Query: 120 GAYPFEDPEDPKNFRK--------------TIGRILSVHYSFPDYVR---------VSLE 156
G F + + + + +F Y +
Sbjct: 197 GTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDES 256
Query: 157 CKHLLSRIFVANSEKRITIPEIKNHPWF 184
LLS++ + +RIT + H +F
Sbjct: 257 GIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 6e-35
Identities = 39/193 (20%), Positives = 65/193 (33%), Gaps = 18/193 (9%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
ME A G L + + + Q+ G+ Y HRDL N LL
Sbjct: 86 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH- 144
Query: 61 PRVKICDFGYSKS----SVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYV 116
KI DFG SK+ + + APE + ++ K +DVWS GV ++
Sbjct: 145 -YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWE 202
Query: 117 ML-VGAYPFEDPEDPKNFRKTIGRILSVHY-SFPDYVRVSLECKHLLSRIFVANSEKRIT 174
G P+ + + P E L++ + + E R
Sbjct: 203 AFSYGQKPYRG----MKGSEVTAMLEKGERMGCPAG--CPREMYDLMNLCWTYDVENRPG 256
Query: 175 IPEIK---NHPWF 184
++ + ++
Sbjct: 257 FAAVELRLRNYYY 269
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 3e-34
Identities = 43/194 (22%), Positives = 70/194 (36%), Gaps = 19/194 (9%)
Query: 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
ME A GG L + + Q+ G+ Y HRDL N LL
Sbjct: 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR- 145
Query: 60 APRVKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY 115
KI DFG SK ++ + + APE + +++ + +DVWS GVT++
Sbjct: 146 -HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMW 203
Query: 116 VML-VGAYPFEDPEDPKNFRKTIGRILSVHY-SFPDYVRVSLECKHLLSRIFVANSEKRI 173
L G P++ + + I P E L+S ++ E R
Sbjct: 204 EALSYGQKPYKK----MKGPEVMAFIEQGKRMECPPE--CPPELYALMSDCWIYKWEDRP 257
Query: 174 TIPEIK---NHPWF 184
++ ++
Sbjct: 258 DFLTVEQRMRACYY 271
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 5e-34
Identities = 44/187 (23%), Positives = 73/187 (39%), Gaps = 13/187 (6%)
Query: 1 MEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
E A G L +R+ + G F + Q+ G+ Y S + HRDL N LL
Sbjct: 89 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR- 147
Query: 60 APRVKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY 115
VKI DFG + + + + A+ APE L + + +D W GVTL+
Sbjct: 148 -DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHA-SDTWMFGVTLW 205
Query: 116 VMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRIT 174
M G P+ N + + +I P + +++ + + E R T
Sbjct: 206 EMFTYGQEPWIG----LNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPT 261
Query: 175 IPEIKNH 181
+++
Sbjct: 262 FVALRDF 268
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 6e-34
Identities = 45/203 (22%), Positives = 80/203 (39%), Gaps = 26/203 (12%)
Query: 6 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKI 65
+ F + + QL+ G+++CHS ++ HRDLK +N L++ +K+
Sbjct: 86 DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE--GAIKL 143
Query: 66 CDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPF 124
DFG +++ + + + V T Y APE+L +Y D+WS G M+ F
Sbjct: 144 ADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 203
Query: 125 EDPEDPKNFRKTI-------GRILSVHYSFPDYV----------------RVSLECKHLL 161
+ + + S PDY + + + LL
Sbjct: 204 PGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLL 263
Query: 162 SRIFVANSEKRITIPEIKNHPWF 184
S++ + KRI+ HP+F
Sbjct: 264 SQMLHYDPNKRISAKAALAHPFF 286
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 9e-34
Identities = 48/209 (22%), Positives = 81/209 (38%), Gaps = 27/209 (12%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
E+ G + + F QL+ G+ +CHS + HRDLK +N L++ +
Sbjct: 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG- 138
Query: 61 PRVKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 119
+K+ +FG +++ + + S V T Y P+VL + D+WS G +
Sbjct: 139 -ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN 197
Query: 120 GAYPFEDPEDPKNFRKTIGRILSVH--------YSFPDYV----------------RVSL 155
P D + K I R+L PDY +++
Sbjct: 198 AGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNA 257
Query: 156 ECKHLLSRIFVANSEKRITIPEIKNHPWF 184
+ LL + N +RI+ E HP+F
Sbjct: 258 TGRDLLQNLLKCNPVQRISAEEALQHPYF 286
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 1e-33
Identities = 38/195 (19%), Positives = 68/195 (34%), Gaps = 13/195 (6%)
Query: 1 MEYAAGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
EY + G L + + + Q+ SG++Y M HRDL+ N L+ +
Sbjct: 90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN 149
Query: 59 TAPRVKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYV 116
K+ DFG ++ ++ + + APE + K +DVWS G+ L
Sbjct: 150 --LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTE 206
Query: 117 MLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIP 176
+ + + R Y P L+ + + E+R T
Sbjct: 207 LTTKGRVPYPGMVNREVLDQVER----GYRMPCPPECPESLHDLMCQCWRKEPEERPTFE 262
Query: 177 EIKN--HPWFLRNLP 189
++ +F P
Sbjct: 263 YLQAFLEDYFTSTEP 277
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 4e-33
Identities = 37/213 (17%), Positives = 78/213 (36%), Gaps = 11/213 (5%)
Query: 1 MEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
+ G L + + + + Q+ G++Y ++ HRDL N L+
Sbjct: 89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP- 147
Query: 60 APRVKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYV 116
VKI DFG +K + + ++A E + + Y + +DVWS GVT++
Sbjct: 148 -QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWE 205
Query: 117 MLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIP 176
++ D IL P +++ ++ + ++ +++ R
Sbjct: 206 LMTFGSKPYDGIPASEISS----ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFR 261
Query: 177 EIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQS 209
E+ + P + + +P+ S
Sbjct: 262 ELIIEFSKMARDPQRYLVIQGDERMHLPSPTDS 294
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 119 bits (298), Expect = 9e-33
Identities = 42/206 (20%), Positives = 72/206 (34%), Gaps = 17/206 (8%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL-DGST 59
ME + +FS Q+IS + Y HS HRD+K +N L+ G
Sbjct: 82 MELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKK 141
Query: 60 APRVKICDFGYSK--------SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCG 111
V I DFG +K + + + K+ GT Y + E + D+ S G
Sbjct: 142 GNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLG 200
Query: 112 VTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV---RVSLECKHLLSRIFVAN 168
L +G+ P++ + +K RI S P V E L+
Sbjct: 201 YVLMYFNLGSLPWQGLKAATKRQK-YERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLR 259
Query: 169 SEKRITIPEIKN---HPWFLRNLPIE 191
+ + ++ + + + +
Sbjct: 260 FDDKPDYSYLRQLFRNLFHRQGFSYD 285
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 1e-32
Identities = 43/208 (20%), Positives = 77/208 (37%), Gaps = 34/208 (16%)
Query: 1 MEYAAGGELFERI-----------------------CNAGRFSEDEARFFFQQLISGVSY 37
EY G+L + + + ++ F Q+ G+ +
Sbjct: 120 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 179
Query: 38 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEV 94
HRDL N L+ VKICDFG ++ S + + ++APE
Sbjct: 180 LEFKSCVHRDLAARNVLVTHG--KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPES 237
Query: 95 LTKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRV 153
L + Y K +DVWS G+ L+ + +G P+ NF K ++ +
Sbjct: 238 LFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIPVDANFYK----LIQNGFKMDQPFYA 292
Query: 154 SLECKHLLSRIFVANSEKRITIPEIKNH 181
+ E ++ + +S KR + P + +
Sbjct: 293 TEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 2e-32
Identities = 39/197 (19%), Positives = 67/197 (34%), Gaps = 23/197 (11%)
Query: 1 MEYAAGGELFERI----------------CNAGRFSEDEARFFFQQLISGVSYCHSMQIC 44
+EYA G L + + A S + F + G+ Y Q
Sbjct: 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFI 149
Query: 45 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 104
HRDL N L+ + KI DFG S+ ++ + ++A E L Y
Sbjct: 150 HRDLAARNILVGEN--YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN- 206
Query: 105 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 164
+DVWS GV L+ ++ + + + Y + E L+ +
Sbjct: 207 SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ----GYRLEKPLNCDDEVYDLMRQC 262
Query: 165 FVANSEKRITIPEIKNH 181
+ +R + +I
Sbjct: 263 WREKPYERPSFAQILVS 279
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 3e-32
Identities = 50/256 (19%), Positives = 91/256 (35%), Gaps = 37/256 (14%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
+ G I + ++D +F Q++ G+ Y HS I HRDLK N ++
Sbjct: 100 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-- 157
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
+KI DFG ++ + V T Y APE++ + + D+WS G + +L G
Sbjct: 158 CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215
Query: 121 AYPFEDPEDPKNFRKTIGRILSVHYSFPD-----------------------------YV 151
F + + IL + + ++
Sbjct: 216 RTLFPGTDHIDQLKL----ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 271
Query: 152 RVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLE 211
+ LL ++ V +S+KRIT + H +F + + + ++
Sbjct: 272 GANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLID 331
Query: 212 EVLSLIHEATKPLEAP 227
E SL ++ P
Sbjct: 332 EWKSLTYDEVISFVPP 347
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 117 bits (293), Expect = 6e-32
Identities = 38/189 (20%), Positives = 72/189 (38%), Gaps = 16/189 (8%)
Query: 1 MEYAAGGELFE-RICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
E+ G L N G+F+ + + + +G+ Y M HRDL N L++ +
Sbjct: 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNL 165
Query: 60 APRVKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVT 113
K+ DFG S+ S ++ + APE + +++ +DVWS G+
Sbjct: 166 --VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSA-SDVWSYGIV 222
Query: 114 LYVML-VGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKR 172
++ ++ G P+ D + + Y P + L+ + + R
Sbjct: 223 MWEVMSYGERPYWDMTNQDVINA-----IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHR 277
Query: 173 ITIPEIKNH 181
+I N
Sbjct: 278 PKFGQIVNT 286
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (290), Expect = 7e-32
Identities = 40/185 (21%), Positives = 75/185 (40%), Gaps = 12/185 (6%)
Query: 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
EY A G L + RF + + + + Y S Q HRDL N L++
Sbjct: 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ- 136
Query: 60 APRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVM 117
VK+ DFG S+ + S + PEVL ++ K +D+W+ GV ++ +
Sbjct: 137 -GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK-SDIWAFGVLMWEI 194
Query: 118 L-VGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIP 176
+G P+E +T I + ++ S + ++ + +++R T
Sbjct: 195 YSLGKMPYER----FTNSETAEHIAQGLRLYRPHL-ASEKVYTIMYSCWHEKADERPTFK 249
Query: 177 EIKNH 181
+ ++
Sbjct: 250 ILLSN 254
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 1e-31
Identities = 40/184 (21%), Positives = 72/184 (39%), Gaps = 10/184 (5%)
Query: 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
ME GEL + + QL + ++Y S + HRD+ N L+ +
Sbjct: 86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN- 144
Query: 60 APRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVM 117
VK+ DFG S+ + K++ ++APE + + + +DVW GV ++ +
Sbjct: 145 -DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEI 202
Query: 118 LVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPE 177
L+ P IGRI + P L+++ + + +R E
Sbjct: 203 LMHGVK---PFQGVKNNDVIGRIENGER-LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTE 258
Query: 178 IKNH 181
+K
Sbjct: 259 LKAQ 262
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 114 bits (286), Expect = 5e-31
Identities = 39/182 (21%), Positives = 65/182 (35%), Gaps = 11/182 (6%)
Query: 1 MEYAAGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
E+ G L + + R S + Q+ S + Y HRDL N L+ +
Sbjct: 92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN 151
Query: 59 TAPRVKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYV 116
VK+ DFG S+ + ++ + APE L ++ K +DVW+ GV L+
Sbjct: 152 H--LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWE 208
Query: 117 MLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIP 176
+ D + +L Y + L+ + N R +
Sbjct: 209 IATYGMSPYPGIDLSQVYE----LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFA 264
Query: 177 EI 178
EI
Sbjct: 265 EI 266
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 2e-30
Identities = 35/190 (18%), Positives = 67/190 (35%), Gaps = 13/190 (6%)
Query: 1 MEYAAGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS 58
EY G L + + + + + ++ Q+ G+++ HRDL+ N L+ +
Sbjct: 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT 145
Query: 59 TAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYV 116
KI DFG ++ + + APE + + K +DVWS G+ L
Sbjct: 146 --LSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTE 202
Query: 117 MLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIP 176
++ + + R Y E L+ + E R T
Sbjct: 203 IVTHGRIPYPGMTNPEVIQNLER----GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFD 258
Query: 177 EIKN--HPWF 184
+++ +F
Sbjct: 259 YLRSVLEDFF 268
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 2e-30
Identities = 33/184 (17%), Positives = 64/184 (34%), Gaps = 10/184 (5%)
Query: 1 MEYAAGGELFE-RICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
E+ G L + G F+ + + G++Y + HRDL N L+ +
Sbjct: 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ 138
Query: 60 APRVKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVM 117
+K+ DFG ++ ++ T + +PEV + Y K +DVWS GV ++ +
Sbjct: 139 --VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEV 195
Query: 118 LVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPE 177
+ + I + S +++ + E R
Sbjct: 196 FSEGKIPYENRSNSEVVEDIST----GFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSR 251
Query: 178 IKNH 181
+
Sbjct: 252 LLRQ 255
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 111 bits (278), Expect = 7e-30
Identities = 29/194 (14%), Positives = 62/194 (31%), Gaps = 16/194 (8%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
++ +FS +Q+++ V H + +RD+K +N L+ +
Sbjct: 80 IDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNS 139
Query: 61 P---RVKICDFGYSK--------SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWS 109
+ + DFG K + + + K+ GT Y++ +E + D+ +
Sbjct: 140 KNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRR-DDLEA 198
Query: 110 CGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR---VSLECKHLLSRIFV 166
G L G+ P+ ++ RI S P E +
Sbjct: 199 LGHVFMYFLRGSLPW-QGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARN 257
Query: 167 ANSEKRITIPEIKN 180
+ ++
Sbjct: 258 LAFDATPDYDYLQG 271
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 111 bits (278), Expect = 9e-30
Identities = 42/206 (20%), Positives = 74/206 (35%), Gaps = 36/206 (17%)
Query: 1 MEYAAGGELFERICNAGR------------------------FSEDEARFFFQQLISGVS 36
EY A G+L E + + S E +Q+ +G++
Sbjct: 95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMA 154
Query: 37 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK---SSVLHSQPKSTVGTPAYIAPE 93
Y + HRDL N L+ + VKI DFG S+ S+ + + ++ PE
Sbjct: 155 YLSERKFVHRDLATRNCLVGENM--VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPE 212
Query: 94 VLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY-SFPDYVR 152
+ Y + +DVW+ GV L+ + P + I + + + P+
Sbjct: 213 SIFYNRYTTE-SDVWAYGVVLWEIFSYGLQ---PYYGMAHEEVIYYVRDGNILACPEN-- 266
Query: 153 VSLECKHLLSRIFVANSEKRITIPEI 178
LE +L+ + R + I
Sbjct: 267 CPLELYNLMRLCWSKLPADRPSFCSI 292
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 2e-29
Identities = 34/187 (18%), Positives = 67/187 (35%), Gaps = 13/187 (6%)
Query: 1 MEYAAGGELFE-RICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
+ Y G+L + + F Q+ G+ + S + HRDL N +LD
Sbjct: 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK- 166
Query: 60 APRVKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTL 114
VK+ DFG ++ ++A E L +++ K +DVWS GV L
Sbjct: 167 -FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLL 224
Query: 115 YVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRIT 174
+ ++ P + + + + ++ + + +E R +
Sbjct: 225 WELMTRGAPPYPDVNTFDITVYLLQ----GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPS 280
Query: 175 IPEIKNH 181
E+ +
Sbjct: 281 FSELVSR 287
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 9e-29
Identities = 35/183 (19%), Positives = 67/183 (36%), Gaps = 12/183 (6%)
Query: 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 59
EY G L + + G FS + + + +G+ Y +M HRDL N L++ +
Sbjct: 88 TEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL 147
Query: 60 APRVKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY 115
K+ DFG S+ + APE ++ +++ +DVWS G+ ++
Sbjct: 148 --VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSA-SDVWSFGIVMW 204
Query: 116 VMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITI 175
++ K I + P + L+ + + +R
Sbjct: 205 EVMTYGERPYWELSNHEVMKAIND----GFRLPTPMDCPSAIYQLMMQCWQQERARRPKF 260
Query: 176 PEI 178
+I
Sbjct: 261 ADI 263
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 6e-28
Identities = 39/200 (19%), Positives = 68/200 (34%), Gaps = 25/200 (12%)
Query: 1 MEYAAGGELFERICNAGR----------------FSEDEARFFFQQLISGVSYCHSMQIC 44
+E+ G L + + + + + Q+ G+ + S +
Sbjct: 97 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI 156
Query: 45 HRDLKLENTLLDGSTAPRVKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLTKKEYD 101
HRDL N LL VKICDFG ++ + + ++APE + + Y
Sbjct: 157 HRDLAARNILLSEK--NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 214
Query: 102 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL 161
+ +DVWS GV L+ + P + R L + E +
Sbjct: 215 IQ-SDVWSFGVLLWEIFSLGAS---PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTM 270
Query: 162 SRIFVANSEKRITIPEIKNH 181
+ +R T E+ H
Sbjct: 271 LDCWHGEPSQRPTFSELVEH 290
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 1e-27
Identities = 46/220 (20%), Positives = 77/220 (35%), Gaps = 42/220 (19%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 60
ME + + Q++ G+ + HS I HRDLK N ++
Sbjct: 101 MELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-- 155
Query: 61 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 120
+KI DFG ++++ V T Y APEV+ Y + D+WS G + M+
Sbjct: 156 CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV-DIWSVGCIMGEMVRH 214
Query: 121 AYPFEDPEDPKNFRKTI-----------------------GRILSVHYSFPDYVR----- 152
F + + K I R +FP
Sbjct: 215 KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFP 274
Query: 153 --------VSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184
+ + + LLS++ V + KRI++ + HP+
Sbjct: 275 ADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 1e-26
Identities = 38/199 (19%), Positives = 67/199 (33%), Gaps = 27/199 (13%)
Query: 1 MEYAAGGELFERIC------------------NAGRFSEDEARFFFQQLISGVSYCHSMQ 42
EY G+L + + ++ F Q+ G+++ S
Sbjct: 106 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN 165
Query: 43 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLTKKE 99
HRDL N LL KICDFG ++ S ++APE +
Sbjct: 166 CIHRDLAARNILLTHG--RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV 223
Query: 100 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159
Y + +DVWS G+ L+ + + +++ + E
Sbjct: 224 YTFE-SDVWSYGIFLWELFSLGSSPYPGMPVDS---KFYKMIKEGFRMLSPEHAPAEMYD 279
Query: 160 LLSRIFVANSEKRITIPEI 178
++ + A+ KR T +I
Sbjct: 280 IMKTCWDADPLKRPTFKQI 298
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 2e-26
Identities = 39/197 (19%), Positives = 71/197 (36%), Gaps = 26/197 (13%)
Query: 1 MEYAAGGELFERI----------------CNAGRFSEDEARFFFQQLISGVSYCHSMQIC 44
+EYA+ G L E + + S + Q+ G+ Y S +
Sbjct: 98 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI 157
Query: 45 HRDLKLENTLLDGSTAPRVKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLTKKEYD 101
HRDL N L+ +KI DFG ++ + + + ++APE L + Y
Sbjct: 158 HRDLAARNVLVTED--NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 215
Query: 102 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL 161
+ +DVWS GV L+ + + K + + + E ++
Sbjct: 216 HQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE----GHRMDKPSNCTNELYMMM 270
Query: 162 SRIFVANSEKRITIPEI 178
+ A +R T ++
Sbjct: 271 RDCWHAVPSQRPTFKQL 287
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 102 bits (255), Expect = 4e-26
Identities = 41/228 (17%), Positives = 74/228 (32%), Gaps = 46/228 (20%)
Query: 9 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ-ICHRDLKLENTLLD--GSTAPRVKI 65
+ + +QL+ G+ Y H I H D+K EN L++ S ++I
Sbjct: 112 ALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 171
Query: 66 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPF- 124
+ +++ T Y +PEVL + AD+WS ++ ++ G + F
Sbjct: 172 KIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFE 230
Query: 125 -EDPEDPKNFRKTIGRILSVHYSFPDYV-------------------------------- 151
++ I +I+ + P Y+
Sbjct: 231 PDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVL 290
Query: 152 --------RVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIE 191
+ E LS + + KR + NHPW L +E
Sbjct: 291 TEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGME 338
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99 bits (248), Expect = 2e-25
Identities = 43/213 (20%), Positives = 72/213 (33%), Gaps = 37/213 (17%)
Query: 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS--------MQICHRDLKLEN 52
+Y G LF+ + N + + SG+++ H I HRDLK +N
Sbjct: 80 SDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKN 138
Query: 53 TLLDGSTAPRVKICDFG-----YSKSSVLHSQPKSTVGTPAYIAPEVL-----TKKEYDG 102
L+ + I D G S + + P VGT Y+APEVL K
Sbjct: 139 ILVKKN--GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF 196
Query: 103 KIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTI----------------GRILSVHYS 146
K AD+++ G+ + + ED + + ++ +
Sbjct: 197 KRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPN 256
Query: 147 FPDYVRVSLECKHLLSRIFVANSEKRITIPEIK 179
++ + AN R+T IK
Sbjct: 257 RWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.6 bits (242), Expect = 2e-24
Identities = 38/203 (18%), Positives = 71/203 (34%), Gaps = 26/203 (12%)
Query: 1 MEYAAGGELFERICNAGRF----------SEDEARFFFQQLISGVSYCHSMQICHRDLKL 50
ME G+L + + S + ++ G++Y ++ + HRDL
Sbjct: 102 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAA 161
Query: 51 ENTLLDGSTAPRVKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADV 107
N ++ VKI DFG ++ + + + + +++PE L + DV
Sbjct: 162 RNCMVAED--FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS-DV 218
Query: 108 WSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVA 167
WS GV L+ + A + + + PD L+ +
Sbjct: 219 WSFGVVLWEIATLAEQPYQGLSNEQVLRFVME--GGLLDKPD--NCPDMLFELMRMCWQY 274
Query: 168 NSEKRITIPEI------KNHPWF 184
N + R + EI + P F
Sbjct: 275 NPKMRPSFLEIISSIKEEMEPGF 297
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 53.2 bits (127), Expect = 3e-09
Identities = 17/105 (16%), Positives = 29/105 (27%), Gaps = 16/105 (15%)
Query: 10 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFG 69
R + ++ V+ + I H DL N L+ + I DF
Sbjct: 91 LIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE---EGIWIIDFP 147
Query: 70 YSKSSVLHSQPKSTVGTPAYIAPEVLT-----KKEYDGKIADVWS 109
SV + + +V + Y D+ S
Sbjct: 148 ---QSVEVGEEGW----REILERDVRNIITYFSRTY-RTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 262 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.61 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 96.1 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 94.66 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.42 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 93.93 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 92.48 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=340.38 Aligned_cols=183 Identities=38% Similarity=0.674 Sum_probs=154.5
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC---
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH--- 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~--- 77 (262)
||||+||+|+++|.+++.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus 82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~--~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEEECCCTTCEECEETTEE
T ss_pred EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCC--CEEEccchhheeeccCCcc
Confidence 89999999999999888999999999999999999999999999999999999998776 8999999999865322
Q ss_pred CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHH
Q 024809 78 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 157 (262)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (262)
......+||+.|||||++.+..+++.++||||+||++|+|+||+.||.............. ......+.+..+++++
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~s~~~ 236 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK---EKKTYLNPWKKIDSAP 236 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH---TTCTTSTTGGGSCHHH
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh---cCCCCCCccccCCHHH
Confidence 2234568999999999998888877778999999999999999999987654433222221 1122233445789999
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 024809 158 KHLLSRIFVANSEKRITIPEIKNHPWFLRNL 188 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 188 (262)
++||.+||+.||++|||++|+|+||||++..
T Consensus 237 ~~li~~~L~~dP~~R~t~~eil~hpwf~~~l 267 (271)
T d1nvra_ 237 LALLHKILVENPSARITIPDIKKDRWYNKPL 267 (271)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence 9999999999999999999999999998643
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=333.92 Aligned_cols=176 Identities=34% Similarity=0.660 Sum_probs=153.3
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+.... ...
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~--~~kl~DFG~a~~~~~-~~~ 161 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG--ELKIADFGWSVHAPS-SRR 161 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCCCSCSCCCC-CCC
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCC--CEeecccceeeecCC-Ccc
Confidence 79999999999999988999999999999999999999999999999999999998777 899999999975532 334
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 160 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 160 (262)
....||+.|+|||++.+..++. ++|||||||++|+|++|+.||.+.+..+.+.. +....+.+|. .+++++++|
T Consensus 162 ~~~~Gt~~Y~APE~~~~~~~~~-~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~----i~~~~~~~p~--~~s~~~~~l 234 (263)
T d2j4za1 162 TTLCGTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEFLVGKPPFEANTYQETYKR----ISRVEFTFPD--FVTEGARDL 234 (263)
T ss_dssp EETTEEGGGCCHHHHTTCCCCT-THHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HHTTCCCCCT--TSCHHHHHH
T ss_pred cccCCCCcccCHHHHcCCCCCc-hhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHH----HHcCCCCCCc--cCCHHHHHH
Confidence 5678999999999999887754 48999999999999999999987654433333 3344455555 689999999
Q ss_pred HHHhcccCCCCCCCHhHHhcCccccc
Q 024809 161 LSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 161 i~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
|.+||+.||.+|||++|+|+||||..
T Consensus 235 i~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 235 ISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 99999999999999999999999974
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.4e-49 Score=335.36 Aligned_cols=183 Identities=36% Similarity=0.632 Sum_probs=142.3
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-CCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG-STAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~-~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
||||+||+|.++|...+.+++..++.++.||+.||.|||++||+||||||+|||+.. +..+.+||+|||+|+.......
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~ 165 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 165 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCe
Confidence 899999999999999889999999999999999999999999999999999999964 2234899999999986655555
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
....+||+.|||||++.+..|+. ++|||||||++|+|++|+.||.+.........+..... ....+....+|+++++
T Consensus 166 ~~~~~GT~~y~APE~~~~~~~~~-~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~s~~~~~ 242 (307)
T d1a06a_ 166 LSTACGTPGYVAPEVLAQKPYSK-AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY--EFDSPYWDDISDSAKD 242 (307)
T ss_dssp -------CTTSCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCC--CCCTTTTTTSCHHHHH
T ss_pred eeeeeeCccccCcHHHcCCCCCc-HHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCC--CCCCccccCCCHHHHH
Confidence 56678999999999998887765 58999999999999999999988665444444333221 2223344579999999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
||.+||+.||.+|||++|+++||||+.
T Consensus 243 li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 243 FIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp HHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred HHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 999999999999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=330.41 Aligned_cols=180 Identities=27% Similarity=0.456 Sum_probs=152.0
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-C
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-Q 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (262)
||||+||+|.+++.++ .+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+|+...... .
T Consensus 96 mEy~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~--~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp EECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCCTTCEECCSTTCC
T ss_pred EEecCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCC--cEeeccchhheeecccccc
Confidence 8999999999988765 699999999999999999999999999999999999998776 89999999998654332 3
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
....+||+.|+|||++.+..++. ++||||+||++|+|+||+.||.+.+....+...... ....++....+++++++
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~-~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~---~~~~~~~~~~~s~~~~~ 248 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGP-KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN---GTPELQNPEKLSAIFRD 248 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH---CSCCCSSGGGSCHHHHH
T ss_pred ccccccCCCccChhhhcCCCCCc-hhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhC---CCCCCCCcccCCHHHHH
Confidence 44568999999999999887765 589999999999999999999876655444433222 22233334478999999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
||.+||+.||.+|||+.|+|+||||+..
T Consensus 249 li~~~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 249 FLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 9999999999999999999999999753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-48 Score=323.26 Aligned_cols=177 Identities=25% Similarity=0.437 Sum_probs=147.5
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecC-CCCCcEEEeccCCCcCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--ICHRDLKLENTLLDG-STAPRVKICDFGYSKSSVLH 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~--ivHrDlkp~Nili~~-~~~~~~kl~Dfg~a~~~~~~ 77 (262)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++. ++ .+||+|||+|+... .
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~--~~Kl~DFGla~~~~-~ 167 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG--SVKIGDLGLATLKR-A 167 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTS--CEEECCTTGGGGCC-T
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCC--CEEEeecCcceecc-C
Confidence 799999999999999889999999999999999999999999 999999999999964 44 79999999997432 2
Q ss_pred CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHH
Q 024809 78 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 157 (262)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (262)
......+||+.|||||++.+ .++ .++||||+||++|+|++|+.||.+......+.+.+.. ...........++++
T Consensus 168 ~~~~~~~GT~~Y~aPE~~~~-~~~-~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~---~~~~~~~~~~~~~~~ 242 (270)
T d1t4ha_ 168 SFAKAVIGTPEFMAPEMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS---GVKPASFDKVAIPEV 242 (270)
T ss_dssp TSBEESCSSCCCCCGGGGGT-CCC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT---TCCCGGGGGCCCHHH
T ss_pred CccCCcccCccccCHHHhCC-CCC-CcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc---CCCCcccCccCCHHH
Confidence 23446789999999999865 454 5599999999999999999999876665544333322 111111223578999
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCcccc
Q 024809 158 KHLLSRIFVANSEKRITIPEIKNHPWFL 185 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s~~e~l~hp~~~ 185 (262)
++||.+||+.||++|||++|+|+||||+
T Consensus 243 ~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 243 KEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 9999999999999999999999999995
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=331.76 Aligned_cols=177 Identities=38% Similarity=0.693 Sum_probs=154.7
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCC-CCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (262)
||||+||+|.+++.+.+.++|..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.... ...
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g--~vkl~DFG~a~~~~~~~~~ 161 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCSCCTTCC
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCC--CEEEeecccccccccCCcc
Confidence 79999999999999999999999999999999999999999999999999999998877 899999999986543 234
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
....+||+.|+|||++.+..|+. ++|||||||++|+|++|+.||.+.+....+.. +......+|. .+|+++++
T Consensus 162 ~~~~~GT~~Y~aPE~~~~~~y~~-~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~----i~~~~~~~p~--~~s~~~~d 234 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLEDNDYGR-AVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL----ILMEEIRFPR--TLSPEAKS 234 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCT-THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHCCCCCCT--TSCHHHHH
T ss_pred cccceeCHHHhhhhhccCCCCCh-hhcccchhhHHHHHHHCCCCCCCcCHHHHHHH----HhcCCCCCCc--cCCHHHHH
Confidence 45678999999999999888865 58999999999999999999998665443333 3344455665 68999999
Q ss_pred HHHHhcccCCCCCCC-----HhHHhcCccccc
Q 024809 160 LLSRIFVANSEKRIT-----IPEIKNHPWFLR 186 (262)
Q Consensus 160 li~~~L~~dp~~R~s-----~~e~l~hp~~~~ 186 (262)
||.+||++||.+|++ ++++++||||+.
T Consensus 235 li~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHhhccCCchhhcccccccHHHHHcCccccc
Confidence 999999999999994 899999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.5e-47 Score=333.07 Aligned_cols=182 Identities=30% Similarity=0.569 Sum_probs=154.4
Q ss_pred CCCCCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
||||+||+|.+++.+ .+++++..++.++.||+.||.|||++|||||||||+|||++.+..+.+||+|||+|+.......
T Consensus 102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 899999999999964 4579999999999999999999999999999999999999765545899999999987655555
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCC--CcccCCHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP--DYVRVSLEC 157 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 157 (262)
.....||+.|||||++.+..++ .++|||||||++|+|++|+.||.+.+..+.+..+.. ..+.++ ....+|+++
T Consensus 182 ~~~~~gT~~Y~aPEv~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~----~~~~~~~~~~~~~s~~~ 256 (350)
T d1koaa2 182 VKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS----CDWNMDDSAFSGISEDG 256 (350)
T ss_dssp EEEECSCTTTCCHHHHHTCCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----TCCCSCCGGGGGCCHHH
T ss_pred cceecCcccccCHHHHcCCCCC-hhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHh----CCCCCCcccccCCCHHH
Confidence 5567899999999999888775 458999999999999999999987665544444332 222222 234689999
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 158 KHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
++||.+||+.||.+|||++|+|+||||+..
T Consensus 257 ~~li~~~L~~dP~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 257 KDFIRKLLLADPNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=9.8e-48 Score=334.41 Aligned_cols=182 Identities=30% Similarity=0.554 Sum_probs=155.3
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
||||+||+|++++...+ +|++.+++.++.||+.||.|||++||+||||||+|||++....+.+||+|||+|+.......
T Consensus 105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence 89999999999887654 69999999999999999999999999999999999999855555899999999987665555
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCC--CcccCCHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP--DYVRVSLEC 157 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 157 (262)
.....||+.|+|||++.+..++. ++|||||||++|+|+||+.||.+.+....+..+.. ..+.++ ....+++++
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~----~~~~~~~~~~~~~s~~~ 259 (352)
T d1koba_ 185 VKVTTATAEFAAPEIVDREPVGF-YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR----CDWEFDEDAFSSVSPEA 259 (352)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCH-HHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH----CCCCCCSSTTTTSCHHH
T ss_pred eeeccCcccccCHHHHcCCCCCC-ccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----CCCCCCcccccCCCHHH
Confidence 56678999999999998887764 48999999999999999999988766555444332 222222 334799999
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 158 KHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
++||.+||+.||.+|||+.|+|+||||+..
T Consensus 260 ~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 260 KDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999999999999754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-48 Score=335.57 Aligned_cols=187 Identities=36% Similarity=0.630 Sum_probs=155.5
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCcEEEeccCCCcCCCCC
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-APRVKICDFGYSKSSVLH 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~-~~~~kl~Dfg~a~~~~~~ 77 (262)
||||+||+|+++|.+. .+|++.+++.+++||+.||+|||++||+||||||+|||++... .+.+||+|||+|+.....
T Consensus 88 mEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~ 167 (335)
T d2ozaa1 88 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 167 (335)
T ss_dssp EECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC
T ss_pred EECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCC
Confidence 7999999999999875 3699999999999999999999999999999999999997533 347999999999876655
Q ss_pred CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCC--cccCCH
Q 024809 78 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSL 155 (262)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 155 (262)
.......||+.|+|||++.+..|+. ++|||||||++|+|+||+.||.+.........+...+....+.+|. +..+|+
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~y~~-~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 246 (335)
T d2ozaa1 168 NSLTTPCYTPYYVAPEVLGPEKYDK-SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 246 (335)
T ss_dssp CCCCCCSCCCSSCCCCCCCGGGGSH-HHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCH
T ss_pred CccccccCCcccCCcHHHcCCCCCH-HHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCH
Confidence 6666788999999999998877764 4899999999999999999998766555555555555555555543 446899
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL 188 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 188 (262)
++++||++||+.||++|||+.|+++||||.+..
T Consensus 247 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 247 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred HHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence 999999999999999999999999999997543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-48 Score=327.33 Aligned_cols=177 Identities=36% Similarity=0.666 Sum_probs=149.8
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
||||+||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus 87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~--~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS--CEEECCCTTCEECC-----
T ss_pred EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCc--eEEecccccceecccCCcc
Confidence 89999999999999999999999999999999999999999999999999999998777 89999999998654322
Q ss_pred -CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHH
Q 024809 79 -QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 157 (262)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (262)
.....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+....+.+ +....+.+|. .+++++
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~----i~~~~~~~p~--~~s~~~ 237 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKA 237 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHTTCCCCCT--TCCHHH
T ss_pred cccccccCCccccCceeeccCCCC-cccceehhhHHHHHHhhCCCCCCCcCHHHHHHH----HHcCCCCCCc--cCCHHH
Confidence 23456899999999999888775 459999999999999999999988655444433 3344455665 689999
Q ss_pred HHHHHHhcccCCCCCCCHhH------HhcCccccc
Q 024809 158 KHLLSRIFVANSEKRITIPE------IKNHPWFLR 186 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s~~e------~l~hp~~~~ 186 (262)
++||.+||+.||.+|||++| +++||||+.
T Consensus 238 ~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 238 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp HHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred HHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 99999999999999999998 578899864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-48 Score=332.48 Aligned_cols=182 Identities=30% Similarity=0.492 Sum_probs=145.8
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~-~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++ ++||+|||+|+.... ..
T Consensus 83 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~--~vkl~DFGla~~~~~-~~ 159 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLID-SM 159 (322)
T ss_dssp EECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC--CEEECCCCCCHHHHH-HT
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC--CEEEeeCCCccccCC-Cc
Confidence 7999999999999988899999999999999999999997 5999999999999998777 899999999985432 23
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccc-------------------
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRI------------------- 140 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~------------------- 140 (262)
..+.+||+.|+|||++.+..|+.+ +||||+||++|+|++|+.||.+.+............
T Consensus 160 ~~~~~GT~~Y~APEvl~~~~y~~~-~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
T d1s9ja_ 160 ANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238 (322)
T ss_dssp C---CCSSCCCCHHHHHCSCCCTT-HHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred cccccCCccccCchHHcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence 456789999999999998887655 899999999999999999998755432111000000
Q ss_pred -------------------cccc-ccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 141 -------------------LSVH-YSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 141 -------------------~~~~-~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
.... ...+ ...+|.++++||.+||+.||.+|||++|+|+||||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 239 SYGMDSRPPMAIFELLDYIVNEPPPKLP-SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp -------CCCCHHHHHHHHHTSCCCCCC-BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccccccchhHHHHHhhhhccCCccCc-cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 0000 0011 12368899999999999999999999999999999753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.6e-47 Score=320.71 Aligned_cols=183 Identities=33% Similarity=0.546 Sum_probs=155.6
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
||||+||||.++|..++.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++........
T Consensus 89 mE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~--~~kl~DFG~a~~~~~~~~~ 166 (277)
T d1phka_ 89 FDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM--NIKLTDFGFSCQLDPGEKL 166 (277)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCTTCEECCTTCCB
T ss_pred EEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCC--CeEEccchheeEccCCCce
Confidence 79999999999999988999999999999999999999999999999999999998777 8999999999876555555
Q ss_pred CccccCCCCCCcccccCC-----cCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 81 KSTVGTPAYIAPEVLTKK-----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
....||+.|+|||.+.+. ...+.++||||+||++|+|++|+.||.+.........+.... ..+..+....+|+
T Consensus 167 ~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~s~ 244 (277)
T d1phka_ 167 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN--YQFGSPEWDDYSD 244 (277)
T ss_dssp CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--CCCCTTTGGGSCH
T ss_pred eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCC--CCCCCcccccCCH
Confidence 667899999999998632 223456899999999999999999999876554444433221 1233445567999
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
++++||.+||+.||.+|||++|+|+||||++.
T Consensus 245 ~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 245 TVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred HHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 99999999999999999999999999999764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=324.46 Aligned_cols=180 Identities=28% Similarity=0.425 Sum_probs=148.8
Q ss_pred CCCCCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-C
Q 024809 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-S 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~ 78 (262)
||||+||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+..... .
T Consensus 88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~--~~Kl~DFG~a~~~~~~~~ 165 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDG--DIKLADFGVSAKNTRTIQ 165 (288)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECHHHHH
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCC--CEEEEechhhhccCCCcc
Confidence 899999999999875 45699999999999999999999999999999999999998777 8999999999754321 1
Q ss_pred CCCccccCCCCCCcccccC-----CcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccC
Q 024809 79 QPKSTVGTPAYIAPEVLTK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRV 153 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (262)
......||+.|+|||++.. ..| +.++|||||||++|+|+||+.||.+.+..+.+.++.... ...++....+
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y-~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~~~ 241 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE---PPTLAQPSRW 241 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSST-TTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC---CCCCSSGGGS
T ss_pred cccccccccccCCHHHHhhcccCCCCC-ChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC---CCCCCccccC
Confidence 2345689999999999842 334 455999999999999999999999877655554443221 1122333478
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 154 SLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 154 ~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
++++++||.+||+.||.+|||++|+|+||||+.
T Consensus 242 s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 242 SSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 999999999999999999999999999999964
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5e-47 Score=331.45 Aligned_cols=180 Identities=31% Similarity=0.520 Sum_probs=152.3
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
||||+||+|.++|.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+.... ...
T Consensus 86 mE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g--~iKl~DFGla~~~~~-~~~ 162 (364)
T d1omwa3 86 LDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSK-KKP 162 (364)
T ss_dssp ECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSS--CEEECCCTTCEECSS-SCC
T ss_pred EEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCC--cEEEeeeceeeecCC-Ccc
Confidence 89999999999999998999999999999999999999999999999999999998777 899999999985543 344
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 160 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 160 (262)
...+||+.|+|||++.....++.++|||||||++|+|+||+.||.+...... ......+......+|. .+++++++|
T Consensus 163 ~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~--~~s~~~~~l 239 (364)
T d1omwa3 163 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVELPD--SFSPELRSL 239 (364)
T ss_dssp CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-HHHHHHSSSCCCCCCS--SSCHHHHHH
T ss_pred cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcccCCCCCCC--CCCHHHHHH
Confidence 5678999999999997655445669999999999999999999987554332 2223333333334444 689999999
Q ss_pred HHHhcccCCCCCCC-----HhHHhcCccccc
Q 024809 161 LSRIFVANSEKRIT-----IPEIKNHPWFLR 186 (262)
Q Consensus 161 i~~~L~~dp~~R~s-----~~e~l~hp~~~~ 186 (262)
|.+||+.||.+||| |+++++||||+.
T Consensus 240 i~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 240 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp HHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred HHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 99999999999999 799999999975
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=323.56 Aligned_cols=182 Identities=36% Similarity=0.655 Sum_probs=154.4
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC--CcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA--PRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~--~~~kl~Dfg~a~~~~~~~ 78 (262)
||||+||+|.++|...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. ..+||+|||+|+......
T Consensus 92 ~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~ 171 (293)
T d1jksa_ 92 LELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 171 (293)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSC
T ss_pred EEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCCc
Confidence 799999999999998889999999999999999999999999999999999999976552 259999999998765555
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCC--CcccCCHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP--DYVRVSLE 156 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 156 (262)
......||+.|+|||++.+..++. ++||||+||++|+|++|+.||.+.+..+.+..+.. ....++ ....+|++
T Consensus 172 ~~~~~~~t~~y~APE~~~~~~~~~-~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~----~~~~~~~~~~~~~s~~ 246 (293)
T d1jksa_ 172 EFKNIFGTPEFVAPEIVNYEPLGL-EADMWSIGVITYILLSGASPFLGDTKQETLANVSA----VNYEFEDEYFSNTSAL 246 (293)
T ss_dssp BCSCCCCCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT----TCCCCCHHHHTTSCHH
T ss_pred cccccCCCCcccCHHHHcCCCCCC-cccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHh----cCCCCCchhcCCCCHH
Confidence 566778999999999998877754 48999999999999999999988665444443322 222322 22468999
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
+++||++||+.||.+|||++|+|+||||+..
T Consensus 247 ~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 9999999999999999999999999999753
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.1e-47 Score=324.45 Aligned_cols=177 Identities=26% Similarity=0.331 Sum_probs=149.7
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
||||+||+|..++..++++++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+... ..
T Consensus 94 ~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~--~~Kl~DFG~a~~~~---~~ 168 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG--LVKLGDFGSASIMA---PA 168 (309)
T ss_dssp EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT--EEEECCCTTCBSSS---SB
T ss_pred EEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCC--CEEEeecccccccC---CC
Confidence 79999999988888888999999999999999999999999999999999999998777 89999999998543 23
Q ss_pred CccccCCCCCCcccccC---CcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHH
Q 024809 81 KSTVGTPAYIAPEVLTK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 157 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (262)
....||+.|||||++.+ ..|+ .++|||||||++|+|++|+.||.+....+.+..+... ....+....+|+++
T Consensus 169 ~~~~GT~~Y~APE~~~~~~~~~y~-~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~----~~~~~~~~~~s~~~ 243 (309)
T d1u5ra_ 169 NSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----ESPALQSGHWSEYF 243 (309)
T ss_dssp CCCCSCGGGCCHHHHTTTTSCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS----CCCCCSCTTSCHHH
T ss_pred CccccCccccCHHHHhccCCCCcC-chhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC----CCCCCCCCCCCHHH
Confidence 45689999999999864 2344 4589999999999999999999876655444443322 22222334689999
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 158 KHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
++||.+||+.||.+|||++|+|+||||.+.
T Consensus 244 ~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 999999999999999999999999999754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-47 Score=317.84 Aligned_cols=175 Identities=31% Similarity=0.498 Sum_probs=137.4
Q ss_pred CCCCCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcC-----CeecCCCCCcEEecCCCCCcEEEeccCCC
Q 024809 1 MEYAAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQ-----ICHRDLKLENTLLDGSTAPRVKICDFGYS 71 (262)
Q Consensus 1 mE~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~aL~~LH~~~-----ivHrDlkp~Nili~~~~~~~~kl~Dfg~a 71 (262)
||||+||+|.+++.+ ++.+++..++.++.||+.||.|||+.| |+||||||+|||++.++ .+||+|||+|
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~--~vkl~DFG~a 161 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLA 161 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTS--CEEECCHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCC--cEEEeeccce
Confidence 799999999999863 457999999999999999999999976 99999999999998776 8999999999
Q ss_pred cCCCCC-CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccc-cCCC
Q 024809 72 KSSVLH-SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY-SFPD 149 (262)
Q Consensus 72 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~ 149 (262)
+..... .......||+.|+|||++.+..++ .++|||||||++|+|+||+.||.+.+..+....+ ..... ..|
T Consensus 162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i----~~~~~~~~~- 235 (269)
T d2java1 162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI----REGKFRRIP- 235 (269)
T ss_dssp HHC-----------CCCSCCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH----HHTCCCCCC-
T ss_pred eecccCCCccccCCCCcccCCHHHHcCCCCC-hHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHH----HcCCCCCCC-
Confidence 865432 233457899999999999887775 4599999999999999999999876544433332 22222 222
Q ss_pred cccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 150 YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 150 ~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
..+|+++++||.+||+.||.+|||+.|+++|||+
T Consensus 236 -~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 236 -YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp -TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -cccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 3689999999999999999999999999999995
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.4e-46 Score=320.29 Aligned_cols=175 Identities=40% Similarity=0.712 Sum_probs=152.8
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
||||+||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+... ...
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g--~vkL~DFG~a~~~~--~~~ 158 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG--HIKITDFGFAKYVP--DVT 158 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS--CEEECCCSSCEECS--SCB
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCC--CEEEecCccceEec--ccc
Confidence 79999999999999999999999999999999999999999999999999999998777 89999999998653 334
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 160 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 160 (262)
...+||+.|+|||++.+..|+. ++|||||||++|+|+||+.||.+.+..+.+.+ +......+|. .++++++++
T Consensus 159 ~~~~Gt~~Y~APE~l~~~~y~~-~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~----i~~~~~~~p~--~~s~~~~~l 231 (316)
T d1fota_ 159 YTLCGTPDYIAPEVVSTKPYNK-SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK----ILNAELRFPP--FFNEDVKDL 231 (316)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCT-THHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HHHCCCCCCT--TSCHHHHHH
T ss_pred ccccCcccccCHHHHcCCCCCc-hhhccccchhHHHHHhCCCCCCCcCHHHHHHH----HHcCCCCCCC--CCCHHHHHH
Confidence 5678999999999998888865 48999999999999999999988655444433 3333444554 689999999
Q ss_pred HHHhcccCCCCCC-----CHhHHhcCccccc
Q 024809 161 LSRIFVANSEKRI-----TIPEIKNHPWFLR 186 (262)
Q Consensus 161 i~~~L~~dp~~R~-----s~~e~l~hp~~~~ 186 (262)
|.+||+.||.+|+ |++++++||||+.
T Consensus 232 i~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 232 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp HHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred HHHHhhhCHHhccccchhhHHHHHcCccccc
Confidence 9999999999996 9999999999975
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-46 Score=324.51 Aligned_cols=175 Identities=38% Similarity=0.673 Sum_probs=151.8
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||+.||+|.+++.+.+.+++..++.++.||+.||.|||++|||||||||+|||++.++ ++||+|||+|+... ...
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g--~ikL~DFG~a~~~~--~~~ 195 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG--YIQVTDFGFAKRVK--GRT 195 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECS--SCB
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCC--CEEeeeceeeeecc--ccc
Confidence 79999999999999988999999999999999999999999999999999999998777 89999999998653 234
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHHH
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 160 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 160 (262)
....||+.|||||++.+..++. ++|||||||++|+|+||+.||.+.+....+.+ +......+|. .+++++.+|
T Consensus 196 ~~~~Gt~~Y~APE~~~~~~~~~-~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~----i~~~~~~~p~--~~s~~~~~l 268 (350)
T d1rdqe_ 196 WTLCGTPEALAPEIILSKGYNK-AVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKDL 268 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHCCCCCCT--TCCHHHHHH
T ss_pred ccccCccccCCHHHHcCCCCCc-cccccchhHHHHHHHhCCCCCCCcCHHHHHHH----HhcCCCCCCc--cCCHHHHHH
Confidence 5678999999999999888764 48999999999999999999987654443333 3333344444 689999999
Q ss_pred HHHhcccCCCCCC-----CHhHHhcCccccc
Q 024809 161 LSRIFVANSEKRI-----TIPEIKNHPWFLR 186 (262)
Q Consensus 161 i~~~L~~dp~~R~-----s~~e~l~hp~~~~ 186 (262)
|++||+.||.+|+ |++++++||||+.
T Consensus 269 i~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHHHhhhCHHhccccccccHHHHHcCccccC
Confidence 9999999999995 9999999999974
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-46 Score=320.20 Aligned_cols=177 Identities=39% Similarity=0.700 Sum_probs=153.2
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-C
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-Q 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (262)
||||+||+|.+++...+++++.+++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+++...... .
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~--~~kl~DFG~a~~~~~~~~~ 159 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG--HIKIADFGMCKENMLGDAK 159 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCCCCTTCC
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCC--ceeccccchhhhccccccc
Confidence 79999999999999998999999999999999999999999999999999999998777 89999999998654332 3
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....||+.|+|||++.+..++. ++||||+||++|+|++|+.||.+.+....+.+ +....+.+|. .+|+++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlGvilyemltG~~PF~~~~~~~~~~~----i~~~~~~~p~--~~s~~~~d 232 (320)
T d1xjda_ 160 TNTFCGTPDYIAPEILLGQKYNH-SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS----IRMDNPFYPR--WLEKEAKD 232 (320)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHCCCCCCT--TSCHHHHH
T ss_pred ccccCCCCCcCCHHHHcCCCCCc-hhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHH----HHcCCCCCCc--cCCHHHHH
Confidence 34568999999999999888865 58999999999999999999987655443333 3333445554 68999999
Q ss_pred HHHHhcccCCCCCCCHh-HHhcCccccc
Q 024809 160 LLSRIFVANSEKRITIP-EIKNHPWFLR 186 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~-e~l~hp~~~~ 186 (262)
||.+||+.||.+|||+. ++++||||+.
T Consensus 233 li~~~L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 233 LLVKLFVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp HHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred HHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence 99999999999999996 8999999975
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-46 Score=315.99 Aligned_cols=185 Identities=24% Similarity=0.312 Sum_probs=152.3
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-CC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (262)
||||.||++..++...+.+++..++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||+|+..... ..
T Consensus 79 mE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~--~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 79 FDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG--VLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp EECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECCCGGGSTTTSCCCC
T ss_pred hhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCC--ccccccCccccccCCCccc
Confidence 79999988887777777899999999999999999999999999999999999998776 8999999999765433 23
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccc--------------
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY-------------- 145 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------- 145 (262)
....+||+.|+|||++.....++.++||||+||++|+|+||..||.+....+.+.++.........
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence 445689999999999977665566799999999999999999999987776665554432211000
Q ss_pred --cCCC------cccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 146 --SFPD------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 146 --~~~~------~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
..+. ...+++++++||.+||+.||++||||+|+|+||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 0000 12468899999999999999999999999999999754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=323.94 Aligned_cols=182 Identities=26% Similarity=0.539 Sum_probs=155.2
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
||||+||+|+++|...+ .+++.+++.++.||+.||.|||++||+||||||+|||++.++...+||+|||+++.......
T Consensus 80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~ 159 (321)
T d1tkia_ 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence 89999999999998765 79999999999999999999999999999999999999876666899999999986654444
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCC--cccCCHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLEC 157 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 157 (262)
.....||+.|+|||.+.+..++ .++|||||||++|+|++|..||.+.+..+.+..+. ...+.++. +..+|+++
T Consensus 160 ~~~~~~t~~y~ape~~~~~~~~-~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~----~~~~~~~~~~~~~~s~~~ 234 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM----NAEYTFDEEAFKEISIEA 234 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH----HTCCCCCHHHHTTSCHHH
T ss_pred ccccccccccccchhccCCCCC-chhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHH----hCCCCCChhhccCCCHHH
Confidence 5567899999999999887775 45899999999999999999998866554444433 33333332 34689999
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 158 KHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
++||.+||+.||.+|||+.|+++||||++.
T Consensus 235 ~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 235 MDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 999999999999999999999999999754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-46 Score=311.53 Aligned_cols=173 Identities=36% Similarity=0.607 Sum_probs=146.9
Q ss_pred CCCCCC-CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~g-g~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||+.| +++.+++..++.+++..++.++.||+.||.|||++||+||||||+|||++.+. +.+||+|||+|+... ...
T Consensus 88 ~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~-~~vkl~DFG~a~~~~-~~~ 165 (273)
T d1xwsa_ 88 LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-GELKLIDFGSGALLK-DTV 165 (273)
T ss_dssp EECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT-TEEEECCCTTCEECC-SSC
T ss_pred EEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCC-CeEEECccccceecc-ccc
Confidence 689986 68889999888999999999999999999999999999999999999997542 279999999997543 233
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHHHH
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 159 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
.....||+.|+|||++.+..+++.++||||+||++|+|++|+.||.+.+ . +......++. .+|+++++
T Consensus 166 ~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~-------i~~~~~~~~~--~~s~~~~~ 233 (273)
T d1xwsa_ 166 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---E-------IIRGQVFFRQ--RVSSECQH 233 (273)
T ss_dssp BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---H-------HHHCCCCCSS--CCCHHHHH
T ss_pred ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch---H-------HhhcccCCCC--CCCHHHHH
Confidence 4567899999999999887777777899999999999999999997521 1 1122233443 68999999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 160 LLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 160 li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
||.+||+.||++|||++|+++||||++.
T Consensus 234 li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 234 LIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 9999999999999999999999999753
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-45 Score=310.48 Aligned_cols=183 Identities=26% Similarity=0.330 Sum_probs=149.9
Q ss_pred CCCCCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~-~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
||||.||++..... ....+++..++.+++|++.||+|||++||+||||||+|||++..+ .+||+|||+++.......
T Consensus 94 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~--~~kl~dfg~~~~~~~~~~ 171 (305)
T d1blxa_ 94 FEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADFGLARIYSFQMA 171 (305)
T ss_dssp EECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECSCCSCCCCCGGGG
T ss_pred EEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCC--Ceeecchhhhhhhccccc
Confidence 68999987755544 345699999999999999999999999999999999999998777 899999999986655555
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc-cccC-----------
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-HYSF----------- 147 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~----------- 147 (262)
.....||+.|+|||++.+..|+.+ +||||+||++|+|++|+.||.+.+..+.+..+....... ...+
T Consensus 172 ~~~~~gT~~Y~APE~~~~~~y~~~-~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 250 (305)
T d1blxa_ 172 LTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF 250 (305)
T ss_dssp GCCCCCCCTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGS
T ss_pred CCCcccChhhcCcchhcCCCCChh-ehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhh
Confidence 567789999999999988887655 899999999999999999999877666555543321110 0000
Q ss_pred ---------CCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 148 ---------PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 148 ---------~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
.....+++++++||.+||++||++|||+.|+|+||||+.
T Consensus 251 ~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 251 HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298 (305)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred ccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence 012357889999999999999999999999999999974
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-44 Score=303.32 Aligned_cols=179 Identities=23% Similarity=0.355 Sum_probs=141.3
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (262)
||||+||+|.+++... +++++..+..++.||++||+|||++|||||||||+|||++.++ .+||+|||+|+......
T Consensus 82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~--~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL--TVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTS--SEEECCCCCSCC------
T ss_pred EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCC--CEEEccccceeeccccCC
Confidence 7999999999999754 5699999999999999999999999999999999999998877 89999999997653322
Q ss_pred --CCCccccCCCCCCcccccCCc--CCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCC
Q 024809 79 --QPKSTVGTPAYIAPEVLTKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS 154 (262)
Q Consensus 79 --~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (262)
......||+.|||||++.... .++.++||||+||++|+|+||+.||.+..........+...............++
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 239 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCC
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccch
Confidence 234567999999999986432 2345589999999999999999999987765554444332111110011123578
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 155 LECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
+++++||.+||..||.+|||+.+++++
T Consensus 240 ~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 240 KAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-44 Score=309.33 Aligned_cols=218 Identities=24% Similarity=0.356 Sum_probs=160.3
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||| |++|..++. +++|++..++.+++||+.||.|||++||+||||||+|||++.++ .+|++|||+|+... ...
T Consensus 102 ~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~--~~kl~Dfg~a~~~~--~~~ 175 (346)
T d1cm8a_ 102 MPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC--ELKILDFGLARQAD--SEM 175 (346)
T ss_dssp EECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEECC--SSC
T ss_pred Eecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccc--ccccccccceeccC--Ccc
Confidence 6899 567776665 45799999999999999999999999999999999999998877 89999999998543 344
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc-----------------
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV----------------- 143 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----------------- 143 (262)
....||+.|+|||++.+..+.+.++||||+||++|+|++|+.||.+.+....+..........
T Consensus 176 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (346)
T d1cm8a_ 176 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 255 (346)
T ss_dssp CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHH
T ss_pred ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhh
Confidence 567899999999999876666667999999999999999999998876554443322211000
Q ss_pred -------cccC-CCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCCccccCCCCccccCCCCCCCCHHHHHH
Q 024809 144 -------HYSF-PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLS 215 (262)
Q Consensus 144 -------~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (262)
...+ .....+++++++||.+||+.||.+|||++|+|+||||+.-...+.................+++++.+
T Consensus 256 ~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~e~k~ 335 (346)
T d1cm8a_ 256 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKR 335 (346)
T ss_dssp HHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCCCCCCC-----CCHHHHHH
T ss_pred ccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccccCCCCCCchhhhhcCHHHHHH
Confidence 0000 01135789999999999999999999999999999998644322211111112223344567888888
Q ss_pred HhHHhcCCC
Q 024809 216 LIHEATKPL 224 (262)
Q Consensus 216 ~~~~~~~~~ 224 (262)
++.++...+
T Consensus 336 ~~~~e~~~~ 344 (346)
T d1cm8a_ 336 VTYKEVLSF 344 (346)
T ss_dssp HHHHHHHTC
T ss_pred HHHHHhhcC
Confidence 887665433
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-44 Score=310.55 Aligned_cols=222 Identities=22% Similarity=0.357 Sum_probs=164.9
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
|||+.||+|.+++.. +++++..++.+++||+.||.|||++||+||||||+|||++.++ .+|++|||++.... ...
T Consensus 101 ~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~--~~kl~dfg~a~~~~--~~~ 175 (348)
T d2gfsa1 101 VTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARHTD--DEM 175 (348)
T ss_dssp EEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECCC----CCT--GGG
T ss_pred EEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccc--cccccccchhcccC--ccc
Confidence 578899999998865 4799999999999999999999999999999999999998877 89999999987542 334
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccccc----------------
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH---------------- 144 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---------------- 144 (262)
....||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+.+.......+........
T Consensus 176 ~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 255 (348)
T d2gfsa1 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255 (348)
T ss_dssp SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHH
T ss_pred ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhh
Confidence 5578999999999988877666779999999999999999999988765544433322211100
Q ss_pred ---ccCC------CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCCccccCCCCccccCCCCCCCCHHHHHH
Q 024809 145 ---YSFP------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLS 215 (262)
Q Consensus 145 ---~~~~------~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (262)
...+ ....+++++++||.+||+.||.+|||++|+|+||||++...........-............+++.+
T Consensus 256 ~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~ 335 (348)
T d2gfsa1 256 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 335 (348)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCCCCCCGGGGCCCCHHHHHH
T ss_pred hhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCCCCCCcccchhcCHHHHHH
Confidence 0000 1235789999999999999999999999999999998754332211111111222334557788888
Q ss_pred HhHHhcCCCCCC
Q 024809 216 LIHEATKPLEAP 227 (262)
Q Consensus 216 ~~~~~~~~~~~~ 227 (262)
++.++...+.+|
T Consensus 336 ~~~~e~~~~~p~ 347 (348)
T d2gfsa1 336 LTYDEVISFVPP 347 (348)
T ss_dssp HHHHHHHTCCCC
T ss_pred HHHHHhhccCCC
Confidence 887776555544
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=307.41 Aligned_cols=221 Identities=26% Similarity=0.382 Sum_probs=160.3
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC---
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH--- 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~--- 77 (262)
|||+.||+|++++..+ ++++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.....
T Consensus 89 ~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~--~~kl~DfG~a~~~~~~~~~ 165 (345)
T d1pmea_ 89 VTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC--DLKICDFGLARVADPDHDH 165 (345)
T ss_dssp EEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEECCGGGCB
T ss_pred EEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCC--CEEEcccCceeeccCCCcc
Confidence 4778899999999765 699999999999999999999999999999999999998776 8999999999754322
Q ss_pred -CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc-------------
Q 024809 78 -SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV------------- 143 (262)
Q Consensus 78 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------------- 143 (262)
......+||+.|+|||++.....++.++||||+||++|+|++|+.||.+.................
T Consensus 166 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T d1pmea_ 166 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245 (345)
T ss_dssp CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHH
T ss_pred ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhh
Confidence 123456799999999998776666677999999999999999999998766544333322111000
Q ss_pred ---cccCC---------CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCCccccCC-CCccccCCCCCCCCH
Q 024809 144 ---HYSFP---------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEG-GSWQSHDVNNPSQSL 210 (262)
Q Consensus 144 ---~~~~~---------~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 210 (262)
....+ ....+++++++||.+||+.||.+|||++|+|+||||........... ...............
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (345)
T d1pmea_ 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPK 325 (345)
T ss_dssp HHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSSCC--------CCH
T ss_pred hcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCccccCccCCChhhhhCCH
Confidence 00000 12357889999999999999999999999999999986544322111 111111122223455
Q ss_pred HHHHHHhHHhcCCC
Q 024809 211 EEVLSLIHEATKPL 224 (262)
Q Consensus 211 ~~~~~~~~~~~~~~ 224 (262)
+++..++.++.+..
T Consensus 326 ~~l~~l~~~e~~~~ 339 (345)
T d1pmea_ 326 EKLKELIFEETARF 339 (345)
T ss_dssp HHHHHHHHHHSGGG
T ss_pred HHHHHHHHHHHHhc
Confidence 56666666665544
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-43 Score=306.59 Aligned_cols=186 Identities=28% Similarity=0.390 Sum_probs=148.6
Q ss_pred CCCCCCCchHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC
Q 024809 1 MEYAAGGELFER---ICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH 77 (262)
Q Consensus 1 mE~~~gg~L~~~---i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~ 77 (262)
||||+||.+... ......+++..++.+++||+.||+|||++||+||||||+|||++.++. .+||+|||+++.....
T Consensus 98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~-~~kl~DFG~a~~~~~~ 176 (350)
T d1q5ka_ 98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRG 176 (350)
T ss_dssp EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTC-CEEECCCTTCEECCTT
T ss_pred EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCC-ceeEecccchhhccCC
Confidence 799987643332 335567999999999999999999999999999999999999986542 6899999999876655
Q ss_pred CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccc-------------cc
Q 024809 78 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS-------------VH 144 (262)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-------------~~ 144 (262)
......+||+.|+|||.+.+...++.++||||+||++|+|++|+.||...+..+.+..+...... ..
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~ 256 (350)
T d1q5ka_ 177 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256 (350)
T ss_dssp SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---C
T ss_pred cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhh
Confidence 56667889999999999877655566699999999999999999999887765555444321110 00
Q ss_pred ccCC----------CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 145 YSFP----------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 145 ~~~~----------~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
..++ .....++++++||.+||++||.+|||+.|+|+||||+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp CCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred ccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 0111 123578999999999999999999999999999999764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-43 Score=300.56 Aligned_cols=184 Identities=24% Similarity=0.368 Sum_probs=146.3
Q ss_pred CCCCCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC-C
Q 024809 1 MEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-S 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~-~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~ 78 (262)
||||.|+.+..... ..+++++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+..... .
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~--~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG--AIKLADFGLARAFGVPVR 157 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECSTTHHHHHCCCSB
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccC--cceeccCCcceeccCCcc
Confidence 79998754443333 345699999999999999999999999999999999999998776 8999999999755332 2
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc--------------c
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV--------------H 144 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------------~ 144 (262)
......||+.|+|||++....+.+.++||||+||++|+|++|+.||.+.+..+.+.++....... .
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence 34456899999999999888877777999999999999999999998876555444433211110 0
Q ss_pred ccCCC---------cccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 145 YSFPD---------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 145 ~~~~~---------~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
..++. ...++.++++||++||+.||++|||+.|+|+||||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~ 288 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhcc
Confidence 00111 1257889999999999999999999999999999974
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.5e-43 Score=299.82 Aligned_cols=184 Identities=24% Similarity=0.361 Sum_probs=146.6
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-C
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-Q 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (262)
|||+.|+.+..+....+.+++..++.++.||+.||+|||+.|||||||||+|||++.++ .+||+|||.|....... .
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~--~~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG--ELKIADFGLARAFGIPVRK 156 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECCTTHHHHHCC----
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCC--CEEecccccceecccCccc
Confidence 68999888888877788899999999999999999999999999999999999998877 89999999987543322 2
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc--------------cc
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV--------------HY 145 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------------~~ 145 (262)
.....|++.|+|||.+.+..+.+.++||||+||++|+|++|+.||.+....+.+.++....... ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 3445799999999999887776777999999999999999999998876655544433211100 00
Q ss_pred cC---------CCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 146 SF---------PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 146 ~~---------~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
.+ .....+++++++||++||+.||++|||++|+|+||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 00 011347889999999999999999999999999999974
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=305.36 Aligned_cols=174 Identities=25% Similarity=0.407 Sum_probs=145.1
Q ss_pred CCCCCCCchHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC
Q 024809 1 MEYAAGGELFERICNAG-----------------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG 57 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-----------------------~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~ 57 (262)
||||+||+|.++|.+.. .+++..++.++.||+.||.|||++|||||||||+|||++.
T Consensus 120 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~ 199 (325)
T d1rjba_ 120 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH 199 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEET
T ss_pred EEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcccccc
Confidence 79999999999997642 4899999999999999999999999999999999999987
Q ss_pred CCCCcEEEeccCCCcCCCCCCCC---CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHH
Q 024809 58 STAPRVKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNF 133 (262)
Q Consensus 58 ~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 133 (262)
++ .+||+|||+|+........ ....||+.|||||++.+..++ .++||||+||++|+|+| |+.||.+......+
T Consensus 200 ~~--~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~ 276 (325)
T d1rjba_ 200 GK--VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPVDANF 276 (325)
T ss_dssp TT--EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred CC--eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCC-cceeccchhHHHHHHHhCCCCCCCCCCHHHHH
Confidence 77 8999999999865433322 245689999999999877775 45899999999999997 89999987665555
Q ss_pred HHHhcccccccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 134 RKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
.+.+... ...+....+++++++||.+||+.||++|||++||++|
T Consensus 277 ~~~~~~~----~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 277 YKLIQNG----FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHHTT----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcC----CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 5544332 2222333689999999999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-43 Score=302.93 Aligned_cols=182 Identities=33% Similarity=0.595 Sum_probs=153.4
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC--C
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH--S 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~--~ 78 (262)
||||.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+..... .
T Consensus 108 ~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~--~vkL~DFG~a~~~~~~~~~ 185 (322)
T d1vzoa_ 108 LDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG--HVVLTDFGLSKEFVADETE 185 (322)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEESCSSEEEECCGGGGG
T ss_pred eecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCC--CEEEeeccchhhhcccccc
Confidence 79999999999999999999999999999999999999999999999999999998876 8999999999754322 2
Q ss_pred CCCccccCCCCCCcccccCCc-CCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 157 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (262)
......|++.|+|||.+.+.. +.+.++|||||||+||+|++|+.||.+.........+..........+|. .+++++
T Consensus 186 ~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~--~~s~~~ 263 (322)
T d1vzoa_ 186 RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EMSALA 263 (322)
T ss_dssp GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT--TSCHHH
T ss_pred cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcc--cCCHHH
Confidence 234568999999999997644 34556899999999999999999998876655555554444444444444 689999
Q ss_pred HHHHHHhcccCCCCCC-----CHhHHhcCccccc
Q 024809 158 KHLLSRIFVANSEKRI-----TIPEIKNHPWFLR 186 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~-----s~~e~l~hp~~~~ 186 (262)
++||.+||+.||.+|| |++|+++||||++
T Consensus 264 ~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 264 KDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp HHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 9999999999999999 5899999999974
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.8e-43 Score=301.64 Aligned_cols=182 Identities=23% Similarity=0.411 Sum_probs=146.3
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
||||.||+|..+. +.+++..++.+++||+.||.|||++||+||||||+|||++.++. .+||+|||+|+........
T Consensus 111 ~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~-~vkl~DFG~a~~~~~~~~~ 186 (328)
T d3bqca1 111 FEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEY 186 (328)
T ss_dssp EECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCGGGCEECCTTCCC
T ss_pred EeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCC-eeeecccccceeccCCCcc
Confidence 7999999997653 46999999999999999999999999999999999999976442 5899999999876555556
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccc------------------
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS------------------ 142 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~------------------ 142 (262)
....||+.|+|||.+.+...++.++||||+||++|+|++|+.||....+.......+..+..
T Consensus 187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 266 (328)
T d3bqca1 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266 (328)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGG
T ss_pred cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcc
Confidence 67789999999999887665566699999999999999999999876653322111111000
Q ss_pred --------------ccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 024809 143 --------------VHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 186 (262)
Q Consensus 143 --------------~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 186 (262)
.....+....+++++++||++||++||.+|||++|+|+||||+.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~ 324 (328)
T d3bqca1 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324 (328)
T ss_dssp GGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred cchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 00111122357899999999999999999999999999999974
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-43 Score=298.95 Aligned_cols=185 Identities=21% Similarity=0.282 Sum_probs=145.8
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCC---
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH--- 77 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~--- 77 (262)
||||.+|.+.........+++..++.+++||+.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 96 ~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~--~~kl~dfg~~~~~~~~~~~ 173 (318)
T d3blha1 96 FDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG--VLKLADFGLARAFSLAKNS 173 (318)
T ss_dssp EECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS--CEEECCCTTCEECCC----
T ss_pred EeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCC--cEEeeecceeeeccccccc
Confidence 68999887776666677899999999999999999999999999999999999998877 8999999999654321
Q ss_pred --CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccC--------
Q 024809 78 --SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF-------- 147 (262)
Q Consensus 78 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------- 147 (262)
......+||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.........+...........
T Consensus 174 ~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 253 (318)
T d3blha1 174 QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYE 253 (318)
T ss_dssp -CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-
T ss_pred ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhh
Confidence 2233467999999999998765555669999999999999999999987665444433322211110000
Q ss_pred -------CC-----------cccCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 024809 148 -------PD-----------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 187 (262)
Q Consensus 148 -------~~-----------~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 187 (262)
.. ....++++++||.+||+.||++|||++|+|+||||+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 254 LYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp ------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred hhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 00 01147788999999999999999999999999999853
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=298.42 Aligned_cols=176 Identities=22% Similarity=0.322 Sum_probs=144.1
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC-
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ- 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~- 79 (262)
||||+||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+.......
T Consensus 86 mE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~--~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 86 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH--YAKISDFGLSKALRADENY 163 (277)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--EEEECCCTTCEECCTTCSE
T ss_pred EEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccC--cccccchhhhhhccccccc
Confidence 79999999999999988999999999999999999999999999999999999998777 899999999975433221
Q ss_pred ---CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 80 ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 80 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
.....||+.|+|||++.+..++. ++|||||||++|+|+| |+.||.+....+....+.. ......|. .+++
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~-~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~---~~~~~~p~--~~~~ 237 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSS-KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK---GERMGCPA--GCPR 237 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEH-HHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT---TCCCCCCT--TCCH
T ss_pred cccccccCCCceecCchhhcCCCCCc-hhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc---CCCCCCCc--ccCH
Confidence 22356899999999998877754 4899999999999998 8999998665443332221 11223333 6899
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHh---cCccc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIK---NHPWF 184 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l---~hp~~ 184 (262)
++++||.+||+.||.+|||+++++ +|+|+
T Consensus 238 ~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 238 EMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 999999999999999999999984 55554
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-43 Score=297.50 Aligned_cols=174 Identities=24% Similarity=0.372 Sum_probs=137.8
Q ss_pred CCCCCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEE
Q 024809 1 MEYAAGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVK 64 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~k 64 (262)
||||+||+|.++|... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 97 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~--~~K 174 (299)
T d1ywna1 97 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN--VVK 174 (299)
T ss_dssp EECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG--CEE
T ss_pred EEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCC--cEE
Confidence 7999999999999753 2489999999999999999999999999999999999998777 899
Q ss_pred EeccCCCcCCCCCC---CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhC-CCCCCCCCChhHHHHHhccc
Q 024809 65 ICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEDPKNFRKTIGRI 140 (262)
Q Consensus 65 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~~~~~~ 140 (262)
|+|||+|+...... ......||+.|+|||++.+..++ .++||||+||++|+|+|| ..||.+......+...+...
T Consensus 175 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~ 253 (299)
T d1ywna1 175 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 253 (299)
T ss_dssp ECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHT
T ss_pred EccCcchhhccccccccccCceeeCccccchhHhhcCCCC-cccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC
Confidence 99999997543322 23346799999999999887775 458999999999999986 56888766555554443321
Q ss_pred ccccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 141 LSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
.....|. .+++++++||.+||+.||.+|||+.|+++|
T Consensus 254 --~~~~~~~--~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 254 --TRMRAPD--YTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp --CCCCCCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --CCCCCCc--cCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1222333 689999999999999999999999999986
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6e-43 Score=294.86 Aligned_cols=179 Identities=22% Similarity=0.333 Sum_probs=138.8
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC--
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (262)
||||+||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++ .++++|||.++......
T Consensus 90 mE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~--~~~l~d~~~~~~~~~~~~~ 167 (277)
T d1o6ya_ 90 MEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN--AVKVMDFGIARAIADSGNS 167 (277)
T ss_dssp EECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTS--CEEECCCTTCEECC-----
T ss_pred EECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccc--cceeehhhhhhhhcccccc
Confidence 89999999999999998999999999999999999999999999999999999998777 89999999886443221
Q ss_pred --CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHH
Q 024809 79 --QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 156 (262)
Q Consensus 79 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (262)
.....+||+.|+|||++.+..++ .++|||||||++|+|+||+.||.+.+..+.+.+.+..... ........+|++
T Consensus 168 ~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~ 244 (277)
T d1o6ya_ 168 VTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI--PPSARHEGLSAD 244 (277)
T ss_dssp -----------TTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC--CGGGTSSSCCHH
T ss_pred ccccccccCcccccCHHHHcCCCCC-cceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCC--CCchhccCCCHH
Confidence 23456799999999999887775 4599999999999999999999886655544443332111 111223468999
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcCccc
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKNHPWF 184 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~hp~~ 184 (262)
+++||.+||+.||.+||+..+.+.|+|.
T Consensus 245 l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 245 LDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred HHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 9999999999999999954444456665
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-41 Score=288.89 Aligned_cols=187 Identities=24% Similarity=0.363 Sum_probs=150.1
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-C
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-Q 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (262)
|||+.|++|..++...+.+++..++.+++|++.||+|||++||+||||||+|||++.++ .+||+|||.|+...... .
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~--~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG--ELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCCTTCEECCSCCSC
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCC--ceeeeecchhhcccCCCcc
Confidence 58999999999999888999999999999999999999999999999999999998776 89999999998654433 2
Q ss_pred CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccc----------------
Q 024809 80 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV---------------- 143 (262)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---------------- 143 (262)
.....+++.|+|||++....+.+.++||||+||++|+|++|+.||....+.......+......
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 3345678899999999877766677999999999999999999976655544332222111000
Q ss_pred --------cccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCC
Q 024809 144 --------HYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLP 189 (262)
Q Consensus 144 --------~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 189 (262)
.........+++++++||.+||+.||.+||||+|+|+||||++..+
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~ 291 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence 0001112357889999999999999999999999999999986543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.1e-42 Score=292.15 Aligned_cols=173 Identities=21% Similarity=0.368 Sum_probs=134.2
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
||||+||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++ ++||+|||+|+.......
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~--~~Kl~DFGla~~~~~~~~ 183 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNL--VCKVSDFGLSRFLEDDTS 183 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCC-----------
T ss_pred EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCC--cEEECCcccceEccCCCC
Confidence 7999999999988874 4699999999999999999999999999999999999998877 899999999986543221
Q ss_pred C------CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCccc
Q 024809 80 P------KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR 152 (262)
Q Consensus 80 ~------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (262)
. ....||+.|||||.+.+..++. ++|||||||++|||+| |+.||.+....+....+... ...+....
T Consensus 184 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~-----~~~~~~~~ 257 (299)
T d1jpaa_ 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTS-ASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD-----YRLPPPMD 257 (299)
T ss_dssp ------------CGGGSCHHHHHSCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-----CCCCCCTT
T ss_pred cceeeecccccCCccccCHHHHhcCCCCc-ccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----CCCCCCcc
Confidence 1 1245789999999998877754 4899999999999998 89999886654443333221 22233347
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 153 VSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 153 ~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
++.++.+||.+||+.||.+|||+.+++++
T Consensus 258 ~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 258 CPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 89999999999999999999999999874
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-42 Score=292.80 Aligned_cols=177 Identities=24% Similarity=0.372 Sum_probs=145.9
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (262)
||||+||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~--~~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH--YAKISDFGLSKALGADDS 164 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT--EEEECCCTTCEECTTCSC
T ss_pred EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCC--ceeeccchhhhccccccc
Confidence 7999999999998654 5799999999999999999999999999999999999998877 89999999998654322
Q ss_pred ---CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCC
Q 024809 79 ---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS 154 (262)
Q Consensus 79 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (262)
......||+.|+|||++....++. ++||||+||++|||+| |+.||.+....+....+... .....|. .++
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~-ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~---~~~~~p~--~~~ 238 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECINFRKFSS-RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG---KRMECPP--ECP 238 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEECH-HHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT---CCCCCCT--TCC
T ss_pred ccccccccccCccccChHHHhCCCCCc-cchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---CCCCCCC--cCC
Confidence 123456899999999998777754 4899999999999998 99999987765544332221 1223333 689
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHH---hcCcccc
Q 024809 155 LECKHLLSRIFVANSEKRITIPEI---KNHPWFL 185 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~~e~---l~hp~~~ 185 (262)
+++.+||.+||+.||++|||+.++ |+|+|+.
T Consensus 239 ~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 239 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 999999999999999999999887 5677764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=296.15 Aligned_cols=214 Identities=24% Similarity=0.365 Sum_probs=147.9
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 80 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (262)
||||.|| +.+.+. +.+++..++.+++||+.||.|||++||+||||||+|||++.++ .+|++|||+++........
T Consensus 101 ~Ey~~~~-l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~--~~kl~df~~~~~~~~~~~~ 175 (355)
T d2b1pa1 101 MELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAGTSFMM 175 (355)
T ss_dssp EECCSEE-HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCCCC----------
T ss_pred EeccchH-HHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccccccc--ceeeechhhhhcccccccc
Confidence 7999865 555553 4699999999999999999999999999999999999998777 8999999999876665666
Q ss_pred CccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhccccc------------------
Q 024809 81 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS------------------ 142 (262)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~------------------ 142 (262)
...+||+.|+|||++.+..++.+ +||||+||++|+|++|+.||.+.+......+++.....
T Consensus 176 ~~~~~t~~y~aPE~l~~~~~~~~-~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 254 (355)
T d2b1pa1 176 TPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254 (355)
T ss_dssp -----CCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHH
T ss_pred ccccccccccChhhhcCCCCCCC-cccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhh
Confidence 67789999999999988777554 89999999999999999999876654443333221110
Q ss_pred cccc---------CC---------CcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCCccccC--CCCccccC
Q 024809 143 VHYS---------FP---------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTE--GGSWQSHD 202 (262)
Q Consensus 143 ~~~~---------~~---------~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~--~~~~~~~~ 202 (262)
.... ++ .....++++++||++||+.||++||||+|+|+||||+........+ ........
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~~~~~~~~~~~~~ 334 (355)
T d2b1pa1 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQ 334 (355)
T ss_dssp TSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHTCCCC------
T ss_pred cCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCcccccCCCCCCCCcc
Confidence 0000 00 0112467899999999999999999999999999998765432221 12222223
Q ss_pred CCCCCCCHHHHHHHhHHh
Q 024809 203 VNNPSQSLEEVLSLIHEA 220 (262)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~ 220 (262)
..+...+++++.+++..+
T Consensus 335 ~~~~~~~~~~~~~~~~~~ 352 (355)
T d2b1pa1 335 LDEREHTIEEWKELIYKE 352 (355)
T ss_dssp -CCCCCCHHHHHHHHHHH
T ss_pred hhhhhcCHHHHHHHHHHH
Confidence 334456778887776553
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-42 Score=289.33 Aligned_cols=177 Identities=19% Similarity=0.312 Sum_probs=141.8
Q ss_pred CCCCCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
||||+||+|.+++.... ++++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus 86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~--~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL--SCKIADFGLARLIEDNE 163 (272)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS--CEEECCCTTCEECSSSC
T ss_pred EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeeccc--ceeeccccceEEccCCc
Confidence 79999999999876433 599999999999999999999999999999999999998777 89999999998654322
Q ss_pred --CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCC-CCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 79 --QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYP-FEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 79 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
......||+.|+|||++....++ .++||||+||++|+|+||..| |......+....+... .....| ..+++
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~-~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~---~~~~~p--~~~~~ 237 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG---YRMVRP--DNCPE 237 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT---CCCCCC--TTCCH
T ss_pred cccccccCCcccccChHHHhCCCCC-chhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc---CCCCCc--ccChH
Confidence 23346789999999999877775 458999999999999996555 4444333333222211 122223 36899
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhc--Ccccc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKN--HPWFL 185 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~--hp~~~ 185 (262)
++++|+.+||+.||++|||+.++++ |+||.
T Consensus 238 ~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 9999999999999999999999988 77774
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=284.64 Aligned_cols=173 Identities=20% Similarity=0.352 Sum_probs=131.2
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
||||+||+|.+++... ..++++.+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+|+.......
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~--~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ--VIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGG--CEEECSCC----------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCC--CeEecccchheeccCCCc
Confidence 7999999999998765 4689999999999999999999999999999999999998877 899999999986543322
Q ss_pred --CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhC-CCCCCCCCChhHHHHHhcccccccccCCCcccCCHH
Q 024809 80 --PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 156 (262)
Q Consensus 80 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (262)
.....||+.|+|||++.+..++. ++||||+||++|+|+|+ .+||......+.+..+... .....| ...+++
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~-k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~---~~~~~p--~~~~~~ 230 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSS-KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG---FRLYKP--RLASTH 230 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCH-HHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHT---CCCCCC--TTSCHH
T ss_pred eeecceecCcccCChHHhcCCCCCc-hhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhc---CCCCCc--cccCHH
Confidence 23457899999999998888764 59999999999999995 5556554433333322211 112223 357899
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
+.+|+.+||+.||++|||++++++|
T Consensus 231 l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 231 VYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCCHhHCcCHHHHHHH
Confidence 9999999999999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-41 Score=286.61 Aligned_cols=173 Identities=21% Similarity=0.287 Sum_probs=141.1
Q ss_pred CCCCCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
||||+||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus 92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~--~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSRLMTGDT 169 (287)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECCCCCTTTCCSSS
T ss_pred eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCC--cEEEccccceeecCCCC
Confidence 7999999999999764 4699999999999999999999999999999999999998777 89999999998653322
Q ss_pred C--CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHH
Q 024809 79 Q--PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 156 (262)
Q Consensus 79 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (262)
. .....||+.|+|||++.+..++ .++||||+||++|+|++|..||....+.....+.+.. ....+....++++
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~~~~~~-~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~----~~~~~~~~~~~~~ 244 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK----DYRMERPEGCPEK 244 (287)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT----TCCCCCCTTCCHH
T ss_pred ceeeccccccccccChHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhc----CCCCCCCccchHH
Confidence 1 1234589999999999887775 4599999999999999977776655554444433322 1222222368999
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhc
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
+++||.+||+.||.+|||+.++++
T Consensus 245 l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 245 VYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHH
Confidence 999999999999999999999976
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-41 Score=282.82 Aligned_cols=173 Identities=21% Similarity=0.348 Sum_probs=134.3
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC-
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS- 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (262)
||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+|+......
T Consensus 86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~--~~Kl~DfG~a~~~~~~~~ 163 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND--CVKLGDFGLSRYMEDSTY 163 (273)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECC------------
T ss_pred EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCC--cEEEccchhheeccCCcc
Confidence 7999999999987654 4699999999999999999999999999999999999998877 89999999998654322
Q ss_pred -CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCHH
Q 024809 79 -QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 156 (262)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (262)
......||+.|+|||++.+..++. ++|||||||++|+|+| |..||.+....+.+.++... . ..+....++++
T Consensus 164 ~~~~~~~gt~~y~apE~l~~~~~~~-~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~---~--~~~~~~~~~~~ 237 (273)
T d1mp8a_ 164 YKASKGKLPIKWMAPESINFRRFTS-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG---E--RLPMPPNCPPT 237 (273)
T ss_dssp -------CCGGGCCHHHHHHCCCSH-HHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT---C--CCCCCTTCCHH
T ss_pred eeccceecCcccchhhHhccCCCCC-ccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---C--CCCCCCCCCHH
Confidence 223456899999999998777754 5899999999999998 89999887665544443322 1 12233478999
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
+++||.+||..||.+|||+.++++|
T Consensus 238 ~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 238 LYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-41 Score=278.40 Aligned_cols=173 Identities=21% Similarity=0.359 Sum_probs=144.2
Q ss_pred CCCCCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
||||++|+|..++.. ...+++..++.++.|+++||.|||++||+||||||+||+++.++ .+||+|||+++.......
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~--~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG--VVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTC--CEEECCCSSCCBCSSSSC
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCC--cEEECcchhheeccCCCc
Confidence 799999999999765 45699999999999999999999999999999999999998776 899999999975543322
Q ss_pred --CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCHH
Q 024809 80 --PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 156 (262)
Q Consensus 80 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (262)
.....||+.|+|||++....++. ++||||+||++|+|+| |+.||.+.+..+...++... .....|. ..+++
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~-ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~---~~~~~p~--~~~~~ 229 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSS-KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG---LRLYRPH--LASEK 229 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT---CCCCCCT--TCCHH
T ss_pred eeecccCCCCCcCCcHHhcCCCCCc-ceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhC---CCCCCcc--cccHH
Confidence 23357899999999998877764 5999999999999998 89999987765544433321 1222333 68899
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
+++||.+||+.||++|||++++++|
T Consensus 230 l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 230 VYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCCHhHCcCHHHHHHH
Confidence 9999999999999999999999987
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-40 Score=281.19 Aligned_cols=180 Identities=20% Similarity=0.279 Sum_probs=139.7
Q ss_pred CCCCCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
||||+||+|..++.. .+.+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus 90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~--~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL--VCKVADFGLARLIEDNE 167 (285)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECCCCTTC------
T ss_pred EEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCC--cEEEcccchhhhccCCC
Confidence 799999999998864 35699999999999999999999999999999999999998776 89999999998553222
Q ss_pred --CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCHH
Q 024809 79 --QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 156 (262)
Q Consensus 79 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (262)
......||+.|+|||++....++ .++||||+||++|+|+||..||............+... ...+....++.+
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~----~~~~~~~~~~~~ 242 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG----YRMPCPPECPES 242 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT----CCCCCCTTSCHH
T ss_pred ceeeccccccccccChHHHhCCCCC-cHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhc----CCCCCCcccCHH
Confidence 22345789999999999887776 45899999999999999666655444433333322221 122333478999
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhc--Ccccccc
Q 024809 157 CKHLLSRIFVANSEKRITIPEIKN--HPWFLRN 187 (262)
Q Consensus 157 ~~~li~~~L~~dp~~R~s~~e~l~--hp~~~~~ 187 (262)
+++||.+||+.||++|||+.+++. ++||...
T Consensus 243 l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 243 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 999999999999999999999987 7888643
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-39 Score=277.80 Aligned_cols=172 Identities=24% Similarity=0.363 Sum_probs=142.1
Q ss_pred CCCCCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEE
Q 024809 1 MEYAAGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVK 64 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~k 64 (262)
||||+||+|.++|... +.+++..++.++.||+.||+|||++|||||||||+|||++.++ .+|
T Consensus 98 ~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~--~~k 175 (299)
T d1fgka_ 98 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN--VMK 175 (299)
T ss_dssp ECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC--CEE
T ss_pred EEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCC--CeE
Confidence 7999999999999754 3589999999999999999999999999999999999998877 899
Q ss_pred EeccCCCcCCCCCC---CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhccc
Q 024809 65 ICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRI 140 (262)
Q Consensus 65 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~ 140 (262)
|+|||+++...... ......||+.|+|||.+.+..|+ .++|||||||++|+|++ |..||.+......+..+..
T Consensus 176 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~-~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~-- 252 (299)
T d1fgka_ 176 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE-- 252 (299)
T ss_dssp ECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT--
T ss_pred eccchhhccccccccccccccCCCChhhhhhhHhcCCCCC-chhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHc--
Confidence 99999998654332 23346789999999999887776 45899999999999998 7888987655443332221
Q ss_pred ccccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 141 LSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
......| ..+++++++||.+||+.||++|||+.|+++
T Consensus 253 -~~~~~~p--~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 253 -GHRMDKP--SNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp -TCCCCCC--SSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCCCCCC--ccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 1122333 368999999999999999999999999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=275.49 Aligned_cols=173 Identities=20% Similarity=0.332 Sum_probs=133.7
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
||||.+|+|.+++... +.+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+|+.......
T Consensus 88 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~--~~Kl~DFGla~~~~~~~~ 165 (283)
T d1mqba_ 88 TEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL--VCKVSDFGLSRVLEDDPE 165 (283)
T ss_dssp EECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCCCC---------
T ss_pred EEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCC--eEEEcccchhhcccCCCc
Confidence 7999999999988755 5799999999999999999999999999999999999998877 899999999986433221
Q ss_pred ----CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 80 ----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 80 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
.....||+.|+|||++.+..++. ++|||||||++|||++|..||............+.. ....+....++.
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~-~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~----~~~~~~~~~~~~ 240 (283)
T d1mqba_ 166 ATYTTSGGKIPIRWTAPEAISYRKFTS-ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND----GFRLPTPMDCPS 240 (283)
T ss_dssp --------CCCGGGSCHHHHHSCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT----TCCCCCCTTCBH
T ss_pred cceEeccCCCCccccCHHHHccCCCCC-cccccccHHHHHHHHhCCCCccccCCHHHHHHHHhc----cCCCCCchhhHH
Confidence 12346899999999998887765 489999999999999976665544443333332221 112233336889
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
++.+||.+||..||++|||+.++++
T Consensus 241 ~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 241 AIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 9999999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-40 Score=280.08 Aligned_cols=173 Identities=23% Similarity=0.336 Sum_probs=140.9
Q ss_pred CCCCCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEE
Q 024809 1 MEYAAGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVK 64 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~k 64 (262)
||||+||+|.++|... +.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~--~~k 167 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY--VAK 167 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG--CEE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC--ceE
Confidence 7999999999999754 5699999999999999999999999999999999999998777 899
Q ss_pred EeccCCCcCCCCCCCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCC-CCCCCCCChhHHHHHhcccccc
Q 024809 65 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGA-YPFEDPEDPKNFRKTIGRILSV 143 (262)
Q Consensus 65 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~ 143 (262)
|+|||+|+............||..|+|||.+.+..++. ++|||||||++|+|++|. .||.+.+..+....+.. .
T Consensus 168 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~-~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~----~ 242 (309)
T d1fvra_ 168 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTT-NSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ----G 242 (309)
T ss_dssp ECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG----T
T ss_pred EccccccccccccccccceecCCcccchHHhccCCCCc-cceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh----c
Confidence 99999998665444455667999999999998887754 489999999999999965 56766544333332221 1
Q ss_pred cccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 144 HYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 144 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
...+....+++++++||.+||+.||++|||+.++++|
T Consensus 243 -~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 243 -YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp -CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1222334689999999999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-40 Score=281.75 Aligned_cols=174 Identities=19% Similarity=0.315 Sum_probs=140.6
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
|||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+.......
T Consensus 89 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~--~~kl~DFGla~~~~~~~~ 166 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ--HVKITDFGLAKLLGAEEK 166 (317)
T ss_dssp EECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT--EEEECCCSHHHHTTTTCC
T ss_pred EEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCC--CeEeeccccceecccccc
Confidence 6899999999988764 5799999999999999999999999999999999999998877 899999999986543322
Q ss_pred ---CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCH
Q 024809 80 ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 155 (262)
Q Consensus 80 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (262)
.....||+.|+|||++.+..++ .++||||+||++|+|+| |..||.+....+....+... .....| ..+++
T Consensus 167 ~~~~~~~~gt~~y~APE~l~~~~~~-~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~---~~~~~p--~~~~~ 240 (317)
T d1xkka_ 167 EYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG---ERLPQP--PICTI 240 (317)
T ss_dssp --------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT---CCCCCC--TTBCH
T ss_pred cccccccccCccccChHHHhcCCCC-hhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC---CCCCCC--cccCH
Confidence 2234689999999999887775 45899999999999998 89999876554433222111 112223 36889
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhcCc
Q 024809 156 ECKHLLSRIFVANSEKRITIPEIKNHP 182 (262)
Q Consensus 156 ~~~~li~~~L~~dp~~R~s~~e~l~hp 182 (262)
++.+|+.+||..||.+|||+.+++.|.
T Consensus 241 ~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 241 DVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 999999999999999999999999883
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-40 Score=276.08 Aligned_cols=173 Identities=25% Similarity=0.381 Sum_probs=141.0
Q ss_pred CCCCCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
||||++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.+. .+||+|||+++.......
T Consensus 89 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~--~vkl~DfGl~~~~~~~~~ 166 (273)
T d1u46a_ 89 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD--LVKIGDFGLMRALPQNDD 166 (273)
T ss_dssp EECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT--EEEECCCTTCEECCC-CC
T ss_pred eeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccccc--ceeeccchhhhhcccCCC
Confidence 7999999999987654 4699999999999999999999999999999999999998877 899999999986533322
Q ss_pred ----CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCC
Q 024809 80 ----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS 154 (262)
Q Consensus 80 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (262)
.....|+..|+|||++.+..++ .++|||||||++|||+| |+.||.+.+..+....+.. .....+....++
T Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~----~~~~~~~~~~~~ 241 (273)
T d1u46a_ 167 HYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK----EGERLPRPEDCP 241 (273)
T ss_dssp EEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT----SCCCCCCCTTCC
T ss_pred cceecCccccCcccCCHHHHhCCCCC-cchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHh----CCCCCCCccccc
Confidence 2234578899999999887765 44899999999999998 8999988766554444332 223334445789
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 155 LECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
+++++||.+||..||++|||+.++++
T Consensus 242 ~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 242 QDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999999874
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-39 Score=270.98 Aligned_cols=171 Identities=22% Similarity=0.368 Sum_probs=136.1
Q ss_pred CCCCCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (262)
||||+||+|.++|.+.+ .+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+++... .
T Consensus 80 ~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~--~~kl~dfg~s~~~~--~ 155 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN--VAKVSDFGLTKEAS--S 155 (262)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS--CEEECCCCC--------
T ss_pred EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCC--CEeecccccceecC--C
Confidence 79999999999997653 499999999999999999999999999999999999998877 89999999998543 2
Q ss_pred CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhcccccccccCCCcccCCHHH
Q 024809 79 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 157 (262)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (262)
......+|+.|+|||++.+..++ .++|||||||++|||+| |+.||......+....+... ....+|. .+++++
T Consensus 156 ~~~~~~~~~~y~aPE~l~~~~~t-~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~---~~~~~~~--~~~~~~ 229 (262)
T d1byga_ 156 TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---YKMDAPD--GCPPAV 229 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT---CCCCCCT--TCCHHH
T ss_pred CCccccccccCCChHHHhCCCCC-hHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC---CCCCCCc--cCCHHH
Confidence 34456789999999999877765 55999999999999998 78888876555444433221 2223333 688999
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcC
Q 024809 158 KHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 158 ~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
++||.+||..||.+|||+.+++++
T Consensus 230 ~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 230 YEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcccCHhHCcCHHHHHHH
Confidence 999999999999999999999874
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.6e-39 Score=274.69 Aligned_cols=172 Identities=23% Similarity=0.324 Sum_probs=138.4
Q ss_pred CCCCCCCchHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec
Q 024809 1 MEYAAGGELFERICNAG------------------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD 56 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~------------------------~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~ 56 (262)
||||++|+|.+++.... .+++..+..++.||+.||+|||++|||||||||+|||++
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld 174 (301)
T d1lufa_ 95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG 174 (301)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred EEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEEC
Confidence 69999999999996532 389999999999999999999999999999999999998
Q ss_pred CCCCCcEEEeccCCCcCCCCC---CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCC-CCCCCCCChhH
Q 024809 57 GSTAPRVKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGA-YPFEDPEDPKN 132 (262)
Q Consensus 57 ~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~~~~ 132 (262)
.++ .+||+|||+|+..... .......||+.|+|||.+.+..++. ++|||||||++|||++|. .||.+....+.
T Consensus 175 ~~~--~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~-ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~ 251 (301)
T d1lufa_ 175 ENM--VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTT-ESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251 (301)
T ss_dssp GGG--CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred CCC--cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCCh-hhhhccchhhHHHHHccCCCCCCCCCHHHH
Confidence 776 8999999999744322 2223467899999999998887764 589999999999999985 67877655544
Q ss_pred HHHHhcccccccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 133 FRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
...+.... ....| ..+++++.+||.+||+.+|++|||+.|+++
T Consensus 252 ~~~v~~~~---~~~~p--~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 252 IYYVRDGN---ILACP--ENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHTTC---CCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCC---CCCCC--ccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 43332211 11223 368999999999999999999999999975
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-38 Score=271.59 Aligned_cols=173 Identities=25% Similarity=0.371 Sum_probs=141.4
Q ss_pred CCCCCCCchHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCc
Q 024809 1 MEYAAGGELFERICNAG------------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPR 62 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~------------------~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~ 62 (262)
||||+||+|.+++.... .+++..+..++.||+.||.|||++|++||||||+||+++.++ .
T Consensus 106 mE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~--~ 183 (311)
T d1t46a_ 106 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR--I 183 (311)
T ss_dssp EECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT--E
T ss_pred EEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccC--c
Confidence 79999999999997543 589999999999999999999999999999999999998777 8
Q ss_pred EEEeccCCCcCCCCCCC---CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChhHHHHHhc
Q 024809 63 VKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIG 138 (262)
Q Consensus 63 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~ 138 (262)
+|++|||+++....... .....||+.|+|||++.+..++ .++|||||||++|+|+| |.+||........+.+.+.
T Consensus 184 ~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~ 262 (311)
T d1t46a_ 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 262 (311)
T ss_dssp EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHH
T ss_pred ccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCC-CcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 99999999986543222 2345789999999999877665 45899999999999998 6666766555455444433
Q ss_pred ccccccccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 139 RILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
.- ...+....+++++++||.+||+.||.+|||++++++
T Consensus 263 ~~----~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 263 EG----FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HT----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cC----CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 21 122222368899999999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.6e-39 Score=271.69 Aligned_cols=184 Identities=21% Similarity=0.209 Sum_probs=137.0
Q ss_pred CCCCCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCcEEEeccCCCcCCCCCC
Q 024809 1 MEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-APRVKICDFGYSKSSVLHS 78 (262)
Q Consensus 1 mE~~~gg~L~~~i~-~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~-~~~~kl~Dfg~a~~~~~~~ 78 (262)
||||. |+|.+.+. ..+.+++..+..++.|++.||+|||++||+||||||+|||++..+ ...+||+|||+|+......
T Consensus 82 me~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 82 MELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 68885 46666654 455799999999999999999999999999999999999985432 3379999999998653322
Q ss_pred --------CCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCC--
Q 024809 79 --------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP-- 148 (262)
Q Consensus 79 --------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-- 148 (262)
......||+.|+|||++.+..++ .++|||||||++|+|+||+.||............... .......+
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~-~~~~~~~~~~ 238 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI-SEKKMSTPIE 238 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCC-HHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHH-HHHHHHSCHH
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCC-ChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHh-hcccCCCChh
Confidence 22345799999999999887775 5599999999999999999999876554332222111 11111111
Q ss_pred -CcccCCHHHHHHHHHhcccCCCCCCCHhH---HhcCcccccc
Q 024809 149 -DYVRVSLECKHLLSRIFVANSEKRITIPE---IKNHPWFLRN 187 (262)
Q Consensus 149 -~~~~~~~~~~~li~~~L~~dp~~R~s~~e---~l~hp~~~~~ 187 (262)
....+++++.+||.+||..+|.+||++.+ +|+|+|.+..
T Consensus 239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~ 281 (299)
T d1ckia_ 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281 (299)
T ss_dssp HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence 12368899999999999999999999874 5677776543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-38 Score=268.95 Aligned_cols=172 Identities=21% Similarity=0.284 Sum_probs=140.4
Q ss_pred CCCCCCCchHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCC
Q 024809 1 MEYAAGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGY 70 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~----------~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~ 70 (262)
||||+||+|.+++... ..+++..+..++.|+++||.|||+++|+||||||+|||++.+. ++||+|||+
T Consensus 102 ~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~--~~Kl~DFGl 179 (308)
T d1p4oa_ 102 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF--TVKIGDFGM 179 (308)
T ss_dssp EECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC--CEEECCTTC
T ss_pred EeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc--eEEEeeccc
Confidence 7999999999998643 2478999999999999999999999999999999999998777 899999999
Q ss_pred CcCCCCCCC---CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhC-CCCCCCCCChhHHHHHhccccccccc
Q 024809 71 SKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEDPKNFRKTIGRILSVHYS 146 (262)
Q Consensus 71 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~ 146 (262)
|+....... .....||+.|+|||.+.+..++. ++||||+||++|+|+|| +.||.+....+.+..+... ....
T Consensus 180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~-~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~---~~~~ 255 (308)
T d1p4oa_ 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTT-YSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG---GLLD 255 (308)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT---CCCC
T ss_pred ceeccCCcceeeccceecccccCCHHHHccCCCCc-ccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC---CCCC
Confidence 985433222 23346899999999998877764 48999999999999998 5778776655544443322 1122
Q ss_pred CCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 147 FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 147 ~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
.| ..+++.+.++|.+||+.+|++|||+.++++
T Consensus 256 ~p--~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 256 KP--DNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp CC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Cc--ccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 22 368899999999999999999999999987
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-38 Score=268.91 Aligned_cols=174 Identities=21% Similarity=0.289 Sum_probs=137.5
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCCCCCCC
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 79 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (262)
||||+||+|.+++.... .+++..+..++.|++.||.|||+.+|+||||||+|||++.+. .+||+|||+++.......
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~--~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF--TVKVADFGLARDMYDKEF 185 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC--CEEECSSGGGCCTTTTTC
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCC--CEEEecccchhhcccccc
Confidence 79999999999988554 588999999999999999999999999999999999998776 899999999986543221
Q ss_pred -----CCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCCCcccCC
Q 024809 80 -----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS 154 (262)
Q Consensus 80 -----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (262)
.....||+.|+|||.+....++ .++||||||+++|||+||..||............+.. ......|. .++
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~--g~~~~~p~--~~~ 260 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--GRRLLQPE--YCP 260 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHT--TCCCCCCT--TCC
T ss_pred ccceecccccccccccChHHHhcCCCC-ChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHc--CCCCCCcc--cCc
Confidence 2235689999999999877765 4589999999999999988887654433222221111 11222333 578
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 155 LECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 155 ~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
+++.+||.+||+.||++|||+.|+++|
T Consensus 261 ~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 261 DPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999999987
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.2e-37 Score=259.44 Aligned_cols=177 Identities=20% Similarity=0.227 Sum_probs=136.8
Q ss_pred CCCCCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC---CCCcEEEeccCCCcCCCC
Q 024809 1 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS---TAPRVKICDFGYSKSSVL 76 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~---~~~~~kl~Dfg~a~~~~~ 76 (262)
|||| ||+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.. ..+.+||+|||+|+....
T Consensus 80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 7898 689999987654 69999999999999999999999999999999999999642 234799999999975432
Q ss_pred C--------CCCCccccCCCCCCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCChhHHHHHhcccccccccCC
Q 024809 77 H--------SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP 148 (262)
Q Consensus 77 ~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 148 (262)
. ......+||+.|||||++.+..++ .++|||||||++|+|+||+.||.+........... .+.......+
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~-~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~-~i~~~~~~~~ 236 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE-RIGEKKQSTP 236 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH-HHHHHHHHSC
T ss_pred CccccceeecccCceEEchhhcCHHHhcCCCCC-hHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHH-HHHhccCCCC
Confidence 1 123346799999999999887775 45899999999999999999998755433222111 1111000001
Q ss_pred ---CcccCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 024809 149 ---DYVRVSLECKHLLSRIFVANSEKRITIPEIKN 180 (262)
Q Consensus 149 ---~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 180 (262)
....+++++.+++..|+..+|++||+++.+.+
T Consensus 237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 11357899999999999999999999877654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-37 Score=264.58 Aligned_cols=178 Identities=23% Similarity=0.300 Sum_probs=131.6
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH--------cCCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS--------MQICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~--------~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
||||++|+|.++|.+. ++++.....++.|++.||.|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus 80 ~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~--~~Kl~DFGl~~ 156 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGLAV 156 (303)
T ss_dssp EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS--CEEECCCTTCE
T ss_pred EecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC--CeEEEecCccc
Confidence 7999999999999876 69999999999999999999996 5999999999999998777 89999999997
Q ss_pred CCCCCC-----CCCccccCCCCCCcccccCCcC-----CCCchhHHHHHHHHHHHHhCCCCCCCCCChh-----------
Q 024809 73 SSVLHS-----QPKSTVGTPAYIAPEVLTKKEY-----DGKIADVWSCGVTLYVMLVGAYPFEDPEDPK----------- 131 (262)
Q Consensus 73 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----------- 131 (262)
...... ......||+.|+|||++..... .+.++|||||||+||+|+||..||.......
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 543322 2234679999999999865431 1334899999999999999998875322110
Q ss_pred HHHHHhccccc--ccccCCCc---ccCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 024809 132 NFRKTIGRILS--VHYSFPDY---VRVSLECKHLLSRIFVANSEKRITIPEIKNH 181 (262)
Q Consensus 132 ~~~~~~~~~~~--~~~~~~~~---~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 181 (262)
........... ....+|.. ......+.+|+.+||+.||.+|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 00111111111 11112221 1233458899999999999999999999863
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.6e-36 Score=261.84 Aligned_cols=171 Identities=24% Similarity=0.376 Sum_probs=127.7
Q ss_pred hCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCC----CcEEEeccCCCcCCCCCCCCCccccCCCC
Q 024809 15 NAGRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSTA----PRVKICDFGYSKSSVLHSQPKSTVGTPAY 89 (262)
Q Consensus 15 ~~~~l~e~~~~~~~~ql~~aL~~LH~-~~ivHrDlkp~Nili~~~~~----~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y 89 (262)
....+++..++.++.||+.||.|||+ .||+||||||+|||++..+. ..++++|||.|.... ......+||+.|
T Consensus 118 ~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~--~~~~~~~gt~~y 195 (362)
T d1q8ya_ 118 EHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSIQTREY 195 (362)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETT--BCCCSCCSCGGG
T ss_pred cccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeecccccccc--cccccccccccc
Confidence 44579999999999999999999998 89999999999999975542 148999999987543 334567899999
Q ss_pred CCcccccCCcCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh------hHHHHHhccccc--------------------c
Q 024809 90 IAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP------KNFRKTIGRILS--------------------V 143 (262)
Q Consensus 90 ~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~~~~~~~~--------------------~ 143 (262)
+|||++....++. ++||||+||++++|++|+.||...... ......+..+.. .
T Consensus 196 ~aPE~~~~~~~~~-~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~ 274 (362)
T d1q8ya_ 196 RSPEVLLGAPWGC-GADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGL 274 (362)
T ss_dssp CCHHHHHTCCCCT-HHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--C
T ss_pred cChhhccccCCCc-cccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchh
Confidence 9999999888865 489999999999999999999754321 111111100000 0
Q ss_pred --c--------------ccCCCcccCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 024809 144 --H--------------YSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL 188 (262)
Q Consensus 144 --~--------------~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 188 (262)
. .........++++++||.+||++||.+||||+|+|+||||+...
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 275 LRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp BSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred hhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCC
Confidence 0 00011123567899999999999999999999999999998543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.61 E-value=5.1e-17 Score=127.79 Aligned_cols=64 Identities=25% Similarity=0.301 Sum_probs=54.5
Q ss_pred CCCCCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCcEEEeccCCCcCC
Q 024809 1 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSS 74 (262)
Q Consensus 1 mE~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aL~~LH~~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~~~ 74 (262)
|||++|+.+. .+++..+..++.|++.+|.|||++||+||||||+|||++.+ .++|+|||+|+..
T Consensus 89 me~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~---~~~liDFG~a~~~ 152 (191)
T d1zara2 89 MELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE---GIWIIDFPQSVEV 152 (191)
T ss_dssp EECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT---EEEECCCTTCEET
T ss_pred EEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC---CEEEEECCCcccC
Confidence 6888876543 35667788999999999999999999999999999999854 4899999998744
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=96.10 E-value=0.0013 Score=51.76 Aligned_cols=28 Identities=25% Similarity=0.316 Sum_probs=23.0
Q ss_pred CeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 43 ICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 43 ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
++|+|+.|.||+++.++ .+-|+||+.+.
T Consensus 185 l~HgD~~~~Nil~~~~~--~~~lIDwe~a~ 212 (263)
T d1j7la_ 185 FSHGDLGDSNIFVKDGK--VSGFIDLGRSG 212 (263)
T ss_dssp EECSCCCTTSEEEETTE--EEEECCCTTCE
T ss_pred EEEeeccCcceeecCCc--eEEEeechhcc
Confidence 78999999999998654 44699998664
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=94.66 E-value=0.014 Score=48.90 Aligned_cols=28 Identities=18% Similarity=0.277 Sum_probs=24.1
Q ss_pred CCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 42 QICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 42 ~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
.++|+|+.|.|||++.+ .++|+||..+.
T Consensus 224 ~LiHGDl~~gNIlv~~~---~~~vID~E~a~ 251 (392)
T d2pula1 224 TLIHGDLHTGSIFASEH---ETKVIDPEFAF 251 (392)
T ss_dssp EEECSCCCGGGEEECSS---CEEECCCTTCE
T ss_pred ceeccCCcCCceeEcCC---ceEEechhhcc
Confidence 58999999999999765 48999998765
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.42 E-value=0.005 Score=49.79 Aligned_cols=30 Identities=23% Similarity=0.351 Sum_probs=25.2
Q ss_pred cCCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 41 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 41 ~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
.|+||+|+.+.||+++.+. ..-+.||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~--v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDE--LSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTE--EEEECCCTTCE
T ss_pred cccccCCcchhhhhccccc--ceeEecccccc
Confidence 5799999999999998664 45799998764
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=93.93 E-value=0.021 Score=46.43 Aligned_cols=28 Identities=18% Similarity=0.183 Sum_probs=22.5
Q ss_pred cCCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 41 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 41 ~~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
.+++|+|+.+.|||++.+ ..++||+-+.
T Consensus 192 ~~liHgDlh~~NvL~~~~----~~~IDFdd~~ 219 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG----PMFVDLDDAR 219 (325)
T ss_dssp CEECCSSCSGGGEEESSS----EEECCCTTCC
T ss_pred ceeecCCCCcccEEEeCC----ceEEechhcc
Confidence 368999999999999643 3578998765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=92.48 E-value=0.02 Score=44.30 Aligned_cols=29 Identities=21% Similarity=0.249 Sum_probs=23.7
Q ss_pred CCeecCCCCCcEEecCCCCCcEEEeccCCCc
Q 024809 42 QICHRDLKLENTLLDGSTAPRVKICDFGYSK 72 (262)
Q Consensus 42 ~ivHrDlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (262)
.++|+|+.|.||+++.+. .+-|+||+.+.
T Consensus 176 ~liHgD~~~~Nvl~~~~~--~~~iID~~~~~ 204 (255)
T d1nd4a_ 176 VVTHGDACLPNIMVENGR--FSGFIDCGRLG 204 (255)
T ss_dssp EEECSSCCGGGEEEETTE--EEEECCCTTCE
T ss_pred eEEeCCCCCcceEEeCCc--eEEEEEchhcc
Confidence 379999999999998654 45799998664
|